data_3nla_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3nla _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.271 0.558 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.27 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.3 p -123.88 148.82 46.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.156 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 ' HG2' ' A' ' 22' ' ' MET . 76.2 t -62.48 116.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 110.207 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' SER . 4.6 t -121.03 105.91 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -42.62 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -75.69 -70.85 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.429 ' O ' HG12 ' A' ' 11' ' ' ILE . 13.0 tp60 -65.04 143.35 57.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.8 114.08 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 17' ' ' LEU . 1.5 pt -128.78 128.32 23.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.78 -158.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.87 1.458 . . . . 0.0 109.788 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 44.5 pt -98.98 -170.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.069 -1.019 . . . . 0.0 110.194 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 2.6 p30 49.41 20.31 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.489 -0.757 . . . . 0.0 110.735 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -118.71 102.13 8.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.007 -1.058 . . . . 0.0 109.928 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.74 124.12 15.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.353 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.516 ' CD2' HD11 ' A' ' 11' ' ' ILE . 21.9 mt -94.13 163.4 13.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' CG1' ' A' ' 20' ' ' ILE . 67.4 p -130.51 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 110.027 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD22 ' CG2' ' A' ' 41' ' ' VAL . 56.0 mt -72.0 -42.62 66.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.03 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CG1' ' OG1' ' A' ' 18' ' ' THR . 2.6 pt -58.62 -26.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.106 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.0 mtt -94.46 15.98 16.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.469 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -123.59 111.6 16.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -119.38 114.45 22.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.61 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.182 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.24 152.53 28.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -95.33 82.8 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.224 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.404 HG21 ' N ' ' A' ' 28' ' ' THR . 10.4 p -137.09 157.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.196 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.0 t -95.82 148.91 35.31 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.074 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -75.87 -165.18 4.13 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.729 -2.196 . . . . 0.0 110.541 -0.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.86 -19.53 51.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 45.95 -143.17 4.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 55' ' ' LEU . 3.0 mt -97.49 125.29 45.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -1.162 . . . . 0.0 110.066 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.03 -161.5 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.846 1.445 . . . . 0.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -103.92 17.79 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -56.79 -36.64 70.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 109.971 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 10.1 pt-20 -104.58 35.98 2.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 110.286 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.0 mm -55.57 -54.96 45.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.243 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -70.5 -4.15 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.636 1.335 . . . . 0.0 110.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.0 m-20 -109.36 -25.25 10.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD13 ' HE1' ' A' ' 43' ' ' MET . 5.3 tp -84.85 -29.32 25.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.29 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' CG2' HD22 ' A' ' 19' ' ' LEU . 36.7 t -42.88 104.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 103.85 29.45 5.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.464 ' HE1' HD13 ' A' ' 40' ' ' LEU . 45.2 tpp -97.8 140.76 31.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 110.273 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.98 121.73 44.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.045 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.4 m -80.7 166.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 110.304 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' HB2' ' CD ' ' A' ' 61' ' ' LYS . 11.7 t-20 -111.58 -4.75 14.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -125.17 132.78 52.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.848 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' N ' ' HD3' ' A' ' 47' ' ' ARG . . . -46.8 135.8 8.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.366 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' A' ' 7' ' ' ALA . 76.6 t -116.86 113.95 39.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.72 -169.54 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.901 1.474 . . . . 0.0 110.382 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -71.84 148.78 45.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.75 53.49 6.2 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.481 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 99.8 m -96.51 120.95 37.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.278 -1.131 . . . . 0.0 110.253 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 128.05 35.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -62.5 115.8 4.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 110.184 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.0 mtt -110.2 157.98 36.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -3.3 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.61 -10.24 41.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' CG ' ' A' ' 47' ' ' ARG . 7.0 mtm -112.22 35.59 3.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.09 111.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.304 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' CD ' ' HB2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -69.51 -71.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.147 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 7.2 p30 -96.79 86.69 4.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.115 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.441 ' OH ' HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -55.86 120.52 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.29 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.3 mm-40 -75.51 -81.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.189 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.0 m-20 -89.04 69.28 8.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.56 82.69 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 67' ' ' THR . 36.6 m -85.06 9.7 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -1.17 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.3 t -69.93 -21.99 63.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.922 . . . . 0.0 110.154 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.571 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -175.83 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.571 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -72.65 59.86 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.444 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.74 35.31 5.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.13 -41.26 10.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -1.142 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.235 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tttm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.221 0.534 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.63 131.77 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.63 145.32 40.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.129 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 59.3 t -73.68 133.53 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 27' ' ' VAL . 4.2 t -129.79 121.18 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.04 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.24 130.41 19.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.508 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 13.3 t30 -86.68 -68.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -82.73 139.18 33.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -68.49 132.62 47.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 111.08 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -130.82 154.78 81.98 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 109.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.19 -96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.935 1.492 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.518 ' CG1' ' C ' ' A' ' 12' ' ' PRO . 5.2 mt -153.28 -174.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.852 -1.155 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER 41.39 32.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.417 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 7.2 m -112.42 129.89 56.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -67.45 158.7 31.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -125.84 135.45 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.294 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' MET . 0.0 OUTLIER -123.24 173.38 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.34 -56.71 17.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -19.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 18' ' ' THR . 24.4 mmm -88.31 -46.61 9.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.45 ' HE1' HG12 ' A' ' 5' ' ' VAL . 2.8 ptm -116.44 135.64 53.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -117.29 166.58 12.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.171 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.37 103.37 15.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -112.94 156.82 22.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.169 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.95 91.03 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.153 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.408 HG13 HG23 ' A' ' 6' ' ' VAL . 11.7 p -156.56 148.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.444 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -99.18 167.09 11.81 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.11 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.6 Cg_endo -73.86 163.58 89.6 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.401 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.39 93.3 3.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.415 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.97 -111.62 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 14.7 mm -91.44 113.6 59.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.337 -1.096 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.71 -174.84 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.944 1.497 . . . . 0.0 110.478 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -87.13 17.88 3.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -76.62 -53.96 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.52 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 19.3 pt-20 -92.39 33.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.743 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -62.34 -52.71 64.25 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 110.049 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -72.3 -1.96 10.96 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.651 1.342 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 8.8 m-80 -112.45 -32.06 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.1 tp -86.72 -39.86 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 0.0 110.131 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 t -50.39 127.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.221 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.71 28.89 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.2 mtm -100.01 159.4 15.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mp0 -109.95 165.95 11.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.0 m -101.63 165.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' MET . 26.3 t-20 -111.13 16.32 21.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.278 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 5.3 mmt180 -143.92 176.63 9.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -80.41 134.71 36.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -124.24 108.59 29.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 110.049 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -72.72 -163.14 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.976 1.514 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -78.45 156.83 29.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.32 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.02 32.87 1.59 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' OG1' ' CD ' ' A' ' 50' ' ' PRO . 18.3 m -75.0 112.46 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 110.315 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.436 ' HB ' ' HE1' ' A' ' 56' ' ' MET . 20.2 m -48.13 131.23 16.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.853 . . . . 0.0 109.978 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.84 100.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.436 ' HE1' ' HB ' ' A' ' 54' ' ' THR . 1.8 mtt -101.46 139.14 20.16 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.0 2.65 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.995 1.524 . . . . 0.0 110.592 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.36 -28.71 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' ASN . 9.2 mtm -95.3 -2.87 48.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.08 127.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -64.99 -92.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.396 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 17.9 p-10 -95.78 90.65 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.17 -0.956 . . . . 0.0 110.197 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.7 t80 -44.92 157.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 10.2 mm-40 -80.79 -80.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.36 33.12 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.09 90.47 0.55 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -96.94 17.53 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.191 . . . . 0.0 110.143 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' CB ' ' A' ' 69' ' ' SER . 9.2 t -77.15 0.73 20.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 110.302 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.528 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 172.99 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.207 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -72.65 172.07 15.95 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.989 1.521 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -34.42 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -77.06 98.42 5.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -1.124 . . . . 0.0 110.228 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.503 ' CD ' ' HB3' ' A' ' 33' ' ' PRO . 9.4 ptpp? . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.267 0.556 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -83.3 174.49 10.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 30' ' ' MET . 0.9 OUTLIER -120.6 165.3 15.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.134 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 97.1 t -92.63 95.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.46 HG13 ' HA2' ' A' ' 52' ' ' GLY . 3.8 t -119.12 127.12 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 21' ' ' MET . . . -80.66 144.49 32.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 t-20 -77.06 -66.42 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 109.686 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.16 148.78 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -59.33 148.33 32.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -0.954 . . . . 0.0 110.061 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.22 138.01 30.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.89 -159.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.067 1.561 . . . . 0.0 110.258 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.519 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.6 mp -123.16 173.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 3.6 m120 59.25 19.92 8.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -118.08 151.41 37.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 165.97 21.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 45' ' ' VAL . 38.8 mt -121.56 117.86 27.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.98 165.05 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -54.2 -33.69 58.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.274 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.1 mm -55.51 -41.12 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.389 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -96.92 8.91 43.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.97 124.4 42.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.98 144.18 48.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.999 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.6 94.63 5.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.03 154.53 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 3' ' ' ALA . 9.2 t -92.15 39.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.158 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.12 159.1 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 11.1 p -81.89 163.13 54.92 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.19 178.78 32.18 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.625 -0.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' SER . 1.9 mtt -77.84 -68.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.7 -128.75 18.12 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 55' ' ' LEU . 3.0 mt -103.67 137.1 19.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.159 -1.201 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HB3' ' CD ' ' A' ' 2' ' ' LYS . 44.8 Cg_endo -72.07 177.72 6.81 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.973 1.512 . . . . 0.0 110.43 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.12 23.96 6.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.303 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -18.78 57.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 109.47 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -105.17 10.81 33.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.3 mm -41.99 -54.44 7.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.697 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -70.04 -3.84 13.01 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.529 1.278 . . . . 0.0 110.737 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 90.4 m-20 -114.15 -36.95 4.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -78.78 -42.14 28.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 42.2 t -42.63 121.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.255 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.71 1.04 27.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttm -99.84 149.77 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -1.178 . . . . 0.0 110.12 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -100.8 159.83 14.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 5.7 m -102.45 163.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.43 -9.62 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -136.27 155.69 49.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.938 . . . . 0.0 110.183 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -86.17 144.12 27.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 38.2 t -130.2 140.35 38.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.0 Cg_endo -73.4 -175.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.083 1.57 . . . . 0.0 110.391 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -44.25 169.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.905 . . . . 0.0 110.286 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 44.11 52.19 7.07 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.513 ' OG1' ' CG1' ' A' ' 49' ' ' VAL . 2.2 m -75.36 94.58 3.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -1.109 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 ' O ' HG21 ' A' ' 54' ' ' THR . 6.6 t -68.11 148.75 50.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.086 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -70.24 105.64 3.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.342 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.523 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.54 155.45 44.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.163 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 56' ' ' MET . 45.9 Cg_endo -73.24 -5.98 18.1 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.012 1.532 . . . . 0.0 110.489 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.3 -45.81 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.527 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -94.52 49.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 56' ' ' MET . 98.9 t -130.11 83.94 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -67.35 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -99.59 88.63 3.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.246 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 3.2 t80 -44.33 141.06 1.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 3.4 pt-20 -64.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.352 -0.843 . . . . 0.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 13.9 p-10 -61.91 84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 70' ' ' PRO . . . -86.04 71.76 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -79.63 5.14 13.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -1.177 . . . . 0.0 110.199 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -100.46 -104.22 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -96.22 -66.05 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.884 -1.135 . . . . 0.0 110.493 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.6 Cg_endo -72.64 126.25 11.29 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.508 1.268 . . . . 0.0 110.425 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.85 94.34 0.14 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.409 HD21 ' N ' ' A' ' 72' ' ' LEU . 3.1 mm? -71.4 -48.1 51.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -1.159 . . . . 0.0 110.257 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.22 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.235 0.541 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.54 121.48 7.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.157 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -90.91 150.37 21.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 22' ' ' MET . 54.2 t -77.8 114.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.89 95.0 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -48.58 128.94 15.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.58 -80.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 110.022 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -58.98 160.07 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.822 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -90.25 140.57 29.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.42 140.03 37.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.44 -0.788 . . . . 0.0 110.03 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.4 163.37 37.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.961 1.506 . . . . 0.0 110.211 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.9 pt -71.7 -177.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 60.29 16.39 6.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.285 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 140.2 50.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.19 152.71 44.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mt -105.38 138.36 41.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 77.8 p -115.12 153.91 29.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 21' ' ' MET . 13.0 pt -64.81 -20.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.454 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 7.6 mtm -97.69 -7.55 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HD11 ' A' ' 37' ' ' ILE . 1.4 mmm -96.26 105.49 17.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CD ' ' OD1' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -96.24 141.29 29.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.875 . . . . 0.0 110.311 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.62 89.99 7.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.62 120.12 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.097 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' HG11 ' A' ' 27' ' ' VAL . 94.2 t -68.87 79.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 26' ' ' VAL . 27.0 m -151.28 170.22 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.912 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -93.31 165.83 17.49 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.274 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 47.5 Cg_endo -74.97 167.24 81.01 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.357 -0.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.34 68.89 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.268 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.57 -130.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.443 HG23 ' CD ' ' A' ' 36' ' ' GLU . 2.0 mt -97.33 126.45 41.75 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.165 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.56 50.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.924 1.486 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.497 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . 45.93 26.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -69.91 -45.73 66.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 1.4 pt-20 -95.25 28.39 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.109 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.3 mm -47.09 -55.02 16.89 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -71.0 -2.74 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.569 1.299 . . . . 0.0 110.542 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 83.9 m-20 -109.48 -31.45 7.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.33 -31.85 15.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.505 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 25.4 t -43.69 110.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.32 4.45 27.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -100.23 152.83 19.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -1.219 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.81 154.85 18.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.893 . . . . 0.0 110.232 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 5.9 m -102.28 167.02 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' MET . 9.3 t30 -111.1 -11.4 14.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 3.7 mtt-85 -116.18 133.13 56.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 13' ' ' ILE . . . -51.48 124.98 13.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 61.9 t -99.07 109.89 55.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.15 -165.02 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.957 1.504 . . . . 0.0 110.424 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -75.56 150.91 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.5 44.03 11.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 88.2 m -89.35 122.19 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -67.01 138.92 57.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 109.993 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.45 106.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 110.241 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.15 152.58 40.46 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.41 -0.806 . . . . 0.0 110.344 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.49 -0.68 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.563 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.71 -13.9 38.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.521 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 7.8 mtt -104.24 -2.57 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 28.4 t -100.96 106.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -80.81 78.0 7.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.47 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 11.2 t80 -46.13 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.41 -86.14 0.38 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.16 80.1 2.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.58 98.35 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 10.26 38.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.348 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.421 ' CG2' ' N ' ' A' ' 69' ' ' SER . 18.0 m -73.36 -91.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -77.78 -56.13 1.15 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.175 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 69' ' ' SER . 49.5 Cg_endo -76.29 52.64 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.034 1.544 . . . . 0.0 110.297 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.92 72.61 0.54 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.82 17.58 22.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -1.174 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' NZ ' ' CB ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.201 0.524 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.06 137.35 51.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.245 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -97.87 157.06 16.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -87.83 104.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG1' ' C ' ' A' ' 52' ' ' GLY . 20.3 t -93.32 114.87 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -42.26 126.73 3.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.152 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 50.8 t30 -82.46 -73.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -65.54 140.29 58.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.474 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 4.2 tt -72.15 126.21 29.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 4.0 pt -130.67 151.05 78.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.527 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 47.6 Cg_endo -73.69 -95.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.399 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 6.2 mm -142.0 163.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 16.2 m-80 42.26 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.261 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 88.3 m -154.32 123.18 6.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 110.237 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.73 144.64 21.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mt -107.63 143.36 36.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.448 ' HB ' HG12 ' A' ' 20' ' ' ILE . 1.1 p -116.56 167.13 11.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.35 -21.85 62.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.516 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 8.2 pt -73.8 -18.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.45 ' SD ' ' HB3' ' A' ' 9' ' ' GLN . 2.4 mtt -97.74 21.15 10.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 110.036 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.93 122.27 43.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.1 mmmt -119.11 127.3 53.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.7 74.85 6.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HB3' HG23 ' A' ' 27' ' ' VAL . 7.7 mm-40 -107.95 118.46 36.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -88.38 72.56 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 25' ' ' GLU . 7.6 m -135.69 -173.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 12.2 t -103.86 149.41 37.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.9 Cg_endo -76.83 167.48 79.87 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.319 -0.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -82.6 81.3 8.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.3 -157.97 0.03 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.442 HG21 ' HD2' ' A' ' 33' ' ' PRO . 1.9 mt -75.51 140.04 71.67 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.366 -1.079 . . . . 0.0 110.298 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.12 -168.48 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.1 1.579 . . . . 0.0 110.648 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -106.8 -5.54 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -24.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mm-40 -104.89 47.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 mm -60.74 -53.91 59.72 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 110.339 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.4 Cg_endo -73.05 -5.23 16.83 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.829 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -114.25 -30.82 6.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 0.0 110.372 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 HD23 ' CD1' ' A' ' 55' ' ' LEU . 7.3 tp -82.06 -50.1 9.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 37' ' ' ILE . 96.9 t -44.46 114.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.16 11.45 18.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.442 ' HE1' ' O ' ' A' ' 62' ' ' ASN . 4.2 ttm -97.9 143.84 28.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.6 mt-30 -104.31 112.8 25.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.226 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' ASN . 17.6 m -76.84 152.39 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.467 ' HA ' HG21 ' A' ' 13' ' ' ILE . 24.4 t-20 -109.95 42.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.495 ' NE ' HG11 ' A' ' 49' ' ' VAL . 4.1 ptm180 -141.23 156.29 45.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.95 . . . . 0.0 110.246 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -86.35 116.73 24.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.601 ' CG2' ' CG1' ' A' ' 11' ' ' ILE . 2.7 m -115.22 112.02 44.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.77 54.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.1 1.579 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 67.82 151.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 110.861 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' ' CG1' ' A' ' 6' ' ' VAL . . . 45.41 38.04 6.69 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.545 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 5.8 m -96.87 141.51 29.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.249 . . . . 0.0 110.225 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' SD ' ' A' ' 56' ' ' MET . 10.1 t -70.42 131.77 44.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.533 ' CD1' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.35 122.93 17.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.302 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.482 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.15 135.31 19.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 60' ' ' VAL . 49.2 Cg_endo -76.47 -24.24 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.101 1.579 . . . . 0.0 111.365 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' MET . 10.5 p-10 -63.64 -37.21 86.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.529 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.7 mmt -99.52 57.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.007 . . . . 0.0 110.003 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 57' ' ' PRO . 77.6 t -124.45 128.71 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 58.5 m-80 -96.09 100.48 12.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.7 t80 -45.43 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -98.43 -155.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 65' ' ' ASP . 27.1 t0 -59.9 79.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -136.25 81.4 0.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 24.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.7 m -86.3 -97.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.541 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -80.74 -59.02 0.51 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.024 -1.047 . . . . 0.0 110.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.7 Cg_endo -73.72 -164.2 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.825 1.434 . . . . 0.0 110.58 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.58 -2.64 5.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -75.06 67.13 1.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 63' ' ' TYR . 2.5 mttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 tptp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.204 0.526 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -64.19 120.65 12.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.298 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.5 t -97.44 148.21 23.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.08 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.519 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 53.7 t -71.32 109.68 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 110.289 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 54' ' ' THR . 10.7 t -124.16 120.27 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.093 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -72.92 130.23 39.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 10.2 m-80 -75.25 -23.52 57.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -96.4 155.33 16.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -80.69 127.6 32.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 pt -129.06 106.87 17.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -72.98 157.35 51.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.53 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -44.71 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.1 m120 57.39 59.06 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 12' ' ' PRO . 1.6 m -160.41 119.24 2.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.11 165.05 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 43' ' ' MET . 15.8 mt -122.5 111.8 17.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 17.6 p -89.13 139.78 30.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.097 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.457 ' HA ' ' CG ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -50.69 -30.82 14.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.252 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB ' ' A' ' 18' ' ' THR . 9.6 pt -71.15 -13.47 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.456 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 7.6 ttm -97.67 -10.41 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.457 ' CG ' ' HA ' ' A' ' 19' ' ' LEU . 5.5 ptp -117.3 123.23 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -121.11 147.51 45.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.29 96.39 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -109.83 142.96 40.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.177 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 3' ' ' ALA . 4.0 t -94.74 81.06 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 110.126 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 28' ' ' THR . 8.6 p -126.63 166.52 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.256 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.482 ' N ' HG23 ' A' ' 27' ' ' VAL . 13.8 t -114.47 149.24 41.86 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.33 164.37 88.39 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.771 -2.179 . . . . 0.0 110.523 -0.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.2 mtt -81.74 -150.64 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.402 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.8 -99.31 0.15 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 1.7 mt -118.63 132.33 23.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.124 -1.221 . . . . 0.0 109.636 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.66 -175.21 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.847 1.446 . . . . 0.0 110.359 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -86.97 21.88 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 110.299 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -43.83 74.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -95.22 35.01 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.6 mm -62.85 -53.25 57.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.925 . . . . 0.0 110.435 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.31 -3.07 12.23 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.581 1.306 . . . . 0.0 110.496 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -103.13 -32.49 9.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' OE2' ' A' ' 36' ' ' GLU . 4.0 tp -88.66 -31.69 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 46.0 t -45.51 139.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 110.316 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.08 -32.46 5.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.508 ' HE2' ' N ' ' A' ' 62' ' ' ASN . 3.2 ttp -74.91 144.78 43.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -178.43 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 3.3 m -119.08 164.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.074 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 13' ' ' ILE . 1.8 t-20 -110.94 -8.58 14.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 110.768 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HB2' ' CA ' ' A' ' 59' ' ' MET . 0.3 OUTLIER -130.05 114.86 16.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -0.992 . . . . 0.0 110.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -54.56 138.16 41.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 0.0 110.402 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.519 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 4.9 t -130.4 136.61 29.25 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.84 . . . . 0.0 110.15 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' O ' ' CG2' ' A' ' 53' ' ' THR . 44.9 Cg_endo -72.13 179.84 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.343 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -41.87 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.209 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.421 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 54.15 51.76 48.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 7' ' ' ALA . 59.8 p -70.63 96.73 1.24 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -1.119 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.45 ' N ' HG11 ' A' ' 6' ' ' VAL . 15.5 m -55.35 125.87 22.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.074 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD2' ' HB ' ' A' ' 5' ' ' VAL . 4.7 tp -61.93 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.526 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.12 167.46 9.22 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.455 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 48.8 Cg_endo -74.6 2.1 6.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.06 1.558 . . . . 0.0 110.592 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -75.05 -69.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.525 ' CA ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -84.12 62.02 6.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.959 . . . . 0.0 110.578 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 56' ' ' MET . 9.8 t -130.08 124.48 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.36 -94.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.395 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' N ' ' HE2' ' A' ' 43' ' ' MET . 80.3 m-20 -100.51 100.42 11.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.246 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 95.3 m-85 -46.96 116.59 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -65.38 -79.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.34 88.31 7.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.86 77.13 0.32 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.2 m -82.11 -11.57 58.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -1.15 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -88.95 -143.71 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -53.31 -57.22 17.71 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.6 128.32 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.939 1.494 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.11 38.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 72' ' ' LEU . 3.5 mm? -78.11 97.34 5.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -1.131 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.147 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.557 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.448 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -62.49 131.86 50.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.24 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -94.13 136.51 34.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.117 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 96.6 t -70.19 118.06 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.53 107.96 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.947 . . . . 0.0 110.235 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -51.35 120.1 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.907 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -79.59 -42.3 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 40.8 tp60 -91.12 141.26 29.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.42 113.64 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 12.6 mm -106.21 131.83 21.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.24 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.87 -163.26 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.825 1.434 . . . . 0.0 110.192 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 1.6 mt -106.94 -174.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 109.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 52.26 19.41 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -117.5 155.39 29.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.1 156.69 25.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.3 116.22 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' HG21 ' A' ' 20' ' ' ILE . 25.3 p -101.14 126.73 47.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.9 OUTLIER -46.68 -40.74 13.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 21' ' ' MET . 3.6 tt -43.42 -42.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.443 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -93.35 11.77 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 110.354 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.453 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 28.8 mtm -123.99 112.28 17.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.0 153.88 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' CB ' ' HB2' ' A' ' 3' ' ' ALA . . . -88.31 99.38 12.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -112.95 127.15 56.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 3' ' ' ALA . 70.1 t -68.84 81.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.429 HG21 ' C ' ' A' ' 26' ' ' VAL . 83.8 t -131.8 162.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.9 t -100.28 150.18 36.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.8 Cg_endo -75.95 -169.43 7.54 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.393 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' SER . 8.8 ptp -74.18 -29.51 61.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 44.68 -145.52 2.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 42.3 mm -83.32 115.32 58.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.14 . . . . 0.0 110.073 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 46.3 Cg_endo -72.15 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.894 1.471 . . . . 0.0 110.507 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -94.0 23.97 4.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.9 mm-40 -76.95 -49.67 15.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.841 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE2' ' CG ' ' A' ' 65' ' ' ASP . 3.1 mm-40 -100.39 37.8 1.62 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.823 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.2 mm -63.96 -54.03 43.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.7 Cg_endo -72.01 -2.14 11.08 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.694 1.365 . . . . 0.0 110.294 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' OD1' ' OE2' ' A' ' 64' ' ' GLU . 17.1 m-80 -106.95 -41.72 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' MET . 2.9 tp -74.5 -24.88 59.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 34.6 t -45.7 99.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.78 11.9 21.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' LEU . 53.5 tpp -81.43 155.12 26.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -1.188 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.7 157.83 16.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 110.252 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.492 ' CG1' ' HA ' ' A' ' 13' ' ' ILE . 2.7 p -118.76 159.97 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.428 ' C ' HG22 ' A' ' 13' ' ' ILE . 35.4 t-20 -110.67 -13.76 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.5 OUTLIER -118.02 174.74 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 0.0 110.145 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -85.53 149.04 25.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.589 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG11 ' HB ' ' A' ' 53' ' ' THR . 54.2 t -128.24 107.5 19.57 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.833 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.4 Cg_endo -71.93 -160.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.966 1.509 . . . . 0.0 110.694 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -78.17 153.81 31.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.429 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.9 43.64 5.41 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.504 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 40.1 m -89.84 119.5 30.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -1.136 . . . . 0.0 110.328 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.9 141.26 58.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -66.05 115.45 6.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.279 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.57 138.58 21.52 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.71 -0.05 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.341 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -84.05 -20.71 32.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.892 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.486 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 22.0 mtt -99.67 -15.16 18.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.99 111.93 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 110.054 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -73.48 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.58 97.12 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.189 -0.945 . . . . 0.0 110.304 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.4 t80 -62.4 152.41 34.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -71.78 -53.28 13.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 110.385 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' CG ' ' OE2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -60.19 -42.31 94.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.413 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' CA ' ' HA2' ' A' ' 71' ' ' GLY . . . 48.92 83.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 68' ' ' THR . 34.2 m -89.01 -87.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.336 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.437 ' N ' HG23 ' A' ' 67' ' ' THR . 1.3 p -110.16 -92.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 110.52 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -49.97 -53.79 39.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.4 Cg_endo -74.61 2.09 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.906 1.477 . . . . 0.0 110.74 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.416 ' HA2' ' CA ' ' A' ' 66' ' ' GLY . . . -56.45 -56.98 21.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 156.85 18.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.195 . . . . 0.0 110.277 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.119 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.2 0.524 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.43 169.65 12.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -122.52 169.8 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 ' CG1' HD22 ' A' ' 55' ' ' LEU . 21.8 t -94.27 110.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.421 HG11 ' C ' ' A' ' 52' ' ' GLY . 15.3 t -116.52 114.04 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -52.94 127.68 24.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -0.949 . . . . 0.0 110.041 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 39.6 t30 -74.57 -55.12 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.543 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -91.24 148.18 22.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.497 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 9.0 tt -61.32 128.47 36.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.889 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -101.4 123.6 44.02 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.2 Cg_endo -78.4 47.34 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.874 1.46 . . . . 0.0 110.78 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.524 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.3 mt 49.91 177.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.17 -0.956 . . . . 0.0 110.387 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 45.42 36.17 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.448 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 16.4 m -132.53 119.69 20.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.02 159.29 5.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.3 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 23.6 mt -103.17 134.8 45.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.61 -168.75 1.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.47 -45.14 73.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.447 ' CD1' ' SD ' ' A' ' 21' ' ' MET . 5.9 pt -55.41 -28.26 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -96.01 11.47 33.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.438 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -115.12 109.75 18.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -114.36 122.94 48.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.302 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.09 79.93 9.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.98 129.07 46.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.65 55.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.68 155.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 p -93.42 165.15 18.86 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 47.4 Cg_endo -74.92 159.87 97.36 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.493 -0.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -53.58 56.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.19 -113.36 5.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 55' ' ' LEU . 8.3 mt -127.67 127.36 24.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.163 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -175.8 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.883 1.464 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -98.94 26.38 5.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -62.38 -38.99 91.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -102.09 45.94 0.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.0 110.321 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -57.14 -42.52 96.67 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.5 Cg_endo -78.0 -7.13 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.529 1.278 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 1.3 m-20 -111.36 -36.49 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 47.6 tp -79.86 -38.63 32.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 23.0 t -52.21 141.57 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.26 -18.72 55.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 4.9 ttp -81.23 132.08 35.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -1.198 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -89.91 147.59 23.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.122 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 7.3 m -87.34 156.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -98.83 -5.95 30.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.344 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -127.94 163.08 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.159 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -82.21 135.79 35.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.664 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 0.1 OUTLIER -119.83 124.99 27.62 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 109.781 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.41 -177.77 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.856 1.451 . . . . 0.0 110.55 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.14 143.41 56.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.328 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.421 ' C ' HG11 ' A' ' 6' ' ' VAL . . . 56.93 47.35 87.57 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 7' ' ' ALA . 4.9 t -86.08 113.54 22.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -1.145 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 29' ' ' PRO . 10.4 m -55.04 143.36 27.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.033 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD22 ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -61.83 101.32 0.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.169 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -108.5 148.61 38.03 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.02 1.88 6.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.99 1.521 . . . . 0.0 110.709 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' CB ' ' HE1' ' A' ' 59' ' ' MET . 0.9 OUTLIER -78.49 -52.81 7.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.525 ' HE1' ' CB ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -87.32 45.67 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -123.96 133.12 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.236 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -91.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.9 104.42 15.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.35 155.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.9 mm-40 -103.57 -96.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.64 52.34 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 110.346 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.67 60.08 0.51 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -82.3 59.38 4.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.6 m -96.67 -89.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.48 -56.65 3.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.134 -0.979 . . . . 0.0 110.112 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -73.55 -166.32 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.044 1.55 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.14 173.56 40.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.16 175.2 6.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.193 -1.181 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.253 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.253 0.549 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . . . -86.4 142.59 28.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.272 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.4 p -97.03 169.23 9.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.071 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 24.8 t -86.74 88.93 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 53' ' ' THR . 3.1 t -106.55 121.9 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.132 -0.98 . . . . 0.0 109.868 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 53' ' ' THR . . . -80.73 143.8 32.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.443 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.82 -72.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -62.71 148.6 46.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.074 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.568 HD11 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -60.3 159.37 10.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 1.8 pt -130.95 117.99 17.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.694 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 51.3 Cg_endo -80.45 50.57 3.59 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.834 1.439 . . . . 0.0 110.19 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 23.4 pt 39.18 -164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.615 -0.678 . . . . 0.0 110.755 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' ILE . 15.1 p30 37.88 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.568 -0.708 . . . . 0.0 110.781 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.4 m -138.45 118.67 13.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' N ' ' HG2' ' A' ' 44' ' ' GLN . . . -58.62 155.19 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 109.992 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.39 127.0 53.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.4 OUTLIER -100.87 150.74 22.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.424 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 7.5 tt -42.67 -49.53 5.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 19' ' ' LEU . 3.6 mt -63.54 -24.78 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -84.55 -19.39 33.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.506 ' HE3' ' CD1' ' A' ' 37' ' ' ILE . 1.8 ptm -116.48 136.69 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.88 131.04 55.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.942 . . . . 0.0 110.2 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 3' ' ' ALA . . . -74.77 97.18 3.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 139.42 40.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.37 81.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 27' ' ' VAL . 11.1 p -161.82 154.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 110.043 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.4 t -74.65 150.24 86.49 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 110.155 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.42 161.91 93.61 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.693 -2.211 . . . . 0.0 110.481 -0.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -82.65 -81.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.386 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.77 -122.54 7.44 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.519 ' HB ' ' HG ' ' A' ' 55' ' ' LEU . 5.5 mt -123.95 139.12 31.8 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.106 -1.232 . . . . 0.0 109.919 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.1 1.579 . . . . 0.0 110.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -108.25 41.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -65.09 -21.92 66.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.987 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 64' ' ' GLU . 4.8 mm-40 -105.32 35.5 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 mm -40.62 -54.94 4.78 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.531 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.39 -6.8 19.95 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.632 1.333 . . . . 0.0 110.889 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 m-20 -114.25 -18.87 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.128 -0.983 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -102.07 -34.7 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 25.6 t -42.69 103.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.12 9.38 5.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.63 144.92 26.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -1.174 . . . . 0.0 110.12 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 3.6 mt-30 -109.75 168.16 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.4 m -116.09 174.79 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 -7.3 14.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.426 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -125.4 119.21 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.182 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -68.33 145.03 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.398 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 23.7 t -129.42 139.79 36.73 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 110.178 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.66 89.68 0.97 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.304 1.686 . . . . 0.0 110.713 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 55.25 160.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.395 -0.816 . . . . 0.0 110.73 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 41.37 65.95 1.04 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.548 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 15.3 t -91.83 113.52 25.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.096 -1.238 . . . . 0.0 110.015 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 30' ' ' MET . 1.5 m -73.68 121.96 21.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HG ' ' HB ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -61.82 106.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.733 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.8 mtt -112.92 156.94 41.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.57 -2.98 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.076 1.566 . . . . 0.0 110.485 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.45 -30.41 16.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 7.5 mmt -99.16 0.31 43.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.068 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.8 t -91.36 102.23 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CD ' ' OXT' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -67.36 -58.98 3.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.042 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 14.5 p-10 -100.59 80.11 2.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' OG ' ' A' ' 69' ' ' SER . 1.6 t80 -46.49 146.12 1.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.9 . . . . 0.0 110.464 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -70.41 -175.28 0.99 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.235 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -60.03 -57.74 11.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.97 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 50.68 179.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -107.61 -60.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 0.0 110.052 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -102.71 55.61 0.77 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.931 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -95.67 -177.91 0.71 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 110.303 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 43.6 Cg_endo -72.55 -89.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.481 . . . . 0.0 110.341 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.76 -15.68 3.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.51 130.66 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 110.138 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.492 ' OXT' ' CD ' ' A' ' 61' ' ' LYS . 4.0 mptt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.251 0.548 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -55.98 135.9 52.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.142 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 30' ' ' MET . 46.5 t -113.31 160.24 18.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.295 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.02 97.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 54' ' ' THR . 14.9 t -117.44 125.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -72.57 137.1 45.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.461 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 8.6 t-20 -73.6 -44.49 56.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 110.248 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 14.6 tt0 -88.28 152.81 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -64.21 152.14 41.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.448 HG21 ' HD2' ' A' ' 12' ' ' PRO . 80.2 mt -129.84 133.9 25.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' HG21 ' A' ' 11' ' ' ILE . 45.4 Cg_endo -72.16 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.92 1.484 . . . . 0.0 110.183 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 HG12 ' CA ' ' A' ' 48' ' ' ALA . 2.3 mt -116.17 170.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -0.915 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.16 11.75 4.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.4 HG21 ' N ' ' A' ' 16' ' ' ALA . 7.3 m -115.79 140.83 48.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -62.16 163.22 8.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.21 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 42' ' ' GLY . 9.1 mt -112.03 120.79 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.135 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.413 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -100.11 130.93 46.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -46.29 -40.75 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -46.91 -36.71 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 62.4 mtp -86.61 -19.01 29.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.273 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.2 mtm -102.05 127.56 48.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.223 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -114.6 170.76 8.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.42 94.45 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.2 131.71 55.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 32.4 t -78.66 87.63 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 28' ' ' THR . 47.7 t -139.99 149.41 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 10.6 t -102.5 149.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.066 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.72 133.51 31.65 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.741 -2.191 . . . . 0.0 110.516 -0.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ILE . 3.9 ptp -60.21 -29.63 68.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 57.8 -85.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 30' ' ' MET . 3.8 mt -132.74 127.67 20.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.188 -1.184 . . . . 0.0 110.202 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.28 -160.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.885 1.466 . . . . 0.0 110.405 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -100.51 28.79 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.301 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -46.08 37.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.42 24.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.7 mm -50.94 -53.1 51.4 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.844 . . . . 0.0 110.565 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -70.78 -1.13 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.53 1.279 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' O ' ' CD ' ' A' ' 64' ' ' GLU . 35.3 m120 -113.5 -46.01 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -0.97 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -78.78 -35.4 44.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.472 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 5.9 t -44.29 107.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.045 -1.034 . . . . 0.0 110.034 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 113.76 12.28 11.67 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.44 ' HE3' HG11 ' A' ' 60' ' ' VAL . 1.1 mmm -94.49 160.69 14.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.164 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.21 147.14 34.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.37 166.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 47' ' ' ARG . 55.6 p30 -101.59 -11.95 18.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.22 -0.925 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 13' ' ' ILE . 63.4 mtt180 -130.99 156.96 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -86.05 141.53 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 110.279 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 6.7 t -121.63 132.85 24.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' O ' ' CG2' ' A' ' 53' ' ' THR . 44.8 Cg_endo -71.9 -172.96 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.885 1.466 . . . . 0.0 110.339 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -46.36 155.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.89 59.99 9.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' A' ' 7' ' ' ALA . 38.8 p -78.34 95.24 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -1.077 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.405 ' N ' HG12 ' A' ' 6' ' ' VAL . 7.0 m -62.88 133.85 55.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.37 96.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.219 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mmm -112.65 153.64 44.96 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.155 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 60' ' ' VAL . 49.4 Cg_endo -76.23 3.16 6.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.944 1.497 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -39.11 36.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.482 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 5.9 mtm -111.82 60.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.342 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 57' ' ' PRO . 83.9 t -129.49 104.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -81.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.518 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 73' ' ' LYS . 18.2 t30 -93.04 93.17 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.422 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -47.76 150.22 1.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 39' ' ' ASN . 71.8 mm-40 -80.1 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.02 82.2 8.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.6 65.4 3.96 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -30.3 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -1.114 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.456 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 56.8 p -110.44 -129.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.554 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -73.73 -54.26 3.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.949 -1.094 . . . . 0.0 111.041 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' SER . 42.8 Cg_endo -69.2 59.79 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.693 1.365 . . . . 0.0 110.924 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.527 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -133.04 -2.37 3.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.26 135.01 46.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 0.0 110.424 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 1.9 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.193 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.277 0.56 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -67.93 156.89 36.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.178 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.465 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.44 149.39 42.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 73.7 t -75.0 97.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 4' ' ' SER . 4.0 t -108.25 123.89 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.207 -0.933 . . . . 0.0 110.153 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB3' ' HE1' ' A' ' 22' ' ' MET . . . -57.79 141.07 50.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.35 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t-20 -80.19 -67.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.845 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.409 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.1 tt0 -87.54 155.33 20.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.819 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -59.36 141.11 55.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 110.201 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 10.8 mm -130.55 144.9 55.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 110.058 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 44.2 Cg_endo -71.37 -170.94 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.947 1.498 . . . . 0.0 110.261 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 48' ' ' ALA . 6.2 mt -107.27 167.47 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.92 . . . . 0.0 110.023 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 54.72 26.18 7.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.185 -0.947 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -113.72 141.33 47.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.923 . . . . 0.0 110.217 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 104.96 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' CD1' ' HE2' ' A' ' 22' ' ' MET . 0.9 OUTLIER -87.27 162.79 17.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.356 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.29 163.21 23.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.99 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -57.24 -28.66 63.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 HG13 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.1 -17.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.67 -10.14 25.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.526 ' HE2' ' CD1' ' A' ' 17' ' ' LEU . 3.3 mtt -123.27 139.34 54.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.46 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -112.24 170.08 8.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.016 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.18 6.31 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 141.63 46.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 3' ' ' ALA . 91.1 t -87.66 82.02 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.63 155.18 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 110.127 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.436 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.2 p -111.85 159.86 31.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.263 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -76.17 132.24 26.87 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.511 -2.287 . . . . 0.0 110.477 -0.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.78 153.44 29.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -120.57 -71.4 0.31 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' CA ' ' A' ' 57' ' ' PRO . 3.1 mt -136.2 137.93 25.94 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.3 Cg_endo -73.07 -162.97 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.067 1.562 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.49 38.63 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -31.46 69.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 33.2 mm-40 -101.74 30.36 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.9 mm -44.89 -54.19 13.86 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -70.99 -5.77 17.71 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.632 1.333 . . . . 0.0 110.441 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' OD1' ' OE1' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -108.46 -24.83 11.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 110.127 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -93.74 -12.86 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 109.967 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 41.5 t -46.79 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.37 24.12 9.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.532 ' CE ' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.94 137.49 36.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.996 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 3.5 mt-30 -96.57 116.49 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.158 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.99 167.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.095 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 17.8 t30 -110.84 2.38 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HG2' ' CB ' ' A' ' 59' ' ' MET . 9.3 ptm180 -136.63 155.93 49.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.418 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -79.42 113.34 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.865 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.534 ' HB ' ' CB ' ' A' ' 53' ' ' THR . 19.1 m -81.87 112.33 34.05 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 48.2 Cg_endo -73.6 53.05 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.887 1.467 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER 66.82 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.496 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 46.22 49.11 14.93 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.534 ' CB ' ' HB ' ' A' ' 49' ' ' VAL . 11.3 m -96.83 123.71 40.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 54' ' ' THR . 8.9 t -65.22 142.63 58.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 110.165 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.462 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -64.22 120.74 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.463 ' O ' HG21 ' A' ' 60' ' ' VAL . 46.5 mmm -112.7 137.49 21.75 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.522 ' CB ' ' OH ' ' A' ' 63' ' ' TYR . 46.8 Cg_endo -74.2 -7.39 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.62 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -52.49 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.489 ' CB ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 mpt? -87.78 62.12 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.329 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 56' ' ' MET . 28.8 t -128.57 106.47 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.171 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 9.4 mmtt -49.92 -84.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.422 ' O ' ' HE2' ' A' ' 43' ' ' MET . 3.4 m120 -88.79 91.79 8.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -48.66 135.82 14.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 8.2 pm0 -78.41 -37.81 43.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -0.939 . . . . 0.0 110.53 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 24.9 t70 -84.39 99.99 11.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.89 31.12 4.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -99.78 -64.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -108.82 -14.35 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.579 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -70.27 -171.47 0.16 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 47.3 Cg_endo -77.52 -4.83 15.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.778 1.409 . . . . 0.0 110.497 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.57 40.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.37 158.88 15.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 110.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 114.13 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -95.08 147.55 23.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LEU . 53.0 t -79.57 120.11 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 110.181 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t -126.53 110.19 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.509 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -54.73 135.02 47.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -87.42 -71.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 2.2 pt20 -58.44 144.8 40.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.469 HD21 ' O ' ' A' ' 10' ' ' LEU . 2.9 tt -71.42 126.6 30.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -126.38 144.21 48.61 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.202 -0.936 . . . . 0.0 110.363 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.91 -158.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.982 1.517 . . . . 0.0 110.349 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.535 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 5.8 mt -95.74 -172.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' HG11 ' A' ' 45' ' ' VAL . 9.9 p30 39.86 30.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.83 115.81 30.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.25 98.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' HA ' ' CE ' ' A' ' 21' ' ' MET . 1.7 pp -70.4 152.62 43.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.7 p -130.17 -160.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD22 ' CG2' ' A' ' 37' ' ' ILE . 1.3 mp -77.05 -43.11 35.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pt -69.18 -16.88 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.501 ' CE ' ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -97.37 -12.73 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.33 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.459 ' HG3' HD11 ' A' ' 17' ' ' LEU . 39.3 mmm -124.13 107.46 11.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.153 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 21.9 mttt -99.22 144.18 28.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.76 98.56 11.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.4 mp0 -113.24 143.51 44.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 26' ' ' VAL . 8.1 p -96.75 62.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.92 -174.51 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 0.0 110.39 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.8 t -100.34 150.86 37.3 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.103 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 51.0 Cg_endo -81.84 153.74 78.65 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.689 -2.213 . . . . 0.0 110.563 -0.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -82.66 159.78 22.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.866 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -113.31 0.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -99.99 141.41 22.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 44.4 Cg_endo -71.43 -164.05 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.004 1.528 . . . . 0.0 110.466 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -116.91 27.29 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.925 . . . . 0.0 110.376 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -74.46 -17.13 60.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.246 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 pm0 -102.68 1.41 34.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -41.32 -54.56 5.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.496 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -70.5 -8.11 22.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.647 1.341 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -114.39 -18.61 11.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.067 -1.021 . . . . 0.0 110.501 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -102.4 -26.71 13.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.582 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 10.6 t -42.63 127.96 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.97 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.25 -0.65 47.07 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -87.53 152.24 22.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -1.123 . . . . 0.0 110.139 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -99.72 174.73 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG1' ' HA ' ' A' ' 13' ' ' ILE . 1.6 p -113.43 163.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.2 m-20 -102.81 -29.34 11.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 110.611 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' C ' HG12 ' A' ' 13' ' ' ILE . 17.2 mtp180 -121.74 164.99 16.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.548 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -57.56 150.1 19.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 0.0 110.508 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 80.5 t -127.88 107.27 20.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.056 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.72 -171.94 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.06 1.558 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -73.89 160.69 31.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.867 . . . . 0.0 110.184 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.54 46.92 7.19 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.575 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 8.1 t -92.38 104.87 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.1 t -51.54 157.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.304 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -62.93 112.0 2.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.0 tpt -112.51 127.58 26.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.197 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' HG22 ' A' ' 60' ' ' VAL . 46.9 Cg_endo -73.91 -20.55 19.5 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.857 1.451 . . . . 0.0 110.465 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -65.84 -23.1 66.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HB3' HG21 ' A' ' 45' ' ' VAL . 33.0 mtm -113.51 49.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 61.5 t -127.09 139.53 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' CE ' ' A' ' 43' ' ' MET . 37.3 t30 -90.34 92.66 9.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 86.3 m-85 -44.69 149.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -94.58 -47.21 6.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' OD2' HG22 ' A' ' 68' ' ' THR . 12.0 t70 -88.89 95.39 10.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.58 5.34 83.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -9.69 47.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.0 110.176 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.459 HG22 ' OD2' ' A' ' 65' ' ' ASP . 3.2 p -106.04 -178.56 3.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.282 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -50.76 -56.0 22.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.467 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.2 Cg_endo -72.21 112.54 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.916 1.482 . . . . 0.0 110.522 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.29 49.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 72' ' ' LEU . 11.3 mt -80.93 -2.71 48.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -1.115 . . . . 0.0 110.329 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.252 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.443 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -65.01 126.79 29.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -95.01 166.44 11.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.156 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 15.0 t -85.54 110.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.32 113.2 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.088 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -49.09 128.78 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 7.2 t-20 -80.59 -55.69 4.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -91.02 177.69 6.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.068 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -99.65 130.53 45.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -126.8 133.17 24.74 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -73.15 56.96 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.983 1.517 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 45' ' ' VAL . 1.5 mt 45.66 -172.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.076 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' ILE . 1.6 m-20 43.63 63.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.114 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 m -159.61 119.09 2.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.4 85.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 43' ' ' MET . 1.2 pp -50.71 155.29 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 0.5 OUTLIER -130.01 159.91 35.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.178 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 2.1 tt -59.72 -48.42 81.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.412 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 88.3 mt -57.7 -31.6 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.233 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.461 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -86.19 -26.15 25.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 18' ' ' THR . 15.9 mmt -110.91 131.2 55.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -107.41 165.33 11.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.97 9.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -104.57 135.47 45.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.191 -0.943 . . . . 0.0 110.277 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG23 ' CA ' ' A' ' 3' ' ' ALA . 12.2 t -85.38 71.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 28' ' ' THR . 77.9 t -133.07 160.4 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.4 t -88.13 152.22 50.21 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.8 Cg_endo -77.77 160.31 93.05 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.546 -0.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtm -82.68 101.13 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.65 -119.9 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.531 ' CD1' HD11 ' A' ' 55' ' ' LEU . 1.8 mt -99.59 129.31 29.19 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 110.02 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 178.38 5.82 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.889 1.468 . . . . 0.0 110.761 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.508 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -79.3 2.79 20.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.378 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 34' ' ' ALA . 8.3 tt0 -43.58 -39.86 3.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -104.92 39.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.233 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.99 -54.56 50.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 110.233 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -70.61 -4.48 14.68 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.661 1.348 . . . . 0.0 110.45 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -111.45 -31.18 7.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.139 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -73.5 -39.61 64.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.141 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.4 t -45.24 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.113 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 119.57 19.27 4.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.445 ' SD ' HG12 ' A' ' 60' ' ' VAL . 2.0 ttt -98.5 144.34 27.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -1.095 . . . . 0.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.83 146.53 28.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.162 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 7.5 m -104.87 153.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.439 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.1 t30 -111.08 28.71 8.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 8.8 ptt180 -151.21 137.93 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -48.95 130.86 18.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 53' ' ' THR . 9.9 t -117.32 106.86 46.17 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.98 -168.14 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.539 . . . . 0.0 110.398 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -70.37 136.82 50.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 60.98 52.67 50.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.535 ' CB ' HG11 ' A' ' 49' ' ' VAL . 63.3 m -96.49 124.87 40.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -1.119 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.8 t -68.45 149.84 48.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.531 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.12 111.34 12.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.336 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtt -104.8 133.01 20.38 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.467 ' HA ' HG22 ' A' ' 60' ' ' VAL . 50.0 Cg_endo -76.99 6.23 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.948 1.499 . . . . 0.0 110.677 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 -42.19 21.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.055 -1.028 . . . . 0.0 110.521 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.539 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 3.2 mmt -110.54 67.28 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.6 t -126.25 122.36 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.867 . . . . 0.0 110.141 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.3 -77.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.09 105.62 17.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 70' ' ' PRO . 59.1 m-85 -67.26 155.61 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 110.223 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -104.54 -65.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.9 -43.91 67.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.02 90.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 m -105.07 -83.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.0 m -106.96 -80.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.283 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -51.8 -61.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.1 Cg_endo -71.13 154.6 62.1 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.814 1.428 . . . . 0.0 110.428 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.88 162.38 31.23 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 109.94 4.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -1.105 . . . . 0.0 110.216 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 21.4 mmtt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.432 0.634 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -47.88 112.44 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.15 148.21 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.016 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' A' ' 34' ' ' ALA . 59.4 t -72.86 104.33 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.173 -0.954 . . . . 0.0 110.269 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 HG22 ' CB ' ' A' ' 25' ' ' GLU . 4.6 t -107.97 105.87 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.048 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' CB ' ' HE3' ' A' ' 22' ' ' MET . . . -42.56 115.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -72.75 -62.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.056 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -86.61 152.43 22.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 2.3 tt -59.34 142.26 52.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 11' ' ' ILE . 35.2 mm -123.04 139.18 31.01 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 -162.11 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.024 1.539 . . . . 0.0 110.329 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 13' ' ' ILE . 6.5 mt -116.55 157.82 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 64.31 38.26 8.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 6.1 m -132.49 138.4 47.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -61.89 158.72 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.2 mt -110.01 148.16 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.96 132.23 46.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -31.28 9.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.51 -16.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 109.985 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.84 -15.65 22.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 110.073 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.505 ' HE3' ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -121.64 119.66 32.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.29 164.55 14.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 115.63 27.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' CB ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -111.28 124.88 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 3' ' ' ALA . 16.5 t -90.17 65.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG11 ' C ' ' A' ' 26' ' ' VAL . 30.7 m -132.55 -173.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.7 t -111.94 153.0 44.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.086 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.33 161.93 92.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.432 -0.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.3 mtp -82.82 92.01 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.64 -144.73 0.28 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -79.63 136.24 55.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.325 -1.103 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.51 -174.26 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.002 1.527 . . . . 0.0 110.644 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . . . -112.32 17.34 19.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.316 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -34.03 77.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.136 -0.977 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.5 mm-40 -89.24 26.41 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.592 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -59.96 -40.81 81.22 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.0 111.217 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 44.5 Cg_endo -74.81 -18.54 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.315 1.166 . . . . 0.0 111.256 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -114.31 -11.75 12.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 110.272 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 9.3 tt -102.42 -44.01 5.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 33.3 t -41.8 148.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.434 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' N ' HG11 ' A' ' 41' ' ' VAL . . . 96.04 -16.3 61.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 63' ' ' TYR . 3.6 mtp -73.27 157.01 37.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -1.107 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 15' ' ' THR . 4.4 mp0 -110.05 170.34 8.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.8 m -109.5 166.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 110.252 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.92 -4.23 18.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.424 ' C ' HG12 ' A' ' 13' ' ' ILE . 3.4 mtp180 -143.18 168.45 19.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.192 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.11 139.24 39.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.532 HG11 ' CB ' ' A' ' 53' ' ' THR . 88.8 t -112.04 127.28 27.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.84 . . . . 0.0 110.164 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.06 -171.88 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.841 1.442 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 2.1 mp -74.97 153.13 38.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.502 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 42.69 53.33 5.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.532 ' CB ' HG11 ' A' ' 49' ' ' VAL . 83.0 m -96.97 109.57 22.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.26 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 148.51 2.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.885 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.0 102.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.973 . . . . 0.0 110.211 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.1 mmt -111.35 149.63 40.89 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 48.1 Cg_endo -75.66 4.07 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.975 1.513 . . . . 0.0 110.798 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.32 -42.16 62.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 110.644 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.12 55.15 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.28 102.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -66.88 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.06 86.87 6.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HA ' ' HE2' ' A' ' 43' ' ' MET . 27.8 m-85 -44.29 155.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 36' ' ' GLU . 1.4 pt-20 -76.38 -158.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 110.342 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 4.1 m-20 -68.6 73.35 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -111.68 92.53 0.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 67' ' ' THR . 85.6 m -97.39 21.71 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.3 p -97.43 -15.06 20.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.087 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.59 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -173.54 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.046 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.0 Cg_endo -72.24 169.76 20.78 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.854 1.449 . . . . 0.0 110.227 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.35 56.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.15 75.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.087 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.237 0.541 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -87.95 127.65 35.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -102.24 137.34 40.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 15.9 m -78.22 129.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 t -122.13 131.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.414 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -55.69 129.31 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.89 -70.82 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -80.0 160.85 25.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 1.9 tt -77.98 130.97 37.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' VAL . 4.4 mt -116.59 113.54 40.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.151 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.9 Cg_endo -73.25 66.12 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.83 1.437 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.541 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 32.78 -161.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.534 0.683 . . . . 0.0 111.696 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 5.1 m120 36.52 42.17 0.19 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -147.72 124.53 11.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.58 7.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.812 . . . . 0.0 110.02 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 HD12 ' CG1' ' A' ' 45' ' ' VAL . 60.7 mt -62.33 133.46 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HE1' ' A' ' 21' ' ' MET . 0.6 OUTLIER -111.68 155.78 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.064 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -67.79 -29.1 68.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.345 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 21' ' ' MET . 1.4 pt -65.15 -19.67 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 110.139 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.523 ' N ' HG13 ' A' ' 20' ' ' ILE . 3.2 mtm -97.98 -2.25 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.9 118.57 32.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.272 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.6 pttt -114.81 142.27 46.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.56 96.32 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.957 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -112.2 133.93 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 3' ' ' ALA . 18.2 t -90.71 87.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.194 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.76 -167.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.384 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.6 t -118.71 153.44 52.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 110.236 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.3 Cg_endo -77.2 160.63 94.11 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.446 -0.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.1 mmm -82.62 71.27 9.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.154 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -55.96 -108.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.6 mt -113.12 136.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -162.0 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.928 1.488 . . . . 0.0 110.352 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -93.69 32.91 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -56.86 4.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 15.5 mm-40 -88.67 33.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.43 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.9 mm -60.04 -54.71 52.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.0 Cg_endo -71.39 -8.85 24.2 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.262 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.99 -47.71 4.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 0.0 110.14 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -68.3 -41.25 81.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -54.78 119.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.7 -8.26 10.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.513 ' CE ' HG11 ' A' ' 60' ' ' VAL . 1.4 ttm -100.78 162.25 13.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -1.115 . . . . 0.0 110.218 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -109.86 138.2 46.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.6 m -91.48 154.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -104.61 -2.73 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' CB ' ' HG2' ' A' ' 59' ' ' MET . 4.2 mtt180 -113.14 131.35 55.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.002 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.86 132.27 9.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.384 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 53' ' ' THR . 55.8 t -113.17 102.4 54.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 110.058 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.03 -167.13 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.543 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.58 138.54 40.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.24 34.93 91.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.51 ' CB ' HG11 ' A' ' 49' ' ' VAL . 73.2 m -73.5 97.87 2.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.98 137.9 3.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.24 98.66 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.431 ' CG ' ' HG3' ' A' ' 59' ' ' MET . 2.9 ptm -113.11 146.5 35.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.53 -5.44 17.15 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.541 . . . . 0.0 110.458 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -76.99 -25.48 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.295 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.505 ' HG2' ' CB ' ' A' ' 47' ' ' ARG . 11.0 mtt -108.21 41.53 1.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG11 ' CE ' ' A' ' 43' ' ' MET . 49.7 t -130.26 104.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -69.16 -60.35 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.454 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -98.37 71.57 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 13.1 t80 -53.36 158.47 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mm-40 -87.84 -65.63 1.0 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.36 85.21 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.65 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.91 17.86 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.171 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -80.22 -137.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.8 -55.98 4.22 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.594 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.35 -163.89 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.912 1.48 . . . . 0.0 110.457 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.7 87.79 0.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -85.49 -7.68 58.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 110.342 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.227 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.178 0.513 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.69 126.55 29.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' GLU . 3.5 t -95.86 -178.48 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 55' ' ' LEU . 77.3 t -89.18 119.9 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.82 101.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.219 -0.926 . . . . 0.0 110.165 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -47.15 116.48 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.106 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -79.66 -63.65 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.05 135.55 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.309 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 5.0 tt -60.45 142.06 55.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -130.1 116.69 17.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.581 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.84 59.71 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.849 1.447 . . . . 0.0 110.1 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 13.9 pt 39.92 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.661 . . . . 0.0 110.727 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 40.34 47.25 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.467 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -156.71 110.36 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.56 118.12 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 45' ' ' VAL . 5.9 mt -75.92 128.48 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -171.15 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.132 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.66 -45.96 67.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.119 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.31 -9.24 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -28.89 21.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 55' ' ' LEU . 1.4 mmt -118.92 143.26 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' OD1' ' A' ' 8' ' ' ASN . 8.5 mttt -115.68 166.68 11.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.33 79.1 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -101.82 152.99 20.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 26' ' ' VAL . 9.1 p -90.08 14.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 25' ' ' GLU . 22.8 t -62.36 142.44 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -88.14 163.82 35.7 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.136 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.79 174.17 53.79 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.608 -2.246 . . . . 0.0 110.42 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.61 86.95 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.422 ' HA3' ' CG2' ' A' ' 54' ' ' THR . . . -68.49 -150.75 0.3 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -76.26 137.59 68.28 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.361 -1.082 . . . . 0.0 110.063 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' HG21 ' A' ' 32' ' ' ILE . 44.9 Cg_endo -72.07 170.56 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.955 1.503 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -94.07 38.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.863 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -25.54 53.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.119 -0.988 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 7.6 mm-40 -105.09 41.97 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.63 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -44.78 -50.18 25.62 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.89 -11.99 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.632 1.332 . . . . 0.0 110.619 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.89 -30.6 11.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' N ' HD21 ' A' ' 40' ' ' LEU . 4.0 mm? -83.11 -47.07 12.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.105 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 37' ' ' ILE . 31.4 t -43.22 104.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.056 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.07 11.98 11.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 64' ' ' GLU . 9.4 ttm -83.37 134.33 34.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.241 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 144.8 31.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 14.4 m -119.11 160.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -110.85 0.63 17.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 0.0 110.359 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -120.02 122.3 40.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 110.366 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -47.12 140.61 4.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.34 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 53' ' ' THR . 12.0 t -124.84 130.36 24.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' HG11 ' A' ' 49' ' ' VAL . 43.3 Cg_endo -69.6 -174.38 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.944 1.497 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.69 154.67 28.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 48.66 43.67 29.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.514 ' CG2' HG11 ' A' ' 49' ' ' VAL . 55.4 m -92.02 134.18 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -1.154 . . . . 0.0 110.266 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' ' HA3' ' A' ' 31' ' ' GLY . 7.6 m -67.38 141.24 57.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.095 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 ' CD2' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -61.93 99.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 mtp -102.83 142.51 24.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.31 2.59 6.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.013 1.533 . . . . 0.0 110.593 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.11 -32.47 24.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.133 -0.979 . . . . 0.0 110.521 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.453 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 mtt -96.31 3.49 52.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 110.393 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.68 82.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.324 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 51.7 pttt -59.53 -37.11 77.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TYR . 18.5 p30 -100.45 74.2 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 109.852 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.522 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -46.13 175.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.51 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -95.12 -152.82 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.028 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 11.9 t70 -58.77 83.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.798 -1.189 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -123.74 112.98 1.96 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 31.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -1.189 . . . . 0.0 110.471 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -106.63 -23.4 12.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.6 -61.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.65 150.39 56.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.921 1.485 . . . . 0.0 110.579 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.05 -48.51 0.37 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 72' ' ' LEU . 2.0 mm? -81.44 125.03 29.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.331 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 pttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.151 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.472 ' CE ' ' HB3' ' A' ' 33' ' ' PRO . 12.6 pttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.265 0.555 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB2' ' C ' ' A' ' 24' ' ' ALA . . . -63.1 138.64 58.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.2 t -103.46 -174.48 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 33' ' ' PRO . 59.3 t -92.14 123.59 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.86 118.47 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.43 138.99 44.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.103 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 4.0 t-20 -90.8 -62.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.287 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -77.36 162.43 27.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.21 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HB2' HD13 ' A' ' 51' ' ' LEU . 1.2 tt -93.06 130.78 38.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.112 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 26.3 pt -130.03 137.87 31.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.49 71.88 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.067 1.561 . . . . 0.0 110.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.7 mt 54.65 -172.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' N ' HG21 ' A' ' 45' ' ' VAL . 49.7 m-80 42.13 -141.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 14' ' ' ASN . 42.6 m 57.48 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -55.27 132.28 47.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 110.065 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -75.46 143.89 42.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.5 p -123.46 160.07 27.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.217 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 4.8 tt -67.58 -34.6 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.287 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -59.08 -36.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.4 mtm -93.76 6.88 46.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.374 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.412 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -98.97 123.56 43.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 147.71 34.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -105.7 75.91 1.16 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.161 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.81 20.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 71.0 t -81.65 91.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.181 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.31 154.92 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.9 t -113.13 150.02 42.31 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.8 Cg_endo -76.67 171.09 69.83 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.678 -2.218 . . . . 0.0 110.433 -0.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -80.61 81.43 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.03 -112.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 32' ' ' ILE . 1.6 mt -103.87 138.89 19.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 110.153 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HB3' ' CE ' ' A' ' 2' ' ' LYS . 45.7 Cg_endo -73.19 -177.22 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.117 1.588 . . . . 0.0 110.394 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -95.82 20.99 9.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -76.61 -36.88 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.406 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -92.49 27.35 2.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 110.481 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.76 -48.75 96.26 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -77.0 -5.62 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.801 1.422 . . . . 0.0 110.44 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 17.9 m120 -114.29 -20.01 11.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.341 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -97.46 -38.63 9.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.283 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 37' ' ' ILE . 25.1 t -43.63 123.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.331 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.59 -4.83 23.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.457 ' CE ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -93.63 152.91 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -1.135 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 51.7 mt-30 -103.75 145.36 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.106 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.9 m -91.98 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.105 -0.997 . . . . 0.0 110.256 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.412 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.7 m-20 -111.12 -9.03 14.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 11.6 ptm180 -119.22 171.59 8.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.341 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.39 123.67 27.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.815 . . . . 0.0 110.413 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.522 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 72.2 t -107.85 96.0 16.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.952 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' O ' ' OG1' ' A' ' 53' ' ' THR . 44.5 Cg_endo -71.97 -165.23 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -69.25 141.17 54.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 55.56 49.43 65.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 52.7 m -92.65 134.74 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 144.15 51.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.43 105.98 8.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.453 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -96.85 129.66 32.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.6 Cg_endo -75.01 1.89 7.24 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.928 1.489 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' HB2' ' HG2' ' A' ' 56' ' ' MET . 70.4 m-20 -81.46 -70.34 0.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.466 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 4.4 mmt -72.94 66.35 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.515 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 57' ' ' PRO . 62.0 t -126.64 128.93 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -96.78 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -0.939 . . . . 0.0 110.475 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 43' ' ' MET . 47.4 t30 -82.11 85.99 6.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.989 -1.07 . . . . 0.0 110.23 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' HB3' ' CA ' ' A' ' 71' ' ' GLY . 40.4 t80 -48.69 169.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.07 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 1.5 tt0 -64.67 -133.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.977 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -36.38 75.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 71' ' ' GLY . . . 62.04 55.52 27.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 0.08 51.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 70' ' ' PRO . 14.8 t -110.03 -28.69 8.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.5 -61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.08 -1.012 . . . . 0.0 110.825 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.2 Cg_endo -70.57 -175.49 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.904 1.476 . . . . 0.0 110.768 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 85.21 44.34 6.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -98.55 63.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.171 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.183 0.516 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -73.04 132.18 43.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -110.08 160.76 16.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 67.8 t -89.44 113.72 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 23.4 t -111.68 113.34 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -54.25 118.89 4.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -76.27 -75.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -63.39 144.0 57.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.127 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.5 136.17 57.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mt -125.02 131.59 24.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.55 -157.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.93 -179.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 8.8 p30 40.95 27.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.197 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 13' ' ' ILE . 7.7 m -126.68 114.51 18.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.136 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.31 148.56 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -134.2 157.67 45.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.58 169.83 8.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.72 -10.58 53.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 34.4 mm -69.82 -21.73 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.768 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.8 mtp -98.1 10.36 40.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.309 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.518 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 3.6 mtp -117.69 138.81 51.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.11 167.05 11.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 110.121 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.45 95.21 5.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.922 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 128.35 55.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 3' ' ' ALA . 5.2 t -91.99 58.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.97 160.06 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.4 t -74.9 149.39 85.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -75.72 169.83 73.44 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.668 -2.222 . . . . 0.0 110.398 -0.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.4 -142.25 19.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 2.9 mt -100.83 134.06 20.72 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.121 -1.223 . . . . 0.0 110.177 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.68 -166.28 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.908 1.478 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.82 34.04 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.37 -39.93 62.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.928 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 40' ' ' LEU . 63.7 mm-40 -103.45 32.38 3.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.6 mm -53.04 -46.91 97.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.3 Cg_endo -73.88 -1.17 10.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.486 1.256 . . . . 0.0 110.447 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.73 -37.97 4.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.897 . . . . 0.0 110.101 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.3 -41.6 27.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 19' ' ' LEU . 40.7 t -44.66 125.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 93.92 9.09 59.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 64' ' ' GLU . 23.4 ttt -101.35 158.34 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.18 . . . . 0.0 110.245 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 158.38 18.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 13' ' ' ILE . 26.8 m -107.09 168.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -110.76 5.78 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.301 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 10.2 mmt85 -138.09 135.53 35.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.74 146.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.367 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.519 HG11 ' CB ' ' A' ' 53' ' ' THR . 95.2 t -129.97 120.84 19.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -73.48 -160.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.871 1.458 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -85.32 157.13 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.83 39.47 4.9 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.519 ' CB ' HG11 ' A' ' 49' ' ' VAL . 95.8 m -85.25 109.17 18.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -1.105 . . . . 0.0 110.399 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.9 m -47.41 149.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.1 103.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.466 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -97.85 133.89 22.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.133 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 46.4 Cg_endo -73.05 -34.88 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.955 1.503 . . . . 0.0 110.66 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 10.6 p-10 -57.18 -17.08 9.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 0.0 110.552 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.463 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 6.8 mtt -108.85 25.27 11.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG11 ' HE3' ' A' ' 43' ' ' MET . 47.0 t -117.41 129.22 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.314 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -69.42 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -78.08 83.99 4.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 57' ' ' PRO . 88.8 m-85 -44.26 129.21 6.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 2.9 mp0 -92.27 -37.47 12.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 17.5 p-10 -67.33 97.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.66 147.99 12.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -81.01 -92.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -1.149 . . . . 0.0 110.197 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 69' ' ' SER . 18.3 m -110.16 107.64 17.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.132 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.558 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 172.2 -58.98 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -73.01 -22.41 19.57 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.021 1.537 . . . . 0.0 110.503 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.68 159.79 13.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.07 -6.95 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.165 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.251 0.548 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -63.0 148.31 48.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.2 p -103.8 161.1 14.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.97 101.67 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.38 107.17 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -62.61 116.84 5.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.459 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 t-20 -79.92 -57.51 3.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 110.063 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 1.2 tp-100 -59.93 117.92 5.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 1.7 pt? -62.08 129.21 39.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.458 HG13 ' HB ' ' A' ' 49' ' ' VAL . 4.7 pt -130.06 146.04 59.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 0.0 109.941 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 45.1 Cg_endo -71.78 -94.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.0 110.158 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 47' ' ' ARG . 1.5 mt -152.01 -179.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.038 . . . . 0.0 109.972 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 51.75 21.12 1.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 15' ' ' THR . 8.0 t -99.75 128.65 45.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.44 100.62 4.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.065 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -49.0 124.24 8.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.33 158.01 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tt -49.6 -46.01 48.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.437 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.7 mt -51.4 -47.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.4 ' HG2' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -78.67 -25.2 44.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.43 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 20.8 mtm -85.35 110.51 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.34 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.29 151.16 25.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 95.76 7.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.23 123.49 50.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.134 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 3' ' ' ALA . 3.9 t -77.47 98.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.53 139.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.2 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.3 t -77.68 151.59 80.02 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.5 Cg_endo -75.52 156.34 99.29 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.433 -0.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -82.56 86.4 6.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -144.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 32' ' ' ILE . 1.1 mt -72.56 130.45 85.7 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 109.966 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.54 -179.44 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.984 1.518 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -94.2 2.15 55.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.6 -21.72 7.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 40' ' ' LEU . 7.1 mm-40 -104.64 23.5 13.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.418 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -42.27 -53.02 9.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.3 Cg_endo -72.01 -6.0 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.641 1.337 . . . . 0.0 110.757 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' GLU . 4.2 m120 -113.84 -20.25 11.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 55' ' ' LEU . 1.6 mp -85.85 -43.88 12.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 37' ' ' ILE . 55.6 t -44.8 122.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.11 37.19 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.64 136.95 34.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -106.7 129.27 54.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -84.88 163.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' C ' HG22 ' A' ' 13' ' ' ILE . 25.6 t-20 -111.3 5.46 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' N ' HG22 ' A' ' 13' ' ' ILE . 27.3 mtt180 -144.03 167.55 22.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -68.54 144.68 54.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' HB ' HG13 ' A' ' 11' ' ' ILE . 30.2 t -126.52 126.07 24.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.24 -176.67 2.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.521 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.91 137.96 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 60.68 51.15 60.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.443 HG22 ' HD2' ' A' ' 50' ' ' PRO . 96.5 m -96.3 129.52 43.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -1.128 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 m -66.54 136.39 55.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' CD1' HD22 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.36 105.67 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.424 ' O ' HG21 ' A' ' 60' ' ' VAL . 2.5 mtt -109.39 154.59 42.15 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.855 . . . . 0.0 110.1 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.4 1.6 7.21 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.002 1.527 . . . . 0.0 110.56 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -45.57 31.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.428 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.488 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 14.6 mtm -107.58 57.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.351 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 56' ' ' MET . 98.8 t -125.03 84.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 14.7 tptm -52.85 -65.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 32.4 p-10 -99.59 86.39 3.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.882 . . . . 0.0 110.218 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.56 150.34 12.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.472 ' CD ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -73.75 -162.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' ND2' ' A' ' 39' ' ' ASN . 44.3 p-10 -73.0 75.11 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.32 127.86 4.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -77.18 55.93 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -1.099 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 171.37 8.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.519 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -45.77 -55.69 12.03 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 110.455 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -73.42 88.48 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.925 1.487 . . . . 0.0 110.436 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.79 37.46 1.86 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 73.06 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.244 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.131 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.202 0.525 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.97 111.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 t -99.75 164.88 11.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 22' ' ' MET . 32.2 t -73.05 117.91 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 53' ' ' THR . 17.0 t -127.34 99.35 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -59.28 141.34 54.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.945 . . . . 0.0 110.2 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.85 -63.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.21 145.12 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.009 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -59.55 150.0 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -130.13 137.54 31.1 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.276 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.04 166.32 30.37 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.498 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 11.2 pt -81.49 175.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 3.0 m120 58.23 16.77 4.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 110.22 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m -125.12 105.94 9.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -59.32 122.63 14.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.9 OUTLIER -83.75 155.46 23.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.912 . . . . 0.0 110.392 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 22' ' ' MET . 1.7 m -106.69 169.83 8.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 HD13 ' CG2' ' A' ' 20' ' ' ILE . 1.5 pp -65.0 -33.1 75.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.462 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' CG2' HD13 ' A' ' 19' ' ' LEU . 3.7 pt -67.54 -20.34 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.173 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.99 -14.99 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.533 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.481 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -121.69 127.68 51.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.96 . . . . 0.0 110.495 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.4 mttt -121.07 179.37 4.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.985 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.89 99.36 9.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.21 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -101.8 145.33 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -90.4 76.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' HG23 ' A' ' 6' ' ' VAL . 36.0 m -125.81 155.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.15 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 9.6 t -101.37 150.01 36.83 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.151 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.19 176.29 44.42 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.708 -2.205 . . . . 0.0 110.513 -0.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -73.55 -139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 30' ' ' MET . . . 151.89 -117.01 0.79 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.546 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 2.9 mt -110.56 118.97 47.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 50.1 Cg_endo -75.26 5.08 4.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.852 1.448 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 33' ' ' PRO . . . 71.92 20.69 4.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.457 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.0 -26.51 4.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.006 -1.059 . . . . 0.0 109.729 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 43.3 mm-40 -105.16 60.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -56.89 -41.48 91.57 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 111.058 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -75.69 -9.74 19.9 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.288 1.152 . . . . 0.0 110.508 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -114.47 -26.88 7.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD11 ' OE1' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.44 -45.6 15.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.329 -0.857 . . . . 0.0 110.398 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 37' ' ' ILE . 20.3 t -42.22 115.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 112.93 0.27 25.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.25 136.98 48.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -1.16 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 26.8 mt-30 -110.1 163.9 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 13' ' ' ILE . 7.2 m -120.54 170.29 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.421 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 47.7 p-10 -110.81 -8.73 14.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 13' ' ' ILE . 1.8 mtt180 -126.33 121.21 31.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -48.23 140.44 7.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG13 ' CG2' ' A' ' 53' ' ' THR . 67.2 t -127.46 135.14 26.99 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -73.13 -161.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.79 168.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.15 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 46.8 80.89 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 64.0 m -94.31 90.54 6.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.114 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -66.88 133.1 49.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -71.44 88.63 0.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.454 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.3 mtm -111.82 164.27 15.54 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.33 10.15 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -54.44 5.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.805 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.5 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 36.5 mtt -113.04 69.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.853 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 56' ' ' MET . 12.8 t -130.31 103.4 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.044 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 46' ' ' ASN . 5.6 mtpt -55.6 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.277 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.88 84.0 4.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 110.352 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.546 ' CZ ' HD12 ' A' ' 32' ' ' ILE . 2.1 t80 -46.57 144.89 2.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE1' ' HB2' ' A' ' 36' ' ' GLU . 1.9 pt-20 -68.64 -151.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.25 -0.906 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.3 m-20 -59.39 -46.4 88.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.67 146.96 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -87.42 -30.91 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -1.184 . . . . 0.0 110.079 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.0 OUTLIER -93.06 23.46 4.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.15 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.602 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 4.3 t 54.55 44.12 1.64 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 111.001 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -74.26 103.54 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.692 1.364 . . . . 0.0 110.415 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.02 128.47 3.56 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -77.41 -21.46 53.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HE3' ' SD ' ' A' ' 30' ' ' MET . 3.2 ptpt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.229 0.538 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.463 ' HB3' HG23 ' A' ' 26' ' ' VAL . . . -79.11 135.33 36.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -106.28 152.99 22.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 36.8 t -87.44 96.1 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.329 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG11 ' C ' ' A' ' 52' ' ' GLY . 2.9 t -107.04 112.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.037 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -62.72 136.82 58.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.72 -54.91 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -83.21 146.27 28.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.484 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 pt? -63.57 145.85 54.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' VAL . 6.6 mt -130.37 136.3 28.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.51 -162.43 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.934 1.491 . . . . 0.0 110.273 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' THR . 5.7 mt -104.3 -173.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.4 p30 40.08 28.11 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 110.571 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 13' ' ' ILE . 25.6 m -120.57 121.64 38.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.247 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -57.17 162.66 2.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 110.14 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -121.13 144.79 48.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -116.95 169.17 9.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 20' ' ' ILE . 3.2 tt -60.66 -50.26 74.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.486 ' N ' HD22 ' A' ' 19' ' ' LEU . 58.0 mt -55.39 -38.74 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -13.89 60.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.41 112.01 20.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.6 mttt -106.0 145.0 31.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -94.0 102.63 14.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' SER . 41.6 tt0 -108.16 133.56 52.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 3' ' ' ALA . 11.8 t -85.71 74.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 26' ' ' VAL . 10.5 m -143.41 -173.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 5.2 t -109.52 150.66 41.49 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.153 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.4 Cg_endo -76.16 168.11 78.21 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.613 -2.244 . . . . 0.0 110.465 -0.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.452 ' SD ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -76.95 -112.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.098 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.79 -134.58 10.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.8 mt -99.12 125.69 40.75 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -1.122 . . . . 0.0 110.03 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.29 -170.96 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.931 1.49 . . . . 0.0 110.547 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.17 16.76 17.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -47.76 84.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 mm-40 -89.36 47.78 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.108 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.654 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 5.9 tp -69.79 -30.68 2.14 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 111.719 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.4 Cg_endo -80.15 -7.93 14.13 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 122.813 0.901 . . . . 0.0 109.928 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -108.55 -35.14 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -44.5 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 29.2 t -48.57 103.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 110.013 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.17 -0.55 19.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -92.52 157.09 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 110.053 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 61' ' ' LYS . 18.0 mt-30 -109.54 171.13 7.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.332 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 59' ' ' MET . 11.7 m -116.93 156.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -103.5 5.06 36.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' CB ' ' CG ' ' A' ' 59' ' ' MET . 2.4 mtt180 -136.39 159.91 40.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' C ' HG21 ' A' ' 49' ' ' VAL . . . -65.51 150.59 48.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.13 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 21.8 t -129.31 111.66 18.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -164.19 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.886 1.466 . . . . 0.0 110.432 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 10' ' ' LEU . 3.2 mp -79.38 163.58 24.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.066 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' HG11 ' A' ' 6' ' ' VAL . . . 43.21 28.97 0.91 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.591 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 6.7 t -65.14 124.52 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.391 -1.064 . . . . 0.0 110.417 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 30' ' ' MET . 0.2 OUTLIER -77.24 140.52 40.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.66 101.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.106 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.6 mtt -111.55 153.81 44.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.989 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.4 -0.26 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.958 1.504 . . . . 0.0 110.493 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.31 -46.82 21.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 110.319 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.505 ' CG ' ' CB ' ' A' ' 47' ' ' ARG . 1.4 mpt? -97.92 50.0 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 56' ' ' MET . 39.4 t -121.4 103.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.905 . . . . 0.0 110.17 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -50.27 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 17.1 p-10 -95.57 92.25 6.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.945 . . . . 0.0 110.246 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -44.69 135.73 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.278 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 77.8 mm-40 -88.12 -75.5 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.68 76.84 2.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.82 52.9 0.63 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 p -90.01 25.56 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -1.138 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 p -101.95 -11.76 18.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.561 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -178.64 -59.76 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.11 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.3 Cg_endo -72.74 -90.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.0 -79.86 1.13 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.59 86.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -1.091 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.214 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -87.54 141.72 28.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -121.29 153.79 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG12 ' SD ' ' A' ' 22' ' ' MET . 25.3 t -87.44 127.49 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.272 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 ' CG1' ' C ' ' A' ' 52' ' ' GLY . 11.9 t -130.09 121.63 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.89 142.15 6.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.463 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 10.1 t-20 -89.09 -59.33 2.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -97.07 148.26 23.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.44 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 7.7 tt -64.75 131.84 47.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.18 130.28 23.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 0.0 110.644 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.3 Cg_endo -74.86 71.03 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.941 1.495 . . . . 0.0 109.841 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 32.4 pt 39.39 -164.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.732 -0.605 . . . . 0.0 110.692 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER 65.56 -62.31 0.23 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -58.36 106.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.349 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.78 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.179 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -106.75 129.4 54.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.28 -0.887 . . . . 0.0 110.095 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -125.75 156.12 39.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 110.349 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -46.25 -62.49 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 0.0 110.38 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mt -59.82 -13.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.459 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -91.53 -47.38 7.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.436 ' SD ' HG12 ' A' ' 5' ' ' VAL . 17.5 ptt? -104.84 148.26 26.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -120.17 160.76 22.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.86 103.2 14.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.25 137.58 50.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 3' ' ' ALA . 52.2 t -96.42 80.41 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.258 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -174.2 168.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.3 t -82.9 151.75 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.3 Cg_endo -75.89 133.13 29.93 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.602 -0.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.5 mtp -82.46 175.29 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.88 -132.77 1.4 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -90.23 136.85 28.17 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.213 -1.169 . . . . 0.0 109.924 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.56 -170.79 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.003 1.528 . . . . 0.0 110.676 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.75 31.73 5.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.275 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -48.04 82.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.016 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 74.3 mm-40 -100.0 65.65 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.636 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 8.7 tp -70.62 -29.87 1.65 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 111.929 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.0 Cg_endo -78.01 -7.19 16.26 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.704 0.844 . . . . 0.0 109.944 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.27 -19.6 11.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -88.34 -40.96 13.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.161 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 90.8 t -46.53 105.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.54 10.0 8.91 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.21 121.48 23.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.46 148.47 22.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.1 m -117.98 155.87 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.11 5.05 19.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' N ' HG23 ' A' ' 13' ' ' ILE . 66.4 mtt-85 -120.99 127.0 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.233 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 13' ' ' ILE . . . -45.78 133.44 8.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 110.496 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.518 HG11 ' CB ' ' A' ' 53' ' ' THR . 24.8 t -117.9 121.54 31.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -72.6 -174.93 1.62 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.96 1.505 . . . . 0.0 110.513 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.89 156.16 39.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' C ' ' CG1' ' A' ' 6' ' ' VAL . . . 46.83 44.77 18.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CB ' HG11 ' A' ' 49' ' ' VAL . 4.9 m -93.47 114.64 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.147 . . . . 0.0 110.126 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.461 HG23 ' HG2' ' A' ' 29' ' ' PRO . 2.4 t -57.79 144.15 39.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.453 HD13 HD22 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -64.11 108.85 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.511 ' CG ' ' HD2' ' A' ' 57' ' ' PRO . 20.7 ttm -103.18 145.62 30.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 47.0 Cg_endo -74.13 -0.5 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.075 1.566 . . . . 0.0 110.613 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -41.35 13.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.16 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.473 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 8.9 mtm -90.9 45.38 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 56' ' ' MET . 3.0 t -129.96 126.03 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.107 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -74.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' TYR . 7.6 p30 -100.05 104.25 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -47.22 176.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.331 -0.855 . . . . 0.0 110.334 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -144.51 0.05 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.101 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 8.1 p-10 -75.18 80.37 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.75 97.48 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -101.65 39.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -1.111 . . . . 0.0 110.406 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 70' ' ' PRO . 15.4 t -72.76 -11.83 60.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.955 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -177.31 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 48.3 Cg_endo -73.61 98.12 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.715 1.376 . . . . 0.0 110.399 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.43 -31.25 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.54 96.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -1.181 . . . . 0.0 110.287 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.127 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.72 128.68 35.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -116.12 145.48 43.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.151 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 39.2 t -86.48 135.24 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.47 124.37 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -57.46 115.52 2.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.85 -51.88 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 110.19 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -84.32 142.7 30.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.173 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -74.11 127.94 34.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.472 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.2 pt -130.49 119.91 18.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.53 64.66 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.881 1.464 . . . . 0.0 110.544 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.4 pt 39.32 -164.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' ILE . 71.6 m-20 40.8 32.29 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.885 . . . . 0.0 110.456 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 18.6 m -145.53 107.2 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.144 -0.973 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' CA ' ' HG2' ' A' ' 44' ' ' GLN . . . -59.59 163.84 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.06 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -141.12 157.71 44.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -119.42 -157.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.845 . . . . 0.0 110.188 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.27 -62.28 1.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -47.52 -23.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.348 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -72.34 -57.32 4.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.091 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.442 ' HG3' ' CD1' ' A' ' 17' ' ' LEU . 1.4 mtt -107.88 141.11 39.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.22 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.08 108.35 19.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.338 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.04 145.1 41.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 80.3 t -86.86 97.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG21 ' N ' ' A' ' 28' ' ' THR . 13.5 p -168.04 154.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.211 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' N ' HG21 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.78 159.15 77.09 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.44 -163.68 3.31 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.72 -2.2 . . . . 0.0 110.547 -0.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.3 mtt -81.82 -73.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.266 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.31 -144.1 33.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.477 ' CD1' HD11 ' A' ' 55' ' ' LEU . 4.4 mt -103.56 130.76 22.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 110.142 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 -172.3 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.327 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' A' ' 37' ' ' ILE . . . -97.7 32.33 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -76.83 -28.81 55.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.92 40.78 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -59.66 -51.91 77.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.6 Cg_endo -73.43 -1.81 11.21 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.741 1.39 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 89.8 m-20 -114.26 -42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.227 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 tp -73.42 -42.07 62.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.4 t -46.8 116.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.35 10.89 50.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 ttt -104.64 147.73 27.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HG2' ' CA ' ' A' ' 16' ' ' ALA . 44.1 mt-30 -110.06 164.53 12.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.281 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 8.4 m -115.66 164.33 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.98 -1.45 16.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 14.5 mtt180 -118.22 131.58 56.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.12 127.28 8.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.56 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.531 HG11 ' CB ' ' A' ' 53' ' ' THR . 22.4 t -116.15 108.75 45.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.37 -176.09 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.987 1.519 . . . . 0.0 110.466 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.05 134.34 48.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 70.42 46.28 49.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.531 ' CB ' HG11 ' A' ' 49' ' ' VAL . 67.1 m -96.63 113.82 25.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -1.153 . . . . 0.0 110.386 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 m -54.52 142.51 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.304 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.11 100.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.412 ' HB2' ' HG3' ' A' ' 59' ' ' MET . 2.9 mmt -98.47 139.08 20.91 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 -2.26 11.84 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.059 1.557 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.35 -37.79 14.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.505 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -73.05 -14.2 61.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 25.4 t -85.35 118.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.32 -74.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' CE ' ' A' ' 43' ' ' MET . 71.6 m-20 -100.58 93.48 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE1' ' OG1' ' A' ' 67' ' ' THR . 9.4 t80 -46.65 165.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 23.6 mm-40 -89.8 -171.37 3.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 63.75 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.143 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.04 -71.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 63' ' ' TYR . 2.2 m -79.76 108.82 13.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -72.1 69.2 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.576 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -171.68 -62.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.383 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.51 65.08 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.833 1.438 . . . . 0.0 110.432 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.09 97.41 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.74 -55.31 3.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 110.159 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.154 179.96 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.267 0.556 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.73 154.11 22.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' MET . 7.3 p -121.41 168.29 11.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.8 t -88.38 117.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 0.0 110.279 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.64 123.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -52.61 118.99 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -74.54 -68.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -89.27 147.0 24.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 10' ' ' LEU . 1.8 pt? -67.74 134.19 50.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.291 -0.881 . . . . 0.0 110.512 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.452 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.0 pt -120.38 156.12 55.66 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.339 -0.851 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.59 -158.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.07 1.563 . . . . 0.0 109.991 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.5 mt -103.25 166.73 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.878 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER 58.99 25.84 14.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.359 179.953 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -102.93 124.26 48.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.12 157.36 22.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.091 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 43' ' ' MET . 2.5 mt -93.81 131.65 38.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' SD ' ' A' ' 22' ' ' MET . 1.1 p -116.8 172.92 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.163 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.45 -55.57 15.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 21' ' ' MET . 5.8 pt -48.32 -24.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.495 ' N ' HG13 ' A' ' 20' ' ' ILE . 4.6 mtt -97.55 3.9 50.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -117.34 96.47 5.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -112.8 127.05 56.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -80.05 99.3 7.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.211 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.19 139.44 46.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.892 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -79.64 93.69 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.1 146.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.9 t -87.86 149.43 45.78 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.233 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.89 176.14 45.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.691 -2.212 . . . . 0.0 110.503 -0.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 4' ' ' SER . 3.2 mtp -75.87 -57.86 3.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.318 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.75 -145.67 35.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.3 mt -88.3 124.86 65.5 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -1.208 . . . . 0.0 109.928 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.83 -163.48 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.465 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -103.15 25.48 9.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -38.99 69.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.76 38.77 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.568 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 8.6 mm -65.98 -45.24 63.52 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.6 Cg_endo -75.38 0.75 8.69 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.513 1.27 . . . . 0.0 110.456 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 3.6 t-20 -111.18 -33.95 6.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -83.13 -29.6 28.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.9 t -43.1 116.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.73 7.54 25.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -94.55 132.64 39.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 110.298 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 10.7 mp0 -93.73 150.08 20.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 9.6 m -87.72 174.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -102.93 -25.49 13.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.576 -179.67 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CG ' ' CG ' ' A' ' 59' ' ' MET . 7.6 ptm180 -135.05 179.88 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.209 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -70.47 149.9 46.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.631 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' HB ' HG13 ' A' ' 11' ' ' ILE . 19.5 t -127.92 124.79 23.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.874 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.48 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.961 1.506 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 1.1 mp -90.61 166.43 13.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.42 33.1 2.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.446 HG22 HG11 ' A' ' 49' ' ' VAL . 92.3 m -78.13 98.44 5.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -1.175 . . . . 0.0 110.075 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.0 m -44.84 148.33 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.84 88.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.163 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.434 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.29 156.04 43.68 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.059 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' CB ' ' HB3' ' A' ' 70' ' ' PRO . 45.3 Cg_endo -72.34 -0.54 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.925 1.487 . . . . 0.0 110.598 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -52.01 65.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.496 ' CG ' ' CG ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -109.99 33.07 4.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 56' ' ' MET . 12.4 t -128.59 109.47 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.541 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 11.1 ptmt -65.8 -149.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 109.835 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 62.6 t30 -64.88 84.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 109.92 179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.551 ' CE2' ' O ' ' A' ' 65' ' ' ASP . 36.5 p90 -83.45 -159.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 55.8 mm-40 -63.44 -124.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 8.3 p-10 -58.61 94.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 110.63 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA3' ' CZ ' ' A' ' 63' ' ' TYR . . . -149.14 54.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -107.93 -12.92 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -1.133 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.447 HG21 ' HD2' ' A' ' 70' ' ' PRO . 6.0 t -70.74 -6.01 34.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.589 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER 174.57 -62.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -72.37 -158.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 110.137 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 62' ' ' ASN . . . 86.32 -83.94 1.59 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 72' ' ' LEU . 4.6 mm? -65.93 143.52 57.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 tttp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.261 -179.904 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.233 0.54 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.32 115.21 7.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.8 t -102.66 141.46 35.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' HB ' ' CG ' ' A' ' 55' ' ' LEU . 23.5 t -73.25 105.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.426 HG11 ' C ' ' A' ' 52' ' ' GLY . 18.0 t -123.62 117.7 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.211 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.514 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -71.87 144.56 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.091 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 17.7 t-20 -83.49 -52.81 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 110.503 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.49 142.5 32.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 110.358 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -60.38 138.57 57.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.091 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.466 HG23 ' CD2' ' A' ' 17' ' ' LEU . 4.0 mt -129.33 133.76 25.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.16 -179.13 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.971 1.511 . . . . 0.0 110.395 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 47' ' ' ARG . 2.6 pt -93.67 -174.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.63 16.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -130.58 118.33 20.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.069 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 44' ' ' GLN . . . -54.9 160.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' CD2' HG23 ' A' ' 11' ' ' ILE . 6.2 mt -118.7 145.26 45.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -119.89 -166.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 110.281 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.9 mt -76.61 -52.32 9.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mt -50.37 -21.76 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.163 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.65 -44.83 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -108.22 120.13 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.266 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -111.11 165.88 11.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 98.42 8.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.01 160.1 17.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.11 50.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 t -117.22 166.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.455 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 48.2 p -81.99 159.75 64.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -74.83 -167.49 5.65 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.536 -0.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 4' ' ' SER . 51.6 mtp -81.64 -46.47 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.474 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.73 -156.35 0.43 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mt -90.5 142.22 27.94 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.22 -1.164 . . . . 0.0 110.409 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 47.4 Cg_endo -73.56 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.086 1.571 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.4 42.63 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.61 -42.43 51.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -103.26 36.91 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 mm -53.04 -54.08 48.22 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.469 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.1 Cg_endo -70.9 -5.88 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.702 1.369 . . . . 0.0 110.709 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.13 -19.05 11.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.955 . . . . 0.0 110.355 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.4 tp -88.14 -29.54 20.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 47.3 t -46.1 116.32 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.31 10.59 23.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -85.29 135.45 33.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 110.211 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.455 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 1.5 mt-30 -106.38 138.69 42.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 110.285 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 13' ' ' ILE . 18.3 m -99.49 170.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.358 -0.839 . . . . 0.0 110.114 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -110.67 -4.85 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.511 ' N ' HG23 ' A' ' 13' ' ' ILE . 6.0 mtt180 -129.05 126.43 39.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.43 143.19 56.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.325 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 80.9 t -129.97 135.7 27.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HD13 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -70.09 -173.78 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.961 1.506 . . . . 0.0 110.427 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -43.05 164.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.955 179.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 51.82 61.31 6.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 53.5 m -84.39 87.72 7.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -1.093 . . . . 0.0 110.628 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.5 m -71.83 121.17 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.634 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -61.37 114.43 3.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.83 -179.276 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.468 ' O ' HG21 ' A' ' 60' ' ' VAL . 5.8 mtm -113.67 156.72 43.18 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.0 1.02 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.97 1.511 . . . . 0.0 110.669 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' MET . 33.7 p30 -91.88 -21.88 20.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.018 . . . . 0.0 110.74 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 44.8 mtt -112.0 -7.75 14.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 56' ' ' MET . 10.8 t -101.14 91.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.082 -1.011 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -48.85 39.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -95.04 74.37 3.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.043 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.525 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -54.12 -165.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.87 . . . . 0.0 110.549 -179.793 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -104.99 -172.39 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.09 66.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.356 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -114.87 114.44 3.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 m -88.56 59.44 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -1.14 . . . . 0.0 110.062 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -106.71 -40.28 5.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.15 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 171.9 -59.25 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.129 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -72.93 55.6 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.974 1.513 . . . . 0.0 110.461 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.77 57.8 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -87.97 -45.56 10.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -1.148 . . . . 0.0 110.205 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.196 0.522 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.56 138.59 39.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.98 162.72 20.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG13 HD22 ' A' ' 55' ' ' LEU . 53.0 t -72.97 102.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.412 HG11 ' C ' ' A' ' 53' ' ' THR . 14.3 t -113.7 103.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -46.67 121.67 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.431 ' OD1' ' HB2' ' A' ' 23' ' ' LYS . 8.4 m120 -72.96 -64.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.877 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tp60 -81.58 149.13 28.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 110.227 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.54 133.62 56.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.956 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD11 HG22 ' A' ' 11' ' ' ILE . 13.1 mm -121.75 136.08 25.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.73 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.058 1.557 . . . . 0.0 110.191 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.2 pt -120.1 -174.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -0.994 . . . . 0.0 110.485 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m120 56.53 16.54 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.06 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 19.1 m -123.05 154.33 38.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.958 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . . . -77.03 163.77 26.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.405 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -111.63 122.62 48.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 179.93 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.1 170.96 7.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 HD23 ' CG1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -67.24 -54.7 18.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.324 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -51.27 -21.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.505 ' N ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -80.97 -48.38 12.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 9.4 ptt? -110.98 141.09 44.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -0.961 . . . . 0.0 110.191 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 21.0 mmtt -120.92 172.63 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.91 92.74 7.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.248 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.74 141.37 32.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -84.29 76.92 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -133.71 150.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.447 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -111.39 161.01 27.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.74 153.29 99.09 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.704 -2.207 . . . . 0.0 110.479 -0.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.5 ptt? -80.48 125.87 30.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.48 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -90.54 -100.71 1.17 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -109.06 131.67 21.66 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 110.137 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.21 177.84 6.75 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -92.56 24.15 3.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.92 -77.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.457 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 pm0 -78.18 55.19 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.057 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -70.73 -30.5 1.79 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.376 -0.827 . . . . 0.0 111.764 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.5 Cg_endo -78.73 -4.46 14.07 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 122.686 0.835 . . . . 0.0 110.047 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 1.8 m120 -112.52 -37.95 4.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.99 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' CA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -76.25 -44.39 37.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 37' ' ' ILE . 21.1 t -45.71 109.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 16' ' ' ALA . . . 122.76 6.75 7.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.524 ' CE ' ' HG3' ' A' ' 64' ' ' GLU . 1.6 ttt -91.69 157.54 16.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.168 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' THR . 42.5 mt-30 -110.14 136.26 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.9 m -88.64 171.63 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.53 -15.85 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.0 111.255 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.6 ptm85 -128.16 150.73 49.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.88 -1.137 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.53 156.44 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 110.752 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' CB ' ' A' ' 53' ' ' THR . 91.6 t -130.17 127.55 22.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -72.57 -168.96 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.832 1.438 . . . . 0.0 110.509 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -80.17 155.95 27.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.188 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.66 43.94 6.64 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.526 ' CB ' HG11 ' A' ' 49' ' ' VAL . 84.9 m -86.33 128.28 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -69.39 141.23 54.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.78 110.4 2.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.455 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -109.42 159.93 29.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.463 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 46.2 Cg_endo -73.97 0.12 8.76 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.089 1.573 . . . . 0.0 110.648 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD1' ' CG ' ' A' ' 59' ' ' MET . 1.3 p30 -91.7 -26.2 18.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.653 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 3.4 mtt -97.2 32.31 2.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 110.077 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.47 125.97 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.552 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -75.39 -80.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 109.84 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' HE1' ' A' ' 43' ' ' MET . 8.0 p30 -100.74 101.44 12.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.463 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -45.78 167.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.799 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 2.1 mp0 -83.05 -68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' OD1' ' OG1' ' A' ' 67' ' ' THR . 3.2 p30 -98.94 -30.47 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.46 51.99 23.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.482 HG21 ' N ' ' A' ' 68' ' ' THR . 38.6 m -72.23 -89.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.087 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.482 ' N ' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -94.17 5.46 51.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 179.766 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -111.27 -178.44 0.54 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 44.7 Cg_endo -72.86 117.4 5.11 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.917 1.482 . . . . 0.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.6 48.78 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.84 130.4 36.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.956 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -76.9 150.77 35.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 40.4 t -116.53 164.56 14.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG12 ' SD ' ' A' ' 22' ' ' MET . 33.3 t -92.54 102.36 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.347 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' HA2' ' A' ' 52' ' ' GLY . 3.4 t -123.71 121.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -70.21 138.85 52.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.115 -0.99 . . . . 0.0 109.998 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.45 -52.49 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -82.2 162.71 22.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.75 179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -67.63 142.97 56.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.466 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 11' ' ' ILE . 14.7 mt -131.25 127.34 21.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.219 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.69 -159.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.79 1.416 . . . . 0.0 110.037 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 36.1 pt -112.44 -165.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.115 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 p30 39.9 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 110.412 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 47.7 m -130.38 136.6 49.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -87.55 130.62 34.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.504 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.7 OUTLIER -103.34 161.48 13.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -130.07 -175.6 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -51.88 -34.28 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -50.06 -60.01 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.76 30.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.317 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.504 ' CE ' HD13 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -123.96 115.32 21.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.297 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.81 124.81 45.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.917 . . . . 0.0 110.215 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.96 97.22 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 26.6 pt-20 -113.13 157.86 21.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 23.0 t -98.51 57.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -126.06 154.65 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 62.7 p -79.14 158.95 73.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.48 176.67 42.57 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.722 -2.199 . . . . 0.0 110.5 -0.167 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.3 mtt -77.13 -107.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.209 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.72 -129.37 9.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 55' ' ' LEU . 4.7 mt -112.04 132.45 22.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.83 -158.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.962 1.506 . . . . 0.0 110.304 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.09 30.92 7.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.433 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -77.41 -15.92 59.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.033 -1.042 . . . . 0.0 109.605 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.3 mp0 -105.02 24.66 11.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.574 -0.704 . . . . 0.0 109.966 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.4 mm -41.7 -53.5 7.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.701 -179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -71.24 -4.65 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.564 1.297 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.32 -36.23 4.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' MET . 2.7 mp -79.8 -42.47 24.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.259 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 42.7 t -42.18 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.367 -0.833 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . 118.67 -6.5 13.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.51 148.96 30.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -1.202 . . . . 0.0 110.207 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' THR . 31.5 mt-30 -109.36 172.25 6.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.8 m -119.53 172.54 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -111.16 -12.81 14.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CD ' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -123.88 140.61 52.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.34 144.34 27.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 110.083 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 34.1 t -130.41 130.23 22.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.1 Cg_endo -77.01 99.77 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.174 1.618 . . . . 0.0 110.331 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 58.4 136.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 110.597 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.33 75.79 0.34 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.537 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 23.4 p -96.63 96.37 8.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.1 m -63.47 136.43 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.273 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.52 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -79.52 103.96 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 110.123 179.973 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 56' ' ' MET . 17.0 ptp -109.48 143.58 28.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.031 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 47.4 Cg_endo -74.25 0.29 8.68 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.035 1.545 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.451 ' HB3' ' SD ' ' A' ' 56' ' ' MET . 50.4 t0 -83.09 -47.2 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.43 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.531 ' HG3' ' CD ' ' A' ' 47' ' ' ARG . 25.7 mmt -99.58 47.52 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.341 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.48 HG13 ' CD1' ' A' ' 63' ' ' TYR . 36.1 t -126.51 91.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.091 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 62' ' ' ASN . 28.9 pttt -71.42 -32.18 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.514 ' N ' ' HG3' ' A' ' 61' ' ' LYS . 61.1 t30 -96.29 52.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.48 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -44.59 152.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.48 -125.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 66' ' ' GLY . 44.4 m-20 -59.34 -43.67 92.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.139 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 46.22 96.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -96.4 -7.35 35.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -96.59 -161.56 0.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -41.11 -55.94 4.56 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 179.97 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -73.88 153.5 47.76 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.963 1.507 . . . . 0.0 110.437 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.44 ' HA2' ' HA3' ' A' ' 66' ' ' GLY . . . 176.24 -57.05 0.11 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -154.06 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -1.126 . . . . 0.0 110.174 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.201 0.524 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.79 113.59 23.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.895 . . . . 0.0 110.215 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -88.52 129.76 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG1' HD23 ' A' ' 55' ' ' LEU . 5.0 t -78.13 125.69 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.273 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 15.2 t -118.39 118.68 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.96 . . . . 0.0 110.281 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -44.97 117.58 1.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.5 t30 -73.58 -52.76 12.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -95.2 148.03 22.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.62 119.77 8.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -129.74 134.33 26.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.2 Cg_endo -72.96 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.963 1.507 . . . . 0.0 110.124 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -146.9 -171.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.212 -0.93 . . . . 0.0 109.99 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.9 p30 36.26 48.83 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.63 . . . . 0.0 110.999 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -123.93 103.34 8.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 110.154 179.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -65.53 144.44 57.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 1.4 mp -98.64 140.48 32.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.3 p -129.34 84.5 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.637 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' MET . 7.7 tp 52.15 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.332 -0.855 . . . . 0.0 110.808 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' THR . 3.3 mt -41.41 -53.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.634 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 mtt -65.58 -13.09 58.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -104.26 119.87 39.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.26 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 19.9 mmtm -118.86 90.83 3.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.96 95.04 2.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 28.9 t -78.69 71.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 26' ' ' VAL . 63.6 t -142.07 161.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.0 t -75.29 151.89 85.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -77.19 -174.93 15.72 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.558 -2.268 . . . . 0.0 110.455 -0.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.2 mpt? -76.63 -109.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.919 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 97.52 -145.29 17.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 55' ' ' LEU . 23.3 mm -74.52 112.3 16.75 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.344 -1.092 . . . . 0.0 110.398 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 47.7 Cg_endo -75.14 -1.86 11.8 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.928 1.488 . . . . 0.0 110.303 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 33' ' ' PRO . . . 69.49 24.64 5.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.82 -44.93 63.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 61.0 mm-40 -99.4 67.43 1.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.622 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 1.9 tp -70.08 -30.97 2.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 112.137 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 45.2 Cg_endo -74.59 -8.25 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 N-CA-C 109.93 -0.835 . . . . 0.0 109.93 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -114.18 -31.1 6.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.368 -0.833 . . . . 0.0 109.529 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.1 tp -69.82 -36.99 76.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 110.059 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 37' ' ' ILE . 22.7 t -43.53 103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.6 24.52 7.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 62' ' ' ASN . 2.4 ttm -95.92 138.97 32.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -1.093 . . . . 0.0 110.241 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 44.7 mt-30 -106.72 151.45 25.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.7 m -95.91 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' C ' HG22 ' A' ' 13' ' ' ILE . 53.9 t30 -111.06 16.71 20.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.383 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HB2' ' HG2' ' A' ' 59' ' ' MET . 20.8 mtt180 -144.1 161.96 37.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.38 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -72.52 134.95 45.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 21.3 t -128.65 128.25 23.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.63 -158.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.825 1.434 . . . . 0.0 110.445 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -87.37 155.31 20.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 110.822 -179.438 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 41.57 40.67 2.94 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 2.2 m -96.97 125.2 41.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.2 m -63.47 108.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD23 ' CG1' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -70.38 122.93 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 110.514 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.449 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 7.6 mtt -100.48 171.23 5.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 109.923 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 45.4 Cg_endo -73.04 -0.65 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.905 1.476 . . . . 0.0 110.55 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.93 -43.65 52.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.323 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -92.13 60.7 3.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.259 -179.831 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 63' ' ' TYR . 25.4 t -130.16 95.57 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -94.49 82.51 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.526 ' CD2' HG12 ' A' ' 60' ' ' VAL . 7.8 t80 -62.31 139.34 58.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 8.6 mm-40 -75.75 -56.64 4.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -96.05 83.17 3.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 70' ' ' PRO . . . -109.4 91.66 0.66 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -107.6 -38.75 5.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -1.142 . . . . 0.0 110.303 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 81.9 p -93.24 -137.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.79 -58.53 3.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.549 -179.798 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -71.07 118.49 5.72 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.907 1.477 . . . . 0.0 110.563 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.3 13.48 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -178.4 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.311 0.577 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -63.18 125.8 25.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.931 . . . . 0.0 110.356 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 30' ' ' MET . 1.1 p -121.76 149.78 42.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 56.0 t -83.13 113.0 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.1 t -121.09 104.59 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.065 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.54 131.53 3.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.412 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -88.75 -63.49 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -73.16 141.72 47.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.067 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -59.35 131.11 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mt -122.96 140.1 32.74 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.56 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.087 1.572 . . . . 0.0 110.366 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.513 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.3 mt -110.63 -175.77 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.7 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 13' ' ' ILE . 10.0 p30 39.35 29.98 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.613 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 13' ' ' ILE . 52.4 m -122.02 133.34 54.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.11 151.93 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.233 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 pp -119.96 157.05 29.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.56 159.06 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 -43.34 51.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.8 mt -53.97 -29.98 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 mtt -85.77 -21.28 28.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.492 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.94 106.66 17.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.442 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -106.17 118.13 35.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.55 109.92 14.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.143 -0.973 . . . . 0.0 110.306 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.18 152.16 25.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' O ' HG11 ' A' ' 27' ' ' VAL . 60.4 t -90.69 63.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 26' ' ' VAL . 11.5 m -147.75 -178.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -94.84 162.15 26.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.61 165.41 85.73 Favored 'Cis proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.404 -0.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -61.66 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 -149.28 28.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 55' ' ' LEU . 4.9 mt -104.28 136.74 19.14 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.04 -159.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.999 1.526 . . . . 0.0 110.377 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -116.53 46.61 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.444 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 6.2 pt-20 -74.27 -27.04 60.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.11 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 6.9 mm-40 -104.55 36.18 2.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.9 mm -54.79 -51.1 81.93 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 110.8 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -71.02 -5.1 16.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.389 1.205 . . . . 0.0 110.715 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 63.1 m-80 -114.2 -50.18 2.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.367 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -68.27 -35.21 77.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 17.2 t -53.74 122.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.96 -14.91 31.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -85.0 159.78 20.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.146 . . . . 0.0 110.161 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -105.42 178.3 4.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.5 m -116.78 173.01 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 59.2 t30 -111.06 -9.04 14.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.473 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -130.56 172.06 12.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -0.923 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -76.09 151.55 37.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 53' ' ' THR . 37.3 t -127.95 108.0 20.13 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HD11 ' A' ' 10' ' ' LEU . 43.9 Cg_endo -71.61 -165.26 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.032 1.543 . . . . 0.0 110.461 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -77.6 150.08 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.12 49.19 24.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.498 ' CB ' HG11 ' A' ' 49' ' ' VAL . 16.7 m -91.69 120.09 32.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 54' ' ' THR . 10.7 t -61.13 149.38 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -68.38 105.73 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtm -110.34 139.35 21.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 110.277 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.9 -4.11 14.88 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.989 1.521 . . . . 0.0 110.631 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.91 -20.85 48.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 46' ' ' ASN . 3.8 mtt -105.23 12.37 31.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.232 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . 21.3 t -106.44 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 60' ' ' VAL . 73.0 mttt -43.9 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.091 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.431 ' O ' ' HE3' ' A' ' 43' ' ' MET . 4.1 m120 -100.78 104.43 15.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.088 -1.007 . . . . 0.0 110.085 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.564 ' CE2' ' HG2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -44.33 165.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.956 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 2.4 mm-40 -64.36 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.116 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -48.75 79.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.82 -22.64 16.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 30.2 2.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 110.183 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' SER . 20.7 m -100.73 -60.0 1.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER 173.27 -59.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.203 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.564 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.17 90.99 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.887 1.467 . . . . 0.0 110.373 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.44 120.32 0.76 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -28.13 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -1.164 . . . . 0.0 110.319 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.219 0.533 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.35 143.1 24.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -119.38 125.89 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 53.8 t -65.97 124.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.295 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 53' ' ' THR . 25.6 t -116.99 123.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 53' ' ' THR . . . -46.57 134.89 9.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.258 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -90.37 -69.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.4 144.54 30.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.92 135.82 57.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.4 pt -124.9 119.72 25.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' ILE . 45.4 Cg_endo -72.09 57.79 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.847 1.446 . . . . 0.0 110.251 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 1.8 mt 49.64 179.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.705 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 m-80 43.76 26.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 110.241 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.487 ' N ' ' HB3' ' A' ' 44' ' ' GLN . 17.8 m -119.92 103.05 9.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.862 . . . . 0.0 110.1 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . . . -57.86 152.89 15.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 110.405 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.93 156.35 23.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.76 -169.83 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 7.7 mp -64.55 -46.83 81.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.14 -20.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.05 3.61 54.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.478 ' SD ' ' CG1' ' A' ' 5' ' ' VAL . 1.7 mmm -112.47 106.18 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -105.98 115.33 30.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.255 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.03 98.07 4.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.9 142.05 46.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.0 85.84 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 110.18 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.52 153.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.4 p -91.69 157.6 41.52 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.89 -172.7 11.34 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.486 -0.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 ptp -82.4 -151.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.334 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 154.69 -127.46 2.1 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 32' ' ' ILE . 20.1 mm -91.12 108.86 31.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.279 -1.13 . . . . 0.0 110.277 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 31' ' ' GLY . 50.2 Cg_endo -76.5 50.41 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.936 1.492 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 45.67 24.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.33 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 67' ' ' THR . 36.1 tt0 -77.01 -33.81 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.88 39.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.906 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 2.4 mm -54.75 -57.2 20.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.77 -1.78 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.652 1.343 . . . . 0.0 110.744 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.94 -51.21 2.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.396 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HG ' ' CE ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -69.22 -39.79 78.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 58.4 t -52.6 103.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.223 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -35.1 2.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.469 ' CE ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.51 159.58 18.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -1.123 . . . . 0.0 110.286 -179.975 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HG3' ' CA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -110.26 -169.28 1.44 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.821 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 11' ' ' ILE . 3.7 m -120.19 172.24 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.19 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 2.8 m120 -111.18 0.47 16.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.411 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -123.31 142.54 50.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -62.2 129.14 39.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 54.6 t -121.12 123.67 27.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.05 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.849 1.447 . . . . 0.0 110.513 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.5 144.09 27.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' C ' HG11 ' A' ' 6' ' ' VAL . . . 61.31 39.92 97.89 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.509 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 79.5 m -88.75 145.73 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -1.174 . . . . 0.0 110.106 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.3 m -72.45 143.97 48.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 5' ' ' VAL . 1.7 mm? -69.93 80.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -94.06 143.82 27.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.915 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.19 -1.42 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.96 1.505 . . . . 0.0 110.377 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CB ' ' A' ' 56' ' ' MET . 18.7 p-10 -70.44 -12.01 61.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.28 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.526 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -108.75 -25.06 11.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.83 105.56 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.181 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -63.11 1.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.196 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' TYR . 10.2 m120 -95.04 86.41 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.37 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -44.46 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 0.0 110.168 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HG2' ' HE1' ' A' ' 43' ' ' MET . 33.4 mm-40 -79.93 -97.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.56 -32.14 18.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 0.0 110.223 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' CA ' ' HA3' ' A' ' 71' ' ' GLY . . . 102.85 105.02 2.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.446 HG23 ' OE1' ' A' ' 35' ' ' GLU . 1.7 m -107.69 -54.76 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -1.133 . . . . 0.0 110.436 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 60.8 p -101.98 -157.18 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -44.63 -57.27 6.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -71.49 79.93 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.999 1.526 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CA ' ' A' ' 66' ' ' GLY . . . -173.67 47.88 0.15 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -94.24 -40.9 9.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.31 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.197 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 mttp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.212 0.529 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.533 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -87.7 138.05 31.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -120.42 146.91 45.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.237 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 45.0 t -77.39 111.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.38 124.5 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -69.5 119.89 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.492 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.9 p-10 -74.97 -43.57 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -96.56 135.64 38.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.182 179.887 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.98 153.82 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.674 -179.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -130.45 126.8 22.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.995 . . . . 0.0 110.07 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.6 Cg_endo -76.85 47.97 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.831 1.437 . . . . 0.0 110.82 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.517 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.2 mt 51.72 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 44.98 31.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -126.32 105.17 8.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 138.85 42.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -92.26 139.49 30.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.8 OUTLIER -108.16 167.92 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 20' ' ' ILE . 6.1 tt -58.84 -42.78 90.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.947 . . . . 0.0 110.266 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' MET . 18.1 pt -67.03 -41.37 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.911 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.774 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.495 ' CG ' ' O ' ' A' ' 22' ' ' MET . 6.0 ptt? -115.38 123.8 49.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 159.94 24.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.0 101.78 13.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.362 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -113.07 136.91 52.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 54.9 t -91.64 88.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.99 -173.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 23.9 m -116.31 146.03 36.4 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 110.013 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 50.2 Cg_endo -75.58 -178.51 23.9 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.788 -2.172 . . . . 0.0 110.509 -0.174 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -159.51 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.14 -148.48 10.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.1 mt -85.11 131.48 48.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.294 -1.121 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.26 178.99 5.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.63 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 37' ' ' ILE . . . -98.48 25.79 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 18.2 pt-20 -76.96 -18.68 58.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 10.2 mm-40 -104.85 48.81 0.83 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.286 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -54.53 -50.59 84.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.943 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.53 -0.58 9.93 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.818 1.43 . . . . 0.0 110.703 -179.594 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -114.29 -28.03 7.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.932 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -89.13 -38.09 14.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 110.371 -179.857 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.08 91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 121.64 28.39 1.59 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.499 ' HE2' ' N ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -98.93 131.5 44.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -1.182 . . . . 0.0 110.256 179.957 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -109.46 126.77 53.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.2 m -83.71 168.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.429 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 t30 -110.96 1.64 17.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.522 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -134.84 133.65 39.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -50.55 140.58 13.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.336 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 53' ' ' THR . 55.1 t -130.09 135.94 28.25 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.071 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.2 Cg_endo -72.13 -173.26 1.04 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.717 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -76.5 162.36 27.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.91 . . . . 0.0 110.536 -179.717 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.24 44.67 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.573 ' CB ' ' CG1' ' A' ' 49' ' ' VAL . 82.1 m -96.43 119.86 35.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -1.212 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.3 p -54.75 127.3 27.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -61.68 113.34 2.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.177 -179.933 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.0 ptp -106.99 151.69 40.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.46 1.59 7.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.135 1.597 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' CE ' ' A' ' 59' ' ' MET . 1.8 t70 -76.71 -43.88 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 110.558 -179.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.522 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 9.2 mmt -105.5 63.54 0.69 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.361 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.2 t -130.17 99.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -61.02 -71.62 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -90.8 75.37 6.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.118 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.5 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 25.6 t80 -51.71 145.36 9.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.381 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' N ' ' HE2' ' A' ' 43' ' ' MET . 7.4 pm0 -64.42 -141.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.18 78.24 0.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.85 100.05 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -81.6 4.51 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -1.162 . . . . 0.0 110.248 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -76.67 -160.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.965 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -42.4 -56.42 5.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.301 179.867 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -72.46 162.49 41.29 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.972 1.512 . . . . 0.0 110.493 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.64 61.58 0.62 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.25 -44.82 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.0 110.254 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.182 179.982 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.258 0.551 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 164.97 19.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -123.17 158.6 30.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.77 114.72 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 4.2 t -126.49 122.09 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . . . -56.67 127.62 32.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 24.2 t-20 -77.45 -48.68 16.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.09 158.29 15.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.132 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.02 132.49 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 7' ' ' ALA . 1.1 mp -117.65 122.67 30.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HB2' HD13 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -71.57 -95.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.749 1.394 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -162.02 -173.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.095 179.527 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.9 p30 40.21 31.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' CG2' ' A' ' 11' ' ' ILE . 5.7 t -124.11 138.2 54.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.452 ' O ' ' HE3' ' A' ' 21' ' ' MET . . . -71.55 154.97 41.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.424 HD11 ' HE1' ' A' ' 43' ' ' MET . 51.3 mt -120.97 104.42 9.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.886 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -96.81 167.89 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.978 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -64.96 -25.15 67.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.503 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.6 mt -69.63 -19.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.452 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 1.6 ttp -97.73 -20.88 17.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' A' ' 7' ' ' ALA . 1.4 mtt -118.91 143.51 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.112 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.75 172.09 7.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.07 102.05 14.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp10 -112.03 128.58 56.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 14.5 p -91.95 77.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.38 166.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.18 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.429 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.9 t -92.83 144.83 29.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.55 157.21 99.12 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.416 -0.248 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.3 mtt -72.79 -26.25 61.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.77 -132.02 43.99 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.8 mt -106.28 134.79 19.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.287 -1.125 . . . . 0.0 110.223 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -170.52 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.942 1.496 . . . . 0.0 110.407 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.47 46.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.272 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.05 -40.07 54.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 14.9 mm-40 -104.91 31.2 4.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.2 mm -42.68 -54.27 8.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.4 Cg_endo -71.53 -2.22 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.615 1.323 . . . . 0.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.02 -32.15 6.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.894 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -85.55 -24.6 27.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.351 -179.848 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 24.8 t -42.58 119.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.2 8.78 28.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.447 ' SD ' HG12 ' A' ' 60' ' ' VAL . 18.9 ttp -72.34 134.66 45.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -1.194 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mt-30 -110.01 125.59 53.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 3.7 m -79.99 154.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 110.141 179.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -108.26 10.1 27.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.405 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.57 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.52 137.44 26.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -45.06 128.19 7.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 47.5 t -111.85 134.75 21.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 47.6 Cg_endo -74.12 -171.57 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.023 1.539 . . . . 0.0 110.477 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.31 164.01 22.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 110.281 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 43.43 30.32 1.31 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.591 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 72.9 m -76.15 104.16 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -1.196 . . . . 0.0 110.401 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.39 153.69 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.053 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -62.16 100.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.314 -179.841 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.7 mtm -113.55 145.34 33.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.435 -0.791 . . . . 0.0 110.287 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.62 0.18 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.001 1.527 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.97 -55.36 14.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.444 ' SD ' HG21 ' A' ' 49' ' ' VAL . 46.8 mtt -103.35 40.72 1.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 110.431 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 56' ' ' MET . 93.6 t -130.47 133.34 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -142.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' C ' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-20 -76.39 79.61 3.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 110.297 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CD2' ' N ' ' A' ' 64' ' ' GLU . 18.0 p90 -84.62 -167.96 2.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.501 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 47.5 tp10 -71.94 76.79 0.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' HD2' ' A' ' 70' ' ' PRO . 10.1 t0 -99.31 -64.74 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.46 -126.94 1.06 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -108.92 -70.72 0.79 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 110.477 -179.77 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -18.29 59.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.51 -179.16 0.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.956 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -72.55 84.67 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.958 1.504 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -165.7 -36.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.7 113.76 5.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.144 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.3 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.143 179.949 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.232 0.539 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.01 138.26 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.3 p -123.74 157.5 33.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.442 ' CG1' ' HE3' ' A' ' 22' ' ' MET . 61.6 t -80.1 124.28 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -129.2 107.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 179.975 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -46.65 116.18 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 52.6 t30 -77.79 -46.52 21.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.15 136.22 33.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.7 pt? -78.12 131.68 37.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.34 -179.891 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 10.4 pt -128.9 155.73 79.06 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.872 . . . . 0.0 109.989 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.491 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.85 -96.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.89 1.468 . . . . 0.0 110.159 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -152.24 172.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.961 -1.087 . . . . 0.0 109.889 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.81 21.38 5.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 110.353 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -97.91 117.07 31.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.03 157.55 5.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' O ' HG11 ' A' ' 41' ' ' VAL . 30.1 mt -98.43 111.16 23.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 p -95.41 155.91 16.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -28.08 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.378 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mt -68.64 -36.88 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.922 . . . . 0.0 110.235 -179.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 42.3 mtp -88.74 11.82 16.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.455 ' HA ' ' CE ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -112.35 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -109.59 112.83 25.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.18 105.53 3.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.326 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -109.68 155.37 21.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.157 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.65 24.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 28' ' ' THR . 31.7 t -95.68 148.38 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -77.34 168.25 29.55 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.955 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -73.77 -170.58 7.97 Favored 'Cis proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.624 -2.24 . . . . 0.0 110.417 -0.134 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.412 ' HG3' ' N ' ' A' ' 31' ' ' GLY . 5.3 ptt? -76.56 -34.82 58.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.248 180.0 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 45.56 -131.45 9.42 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.451 HG21 ' HD2' ' A' ' 33' ' ' PRO . 4.7 mt -112.26 137.35 21.49 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.276 179.994 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HD2' HG21 ' A' ' 32' ' ' ILE . 44.4 Cg_endo -71.99 -166.86 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.008 1.531 . . . . 0.0 110.479 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -116.84 33.83 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -41.35 85.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASN . 73.4 mm-40 -104.78 32.53 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.3 mm -42.88 -51.32 12.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.599 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -72.04 -1.4 9.97 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.483 1.254 . . . . 0.0 110.681 -179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.75 -38.08 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 179.933 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -75.26 -34.12 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.911 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 17' ' ' LEU . 21.6 t -46.96 139.61 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -11.69 54.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.4 tpp -82.01 132.52 35.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.116 . . . . 0.0 110.209 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -92.94 -179.41 5.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.17 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.0 m -118.42 163.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.343 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -111.19 3.42 18.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.542 -179.91 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.7 mmt180 -139.18 -176.75 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 0.0 110.41 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -79.8 140.83 36.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.25 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 11' ' ' ILE . 4.5 t -119.28 116.49 33.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . 47.0 Cg_endo -73.96 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -76.89 152.01 35.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.45 42.01 25.81 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 50' ' ' PRO . 61.4 m -82.36 115.02 21.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.2 t -54.74 155.63 4.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.98 103.63 3.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.924 . . . . 0.0 110.229 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.452 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -112.17 145.14 32.2 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.997 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -12.24 25.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.982 1.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -62.17 -56.76 15.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.288 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 5.9 mtt -93.45 39.81 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 56' ' ' MET . 53.3 t -130.44 126.87 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 110.233 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -161.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 110.056 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.542 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 27.3 p-10 -69.2 79.81 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 3.4 p90 -82.2 -170.11 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -63.76 145.46 55.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.075 -1.016 . . . . 0.0 111.205 -178.679 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 10.3 t0 -98.17 79.06 2.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.577 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.22 -87.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.259 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -52.39 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.793 -179.286 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 21.2 p -69.72 -174.07 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.611 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 6.5 t -119.02 41.16 0.39 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 111.564 -179.456 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 69' ' ' SER . 43.8 Cg_endo -72.33 -169.44 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.569 1.299 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 66.5 33.79 85.74 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -43.98 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -1.158 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.277 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.214 0.531 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -85.38 151.24 24.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.99 135.7 54.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG13 HD22 ' A' ' 55' ' ' LEU . 94.7 t -78.88 121.82 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.59 116.66 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.026 179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -67.16 122.35 17.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.133 179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -42.29 32.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.429 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -88.05 143.53 27.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.263 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.6 tt -63.92 143.93 57.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 mt -130.38 112.53 16.77 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.278 -0.889 . . . . 0.0 110.401 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.35 59.56 5.45 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.787 1.414 . . . . 0.0 110.408 179.615 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 42.3 pt 38.19 -163.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.834 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 42.46 27.75 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.821 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.3 m -140.93 121.32 14.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' N ' ' HG3' ' A' ' 44' ' ' GLN . . . -58.18 171.31 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.917 . . . . 0.0 110.161 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mt -113.8 138.03 50.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -124.47 -179.67 4.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.262 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.19 -53.53 16.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' HG21 ' A' ' 20' ' ' ILE . 2.7 mp -58.36 -15.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtt -82.45 -47.02 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 1.7 ptt? -119.91 149.42 42.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -111.9 169.33 8.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.03 92.29 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.213 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.52 137.64 50.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 3' ' ' ALA . 76.3 t -90.73 60.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 28' ' ' THR . 55.3 t -132.7 170.23 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -79.93 151.86 73.85 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.998 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 48.8 Cg_endo -75.69 178.95 32.65 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.678 -2.217 . . . . 0.0 110.535 -0.227 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -74.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.89 -166.88 53.09 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.535 HD13 ' CE1' ' A' ' 63' ' ' TYR . 16.2 mm -63.19 133.64 95.52 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.155 -1.203 . . . . 0.0 110.005 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 43.6 Cg_endo -72.75 -174.5 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.851 1.448 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.57 23.41 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.731 -179.496 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -77.33 -19.08 56.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -105.11 10.03 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.789 . . . . 0.0 110.116 -179.52 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 5.8 mm -41.9 -55.33 6.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 110.552 -179.79 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.51 -4.55 14.76 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.584 1.307 . . . . 0.0 110.72 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.8 m120 -114.18 -25.96 8.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 110.457 -179.835 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -91.27 -25.29 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.863 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 33.1 t -42.99 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 121.01 15.15 4.83 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.416 ' CE ' ' HG2' ' A' ' 64' ' ' GLU . 36.3 tpp -87.75 136.5 32.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -1.169 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -102.54 149.09 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 6.2 m -113.6 161.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 46' ' ' ASN . 2.3 t30 -111.32 -1.82 15.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 179.792 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 3.5 mtt180 -115.12 137.98 51.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.253 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.53 145.13 1.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.333 -179.516 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.601 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 2.8 t -126.05 110.82 24.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.086 -179.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' HB ' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -176.34 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.929 1.489 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' GLY . 1.6 mp -71.45 157.23 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.046 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.82 32.21 1.33 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.8 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.601 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 6.7 t -69.16 138.44 54.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.444 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 12.6 t -85.21 142.28 29.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.611 179.255 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 mm? -61.67 117.94 6.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.1 mtt -111.99 150.02 41.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.922 . . . . 0.0 110.338 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 -16.83 24.31 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.021 1.537 . . . . 0.0 110.364 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.73 -16.31 42.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.468 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 mtm -111.78 38.24 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.957 . . . . 0.0 110.182 -179.917 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 63' ' ' TYR . 77.5 t -130.33 114.91 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.07 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -57.12 -99.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.374 -179.725 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 62' ' ' ASN . 22.0 p-10 -100.34 96.98 7.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.99 -1.068 . . . . 0.0 110.182 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.563 ' CE1' HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -49.24 146.7 3.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 110.26 179.936 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 72.9 mm-40 -76.72 -56.05 4.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 42.0 p-10 -84.22 55.13 3.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.029 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.44 67.54 3.69 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -93.49 -20.27 20.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.054 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.52 -158.81 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.93 -55.78 4.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.899 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.5 Cg_endo -73.53 138.13 26.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.019 1.536 . . . . 0.0 110.395 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -25.98 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.18 27.13 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.232 179.989 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.253 0.549 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -81.26 130.88 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.34 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 159.67 15.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 32' ' ' ILE . 37.7 t -83.15 127.38 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 54' ' ' THR . 5.3 t -124.44 127.32 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.406 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -45.56 127.79 7.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.19 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 28.0 t30 -89.57 -58.22 2.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.204 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -91.88 145.65 24.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 10' ' ' LEU . 2.0 tt -64.2 109.64 1.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 pt -123.6 137.36 28.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.069 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.467 ' O ' HG21 ' A' ' 13' ' ' ILE . 46.8 Cg_endo -73.41 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.014 1.534 . . . . 0.0 110.14 179.845 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.537 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.0 pt -146.41 -164.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.128 -0.982 . . . . 0.0 110.197 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.8 p30 40.37 27.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 0.0 110.561 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.3 m -116.61 111.71 20.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . . . -62.88 133.99 55.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.9 mt -81.18 145.64 30.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 110.061 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -129.93 137.5 50.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 110.322 179.915 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' THR . 3.6 tt -43.76 -43.67 6.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 HD21 ' A' ' 19' ' ' LEU . 8.1 mt -67.55 -21.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.358 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -97.54 -23.36 16.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.477 ' HE3' ' CG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -116.42 120.0 37.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.34 147.95 27.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 110.164 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.0 116.41 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.32 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.33 151.2 30.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 44.1 t -92.37 78.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.288 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.8 149.91 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.141 179.931 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 43.6 p -97.7 159.96 29.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.472 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.85 152.88 97.42 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.439 -0.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.06 127.2 32.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.834 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.9 -110.66 3.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.786 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 55' ' ' LEU . 8.5 mm -86.03 114.69 58.51 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.107 . . . . 0.0 110.628 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.51 -161.57 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.449 179.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -109.76 27.79 9.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.23 -38.24 51.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.958 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' OE2' ' HB3' ' A' ' 65' ' ' ASP . 48.0 mm-40 -94.12 32.68 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.133 -0.979 . . . . 0.0 110.943 -179.288 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -43.65 -51.72 15.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.963 -1.085 . . . . 0.0 110.4 179.722 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -73.23 -11.39 24.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.732 1.385 . . . . 0.0 110.996 -179.427 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -105.66 -46.43 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.099 179.835 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.2 -43.98 97.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.202 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 39.9 t -43.61 119.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . 93.91 16.02 46.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.501 ' HE3' ' CG1' ' A' ' 60' ' ' VAL . 4.6 ttm -83.91 135.09 34.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -1.147 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -106.92 124.83 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 3.2 m -85.08 158.55 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -103.73 -3.57 24.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.124 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.522 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 10.2 mtt180 -123.28 155.66 36.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.7 58.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.425 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 53' ' ' THR . 28.2 t -127.86 113.61 20.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 179.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 53' ' ' THR . 44.9 Cg_endo -72.07 -162.9 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.946 1.498 . . . . 0.0 110.6 -179.871 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.32 155.98 28.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.968 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.5 45.82 6.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 50' ' ' PRO . 87.4 m -94.02 100.07 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.157 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' HG11 ' A' ' 6' ' ' VAL . 23.8 m -44.91 123.77 4.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD1' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -61.97 115.47 4.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 60' ' ' VAL . 19.8 mtp -112.25 164.24 15.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.48 -0.763 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 49.7 Cg_endo -76.37 6.5 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.08 1.568 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -42.16 11.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.07 -1.019 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.522 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -100.22 52.6 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 -179.9 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HE3' ' A' ' 43' ' ' MET . 17.4 t -129.97 123.42 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.898 . . . . 0.0 110.22 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -73.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 6.7 t-20 -100.52 93.31 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.462 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 96.3 m-85 -52.64 151.9 4.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.5 mp0 -68.44 -70.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.148 179.865 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 33.2 p-10 -84.49 94.89 8.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.938 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.67 38.39 3.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.4 m -107.81 -16.5 14.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.96 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 61.6 p -100.58 -140.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.511 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -75.65 -56.94 1.67 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 -179.828 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.8 Cg_endo -72.97 73.21 3.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.919 1.484 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.426 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -130.81 0.65 5.42 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.21 137.74 34.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.242 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.62 124.55 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 -179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 t -82.93 173.2 12.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.172 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 33' ' ' PRO . 78.8 t -84.23 108.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.462 HG12 HG21 ' A' ' 54' ' ' THR . 4.1 t -123.78 107.4 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -58.68 121.62 11.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 3.5 m-20 -72.65 -55.34 7.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.459 ' O ' HG12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.73 156.45 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.746 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.31 124.41 24.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 9' ' ' GLN . 22.0 mm -124.0 113.19 28.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.458 ' O ' HG21 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -73.82 -92.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.0 110.404 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -161.89 -177.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.108 -0.995 . . . . 0.0 110.291 179.99 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 50.74 21.74 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.5 m -124.5 113.34 17.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.085 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -55.66 152.79 8.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.126 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -96.76 138.62 34.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -167.02 1.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.276 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.68 -63.36 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.295 -179.954 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -49.09 -24.93 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 110.194 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -85.93 3.72 40.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 110.201 179.948 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.7 mtt -116.37 118.37 32.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.0 160.07 23.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.092 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.08 83.03 1.92 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.34 135.83 44.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -94.38 77.83 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.7 120.03 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.451 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.2 p -83.25 150.39 60.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 110.152 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.82 129.89 19.93 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.483 -0.151 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.402 ' N ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -71.25 118.37 13.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -102.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.471 ' CD1' ' OH ' ' A' ' 63' ' ' TYR . 3.0 mt -118.15 137.62 24.73 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.238 -1.154 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' O ' HG22 ' A' ' 5' ' ' VAL . 48.3 Cg_endo -73.46 -162.68 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.12 1.589 . . . . 0.0 110.615 -179.887 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -107.69 45.63 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.92 -35.58 67.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' ASN . 6.9 mm-40 -104.97 35.29 2.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.817 . . . . 0.0 109.872 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mm -40.5 -52.17 6.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -71.39 -9.49 25.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.594 1.313 . . . . 0.0 110.766 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -106.25 -25.62 11.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.087 179.715 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' HG ' ' HE1' ' A' ' 43' ' ' MET . 0.2 OUTLIER -94.6 -40.36 9.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.83 . . . . 0.0 110.26 179.996 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 42.8 t -45.08 107.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 112.42 18.26 7.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.82 147.61 23.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -104.16 148.73 25.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 13' ' ' ILE . 3.2 m -111.27 161.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' C ' HG23 ' A' ' 13' ' ' ILE . 15.4 t-20 -109.44 17.74 21.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.282 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -136.44 128.01 28.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.39 179.889 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -62.19 130.17 44.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -128.67 128.17 23.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.77 -166.06 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.314 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.66 126.75 26.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.954 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 90.15 73.72 1.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.507 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 68.9 m -92.06 99.1 11.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -1.127 . . . . 0.0 110.326 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 6' ' ' VAL . 41.1 p -64.58 132.37 49.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.93 85.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.112 179.935 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.2 mtt -103.33 142.9 25.53 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.25 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.516 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -75.2 2.78 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.078 1.567 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.13 -20.8 21.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.355 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.449 ' HE2' HG23 ' A' ' 49' ' ' VAL . 50.7 mtm -108.36 -6.86 16.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.445 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.569 HG13 ' CG ' ' A' ' 63' ' ' TYR . 85.6 t -93.95 107.69 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -77.42 -60.68 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.1 t-20 -95.68 74.4 3.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.334 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.569 ' CG ' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -54.48 163.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.158 179.937 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -65.04 -178.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.108 179.892 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLY . 1.4 m-20 -59.75 -58.2 9.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.4 131.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 m -88.86 -62.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -108.7 51.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -154.32 -178.83 0.94 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.878 . . . . 0.0 110.0 179.904 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -72.93 103.06 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.909 1.478 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.89 56.25 0.17 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.91 85.42 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -1.129 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.293 0.568 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.29 159.0 18.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.16 179.933 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -122.47 145.81 47.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.95 112.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 110.208 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.63 132.49 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 0.0 110.158 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -80.15 130.29 35.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.278 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 39.5 t30 -80.02 -69.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -65.78 130.85 44.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 179.85 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 2.0 pt? -62.26 133.0 54.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.58 -179.716 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.46 HG13 HG21 ' A' ' 49' ' ' VAL . 1.3 pt -130.13 134.77 26.5 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.1 Cg_endo -73.68 168.78 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.935 1.492 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -46.66 174.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 60.35 -152.4 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 58.49 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.92 . . . . 0.0 110.057 -179.835 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -56.28 154.02 8.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.43 144.14 26.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.2 OUTLIER -124.86 155.22 39.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 110.31 -179.934 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 2.0 tt -68.07 -46.35 71.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.72 -14.63 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.943 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.442 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -87.85 -47.34 8.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.265 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.416 ' CE ' ' HB1' ' A' ' 7' ' ' ALA . 20.1 mtp -97.36 142.14 29.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -108.46 167.65 9.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.046 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.69 106.81 18.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.43 144.42 32.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 45.7 t -97.1 66.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.207 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.06 -166.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 35.3 p -118.13 160.14 40.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.873 . . . . 0.0 110.132 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 50.5 Cg_endo -77.13 145.18 80.24 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.47 -0.137 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -76.1 75.24 2.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.957 179.742 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.08 -119.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 10.2 mm -82.49 115.14 56.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.446 -1.032 . . . . 0.0 110.47 -179.619 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 49.0 Cg_endo -75.64 50.21 2.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.95 1.5 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . 41.82 29.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -42.98 99.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 110.457 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 59.3 mm-40 -104.16 34.08 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mm -42.77 -54.57 8.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -71.7 -4.56 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.639 1.336 . . . . 0.0 110.676 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.03 -21.58 10.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.874 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 36' ' ' GLU . 16.0 tp -92.1 -40.1 11.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 75.0 t -44.53 115.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 110.184 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.53 14.96 24.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.538 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 5.0 ttp -104.45 157.94 16.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -106.75 141.4 38.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -90.22 164.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -110.49 10.7 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.172 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.523 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -153.17 124.71 7.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.022 179.996 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.74 150.09 5.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.514 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -128.22 137.85 31.74 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' O ' ' HB ' ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.18 -168.79 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.99 1.521 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -70.14 155.59 40.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 110.06 179.864 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 44.36 40.71 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.545 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 15.2 t -78.37 130.11 35.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 110.326 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 t -78.05 145.04 36.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.15 107.37 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -106.64 146.46 33.11 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 179.988 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.28 -0.77 10.06 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.428 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.94 -20.27 26.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.523 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 4.1 mtt -112.45 32.82 5.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.923 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 11.8 t -121.09 118.95 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.031 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -86.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.857 . . . . 0.0 110.271 -179.785 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.95 89.57 7.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -45.11 160.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CE ' ' A' ' 43' ' ' MET . 1.3 mp0 -103.97 -47.96 4.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.14 85.6 3.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 72.57 0.53 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.455 HG21 ' HA3' ' A' ' 71' ' ' GLY . 14.1 m -84.53 54.65 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 69' ' ' SER . 58.1 p -106.27 -89.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.79 -57.97 2.32 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -72.52 -3.02 12.67 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.904 1.476 . . . . 0.0 110.321 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.455 ' HA3' HG21 ' A' ' 67' ' ' THR . . . -108.62 128.37 9.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -15.36 16.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 -179.932 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.311 0.577 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -85.3 135.78 33.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -105.84 144.72 32.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.912 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 29.9 m -76.31 130.05 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.253 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 54' ' ' THR . 12.4 t -129.57 118.06 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.61 116.94 2.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.148 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 5.1 p-10 -75.07 -43.8 51.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tt0 -97.12 150.96 20.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 50' ' ' PRO . 4.9 tt -63.88 105.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 109.89 179.769 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 7.9 mm -99.5 139.37 20.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.516 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.6 -157.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.124 1.592 . . . . 0.0 110.201 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.26 -165.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.008 179.715 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.4 p30 38.45 32.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.6 m -133.39 142.98 48.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.341 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -75.27 148.83 39.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -105.88 151.36 24.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -115.05 -170.58 1.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.16 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.99 -49.45 45.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.856 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.428 HG13 ' HG2' ' A' ' 21' ' ' MET . 3.4 pt -55.36 -18.98 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.201 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.5 mmm -90.57 9.38 29.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.27 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.418 ' HE2' HD22 ' A' ' 40' ' ' LEU . 33.6 mtp -123.3 122.83 39.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -117.16 114.04 23.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.259 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.75 83.89 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.47 126.09 42.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 3' ' ' ALA . 73.0 t -86.42 79.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.6 169.57 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.968 . . . . 0.0 110.368 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -117.21 150.16 45.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.982 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.2 Cg_endo -75.48 134.73 37.14 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.679 -2.217 . . . . 0.0 110.395 -0.132 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 30' ' ' MET . 1.1 ptt? -80.83 136.93 36.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.552 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -89.9 -116.35 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.512 ' CG2' ' OE2' ' A' ' 36' ' ' GLU . 9.9 mm -81.24 136.28 49.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.281 -1.129 . . . . 0.0 109.802 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 47.3 Cg_endo -74.05 4.88 3.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.965 1.508 . . . . 0.0 111.238 -179.478 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . . . 68.12 18.4 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -11.43 59.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 179.642 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -105.04 28.27 7.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 110.324 -179.375 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.8 mm -42.19 -53.34 8.79 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.566 -179.852 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.23 -5.07 16.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.61 1.321 . . . . 0.0 110.81 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 65' ' ' ASP . 8.4 m-80 -114.03 -49.02 2.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.973 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 55' ' ' LEU . 2.3 tp -66.69 -39.97 88.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 38.9 t -50.87 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 116.96 24.57 3.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.452 ' HG2' ' HG ' ' A' ' 40' ' ' LEU . 2.8 ppp? -104.53 154.58 19.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -1.169 . . . . 0.0 110.265 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -109.39 123.86 50.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -77.76 165.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 59' ' ' MET . 44.5 t30 -110.35 -12.28 14.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.139 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.8 mtp85 -120.32 146.57 45.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 149.86 15.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 11' ' ' ILE . 38.5 t -126.13 112.52 24.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -72.72 -167.78 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.852 1.448 . . . . 0.0 110.522 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -73.64 149.04 42.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.82 53.21 6.38 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.51 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 84.6 m -96.52 122.16 39.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.441 ' HA ' HG12 ' A' ' 6' ' ' VAL . 1.3 m -64.14 123.37 18.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.863 . . . . 0.0 110.135 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD1' HD22 ' A' ' 40' ' ' LEU . 1.3 tt -62.03 113.01 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.064 179.895 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.47 ' O ' HG21 ' A' ' 60' ' ' VAL . 1.5 mtt -111.63 162.57 20.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.52 0.74 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.044 1.55 . . . . 0.0 110.435 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.79 -23.98 22.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -98.87 1.0 45.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 179.87 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 56' ' ' MET . 7.1 t -91.5 116.47 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -80.18 -72.73 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.918 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 73' ' ' LYS . 65.0 m-80 -100.22 87.86 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.409 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.99 144.58 28.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . 8.7 mm-40 -83.23 -95.79 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.986 . . . . 0.0 110.352 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.442 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 13.8 t70 -94.45 82.95 4.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.99 93.1 0.28 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -74.36 -39.68 62.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 32.36 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.22 -179.6 1.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.6 Cg_endo -72.36 174.97 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.887 1.467 . . . . 0.0 110.56 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.24 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 153.16 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -1.177 . . . . 0.0 110.317 -179.853 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.269 0.557 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.52 135.35 51.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.435 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -112.53 148.8 33.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.929 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 29.3 t -73.58 107.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 4' ' ' SER . 5.1 t -107.53 102.18 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.05 130.28 21.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.228 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -57.97 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.136 -179.942 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' CD ' ' SD ' ' A' ' 21' ' ' MET . 4.6 pt20 -81.44 162.08 23.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.188 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.7 tt -86.48 149.18 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.036 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.513 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 13.1 pt -129.79 127.91 22.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 110.399 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.53 54.01 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.033 1.544 . . . . 0.0 110.38 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER 47.44 -177.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 -179.902 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 7.1 m-20 41.15 28.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 13' ' ' ILE . 54.0 m -118.36 114.4 22.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.19 128.44 35.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.051 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.443 HD22 HD12 ' A' ' 11' ' ' ILE . 4.2 mt -83.03 143.19 30.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -122.21 176.42 5.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 20' ' ' ILE . 7.2 tt -68.32 -44.86 74.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.279 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 21' ' ' MET . 4.7 pt -60.03 -22.51 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.497 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -95.88 -21.62 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.954 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.488 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mtm -108.39 108.0 18.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.68 139.59 47.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.75 84.99 6.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 179.985 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 148.55 28.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.34 93.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 0.0 110.085 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 28' ' ' THR . 94.9 t -131.01 161.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 28.8 m -114.51 145.74 34.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 -179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 50.5 Cg_endo -80.29 147.65 76.29 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.716 -2.202 . . . . 0.0 110.42 -0.445 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -68.2 68.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -42.17 -83.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.835 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.465 ' CG2' ' HD2' ' A' ' 33' ' ' PRO . 4.8 mt -135.27 142.84 43.11 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.0 110.224 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.7 Cg_endo -72.36 -159.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.332 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.57 40.01 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.96 -29.86 64.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.9 24.58 10.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 6.1 mm -45.19 -53.32 17.56 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.6 Cg_endo -71.02 -6.43 19.2 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.505 1.266 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.27 -27.08 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.116 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.97 -26.46 21.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.081 179.932 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 53.3 t -51.46 99.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.08 2.59 12.38 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.439 ' HE2' HG12 ' A' ' 60' ' ' VAL . 2.0 tmm? -94.86 143.75 26.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -1.187 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.45 134.0 50.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.8 m -77.48 154.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.171 179.866 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -97.75 1.49 48.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -132.59 142.41 49.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -56.96 136.76 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.45 -179.76 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 11' ' ' ILE . 45.5 t -124.29 120.71 26.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.955 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.65 -161.26 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.973 1.512 . . . . 0.0 110.647 -179.737 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 52' ' ' GLY . 2.4 mp -81.04 160.11 24.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.335 -0.853 . . . . 0.0 110.471 -179.658 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.37 49.5 6.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.491 ' CB ' HG11 ' A' ' 49' ' ' VAL . 39.7 m -96.75 106.37 18.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -1.152 . . . . 0.0 110.081 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -50.35 147.98 3.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 -179.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -65.07 108.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.115 179.925 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.413 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -110.07 150.31 41.28 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.981 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.08 0.44 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.051 1.553 . . . . 0.0 110.58 -179.981 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.15 -50.89 7.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.495 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.74 47.65 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.84 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' A' ' 43' ' ' MET . 19.5 t -127.88 109.85 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -82.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.255 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -91.86 88.58 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.856 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HA ' ' HE3' ' A' ' 43' ' ' MET . 2.7 t80 -59.74 139.0 57.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.9 -92.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.924 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.01 82.75 3.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.0 110.398 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.74 94.28 0.25 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.18 18.15 21.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -1.146 . . . . 0.0 110.266 -179.887 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 69' ' ' SER . 88.0 m -100.41 -33.91 10.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.05 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.52 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 173.25 -56.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.995 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -73.14 85.68 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.928 1.489 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.3 70.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.64 -32.63 72.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -1.165 . . . . 0.0 110.328 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 tptt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.257 179.992 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.235 0.541 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.41 156.99 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.219 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.84 161.27 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.253 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' CB ' HD13 ' A' ' 55' ' ' LEU . 39.4 t -79.04 121.42 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.093 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -125.42 107.59 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 110.263 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.9 111.09 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 51.1 t30 -74.91 -59.91 2.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -72.18 139.43 48.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.98 132.58 51.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 179.919 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.457 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.6 pt -130.13 110.89 16.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -74.82 69.69 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.93 1.49 . . . . 0.0 110.43 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.7 pt 39.0 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 45.9 29.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' HG21 ' A' ' 15' ' ' THR . 5.1 t -131.0 130.32 43.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 110.135 -179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 142.68 53.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.179 -179.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.46 HD12 HD22 ' A' ' 40' ' ' LEU . 5.5 mt -77.79 124.72 28.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 110.27 -179.92 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.94 172.04 8.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.993 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.23 -30.99 54.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 21' ' ' MET . 6.3 pt -62.62 -25.55 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.493 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -97.38 -14.06 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.04 126.28 32.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 12.7 mttt -111.55 124.06 51.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.21 10.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 150.08 29.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 26' ' ' VAL . 61.3 t -81.68 4.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.47 130.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.21 -179.995 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.454 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -84.8 168.27 21.91 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -73.76 156.69 99.61 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.428 -0.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' GLY . 5.5 mtt -76.34 83.23 3.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.69 -116.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.504 HD12 HG22 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -110.48 139.9 22.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.219 -1.165 . . . . 0.0 109.948 179.946 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.9 168.7 24.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.553 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -84.14 47.1 1.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -77.15 -27.06 53.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.797 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 40' ' ' LEU . 15.1 mm-40 -104.72 45.34 0.97 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 111.023 -179.406 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -63.05 -51.43 70.46 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.008 179.637 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.9 Cg_endo -75.08 -5.4 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.755 1.398 . . . . 0.0 110.722 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 3.9 m-80 -114.77 -35.3 4.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.591 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -87.51 -38.9 15.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.799 -179.46 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 9.1 t -41.93 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.9 -7.3 6.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.652 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.54 131.0 35.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -1.089 . . . . 0.0 110.194 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' THR . 15.2 mt-30 -99.33 151.39 21.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.961 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.1 m -99.92 161.78 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -111.18 0.29 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -114.39 135.85 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 110.042 -179.858 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -55.8 123.15 13.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.325 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 53' ' ' THR . 19.7 t -109.99 125.47 31.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 179.605 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.67 -167.63 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.858 1.452 . . . . 0.0 110.512 -179.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -81.53 155.28 25.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.231 -179.9 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 45.29 44.61 10.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.51 ' CB ' HG11 ' A' ' 49' ' ' VAL . 43.6 m -90.61 122.58 33.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -1.174 . . . . 0.0 110.203 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.493 HD13 ' CB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -80.04 106.5 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.194 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.469 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -113.1 143.27 28.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 179.822 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.36 1.46 7.34 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.951 1.5 . . . . 0.0 110.634 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.84 -15.55 44.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.812 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' HG2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -99.47 -21.43 15.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.52 120.75 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.311 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.95 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 179.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 22.6 p-10 -92.06 87.79 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.103 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.467 ' OH ' HG22 ' A' ' 32' ' ' ILE . 2.7 t80 -45.45 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG3' ' C ' ' A' ' 39' ' ' ASN . 1.5 tm-20 -66.91 -60.14 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HB3' ' OG1' ' A' ' 67' ' ' THR . 2.0 m-20 -65.97 -49.89 66.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.62 2.54 78.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -90.16 4.65 49.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -1.19 . . . . 0.0 110.203 -179.934 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -98.4 -150.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.953 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.57 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -61.03 -60.17 11.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.04 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 47.2 Cg_endo -72.67 140.06 31.93 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.533 . . . . 0.0 110.201 179.714 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.67 48.68 0.55 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.04 -170.7 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -1.157 . . . . 0.0 110.239 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.162 0.505 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -66.59 115.65 6.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.27 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.3 p -123.88 148.82 46.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.156 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 ' HG2' ' A' ' 22' ' ' MET . 76.2 t -62.48 116.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 110.207 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' SER . 4.6 t -121.03 105.91 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -42.62 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -75.69 -70.85 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.429 ' O ' HG12 ' A' ' 11' ' ' ILE . 13.0 tp60 -65.04 143.35 57.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.8 114.08 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 17' ' ' LEU . 1.5 pt -128.78 128.32 23.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.78 -158.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.87 1.458 . . . . 0.0 109.788 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 44.5 pt -98.98 -170.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.069 -1.019 . . . . 0.0 110.194 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 2.6 p30 49.41 20.31 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.489 -0.757 . . . . 0.0 110.735 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -118.71 102.13 8.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.007 -1.058 . . . . 0.0 109.928 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.74 124.12 15.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.353 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.516 ' CD2' HD11 ' A' ' 11' ' ' ILE . 21.9 mt -94.13 163.4 13.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' CG1' ' A' ' 20' ' ' ILE . 67.4 p -130.51 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 110.027 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD22 ' CG2' ' A' ' 41' ' ' VAL . 56.0 mt -72.0 -42.62 66.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.03 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CG1' ' OG1' ' A' ' 18' ' ' THR . 2.6 pt -58.62 -26.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.106 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.0 mtt -94.46 15.98 16.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.469 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -123.59 111.6 16.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -119.38 114.45 22.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.61 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.182 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.24 152.53 28.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -95.33 82.8 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.224 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.404 HG21 ' N ' ' A' ' 28' ' ' THR . 10.4 p -137.09 157.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.196 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.0 t -95.82 148.91 35.31 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.074 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -75.87 -165.18 4.13 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.729 -2.196 . . . . 0.0 110.541 -0.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.86 -19.53 51.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 45.95 -143.17 4.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 55' ' ' LEU . 3.0 mt -97.49 125.29 45.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -1.162 . . . . 0.0 110.066 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.03 -161.5 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.846 1.445 . . . . 0.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -103.92 17.79 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -56.79 -36.64 70.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 109.971 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 10.1 pt-20 -104.58 35.98 2.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 110.286 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.0 mm -55.57 -54.96 45.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.243 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -70.5 -4.15 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.636 1.335 . . . . 0.0 110.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.0 m-20 -109.36 -25.25 10.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD13 ' HE1' ' A' ' 43' ' ' MET . 5.3 tp -84.85 -29.32 25.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.29 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' CG2' HD22 ' A' ' 19' ' ' LEU . 36.7 t -42.88 104.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 103.85 29.45 5.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.464 ' HE1' HD13 ' A' ' 40' ' ' LEU . 45.2 tpp -97.8 140.76 31.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 110.273 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.98 121.73 44.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.045 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.4 m -80.7 166.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 110.304 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' HB2' ' CD ' ' A' ' 61' ' ' LYS . 11.7 t-20 -111.58 -4.75 14.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -125.17 132.78 52.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.848 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' N ' ' HD3' ' A' ' 47' ' ' ARG . . . -46.8 135.8 8.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.366 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' A' ' 7' ' ' ALA . 76.6 t -116.86 113.95 39.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.72 -169.54 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.901 1.474 . . . . 0.0 110.382 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -71.84 148.78 45.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.75 53.49 6.2 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.481 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 99.8 m -96.51 120.95 37.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.278 -1.131 . . . . 0.0 110.253 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 128.05 35.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -62.5 115.8 4.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 110.184 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.0 mtt -110.2 157.98 36.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -3.3 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.61 -10.24 41.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' CG ' ' A' ' 47' ' ' ARG . 7.0 mtm -112.22 35.59 3.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.09 111.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.304 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' CD ' ' HB2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -69.51 -71.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.147 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 7.2 p30 -96.79 86.69 4.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.115 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.441 ' OH ' HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -55.86 120.52 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.29 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.3 mm-40 -75.51 -81.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.189 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.0 m-20 -89.04 69.28 8.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.56 82.69 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 67' ' ' THR . 36.6 m -85.06 9.7 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -1.17 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.3 t -69.93 -21.99 63.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.922 . . . . 0.0 110.154 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.571 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -175.83 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.571 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -72.65 59.86 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.444 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.74 35.31 5.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.13 -41.26 10.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -1.142 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.235 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -68.47 142.21 55.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.63 131.77 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.63 145.32 40.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.129 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 59.3 t -73.68 133.53 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 27' ' ' VAL . 4.2 t -129.79 121.18 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.04 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.24 130.41 19.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 13.3 t30 -86.68 -68.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -82.73 139.18 33.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -68.49 132.62 47.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 111.08 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -130.82 154.78 81.98 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 109.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.19 -96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.935 1.492 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.518 ' CG1' ' C ' ' A' ' 12' ' ' PRO . 5.2 mt -153.28 -174.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.852 -1.155 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER 41.39 32.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.417 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 7.2 m -112.42 129.89 56.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -67.45 158.7 31.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -125.84 135.45 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.294 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' MET . 0.0 OUTLIER -123.24 173.38 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.34 -56.71 17.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -19.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 18' ' ' THR . 24.4 mmm -88.31 -46.61 9.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.45 ' HE1' HG12 ' A' ' 5' ' ' VAL . 2.8 ptm -116.44 135.64 53.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -117.29 166.58 12.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.171 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.37 103.37 15.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -112.94 156.82 22.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.169 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.95 91.03 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.153 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.408 HG13 HG23 ' A' ' 6' ' ' VAL . 11.7 p -156.56 148.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.444 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -99.18 167.09 11.81 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.11 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.6 Cg_endo -73.86 163.58 89.6 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.401 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.39 93.3 3.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.415 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.97 -111.62 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 14.7 mm -91.44 113.6 59.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.337 -1.096 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.71 -174.84 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.944 1.497 . . . . 0.0 110.478 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -87.13 17.88 3.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -76.62 -53.96 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 19.3 pt-20 -92.39 33.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.743 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -62.34 -52.71 64.25 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 110.049 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -72.3 -1.96 10.96 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.651 1.342 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 8.8 m-80 -112.45 -32.06 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.1 tp -86.72 -39.86 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 0.0 110.131 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 t -50.39 127.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.221 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.71 28.89 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.2 mtm -100.01 159.4 15.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mp0 -109.95 165.95 11.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.0 m -101.63 165.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' MET . 26.3 t-20 -111.13 16.32 21.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.278 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 5.3 mmt180 -143.92 176.63 9.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -80.41 134.71 36.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -124.24 108.59 29.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 110.049 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -72.72 -163.14 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.976 1.514 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -78.45 156.83 29.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.32 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.02 32.87 1.59 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' OG1' ' CD ' ' A' ' 50' ' ' PRO . 18.3 m -75.0 112.46 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 110.315 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.436 ' HB ' ' HE1' ' A' ' 56' ' ' MET . 20.2 m -48.13 131.23 16.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.853 . . . . 0.0 109.978 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.84 100.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.436 ' HE1' ' HB ' ' A' ' 54' ' ' THR . 1.8 mtt -101.46 139.14 20.16 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.0 2.65 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.995 1.524 . . . . 0.0 110.592 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.36 -28.71 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' ASN . 9.2 mtm -95.3 -2.87 48.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.08 127.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -64.99 -92.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.396 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 17.9 p-10 -95.78 90.65 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.17 -0.956 . . . . 0.0 110.197 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.7 t80 -44.92 157.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 10.2 mm-40 -80.79 -80.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.36 33.12 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.09 90.47 0.55 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -96.94 17.53 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.191 . . . . 0.0 110.143 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' CB ' ' A' ' 69' ' ' SER . 9.2 t -77.15 0.73 20.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 110.302 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.528 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 172.99 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.207 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -72.65 172.07 15.95 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.989 1.521 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -34.42 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -77.06 98.42 5.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -1.124 . . . . 0.0 110.228 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 1' ' ' ASN . 52.4 p-10 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.274 0.559 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.503 ' CD ' ' HB3' ' A' ' 33' ' ' PRO . 9.4 ptpp? -95.79 160.82 14.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -83.3 174.49 10.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 30' ' ' MET . 0.9 OUTLIER -120.6 165.3 15.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.134 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 97.1 t -92.63 95.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG13 ' HA2' ' A' ' 52' ' ' GLY . 3.8 t -119.12 127.12 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 21' ' ' MET . . . -80.66 144.49 32.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 t-20 -77.06 -66.42 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 109.686 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.16 148.78 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -59.33 148.33 32.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -0.954 . . . . 0.0 110.061 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.22 138.01 30.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.89 -159.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.067 1.561 . . . . 0.0 110.258 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.519 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.6 mp -123.16 173.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 3.6 m120 59.25 19.92 8.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -118.08 151.41 37.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 165.97 21.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 45' ' ' VAL . 38.8 mt -121.56 117.86 27.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.98 165.05 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -54.2 -33.69 58.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.274 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.1 mm -55.51 -41.12 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.389 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -96.92 8.91 43.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.97 124.4 42.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.98 144.18 48.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.999 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.6 94.63 5.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.03 154.53 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 3' ' ' ALA . 9.2 t -92.15 39.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.158 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.12 159.1 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 11.1 p -81.89 163.13 54.92 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.19 178.78 32.18 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.625 -0.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' SER . 1.9 mtt -77.84 -68.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.7 -128.75 18.12 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 55' ' ' LEU . 3.0 mt -103.67 137.1 19.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.159 -1.201 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HB3' ' CD ' ' A' ' 2' ' ' LYS . 44.8 Cg_endo -72.07 177.72 6.81 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.973 1.512 . . . . 0.0 110.43 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.12 23.96 6.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.303 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -18.78 57.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 109.47 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -105.17 10.81 33.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.3 mm -41.99 -54.44 7.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.697 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -70.04 -3.84 13.01 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.529 1.278 . . . . 0.0 110.737 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 90.4 m-20 -114.15 -36.95 4.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -78.78 -42.14 28.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 42.2 t -42.63 121.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.255 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.71 1.04 27.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttm -99.84 149.77 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -1.178 . . . . 0.0 110.12 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -100.8 159.83 14.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 5.7 m -102.45 163.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.43 -9.62 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -136.27 155.69 49.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.938 . . . . 0.0 110.183 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -86.17 144.12 27.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 38.2 t -130.2 140.35 38.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.0 Cg_endo -73.4 -175.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.083 1.57 . . . . 0.0 110.391 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -44.25 169.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.905 . . . . 0.0 110.286 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 44.11 52.19 7.07 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.513 ' OG1' ' CG1' ' A' ' 49' ' ' VAL . 2.2 m -75.36 94.58 3.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -1.109 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 ' O ' HG21 ' A' ' 54' ' ' THR . 6.6 t -68.11 148.75 50.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.086 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -70.24 105.64 3.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.342 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.523 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.54 155.45 44.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.163 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 56' ' ' MET . 45.9 Cg_endo -73.24 -5.98 18.1 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.012 1.532 . . . . 0.0 110.489 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.3 -45.81 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.527 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -94.52 49.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 56' ' ' MET . 98.9 t -130.11 83.94 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -67.35 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -99.59 88.63 3.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.246 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 3.2 t80 -44.33 141.06 1.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 3.4 pt-20 -64.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.352 -0.843 . . . . 0.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 13.9 p-10 -61.91 84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 70' ' ' PRO . . . -86.04 71.76 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -79.63 5.14 13.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -1.177 . . . . 0.0 110.199 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -100.46 -104.22 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -96.22 -66.05 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.884 -1.135 . . . . 0.0 110.493 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.6 Cg_endo -72.64 126.25 11.29 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.508 1.268 . . . . 0.0 110.425 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.85 94.34 0.14 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.409 HD21 ' N ' ' A' ' 72' ' ' LEU . 3.1 mm? -71.4 -48.1 51.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -1.159 . . . . 0.0 110.257 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.22 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.24 0.543 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -96.23 151.14 19.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -53.54 121.48 7.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.157 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -90.91 150.37 21.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 22' ' ' MET . 54.2 t -77.8 114.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.89 95.0 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -48.58 128.94 15.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.58 -80.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 110.022 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -58.98 160.07 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.822 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -90.25 140.57 29.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.42 140.03 37.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.44 -0.788 . . . . 0.0 110.03 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.4 163.37 37.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.961 1.506 . . . . 0.0 110.211 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.9 pt -71.7 -177.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 60.29 16.39 6.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.285 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 140.2 50.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.19 152.71 44.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mt -105.38 138.36 41.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 77.8 p -115.12 153.91 29.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 21' ' ' MET . 13.0 pt -64.81 -20.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.454 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 7.6 mtm -97.69 -7.55 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HD11 ' A' ' 37' ' ' ILE . 1.4 mmm -96.26 105.49 17.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CD ' ' OD1' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -96.24 141.29 29.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.875 . . . . 0.0 110.311 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.62 89.99 7.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.62 120.12 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.097 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' HG11 ' A' ' 27' ' ' VAL . 94.2 t -68.87 79.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 26' ' ' VAL . 27.0 m -151.28 170.22 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.912 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -93.31 165.83 17.49 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.274 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 47.5 Cg_endo -74.97 167.24 81.01 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.357 -0.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.34 68.89 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.268 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.57 -130.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.443 HG23 ' CD ' ' A' ' 36' ' ' GLU . 2.0 mt -97.33 126.45 41.75 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.165 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.56 50.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.924 1.486 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.497 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . 45.93 26.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -69.91 -45.73 66.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 1.4 pt-20 -95.25 28.39 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.109 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.3 mm -47.09 -55.02 16.89 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -71.0 -2.74 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.569 1.299 . . . . 0.0 110.542 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 83.9 m-20 -109.48 -31.45 7.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.33 -31.85 15.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.505 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 25.4 t -43.69 110.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.32 4.45 27.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -100.23 152.83 19.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -1.219 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.81 154.85 18.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.893 . . . . 0.0 110.232 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 5.9 m -102.28 167.02 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' MET . 9.3 t30 -111.1 -11.4 14.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 3.7 mtt-85 -116.18 133.13 56.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 13' ' ' ILE . . . -51.48 124.98 13.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 61.9 t -99.07 109.89 55.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.15 -165.02 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.957 1.504 . . . . 0.0 110.424 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -75.56 150.91 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.5 44.03 11.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 88.2 m -89.35 122.19 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -67.01 138.92 57.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 109.993 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.45 106.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 110.241 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.15 152.58 40.46 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.41 -0.806 . . . . 0.0 110.344 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.49 -0.68 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.563 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.71 -13.9 38.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.521 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 7.8 mtt -104.24 -2.57 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 28.4 t -100.96 106.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -80.81 78.0 7.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.47 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 11.2 t80 -46.13 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.41 -86.14 0.38 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.16 80.1 2.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.58 98.35 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 10.26 38.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.348 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.421 ' CG2' ' N ' ' A' ' 69' ' ' SER . 18.0 m -73.36 -91.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -77.78 -56.13 1.15 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.175 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 69' ' ' SER . 49.5 Cg_endo -76.29 52.64 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.034 1.544 . . . . 0.0 110.297 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.92 72.61 0.54 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.82 17.58 22.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -1.174 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' NZ ' ' CB ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.219 0.533 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -83.81 159.34 21.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 0.0 110.186 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.06 137.35 51.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.245 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -97.87 157.06 16.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -87.83 104.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG1' ' C ' ' A' ' 52' ' ' GLY . 20.3 t -93.32 114.87 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -42.26 126.73 3.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.152 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 50.8 t30 -82.46 -73.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -65.54 140.29 58.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 4.2 tt -72.15 126.21 29.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 4.0 pt -130.67 151.05 78.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.527 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 47.6 Cg_endo -73.69 -95.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.399 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 6.2 mm -142.0 163.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 16.2 m-80 42.26 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.261 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 88.3 m -154.32 123.18 6.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 110.237 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.73 144.64 21.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mt -107.63 143.36 36.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.448 ' HB ' HG12 ' A' ' 20' ' ' ILE . 1.1 p -116.56 167.13 11.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.35 -21.85 62.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.516 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 8.2 pt -73.8 -18.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.45 ' SD ' ' HB3' ' A' ' 9' ' ' GLN . 2.4 mtt -97.74 21.15 10.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 110.036 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.93 122.27 43.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.1 mmmt -119.11 127.3 53.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.7 74.85 6.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HB3' HG23 ' A' ' 27' ' ' VAL . 7.7 mm-40 -107.95 118.46 36.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -88.38 72.56 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 25' ' ' GLU . 7.6 m -135.69 -173.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 12.2 t -103.86 149.41 37.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.9 Cg_endo -76.83 167.48 79.87 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.319 -0.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -82.6 81.3 8.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.3 -157.97 0.03 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.442 HG21 ' HD2' ' A' ' 33' ' ' PRO . 1.9 mt -75.51 140.04 71.67 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.366 -1.079 . . . . 0.0 110.298 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.12 -168.48 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.1 1.579 . . . . 0.0 110.648 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -106.8 -5.54 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -24.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mm-40 -104.89 47.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 mm -60.74 -53.91 59.72 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 110.339 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.4 Cg_endo -73.05 -5.23 16.83 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.829 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -114.25 -30.82 6.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 0.0 110.372 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 HD23 ' CD1' ' A' ' 55' ' ' LEU . 7.3 tp -82.06 -50.1 9.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 37' ' ' ILE . 96.9 t -44.46 114.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.16 11.45 18.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.442 ' HE1' ' O ' ' A' ' 62' ' ' ASN . 4.2 ttm -97.9 143.84 28.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.6 mt-30 -104.31 112.8 25.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.226 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' ASN . 17.6 m -76.84 152.39 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' HA ' HG21 ' A' ' 13' ' ' ILE . 24.4 t-20 -109.95 42.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.495 ' NE ' HG11 ' A' ' 49' ' ' VAL . 4.1 ptm180 -141.23 156.29 45.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.95 . . . . 0.0 110.246 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -86.35 116.73 24.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.601 ' CG2' ' CG1' ' A' ' 11' ' ' ILE . 2.7 m -115.22 112.02 44.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.77 54.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.1 1.579 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 67.82 151.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 110.861 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' ' CG1' ' A' ' 6' ' ' VAL . . . 45.41 38.04 6.69 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.545 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 5.8 m -96.87 141.51 29.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.249 . . . . 0.0 110.225 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' SD ' ' A' ' 56' ' ' MET . 10.1 t -70.42 131.77 44.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.533 ' CD1' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.35 122.93 17.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.302 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.482 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.15 135.31 19.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 60' ' ' VAL . 49.2 Cg_endo -76.47 -24.24 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.101 1.579 . . . . 0.0 111.365 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' MET . 10.5 p-10 -63.64 -37.21 86.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.529 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.7 mmt -99.52 57.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.007 . . . . 0.0 110.003 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 57' ' ' PRO . 77.6 t -124.45 128.71 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 58.5 m-80 -96.09 100.48 12.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.7 t80 -45.43 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -98.43 -155.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 65' ' ' ASP . 27.1 t0 -59.9 79.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -136.25 81.4 0.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 24.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.7 m -86.3 -97.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.541 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -80.74 -59.02 0.51 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.024 -1.047 . . . . 0.0 110.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.7 Cg_endo -73.72 -164.2 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.825 1.434 . . . . 0.0 110.58 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.58 -2.64 5.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -75.06 67.13 1.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 63' ' ' TYR . 2.5 mttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.309 0.576 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -80.97 151.34 28.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 110.163 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -64.19 120.65 12.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.298 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.5 t -97.44 148.21 23.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.08 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.519 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 53.7 t -71.32 109.68 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 110.289 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 54' ' ' THR . 10.7 t -124.16 120.27 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.093 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -72.92 130.23 39.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 10.2 m-80 -75.25 -23.52 57.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -96.4 155.33 16.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -80.69 127.6 32.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 pt -129.06 106.87 17.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -72.98 157.35 51.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.53 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -44.71 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.1 m120 57.39 59.06 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 12' ' ' PRO . 1.6 m -160.41 119.24 2.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.11 165.05 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 43' ' ' MET . 15.8 mt -122.5 111.8 17.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 17.6 p -89.13 139.78 30.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.097 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.457 ' HA ' ' CG ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -50.69 -30.82 14.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.252 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB ' ' A' ' 18' ' ' THR . 9.6 pt -71.15 -13.47 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.456 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 7.6 ttm -97.67 -10.41 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.457 ' CG ' ' HA ' ' A' ' 19' ' ' LEU . 5.5 ptp -117.3 123.23 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -121.11 147.51 45.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.29 96.39 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -109.83 142.96 40.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.177 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 3' ' ' ALA . 4.0 t -94.74 81.06 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 110.126 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 28' ' ' THR . 8.6 p -126.63 166.52 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.256 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.482 ' N ' HG23 ' A' ' 27' ' ' VAL . 13.8 t -114.47 149.24 41.86 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.33 164.37 88.39 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.771 -2.179 . . . . 0.0 110.523 -0.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.2 mtt -81.74 -150.64 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.402 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.8 -99.31 0.15 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 1.7 mt -118.63 132.33 23.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.124 -1.221 . . . . 0.0 109.636 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.66 -175.21 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.847 1.446 . . . . 0.0 110.359 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -86.97 21.88 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 110.299 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -43.83 74.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -95.22 35.01 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.6 mm -62.85 -53.25 57.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.925 . . . . 0.0 110.435 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.31 -3.07 12.23 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.581 1.306 . . . . 0.0 110.496 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -103.13 -32.49 9.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' OE2' ' A' ' 36' ' ' GLU . 4.0 tp -88.66 -31.69 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 46.0 t -45.51 139.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 110.316 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.08 -32.46 5.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.508 ' HE2' ' N ' ' A' ' 62' ' ' ASN . 3.2 ttp -74.91 144.78 43.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -178.43 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 3.3 m -119.08 164.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.074 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 13' ' ' ILE . 1.8 t-20 -110.94 -8.58 14.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 110.768 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HB2' ' CA ' ' A' ' 59' ' ' MET . 0.3 OUTLIER -130.05 114.86 16.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -0.992 . . . . 0.0 110.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -54.56 138.16 41.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 0.0 110.402 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.519 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 4.9 t -130.4 136.61 29.25 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.84 . . . . 0.0 110.15 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' O ' ' CG2' ' A' ' 53' ' ' THR . 44.9 Cg_endo -72.13 179.84 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.343 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -41.87 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.209 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.421 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 54.15 51.76 48.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 7' ' ' ALA . 59.8 p -70.63 96.73 1.24 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -1.119 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.45 ' N ' HG11 ' A' ' 6' ' ' VAL . 15.5 m -55.35 125.87 22.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.074 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD2' ' HB ' ' A' ' 5' ' ' VAL . 4.7 tp -61.93 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.526 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.12 167.46 9.22 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.455 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 48.8 Cg_endo -74.6 2.1 6.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.06 1.558 . . . . 0.0 110.592 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -75.05 -69.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.525 ' CA ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -84.12 62.02 6.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.959 . . . . 0.0 110.578 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 56' ' ' MET . 9.8 t -130.08 124.48 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.36 -94.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.395 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' N ' ' HE2' ' A' ' 43' ' ' MET . 80.3 m-20 -100.51 100.42 11.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.246 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 95.3 m-85 -46.96 116.59 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -65.38 -79.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.34 88.31 7.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.86 77.13 0.32 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.2 m -82.11 -11.57 58.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -1.15 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -88.95 -143.71 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -53.31 -57.22 17.71 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.6 128.32 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.939 1.494 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.11 38.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 72' ' ' LEU . 3.5 mm? -78.11 97.34 5.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -1.131 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.147 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -97.22 154.2 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.199 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.448 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -62.49 131.86 50.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.24 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -94.13 136.51 34.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.117 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 96.6 t -70.19 118.06 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.53 107.96 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.947 . . . . 0.0 110.235 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -51.35 120.1 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.907 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -79.59 -42.3 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 40.8 tp60 -91.12 141.26 29.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.42 113.64 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 12.6 mm -106.21 131.83 21.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.24 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.87 -163.26 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.825 1.434 . . . . 0.0 110.192 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 1.6 mt -106.94 -174.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 109.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 52.26 19.41 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -117.5 155.39 29.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.1 156.69 25.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.3 116.22 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' HG21 ' A' ' 20' ' ' ILE . 25.3 p -101.14 126.73 47.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.9 OUTLIER -46.68 -40.74 13.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 21' ' ' MET . 3.6 tt -43.42 -42.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.443 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -93.35 11.77 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 110.354 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.453 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 28.8 mtm -123.99 112.28 17.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.0 153.88 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' CB ' ' HB2' ' A' ' 3' ' ' ALA . . . -88.31 99.38 12.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -112.95 127.15 56.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 3' ' ' ALA . 70.1 t -68.84 81.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.429 HG21 ' C ' ' A' ' 26' ' ' VAL . 83.8 t -131.8 162.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.9 t -100.28 150.18 36.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.8 Cg_endo -75.95 -169.43 7.54 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.393 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' SER . 8.8 ptp -74.18 -29.51 61.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 44.68 -145.52 2.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 42.3 mm -83.32 115.32 58.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.14 . . . . 0.0 110.073 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 46.3 Cg_endo -72.15 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.894 1.471 . . . . 0.0 110.507 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -94.0 23.97 4.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.9 mm-40 -76.95 -49.67 15.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.841 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE2' ' CG ' ' A' ' 65' ' ' ASP . 3.1 mm-40 -100.39 37.8 1.62 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.823 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.2 mm -63.96 -54.03 43.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.7 Cg_endo -72.01 -2.14 11.08 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.694 1.365 . . . . 0.0 110.294 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' OD1' ' OE2' ' A' ' 64' ' ' GLU . 17.1 m-80 -106.95 -41.72 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' MET . 2.9 tp -74.5 -24.88 59.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 34.6 t -45.7 99.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.78 11.9 21.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' LEU . 53.5 tpp -81.43 155.12 26.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -1.188 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.7 157.83 16.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 110.252 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.492 ' CG1' ' HA ' ' A' ' 13' ' ' ILE . 2.7 p -118.76 159.97 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.428 ' C ' HG22 ' A' ' 13' ' ' ILE . 35.4 t-20 -110.67 -13.76 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.5 OUTLIER -118.02 174.74 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 0.0 110.145 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -85.53 149.04 25.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.589 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG11 ' HB ' ' A' ' 53' ' ' THR . 54.2 t -128.24 107.5 19.57 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.833 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.4 Cg_endo -71.93 -160.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.966 1.509 . . . . 0.0 110.694 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -78.17 153.81 31.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.429 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.9 43.64 5.41 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.504 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 40.1 m -89.84 119.5 30.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -1.136 . . . . 0.0 110.328 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.9 141.26 58.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -66.05 115.45 6.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.279 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.57 138.58 21.52 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.71 -0.05 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.341 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -84.05 -20.71 32.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.892 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.486 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 22.0 mtt -99.67 -15.16 18.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.99 111.93 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 110.054 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -73.48 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.58 97.12 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.189 -0.945 . . . . 0.0 110.304 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.4 t80 -62.4 152.41 34.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -71.78 -53.28 13.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 110.385 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' CG ' ' OE2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -60.19 -42.31 94.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.413 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' CA ' ' HA2' ' A' ' 71' ' ' GLY . . . 48.92 83.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 68' ' ' THR . 34.2 m -89.01 -87.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.336 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' N ' HG23 ' A' ' 67' ' ' THR . 1.3 p -110.16 -92.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 110.52 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -49.97 -53.79 39.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.4 Cg_endo -74.61 2.09 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.906 1.477 . . . . 0.0 110.74 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.416 ' HA2' ' CA ' ' A' ' 66' ' ' GLY . . . -56.45 -56.98 21.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 156.85 18.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.195 . . . . 0.0 110.277 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.119 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.236 0.541 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 116.4 28.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.43 169.65 12.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -122.52 169.8 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 ' CG1' HD22 ' A' ' 55' ' ' LEU . 21.8 t -94.27 110.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.421 HG11 ' C ' ' A' ' 52' ' ' GLY . 15.3 t -116.52 114.04 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -52.94 127.68 24.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -0.949 . . . . 0.0 110.041 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 39.6 t30 -74.57 -55.12 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.543 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -91.24 148.18 22.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.497 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 9.0 tt -61.32 128.47 36.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.889 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -101.4 123.6 44.02 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.2 Cg_endo -78.4 47.34 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.874 1.46 . . . . 0.0 110.78 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.524 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.3 mt 49.91 177.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.17 -0.956 . . . . 0.0 110.387 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 45.42 36.17 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.448 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 16.4 m -132.53 119.69 20.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.02 159.29 5.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.3 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 23.6 mt -103.17 134.8 45.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.61 -168.75 1.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.47 -45.14 73.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.447 ' CD1' ' SD ' ' A' ' 21' ' ' MET . 5.9 pt -55.41 -28.26 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -96.01 11.47 33.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.438 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -115.12 109.75 18.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -114.36 122.94 48.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.302 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.09 79.93 9.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.98 129.07 46.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.65 55.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.68 155.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 p -93.42 165.15 18.86 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 47.4 Cg_endo -74.92 159.87 97.36 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.493 -0.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -53.58 56.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.19 -113.36 5.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 55' ' ' LEU . 8.3 mt -127.67 127.36 24.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.163 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -175.8 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.883 1.464 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -98.94 26.38 5.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -62.38 -38.99 91.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -102.09 45.94 0.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.0 110.321 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -57.14 -42.52 96.67 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.5 Cg_endo -78.0 -7.13 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.529 1.278 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 1.3 m-20 -111.36 -36.49 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 47.6 tp -79.86 -38.63 32.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 23.0 t -52.21 141.57 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.26 -18.72 55.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 4.9 ttp -81.23 132.08 35.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -1.198 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -89.91 147.59 23.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.122 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 7.3 m -87.34 156.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -98.83 -5.95 30.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.344 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -127.94 163.08 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.159 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -82.21 135.79 35.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.664 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 0.1 OUTLIER -119.83 124.99 27.62 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 109.781 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.41 -177.77 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.856 1.451 . . . . 0.0 110.55 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.14 143.41 56.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.328 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.421 ' C ' HG11 ' A' ' 6' ' ' VAL . . . 56.93 47.35 87.57 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 7' ' ' ALA . 4.9 t -86.08 113.54 22.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -1.145 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 29' ' ' PRO . 10.4 m -55.04 143.36 27.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.033 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD22 ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -61.83 101.32 0.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.169 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -108.5 148.61 38.03 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.02 1.88 6.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.99 1.521 . . . . 0.0 110.709 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' CB ' ' HE1' ' A' ' 59' ' ' MET . 0.9 OUTLIER -78.49 -52.81 7.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.525 ' HE1' ' CB ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -87.32 45.67 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -123.96 133.12 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.236 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -91.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.9 104.42 15.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.35 155.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.9 mm-40 -103.57 -96.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.64 52.34 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 110.346 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.67 60.08 0.51 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -82.3 59.38 4.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.6 m -96.67 -89.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.48 -56.65 3.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.134 -0.979 . . . . 0.0 110.112 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -73.55 -166.32 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.044 1.55 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.14 173.56 40.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.16 175.2 6.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.193 -1.181 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.253 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.317 0.58 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -64.34 -177.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . . . -86.4 142.59 28.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.272 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.4 p -97.03 169.23 9.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.071 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 24.8 t -86.74 88.93 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 53' ' ' THR . 3.1 t -106.55 121.9 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.132 -0.98 . . . . 0.0 109.868 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 53' ' ' THR . . . -80.73 143.8 32.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.443 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.82 -72.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -62.71 148.6 46.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.074 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.568 HD11 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -60.3 159.37 10.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 1.8 pt -130.95 117.99 17.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.694 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 51.3 Cg_endo -80.45 50.57 3.59 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.834 1.439 . . . . 0.0 110.19 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 23.4 pt 39.18 -164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.615 -0.678 . . . . 0.0 110.755 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' ILE . 15.1 p30 37.88 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.568 -0.708 . . . . 0.0 110.781 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.4 m -138.45 118.67 13.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' N ' ' HG2' ' A' ' 44' ' ' GLN . . . -58.62 155.19 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 109.992 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.39 127.0 53.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.4 OUTLIER -100.87 150.74 22.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.424 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 7.5 tt -42.67 -49.53 5.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 19' ' ' LEU . 3.6 mt -63.54 -24.78 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -84.55 -19.39 33.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.506 ' HE3' ' CD1' ' A' ' 37' ' ' ILE . 1.8 ptm -116.48 136.69 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.88 131.04 55.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.942 . . . . 0.0 110.2 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 3' ' ' ALA . . . -74.77 97.18 3.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 139.42 40.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.37 81.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 27' ' ' VAL . 11.1 p -161.82 154.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 110.043 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.4 t -74.65 150.24 86.49 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 110.155 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.42 161.91 93.61 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.693 -2.211 . . . . 0.0 110.481 -0.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -82.65 -81.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.386 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.77 -122.54 7.44 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.519 ' HB ' ' HG ' ' A' ' 55' ' ' LEU . 5.5 mt -123.95 139.12 31.8 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.106 -1.232 . . . . 0.0 109.919 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.1 1.579 . . . . 0.0 110.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -108.25 41.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -65.09 -21.92 66.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.987 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 64' ' ' GLU . 4.8 mm-40 -105.32 35.5 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 mm -40.62 -54.94 4.78 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.531 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.39 -6.8 19.95 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.632 1.333 . . . . 0.0 110.889 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 m-20 -114.25 -18.87 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.128 -0.983 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -102.07 -34.7 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 25.6 t -42.69 103.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.12 9.38 5.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.63 144.92 26.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -1.174 . . . . 0.0 110.12 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 3.6 mt-30 -109.75 168.16 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.4 m -116.09 174.79 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 -7.3 14.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.426 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -125.4 119.21 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.182 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -68.33 145.03 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.398 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 23.7 t -129.42 139.79 36.73 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 110.178 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.66 89.68 0.97 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.304 1.686 . . . . 0.0 110.713 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 55.25 160.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.395 -0.816 . . . . 0.0 110.73 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 41.37 65.95 1.04 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.548 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 15.3 t -91.83 113.52 25.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.096 -1.238 . . . . 0.0 110.015 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 30' ' ' MET . 1.5 m -73.68 121.96 21.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HG ' ' HB ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -61.82 106.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.733 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.8 mtt -112.92 156.94 41.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.57 -2.98 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.076 1.566 . . . . 0.0 110.485 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.45 -30.41 16.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 7.5 mmt -99.16 0.31 43.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.068 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.8 t -91.36 102.23 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CD ' ' OXT' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -67.36 -58.98 3.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.042 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 14.5 p-10 -100.59 80.11 2.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' OG ' ' A' ' 69' ' ' SER . 1.6 t80 -46.49 146.12 1.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.9 . . . . 0.0 110.464 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -70.41 -175.28 0.99 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.235 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -60.03 -57.74 11.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.97 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 50.68 179.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -107.61 -60.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 0.0 110.052 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -102.71 55.61 0.77 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.931 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -95.67 -177.91 0.71 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 110.303 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 43.6 Cg_endo -72.55 -89.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.481 . . . . 0.0 110.341 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.76 -15.68 3.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.51 130.66 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 110.138 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.492 ' OXT' ' CD ' ' A' ' 61' ' ' LYS . 4.0 mptt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.238 0.542 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -88.07 154.52 20.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 110.144 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -55.98 135.9 52.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.142 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 30' ' ' MET . 46.5 t -113.31 160.24 18.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.295 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.02 97.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 54' ' ' THR . 14.9 t -117.44 125.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -72.57 137.1 45.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.461 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 8.6 t-20 -73.6 -44.49 56.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 110.248 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 14.6 tt0 -88.28 152.81 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -64.21 152.14 41.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.448 HG21 ' HD2' ' A' ' 12' ' ' PRO . 80.2 mt -129.84 133.9 25.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' HG21 ' A' ' 11' ' ' ILE . 45.4 Cg_endo -72.16 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.92 1.484 . . . . 0.0 110.183 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 HG12 ' CA ' ' A' ' 48' ' ' ALA . 2.3 mt -116.17 170.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -0.915 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.16 11.75 4.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.4 HG21 ' N ' ' A' ' 16' ' ' ALA . 7.3 m -115.79 140.83 48.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -62.16 163.22 8.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.21 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 42' ' ' GLY . 9.1 mt -112.03 120.79 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.135 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.413 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -100.11 130.93 46.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -46.29 -40.75 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -46.91 -36.71 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 62.4 mtp -86.61 -19.01 29.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.273 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.2 mtm -102.05 127.56 48.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.223 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -114.6 170.76 8.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.42 94.45 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.2 131.71 55.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 32.4 t -78.66 87.63 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 28' ' ' THR . 47.7 t -139.99 149.41 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 10.6 t -102.5 149.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.066 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.72 133.51 31.65 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.741 -2.191 . . . . 0.0 110.516 -0.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ILE . 3.9 ptp -60.21 -29.63 68.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 57.8 -85.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 30' ' ' MET . 3.8 mt -132.74 127.67 20.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.188 -1.184 . . . . 0.0 110.202 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.28 -160.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.885 1.466 . . . . 0.0 110.405 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -100.51 28.79 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.301 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -46.08 37.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.42 24.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.7 mm -50.94 -53.1 51.4 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.844 . . . . 0.0 110.565 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -70.78 -1.13 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.53 1.279 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' O ' ' CD ' ' A' ' 64' ' ' GLU . 35.3 m120 -113.5 -46.01 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -0.97 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -78.78 -35.4 44.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.472 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 5.9 t -44.29 107.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.045 -1.034 . . . . 0.0 110.034 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 113.76 12.28 11.67 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.44 ' HE3' HG11 ' A' ' 60' ' ' VAL . 1.1 mmm -94.49 160.69 14.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.164 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.21 147.14 34.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.37 166.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 47' ' ' ARG . 55.6 p30 -101.59 -11.95 18.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.22 -0.925 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 13' ' ' ILE . 63.4 mtt180 -130.99 156.96 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -86.05 141.53 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 110.279 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 6.7 t -121.63 132.85 24.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' O ' ' CG2' ' A' ' 53' ' ' THR . 44.8 Cg_endo -71.9 -172.96 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.885 1.466 . . . . 0.0 110.339 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -46.36 155.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.89 59.99 9.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' A' ' 7' ' ' ALA . 38.8 p -78.34 95.24 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -1.077 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.405 ' N ' HG12 ' A' ' 6' ' ' VAL . 7.0 m -62.88 133.85 55.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.37 96.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.219 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mmm -112.65 153.64 44.96 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.155 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 60' ' ' VAL . 49.4 Cg_endo -76.23 3.16 6.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.944 1.497 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -39.11 36.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.482 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 5.9 mtm -111.82 60.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.342 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 57' ' ' PRO . 83.9 t -129.49 104.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -81.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.518 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 73' ' ' LYS . 18.2 t30 -93.04 93.17 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.422 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -47.76 150.22 1.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 39' ' ' ASN . 71.8 mm-40 -80.1 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.02 82.2 8.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.6 65.4 3.96 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -30.3 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -1.114 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.456 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 56.8 p -110.44 -129.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.554 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -73.73 -54.26 3.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.949 -1.094 . . . . 0.0 111.041 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' SER . 42.8 Cg_endo -69.2 59.79 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.693 1.365 . . . . 0.0 110.924 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -133.04 -2.37 3.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.26 135.01 46.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 0.0 110.424 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 1.9 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.193 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 160.04 26.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.256 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -67.93 156.89 36.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.178 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.465 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.44 149.39 42.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 73.7 t -75.0 97.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 4' ' ' SER . 4.0 t -108.25 123.89 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.207 -0.933 . . . . 0.0 110.153 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB3' ' HE1' ' A' ' 22' ' ' MET . . . -57.79 141.07 50.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.35 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t-20 -80.19 -67.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.845 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.409 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.1 tt0 -87.54 155.33 20.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.819 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -59.36 141.11 55.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 110.201 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 10.8 mm -130.55 144.9 55.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 110.058 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 44.2 Cg_endo -71.37 -170.94 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.947 1.498 . . . . 0.0 110.261 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 48' ' ' ALA . 6.2 mt -107.27 167.47 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.92 . . . . 0.0 110.023 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 54.72 26.18 7.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.185 -0.947 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -113.72 141.33 47.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.923 . . . . 0.0 110.217 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 104.96 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' CD1' ' HE2' ' A' ' 22' ' ' MET . 0.9 OUTLIER -87.27 162.79 17.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.356 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.29 163.21 23.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.99 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -57.24 -28.66 63.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 HG13 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.1 -17.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.67 -10.14 25.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.526 ' HE2' ' CD1' ' A' ' 17' ' ' LEU . 3.3 mtt -123.27 139.34 54.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.46 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -112.24 170.08 8.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.016 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.18 6.31 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 141.63 46.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 3' ' ' ALA . 91.1 t -87.66 82.02 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.63 155.18 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 110.127 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.436 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.2 p -111.85 159.86 31.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.263 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -76.17 132.24 26.87 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.511 -2.287 . . . . 0.0 110.477 -0.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.78 153.44 29.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -120.57 -71.4 0.31 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' CA ' ' A' ' 57' ' ' PRO . 3.1 mt -136.2 137.93 25.94 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.3 Cg_endo -73.07 -162.97 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.067 1.562 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.49 38.63 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -31.46 69.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 33.2 mm-40 -101.74 30.36 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.9 mm -44.89 -54.19 13.86 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -70.99 -5.77 17.71 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.632 1.333 . . . . 0.0 110.441 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' OD1' ' OE1' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -108.46 -24.83 11.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 110.127 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -93.74 -12.86 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 109.967 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 41.5 t -46.79 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.37 24.12 9.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.532 ' CE ' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.94 137.49 36.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.996 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 3.5 mt-30 -96.57 116.49 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.158 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.99 167.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.095 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 17.8 t30 -110.84 2.38 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HG2' ' CB ' ' A' ' 59' ' ' MET . 9.3 ptm180 -136.63 155.93 49.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.418 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -79.42 113.34 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.865 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' HB ' ' CB ' ' A' ' 53' ' ' THR . 19.1 m -81.87 112.33 34.05 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 48.2 Cg_endo -73.6 53.05 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.887 1.467 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER 66.82 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.496 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 46.22 49.11 14.93 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.534 ' CB ' ' HB ' ' A' ' 49' ' ' VAL . 11.3 m -96.83 123.71 40.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 54' ' ' THR . 8.9 t -65.22 142.63 58.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 110.165 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.462 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -64.22 120.74 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.463 ' O ' HG21 ' A' ' 60' ' ' VAL . 46.5 mmm -112.7 137.49 21.75 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.522 ' CB ' ' OH ' ' A' ' 63' ' ' TYR . 46.8 Cg_endo -74.2 -7.39 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.62 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -52.49 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.489 ' CB ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 mpt? -87.78 62.12 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.329 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 56' ' ' MET . 28.8 t -128.57 106.47 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.171 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 9.4 mmtt -49.92 -84.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.422 ' O ' ' HE2' ' A' ' 43' ' ' MET . 3.4 m120 -88.79 91.79 8.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -48.66 135.82 14.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 8.2 pm0 -78.41 -37.81 43.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -0.939 . . . . 0.0 110.53 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 24.9 t70 -84.39 99.99 11.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.89 31.12 4.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -99.78 -64.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -108.82 -14.35 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.579 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -70.27 -171.47 0.16 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 47.3 Cg_endo -77.52 -4.83 15.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.778 1.409 . . . . 0.0 110.497 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.57 40.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.37 158.88 15.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 110.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.307 0.575 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.09 137.03 56.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 114.13 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -95.08 147.55 23.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LEU . 53.0 t -79.57 120.11 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 110.181 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t -126.53 110.19 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.509 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -54.73 135.02 47.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -87.42 -71.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 2.2 pt20 -58.44 144.8 40.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.469 HD21 ' O ' ' A' ' 10' ' ' LEU . 2.9 tt -71.42 126.6 30.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -126.38 144.21 48.61 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.202 -0.936 . . . . 0.0 110.363 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.91 -158.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.982 1.517 . . . . 0.0 110.349 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.535 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 5.8 mt -95.74 -172.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' HG11 ' A' ' 45' ' ' VAL . 9.9 p30 39.86 30.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.83 115.81 30.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.25 98.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' HA ' ' CE ' ' A' ' 21' ' ' MET . 1.7 pp -70.4 152.62 43.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.7 p -130.17 -160.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD22 ' CG2' ' A' ' 37' ' ' ILE . 1.3 mp -77.05 -43.11 35.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pt -69.18 -16.88 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.501 ' CE ' ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -97.37 -12.73 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.33 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.459 ' HG3' HD11 ' A' ' 17' ' ' LEU . 39.3 mmm -124.13 107.46 11.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.153 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 21.9 mttt -99.22 144.18 28.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.76 98.56 11.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.4 mp0 -113.24 143.51 44.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 26' ' ' VAL . 8.1 p -96.75 62.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.92 -174.51 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 0.0 110.39 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.8 t -100.34 150.86 37.3 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.103 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 51.0 Cg_endo -81.84 153.74 78.65 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.689 -2.213 . . . . 0.0 110.563 -0.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -82.66 159.78 22.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.866 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -113.31 0.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -99.99 141.41 22.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 44.4 Cg_endo -71.43 -164.05 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.004 1.528 . . . . 0.0 110.466 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -116.91 27.29 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.925 . . . . 0.0 110.376 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -74.46 -17.13 60.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.246 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 pm0 -102.68 1.41 34.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -41.32 -54.56 5.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.496 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -70.5 -8.11 22.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.647 1.341 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -114.39 -18.61 11.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.067 -1.021 . . . . 0.0 110.501 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -102.4 -26.71 13.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.582 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 10.6 t -42.63 127.96 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.97 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.25 -0.65 47.07 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -87.53 152.24 22.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -1.123 . . . . 0.0 110.139 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -99.72 174.73 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG1' ' HA ' ' A' ' 13' ' ' ILE . 1.6 p -113.43 163.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.2 m-20 -102.81 -29.34 11.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 110.611 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' C ' HG12 ' A' ' 13' ' ' ILE . 17.2 mtp180 -121.74 164.99 16.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.548 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -57.56 150.1 19.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 0.0 110.508 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 80.5 t -127.88 107.27 20.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.056 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.72 -171.94 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.06 1.558 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -73.89 160.69 31.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.867 . . . . 0.0 110.184 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.54 46.92 7.19 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.575 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 8.1 t -92.38 104.87 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.1 t -51.54 157.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.304 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -62.93 112.0 2.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.0 tpt -112.51 127.58 26.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.197 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' HG22 ' A' ' 60' ' ' VAL . 46.9 Cg_endo -73.91 -20.55 19.5 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.857 1.451 . . . . 0.0 110.465 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -65.84 -23.1 66.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HB3' HG21 ' A' ' 45' ' ' VAL . 33.0 mtm -113.51 49.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 61.5 t -127.09 139.53 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' CE ' ' A' ' 43' ' ' MET . 37.3 t30 -90.34 92.66 9.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 86.3 m-85 -44.69 149.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -94.58 -47.21 6.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' OD2' HG22 ' A' ' 68' ' ' THR . 12.0 t70 -88.89 95.39 10.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.58 5.34 83.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -9.69 47.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.0 110.176 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.459 HG22 ' OD2' ' A' ' 65' ' ' ASP . 3.2 p -106.04 -178.56 3.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.282 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -50.76 -56.0 22.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.467 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.2 Cg_endo -72.21 112.54 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.916 1.482 . . . . 0.0 110.522 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.29 49.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 72' ' ' LEU . 11.3 mt -80.93 -2.71 48.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -1.115 . . . . 0.0 110.329 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.252 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 1' ' ' ASN . 29.0 p-10 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.312 0.577 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 162.75 12.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -65.01 126.79 29.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -95.01 166.44 11.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.156 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 15.0 t -85.54 110.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.32 113.2 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.088 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -49.09 128.78 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 7.2 t-20 -80.59 -55.69 4.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -91.02 177.69 6.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.068 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -99.65 130.53 45.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -126.8 133.17 24.74 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -73.15 56.96 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.983 1.517 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 45' ' ' VAL . 1.5 mt 45.66 -172.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.076 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' ILE . 1.6 m-20 43.63 63.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.114 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 m -159.61 119.09 2.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.4 85.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 43' ' ' MET . 1.2 pp -50.71 155.29 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 0.5 OUTLIER -130.01 159.91 35.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.178 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 2.1 tt -59.72 -48.42 81.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.412 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 88.3 mt -57.7 -31.6 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.233 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.461 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -86.19 -26.15 25.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 18' ' ' THR . 15.9 mmt -110.91 131.2 55.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -107.41 165.33 11.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.97 9.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -104.57 135.47 45.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.191 -0.943 . . . . 0.0 110.277 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG23 ' CA ' ' A' ' 3' ' ' ALA . 12.2 t -85.38 71.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 28' ' ' THR . 77.9 t -133.07 160.4 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.4 t -88.13 152.22 50.21 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.8 Cg_endo -77.77 160.31 93.05 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.546 -0.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtm -82.68 101.13 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.65 -119.9 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.531 ' CD1' HD11 ' A' ' 55' ' ' LEU . 1.8 mt -99.59 129.31 29.19 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 110.02 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 178.38 5.82 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.889 1.468 . . . . 0.0 110.761 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.508 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -79.3 2.79 20.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.378 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 34' ' ' ALA . 8.3 tt0 -43.58 -39.86 3.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -104.92 39.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.233 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.99 -54.56 50.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 110.233 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -70.61 -4.48 14.68 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.661 1.348 . . . . 0.0 110.45 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -111.45 -31.18 7.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.139 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -73.5 -39.61 64.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.141 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.4 t -45.24 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.113 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 119.57 19.27 4.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.445 ' SD ' HG12 ' A' ' 60' ' ' VAL . 2.0 ttt -98.5 144.34 27.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -1.095 . . . . 0.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.83 146.53 28.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.162 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 7.5 m -104.87 153.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.439 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.1 t30 -111.08 28.71 8.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 8.8 ptt180 -151.21 137.93 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -48.95 130.86 18.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 53' ' ' THR . 9.9 t -117.32 106.86 46.17 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.98 -168.14 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.539 . . . . 0.0 110.398 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -70.37 136.82 50.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 60.98 52.67 50.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.535 ' CB ' HG11 ' A' ' 49' ' ' VAL . 63.3 m -96.49 124.87 40.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -1.119 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.8 t -68.45 149.84 48.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.531 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.12 111.34 12.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.336 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtt -104.8 133.01 20.38 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.467 ' HA ' HG22 ' A' ' 60' ' ' VAL . 50.0 Cg_endo -76.99 6.23 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.948 1.499 . . . . 0.0 110.677 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 -42.19 21.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.055 -1.028 . . . . 0.0 110.521 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.539 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 3.2 mmt -110.54 67.28 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.6 t -126.25 122.36 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.867 . . . . 0.0 110.141 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.3 -77.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.09 105.62 17.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 70' ' ' PRO . 59.1 m-85 -67.26 155.61 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 110.223 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -104.54 -65.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.9 -43.91 67.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.02 90.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 m -105.07 -83.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.213 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.0 m -106.96 -80.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.283 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -51.8 -61.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.1 Cg_endo -71.13 154.6 62.1 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.814 1.428 . . . . 0.0 110.428 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.88 162.38 31.23 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 109.94 4.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -1.105 . . . . 0.0 110.216 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.305 0.574 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 21.4 mmtt -90.59 -16.93 27.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -47.88 112.44 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.15 148.21 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.016 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' A' ' 34' ' ' ALA . 59.4 t -72.86 104.33 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.173 -0.954 . . . . 0.0 110.269 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 HG22 ' CB ' ' A' ' 25' ' ' GLU . 4.6 t -107.97 105.87 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.048 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' CB ' ' HE3' ' A' ' 22' ' ' MET . . . -42.56 115.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -72.75 -62.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.056 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -86.61 152.43 22.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 2.3 tt -59.34 142.26 52.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 11' ' ' ILE . 35.2 mm -123.04 139.18 31.01 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 -162.11 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.024 1.539 . . . . 0.0 110.329 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 13' ' ' ILE . 6.5 mt -116.55 157.82 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 64.31 38.26 8.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 6.1 m -132.49 138.4 47.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -61.89 158.72 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.2 mt -110.01 148.16 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.96 132.23 46.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -31.28 9.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.51 -16.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 109.985 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.84 -15.65 22.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 110.073 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.505 ' HE3' ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -121.64 119.66 32.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.29 164.55 14.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 115.63 27.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' CB ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -111.28 124.88 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 3' ' ' ALA . 16.5 t -90.17 65.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG11 ' C ' ' A' ' 26' ' ' VAL . 30.7 m -132.55 -173.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.7 t -111.94 153.0 44.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.086 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.33 161.93 92.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.432 -0.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.3 mtp -82.82 92.01 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.64 -144.73 0.28 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -79.63 136.24 55.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.325 -1.103 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.51 -174.26 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.002 1.527 . . . . 0.0 110.644 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . . . -112.32 17.34 19.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.316 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -34.03 77.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.136 -0.977 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.5 mm-40 -89.24 26.41 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.592 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -59.96 -40.81 81.22 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.0 111.217 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 44.5 Cg_endo -74.81 -18.54 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.315 1.166 . . . . 0.0 111.256 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -114.31 -11.75 12.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 110.272 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 9.3 tt -102.42 -44.01 5.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 33.3 t -41.8 148.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.434 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' N ' HG11 ' A' ' 41' ' ' VAL . . . 96.04 -16.3 61.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 63' ' ' TYR . 3.6 mtp -73.27 157.01 37.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -1.107 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 15' ' ' THR . 4.4 mp0 -110.05 170.34 8.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.8 m -109.5 166.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 110.252 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.92 -4.23 18.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.424 ' C ' HG12 ' A' ' 13' ' ' ILE . 3.4 mtp180 -143.18 168.45 19.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.192 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.11 139.24 39.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.532 HG11 ' CB ' ' A' ' 53' ' ' THR . 88.8 t -112.04 127.28 27.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.84 . . . . 0.0 110.164 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.06 -171.88 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.841 1.442 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 2.1 mp -74.97 153.13 38.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.502 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 42.69 53.33 5.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.532 ' CB ' HG11 ' A' ' 49' ' ' VAL . 83.0 m -96.97 109.57 22.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.26 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 148.51 2.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.885 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.0 102.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.973 . . . . 0.0 110.211 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.1 mmt -111.35 149.63 40.89 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 48.1 Cg_endo -75.66 4.07 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.975 1.513 . . . . 0.0 110.798 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.32 -42.16 62.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 110.644 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.12 55.15 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.28 102.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -66.88 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.06 86.87 6.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HA ' ' HE2' ' A' ' 43' ' ' MET . 27.8 m-85 -44.29 155.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 36' ' ' GLU . 1.4 pt-20 -76.38 -158.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 110.342 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 4.1 m-20 -68.6 73.35 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -111.68 92.53 0.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 67' ' ' THR . 85.6 m -97.39 21.71 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.3 p -97.43 -15.06 20.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.087 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.59 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -173.54 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.046 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.0 Cg_endo -72.24 169.76 20.78 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.854 1.449 . . . . 0.0 110.227 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.35 56.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.15 75.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.087 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.238 0.542 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -92.92 170.4 9.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.126 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -87.95 127.65 35.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -102.24 137.34 40.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 15.9 m -78.22 129.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 t -122.13 131.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.414 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -55.69 129.31 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.89 -70.82 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -80.0 160.85 25.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 1.9 tt -77.98 130.97 37.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' VAL . 4.4 mt -116.59 113.54 40.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.151 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.9 Cg_endo -73.25 66.12 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.83 1.437 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.541 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 32.78 -161.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.534 0.683 . . . . 0.0 111.696 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 5.1 m120 36.52 42.17 0.19 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -147.72 124.53 11.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.58 7.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.812 . . . . 0.0 110.02 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 HD12 ' CG1' ' A' ' 45' ' ' VAL . 60.7 mt -62.33 133.46 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HE1' ' A' ' 21' ' ' MET . 0.6 OUTLIER -111.68 155.78 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.064 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -67.79 -29.1 68.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.345 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 21' ' ' MET . 1.4 pt -65.15 -19.67 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 110.139 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.523 ' N ' HG13 ' A' ' 20' ' ' ILE . 3.2 mtm -97.98 -2.25 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.9 118.57 32.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.272 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.6 pttt -114.81 142.27 46.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.56 96.32 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.957 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -112.2 133.93 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 3' ' ' ALA . 18.2 t -90.71 87.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.194 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.76 -167.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.384 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.6 t -118.71 153.44 52.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 110.236 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.3 Cg_endo -77.2 160.63 94.11 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.446 -0.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.1 mmm -82.62 71.27 9.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.154 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -55.96 -108.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.6 mt -113.12 136.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -162.0 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.928 1.488 . . . . 0.0 110.352 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -93.69 32.91 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -56.86 4.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 15.5 mm-40 -88.67 33.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.43 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.9 mm -60.04 -54.71 52.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.0 Cg_endo -71.39 -8.85 24.2 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.262 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.99 -47.71 4.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 0.0 110.14 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -68.3 -41.25 81.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -54.78 119.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.7 -8.26 10.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.513 ' CE ' HG11 ' A' ' 60' ' ' VAL . 1.4 ttm -100.78 162.25 13.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -1.115 . . . . 0.0 110.218 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -109.86 138.2 46.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.6 m -91.48 154.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -104.61 -2.73 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' CB ' ' HG2' ' A' ' 59' ' ' MET . 4.2 mtt180 -113.14 131.35 55.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.002 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.86 132.27 9.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.384 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 53' ' ' THR . 55.8 t -113.17 102.4 54.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 110.058 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.03 -167.13 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.543 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.58 138.54 40.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.24 34.93 91.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.51 ' CB ' HG11 ' A' ' 49' ' ' VAL . 73.2 m -73.5 97.87 2.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.98 137.9 3.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.24 98.66 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.431 ' CG ' ' HG3' ' A' ' 59' ' ' MET . 2.9 ptm -113.11 146.5 35.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.53 -5.44 17.15 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.541 . . . . 0.0 110.458 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -76.99 -25.48 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.295 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' HG2' ' CB ' ' A' ' 47' ' ' ARG . 11.0 mtt -108.21 41.53 1.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG11 ' CE ' ' A' ' 43' ' ' MET . 49.7 t -130.26 104.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -69.16 -60.35 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -98.37 71.57 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 13.1 t80 -53.36 158.47 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mm-40 -87.84 -65.63 1.0 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.36 85.21 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.65 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.91 17.86 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.171 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -80.22 -137.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.8 -55.98 4.22 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.594 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.35 -163.89 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.912 1.48 . . . . 0.0 110.457 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.7 87.79 0.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -85.49 -7.68 58.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 110.342 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.227 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.253 0.549 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -93.37 142.65 27.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.69 126.55 29.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' GLU . 3.5 t -95.86 -178.48 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 55' ' ' LEU . 77.3 t -89.18 119.9 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.82 101.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.219 -0.926 . . . . 0.0 110.165 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -47.15 116.48 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.106 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -79.66 -63.65 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.05 135.55 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.309 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 5.0 tt -60.45 142.06 55.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -130.1 116.69 17.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.581 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.84 59.71 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.849 1.447 . . . . 0.0 110.1 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 13.9 pt 39.92 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.661 . . . . 0.0 110.727 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 40.34 47.25 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.467 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -156.71 110.36 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.56 118.12 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 45' ' ' VAL . 5.9 mt -75.92 128.48 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -171.15 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.132 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.66 -45.96 67.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.119 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.31 -9.24 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -28.89 21.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 55' ' ' LEU . 1.4 mmt -118.92 143.26 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' OD1' ' A' ' 8' ' ' ASN . 8.5 mttt -115.68 166.68 11.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.33 79.1 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -101.82 152.99 20.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 26' ' ' VAL . 9.1 p -90.08 14.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 25' ' ' GLU . 22.8 t -62.36 142.44 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -88.14 163.82 35.7 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.136 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.79 174.17 53.79 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.608 -2.246 . . . . 0.0 110.42 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.61 86.95 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' HA3' ' CG2' ' A' ' 54' ' ' THR . . . -68.49 -150.75 0.3 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -76.26 137.59 68.28 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.361 -1.082 . . . . 0.0 110.063 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' HG21 ' A' ' 32' ' ' ILE . 44.9 Cg_endo -72.07 170.56 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.955 1.503 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -94.07 38.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.863 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -25.54 53.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.119 -0.988 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 7.6 mm-40 -105.09 41.97 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.63 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -44.78 -50.18 25.62 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.89 -11.99 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.632 1.332 . . . . 0.0 110.619 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.89 -30.6 11.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' N ' HD21 ' A' ' 40' ' ' LEU . 4.0 mm? -83.11 -47.07 12.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.105 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 37' ' ' ILE . 31.4 t -43.22 104.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.056 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.07 11.98 11.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 64' ' ' GLU . 9.4 ttm -83.37 134.33 34.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.241 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 144.8 31.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 14.4 m -119.11 160.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -110.85 0.63 17.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 0.0 110.359 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -120.02 122.3 40.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 110.366 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -47.12 140.61 4.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.34 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 53' ' ' THR . 12.0 t -124.84 130.36 24.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HD2' HG11 ' A' ' 49' ' ' VAL . 43.3 Cg_endo -69.6 -174.38 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.944 1.497 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.69 154.67 28.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 48.66 43.67 29.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.514 ' CG2' HG11 ' A' ' 49' ' ' VAL . 55.4 m -92.02 134.18 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -1.154 . . . . 0.0 110.266 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' ' HA3' ' A' ' 31' ' ' GLY . 7.6 m -67.38 141.24 57.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.095 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 ' CD2' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -61.93 99.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 mtp -102.83 142.51 24.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.31 2.59 6.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.013 1.533 . . . . 0.0 110.593 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.11 -32.47 24.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.133 -0.979 . . . . 0.0 110.521 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.453 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 mtt -96.31 3.49 52.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 110.393 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.68 82.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.324 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 51.7 pttt -59.53 -37.11 77.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TYR . 18.5 p30 -100.45 74.2 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 109.852 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.522 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -46.13 175.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.51 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -95.12 -152.82 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.028 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 11.9 t70 -58.77 83.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.798 -1.189 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -123.74 112.98 1.96 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 31.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -1.189 . . . . 0.0 110.471 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -106.63 -23.4 12.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.6 -61.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.65 150.39 56.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.921 1.485 . . . . 0.0 110.579 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.05 -48.51 0.37 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 72' ' ' LEU . 2.0 mm? -81.44 125.03 29.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.331 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 pttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.151 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 9.4 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' CE ' ' HB3' ' A' ' 33' ' ' PRO . 12.6 pttt -71.07 153.56 42.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB2' ' C ' ' A' ' 24' ' ' ALA . . . -63.1 138.64 58.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.2 t -103.46 -174.48 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 33' ' ' PRO . 59.3 t -92.14 123.59 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.86 118.47 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.43 138.99 44.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.103 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 4.0 t-20 -90.8 -62.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.287 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -77.36 162.43 27.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.21 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HB2' HD13 ' A' ' 51' ' ' LEU . 1.2 tt -93.06 130.78 38.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.112 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 26.3 pt -130.03 137.87 31.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.49 71.88 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.067 1.561 . . . . 0.0 110.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.7 mt 54.65 -172.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' N ' HG21 ' A' ' 45' ' ' VAL . 49.7 m-80 42.13 -141.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 14' ' ' ASN . 42.6 m 57.48 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -55.27 132.28 47.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 110.065 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -75.46 143.89 42.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.5 p -123.46 160.07 27.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.217 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 4.8 tt -67.58 -34.6 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.287 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -59.08 -36.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.4 mtm -93.76 6.88 46.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.374 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.412 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -98.97 123.56 43.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 147.71 34.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -105.7 75.91 1.16 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.161 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.81 20.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 71.0 t -81.65 91.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.181 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.31 154.92 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.9 t -113.13 150.02 42.31 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.8 Cg_endo -76.67 171.09 69.83 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.678 -2.218 . . . . 0.0 110.433 -0.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -80.61 81.43 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.03 -112.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 32' ' ' ILE . 1.6 mt -103.87 138.89 19.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 110.153 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HB3' ' CE ' ' A' ' 2' ' ' LYS . 45.7 Cg_endo -73.19 -177.22 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.117 1.588 . . . . 0.0 110.394 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -95.82 20.99 9.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -76.61 -36.88 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.406 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -92.49 27.35 2.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 110.481 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.76 -48.75 96.26 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -77.0 -5.62 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.801 1.422 . . . . 0.0 110.44 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 17.9 m120 -114.29 -20.01 11.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.341 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -97.46 -38.63 9.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.283 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 37' ' ' ILE . 25.1 t -43.63 123.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.331 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.59 -4.83 23.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.457 ' CE ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -93.63 152.91 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -1.135 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 51.7 mt-30 -103.75 145.36 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.106 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.9 m -91.98 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.105 -0.997 . . . . 0.0 110.256 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.412 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.7 m-20 -111.12 -9.03 14.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 11.6 ptm180 -119.22 171.59 8.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.341 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.39 123.67 27.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.815 . . . . 0.0 110.413 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.522 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 72.2 t -107.85 96.0 16.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.952 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' O ' ' OG1' ' A' ' 53' ' ' THR . 44.5 Cg_endo -71.97 -165.23 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -69.25 141.17 54.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 55.56 49.43 65.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 52.7 m -92.65 134.74 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 144.15 51.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.43 105.98 8.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.453 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -96.85 129.66 32.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.6 Cg_endo -75.01 1.89 7.24 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.928 1.489 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' HB2' ' HG2' ' A' ' 56' ' ' MET . 70.4 m-20 -81.46 -70.34 0.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.466 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 4.4 mmt -72.94 66.35 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.515 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 57' ' ' PRO . 62.0 t -126.64 128.93 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -96.78 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -0.939 . . . . 0.0 110.475 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 43' ' ' MET . 47.4 t30 -82.11 85.99 6.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.989 -1.07 . . . . 0.0 110.23 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' HB3' ' CA ' ' A' ' 71' ' ' GLY . 40.4 t80 -48.69 169.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.07 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 1.5 tt0 -64.67 -133.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.977 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -36.38 75.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 71' ' ' GLY . . . 62.04 55.52 27.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 0.08 51.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 70' ' ' PRO . 14.8 t -110.03 -28.69 8.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.5 -61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.08 -1.012 . . . . 0.0 110.825 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.2 Cg_endo -70.57 -175.49 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.904 1.476 . . . . 0.0 110.768 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 85.21 44.34 6.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -98.55 63.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.171 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.8 p30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.266 0.555 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.53 -161.34 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.243 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -73.04 132.18 43.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -110.08 160.76 16.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 67.8 t -89.44 113.72 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 23.4 t -111.68 113.34 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -54.25 118.89 4.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -76.27 -75.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -63.39 144.0 57.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.127 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.5 136.17 57.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mt -125.02 131.59 24.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.55 -157.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.93 -179.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 8.8 p30 40.95 27.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.197 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 13' ' ' ILE . 7.7 m -126.68 114.51 18.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.136 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.31 148.56 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -134.2 157.67 45.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.58 169.83 8.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.72 -10.58 53.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 34.4 mm -69.82 -21.73 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.768 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.8 mtp -98.1 10.36 40.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.309 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.518 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 3.6 mtp -117.69 138.81 51.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.11 167.05 11.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 110.121 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.45 95.21 5.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.922 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 128.35 55.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 3' ' ' ALA . 5.2 t -91.99 58.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.97 160.06 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.4 t -74.9 149.39 85.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -75.72 169.83 73.44 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.668 -2.222 . . . . 0.0 110.398 -0.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.4 -142.25 19.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 2.9 mt -100.83 134.06 20.72 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.121 -1.223 . . . . 0.0 110.177 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.68 -166.28 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.908 1.478 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.82 34.04 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.37 -39.93 62.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.928 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 40' ' ' LEU . 63.7 mm-40 -103.45 32.38 3.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.6 mm -53.04 -46.91 97.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.3 Cg_endo -73.88 -1.17 10.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.486 1.256 . . . . 0.0 110.447 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.73 -37.97 4.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.897 . . . . 0.0 110.101 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.3 -41.6 27.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 19' ' ' LEU . 40.7 t -44.66 125.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 93.92 9.09 59.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 64' ' ' GLU . 23.4 ttt -101.35 158.34 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.18 . . . . 0.0 110.245 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 158.38 18.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 13' ' ' ILE . 26.8 m -107.09 168.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -110.76 5.78 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.301 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 10.2 mmt85 -138.09 135.53 35.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.74 146.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.367 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.519 HG11 ' CB ' ' A' ' 53' ' ' THR . 95.2 t -129.97 120.84 19.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -73.48 -160.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.871 1.458 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -85.32 157.13 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.83 39.47 4.9 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.519 ' CB ' HG11 ' A' ' 49' ' ' VAL . 95.8 m -85.25 109.17 18.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -1.105 . . . . 0.0 110.399 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.9 m -47.41 149.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.1 103.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.466 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -97.85 133.89 22.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.133 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 46.4 Cg_endo -73.05 -34.88 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.955 1.503 . . . . 0.0 110.66 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 10.6 p-10 -57.18 -17.08 9.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 0.0 110.552 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.463 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 6.8 mtt -108.85 25.27 11.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG11 ' HE3' ' A' ' 43' ' ' MET . 47.0 t -117.41 129.22 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.314 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -69.42 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -78.08 83.99 4.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 57' ' ' PRO . 88.8 m-85 -44.26 129.21 6.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 2.9 mp0 -92.27 -37.47 12.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 17.5 p-10 -67.33 97.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.66 147.99 12.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -81.01 -92.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -1.149 . . . . 0.0 110.197 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 69' ' ' SER . 18.3 m -110.16 107.64 17.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.132 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.558 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 172.2 -58.98 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -73.01 -22.41 19.57 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.021 1.537 . . . . 0.0 110.503 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.68 159.79 13.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.07 -6.95 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.165 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.349 0.595 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.85 140.17 38.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -63.0 148.31 48.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.2 p -103.8 161.1 14.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.97 101.67 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.38 107.17 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -62.61 116.84 5.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.459 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 t-20 -79.92 -57.51 3.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 110.063 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 1.2 tp-100 -59.93 117.92 5.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 1.7 pt? -62.08 129.21 39.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.458 HG13 ' HB ' ' A' ' 49' ' ' VAL . 4.7 pt -130.06 146.04 59.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 0.0 109.941 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 45.1 Cg_endo -71.78 -94.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.0 110.158 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 47' ' ' ARG . 1.5 mt -152.01 -179.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.038 . . . . 0.0 109.972 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 51.75 21.12 1.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 15' ' ' THR . 8.0 t -99.75 128.65 45.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.44 100.62 4.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.065 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -49.0 124.24 8.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.33 158.01 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tt -49.6 -46.01 48.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.437 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.7 mt -51.4 -47.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.4 ' HG2' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -78.67 -25.2 44.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.43 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 20.8 mtm -85.35 110.51 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.34 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.29 151.16 25.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 95.76 7.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.23 123.49 50.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.134 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 3' ' ' ALA . 3.9 t -77.47 98.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.53 139.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.2 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.3 t -77.68 151.59 80.02 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.5 Cg_endo -75.52 156.34 99.29 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.433 -0.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -82.56 86.4 6.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -144.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 32' ' ' ILE . 1.1 mt -72.56 130.45 85.7 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 109.966 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.54 -179.44 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.984 1.518 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -94.2 2.15 55.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.6 -21.72 7.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 40' ' ' LEU . 7.1 mm-40 -104.64 23.5 13.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.418 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -42.27 -53.02 9.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.3 Cg_endo -72.01 -6.0 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.641 1.337 . . . . 0.0 110.757 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' GLU . 4.2 m120 -113.84 -20.25 11.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 55' ' ' LEU . 1.6 mp -85.85 -43.88 12.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 37' ' ' ILE . 55.6 t -44.8 122.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.11 37.19 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.64 136.95 34.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -106.7 129.27 54.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -84.88 163.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' C ' HG22 ' A' ' 13' ' ' ILE . 25.6 t-20 -111.3 5.46 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' N ' HG22 ' A' ' 13' ' ' ILE . 27.3 mtt180 -144.03 167.55 22.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -68.54 144.68 54.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' HB ' HG13 ' A' ' 11' ' ' ILE . 30.2 t -126.52 126.07 24.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.24 -176.67 2.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.521 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.91 137.96 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 60.68 51.15 60.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.443 HG22 ' HD2' ' A' ' 50' ' ' PRO . 96.5 m -96.3 129.52 43.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -1.128 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 m -66.54 136.39 55.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' CD1' HD22 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -63.36 105.67 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.424 ' O ' HG21 ' A' ' 60' ' ' VAL . 2.5 mtt -109.39 154.59 42.15 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.855 . . . . 0.0 110.1 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.4 1.6 7.21 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.002 1.527 . . . . 0.0 110.56 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -45.57 31.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.428 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.488 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 14.6 mtm -107.58 57.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.351 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 56' ' ' MET . 98.8 t -125.03 84.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 14.7 tptm -52.85 -65.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 32.4 p-10 -99.59 86.39 3.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.882 . . . . 0.0 110.218 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.56 150.34 12.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.472 ' CD ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -73.75 -162.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' ND2' ' A' ' 39' ' ' ASN . 44.3 p-10 -73.0 75.11 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.32 127.86 4.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -77.18 55.93 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -1.099 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 171.37 8.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.519 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -45.77 -55.69 12.03 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 110.455 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -73.42 88.48 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.925 1.487 . . . . 0.0 110.436 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.79 37.46 1.86 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 73.06 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.244 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.131 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.214 0.531 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 16.96 9.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.906 . . . . 0.0 110.221 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.97 111.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 t -99.75 164.88 11.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 22' ' ' MET . 32.2 t -73.05 117.91 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 53' ' ' THR . 17.0 t -127.34 99.35 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -59.28 141.34 54.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.945 . . . . 0.0 110.2 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.85 -63.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.21 145.12 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.009 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -59.55 150.0 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -130.13 137.54 31.1 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.276 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.04 166.32 30.37 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.498 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 11.2 pt -81.49 175.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 3.0 m120 58.23 16.77 4.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 110.22 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m -125.12 105.94 9.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -59.32 122.63 14.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.9 OUTLIER -83.75 155.46 23.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.912 . . . . 0.0 110.392 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 22' ' ' MET . 1.7 m -106.69 169.83 8.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD13 ' CG2' ' A' ' 20' ' ' ILE . 1.5 pp -65.0 -33.1 75.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.462 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' CG2' HD13 ' A' ' 19' ' ' LEU . 3.7 pt -67.54 -20.34 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.173 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.99 -14.99 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.533 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.481 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -121.69 127.68 51.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.96 . . . . 0.0 110.495 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.4 mttt -121.07 179.37 4.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.985 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.89 99.36 9.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.21 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -101.8 145.33 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -90.4 76.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' HG23 ' A' ' 6' ' ' VAL . 36.0 m -125.81 155.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.15 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 9.6 t -101.37 150.01 36.83 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.151 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.19 176.29 44.42 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.708 -2.205 . . . . 0.0 110.513 -0.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -73.55 -139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 30' ' ' MET . . . 151.89 -117.01 0.79 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.546 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 2.9 mt -110.56 118.97 47.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 50.1 Cg_endo -75.26 5.08 4.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.852 1.448 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 33' ' ' PRO . . . 71.92 20.69 4.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.457 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.0 -26.51 4.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.006 -1.059 . . . . 0.0 109.729 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 43.3 mm-40 -105.16 60.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -56.89 -41.48 91.57 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 111.058 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -75.69 -9.74 19.9 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.288 1.152 . . . . 0.0 110.508 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -114.47 -26.88 7.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD11 ' OE1' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.44 -45.6 15.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.329 -0.857 . . . . 0.0 110.398 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 37' ' ' ILE . 20.3 t -42.22 115.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 112.93 0.27 25.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.25 136.98 48.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -1.16 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 26.8 mt-30 -110.1 163.9 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 13' ' ' ILE . 7.2 m -120.54 170.29 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.421 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 47.7 p-10 -110.81 -8.73 14.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 13' ' ' ILE . 1.8 mtt180 -126.33 121.21 31.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -48.23 140.44 7.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG13 ' CG2' ' A' ' 53' ' ' THR . 67.2 t -127.46 135.14 26.99 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -73.13 -161.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.79 168.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.15 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 46.8 80.89 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 64.0 m -94.31 90.54 6.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.114 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -66.88 133.1 49.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -71.44 88.63 0.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.454 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.3 mtm -111.82 164.27 15.54 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.33 10.15 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -54.44 5.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.805 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 36.5 mtt -113.04 69.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.853 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 56' ' ' MET . 12.8 t -130.31 103.4 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.044 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 46' ' ' ASN . 5.6 mtpt -55.6 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.277 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.88 84.0 4.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 110.352 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.546 ' CZ ' HD12 ' A' ' 32' ' ' ILE . 2.1 t80 -46.57 144.89 2.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE1' ' HB2' ' A' ' 36' ' ' GLU . 1.9 pt-20 -68.64 -151.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.25 -0.906 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.3 m-20 -59.39 -46.4 88.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.67 146.96 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -87.42 -30.91 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -1.184 . . . . 0.0 110.079 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.0 OUTLIER -93.06 23.46 4.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.15 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.602 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 4.3 t 54.55 44.12 1.64 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 111.001 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -74.26 103.54 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.692 1.364 . . . . 0.0 110.415 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.02 128.47 3.56 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -77.41 -21.46 53.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.31 0.576 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HE3' ' SD ' ' A' ' 30' ' ' MET . 3.2 ptpt -70.97 146.92 49.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' HB3' HG23 ' A' ' 26' ' ' VAL . . . -79.11 135.33 36.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -106.28 152.99 22.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 36.8 t -87.44 96.1 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.329 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG11 ' C ' ' A' ' 52' ' ' GLY . 2.9 t -107.04 112.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.037 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -62.72 136.82 58.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.72 -54.91 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -83.21 146.27 28.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.484 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 pt? -63.57 145.85 54.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' VAL . 6.6 mt -130.37 136.3 28.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.51 -162.43 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.934 1.491 . . . . 0.0 110.273 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' THR . 5.7 mt -104.3 -173.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.4 p30 40.08 28.11 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 110.571 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 13' ' ' ILE . 25.6 m -120.57 121.64 38.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.247 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -57.17 162.66 2.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 110.14 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -121.13 144.79 48.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -116.95 169.17 9.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 20' ' ' ILE . 3.2 tt -60.66 -50.26 74.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.486 ' N ' HD22 ' A' ' 19' ' ' LEU . 58.0 mt -55.39 -38.74 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -13.89 60.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.41 112.01 20.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.6 mttt -106.0 145.0 31.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -94.0 102.63 14.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' SER . 41.6 tt0 -108.16 133.56 52.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 3' ' ' ALA . 11.8 t -85.71 74.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 26' ' ' VAL . 10.5 m -143.41 -173.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 5.2 t -109.52 150.66 41.49 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.153 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.4 Cg_endo -76.16 168.11 78.21 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.613 -2.244 . . . . 0.0 110.465 -0.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.452 ' SD ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -76.95 -112.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.098 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.79 -134.58 10.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.8 mt -99.12 125.69 40.75 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -1.122 . . . . 0.0 110.03 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.29 -170.96 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.931 1.49 . . . . 0.0 110.547 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.17 16.76 17.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -47.76 84.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 mm-40 -89.36 47.78 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.108 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.654 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 5.9 tp -69.79 -30.68 2.14 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 111.719 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.4 Cg_endo -80.15 -7.93 14.13 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 122.813 0.901 . . . . 0.0 109.928 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -108.55 -35.14 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -44.5 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 29.2 t -48.57 103.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 110.013 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.17 -0.55 19.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -92.52 157.09 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 110.053 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 61' ' ' LYS . 18.0 mt-30 -109.54 171.13 7.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.332 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 59' ' ' MET . 11.7 m -116.93 156.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -103.5 5.06 36.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' CB ' ' CG ' ' A' ' 59' ' ' MET . 2.4 mtt180 -136.39 159.91 40.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' C ' HG21 ' A' ' 49' ' ' VAL . . . -65.51 150.59 48.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.13 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 21.8 t -129.31 111.66 18.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -164.19 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.886 1.466 . . . . 0.0 110.432 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 10' ' ' LEU . 3.2 mp -79.38 163.58 24.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.066 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' C ' HG11 ' A' ' 6' ' ' VAL . . . 43.21 28.97 0.91 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.591 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 6.7 t -65.14 124.52 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.391 -1.064 . . . . 0.0 110.417 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 30' ' ' MET . 0.2 OUTLIER -77.24 140.52 40.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.66 101.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.106 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.6 mtt -111.55 153.81 44.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.989 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.4 -0.26 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.958 1.504 . . . . 0.0 110.493 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.31 -46.82 21.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 110.319 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' CG ' ' CB ' ' A' ' 47' ' ' ARG . 1.4 mpt? -97.92 50.0 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 56' ' ' MET . 39.4 t -121.4 103.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.905 . . . . 0.0 110.17 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -50.27 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 17.1 p-10 -95.57 92.25 6.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.945 . . . . 0.0 110.246 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -44.69 135.73 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.278 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 77.8 mm-40 -88.12 -75.5 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.68 76.84 2.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.82 52.9 0.63 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 p -90.01 25.56 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -1.138 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 p -101.95 -11.76 18.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.561 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -178.64 -59.76 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.11 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.3 Cg_endo -72.74 -90.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.0 -79.86 1.13 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.59 86.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -1.091 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.214 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.426 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.1 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.276 0.56 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -67.33 175.82 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -87.54 141.72 28.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -121.29 153.79 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG12 ' SD ' ' A' ' 22' ' ' MET . 25.3 t -87.44 127.49 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.272 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 ' CG1' ' C ' ' A' ' 52' ' ' GLY . 11.9 t -130.09 121.63 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.89 142.15 6.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.463 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 10.1 t-20 -89.09 -59.33 2.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -97.07 148.26 23.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.44 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 7.7 tt -64.75 131.84 47.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.18 130.28 23.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 0.0 110.644 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.3 Cg_endo -74.86 71.03 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.941 1.495 . . . . 0.0 109.841 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 32.4 pt 39.39 -164.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.732 -0.605 . . . . 0.0 110.692 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER 65.56 -62.31 0.23 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -58.36 106.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.349 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.78 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.179 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -106.75 129.4 54.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.28 -0.887 . . . . 0.0 110.095 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -125.75 156.12 39.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 110.349 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -46.25 -62.49 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 0.0 110.38 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mt -59.82 -13.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.459 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -91.53 -47.38 7.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.436 ' SD ' HG12 ' A' ' 5' ' ' VAL . 17.5 ptt? -104.84 148.26 26.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -120.17 160.76 22.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.86 103.2 14.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.25 137.58 50.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 3' ' ' ALA . 52.2 t -96.42 80.41 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.258 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 p -174.2 168.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.3 t -82.9 151.75 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.3 Cg_endo -75.89 133.13 29.93 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.602 -0.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.5 mtp -82.46 175.29 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.88 -132.77 1.4 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -90.23 136.85 28.17 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.213 -1.169 . . . . 0.0 109.924 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.56 -170.79 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.003 1.528 . . . . 0.0 110.676 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.75 31.73 5.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.275 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -48.04 82.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.016 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 74.3 mm-40 -100.0 65.65 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.636 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 8.7 tp -70.62 -29.87 1.65 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 111.929 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.0 Cg_endo -78.01 -7.19 16.26 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.704 0.844 . . . . 0.0 109.944 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.27 -19.6 11.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -88.34 -40.96 13.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.161 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 90.8 t -46.53 105.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.54 10.0 8.91 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.21 121.48 23.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.46 148.47 22.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.1 m -117.98 155.87 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.11 5.05 19.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' N ' HG23 ' A' ' 13' ' ' ILE . 66.4 mtt-85 -120.99 127.0 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.233 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 13' ' ' ILE . . . -45.78 133.44 8.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 110.496 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.518 HG11 ' CB ' ' A' ' 53' ' ' THR . 24.8 t -117.9 121.54 31.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -72.6 -174.93 1.62 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.96 1.505 . . . . 0.0 110.513 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.89 156.16 39.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' C ' ' CG1' ' A' ' 6' ' ' VAL . . . 46.83 44.77 18.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CB ' HG11 ' A' ' 49' ' ' VAL . 4.9 m -93.47 114.64 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.147 . . . . 0.0 110.126 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.461 HG23 ' HG2' ' A' ' 29' ' ' PRO . 2.4 t -57.79 144.15 39.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.453 HD13 HD22 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -64.11 108.85 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.511 ' CG ' ' HD2' ' A' ' 57' ' ' PRO . 20.7 ttm -103.18 145.62 30.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 47.0 Cg_endo -74.13 -0.5 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.075 1.566 . . . . 0.0 110.613 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -41.35 13.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.16 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.473 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 8.9 mtm -90.9 45.38 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 56' ' ' MET . 3.0 t -129.96 126.03 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.107 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -74.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' TYR . 7.6 p30 -100.05 104.25 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -47.22 176.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.331 -0.855 . . . . 0.0 110.334 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -144.51 0.05 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.101 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 8.1 p-10 -75.18 80.37 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.75 97.48 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -101.65 39.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -1.111 . . . . 0.0 110.406 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 70' ' ' PRO . 15.4 t -72.76 -11.83 60.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.955 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -177.31 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 48.3 Cg_endo -73.61 98.12 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.715 1.376 . . . . 0.0 110.399 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.43 -31.25 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.54 96.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -1.181 . . . . 0.0 110.287 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.127 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.241 0.543 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 175.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.72 128.68 35.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -116.12 145.48 43.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.151 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 39.2 t -86.48 135.24 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.47 124.37 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -57.46 115.52 2.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.85 -51.88 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 110.19 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -84.32 142.7 30.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.173 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -74.11 127.94 34.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.472 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.2 pt -130.49 119.91 18.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.53 64.66 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.881 1.464 . . . . 0.0 110.544 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.4 pt 39.32 -164.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' ILE . 71.6 m-20 40.8 32.29 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.885 . . . . 0.0 110.456 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 18.6 m -145.53 107.2 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.144 -0.973 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' CA ' ' HG2' ' A' ' 44' ' ' GLN . . . -59.59 163.84 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.06 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -141.12 157.71 44.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -119.42 -157.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.845 . . . . 0.0 110.188 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.27 -62.28 1.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -47.52 -23.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.348 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -72.34 -57.32 4.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.091 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.442 ' HG3' ' CD1' ' A' ' 17' ' ' LEU . 1.4 mtt -107.88 141.11 39.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.22 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.08 108.35 19.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.338 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.04 145.1 41.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 80.3 t -86.86 97.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG21 ' N ' ' A' ' 28' ' ' THR . 13.5 p -168.04 154.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.211 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' N ' HG21 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.78 159.15 77.09 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.44 -163.68 3.31 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.72 -2.2 . . . . 0.0 110.547 -0.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.3 mtt -81.82 -73.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.266 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.31 -144.1 33.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.477 ' CD1' HD11 ' A' ' 55' ' ' LEU . 4.4 mt -103.56 130.76 22.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 110.142 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 -172.3 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.327 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' A' ' 37' ' ' ILE . . . -97.7 32.33 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -76.83 -28.81 55.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.92 40.78 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -59.66 -51.91 77.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.6 Cg_endo -73.43 -1.81 11.21 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.741 1.39 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 89.8 m-20 -114.26 -42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.227 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 tp -73.42 -42.07 62.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.4 t -46.8 116.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.35 10.89 50.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 ttt -104.64 147.73 27.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HG2' ' CA ' ' A' ' 16' ' ' ALA . 44.1 mt-30 -110.06 164.53 12.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.281 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 8.4 m -115.66 164.33 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.98 -1.45 16.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 14.5 mtt180 -118.22 131.58 56.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.12 127.28 8.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.56 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.531 HG11 ' CB ' ' A' ' 53' ' ' THR . 22.4 t -116.15 108.75 45.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.37 -176.09 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.987 1.519 . . . . 0.0 110.466 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.05 134.34 48.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 70.42 46.28 49.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.531 ' CB ' HG11 ' A' ' 49' ' ' VAL . 67.1 m -96.63 113.82 25.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -1.153 . . . . 0.0 110.386 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 m -54.52 142.51 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.304 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.11 100.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.412 ' HB2' ' HG3' ' A' ' 59' ' ' MET . 2.9 mmt -98.47 139.08 20.91 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 -2.26 11.84 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.059 1.557 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.35 -37.79 14.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -73.05 -14.2 61.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 25.4 t -85.35 118.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.32 -74.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' CE ' ' A' ' 43' ' ' MET . 71.6 m-20 -100.58 93.48 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE1' ' OG1' ' A' ' 67' ' ' THR . 9.4 t80 -46.65 165.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 23.6 mm-40 -89.8 -171.37 3.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 63.75 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.143 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.04 -71.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 63' ' ' TYR . 2.2 m -79.76 108.82 13.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -72.1 69.2 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.576 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -171.68 -62.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.383 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.51 65.08 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.833 1.438 . . . . 0.0 110.432 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.09 97.41 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.74 -55.31 3.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 110.159 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.154 179.96 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.261 0.553 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 131.45 49.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.73 154.11 22.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' MET . 7.3 p -121.41 168.29 11.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.8 t -88.38 117.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 0.0 110.279 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.64 123.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -52.61 118.99 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -74.54 -68.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -89.27 147.0 24.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 10' ' ' LEU . 1.8 pt? -67.74 134.19 50.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.291 -0.881 . . . . 0.0 110.512 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.452 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.0 pt -120.38 156.12 55.66 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.339 -0.851 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.59 -158.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.07 1.563 . . . . 0.0 109.991 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.5 mt -103.25 166.73 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.878 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER 58.99 25.84 14.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.359 179.953 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -102.93 124.26 48.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.12 157.36 22.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.091 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 43' ' ' MET . 2.5 mt -93.81 131.65 38.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' SD ' ' A' ' 22' ' ' MET . 1.1 p -116.8 172.92 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.163 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.45 -55.57 15.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 21' ' ' MET . 5.8 pt -48.32 -24.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.495 ' N ' HG13 ' A' ' 20' ' ' ILE . 4.6 mtt -97.55 3.9 50.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -117.34 96.47 5.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -112.8 127.05 56.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -80.05 99.3 7.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.211 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.19 139.44 46.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.892 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -79.64 93.69 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.1 146.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.9 t -87.86 149.43 45.78 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.233 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.89 176.14 45.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.691 -2.212 . . . . 0.0 110.503 -0.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 4' ' ' SER . 3.2 mtp -75.87 -57.86 3.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.318 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.75 -145.67 35.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.3 mt -88.3 124.86 65.5 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -1.208 . . . . 0.0 109.928 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.83 -163.48 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.465 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -103.15 25.48 9.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -38.99 69.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.76 38.77 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.568 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 8.6 mm -65.98 -45.24 63.52 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.6 Cg_endo -75.38 0.75 8.69 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.513 1.27 . . . . 0.0 110.456 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 3.6 t-20 -111.18 -33.95 6.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -83.13 -29.6 28.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.9 t -43.1 116.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.73 7.54 25.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -94.55 132.64 39.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 110.298 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 10.7 mp0 -93.73 150.08 20.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 9.6 m -87.72 174.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -102.93 -25.49 13.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.576 -179.67 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CG ' ' CG ' ' A' ' 59' ' ' MET . 7.6 ptm180 -135.05 179.88 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.209 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -70.47 149.9 46.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.631 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' HB ' HG13 ' A' ' 11' ' ' ILE . 19.5 t -127.92 124.79 23.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.874 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.48 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.961 1.506 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 1.1 mp -90.61 166.43 13.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.42 33.1 2.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.446 HG22 HG11 ' A' ' 49' ' ' VAL . 92.3 m -78.13 98.44 5.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -1.175 . . . . 0.0 110.075 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.0 m -44.84 148.33 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.84 88.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.163 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.434 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.29 156.04 43.68 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.059 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' CB ' ' HB3' ' A' ' 70' ' ' PRO . 45.3 Cg_endo -72.34 -0.54 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.925 1.487 . . . . 0.0 110.598 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -52.01 65.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.496 ' CG ' ' CG ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -109.99 33.07 4.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 56' ' ' MET . 12.4 t -128.59 109.47 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.541 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 11.1 ptmt -65.8 -149.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 109.835 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 62.6 t30 -64.88 84.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 109.92 179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.551 ' CE2' ' O ' ' A' ' 65' ' ' ASP . 36.5 p90 -83.45 -159.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 55.8 mm-40 -63.44 -124.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 8.3 p-10 -58.61 94.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 110.63 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA3' ' CZ ' ' A' ' 63' ' ' TYR . . . -149.14 54.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -107.93 -12.92 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -1.133 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.447 HG21 ' HD2' ' A' ' 70' ' ' PRO . 6.0 t -70.74 -6.01 34.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.589 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER 174.57 -62.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -72.37 -158.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 110.137 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 62' ' ' ASN . . . 86.32 -83.94 1.59 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 72' ' ' LEU . 4.6 mm? -65.93 143.52 57.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 tttp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.261 -179.904 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.292 0.568 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.23 172.73 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.32 115.21 7.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.8 t -102.66 141.46 35.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' HB ' ' CG ' ' A' ' 55' ' ' LEU . 23.5 t -73.25 105.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.426 HG11 ' C ' ' A' ' 52' ' ' GLY . 18.0 t -123.62 117.7 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.211 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -71.87 144.56 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.091 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 17.7 t-20 -83.49 -52.81 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 110.503 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.49 142.5 32.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 110.358 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -60.38 138.57 57.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.091 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.466 HG23 ' CD2' ' A' ' 17' ' ' LEU . 4.0 mt -129.33 133.76 25.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.16 -179.13 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.971 1.511 . . . . 0.0 110.395 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 47' ' ' ARG . 2.6 pt -93.67 -174.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.63 16.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -130.58 118.33 20.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.069 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 44' ' ' GLN . . . -54.9 160.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' CD2' HG23 ' A' ' 11' ' ' ILE . 6.2 mt -118.7 145.26 45.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -119.89 -166.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 110.281 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.9 mt -76.61 -52.32 9.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mt -50.37 -21.76 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.163 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.65 -44.83 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -108.22 120.13 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.266 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -111.11 165.88 11.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 98.42 8.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.01 160.1 17.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.11 50.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 t -117.22 166.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.455 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 48.2 p -81.99 159.75 64.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -74.83 -167.49 5.65 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.536 -0.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 4' ' ' SER . 51.6 mtp -81.64 -46.47 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.474 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.73 -156.35 0.43 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mt -90.5 142.22 27.94 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.22 -1.164 . . . . 0.0 110.409 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 47.4 Cg_endo -73.56 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.086 1.571 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.4 42.63 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.61 -42.43 51.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -103.26 36.91 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.7 mm -53.04 -54.08 48.22 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.469 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.1 Cg_endo -70.9 -5.88 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.702 1.369 . . . . 0.0 110.709 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.13 -19.05 11.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.955 . . . . 0.0 110.355 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.4 tp -88.14 -29.54 20.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 47.3 t -46.1 116.32 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.31 10.59 23.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -85.29 135.45 33.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 110.211 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 1.5 mt-30 -106.38 138.69 42.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 110.285 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 13' ' ' ILE . 18.3 m -99.49 170.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.358 -0.839 . . . . 0.0 110.114 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -110.67 -4.85 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.511 ' N ' HG23 ' A' ' 13' ' ' ILE . 6.0 mtt180 -129.05 126.43 39.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.43 143.19 56.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.325 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 80.9 t -129.97 135.7 27.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HD13 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -70.09 -173.78 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.961 1.506 . . . . 0.0 110.427 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -43.05 164.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.955 179.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 51.82 61.31 6.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 53.5 m -84.39 87.72 7.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -1.093 . . . . 0.0 110.628 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.5 m -71.83 121.17 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.634 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -61.37 114.43 3.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.83 -179.276 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.468 ' O ' HG21 ' A' ' 60' ' ' VAL . 5.8 mtm -113.67 156.72 43.18 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.0 1.02 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.97 1.511 . . . . 0.0 110.669 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' MET . 33.7 p30 -91.88 -21.88 20.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.018 . . . . 0.0 110.74 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 44.8 mtt -112.0 -7.75 14.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 56' ' ' MET . 10.8 t -101.14 91.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.082 -1.011 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -48.85 39.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -95.04 74.37 3.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.043 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.525 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -54.12 -165.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.87 . . . . 0.0 110.549 -179.793 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -104.99 -172.39 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.09 66.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.356 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -114.87 114.44 3.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 m -88.56 59.44 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -1.14 . . . . 0.0 110.062 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -106.71 -40.28 5.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.15 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 171.9 -59.25 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.129 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -72.93 55.6 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.974 1.513 . . . . 0.0 110.461 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.77 57.8 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -87.97 -45.56 10.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -1.148 . . . . 0.0 110.205 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.247 0.546 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -87.01 136.08 33.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.211 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.56 138.59 39.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.98 162.72 20.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG13 HD22 ' A' ' 55' ' ' LEU . 53.0 t -72.97 102.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG11 ' C ' ' A' ' 53' ' ' THR . 14.3 t -113.7 103.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -46.67 121.67 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.431 ' OD1' ' HB2' ' A' ' 23' ' ' LYS . 8.4 m120 -72.96 -64.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.877 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tp60 -81.58 149.13 28.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 110.227 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.54 133.62 56.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.956 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD11 HG22 ' A' ' 11' ' ' ILE . 13.1 mm -121.75 136.08 25.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.73 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.058 1.557 . . . . 0.0 110.191 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.2 pt -120.1 -174.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -0.994 . . . . 0.0 110.485 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m120 56.53 16.54 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.06 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 19.1 m -123.05 154.33 38.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.958 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . . . -77.03 163.77 26.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.405 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -111.63 122.62 48.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 179.93 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.1 170.96 7.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 HD23 ' CG1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -67.24 -54.7 18.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.324 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -51.27 -21.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.505 ' N ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -80.97 -48.38 12.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 9.4 ptt? -110.98 141.09 44.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -0.961 . . . . 0.0 110.191 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 21.0 mmtt -120.92 172.63 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.91 92.74 7.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.248 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.74 141.37 32.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -84.29 76.92 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -133.71 150.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -111.39 161.01 27.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.74 153.29 99.09 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.704 -2.207 . . . . 0.0 110.479 -0.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.5 ptt? -80.48 125.87 30.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.48 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -90.54 -100.71 1.17 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -109.06 131.67 21.66 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 110.137 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.21 177.84 6.75 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -92.56 24.15 3.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.92 -77.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 pm0 -78.18 55.19 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.057 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -70.73 -30.5 1.79 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.376 -0.827 . . . . 0.0 111.764 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.5 Cg_endo -78.73 -4.46 14.07 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 122.686 0.835 . . . . 0.0 110.047 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 1.8 m120 -112.52 -37.95 4.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.99 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' CA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -76.25 -44.39 37.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 37' ' ' ILE . 21.1 t -45.71 109.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 16' ' ' ALA . . . 122.76 6.75 7.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.524 ' CE ' ' HG3' ' A' ' 64' ' ' GLU . 1.6 ttt -91.69 157.54 16.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.168 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' THR . 42.5 mt-30 -110.14 136.26 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.9 m -88.64 171.63 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.53 -15.85 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.0 111.255 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.6 ptm85 -128.16 150.73 49.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.88 -1.137 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.53 156.44 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 110.752 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' CB ' ' A' ' 53' ' ' THR . 91.6 t -130.17 127.55 22.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -72.57 -168.96 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.832 1.438 . . . . 0.0 110.509 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -80.17 155.95 27.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.188 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.66 43.94 6.64 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.526 ' CB ' HG11 ' A' ' 49' ' ' VAL . 84.9 m -86.33 128.28 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -69.39 141.23 54.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.78 110.4 2.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.455 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -109.42 159.93 29.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.463 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 46.2 Cg_endo -73.97 0.12 8.76 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.089 1.573 . . . . 0.0 110.648 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD1' ' CG ' ' A' ' 59' ' ' MET . 1.3 p30 -91.7 -26.2 18.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.653 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 3.4 mtt -97.2 32.31 2.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 110.077 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.47 125.97 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.552 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -75.39 -80.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 109.84 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' HE1' ' A' ' 43' ' ' MET . 8.0 p30 -100.74 101.44 12.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.463 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -45.78 167.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.799 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 2.1 mp0 -83.05 -68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' OD1' ' OG1' ' A' ' 67' ' ' THR . 3.2 p30 -98.94 -30.47 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.46 51.99 23.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.482 HG21 ' N ' ' A' ' 68' ' ' THR . 38.6 m -72.23 -89.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.087 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.482 ' N ' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -94.17 5.46 51.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 179.766 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -111.27 -178.44 0.54 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 44.7 Cg_endo -72.86 117.4 5.11 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.917 1.482 . . . . 0.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.6 48.78 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.84 130.4 36.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.956 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.314 0.578 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -102.26 170.35 8.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -76.9 150.77 35.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 40.4 t -116.53 164.56 14.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG12 ' SD ' ' A' ' 22' ' ' MET . 33.3 t -92.54 102.36 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.347 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' HA2' ' A' ' 52' ' ' GLY . 3.4 t -123.71 121.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -70.21 138.85 52.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.115 -0.99 . . . . 0.0 109.998 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.45 -52.49 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -82.2 162.71 22.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.75 179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -67.63 142.97 56.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.466 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 11' ' ' ILE . 14.7 mt -131.25 127.34 21.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.219 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.69 -159.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.79 1.416 . . . . 0.0 110.037 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 36.1 pt -112.44 -165.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.115 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 p30 39.9 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 110.412 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 47.7 m -130.38 136.6 49.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -87.55 130.62 34.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.504 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.7 OUTLIER -103.34 161.48 13.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -130.07 -175.6 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -51.88 -34.28 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -50.06 -60.01 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.76 30.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.317 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.504 ' CE ' HD13 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -123.96 115.32 21.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.297 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.81 124.81 45.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.917 . . . . 0.0 110.215 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.96 97.22 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 26.6 pt-20 -113.13 157.86 21.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 23.0 t -98.51 57.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -126.06 154.65 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 62.7 p -79.14 158.95 73.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.48 176.67 42.57 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.722 -2.199 . . . . 0.0 110.5 -0.167 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.3 mtt -77.13 -107.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.209 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.72 -129.37 9.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 55' ' ' LEU . 4.7 mt -112.04 132.45 22.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.83 -158.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.962 1.506 . . . . 0.0 110.304 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.09 30.92 7.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.433 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -77.41 -15.92 59.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.033 -1.042 . . . . 0.0 109.605 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.3 mp0 -105.02 24.66 11.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.574 -0.704 . . . . 0.0 109.966 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.4 mm -41.7 -53.5 7.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.701 -179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -71.24 -4.65 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.564 1.297 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.32 -36.23 4.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' MET . 2.7 mp -79.8 -42.47 24.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.259 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 42.7 t -42.18 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.367 -0.833 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . 118.67 -6.5 13.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.51 148.96 30.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -1.202 . . . . 0.0 110.207 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' THR . 31.5 mt-30 -109.36 172.25 6.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.8 m -119.53 172.54 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -111.16 -12.81 14.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CD ' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -123.88 140.61 52.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.34 144.34 27.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 110.083 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 34.1 t -130.41 130.23 22.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.1 Cg_endo -77.01 99.77 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.174 1.618 . . . . 0.0 110.331 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 58.4 136.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 110.597 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.33 75.79 0.34 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.537 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 23.4 p -96.63 96.37 8.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.1 m -63.47 136.43 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.273 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.52 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -79.52 103.96 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 110.123 179.973 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 56' ' ' MET . 17.0 ptp -109.48 143.58 28.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.031 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 47.4 Cg_endo -74.25 0.29 8.68 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.035 1.545 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' HB3' ' SD ' ' A' ' 56' ' ' MET . 50.4 t0 -83.09 -47.2 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.43 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.531 ' HG3' ' CD ' ' A' ' 47' ' ' ARG . 25.7 mmt -99.58 47.52 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.341 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.48 HG13 ' CD1' ' A' ' 63' ' ' TYR . 36.1 t -126.51 91.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.091 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 62' ' ' ASN . 28.9 pttt -71.42 -32.18 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.514 ' N ' ' HG3' ' A' ' 61' ' ' LYS . 61.1 t30 -96.29 52.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.48 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -44.59 152.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.48 -125.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 66' ' ' GLY . 44.4 m-20 -59.34 -43.67 92.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.139 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 46.22 96.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -96.4 -7.35 35.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -96.59 -161.56 0.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -41.11 -55.94 4.56 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 179.97 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -73.88 153.5 47.76 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.963 1.507 . . . . 0.0 110.437 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.44 ' HA2' ' HA3' ' A' ' 66' ' ' GLY . . . 176.24 -57.05 0.11 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -154.06 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -1.126 . . . . 0.0 110.174 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.6 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.37 152.49 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.79 113.59 23.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.895 . . . . 0.0 110.215 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -88.52 129.76 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG1' HD23 ' A' ' 55' ' ' LEU . 5.0 t -78.13 125.69 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.273 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 15.2 t -118.39 118.68 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.96 . . . . 0.0 110.281 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -44.97 117.58 1.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.5 t30 -73.58 -52.76 12.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -95.2 148.03 22.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.62 119.77 8.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -129.74 134.33 26.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.2 Cg_endo -72.96 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.963 1.507 . . . . 0.0 110.124 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -146.9 -171.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.212 -0.93 . . . . 0.0 109.99 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.9 p30 36.26 48.83 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.63 . . . . 0.0 110.999 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -123.93 103.34 8.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 110.154 179.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -65.53 144.44 57.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 1.4 mp -98.64 140.48 32.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.3 p -129.34 84.5 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.637 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' MET . 7.7 tp 52.15 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.332 -0.855 . . . . 0.0 110.808 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' THR . 3.3 mt -41.41 -53.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.634 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 mtt -65.58 -13.09 58.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -104.26 119.87 39.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.26 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 19.9 mmtm -118.86 90.83 3.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.96 95.04 2.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 28.9 t -78.69 71.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 26' ' ' VAL . 63.6 t -142.07 161.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.0 t -75.29 151.89 85.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -77.19 -174.93 15.72 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.558 -2.268 . . . . 0.0 110.455 -0.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.2 mpt? -76.63 -109.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.919 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 97.52 -145.29 17.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 55' ' ' LEU . 23.3 mm -74.52 112.3 16.75 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.344 -1.092 . . . . 0.0 110.398 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 47.7 Cg_endo -75.14 -1.86 11.8 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.928 1.488 . . . . 0.0 110.303 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 33' ' ' PRO . . . 69.49 24.64 5.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.82 -44.93 63.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 61.0 mm-40 -99.4 67.43 1.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.622 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 1.9 tp -70.08 -30.97 2.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 112.137 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 45.2 Cg_endo -74.59 -8.25 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 N-CA-C 109.93 -0.835 . . . . 0.0 109.93 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -114.18 -31.1 6.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.368 -0.833 . . . . 0.0 109.529 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.1 tp -69.82 -36.99 76.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 110.059 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 37' ' ' ILE . 22.7 t -43.53 103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.6 24.52 7.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 62' ' ' ASN . 2.4 ttm -95.92 138.97 32.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -1.093 . . . . 0.0 110.241 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 44.7 mt-30 -106.72 151.45 25.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.7 m -95.91 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' C ' HG22 ' A' ' 13' ' ' ILE . 53.9 t30 -111.06 16.71 20.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.383 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HB2' ' HG2' ' A' ' 59' ' ' MET . 20.8 mtt180 -144.1 161.96 37.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.38 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -72.52 134.95 45.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 21.3 t -128.65 128.25 23.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.63 -158.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.825 1.434 . . . . 0.0 110.445 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -87.37 155.31 20.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 110.822 -179.438 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 41.57 40.67 2.94 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 2.2 m -96.97 125.2 41.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.2 m -63.47 108.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD23 ' CG1' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -70.38 122.93 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 110.514 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.449 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 7.6 mtt -100.48 171.23 5.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 109.923 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 45.4 Cg_endo -73.04 -0.65 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.905 1.476 . . . . 0.0 110.55 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.93 -43.65 52.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.323 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -92.13 60.7 3.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.259 -179.831 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 63' ' ' TYR . 25.4 t -130.16 95.57 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -94.49 82.51 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.526 ' CD2' HG12 ' A' ' 60' ' ' VAL . 7.8 t80 -62.31 139.34 58.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 8.6 mm-40 -75.75 -56.64 4.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -96.05 83.17 3.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 70' ' ' PRO . . . -109.4 91.66 0.66 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -107.6 -38.75 5.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -1.142 . . . . 0.0 110.303 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 81.9 p -93.24 -137.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.79 -58.53 3.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.549 -179.798 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -71.07 118.49 5.72 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.907 1.477 . . . . 0.0 110.563 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.3 13.48 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -178.4 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.218 0.532 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.88 133.22 41.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -63.18 125.8 25.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.931 . . . . 0.0 110.356 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 30' ' ' MET . 1.1 p -121.76 149.78 42.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 56.0 t -83.13 113.0 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.1 t -121.09 104.59 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.065 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.54 131.53 3.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.412 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -88.75 -63.49 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -73.16 141.72 47.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.067 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -59.35 131.11 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mt -122.96 140.1 32.74 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.56 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.087 1.572 . . . . 0.0 110.366 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.513 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.3 mt -110.63 -175.77 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.7 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 13' ' ' ILE . 10.0 p30 39.35 29.98 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.613 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 13' ' ' ILE . 52.4 m -122.02 133.34 54.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.11 151.93 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.233 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 pp -119.96 157.05 29.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.56 159.06 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 -43.34 51.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.8 mt -53.97 -29.98 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 mtt -85.77 -21.28 28.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.492 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.94 106.66 17.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.442 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -106.17 118.13 35.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.55 109.92 14.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.143 -0.973 . . . . 0.0 110.306 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.18 152.16 25.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' O ' HG11 ' A' ' 27' ' ' VAL . 60.4 t -90.69 63.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 26' ' ' VAL . 11.5 m -147.75 -178.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -94.84 162.15 26.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.61 165.41 85.73 Favored 'Cis proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.404 -0.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -61.66 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 -149.28 28.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 55' ' ' LEU . 4.9 mt -104.28 136.74 19.14 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.04 -159.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.999 1.526 . . . . 0.0 110.377 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -116.53 46.61 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.444 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 6.2 pt-20 -74.27 -27.04 60.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.11 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 6.9 mm-40 -104.55 36.18 2.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.9 mm -54.79 -51.1 81.93 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 110.8 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -71.02 -5.1 16.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.389 1.205 . . . . 0.0 110.715 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 63.1 m-80 -114.2 -50.18 2.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.367 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -68.27 -35.21 77.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 17.2 t -53.74 122.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.96 -14.91 31.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -85.0 159.78 20.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.146 . . . . 0.0 110.161 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -105.42 178.3 4.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.5 m -116.78 173.01 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 59.2 t30 -111.06 -9.04 14.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.473 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -130.56 172.06 12.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -0.923 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -76.09 151.55 37.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 53' ' ' THR . 37.3 t -127.95 108.0 20.13 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HD11 ' A' ' 10' ' ' LEU . 43.9 Cg_endo -71.61 -165.26 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.032 1.543 . . . . 0.0 110.461 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -77.6 150.08 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.12 49.19 24.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.498 ' CB ' HG11 ' A' ' 49' ' ' VAL . 16.7 m -91.69 120.09 32.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 54' ' ' THR . 10.7 t -61.13 149.38 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -68.38 105.73 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtm -110.34 139.35 21.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 110.277 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.9 -4.11 14.88 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.989 1.521 . . . . 0.0 110.631 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.91 -20.85 48.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 46' ' ' ASN . 3.8 mtt -105.23 12.37 31.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.232 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . 21.3 t -106.44 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 60' ' ' VAL . 73.0 mttt -43.9 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.091 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.431 ' O ' ' HE3' ' A' ' 43' ' ' MET . 4.1 m120 -100.78 104.43 15.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.088 -1.007 . . . . 0.0 110.085 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.564 ' CE2' ' HG2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -44.33 165.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.956 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 2.4 mm-40 -64.36 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.116 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -48.75 79.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.82 -22.64 16.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 30.2 2.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 110.183 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' SER . 20.7 m -100.73 -60.0 1.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER 173.27 -59.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.203 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.564 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.17 90.99 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.887 1.467 . . . . 0.0 110.373 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.44 120.32 0.76 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -28.13 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -1.164 . . . . 0.0 110.319 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.326 0.584 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.38 131.97 47.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.35 143.1 24.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -119.38 125.89 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 53.8 t -65.97 124.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.295 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 53' ' ' THR . 25.6 t -116.99 123.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 53' ' ' THR . . . -46.57 134.89 9.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.258 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -90.37 -69.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.4 144.54 30.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.92 135.82 57.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.4 pt -124.9 119.72 25.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' ILE . 45.4 Cg_endo -72.09 57.79 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.847 1.446 . . . . 0.0 110.251 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 1.8 mt 49.64 179.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.705 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 m-80 43.76 26.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 110.241 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.487 ' N ' ' HB3' ' A' ' 44' ' ' GLN . 17.8 m -119.92 103.05 9.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.862 . . . . 0.0 110.1 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . . . -57.86 152.89 15.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 110.405 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.93 156.35 23.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.76 -169.83 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 7.7 mp -64.55 -46.83 81.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.14 -20.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.05 3.61 54.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.478 ' SD ' ' CG1' ' A' ' 5' ' ' VAL . 1.7 mmm -112.47 106.18 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -105.98 115.33 30.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.255 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.03 98.07 4.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.9 142.05 46.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.0 85.84 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 110.18 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.52 153.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.4 p -91.69 157.6 41.52 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.89 -172.7 11.34 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.486 -0.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 ptp -82.4 -151.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.334 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 154.69 -127.46 2.1 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 32' ' ' ILE . 20.1 mm -91.12 108.86 31.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.279 -1.13 . . . . 0.0 110.277 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 31' ' ' GLY . 50.2 Cg_endo -76.5 50.41 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.936 1.492 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 45.67 24.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.33 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 67' ' ' THR . 36.1 tt0 -77.01 -33.81 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.88 39.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.906 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 2.4 mm -54.75 -57.2 20.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.77 -1.78 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.652 1.343 . . . . 0.0 110.744 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.94 -51.21 2.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.396 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HG ' ' CE ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -69.22 -39.79 78.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 58.4 t -52.6 103.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.223 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -35.1 2.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.469 ' CE ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.51 159.58 18.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -1.123 . . . . 0.0 110.286 -179.975 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HG3' ' CA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -110.26 -169.28 1.44 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.821 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 11' ' ' ILE . 3.7 m -120.19 172.24 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.19 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 2.8 m120 -111.18 0.47 16.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.411 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -123.31 142.54 50.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -62.2 129.14 39.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 54.6 t -121.12 123.67 27.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.05 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.849 1.447 . . . . 0.0 110.513 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.5 144.09 27.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' C ' HG11 ' A' ' 6' ' ' VAL . . . 61.31 39.92 97.89 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.509 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 79.5 m -88.75 145.73 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -1.174 . . . . 0.0 110.106 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.3 m -72.45 143.97 48.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 5' ' ' VAL . 1.7 mm? -69.93 80.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -94.06 143.82 27.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.915 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.19 -1.42 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.96 1.505 . . . . 0.0 110.377 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CB ' ' A' ' 56' ' ' MET . 18.7 p-10 -70.44 -12.01 61.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.28 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.526 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -108.75 -25.06 11.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.83 105.56 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.181 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -63.11 1.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.196 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' TYR . 10.2 m120 -95.04 86.41 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.37 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -44.46 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 0.0 110.168 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HG2' ' HE1' ' A' ' 43' ' ' MET . 33.4 mm-40 -79.93 -97.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.56 -32.14 18.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 0.0 110.223 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' CA ' ' HA3' ' A' ' 71' ' ' GLY . . . 102.85 105.02 2.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.446 HG23 ' OE1' ' A' ' 35' ' ' GLU . 1.7 m -107.69 -54.76 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -1.133 . . . . 0.0 110.436 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 60.8 p -101.98 -157.18 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -44.63 -57.27 6.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -71.49 79.93 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.999 1.526 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CA ' ' A' ' 66' ' ' GLY . . . -173.67 47.88 0.15 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -94.24 -40.9 9.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.31 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.197 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -80.58 -172.96 3.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.533 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -87.7 138.05 31.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -120.42 146.91 45.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.237 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 45.0 t -77.39 111.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.38 124.5 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -69.5 119.89 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.492 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.9 p-10 -74.97 -43.57 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -96.56 135.64 38.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.182 179.887 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.98 153.82 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.674 -179.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -130.45 126.8 22.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.995 . . . . 0.0 110.07 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.6 Cg_endo -76.85 47.97 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.831 1.437 . . . . 0.0 110.82 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.517 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.2 mt 51.72 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 44.98 31.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -126.32 105.17 8.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 138.85 42.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -92.26 139.49 30.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.8 OUTLIER -108.16 167.92 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 20' ' ' ILE . 6.1 tt -58.84 -42.78 90.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.947 . . . . 0.0 110.266 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' MET . 18.1 pt -67.03 -41.37 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.911 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.774 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.495 ' CG ' ' O ' ' A' ' 22' ' ' MET . 6.0 ptt? -115.38 123.8 49.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 159.94 24.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.0 101.78 13.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.362 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -113.07 136.91 52.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 54.9 t -91.64 88.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.99 -173.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 23.9 m -116.31 146.03 36.4 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 110.013 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 50.2 Cg_endo -75.58 -178.51 23.9 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.788 -2.172 . . . . 0.0 110.509 -0.174 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -159.51 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.14 -148.48 10.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.1 mt -85.11 131.48 48.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.294 -1.121 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.26 178.99 5.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.63 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 37' ' ' ILE . . . -98.48 25.79 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 18.2 pt-20 -76.96 -18.68 58.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 10.2 mm-40 -104.85 48.81 0.83 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.286 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -54.53 -50.59 84.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.943 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.53 -0.58 9.93 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.818 1.43 . . . . 0.0 110.703 -179.594 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -114.29 -28.03 7.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.932 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -89.13 -38.09 14.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 110.371 -179.857 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.08 91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 121.64 28.39 1.59 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.499 ' HE2' ' N ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -98.93 131.5 44.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -1.182 . . . . 0.0 110.256 179.957 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -109.46 126.77 53.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.2 m -83.71 168.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.429 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 t30 -110.96 1.64 17.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.522 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -134.84 133.65 39.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -50.55 140.58 13.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.336 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 53' ' ' THR . 55.1 t -130.09 135.94 28.25 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.071 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.2 Cg_endo -72.13 -173.26 1.04 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.717 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -76.5 162.36 27.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.91 . . . . 0.0 110.536 -179.717 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.24 44.67 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.573 ' CB ' ' CG1' ' A' ' 49' ' ' VAL . 82.1 m -96.43 119.86 35.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -1.212 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.3 p -54.75 127.3 27.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -61.68 113.34 2.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.177 -179.933 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.0 ptp -106.99 151.69 40.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.46 1.59 7.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.135 1.597 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' CE ' ' A' ' 59' ' ' MET . 1.8 t70 -76.71 -43.88 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 110.558 -179.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.522 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 9.2 mmt -105.5 63.54 0.69 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.361 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.2 t -130.17 99.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -61.02 -71.62 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -90.8 75.37 6.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.118 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.5 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 25.6 t80 -51.71 145.36 9.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.381 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' N ' ' HE2' ' A' ' 43' ' ' MET . 7.4 pm0 -64.42 -141.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.18 78.24 0.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.85 100.05 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -81.6 4.51 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -1.162 . . . . 0.0 110.248 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -76.67 -160.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.965 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -42.4 -56.42 5.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.301 179.867 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -72.46 162.49 41.29 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.972 1.512 . . . . 0.0 110.493 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.64 61.58 0.62 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.25 -44.82 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.0 110.254 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.182 179.982 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.284 0.564 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 128.35 35.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 164.97 19.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -123.17 158.6 30.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.77 114.72 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 4.2 t -126.49 122.09 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . . . -56.67 127.62 32.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 24.2 t-20 -77.45 -48.68 16.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.09 158.29 15.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.132 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.02 132.49 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 7' ' ' ALA . 1.1 mp -117.65 122.67 30.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HB2' HD13 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -71.57 -95.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.749 1.394 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -162.02 -173.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.095 179.527 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.9 p30 40.21 31.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' CG2' ' A' ' 11' ' ' ILE . 5.7 t -124.11 138.2 54.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.452 ' O ' ' HE3' ' A' ' 21' ' ' MET . . . -71.55 154.97 41.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 HD11 ' HE1' ' A' ' 43' ' ' MET . 51.3 mt -120.97 104.42 9.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.886 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 m -96.81 167.89 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.978 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -64.96 -25.15 67.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.503 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.6 mt -69.63 -19.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.452 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 1.6 ttp -97.73 -20.88 17.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' A' ' 7' ' ' ALA . 1.4 mtt -118.91 143.51 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.112 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.75 172.09 7.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.07 102.05 14.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp10 -112.03 128.58 56.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 14.5 p -91.95 77.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.38 166.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.18 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.429 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.9 t -92.83 144.83 29.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.55 157.21 99.12 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.416 -0.248 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.3 mtt -72.79 -26.25 61.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.77 -132.02 43.99 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.8 mt -106.28 134.79 19.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.287 -1.125 . . . . 0.0 110.223 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -170.52 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.942 1.496 . . . . 0.0 110.407 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.47 46.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.272 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.05 -40.07 54.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 14.9 mm-40 -104.91 31.2 4.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.2 mm -42.68 -54.27 8.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.4 Cg_endo -71.53 -2.22 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.615 1.323 . . . . 0.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.473 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.02 -32.15 6.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.894 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -85.55 -24.6 27.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.351 -179.848 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 24.8 t -42.58 119.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.2 8.78 28.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.447 ' SD ' HG12 ' A' ' 60' ' ' VAL . 18.9 ttp -72.34 134.66 45.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -1.194 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mt-30 -110.01 125.59 53.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 3.7 m -79.99 154.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 110.141 179.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -108.26 10.1 27.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.405 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.57 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.52 137.44 26.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -45.06 128.19 7.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 47.5 t -111.85 134.75 21.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 47.6 Cg_endo -74.12 -171.57 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.023 1.539 . . . . 0.0 110.477 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.31 164.01 22.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 110.281 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 43.43 30.32 1.31 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.591 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 72.9 m -76.15 104.16 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -1.196 . . . . 0.0 110.401 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.39 153.69 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.053 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -62.16 100.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.314 -179.841 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.7 mtm -113.55 145.34 33.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.435 -0.791 . . . . 0.0 110.287 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.62 0.18 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.001 1.527 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.97 -55.36 14.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.444 ' SD ' HG21 ' A' ' 49' ' ' VAL . 46.8 mtt -103.35 40.72 1.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 110.431 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 56' ' ' MET . 93.6 t -130.47 133.34 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -142.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' C ' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-20 -76.39 79.61 3.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 110.297 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CD2' ' N ' ' A' ' 64' ' ' GLU . 18.0 p90 -84.62 -167.96 2.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 47.5 tp10 -71.94 76.79 0.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' HD2' ' A' ' 70' ' ' PRO . 10.1 t0 -99.31 -64.74 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.46 -126.94 1.06 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -108.92 -70.72 0.79 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 110.477 -179.77 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -18.29 59.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.51 -179.16 0.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.956 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -72.55 84.67 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.958 1.504 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -165.7 -36.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.7 113.76 5.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.144 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.3 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.143 179.949 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.195 0.521 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 140.97 58.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.01 138.26 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.3 p -123.74 157.5 33.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.442 ' CG1' ' HE3' ' A' ' 22' ' ' MET . 61.6 t -80.1 124.28 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -129.2 107.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 179.975 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -46.65 116.18 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 52.6 t30 -77.79 -46.52 21.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.15 136.22 33.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.7 pt? -78.12 131.68 37.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.34 -179.891 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 10.4 pt -128.9 155.73 79.06 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.872 . . . . 0.0 109.989 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.491 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.85 -96.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.89 1.468 . . . . 0.0 110.159 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -152.24 172.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.961 -1.087 . . . . 0.0 109.889 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.81 21.38 5.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 110.353 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -97.91 117.07 31.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.03 157.55 5.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' O ' HG11 ' A' ' 41' ' ' VAL . 30.1 mt -98.43 111.16 23.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 p -95.41 155.91 16.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -28.08 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.378 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mt -68.64 -36.88 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.922 . . . . 0.0 110.235 -179.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 42.3 mtp -88.74 11.82 16.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.455 ' HA ' ' CE ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -112.35 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -109.59 112.83 25.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.18 105.53 3.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.326 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -109.68 155.37 21.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.157 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.65 24.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 28' ' ' THR . 31.7 t -95.68 148.38 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -77.34 168.25 29.55 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.955 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -73.77 -170.58 7.97 Favored 'Cis proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.624 -2.24 . . . . 0.0 110.417 -0.134 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.412 ' HG3' ' N ' ' A' ' 31' ' ' GLY . 5.3 ptt? -76.56 -34.82 58.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.248 180.0 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 45.56 -131.45 9.42 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.451 HG21 ' HD2' ' A' ' 33' ' ' PRO . 4.7 mt -112.26 137.35 21.49 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.276 179.994 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HD2' HG21 ' A' ' 32' ' ' ILE . 44.4 Cg_endo -71.99 -166.86 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.008 1.531 . . . . 0.0 110.479 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -116.84 33.83 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -41.35 85.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASN . 73.4 mm-40 -104.78 32.53 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.3 mm -42.88 -51.32 12.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.599 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -72.04 -1.4 9.97 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.483 1.254 . . . . 0.0 110.681 -179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.75 -38.08 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 179.933 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -75.26 -34.12 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.911 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 17' ' ' LEU . 21.6 t -46.96 139.61 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -11.69 54.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.4 tpp -82.01 132.52 35.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.116 . . . . 0.0 110.209 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -92.94 -179.41 5.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.17 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.0 m -118.42 163.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.343 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -111.19 3.42 18.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.542 -179.91 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.7 mmt180 -139.18 -176.75 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 0.0 110.41 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -79.8 140.83 36.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.25 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 11' ' ' ILE . 4.5 t -119.28 116.49 33.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . 47.0 Cg_endo -73.96 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -76.89 152.01 35.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.45 42.01 25.81 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 50' ' ' PRO . 61.4 m -82.36 115.02 21.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.2 t -54.74 155.63 4.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.98 103.63 3.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.924 . . . . 0.0 110.229 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.452 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -112.17 145.14 32.2 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.997 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -12.24 25.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.982 1.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -62.17 -56.76 15.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.288 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 5.9 mtt -93.45 39.81 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 56' ' ' MET . 53.3 t -130.44 126.87 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 110.233 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -161.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 110.056 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.542 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 27.3 p-10 -69.2 79.81 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 3.4 p90 -82.2 -170.11 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -63.76 145.46 55.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.075 -1.016 . . . . 0.0 111.205 -178.679 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 10.3 t0 -98.17 79.06 2.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.577 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.22 -87.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.259 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -52.39 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.793 -179.286 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 21.2 p -69.72 -174.07 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.611 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 6.5 t -119.02 41.16 0.39 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 111.564 -179.456 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 69' ' ' SER . 43.8 Cg_endo -72.33 -169.44 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.569 1.299 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 66.5 33.79 85.74 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -43.98 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -1.158 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.277 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.235 0.541 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -99.17 170.71 8.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -85.38 151.24 24.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.99 135.7 54.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG13 HD22 ' A' ' 55' ' ' LEU . 94.7 t -78.88 121.82 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.59 116.66 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.026 179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -67.16 122.35 17.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.133 179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -42.29 32.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.429 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -88.05 143.53 27.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.263 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.6 tt -63.92 143.93 57.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 mt -130.38 112.53 16.77 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.278 -0.889 . . . . 0.0 110.401 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.35 59.56 5.45 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.787 1.414 . . . . 0.0 110.408 179.615 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 42.3 pt 38.19 -163.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.834 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 42.46 27.75 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.821 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.3 m -140.93 121.32 14.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' N ' ' HG3' ' A' ' 44' ' ' GLN . . . -58.18 171.31 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.917 . . . . 0.0 110.161 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mt -113.8 138.03 50.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -124.47 -179.67 4.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.262 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.19 -53.53 16.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' HG21 ' A' ' 20' ' ' ILE . 2.7 mp -58.36 -15.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtt -82.45 -47.02 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 1.7 ptt? -119.91 149.42 42.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -111.9 169.33 8.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.03 92.29 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.213 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.52 137.64 50.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 3' ' ' ALA . 76.3 t -90.73 60.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 28' ' ' THR . 55.3 t -132.7 170.23 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -79.93 151.86 73.85 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.998 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 48.8 Cg_endo -75.69 178.95 32.65 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.678 -2.217 . . . . 0.0 110.535 -0.227 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -74.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.89 -166.88 53.09 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.535 HD13 ' CE1' ' A' ' 63' ' ' TYR . 16.2 mm -63.19 133.64 95.52 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.155 -1.203 . . . . 0.0 110.005 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 43.6 Cg_endo -72.75 -174.5 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.851 1.448 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.57 23.41 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.731 -179.496 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -77.33 -19.08 56.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -105.11 10.03 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.789 . . . . 0.0 110.116 -179.52 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 5.8 mm -41.9 -55.33 6.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 110.552 -179.79 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.51 -4.55 14.76 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.584 1.307 . . . . 0.0 110.72 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.8 m120 -114.18 -25.96 8.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 110.457 -179.835 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -91.27 -25.29 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.863 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 33.1 t -42.99 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 121.01 15.15 4.83 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.416 ' CE ' ' HG2' ' A' ' 64' ' ' GLU . 36.3 tpp -87.75 136.5 32.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -1.169 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -102.54 149.09 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 6.2 m -113.6 161.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 46' ' ' ASN . 2.3 t30 -111.32 -1.82 15.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 179.792 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 3.5 mtt180 -115.12 137.98 51.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.253 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.53 145.13 1.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.333 -179.516 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.601 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 2.8 t -126.05 110.82 24.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.086 -179.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' HB ' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -176.34 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.929 1.489 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' GLY . 1.6 mp -71.45 157.23 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.046 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.82 32.21 1.33 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.8 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.601 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 6.7 t -69.16 138.44 54.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.444 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 12.6 t -85.21 142.28 29.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.611 179.255 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 mm? -61.67 117.94 6.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.1 mtt -111.99 150.02 41.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.922 . . . . 0.0 110.338 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 -16.83 24.31 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.021 1.537 . . . . 0.0 110.364 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.73 -16.31 42.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.468 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 mtm -111.78 38.24 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.957 . . . . 0.0 110.182 -179.917 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 63' ' ' TYR . 77.5 t -130.33 114.91 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.07 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -57.12 -99.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.374 -179.725 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 62' ' ' ASN . 22.0 p-10 -100.34 96.98 7.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.99 -1.068 . . . . 0.0 110.182 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.563 ' CE1' HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -49.24 146.7 3.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 110.26 179.936 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 72.9 mm-40 -76.72 -56.05 4.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 42.0 p-10 -84.22 55.13 3.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.029 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.44 67.54 3.69 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -93.49 -20.27 20.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.054 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.52 -158.81 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.93 -55.78 4.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.899 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.5 Cg_endo -73.53 138.13 26.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.019 1.536 . . . . 0.0 110.395 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -25.98 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.18 27.13 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.232 179.989 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.21 0.528 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 144.24 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -81.26 130.88 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.34 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 159.67 15.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 32' ' ' ILE . 37.7 t -83.15 127.38 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 54' ' ' THR . 5.3 t -124.44 127.32 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -45.56 127.79 7.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.19 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 28.0 t30 -89.57 -58.22 2.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.204 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -91.88 145.65 24.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 10' ' ' LEU . 2.0 tt -64.2 109.64 1.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 pt -123.6 137.36 28.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.069 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.467 ' O ' HG21 ' A' ' 13' ' ' ILE . 46.8 Cg_endo -73.41 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.014 1.534 . . . . 0.0 110.14 179.845 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.537 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 2.0 pt -146.41 -164.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.128 -0.982 . . . . 0.0 110.197 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.8 p30 40.37 27.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 0.0 110.561 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.3 m -116.61 111.71 20.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . . . -62.88 133.99 55.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.9 mt -81.18 145.64 30.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 110.061 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -129.93 137.5 50.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 110.322 179.915 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' THR . 3.6 tt -43.76 -43.67 6.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 HD21 ' A' ' 19' ' ' LEU . 8.1 mt -67.55 -21.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.358 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -97.54 -23.36 16.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.477 ' HE3' ' CG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -116.42 120.0 37.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.34 147.95 27.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 110.164 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.0 116.41 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.32 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.33 151.2 30.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 44.1 t -92.37 78.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.288 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.8 149.91 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.141 179.931 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 43.6 p -97.7 159.96 29.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.472 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.85 152.88 97.42 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.439 -0.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.06 127.2 32.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.834 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.9 -110.66 3.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.786 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 55' ' ' LEU . 8.5 mm -86.03 114.69 58.51 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.107 . . . . 0.0 110.628 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.51 -161.57 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.449 179.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -109.76 27.79 9.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.23 -38.24 51.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.958 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' OE2' ' HB3' ' A' ' 65' ' ' ASP . 48.0 mm-40 -94.12 32.68 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.133 -0.979 . . . . 0.0 110.943 -179.288 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -43.65 -51.72 15.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.963 -1.085 . . . . 0.0 110.4 179.722 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -73.23 -11.39 24.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.732 1.385 . . . . 0.0 110.996 -179.427 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -105.66 -46.43 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.099 179.835 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -62.2 -43.98 97.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.202 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 39.9 t -43.61 119.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . 93.91 16.02 46.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.501 ' HE3' ' CG1' ' A' ' 60' ' ' VAL . 4.6 ttm -83.91 135.09 34.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -1.147 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -106.92 124.83 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 3.2 m -85.08 158.55 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -103.73 -3.57 24.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.124 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.522 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 10.2 mtt180 -123.28 155.66 36.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.7 58.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.425 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 53' ' ' THR . 28.2 t -127.86 113.61 20.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 179.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 53' ' ' THR . 44.9 Cg_endo -72.07 -162.9 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.946 1.498 . . . . 0.0 110.6 -179.871 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.32 155.98 28.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.968 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.5 45.82 6.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 50' ' ' PRO . 87.4 m -94.02 100.07 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.157 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' HG11 ' A' ' 6' ' ' VAL . 23.8 m -44.91 123.77 4.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD1' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -61.97 115.47 4.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 60' ' ' VAL . 19.8 mtp -112.25 164.24 15.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.48 -0.763 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 49.7 Cg_endo -76.37 6.5 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.08 1.568 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -42.16 11.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.07 -1.019 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.522 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -100.22 52.6 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 -179.9 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HE3' ' A' ' 43' ' ' MET . 17.4 t -129.97 123.42 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.898 . . . . 0.0 110.22 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -73.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 6.7 t-20 -100.52 93.31 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.462 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 96.3 m-85 -52.64 151.9 4.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.5 mp0 -68.44 -70.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.148 179.865 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 33.2 p-10 -84.49 94.89 8.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.938 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.67 38.39 3.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.4 m -107.81 -16.5 14.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.96 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 61.6 p -100.58 -140.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.511 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -75.65 -56.94 1.67 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 -179.828 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.8 Cg_endo -72.97 73.21 3.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.919 1.484 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -130.81 0.65 5.42 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.21 137.74 34.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.242 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 1' ' ' ASN . 14.1 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.297 0.57 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 117.22 19.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.62 124.55 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 -179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 t -82.93 173.2 12.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.172 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 33' ' ' PRO . 78.8 t -84.23 108.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.462 HG12 HG21 ' A' ' 54' ' ' THR . 4.1 t -123.78 107.4 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -58.68 121.62 11.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 3.5 m-20 -72.65 -55.34 7.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.459 ' O ' HG12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.73 156.45 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.746 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.31 124.41 24.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 9' ' ' GLN . 22.0 mm -124.0 113.19 28.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' O ' HG21 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -73.82 -92.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.0 110.404 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -161.89 -177.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.108 -0.995 . . . . 0.0 110.291 179.99 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 50.74 21.74 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.5 m -124.5 113.34 17.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.085 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -55.66 152.79 8.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.126 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -96.76 138.62 34.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -167.02 1.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.276 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.68 -63.36 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.295 -179.954 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -49.09 -24.93 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 110.194 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -85.93 3.72 40.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 110.201 179.948 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.7 mtt -116.37 118.37 32.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.0 160.07 23.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.092 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.08 83.03 1.92 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.34 135.83 44.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -94.38 77.83 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.7 120.03 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.451 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.2 p -83.25 150.39 60.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 110.152 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.82 129.89 19.93 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.483 -0.151 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.402 ' N ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -71.25 118.37 13.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -102.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.471 ' CD1' ' OH ' ' A' ' 63' ' ' TYR . 3.0 mt -118.15 137.62 24.73 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.238 -1.154 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' O ' HG22 ' A' ' 5' ' ' VAL . 48.3 Cg_endo -73.46 -162.68 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.12 1.589 . . . . 0.0 110.615 -179.887 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -107.69 45.63 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.92 -35.58 67.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' ASN . 6.9 mm-40 -104.97 35.29 2.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.817 . . . . 0.0 109.872 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mm -40.5 -52.17 6.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -71.39 -9.49 25.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.594 1.313 . . . . 0.0 110.766 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -106.25 -25.62 11.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.087 179.715 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' HG ' ' HE1' ' A' ' 43' ' ' MET . 0.2 OUTLIER -94.6 -40.36 9.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.83 . . . . 0.0 110.26 179.996 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 42.8 t -45.08 107.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 112.42 18.26 7.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.82 147.61 23.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -104.16 148.73 25.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 13' ' ' ILE . 3.2 m -111.27 161.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' C ' HG23 ' A' ' 13' ' ' ILE . 15.4 t-20 -109.44 17.74 21.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.282 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -136.44 128.01 28.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.39 179.889 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -62.19 130.17 44.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -128.67 128.17 23.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.77 -166.06 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.314 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.66 126.75 26.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.954 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 90.15 73.72 1.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.507 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 68.9 m -92.06 99.1 11.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -1.127 . . . . 0.0 110.326 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 6' ' ' VAL . 41.1 p -64.58 132.37 49.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.93 85.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.112 179.935 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.2 mtt -103.33 142.9 25.53 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.25 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.516 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -75.2 2.78 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.078 1.567 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.13 -20.8 21.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.355 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.449 ' HE2' HG23 ' A' ' 49' ' ' VAL . 50.7 mtm -108.36 -6.86 16.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.445 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG13 ' CG ' ' A' ' 63' ' ' TYR . 85.6 t -93.95 107.69 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -77.42 -60.68 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.1 t-20 -95.68 74.4 3.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.334 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.569 ' CG ' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -54.48 163.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.158 179.937 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -65.04 -178.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.108 179.892 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLY . 1.4 m-20 -59.75 -58.2 9.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.4 131.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 m -88.86 -62.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -108.7 51.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -154.32 -178.83 0.94 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.878 . . . . 0.0 110.0 179.904 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -72.93 103.06 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.909 1.478 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.89 56.25 0.17 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.91 85.42 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -1.129 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.268 0.556 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -103.24 176.98 4.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.234 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.29 159.0 18.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.16 179.933 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -122.47 145.81 47.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.95 112.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 110.208 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.63 132.49 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 0.0 110.158 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -80.15 130.29 35.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.278 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 39.5 t30 -80.02 -69.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -65.78 130.85 44.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 179.85 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 2.0 pt? -62.26 133.0 54.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.58 -179.716 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.46 HG13 HG21 ' A' ' 49' ' ' VAL . 1.3 pt -130.13 134.77 26.5 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.1 Cg_endo -73.68 168.78 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.935 1.492 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -46.66 174.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 60.35 -152.4 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 58.49 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.92 . . . . 0.0 110.057 -179.835 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -56.28 154.02 8.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.43 144.14 26.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.2 OUTLIER -124.86 155.22 39.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 110.31 -179.934 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 2.0 tt -68.07 -46.35 71.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.72 -14.63 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.943 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.442 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -87.85 -47.34 8.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.265 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.416 ' CE ' ' HB1' ' A' ' 7' ' ' ALA . 20.1 mtp -97.36 142.14 29.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -108.46 167.65 9.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.046 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.69 106.81 18.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.43 144.42 32.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 45.7 t -97.1 66.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.207 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.06 -166.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 35.3 p -118.13 160.14 40.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.873 . . . . 0.0 110.132 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 50.5 Cg_endo -77.13 145.18 80.24 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.47 -0.137 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -76.1 75.24 2.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.957 179.742 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.08 -119.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 10.2 mm -82.49 115.14 56.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.446 -1.032 . . . . 0.0 110.47 -179.619 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 49.0 Cg_endo -75.64 50.21 2.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.95 1.5 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . 41.82 29.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -42.98 99.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 110.457 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 59.3 mm-40 -104.16 34.08 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mm -42.77 -54.57 8.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -71.7 -4.56 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.639 1.336 . . . . 0.0 110.676 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.03 -21.58 10.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.874 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 36' ' ' GLU . 16.0 tp -92.1 -40.1 11.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 75.0 t -44.53 115.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 110.184 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.53 14.96 24.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.538 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 5.0 ttp -104.45 157.94 16.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -106.75 141.4 38.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -90.22 164.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -110.49 10.7 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.172 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.523 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -153.17 124.71 7.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.022 179.996 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.74 150.09 5.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.514 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 0.0 OUTLIER -128.22 137.85 31.74 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' O ' ' HB ' ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.18 -168.79 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.99 1.521 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -70.14 155.59 40.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 110.06 179.864 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 44.36 40.71 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.545 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 15.2 t -78.37 130.11 35.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 110.326 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 t -78.05 145.04 36.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.15 107.37 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -106.64 146.46 33.11 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 179.988 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.28 -0.77 10.06 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.428 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.94 -20.27 26.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.523 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 4.1 mtt -112.45 32.82 5.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.923 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 11.8 t -121.09 118.95 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.031 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -86.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.857 . . . . 0.0 110.271 -179.785 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.95 89.57 7.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -45.11 160.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CE ' ' A' ' 43' ' ' MET . 1.3 mp0 -103.97 -47.96 4.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.14 85.6 3.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 72.57 0.53 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.455 HG21 ' HA3' ' A' ' 71' ' ' GLY . 14.1 m -84.53 54.65 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 69' ' ' SER . 58.1 p -106.27 -89.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.79 -57.97 2.32 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -72.52 -3.02 12.67 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.904 1.476 . . . . 0.0 110.321 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.455 ' HA3' HG21 ' A' ' 67' ' ' THR . . . -108.62 128.37 9.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -15.36 16.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 -179.932 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.255 0.55 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 148.45 51.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -85.3 135.78 33.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -105.84 144.72 32.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.912 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 29.9 m -76.31 130.05 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.253 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 54' ' ' THR . 12.4 t -129.57 118.06 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.61 116.94 2.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.148 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 5.1 p-10 -75.07 -43.8 51.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tt0 -97.12 150.96 20.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 50' ' ' PRO . 4.9 tt -63.88 105.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 109.89 179.769 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 7.9 mm -99.5 139.37 20.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.516 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.6 -157.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.124 1.592 . . . . 0.0 110.201 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.26 -165.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.008 179.715 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.4 p30 38.45 32.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.6 m -133.39 142.98 48.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.341 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -75.27 148.83 39.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -105.88 151.36 24.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -115.05 -170.58 1.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.16 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.99 -49.45 45.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.856 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.428 HG13 ' HG2' ' A' ' 21' ' ' MET . 3.4 pt -55.36 -18.98 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.201 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.5 mmm -90.57 9.38 29.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.27 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.418 ' HE2' HD22 ' A' ' 40' ' ' LEU . 33.6 mtp -123.3 122.83 39.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -117.16 114.04 23.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.259 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.75 83.89 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.47 126.09 42.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 3' ' ' ALA . 73.0 t -86.42 79.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.6 169.57 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.968 . . . . 0.0 110.368 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -117.21 150.16 45.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.982 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.2 Cg_endo -75.48 134.73 37.14 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.679 -2.217 . . . . 0.0 110.395 -0.132 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 30' ' ' MET . 1.1 ptt? -80.83 136.93 36.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.552 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -89.9 -116.35 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.512 ' CG2' ' OE2' ' A' ' 36' ' ' GLU . 9.9 mm -81.24 136.28 49.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.281 -1.129 . . . . 0.0 109.802 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 47.3 Cg_endo -74.05 4.88 3.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.965 1.508 . . . . 0.0 111.238 -179.478 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . . . 68.12 18.4 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -11.43 59.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 179.642 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -105.04 28.27 7.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 110.324 -179.375 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.8 mm -42.19 -53.34 8.79 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.566 -179.852 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.23 -5.07 16.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.61 1.321 . . . . 0.0 110.81 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 65' ' ' ASP . 8.4 m-80 -114.03 -49.02 2.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.973 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 55' ' ' LEU . 2.3 tp -66.69 -39.97 88.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 38.9 t -50.87 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 116.96 24.57 3.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.452 ' HG2' ' HG ' ' A' ' 40' ' ' LEU . 2.8 ppp? -104.53 154.58 19.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -1.169 . . . . 0.0 110.265 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -109.39 123.86 50.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -77.76 165.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 59' ' ' MET . 44.5 t30 -110.35 -12.28 14.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.139 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.8 mtp85 -120.32 146.57 45.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 149.86 15.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 11' ' ' ILE . 38.5 t -126.13 112.52 24.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -72.72 -167.78 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.852 1.448 . . . . 0.0 110.522 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -73.64 149.04 42.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.82 53.21 6.38 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.51 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 84.6 m -96.52 122.16 39.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.441 ' HA ' HG12 ' A' ' 6' ' ' VAL . 1.3 m -64.14 123.37 18.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.863 . . . . 0.0 110.135 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD1' HD22 ' A' ' 40' ' ' LEU . 1.3 tt -62.03 113.01 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.064 179.895 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.47 ' O ' HG21 ' A' ' 60' ' ' VAL . 1.5 mtt -111.63 162.57 20.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.52 0.74 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.044 1.55 . . . . 0.0 110.435 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.79 -23.98 22.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -98.87 1.0 45.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 179.87 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 56' ' ' MET . 7.1 t -91.5 116.47 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -80.18 -72.73 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.918 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 73' ' ' LYS . 65.0 m-80 -100.22 87.86 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.409 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.99 144.58 28.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . 8.7 mm-40 -83.23 -95.79 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.986 . . . . 0.0 110.352 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 13.8 t70 -94.45 82.95 4.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.99 93.1 0.28 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -74.36 -39.68 62.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 32.36 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.22 -179.6 1.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.6 Cg_endo -72.36 174.97 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.887 1.467 . . . . 0.0 110.56 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.24 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 153.16 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -1.177 . . . . 0.0 110.317 -179.853 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.251 0.548 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.79 128.97 35.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.288 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.52 135.35 51.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -112.53 148.8 33.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.929 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 29.3 t -73.58 107.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 4' ' ' SER . 5.1 t -107.53 102.18 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.05 130.28 21.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.228 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -57.97 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.136 -179.942 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' CD ' ' SD ' ' A' ' 21' ' ' MET . 4.6 pt20 -81.44 162.08 23.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.188 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.7 tt -86.48 149.18 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.036 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.513 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 13.1 pt -129.79 127.91 22.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 110.399 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.53 54.01 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.033 1.544 . . . . 0.0 110.38 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER 47.44 -177.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 -179.902 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 7.1 m-20 41.15 28.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 13' ' ' ILE . 54.0 m -118.36 114.4 22.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.19 128.44 35.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.051 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.443 HD22 HD12 ' A' ' 11' ' ' ILE . 4.2 mt -83.03 143.19 30.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 110.226 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -122.21 176.42 5.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 20' ' ' ILE . 7.2 tt -68.32 -44.86 74.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.279 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 21' ' ' MET . 4.7 pt -60.03 -22.51 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.497 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -95.88 -21.62 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.954 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.488 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mtm -108.39 108.0 18.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.68 139.59 47.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.75 84.99 6.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 179.985 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 148.55 28.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.34 93.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 0.0 110.085 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 28' ' ' THR . 94.9 t -131.01 161.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 28.8 m -114.51 145.74 34.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 -179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 50.5 Cg_endo -80.29 147.65 76.29 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.716 -2.202 . . . . 0.0 110.42 -0.445 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -68.2 68.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -42.17 -83.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.835 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.465 ' CG2' ' HD2' ' A' ' 33' ' ' PRO . 4.8 mt -135.27 142.84 43.11 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.0 110.224 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.7 Cg_endo -72.36 -159.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.332 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.57 40.01 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.96 -29.86 64.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.9 24.58 10.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 6.1 mm -45.19 -53.32 17.56 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.6 Cg_endo -71.02 -6.43 19.2 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.505 1.266 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.27 -27.08 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.116 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.97 -26.46 21.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.081 179.932 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 53.3 t -51.46 99.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.08 2.59 12.38 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.439 ' HE2' HG12 ' A' ' 60' ' ' VAL . 2.0 tmm? -94.86 143.75 26.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -1.187 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.45 134.0 50.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.8 m -77.48 154.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.171 179.866 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -97.75 1.49 48.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -132.59 142.41 49.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -56.96 136.76 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.45 -179.76 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 11' ' ' ILE . 45.5 t -124.29 120.71 26.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.955 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.65 -161.26 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.973 1.512 . . . . 0.0 110.647 -179.737 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 52' ' ' GLY . 2.4 mp -81.04 160.11 24.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.335 -0.853 . . . . 0.0 110.471 -179.658 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.37 49.5 6.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.491 ' CB ' HG11 ' A' ' 49' ' ' VAL . 39.7 m -96.75 106.37 18.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -1.152 . . . . 0.0 110.081 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -50.35 147.98 3.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 -179.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -65.07 108.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.115 179.925 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.413 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -110.07 150.31 41.28 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.981 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.08 0.44 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.051 1.553 . . . . 0.0 110.58 -179.981 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.15 -50.89 7.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.495 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.74 47.65 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.84 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' A' ' 43' ' ' MET . 19.5 t -127.88 109.85 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -82.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.255 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -91.86 88.58 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.856 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HA ' ' HE3' ' A' ' 43' ' ' MET . 2.7 t80 -59.74 139.0 57.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -87.9 -92.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.924 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.01 82.75 3.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.0 110.398 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.74 94.28 0.25 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.18 18.15 21.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -1.146 . . . . 0.0 110.266 -179.887 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 69' ' ' SER . 88.0 m -100.41 -33.91 10.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.05 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.52 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 173.25 -56.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.995 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -73.14 85.68 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.928 1.489 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.3 70.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.64 -32.63 72.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -1.165 . . . . 0.0 110.328 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 tptt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.257 179.992 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.169 0.509 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.64 129.12 44.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.161 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.41 156.99 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.219 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.84 161.27 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.253 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' CB ' HD13 ' A' ' 55' ' ' LEU . 39.4 t -79.04 121.42 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.093 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -125.42 107.59 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 110.263 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.9 111.09 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 51.1 t30 -74.91 -59.91 2.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -72.18 139.43 48.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.98 132.58 51.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 179.919 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.457 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.6 pt -130.13 110.89 16.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -74.82 69.69 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.93 1.49 . . . . 0.0 110.43 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.7 pt 39.0 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 45.9 29.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' HG21 ' A' ' 15' ' ' THR . 5.1 t -131.0 130.32 43.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 110.135 -179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 142.68 53.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.179 -179.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.46 HD12 HD22 ' A' ' 40' ' ' LEU . 5.5 mt -77.79 124.72 28.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 110.27 -179.92 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.94 172.04 8.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.993 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.23 -30.99 54.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 21' ' ' MET . 6.3 pt -62.62 -25.55 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.493 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -97.38 -14.06 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.04 126.28 32.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 12.7 mttt -111.55 124.06 51.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.21 10.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 150.08 29.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 26' ' ' VAL . 61.3 t -81.68 4.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.47 130.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.21 -179.995 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.454 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -84.8 168.27 21.91 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -73.76 156.69 99.61 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.428 -0.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' GLY . 5.5 mtt -76.34 83.23 3.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.69 -116.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.504 HD12 HG22 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -110.48 139.9 22.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.219 -1.165 . . . . 0.0 109.948 179.946 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.9 168.7 24.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.553 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 37' ' ' ILE . . . -84.14 47.1 1.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -77.15 -27.06 53.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.797 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 40' ' ' LEU . 15.1 mm-40 -104.72 45.34 0.97 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 111.023 -179.406 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -63.05 -51.43 70.46 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.008 179.637 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.9 Cg_endo -75.08 -5.4 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.755 1.398 . . . . 0.0 110.722 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 3.9 m-80 -114.77 -35.3 4.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.591 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -87.51 -38.9 15.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.799 -179.46 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 9.1 t -41.93 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.9 -7.3 6.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.652 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.54 131.0 35.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -1.089 . . . . 0.0 110.194 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' THR . 15.2 mt-30 -99.33 151.39 21.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.961 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.1 m -99.92 161.78 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -111.18 0.29 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -114.39 135.85 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 110.042 -179.858 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -55.8 123.15 13.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.325 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 53' ' ' THR . 19.7 t -109.99 125.47 31.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 179.605 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.67 -167.63 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.858 1.452 . . . . 0.0 110.512 -179.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -81.53 155.28 25.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.231 -179.9 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 45.29 44.61 10.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.51 ' CB ' HG11 ' A' ' 49' ' ' VAL . 43.6 m -90.61 122.58 33.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -1.174 . . . . 0.0 110.203 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.493 HD13 ' CB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -80.04 106.5 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.194 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.469 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -113.1 143.27 28.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 179.822 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.36 1.46 7.34 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.951 1.5 . . . . 0.0 110.634 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.84 -15.55 44.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.812 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' HG2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -99.47 -21.43 15.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.52 120.75 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.311 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.95 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 179.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 22.6 p-10 -92.06 87.79 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.103 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.467 ' OH ' HG22 ' A' ' 32' ' ' ILE . 2.7 t80 -45.45 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG3' ' C ' ' A' ' 39' ' ' ASN . 1.5 tm-20 -66.91 -60.14 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HB3' ' OG1' ' A' ' 67' ' ' THR . 2.0 m-20 -65.97 -49.89 66.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.62 2.54 78.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -90.16 4.65 49.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -1.19 . . . . 0.0 110.203 -179.934 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -98.4 -150.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.953 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.57 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -61.03 -60.17 11.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.04 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 47.2 Cg_endo -72.67 140.06 31.93 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.533 . . . . 0.0 110.201 179.714 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.67 48.68 0.55 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.04 -170.7 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -1.157 . . . . 0.0 110.239 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.271 0.558 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.27 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 6' ' ' VAL . 18.3 p -123.88 148.82 46.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.156 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 76.2 t -62.48 116.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 110.207 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -121.03 105.91 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -42.62 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -75.69 -70.85 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.441 ' O ' HG12 ' A' ' 11' ' ' ILE . 13.0 tp60 -65.04 143.35 57.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.8 114.08 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 1.5 pt -128.78 128.32 23.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.78 -158.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.87 1.458 . . . . 0.0 109.788 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 45' ' ' VAL . 44.5 pt -98.98 -170.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.069 -1.019 . . . . 0.0 110.194 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 49.41 20.31 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.489 -0.757 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -118.71 102.13 8.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.007 -1.058 . . . . 0.0 109.928 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.74 124.12 15.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.353 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.9 mt -94.13 163.4 13.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' CG1' ' A' ' 20' ' ' ILE . 67.4 p -130.51 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 110.027 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.0 -42.62 66.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.03 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CG1' ' OG1' ' A' ' 18' ' ' THR . 2.6 pt -58.62 -26.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.106 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.0 mtt -94.46 15.98 16.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.485 ' HE3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.59 111.6 16.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -119.38 114.45 22.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.61 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.182 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.24 152.53 28.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.185 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 26' ' ' VAL . 81.3 t -95.33 82.8 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.224 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.09 157.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.0 t -95.82 148.91 35.31 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.074 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -75.87 -165.18 4.13 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.729 -2.196 . . . . 0.0 110.541 -0.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.86 -19.53 51.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 30' ' ' MET . . . 45.95 -143.17 4.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -97.49 125.29 45.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -1.162 . . . . 0.0 110.066 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.03 -161.5 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.846 1.445 . . . . 0.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.92 17.79 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -56.79 -36.64 70.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 109.971 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 10.1 pt-20 -104.58 35.98 2.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 110.286 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.74 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 4.0 mm -55.57 -54.96 45.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.243 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -70.5 -4.15 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.636 1.335 . . . . 0.0 110.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.0 m-20 -109.36 -25.25 10.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.485 HD23 ' HE3' ' A' ' 22' ' ' MET . 5.3 tp -84.85 -29.32 25.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.29 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 37' ' ' ILE . 36.7 t -42.88 104.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 103.85 29.45 5.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 tpp -97.8 140.76 31.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 110.273 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.98 121.73 44.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.045 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' ILE . 10.4 m -80.7 166.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 110.304 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB2' ' CD ' ' A' ' 61' ' ' LYS . 11.7 t-20 -111.58 -4.75 14.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -125.17 132.78 52.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.848 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' ARG . . . -46.8 135.8 8.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.366 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' A' ' 53' ' ' THR . 76.6 t -116.86 113.95 39.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.72 -169.54 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.901 1.474 . . . . 0.0 110.382 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -71.84 148.78 45.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.75 53.49 6.2 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.675 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 99.8 m -96.51 120.95 37.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.278 -1.131 . . . . 0.0 110.253 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 128.05 35.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.728 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -62.5 115.8 4.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 110.184 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.0 mtt -110.2 157.98 36.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -3.3 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.61 -10.24 41.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' CG ' ' A' ' 47' ' ' ARG . 7.0 mtm -112.22 35.59 3.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.09 111.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.304 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' CD ' ' HB2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -69.51 -71.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.147 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 7.2 p30 -96.79 86.69 4.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.115 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.86 120.52 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.29 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.3 mm-40 -75.51 -81.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.189 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.0 m-20 -89.04 69.28 8.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.56 82.69 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 67' ' ' THR . 36.6 m -85.06 9.7 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -1.17 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.3 t -69.93 -21.99 63.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.922 . . . . 0.0 110.154 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.571 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -175.83 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.571 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -72.65 59.86 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.444 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.74 35.31 5.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.13 -41.26 10.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -1.142 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.235 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tttm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.221 0.534 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.63 131.77 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.63 145.32 40.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.129 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 59.3 t -73.68 133.53 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.79 121.18 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.04 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.24 130.41 19.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t30 -86.68 -68.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -82.73 139.18 33.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -68.49 132.62 47.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 111.08 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -130.82 154.78 81.98 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 109.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.19 -96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.935 1.492 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.2 mt -153.28 -174.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.852 -1.155 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 41.39 32.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.417 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 7.2 m -112.42 129.89 56.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -67.45 158.7 31.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -125.84 135.45 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.294 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.574 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -123.24 173.38 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 20' ' ' ILE . 5.2 tt -56.34 -56.71 17.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.7 mp -52.46 -19.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' THR . 24.4 mmm -88.31 -46.61 9.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 22' ' ' MET . 2.8 ptm -116.44 135.64 53.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -117.29 166.58 12.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.171 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.37 103.37 15.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -112.94 156.82 22.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.169 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.95 91.03 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.153 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.56 148.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -99.18 167.09 11.81 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.11 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.6 Cg_endo -73.86 163.58 89.6 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.401 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.39 93.3 3.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.415 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -81.97 -111.62 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.967 HG23 ' OE2' ' A' ' 36' ' ' GLU . 14.7 mm -91.44 113.6 59.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.337 -1.096 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.71 -174.84 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.944 1.497 . . . . 0.0 110.478 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -87.13 17.88 3.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -76.62 -53.96 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.967 ' OE2' HG23 ' A' ' 32' ' ' ILE . 19.3 pt-20 -92.39 33.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.743 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.2 mm -62.34 -52.71 64.25 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 110.049 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -72.3 -1.96 10.96 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.651 1.342 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.7 m120 -112.45 -32.06 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HG21 ' A' ' 32' ' ' ILE . 1.1 tp -86.72 -39.86 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 0.0 110.131 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 18' ' ' THR . 32.4 t -50.39 127.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.221 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.71 28.89 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.2 mtm -100.01 159.4 15.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 16.2 mp0 -109.95 165.95 11.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.0 m -101.63 165.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER -111.13 16.32 21.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.278 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 13' ' ' ILE . 5.3 mmt180 -143.92 176.63 9.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -80.41 134.71 36.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.487 HG13 HG21 ' A' ' 53' ' ' THR . 15.2 t -124.24 108.59 29.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 110.049 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -72.72 -163.14 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.976 1.514 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -78.45 156.83 29.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.32 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.02 32.87 1.59 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.529 ' OG1' ' CD ' ' A' ' 50' ' ' PRO . 18.3 m -75.0 112.46 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 110.315 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.406 ' HB ' ' CE ' ' A' ' 56' ' ' MET . 20.2 m -48.13 131.23 16.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.853 . . . . 0.0 109.978 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.566 HD12 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.84 100.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.406 ' CE ' ' HB ' ' A' ' 54' ' ' THR . 1.8 mtt -101.46 139.14 20.16 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.0 2.65 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.995 1.524 . . . . 0.0 110.592 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.36 -28.71 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' ASN . 9.2 mtm -95.3 -2.87 48.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.08 127.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -64.99 -92.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.396 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 17.9 p-10 -95.78 90.65 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.17 -0.956 . . . . 0.0 110.197 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.7 t80 -44.92 157.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 10.2 mm-40 -80.79 -80.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.36 33.12 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.09 90.47 0.55 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -96.94 17.53 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.191 . . . . 0.0 110.143 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' CB ' ' A' ' 69' ' ' SER . 9.2 t -77.15 0.73 20.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 110.302 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.528 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 172.99 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.207 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -72.65 172.07 15.95 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.989 1.521 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -34.42 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -77.06 98.42 5.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -1.124 . . . . 0.0 110.228 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.532 ' CD ' ' HB3' ' A' ' 33' ' ' PRO . 9.4 ptpp? . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.267 0.556 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -83.3 174.49 10.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -120.6 165.3 15.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.134 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 97.1 t -92.63 95.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.468 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.8 t -119.12 127.12 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.827 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -80.66 144.49 32.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.462 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 t-20 -77.06 -66.42 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 109.686 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.16 148.78 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -59.33 148.33 32.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -0.954 . . . . 0.0 110.061 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.22 138.01 30.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.89 -159.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.067 1.561 . . . . 0.0 110.258 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.059 HD11 ' HB2' ' A' ' 48' ' ' ALA . 1.6 mp -123.16 173.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 13' ' ' ILE . 11.0 m-20 59.25 19.92 8.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -118.08 151.41 37.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 165.97 21.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.729 HD11 ' CG1' ' A' ' 45' ' ' VAL . 38.8 mt -121.56 117.86 27.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.98 165.05 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.2 -33.69 58.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.274 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.1 mm -55.51 -41.12 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.389 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.92 8.91 43.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.97 124.4 42.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.98 144.18 48.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.999 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.6 94.63 5.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.03 154.53 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 9.2 t -92.15 39.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.158 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.12 159.1 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 11.1 p -81.89 163.13 54.92 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.1 Cg_endo -74.19 178.78 32.18 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.625 -0.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 4' ' ' SER . 1.9 mtt -77.84 -68.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.7 -128.75 18.12 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -103.67 137.1 19.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.159 -1.201 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' CD ' ' A' ' 2' ' ' LYS . 44.8 Cg_endo -72.07 177.72 6.81 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.973 1.512 . . . . 0.0 110.43 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.12 23.96 6.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.303 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -18.78 57.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 109.47 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -105.17 10.81 33.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.3 mm -41.99 -54.44 7.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.697 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -70.04 -3.84 13.01 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.529 1.278 . . . . 0.0 110.737 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLU . 90.4 m-20 -114.15 -36.95 4.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.738 HD12 ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -78.78 -42.14 28.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.2 t -42.63 121.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.255 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.71 1.04 27.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.497 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.6 ttm -99.84 149.77 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -1.178 . . . . 0.0 110.12 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -100.8 159.83 14.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.729 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.7 m -102.45 163.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.43 -9.62 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -136.27 155.69 49.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.938 . . . . 0.0 110.183 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.059 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -86.17 144.12 27.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.709 HG11 HG23 ' A' ' 53' ' ' THR . 38.2 t -130.2 140.35 38.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.0 Cg_endo -73.4 -175.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.083 1.57 . . . . 0.0 110.391 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -44.25 169.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.905 . . . . 0.0 110.286 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 44.11 52.19 7.07 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.827 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 2.2 m -75.36 94.58 3.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -1.109 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.578 HG21 ' HG2' ' A' ' 29' ' ' PRO . 6.6 t -68.11 148.75 50.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.086 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -70.24 105.64 3.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.342 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.54 155.45 44.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.163 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' ' HG2' ' A' ' 56' ' ' MET . 45.9 Cg_endo -73.24 -5.98 18.1 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.012 1.532 . . . . 0.0 110.489 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.3 -45.81 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.548 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -94.52 49.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 98.9 t -130.11 83.94 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -67.35 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -99.59 88.63 3.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.246 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 3.2 t80 -44.33 141.06 1.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.738 ' OE1' HD12 ' A' ' 40' ' ' LEU . 3.4 pt-20 -64.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.352 -0.843 . . . . 0.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 13.9 p-10 -61.91 84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 70' ' ' PRO . . . -86.04 71.76 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 67' ' ' THR . 93.7 m -79.63 5.14 13.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -1.177 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -100.46 -104.22 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -96.22 -66.05 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.884 -1.135 . . . . 0.0 110.493 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.6 Cg_endo -72.64 126.25 11.29 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.508 1.268 . . . . 0.0 110.425 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.85 94.34 0.14 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.4 -48.1 51.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -1.159 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.22 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.235 0.541 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -53.54 121.48 7.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.157 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -90.91 150.37 21.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 55' ' ' LEU . 54.2 t -77.8 114.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 5.8 t -125.89 95.0 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -48.58 128.94 15.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.58 -80.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 110.022 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -58.98 160.07 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.822 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -90.25 140.57 29.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -131.42 140.03 37.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.44 -0.788 . . . . 0.0 110.03 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.4 163.37 37.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.961 1.506 . . . . 0.0 110.211 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 45' ' ' VAL . 3.9 pt -71.7 -177.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.0 m120 60.29 16.39 6.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.285 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 140.2 50.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.19 152.71 44.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.791 HD11 ' CG1' ' A' ' 45' ' ' VAL . 6.9 mt -105.38 138.36 41.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 77.8 p -115.12 153.91 29.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' MET . 13.0 pt -64.81 -20.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 7.6 mtm -97.69 -7.55 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 37' ' ' ILE . 1.4 mmm -96.26 105.49 17.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HD2' ' OD1' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -96.24 141.29 29.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.875 . . . . 0.0 110.311 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -90.62 89.99 7.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.268 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.62 120.12 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.097 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' C ' HG13 ' A' ' 27' ' ' VAL . 94.2 t -68.87 79.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.0 m -151.28 170.22 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.912 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -93.31 165.83 17.49 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.274 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.5 Cg_endo -74.97 167.24 81.01 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.357 -0.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.34 68.89 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.268 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.57 -130.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.596 HG21 ' CD ' ' A' ' 36' ' ' GLU . 2.0 mt -97.33 126.45 41.75 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.165 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.56 50.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.924 1.486 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . 45.93 26.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -69.91 -45.73 66.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' CD ' HG21 ' A' ' 32' ' ' ILE . 1.4 pt-20 -95.25 28.39 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.109 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.3 mm -47.09 -55.02 16.89 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -71.0 -2.74 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.569 1.299 . . . . 0.0 110.542 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 83.9 m-20 -109.48 -31.45 7.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.33 -31.85 15.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.505 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.4 t -43.69 110.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.32 4.45 27.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.5 ' HE3' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -100.23 152.83 19.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -1.219 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.81 154.85 18.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.893 . . . . 0.0 110.232 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.791 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.9 m -102.28 167.02 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' MET . 9.3 t30 -111.1 -11.4 14.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 3.7 mtt-85 -116.18 133.13 56.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 13' ' ' ILE . . . -51.48 124.98 13.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.518 HG13 ' CG2' ' A' ' 53' ' ' THR . 61.9 t -99.07 109.89 55.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.15 -165.02 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.957 1.504 . . . . 0.0 110.424 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -75.56 150.91 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.421 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.5 44.03 11.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' HG13 ' A' ' 49' ' ' VAL . 88.2 m -89.35 122.19 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.01 138.92 57.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 109.993 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -66.45 106.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 110.241 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.401 ' SD ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -106.15 152.58 40.46 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.41 -0.806 . . . . 0.0 110.344 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 56' ' ' MET . 48.0 Cg_endo -74.49 -0.68 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.563 . . . . 0.0 110.583 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.71 -13.9 38.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 7.8 mtt -104.24 -2.57 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG13 ' HE3' ' A' ' 43' ' ' MET . 28.4 t -100.96 106.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -80.81 78.0 7.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.442 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 11.2 t80 -46.13 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -99.41 -86.14 0.38 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.16 80.1 2.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.58 98.35 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 10.26 38.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.348 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.633 HG22 ' N ' ' A' ' 69' ' ' SER . 18.0 m -73.36 -91.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.633 ' N ' HG22 ' A' ' 68' ' ' THR . 0.6 OUTLIER -77.78 -56.13 1.15 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.175 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 69' ' ' SER . 49.5 Cg_endo -76.29 52.64 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.034 1.544 . . . . 0.0 110.297 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.92 72.61 0.54 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.82 17.58 22.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -1.174 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' NZ ' ' CB ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.201 0.524 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.447 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -70.06 137.35 51.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -97.87 157.06 16.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -87.83 104.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' C ' ' A' ' 52' ' ' GLY . 20.3 t -93.32 114.87 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -42.26 126.73 3.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.152 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.545 ' O ' HD23 ' A' ' 51' ' ' LEU . 50.8 t30 -82.46 -73.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.466 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -65.54 140.29 58.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 10' ' ' LEU . 4.2 tt -72.15 126.21 29.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 4.0 pt -130.67 151.05 78.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.966 ' O ' HD13 ' A' ' 13' ' ' ILE . 47.6 Cg_endo -73.69 -95.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.399 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 12' ' ' PRO . 6.2 mm -142.0 163.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 11.8 m120 42.26 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.261 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 88.3 m -154.32 123.18 6.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 110.237 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.73 144.64 21.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 17' ' ' LEU . 3.6 mt -107.63 143.36 36.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.404 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' HG12 ' A' ' 20' ' ' ILE . 1.1 p -116.56 167.13 11.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.35 -21.85 62.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.523 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 8.2 pt -73.8 -18.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' ' HB3' ' A' ' 9' ' ' GLN . 2.4 mtt -97.74 21.15 10.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 110.036 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.93 122.27 43.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.1 mmmt -119.11 127.3 53.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.7 74.85 6.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -107.95 118.46 36.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.38 72.56 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.182 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 m -135.69 -173.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 110.182 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 12.2 t -103.86 149.41 37.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.83 167.48 79.87 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.319 -0.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -82.6 81.3 8.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.3 -157.97 0.03 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -75.51 140.04 71.67 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.366 -1.079 . . . . 0.0 110.298 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.12 -168.48 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.1 1.579 . . . . 0.0 110.648 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -106.8 -5.54 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -24.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mm-40 -104.89 47.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.578 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.3 mm -60.74 -53.91 59.72 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 110.339 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.4 Cg_endo -73.05 -5.23 16.83 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.829 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -114.25 -30.82 6.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 0.0 110.372 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 55' ' ' LEU . 7.3 tp -82.06 -50.1 9.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 37' ' ' ILE . 96.9 t -44.46 114.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.16 11.45 18.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 64' ' ' GLU . 4.2 ttm -97.9 143.84 28.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.6 mt-30 -104.31 112.8 25.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.226 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' ASN . 17.6 m -76.84 152.39 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.494 ' HA ' HG22 ' A' ' 13' ' ' ILE . 9.0 t30 -109.95 42.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' NE ' HG13 ' A' ' 49' ' ' VAL . 4.1 ptm180 -141.23 156.29 45.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.95 . . . . 0.0 110.246 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -86.35 116.73 24.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.095 HG12 HG21 ' A' ' 53' ' ' THR . 2.7 m -115.22 112.02 44.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 46.9 Cg_endo -73.77 54.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.1 1.579 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 67.82 151.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 110.861 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.41 38.04 6.69 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.095 HG21 HG12 ' A' ' 49' ' ' VAL . 5.8 m -96.87 141.51 29.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.249 . . . . 0.0 110.225 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.8 HG21 ' HG2' ' A' ' 29' ' ' PRO . 10.1 t -70.42 131.77 44.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.596 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.35 122.93 17.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.302 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.15 135.31 19.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.468 ' HA ' HG21 ' A' ' 60' ' ' VAL . 49.2 Cg_endo -76.47 -24.24 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.101 1.579 . . . . 0.0 111.365 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' MET . 10.5 p-10 -63.64 -37.21 86.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.529 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.7 mmt -99.52 57.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.007 . . . . 0.0 110.003 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 57' ' ' PRO . 77.6 t -124.45 128.71 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 58.5 m-80 -96.09 100.48 12.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.471 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 2.7 t80 -45.43 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -98.43 -155.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 65' ' ' ASP . 27.1 t0 -59.9 79.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -136.25 81.4 0.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 24.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 69' ' ' SER . 66.7 m -86.3 -97.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.548 ' N ' HG22 ' A' ' 68' ' ' THR . 0.4 OUTLIER -80.74 -59.02 0.51 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.024 -1.047 . . . . 0.0 110.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.7 Cg_endo -73.72 -164.2 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.825 1.434 . . . . 0.0 110.58 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.58 -2.64 5.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -75.06 67.13 1.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 63' ' ' TYR . 2.5 mttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 tptp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.204 0.526 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.19 120.65 12.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.298 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.5 t -97.44 148.21 23.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.08 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 22' ' ' MET . 53.7 t -71.32 109.68 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 110.289 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 54' ' ' THR . 10.7 t -124.16 120.27 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.093 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.911 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.92 130.23 39.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.612 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.2 m-80 -75.25 -23.52 57.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -96.4 155.33 16.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -80.69 127.6 32.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' SD ' ' A' ' 21' ' ' MET . 6.2 pt -129.06 106.87 17.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -72.98 157.35 51.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.53 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.739 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -44.71 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 30.2 m-20 57.39 59.06 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m -160.41 119.24 2.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.11 165.05 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.58 HD11 HG12 ' A' ' 45' ' ' VAL . 15.8 mt -122.5 111.8 17.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 17.6 p -89.13 139.78 30.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.097 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HA ' ' CG ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -50.69 -30.82 14.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.252 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 18' ' ' THR . 9.6 pt -71.15 -13.47 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.553 ' SD ' HG21 ' A' ' 11' ' ' ILE . 7.6 ttm -97.67 -10.41 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.557 ' HE3' HG22 ' A' ' 41' ' ' VAL . 5.5 ptp -117.3 123.23 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -121.11 147.51 45.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.29 96.39 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -109.83 142.96 40.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.177 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -94.74 81.06 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 110.126 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 28' ' ' THR . 8.6 p -126.63 166.52 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.256 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.8 t -114.47 149.24 41.86 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.33 164.37 88.39 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.771 -2.179 . . . . 0.0 110.523 -0.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.2 mtt -81.74 -150.64 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.402 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.8 -99.31 0.15 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 1.7 mt -118.63 132.33 23.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.124 -1.221 . . . . 0.0 109.636 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.66 -175.21 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.847 1.446 . . . . 0.0 110.359 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -86.97 21.88 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 110.299 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -43.83 74.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.479 ' OE2' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -95.22 35.01 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.88 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.6 mm -62.85 -53.25 57.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.925 . . . . 0.0 110.435 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.31 -3.07 12.23 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.581 1.306 . . . . 0.0 110.496 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -103.13 -32.49 9.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.479 HD13 ' OE2' ' A' ' 36' ' ' GLU . 4.0 tp -88.66 -31.69 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 37' ' ' ILE . 46.0 t -45.51 139.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 110.316 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.08 -32.46 5.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.2 ttp -74.91 144.78 43.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -178.43 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.617 HG23 ' HA ' ' A' ' 13' ' ' ILE . 3.3 m -119.08 164.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.074 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.8 t-20 -110.94 -8.58 14.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 110.768 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -130.05 114.86 16.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -0.992 . . . . 0.0 110.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -54.56 138.16 41.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 0.0 110.402 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 4.9 t -130.4 136.61 29.25 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.84 . . . . 0.0 110.15 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.925 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.13 179.84 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.343 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -41.87 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.209 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 54.15 51.76 48.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.911 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 59.8 p -70.63 96.73 1.24 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -1.119 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.593 ' HA ' HG22 ' A' ' 6' ' ' VAL . 15.5 m -55.35 125.87 22.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.074 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 5' ' ' VAL . 4.7 tp -61.93 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.526 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.12 167.46 9.22 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.8 Cg_endo -74.6 2.1 6.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.06 1.558 . . . . 0.0 110.592 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -75.05 -69.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.533 ' CA ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -84.12 62.02 6.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.959 . . . . 0.0 110.578 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 56' ' ' MET . 9.8 t -130.08 124.48 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.36 -94.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.395 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 80.3 m-20 -100.51 100.42 11.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.246 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -46.96 116.59 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -65.38 -79.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.34 88.31 7.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.86 77.13 0.32 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.2 m -82.11 -11.57 58.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -1.15 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -88.95 -143.71 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.528 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -53.31 -57.22 17.71 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.6 128.32 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.939 1.494 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.11 38.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 97.34 5.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -1.131 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.147 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.557 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . . . -62.49 131.86 50.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.24 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.13 136.51 34.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.117 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 96.6 t -70.19 118.06 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 4' ' ' SER . 4.4 t -121.53 107.96 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.947 . . . . 0.0 110.235 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -51.35 120.1 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.907 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -79.59 -42.3 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.458 ' O ' HG12 ' A' ' 11' ' ' ILE . 40.8 tp60 -91.12 141.26 29.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.776 ' O ' HD23 ' A' ' 10' ' ' LEU . 3.0 tt -60.42 113.64 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 9' ' ' GLN . 12.6 mm -106.21 131.83 21.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.24 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.87 -163.26 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.825 1.434 . . . . 0.0 110.192 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.687 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.6 mt -106.94 -174.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 109.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.521 ' H ' HG22 ' A' ' 13' ' ' ILE . 2.7 m-20 52.26 19.41 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -117.5 155.39 29.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -81.1 156.69 25.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 12.8 mt -100.3 116.22 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' HG22 ' A' ' 20' ' ' ILE . 25.3 p -101.14 126.73 47.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -46.68 -40.74 13.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.593 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 tt -43.42 -42.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.593 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -93.35 11.77 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 110.354 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 28.8 mtm -123.99 112.28 17.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.0 153.88 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 3' ' ' ALA . . . -88.31 99.38 12.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -112.95 127.15 56.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -68.84 81.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 28' ' ' THR . 83.8 t -131.8 162.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -100.28 150.18 36.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -75.95 -169.43 7.54 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.393 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 4' ' ' SER . 8.8 ptp -74.18 -29.51 61.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 44.68 -145.52 2.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.972 HD12 ' OH ' ' A' ' 63' ' ' TYR . 42.3 mm -83.32 115.32 58.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.14 . . . . 0.0 110.073 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 46.3 Cg_endo -72.15 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.894 1.471 . . . . 0.0 110.507 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -94.0 23.97 4.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.9 mm-40 -76.95 -49.67 15.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.841 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE2' ' CG ' ' A' ' 65' ' ' ASP . 3.1 mm-40 -100.39 37.8 1.62 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.823 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.969 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -63.96 -54.03 43.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.7 Cg_endo -72.01 -2.14 11.08 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.694 1.365 . . . . 0.0 110.294 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 5.1 m120 -106.95 -41.72 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' MET . 2.9 tp -74.5 -24.88 59.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 37' ' ' ILE . 34.6 t -45.7 99.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.78 11.9 21.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 53.5 tpp -81.43 155.12 26.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -1.188 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.7 157.83 16.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 110.252 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 13' ' ' ILE . 2.7 p -118.76 159.97 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' C ' HG21 ' A' ' 13' ' ' ILE . 35.4 t-20 -110.67 -13.76 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' H ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -118.02 174.74 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 0.0 110.145 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -85.53 149.04 25.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.589 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 53' ' ' THR . 54.2 t -128.24 107.5 19.57 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.833 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' C ' ' HG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -71.93 -160.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.966 1.509 . . . . 0.0 110.694 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.17 153.81 31.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.429 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.9 43.64 5.41 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.658 ' HB ' HG13 ' A' ' 49' ' ' VAL . 40.1 m -89.84 119.5 30.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -1.136 . . . . 0.0 110.328 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.9 141.26 58.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -66.05 115.45 6.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.279 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.57 138.58 21.52 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.71 -0.05 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.341 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -84.05 -20.71 32.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.892 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.502 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 22.0 mtt -99.67 -15.16 18.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.99 111.93 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 110.054 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -73.48 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.58 97.12 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.189 -0.945 . . . . 0.0 110.304 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.972 ' OH ' HD12 ' A' ' 32' ' ' ILE . 2.4 t80 -62.4 152.41 34.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.465 ' OE2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -71.78 -53.28 13.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 110.385 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' CG ' ' OE2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -60.19 -42.31 94.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.413 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' CA ' ' HA2' ' A' ' 71' ' ' GLY . . . 48.92 83.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 68' ' ' THR . 34.2 m -89.01 -87.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.336 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' THR . 1.3 p -110.16 -92.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 110.52 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.549 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -49.97 -53.79 39.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.4 Cg_endo -74.61 2.09 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.906 1.477 . . . . 0.0 110.74 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' ' CA ' ' A' ' 66' ' ' GLY . . . -56.45 -56.98 21.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 156.85 18.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.195 . . . . 0.0 110.277 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.119 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.2 0.524 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.43 169.65 12.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -122.52 169.8 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.568 ' O ' HD23 ' A' ' 55' ' ' LEU . 21.8 t -94.27 110.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' HA2' ' A' ' 52' ' ' GLY . 15.3 t -116.52 114.04 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.045 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -52.94 127.68 24.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -0.949 . . . . 0.0 110.041 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 39.6 t30 -74.57 -55.12 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.543 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -91.24 148.18 22.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.497 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 10' ' ' LEU . 9.0 tt -61.32 128.47 36.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.889 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -101.4 123.6 44.02 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.2 Cg_endo -78.4 47.34 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.874 1.46 . . . . 0.0 110.78 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.3 mt 49.91 177.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.17 -0.956 . . . . 0.0 110.387 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 13' ' ' ILE . 5.9 m-20 45.42 36.17 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.448 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 16.4 m -132.53 119.69 20.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.02 159.29 5.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.3 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 23.6 mt -103.17 134.8 45.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.61 -168.75 1.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.47 -45.14 73.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.511 HD12 ' SD ' ' A' ' 21' ' ' MET . 5.9 pt -55.41 -28.26 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.01 11.47 33.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.479 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -115.12 109.75 18.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -114.36 122.94 48.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.302 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.09 79.93 9.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.98 129.07 46.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 26' ' ' VAL . 49.4 t -76.65 55.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.68 155.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.477 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -93.42 165.15 18.86 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.63 ' O ' HG21 ' A' ' 54' ' ' THR . 47.4 Cg_endo -74.92 159.87 97.36 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.493 -0.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -53.58 56.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.19 -113.36 5.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.911 HD12 HD12 ' A' ' 55' ' ' LEU . 8.3 mt -127.67 127.36 24.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.163 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -175.8 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.883 1.464 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.636 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -98.94 26.38 5.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -62.38 -38.99 91.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -102.09 45.94 0.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.0 110.321 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.636 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -57.14 -42.52 96.67 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.5 Cg_endo -78.0 -7.13 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.529 1.278 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 1.3 m-20 -111.36 -36.49 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 47.6 tp -79.86 -38.63 32.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 23.0 t -52.21 141.57 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.26 -18.72 55.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 4.9 ttp -81.23 132.08 35.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -1.198 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -89.91 147.59 23.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.122 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 7.3 m -87.34 156.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -98.83 -5.95 30.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.344 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -127.94 163.08 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.159 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -82.21 135.79 35.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.664 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.828 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -119.83 124.99 27.62 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 109.781 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.41 -177.77 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.856 1.451 . . . . 0.0 110.55 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.14 143.41 56.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.328 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 56.93 47.35 87.57 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.045 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 4.9 t -86.08 113.54 22.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -1.145 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.63 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.4 m -55.04 143.36 27.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.033 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -61.83 101.32 0.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.169 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -108.5 148.61 38.03 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 60' ' ' VAL . 47.9 Cg_endo -74.02 1.88 6.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.99 1.521 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -52.81 7.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.54 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -87.32 45.67 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.4 t -123.96 133.12 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -91.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.9 104.42 15.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.35 155.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.9 mm-40 -103.57 -96.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.64 52.34 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 110.346 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.67 60.08 0.51 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -82.3 59.38 4.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' SER . 33.6 m -96.67 -89.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.48 -56.65 3.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.134 -0.979 . . . . 0.0 110.112 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -73.55 -166.32 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.044 1.55 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.14 173.56 40.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.16 175.2 6.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.193 -1.181 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.253 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.253 0.549 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -86.4 142.59 28.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.272 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.4 p -97.03 169.23 9.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.071 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 24.8 t -86.74 88.93 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.1 t -106.55 121.9 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.132 -0.98 . . . . 0.0 109.868 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.999 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.73 143.8 32.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.443 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 48.7 t30 -73.82 -72.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -62.71 148.6 46.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.074 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.025 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -60.3 159.37 10.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.932 ' N ' HD22 ' A' ' 10' ' ' LEU . 1.8 pt -130.95 117.99 17.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.694 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 51.3 Cg_endo -80.45 50.57 3.59 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.834 1.439 . . . . 0.0 110.19 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 23.4 pt 39.18 -164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.615 -0.678 . . . . 0.0 110.755 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' ILE . 15.1 p30 37.88 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.568 -0.708 . . . . 0.0 110.781 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.4 m -138.45 118.67 13.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.62 155.19 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 109.992 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.39 127.0 53.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.4 OUTLIER -100.87 150.74 22.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.696 ' C ' HD23 ' A' ' 19' ' ' LEU . 7.5 tt -42.67 -49.53 5.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 3.6 mt -63.54 -24.78 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -84.55 -19.39 33.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.615 ' CE ' HD11 ' A' ' 37' ' ' ILE . 1.8 ptm -116.48 136.69 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.88 131.04 55.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.942 . . . . 0.0 110.2 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -74.77 97.18 3.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 139.42 40.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 3' ' ' ALA . 23.5 t -95.37 81.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.176 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -161.82 154.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 110.043 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.4 t -74.65 150.24 86.49 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 110.155 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.42 161.91 93.61 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.693 -2.211 . . . . 0.0 110.481 -0.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -82.65 -81.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.386 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.77 -122.54 7.44 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' HG ' ' A' ' 55' ' ' LEU . 5.5 mt -123.95 139.12 31.8 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.106 -1.232 . . . . 0.0 109.919 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.1 1.579 . . . . 0.0 110.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -108.25 41.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -65.09 -21.92 66.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.987 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 64' ' ' GLU . 4.8 mm-40 -105.32 35.5 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.785 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.7 mm -40.62 -54.94 4.78 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.531 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.39 -6.8 19.95 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.632 1.333 . . . . 0.0 110.889 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 m-20 -114.25 -18.87 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.128 -0.983 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -102.07 -34.7 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.6 t -42.69 103.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 125.12 9.38 5.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.63 144.92 26.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -1.174 . . . . 0.0 110.12 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 3.6 mt-30 -109.75 168.16 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 11' ' ' ILE . 12.4 m -116.09 174.79 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 -7.3 14.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.426 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.497 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -125.4 119.21 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.182 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -68.33 145.03 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.398 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 53' ' ' THR . 23.7 t -129.42 139.79 36.73 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 110.178 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.66 89.68 0.97 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.304 1.686 . . . . 0.0 110.713 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 55.25 160.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.395 -0.816 . . . . 0.0 110.73 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 41.37 65.95 1.04 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.999 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.3 t -91.83 113.52 25.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.096 -1.238 . . . . 0.0 110.015 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 30' ' ' MET . 1.5 m -73.68 121.96 21.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.82 106.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.733 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.682 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.8 mtt -112.92 156.94 41.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.57 -2.98 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.076 1.566 . . . . 0.0 110.485 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.45 -30.41 16.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 7.5 mmt -99.16 0.31 43.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.068 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 56' ' ' MET . 55.8 t -91.36 102.23 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CD ' ' OXT' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -67.36 -58.98 3.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.042 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 14.5 p-10 -100.59 80.11 2.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' OG ' ' A' ' 69' ' ' SER . 1.6 t80 -46.49 146.12 1.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.9 . . . . 0.0 110.464 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -70.41 -175.28 0.99 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.235 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -60.03 -57.74 11.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.97 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 50.68 179.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -107.61 -60.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 0.0 110.052 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 68' ' ' THR . 8.3 t -102.71 55.61 0.77 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.931 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -95.67 -177.91 0.71 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 110.303 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 43.6 Cg_endo -72.55 -89.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.481 . . . . 0.0 110.341 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.76 -15.68 3.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.51 130.66 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 110.138 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.492 ' OXT' ' CD ' ' A' ' 61' ' ' LYS . 4.0 mptt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.251 0.548 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -55.98 135.9 52.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.142 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 30' ' ' MET . 46.5 t -113.31 160.24 18.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.295 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 53.3 t -92.02 97.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 54' ' ' THR . 14.9 t -117.44 125.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.57 137.1 45.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.581 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.6 t-20 -73.6 -44.49 56.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 110.248 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.418 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 14.6 tt0 -88.28 152.81 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -64.21 152.14 41.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -129.84 133.9 25.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.16 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.92 1.484 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.614 HG23 HG23 ' A' ' 45' ' ' VAL . 2.3 mt -116.17 170.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -0.915 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.16 11.75 4.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.3 m -115.79 140.83 48.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 110.298 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -62.16 163.22 8.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.21 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 45' ' ' VAL . 9.1 mt -112.03 120.79 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.135 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.413 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -100.11 130.93 46.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -46.29 -40.75 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 19' ' ' LEU . 64.3 mt -46.91 -36.71 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 62.4 mtp -86.61 -19.01 29.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.273 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.2 mtm -102.05 127.56 48.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.223 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.9 mtpt -114.6 170.76 8.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.42 94.45 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.2 131.71 55.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 3' ' ' ALA . 32.4 t -78.66 87.63 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.99 149.41 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.6 t -102.5 149.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.066 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.72 133.51 31.65 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.741 -2.191 . . . . 0.0 110.516 -0.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ILE . 3.9 ptp -60.21 -29.63 68.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 57.8 -85.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 55' ' ' LEU . 3.8 mt -132.74 127.67 20.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.188 -1.184 . . . . 0.0 110.202 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.28 -160.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.885 1.466 . . . . 0.0 110.405 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -100.51 28.79 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.301 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -46.08 37.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.42 24.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.7 mm -50.94 -53.1 51.4 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.844 . . . . 0.0 110.565 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -70.78 -1.13 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.53 1.279 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' O ' ' CD ' ' A' ' 64' ' ' GLU . 35.3 m120 -113.5 -46.01 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -0.97 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -78.78 -35.4 44.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.472 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 t -44.29 107.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.045 -1.034 . . . . 0.0 110.034 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 113.76 12.28 11.67 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.1 mmm -94.49 160.69 14.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.164 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.21 147.14 34.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 17' ' ' LEU . 4.5 m -102.37 166.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 47' ' ' ARG . 55.6 p30 -101.59 -11.95 18.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.22 -0.925 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 63.4 mtt180 -130.99 156.96 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -86.05 141.53 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 110.279 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG22 ' SD ' ' A' ' 59' ' ' MET . 6.7 t -121.63 132.85 24.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' O ' HG22 ' A' ' 53' ' ' THR . 44.8 Cg_endo -71.9 -172.96 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.885 1.466 . . . . 0.0 110.339 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -46.36 155.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 55.89 59.99 9.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.797 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 38.8 p -78.34 95.24 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -1.077 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 6' ' ' VAL . 7.0 m -62.88 133.85 55.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.37 96.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.219 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mmm -112.65 153.64 44.96 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.155 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.23 3.16 6.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.944 1.497 . . . . 0.0 110.559 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -39.11 36.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.482 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.605 ' SD ' HG22 ' A' ' 49' ' ' VAL . 5.9 mtm -111.82 60.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.342 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG13 ' CE ' ' A' ' 43' ' ' MET . 83.9 t -129.49 104.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -81.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.518 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -93.04 93.17 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.422 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -47.76 150.22 1.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 39' ' ' ASN . 71.8 mm-40 -80.1 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.02 82.2 8.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.6 65.4 3.96 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -30.3 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -1.114 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 56.8 p -110.44 -129.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -73.73 -54.26 3.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.949 -1.094 . . . . 0.0 111.041 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 69' ' ' SER . 42.8 Cg_endo -69.2 59.79 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.693 1.365 . . . . 0.0 110.924 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -133.04 -2.37 3.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.26 135.01 46.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 0.0 110.424 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.193 179.918 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.277 0.56 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.93 156.89 36.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.44 149.39 42.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 34' ' ' ALA . 73.7 t -75.0 97.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.0 t -108.25 123.89 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.207 -0.933 . . . . 0.0 110.153 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -57.79 141.07 50.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.35 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t-20 -80.19 -67.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.845 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.415 ' O ' HG12 ' A' ' 11' ' ' ILE . 50.3 tt0 -87.54 155.33 20.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.819 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -59.36 141.11 55.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 110.201 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.769 ' H ' HG23 ' A' ' 49' ' ' VAL . 10.8 mm -130.55 144.9 55.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 110.058 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 44.2 Cg_endo -71.37 -170.94 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.947 1.498 . . . . 0.0 110.261 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 47' ' ' ARG . 6.2 mt -107.27 167.47 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.92 . . . . 0.0 110.023 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 54.72 26.18 7.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.185 -0.947 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -113.72 141.33 47.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.923 . . . . 0.0 110.217 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 104.96 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -87.27 162.79 17.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.356 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.29 163.21 23.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.99 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -57.24 -28.66 63.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG13 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.1 -17.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.67 -10.14 25.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.572 ' CE ' HD13 ' A' ' 17' ' ' LEU . 3.3 mtt -123.27 139.34 54.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.46 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -112.24 170.08 8.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.016 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.18 6.31 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 141.63 46.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.66 82.02 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.63 155.18 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 110.127 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.2 p -111.85 159.86 31.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.263 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -76.17 132.24 26.87 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.511 -2.287 . . . . 0.0 110.477 -0.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.78 153.44 29.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -120.57 -71.4 0.31 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 57' ' ' PRO . 3.1 mt -136.2 137.93 25.94 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.452 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.3 Cg_endo -73.07 -162.97 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.067 1.562 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -111.49 38.63 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -31.46 69.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 33.2 mm-40 -101.74 30.36 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.982 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.9 mm -44.89 -54.19 13.86 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -70.99 -5.77 17.71 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.632 1.333 . . . . 0.0 110.441 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.584 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 1.4 m-20 -108.46 -24.83 11.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 110.127 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -93.74 -12.86 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 109.967 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 37' ' ' ILE . 41.5 t -46.79 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.37 24.12 9.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.94 137.49 36.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.996 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 3.5 mt-30 -96.57 116.49 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.158 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.99 167.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.095 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 17.8 t30 -110.84 2.38 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HG2' ' CB ' ' A' ' 59' ' ' MET . 9.3 ptm180 -136.63 155.93 49.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.418 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -79.42 113.34 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.865 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.012 HG12 HG21 ' A' ' 53' ' ' THR . 19.1 m -81.87 112.33 34.05 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 48.2 Cg_endo -73.6 53.05 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.887 1.467 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER 66.82 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.496 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.22 49.11 14.93 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.012 HG21 HG12 ' A' ' 49' ' ' VAL . 11.3 m -96.83 123.71 40.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 142.63 58.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 110.165 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.22 120.74 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.482 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 46.5 mmm -112.7 137.49 21.75 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.8 Cg_endo -74.2 -7.39 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.62 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -52.49 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.488 ' CB ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 mpt? -87.78 62.12 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.329 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 56' ' ' MET . 28.8 t -128.57 106.47 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.171 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 9.4 mmtt -49.92 -84.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.79 91.79 8.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -48.66 135.82 14.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 8.2 pm0 -78.41 -37.81 43.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -0.939 . . . . 0.0 110.53 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 24.9 t70 -84.39 99.99 11.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.89 31.12 4.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -99.78 -64.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -108.82 -14.35 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.597 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -70.27 -171.47 0.16 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 47.3 Cg_endo -77.52 -4.83 15.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.778 1.409 . . . . 0.0 110.497 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.57 40.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.37 158.88 15.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 110.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 114.13 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -95.08 147.55 23.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.666 ' CG1' HD23 ' A' ' 55' ' ' LEU . 53.0 t -79.57 120.11 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 110.181 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.686 HG13 ' N ' ' A' ' 54' ' ' THR . 6.4 t -126.53 110.19 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.264 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -54.73 135.02 47.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.69 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -87.42 -71.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 2.2 pt20 -58.44 144.8 40.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -71.42 126.6 30.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.519 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -126.38 144.21 48.61 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.202 -0.936 . . . . 0.0 110.363 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.91 -158.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.982 1.517 . . . . 0.0 110.349 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.698 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.8 mt -95.74 -172.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.698 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.5 OUTLIER 39.86 30.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -104.83 115.81 30.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -64.25 98.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.591 HD11 HD23 ' A' ' 40' ' ' LEU . 1.7 pp -70.4 152.62 43.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.7 p -130.17 -160.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.3 mp -77.05 -43.11 35.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pt -69.18 -16.88 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -97.37 -12.73 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.33 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.554 ' HG3' HD13 ' A' ' 17' ' ' LEU . 39.3 mmm -124.13 107.46 11.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.153 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 21.9 mttt -99.22 144.18 28.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.76 98.56 11.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.4 mp0 -113.24 143.51 44.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 2' ' ' LYS . 8.1 p -96.75 62.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.92 -174.51 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 0.0 110.39 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.8 t -100.34 150.86 37.3 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.103 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 51.0 Cg_endo -81.84 153.74 78.65 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.689 -2.213 . . . . 0.0 110.563 -0.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -82.66 159.78 22.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.866 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -113.31 0.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -99.99 141.41 22.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 44.4 Cg_endo -71.43 -164.05 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.004 1.528 . . . . 0.0 110.466 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -116.91 27.29 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.925 . . . . 0.0 110.376 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.487 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -74.46 -17.13 60.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.246 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 pm0 -102.68 1.41 34.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.889 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -41.32 -54.56 5.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.496 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -70.5 -8.11 22.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.647 1.341 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.0 m120 -114.39 -18.61 11.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.067 -1.021 . . . . 0.0 110.501 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.591 HD23 HD11 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -102.4 -26.71 13.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.582 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 37' ' ' ILE . 10.6 t -42.63 127.96 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.97 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.25 -0.65 47.07 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -87.53 152.24 22.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -1.123 . . . . 0.0 110.139 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -99.72 174.73 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 13' ' ' ILE . 1.6 p -113.43 163.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 1.2 m-20 -102.81 -29.34 11.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 110.611 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 17.2 mtp180 -121.74 164.99 16.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.548 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -57.56 150.1 19.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 0.0 110.508 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.119 ' CG1' HG21 ' A' ' 53' ' ' THR . 80.5 t -127.88 107.27 20.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.056 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.72 -171.94 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.06 1.558 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -73.89 160.69 31.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.867 . . . . 0.0 110.184 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.54 46.92 7.19 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.119 HG21 ' CG1' ' A' ' 49' ' ' VAL . 8.1 t -92.38 104.87 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.686 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -51.54 157.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.93 112.0 2.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.474 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 3.0 tpt -112.51 127.58 26.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.91 -20.55 19.5 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.857 1.451 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -65.84 -23.1 66.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 45' ' ' VAL . 33.0 mtm -113.51 49.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 61.5 t -127.09 139.53 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' CE ' ' A' ' 43' ' ' MET . 37.3 t30 -90.34 92.66 9.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 86.3 m-85 -44.69 149.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -94.58 -47.21 6.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.89 95.39 10.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.58 5.34 83.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -9.69 47.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.0 110.176 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 3.2 p -106.04 -178.56 3.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.282 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -50.76 -56.0 22.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.467 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.2 Cg_endo -72.21 112.54 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.916 1.482 . . . . 0.0 110.522 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.29 49.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 72' ' ' LEU . 11.3 mt -80.93 -2.71 48.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -1.115 . . . . 0.0 110.329 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.252 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -65.01 126.79 29.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 14.4 t -95.01 166.44 11.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.156 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ILE . 15.0 t -85.54 110.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' GLU . 3.9 t -111.32 113.2 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.088 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.09 128.78 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.695 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.2 t-20 -80.59 -55.69 4.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.02 177.69 6.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.068 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.9 tt -99.65 130.53 45.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.786 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -126.8 133.17 24.74 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -73.15 56.96 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.983 1.517 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 mt 45.66 -172.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.076 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.6 m-20 43.63 63.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.114 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 m -159.61 119.09 2.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.4 85.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 43' ' ' MET . 1.2 pp -50.71 155.29 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.5 OUTLIER -130.01 159.91 35.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.178 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.1 tt -59.72 -48.42 81.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.821 ' N ' HD23 ' A' ' 19' ' ' LEU . 88.3 mt -57.7 -31.6 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.233 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -86.19 -26.15 25.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 18' ' ' THR . 15.9 mmt -110.91 131.2 55.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -107.41 165.33 11.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.67 99.97 9.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.2 tt0 -104.57 135.47 45.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.191 -0.943 . . . . 0.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 3' ' ' ALA . 12.2 t -85.38 71.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.9 t -133.07 160.4 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.4 t -88.13 152.22 50.21 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -77.77 160.31 93.05 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.546 -0.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtm -82.68 101.13 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.65 -119.9 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.582 ' CD1' HD12 ' A' ' 55' ' ' LEU . 1.8 mt -99.59 129.31 29.19 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 110.02 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 178.38 5.82 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.889 1.468 . . . . 0.0 110.761 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.747 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -79.3 2.79 20.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.378 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 34' ' ' ALA . 8.3 tt0 -43.58 -39.86 3.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -104.92 39.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.233 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.747 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -55.99 -54.56 50.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 110.233 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -70.61 -4.48 14.68 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.661 1.348 . . . . 0.0 110.45 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -111.45 -31.18 7.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.139 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -73.5 -39.61 64.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.141 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 41' ' ' VAL . 24.4 t -45.24 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.113 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 119.57 19.27 4.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.499 ' CE ' HG11 ' A' ' 60' ' ' VAL . 2.0 ttt -98.5 144.34 27.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -1.095 . . . . 0.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.83 146.53 28.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.162 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 13' ' ' ILE . 7.5 m -104.87 153.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.08 28.71 8.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 8.8 ptt180 -151.21 137.93 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -48.95 130.86 18.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.926 HG13 ' HB ' ' A' ' 53' ' ' THR . 9.9 t -117.32 106.86 46.17 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.98 -168.14 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.539 . . . . 0.0 110.398 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -70.37 136.82 50.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 60.98 52.67 50.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.926 ' HB ' HG13 ' A' ' 49' ' ' VAL . 63.3 m -96.49 124.87 40.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -1.119 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 54' ' ' THR . 4.8 t -68.45 149.84 48.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.142 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.12 111.34 12.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.336 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtt -104.8 133.01 20.38 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . 50.0 Cg_endo -76.99 6.23 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.948 1.499 . . . . 0.0 110.677 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 -42.19 21.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.055 -1.028 . . . . 0.0 110.521 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.551 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 3.2 mmt -110.54 67.28 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.6 t -126.25 122.36 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.867 . . . . 0.0 110.141 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.3 -77.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.09 105.62 17.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 70' ' ' PRO . 59.1 m-85 -67.26 155.61 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 110.223 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -104.54 -65.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.9 -43.91 67.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.02 90.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 68' ' ' THR . 6.6 m -105.07 -83.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.213 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 67' ' ' THR . 59.0 m -106.96 -80.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -51.8 -61.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.1 Cg_endo -71.13 154.6 62.1 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.814 1.428 . . . . 0.0 110.428 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.88 162.38 31.23 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 109.94 4.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -1.105 . . . . 0.0 110.216 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 26' ' ' VAL . 21.4 mmtt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.432 0.634 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -47.88 112.44 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -102.15 148.21 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.016 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 59.4 t -72.86 104.33 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.173 -0.954 . . . . 0.0 110.269 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -107.97 105.87 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.048 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.56 115.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -72.75 -62.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.056 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -86.61 152.43 22.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.3 tt -59.34 142.26 52.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 11' ' ' ILE . 35.2 mm -123.04 139.18 31.01 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 -162.11 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.024 1.539 . . . . 0.0 110.329 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 6.5 mt -116.55 157.82 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 64.31 38.26 8.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 6.1 m -132.49 138.4 47.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -61.89 158.72 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.2 mt -110.01 148.16 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -129.96 132.23 46.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.767 HD23 HG21 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -49.41 -31.28 9.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' CG1' ' HB ' ' A' ' 18' ' ' THR . 13.4 pt -69.51 -16.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 109.985 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.84 -15.65 22.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 110.073 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -121.64 119.66 32.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.29 164.55 14.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -94.75 115.63 27.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -111.28 124.88 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 2' ' ' LYS . 16.5 t -90.17 65.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.55 -173.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -111.94 153.0 44.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.086 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.33 161.93 92.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.432 -0.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.3 mtp -82.82 92.01 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.64 -144.73 0.28 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -79.63 136.24 55.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.325 -1.103 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.51 -174.26 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.002 1.527 . . . . 0.0 110.644 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.666 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -112.32 17.34 19.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.316 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -34.03 77.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.136 -0.977 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.5 mm-40 -89.24 26.41 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.666 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.96 -40.81 81.22 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.0 111.217 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.5 Cg_endo -74.81 -18.54 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.315 1.166 . . . . 0.0 111.256 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -114.31 -11.75 12.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 110.272 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.598 HD12 ' CD ' ' A' ' 64' ' ' GLU . 9.3 tt -102.42 -44.01 5.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 HD23 ' A' ' 19' ' ' LEU . 33.3 t -41.8 148.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.434 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -16.3 61.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.6 mtp -73.27 157.01 37.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -1.107 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' THR . 4.4 mp0 -110.05 170.34 8.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.8 m -109.5 166.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 110.252 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.92 -4.23 18.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' HD13 ' A' ' 13' ' ' ILE . 3.4 mtp180 -143.18 168.45 19.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.192 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -78.11 139.24 39.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.899 HG13 HG21 ' A' ' 53' ' ' THR . 88.8 t -112.04 127.28 27.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.84 . . . . 0.0 110.164 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.06 -171.88 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.841 1.442 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' A' ' 10' ' ' LEU . 2.1 mp -74.97 153.13 38.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.502 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 42.69 53.33 5.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.899 HG21 HG13 ' A' ' 49' ' ' VAL . 83.0 m -96.97 109.57 22.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.26 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 148.51 2.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.885 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.0 102.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.973 . . . . 0.0 110.211 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.1 mmt -111.35 149.63 40.89 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 Cg_endo -75.66 4.07 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.975 1.513 . . . . 0.0 110.798 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.32 -42.16 62.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 110.644 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.12 55.15 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.2 t -130.28 102.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -66.88 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.06 86.87 6.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 27.8 m-85 -44.29 155.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.598 ' CD ' HD12 ' A' ' 40' ' ' LEU . 1.4 pt-20 -76.38 -158.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 110.342 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 4.1 m-20 -68.6 73.35 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -111.68 92.53 0.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 67' ' ' THR . 85.6 m -97.39 21.71 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.3 p -97.43 -15.06 20.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.087 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.59 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -173.54 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.046 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.0 Cg_endo -72.24 169.76 20.78 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.854 1.449 . . . . 0.0 110.227 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.35 56.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.15 75.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.087 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.237 0.541 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.95 127.65 35.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -102.24 137.34 40.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' ILE . 15.9 m -78.22 129.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 54' ' ' THR . 11.4 t -122.13 131.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.712 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.69 129.31 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.89 -70.82 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -80.0 160.85 25.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.9 tt -77.98 130.97 37.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 49' ' ' VAL . 4.4 mt -116.59 113.54 40.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.151 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.852 ' C ' HD13 ' A' ' 13' ' ' ILE . 46.9 Cg_endo -73.25 66.12 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.83 1.437 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.852 HD13 ' C ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 32.78 -161.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.534 0.683 . . . . 0.0 111.696 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 18.4 m-20 36.52 42.17 0.19 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -147.72 124.53 11.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.58 7.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.812 . . . . 0.0 110.02 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 45' ' ' VAL . 60.7 mt -62.33 133.46 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.68 155.78 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -67.79 -29.1 68.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.345 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 21' ' ' MET . 1.4 pt -65.15 -19.67 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 110.139 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.523 ' N ' HG13 ' A' ' 20' ' ' ILE . 3.2 mtm -97.98 -2.25 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.9 118.57 32.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.272 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.6 pttt -114.81 142.27 46.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.56 96.32 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.957 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -112.2 133.93 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 3' ' ' ALA . 18.2 t -90.71 87.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.194 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG13 ' C ' ' A' ' 26' ' ' VAL . 18.1 m -148.76 -167.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.384 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.6 t -118.71 153.44 52.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 110.236 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -77.2 160.63 94.11 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.446 -0.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.1 mmm -82.62 71.27 9.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.154 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -55.96 -108.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.713 ' O ' HG22 ' A' ' 5' ' ' VAL . 2.6 mt -113.12 136.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -162.0 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.928 1.488 . . . . 0.0 110.352 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -93.69 32.91 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -56.86 4.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 15.5 mm-40 -88.67 33.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.43 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.9 mm -60.04 -54.71 52.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.0 Cg_endo -71.39 -8.85 24.2 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.262 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.99 -47.71 4.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 0.0 110.14 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -68.3 -41.25 81.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -54.78 119.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.7 -8.26 10.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.535 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.4 ttm -100.78 162.25 13.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -1.115 . . . . 0.0 110.218 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -109.86 138.2 46.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 17' ' ' LEU . 12.6 m -91.48 154.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -104.61 -2.73 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 4.2 mtt180 -113.14 131.35 55.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.002 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.86 132.27 9.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.384 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.641 HG13 ' CB ' ' A' ' 53' ' ' THR . 55.8 t -113.17 102.4 54.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 110.058 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.4 Cg_endo -72.03 -167.13 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.543 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.58 138.54 40.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.24 34.93 91.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.2 m -73.5 97.87 2.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -44.98 137.9 3.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.22 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.24 98.66 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.429 ' CG ' ' HG3' ' A' ' 59' ' ' MET . 2.9 ptm -113.11 146.5 35.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.53 -5.44 17.15 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.541 . . . . 0.0 110.458 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -76.99 -25.48 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.295 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' CB ' ' A' ' 47' ' ' ARG . 11.0 mtt -108.21 41.53 1.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG13 ' CE ' ' A' ' 43' ' ' MET . 49.7 t -130.26 104.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 19.2 tptm -69.16 -60.35 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.454 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -98.37 71.57 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 13.1 t80 -53.36 158.47 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mm-40 -87.84 -65.63 1.0 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.36 85.21 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.65 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.91 17.86 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.171 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -80.22 -137.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.8 -55.98 4.22 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.594 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.35 -163.89 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.912 1.48 . . . . 0.0 110.457 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.7 87.79 0.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.678 ' O ' HD23 ' A' ' 72' ' ' LEU . 8.9 tt -85.49 -7.68 58.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 110.342 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.227 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.178 0.513 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.69 126.55 29.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' GLU . 3.5 t -95.86 -178.48 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 55' ' ' LEU . 77.3 t -89.18 119.9 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.413 HG12 ' C ' ' A' ' 52' ' ' GLY . 3.5 t -126.82 101.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.219 -0.926 . . . . 0.0 110.165 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -47.15 116.48 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.106 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -79.66 -63.65 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.05 135.55 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.309 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.615 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.0 tt -60.45 142.06 55.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.615 HD13 HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -130.1 116.69 17.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.581 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.84 59.71 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.849 1.447 . . . . 0.0 110.1 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 13.9 pt 39.92 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.661 . . . . 0.0 110.727 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 13' ' ' ILE . 3.8 m120 40.34 47.25 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.467 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -156.71 110.36 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.825 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.56 118.12 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 22' ' ' MET . 5.9 mt -75.92 128.48 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -171.15 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.132 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.66 -45.96 67.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.119 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.31 -9.24 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -28.89 21.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE3' HD13 ' A' ' 17' ' ' LEU . 1.4 mmt -118.92 143.26 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 8' ' ' ASN . 8.5 mttt -115.68 166.68 11.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.735 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -100.33 79.1 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.82 152.99 20.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -90.08 14.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 25' ' ' GLU . 22.8 t -62.36 142.44 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -88.14 163.82 35.7 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.136 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.79 174.17 53.79 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.608 -2.246 . . . . 0.0 110.42 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.61 86.95 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 54' ' ' THR . . . -68.49 -150.75 0.3 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -76.26 137.59 68.28 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.361 -1.082 . . . . 0.0 110.063 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 170.56 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.955 1.503 . . . . 0.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.037 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -94.07 38.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.863 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -25.54 53.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.119 -0.988 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.77 ' CB ' HD23 ' A' ' 40' ' ' LEU . 7.6 mm-40 -105.09 41.97 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.63 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.037 HD11 ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -44.78 -50.18 25.62 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.89 -11.99 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.632 1.332 . . . . 0.0 110.619 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.89 -30.6 11.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.77 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -83.11 -47.07 12.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.105 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 31.4 t -43.22 104.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.056 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.825 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.07 11.98 11.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.4 ttm -83.37 134.33 34.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 144.8 31.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 14.4 m -119.11 160.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -110.85 0.63 17.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 0.0 110.359 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -120.02 122.3 40.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 110.366 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -47.12 140.61 4.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.34 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.881 HG13 HG21 ' A' ' 53' ' ' THR . 12.0 t -124.84 130.36 24.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.3 Cg_endo -69.6 -174.38 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.944 1.497 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -79.69 154.67 28.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 48.66 43.67 29.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.881 HG21 HG13 ' A' ' 49' ' ' VAL . 55.4 m -92.02 134.18 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -1.154 . . . . 0.0 110.266 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.438 ' CG2' ' HA3' ' A' ' 31' ' ' GLY . 7.6 m -67.38 141.24 57.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.095 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -61.93 99.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 mtp -102.83 142.51 24.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 49.3 Cg_endo -75.31 2.59 6.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.013 1.533 . . . . 0.0 110.593 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.11 -32.47 24.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.133 -0.979 . . . . 0.0 110.521 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 mtt -96.31 3.49 52.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 110.393 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.68 82.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.324 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 51.7 pttt -59.53 -37.11 77.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TYR . 18.5 p30 -100.45 74.2 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 109.852 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.539 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -46.13 175.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.51 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.601 ' HG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.12 -152.82 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.028 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 11.9 t70 -58.77 83.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.798 -1.189 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -123.74 112.98 1.96 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 31.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -1.189 . . . . 0.0 110.471 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -106.63 -23.4 12.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.6 -61.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.65 150.39 56.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.921 1.485 . . . . 0.0 110.579 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.05 -48.51 0.37 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 72' ' ' LEU . 2.0 mm? -81.44 125.03 29.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.331 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 pttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.151 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.495 ' CE ' ' HB3' ' A' ' 33' ' ' PRO . 12.6 pttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.265 0.555 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -63.1 138.64 58.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.2 t -103.46 -174.48 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 22' ' ' MET . 59.3 t -92.14 123.59 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.3 t -125.86 118.47 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.43 138.99 44.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.103 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 33.0 t30 -90.8 -62.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.287 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -77.36 162.43 27.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.21 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.714 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.2 tt -93.06 130.78 38.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.112 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 26.3 pt -130.03 137.87 31.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.49 71.88 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.067 1.561 . . . . 0.0 110.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.67 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.7 mt 54.65 -172.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.67 ' H ' HG22 ' A' ' 13' ' ' ILE . 49.7 m-80 42.13 -141.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 14' ' ' ASN . 42.6 m 57.48 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.625 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.27 132.28 47.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 110.065 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -75.46 143.89 42.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.5 p -123.46 160.07 27.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.217 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.742 ' C ' HD23 ' A' ' 19' ' ' LEU . 4.8 tt -67.58 -34.6 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.287 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' N ' HD23 ' A' ' 19' ' ' LEU . 2.3 mp -59.08 -36.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.4 mtm -93.76 6.88 46.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.374 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.567 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -98.97 123.56 43.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 147.71 34.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -105.7 75.91 1.16 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.161 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.81 20.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -81.65 91.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.181 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.31 154.92 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -113.13 150.02 42.31 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -76.67 171.09 69.83 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.678 -2.218 . . . . 0.0 110.433 -0.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -80.61 81.43 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.03 -112.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 55' ' ' LEU . 1.6 mt -103.87 138.89 19.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 110.153 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HB3' ' CE ' ' A' ' 2' ' ' LYS . 45.7 Cg_endo -73.19 -177.22 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.117 1.588 . . . . 0.0 110.394 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.784 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -95.82 20.99 9.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -76.61 -36.88 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.406 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -92.49 27.35 2.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 110.481 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -58.76 -48.75 96.26 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -77.0 -5.62 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.801 1.422 . . . . 0.0 110.44 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 17.9 m120 -114.29 -20.01 11.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.341 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -97.46 -38.63 9.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.283 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.1 t -43.63 123.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.331 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.625 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.59 -4.83 23.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.63 152.91 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -1.135 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 51.7 mt-30 -103.75 145.36 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.106 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.9 m -91.98 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.105 -0.997 . . . . 0.0 110.256 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 13' ' ' ILE . 1.7 m-20 -111.12 -9.03 14.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 11.6 ptm180 -119.22 171.59 8.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.341 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.39 123.67 27.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.815 . . . . 0.0 110.413 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 53' ' ' THR . 72.2 t -107.85 96.0 16.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.952 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.444 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.5 Cg_endo -71.97 -165.23 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -69.25 141.17 54.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 55.56 49.43 65.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.743 ' HB ' HG13 ' A' ' 49' ' ' VAL . 52.7 m -92.65 134.74 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 144.15 51.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.43 105.98 8.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.469 ' HG2' ' HB2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -96.85 129.66 32.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.6 Cg_endo -75.01 1.89 7.24 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.928 1.489 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HB2' ' HG2' ' A' ' 56' ' ' MET . 70.4 m-20 -81.46 -70.34 0.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 4.4 mmt -72.94 66.35 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.515 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 57' ' ' PRO . 62.0 t -126.64 128.93 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -96.78 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -0.939 . . . . 0.0 110.475 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' MET . 47.4 t30 -82.11 85.99 6.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.989 -1.07 . . . . 0.0 110.23 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.435 ' HB3' ' CA ' ' A' ' 71' ' ' GLY . 40.4 t80 -48.69 169.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.07 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 1.5 tt0 -64.67 -133.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.977 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -36.38 75.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 71' ' ' GLY . . . 62.04 55.52 27.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 0.08 51.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.583 HG23 ' HD2' ' A' ' 70' ' ' PRO . 14.8 t -110.03 -28.69 8.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.5 -61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.08 -1.012 . . . . 0.0 110.825 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 68' ' ' THR . 44.2 Cg_endo -70.57 -175.49 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.904 1.476 . . . . 0.0 110.768 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 85.21 44.34 6.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -98.55 63.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.171 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.183 0.516 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -73.04 132.18 43.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -110.08 160.76 16.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG13 ' HB3' ' A' ' 22' ' ' MET . 67.8 t -89.44 113.72 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 23.4 t -111.68 113.34 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -54.25 118.89 4.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -76.27 -75.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -63.39 144.0 57.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.127 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.5 136.17 57.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 10.2 mt -125.02 131.59 24.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.55 -157.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.782 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.93 -179.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 40.95 27.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.197 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 13' ' ' ILE . 7.7 m -126.68 114.51 18.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.136 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.31 148.56 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 157.67 45.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -102.58 169.83 8.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.72 -10.58 53.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.115 ' N ' HD13 ' A' ' 19' ' ' LEU . 34.4 mm -69.82 -21.73 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.768 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.8 mtp -98.1 10.36 40.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.309 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.545 ' HB3' HG13 ' A' ' 5' ' ' VAL . 3.6 mtp -117.69 138.81 51.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -117.11 167.05 11.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 110.121 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.45 95.21 5.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.922 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 128.35 55.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 3' ' ' ALA . 5.2 t -91.99 58.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.97 160.06 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.503 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.4 t -74.9 149.39 85.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -75.72 169.83 73.44 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.668 -2.222 . . . . 0.0 110.398 -0.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.4 -142.25 19.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.948 ' HB ' HD13 ' A' ' 55' ' ' LEU . 2.9 mt -100.83 134.06 20.72 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.121 -1.223 . . . . 0.0 110.177 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.68 -166.28 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.908 1.478 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -98.82 34.04 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.37 -39.93 62.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.928 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HB2' HD13 ' A' ' 40' ' ' LEU . 63.7 mm-40 -103.45 32.38 3.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.6 mm -53.04 -46.91 97.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.3 Cg_endo -73.88 -1.17 10.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.486 1.256 . . . . 0.0 110.447 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.73 -37.97 4.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.897 . . . . 0.0 110.101 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.3 -41.6 27.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.7 t -44.66 125.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.92 9.09 59.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 64' ' ' GLU . 23.4 ttt -101.35 158.34 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.18 . . . . 0.0 110.245 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 158.38 18.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' MET . 26.8 m -107.09 168.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -110.76 5.78 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.301 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 10.2 mmt85 -138.09 135.53 35.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.74 146.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.367 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.837 HG13 HG21 ' A' ' 53' ' ' THR . 95.2 t -129.97 120.84 19.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.713 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.6 Cg_endo -73.48 -160.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.871 1.458 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -85.32 157.13 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.83 39.47 4.9 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.837 HG21 HG13 ' A' ' 49' ' ' VAL . 95.8 m -85.25 109.17 18.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -1.105 . . . . 0.0 110.399 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.9 m -47.41 149.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.948 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.1 103.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -97.85 133.89 22.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.133 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 46.4 Cg_endo -73.05 -34.88 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.955 1.503 . . . . 0.0 110.66 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 10.6 p-10 -57.18 -17.08 9.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 0.0 110.552 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 6.8 mtt -108.85 25.27 11.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.41 129.22 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.314 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -69.42 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -78.08 83.99 4.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 57' ' ' PRO . 88.8 m-85 -44.26 129.21 6.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 40' ' ' LEU . 2.9 mp0 -92.27 -37.47 12.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 17.5 p-10 -67.33 97.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.66 147.99 12.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 68' ' ' THR . 51.8 m -81.01 -92.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -1.149 . . . . 0.0 110.197 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' THR . 18.3 m -110.16 107.64 17.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.132 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.558 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 172.2 -58.98 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -73.01 -22.41 19.57 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.021 1.537 . . . . 0.0 110.503 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.68 159.79 13.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.07 -6.95 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.165 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.251 0.548 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -63.0 148.31 48.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.2 p -103.8 161.1 14.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.97 101.67 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.38 107.17 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -62.61 116.84 5.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 1.1 t-20 -79.92 -57.51 3.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 110.063 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 1.2 tp-100 -59.93 117.92 5.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.594 ' HB3' HD12 ' A' ' 51' ' ' LEU . 1.7 pt? -62.08 129.21 39.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 HG21 ' A' ' 15' ' ' THR . 4.7 pt -130.06 146.04 59.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 0.0 109.941 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 45.1 Cg_endo -71.78 -94.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.0 110.158 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 45' ' ' VAL . 1.5 mt -152.01 -179.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.038 . . . . 0.0 109.972 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' H ' HG22 ' A' ' 13' ' ' ILE . 11.4 m-80 51.75 21.12 1.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.795 HG21 HD12 ' A' ' 11' ' ' ILE . 8.0 t -99.75 128.65 45.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.44 100.62 4.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.065 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' MET . 3.8 mt -49.0 124.24 8.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.276 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.33 158.01 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tt -49.6 -46.01 48.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.437 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.7 mt -51.4 -47.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -78.67 -25.2 44.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.43 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 20.8 mtm -85.35 110.51 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.34 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.29 151.16 25.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 95.76 7.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.23 123.49 50.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.134 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 3' ' ' ALA . 3.9 t -77.47 98.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.53 139.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.2 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -77.68 151.59 80.02 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.5 Cg_endo -75.52 156.34 99.29 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.433 -0.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -82.56 86.4 6.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -144.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.1 mt -72.56 130.45 85.7 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 109.966 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.54 -179.44 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.984 1.518 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -94.2 2.15 55.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.6 -21.72 7.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HB2' HD13 ' A' ' 40' ' ' LEU . 7.1 mm-40 -104.64 23.5 13.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.418 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -42.27 -53.02 9.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.3 Cg_endo -72.01 -6.0 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.641 1.337 . . . . 0.0 110.757 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLU . 5.7 m-80 -113.84 -20.25 11.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.6 mp -85.85 -43.88 12.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.6 t -44.8 122.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.11 37.19 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.467 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.64 136.95 34.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 110.181 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -106.7 129.27 54.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -84.88 163.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -111.3 5.46 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 27.3 mtt180 -144.03 167.55 22.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -68.54 144.68 54.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.598 HG13 ' CB ' ' A' ' 53' ' ' THR . 30.2 t -126.52 126.07 24.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.24 -176.67 2.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.521 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.91 137.96 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 60.68 51.15 60.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.598 ' CB ' HG13 ' A' ' 49' ' ' VAL . 96.5 m -96.3 129.52 43.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -1.128 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 m -66.54 136.39 55.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.36 105.67 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -109.39 154.59 42.15 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.855 . . . . 0.0 110.1 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.4 1.6 7.21 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.002 1.527 . . . . 0.0 110.56 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -45.57 31.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.428 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.508 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 14.6 mtm -107.58 57.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.351 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 56' ' ' MET . 98.8 t -125.03 84.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 14.7 tptm -52.85 -65.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -99.59 86.39 3.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.882 . . . . 0.0 110.218 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.56 150.34 12.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.472 ' CD ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -73.75 -162.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 44.3 p-10 -73.0 75.11 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.32 127.86 4.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -77.18 55.93 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -1.099 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 171.37 8.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -45.77 -55.69 12.03 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 110.455 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -73.42 88.48 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.925 1.487 . . . . 0.0 110.436 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.79 37.46 1.86 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 73.06 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.244 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.131 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.202 0.525 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.97 111.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.2 t -99.75 164.88 11.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 32' ' ' ILE . 32.2 t -73.05 117.91 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG12 ' HA2' ' A' ' 52' ' ' GLY . 17.0 t -127.34 99.35 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.737 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -59.28 141.34 54.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.945 . . . . 0.0 110.2 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.85 -63.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.21 145.12 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.009 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -59.55 150.0 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 11' ' ' ILE . 17.3 mt -130.13 137.54 31.1 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.04 166.32 30.37 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.498 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.603 HG22 HG23 ' A' ' 45' ' ' VAL . 11.2 pt -81.49 175.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 58.23 16.77 4.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.406 ' C ' ' HG2' ' A' ' 44' ' ' GLN . 1.6 m -125.12 105.94 9.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.32 122.63 14.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.75 155.46 23.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.912 . . . . 0.0 110.392 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 22' ' ' MET . 1.7 m -106.69 169.83 8.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 22' ' ' MET . 1.5 pp -65.0 -33.1 75.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.462 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.54 -20.34 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.173 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.99 -14.99 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.533 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.494 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.69 127.68 51.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.96 . . . . 0.0 110.495 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.4 mttt -121.07 179.37 4.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.985 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.89 99.36 9.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.21 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 tp10 -101.8 145.33 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.0 t -90.4 76.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 155.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.6 t -101.37 150.01 36.83 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.151 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.19 176.29 44.42 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.708 -2.205 . . . . 0.0 110.513 -0.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -73.55 -139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 30' ' ' MET . . . 151.89 -117.01 0.79 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.971 HD12 HD12 ' A' ' 55' ' ' LEU . 2.9 mt -110.56 118.97 47.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 50.1 Cg_endo -75.26 5.08 4.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.852 1.448 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . 71.92 20.69 4.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.457 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.0 -26.51 4.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.006 -1.059 . . . . 0.0 109.729 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 43.3 mm-40 -105.16 60.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.851 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -56.89 -41.48 91.57 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 111.058 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -75.69 -9.74 19.9 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.288 1.152 . . . . 0.0 110.508 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -114.47 -26.88 7.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD12 ' OE1' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.44 -45.6 15.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.329 -0.857 . . . . 0.0 110.398 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 40' ' ' LEU . 20.3 t -42.22 115.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.605 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.93 0.27 25.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.25 136.98 48.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -1.16 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 26.8 mt-30 -110.1 163.9 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 13' ' ' ILE . 7.2 m -120.54 170.29 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 47.7 p-10 -110.81 -8.73 14.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 1.8 mtt180 -126.33 121.21 31.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -48.23 140.44 7.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 53' ' ' THR . 67.2 t -127.46 135.14 26.99 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -73.13 -161.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.79 168.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.15 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.698 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 46.8 80.89 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.794 HG23 HG11 ' A' ' 49' ' ' VAL . 64.0 m -94.31 90.54 6.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.114 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 5.6 m -66.88 133.1 49.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.234 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.971 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.44 88.63 0.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.3 mtm -111.82 164.27 15.54 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.33 10.15 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -54.44 5.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.805 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 36.5 mtt -113.04 69.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.853 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 63' ' ' TYR . 12.8 t -130.31 103.4 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.044 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 46' ' ' ASN . 5.6 mtpt -55.6 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.277 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.88 84.0 4.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 110.352 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 70' ' ' PRO . 2.1 t80 -46.57 144.89 2.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' OE1' HD12 ' A' ' 40' ' ' LEU . 1.9 pt-20 -68.64 -151.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.25 -0.906 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.3 m-20 -59.39 -46.4 88.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.67 146.96 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -87.42 -30.91 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -1.184 . . . . 0.0 110.079 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -93.06 23.46 4.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.15 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.602 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 4.3 t 54.55 44.12 1.64 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 111.001 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -74.26 103.54 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.692 1.364 . . . . 0.0 110.415 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.02 128.47 3.56 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -77.41 -21.46 53.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.48 ' HE3' ' SD ' ' A' ' 30' ' ' MET . 3.2 ptpt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.229 0.538 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.33 36.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -106.28 152.99 22.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 36.8 t -87.44 96.1 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.329 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG12 ' C ' ' A' ' 52' ' ' GLY . 2.9 t -107.04 112.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.037 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.007 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -62.72 136.82 58.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.72 -54.91 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -83.21 146.27 28.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.9 pt? -63.57 145.85 54.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' VAL . 6.6 mt -130.37 136.3 28.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.51 -162.43 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.934 1.491 . . . . 0.0 110.273 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.7 mt -104.3 -173.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.693 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.0 OUTLIER 40.08 28.11 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 110.571 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 13' ' ' ILE . 25.6 m -120.57 121.64 38.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.247 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -57.17 162.66 2.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 110.14 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mt -121.13 144.79 48.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -116.95 169.17 9.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.2 tt -60.66 -50.26 74.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.622 ' N ' HD23 ' A' ' 19' ' ' LEU . 58.0 mt -55.39 -38.74 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -13.89 60.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.41 112.01 20.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.6 mttt -106.0 145.0 31.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -94.0 102.63 14.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 4' ' ' SER . 41.6 tt0 -108.16 133.56 52.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.8 t -85.71 74.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 m -143.41 -173.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.2 t -109.52 150.66 41.49 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.153 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -76.16 168.11 78.21 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.613 -2.244 . . . . 0.0 110.465 -0.272 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.48 ' SD ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -76.95 -112.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.098 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.79 -134.58 10.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.8 mt -99.12 125.69 40.75 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -1.122 . . . . 0.0 110.03 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.29 -170.96 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.931 1.49 . . . . 0.0 110.547 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.17 16.76 17.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -47.76 84.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 mm-40 -89.36 47.78 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.108 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 5.9 tp -69.79 -30.68 2.14 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 111.719 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.4 Cg_endo -80.15 -7.93 14.13 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 122.813 0.901 . . . . 0.0 109.928 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -108.55 -35.14 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -79.63 -44.5 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 110.049 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 29.2 t -48.57 103.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 110.013 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.17 -0.55 19.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.567 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.52 157.09 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 110.053 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB2' ' HG3' ' A' ' 61' ' ' LYS . 41.4 mt-30 -109.54 171.13 7.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.332 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.55 HG13 HD11 ' A' ' 17' ' ' LEU . 11.7 m -116.93 156.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -103.5 5.06 36.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.4 mtt180 -136.39 159.91 40.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 150.59 48.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.13 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.954 ' CG1' HG21 ' A' ' 53' ' ' THR . 21.8 t -129.31 111.66 18.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -164.19 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.886 1.466 . . . . 0.0 110.432 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 3.2 mp -79.38 163.58 24.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.066 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.21 28.97 0.91 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.007 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -65.14 124.52 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.391 -1.064 . . . . 0.0 110.417 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 140.52 40.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.66 101.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.106 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtt -111.55 153.81 44.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.989 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.4 -0.26 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.958 1.504 . . . . 0.0 110.493 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.31 -46.82 21.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 110.319 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 1.4 mpt? -97.92 50.0 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG13 ' CE ' ' A' ' 43' ' ' MET . 39.4 t -121.4 103.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.905 . . . . 0.0 110.17 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -50.27 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 17.1 p-10 -95.57 92.25 6.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.945 . . . . 0.0 110.246 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -44.69 135.73 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.278 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 77.8 mm-40 -88.12 -75.5 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.68 76.84 2.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.82 52.9 0.63 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 p -90.01 25.56 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -1.138 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 p -101.95 -11.76 18.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.561 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -178.64 -59.76 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.11 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.3 Cg_endo -72.74 -90.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.0 -79.86 1.13 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.59 86.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -1.091 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.214 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.54 141.72 28.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -121.29 153.79 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG11 ' SD ' ' A' ' 22' ' ' MET . 25.3 t -87.44 127.49 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.272 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 54' ' ' THR . 11.9 t -130.09 121.63 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.89 142.15 6.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 10.1 t-20 -89.09 -59.33 2.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -97.07 148.26 23.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.702 HD23 ' C ' ' A' ' 10' ' ' LEU . 7.7 tt -64.75 131.84 47.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 10' ' ' LEU . 7.6 pt -130.18 130.28 23.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 0.0 110.644 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.3 Cg_endo -74.86 71.03 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.941 1.495 . . . . 0.0 109.841 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 32.4 pt 39.39 -164.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.732 -0.605 . . . . 0.0 110.692 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER 65.56 -62.31 0.23 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -58.36 106.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.349 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.78 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.179 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -106.75 129.4 54.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.28 -0.887 . . . . 0.0 110.095 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -125.75 156.12 39.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 110.349 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -46.25 -62.49 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mt -59.82 -13.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.462 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -91.53 -47.38 7.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.435 ' SD ' HG11 ' A' ' 5' ' ' VAL . 17.5 ptt? -104.84 148.26 26.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -120.17 160.76 22.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.86 103.2 14.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.25 137.58 50.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 52.2 t -96.42 80.41 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.258 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 28' ' ' THR . 14.0 p -174.2 168.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.511 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -82.9 151.75 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -75.89 133.13 29.93 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.602 -0.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.403 ' C ' ' HG1' ' A' ' 54' ' ' THR . 19.5 mtp -82.46 175.29 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.88 -132.77 1.4 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -90.23 136.85 28.17 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.213 -1.169 . . . . 0.0 109.924 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.56 -170.79 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.003 1.528 . . . . 0.0 110.676 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.75 31.73 5.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.275 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -48.04 82.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.016 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 74.3 mm-40 -100.0 65.65 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 8.7 tp -70.62 -29.87 1.65 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 111.929 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.0 Cg_endo -78.01 -7.19 16.26 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.704 0.844 . . . . 0.0 109.944 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.27 -19.6 11.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -88.34 -40.96 13.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.161 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 37' ' ' ILE . 90.8 t -46.53 105.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.54 10.0 8.91 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.21 121.48 23.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.46 148.47 22.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.1 m -117.98 155.87 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.11 5.05 19.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 66.4 mtt-85 -120.99 127.0 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.233 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.78 133.44 8.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 110.496 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.958 HG13 HG21 ' A' ' 53' ' ' THR . 24.8 t -117.9 121.54 31.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -72.6 -174.93 1.62 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.96 1.505 . . . . 0.0 110.513 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.89 156.16 39.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.556 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.83 44.77 18.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.958 HG21 HG13 ' A' ' 49' ' ' VAL . 4.9 m -93.47 114.64 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.147 . . . . 0.0 110.126 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.589 ' N ' HG13 ' A' ' 6' ' ' VAL . 2.4 t -57.79 144.15 39.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -64.11 108.85 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.515 ' CG ' ' HD2' ' A' ' 57' ' ' PRO . 20.7 ttm -103.18 145.62 30.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.515 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 47.0 Cg_endo -74.13 -0.5 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.075 1.566 . . . . 0.0 110.613 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -41.35 13.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.16 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 8.9 mtm -90.9 45.38 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 56' ' ' MET . 3.0 t -129.96 126.03 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.107 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -74.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -100.05 104.25 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -47.22 176.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.331 -0.855 . . . . 0.0 110.334 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -144.51 0.05 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.101 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 8.1 p-10 -75.18 80.37 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.75 97.48 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -101.65 39.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -1.111 . . . . 0.0 110.406 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -72.76 -11.83 60.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.955 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -177.31 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 48.3 Cg_endo -73.61 98.12 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.715 1.376 . . . . 0.0 110.399 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.43 -31.25 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -65.54 96.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -1.181 . . . . 0.0 110.287 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.127 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.72 128.68 35.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' MET . 3.7 p -116.12 145.48 43.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.151 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 39.2 t -86.48 135.24 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.46 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -129.47 124.37 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -57.46 115.52 2.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.85 -51.88 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 110.19 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -84.32 142.7 30.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.173 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -74.11 127.94 34.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.2 pt -130.49 119.91 18.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.53 64.66 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.881 1.464 . . . . 0.0 110.544 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.4 pt 39.32 -164.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' ILE . 71.6 m-20 40.8 32.29 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.885 . . . . 0.0 110.456 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 m -145.53 107.2 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.144 -0.973 . . . . 0.0 110.339 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' CA ' ' HG2' ' A' ' 44' ' ' GLN . . . -59.59 163.84 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.06 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.883 HD13 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -141.12 157.71 44.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -119.42 -157.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.845 . . . . 0.0 110.188 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.1 mp -69.27 -62.28 1.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -47.52 -23.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.348 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -72.34 -57.32 4.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.091 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.883 ' HG3' HD13 ' A' ' 17' ' ' LEU . 1.4 mtt -107.88 141.11 39.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.22 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.08 108.35 19.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.338 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.04 145.1 41.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 80.3 t -86.86 97.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -168.04 154.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.211 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -77.78 159.15 77.09 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.44 -163.68 3.31 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.72 -2.2 . . . . 0.0 110.547 -0.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 4' ' ' SER . 9.3 mtt -81.82 -73.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.31 -144.1 33.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -103.56 130.76 22.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 110.142 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 -172.3 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.327 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.025 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -97.7 32.33 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -76.83 -28.81 55.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.92 40.78 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.025 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.66 -51.91 77.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.6 Cg_endo -73.43 -1.81 11.21 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.741 1.39 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 89.8 m-20 -114.26 -42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.227 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' MET . 66.7 tp -73.42 -42.07 62.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.4 t -46.8 116.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.35 10.89 50.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 ttt -104.64 147.73 27.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.535 ' HG2' ' CA ' ' A' ' 16' ' ' ALA . 44.1 mt-30 -110.06 164.53 12.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.281 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 8.4 m -115.66 164.33 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.98 -1.45 16.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 14.5 mtt180 -118.22 131.58 56.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.12 127.28 8.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.56 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 53' ' ' THR . 22.4 t -116.15 108.75 45.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -73.37 -176.09 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.987 1.519 . . . . 0.0 110.466 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.05 134.34 48.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 70.42 46.28 49.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.739 ' CB ' HG13 ' A' ' 49' ' ' VAL . 67.1 m -96.63 113.82 25.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -1.153 . . . . 0.0 110.386 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 53.1 m -54.52 142.51 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.304 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.11 100.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.44 ' HB2' ' HG3' ' A' ' 59' ' ' MET . 2.9 mmt -98.47 139.08 20.91 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 -2.26 11.84 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.059 1.557 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.35 -37.79 14.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.519 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -73.05 -14.2 61.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 25.4 t -85.35 118.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.32 -74.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' CE ' ' A' ' 43' ' ' MET . 71.6 m-20 -100.58 93.48 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE1' ' OG1' ' A' ' 67' ' ' THR . 9.4 t80 -46.65 165.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 23.6 mm-40 -89.8 -171.37 3.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 63.75 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.143 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.04 -71.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 63' ' ' TYR . 2.2 m -79.76 108.82 13.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 68' ' ' THR . 5.3 t -72.1 69.2 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.576 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -171.68 -62.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.383 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.51 65.08 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.833 1.438 . . . . 0.0 110.432 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.09 97.41 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.74 -55.31 3.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 110.159 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.154 179.96 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.267 0.556 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.73 154.11 22.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 7.3 p -121.41 168.29 11.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.8 t -88.38 117.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 0.0 110.279 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.64 123.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -52.61 118.99 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -74.54 -68.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -89.27 147.0 24.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' N ' HD23 ' A' ' 10' ' ' LEU . 1.8 pt? -67.74 134.19 50.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.291 -0.881 . . . . 0.0 110.512 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.479 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.0 pt -120.38 156.12 55.66 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.339 -0.851 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.59 -158.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.07 1.563 . . . . 0.0 109.991 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.5 mt -103.25 166.73 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.878 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER 58.99 25.84 14.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.359 179.953 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -102.93 124.26 48.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -63.12 157.36 22.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.645 HD12 ' CB ' ' A' ' 43' ' ' MET . 2.5 mt -93.81 131.65 38.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' SD ' ' A' ' 22' ' ' MET . 1.1 p -116.8 172.92 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.163 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.45 -55.57 15.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' MET . 5.8 pt -48.32 -24.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 4.6 mtt -97.55 3.9 50.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -117.34 96.47 5.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -112.8 127.05 56.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -80.05 99.3 7.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.211 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.19 139.44 46.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.892 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -79.64 93.69 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.1 146.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.504 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.9 t -87.86 149.43 45.78 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.233 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.89 176.14 45.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.691 -2.212 . . . . 0.0 110.503 -0.135 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' SER . 3.2 mtp -75.87 -57.86 3.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.318 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.75 -145.67 35.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 55' ' ' LEU . 2.3 mt -88.3 124.86 65.5 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -1.208 . . . . 0.0 109.928 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.83 -163.48 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.465 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -103.15 25.48 9.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -38.99 69.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' OE2' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.76 38.77 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.877 ' O ' HG23 ' A' ' 41' ' ' VAL . 8.6 mm -65.98 -45.24 63.52 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.6 Cg_endo -75.38 0.75 8.69 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.513 1.27 . . . . 0.0 110.456 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 3.6 t-20 -111.18 -33.95 6.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -83.13 -29.6 28.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.9 t -43.1 116.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 110.73 7.54 25.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.645 ' CB ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -94.55 132.64 39.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 110.298 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -93.73 150.08 20.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 9.6 m -87.72 174.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -102.93 -25.49 13.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.576 -179.67 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 7.6 ptm180 -135.05 179.88 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.209 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -70.47 149.9 46.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.631 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 53' ' ' THR . 19.5 t -127.92 124.79 23.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.874 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.48 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.961 1.506 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 1.1 mp -90.61 166.43 13.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.42 33.1 2.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.793 HG21 HG13 ' A' ' 49' ' ' VAL . 92.3 m -78.13 98.44 5.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -1.175 . . . . 0.0 110.075 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.0 m -44.84 148.33 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.84 88.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.163 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 156.04 43.68 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.059 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.48 ' CB ' ' HB3' ' A' ' 70' ' ' PRO . 45.3 Cg_endo -72.34 -0.54 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.925 1.487 . . . . 0.0 110.598 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -52.01 65.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.75 ' SD ' HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -109.99 33.07 4.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 63' ' ' TYR . 12.4 t -128.59 109.47 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.541 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 11.1 ptmt -65.8 -149.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 109.835 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 62.6 t30 -64.88 84.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 109.92 179.665 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 60' ' ' VAL . 36.5 p90 -83.45 -159.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 55.8 mm-40 -63.44 -124.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 8.3 p-10 -58.61 94.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 110.63 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 63' ' ' TYR . . . -149.14 54.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -107.93 -12.92 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -1.133 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' A' ' 69' ' ' SER . 6.0 t -70.74 -6.01 34.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.589 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER 174.57 -62.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -72.37 -158.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 110.137 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 62' ' ' ASN . . . 86.32 -83.94 1.59 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.6 mm? -65.93 143.52 57.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 tttp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.261 -179.904 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.233 0.54 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.32 115.21 7.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.8 t -102.66 141.46 35.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' HB ' HD21 ' A' ' 55' ' ' LEU . 23.5 t -73.25 105.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.726 HG12 ' HA2' ' A' ' 52' ' ' GLY . 18.0 t -123.62 117.7 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.211 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -71.87 144.56 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.091 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 17.7 t-20 -83.49 -52.81 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 110.503 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.49 142.5 32.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 110.358 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.747 HD23 ' C ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -60.38 138.57 57.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.091 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HB1' ' A' ' 7' ' ' ALA . 4.0 mt -129.33 133.76 25.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.16 -179.13 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.971 1.511 . . . . 0.0 110.395 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.861 HG22 HG23 ' A' ' 45' ' ' VAL . 2.6 pt -93.67 -174.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.63 16.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -130.58 118.33 20.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.069 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.9 160.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 11' ' ' ILE . 6.2 mt -118.7 145.26 45.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -119.89 -166.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 110.281 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 19' ' ' LEU . 27.9 mt -76.61 -52.32 9.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mt -50.37 -21.76 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.163 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.65 -44.83 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -108.22 120.13 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.266 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -111.11 165.88 11.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 98.42 8.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.01 160.1 17.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.11 50.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 t -117.22 166.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 48.2 p -81.99 159.75 64.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -74.83 -167.49 5.65 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.536 -0.143 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' SER . 51.6 mtp -81.64 -46.47 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.474 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.73 -156.35 0.43 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.02 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.6 mt -90.5 142.22 27.94 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.22 -1.164 . . . . 0.0 110.409 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 47.4 Cg_endo -73.56 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.086 1.571 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -107.4 42.63 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.174 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.61 -42.43 51.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -103.26 36.91 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -53.04 -54.08 48.22 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.469 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.1 Cg_endo -70.9 -5.88 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.702 1.369 . . . . 0.0 110.709 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -114.13 -19.05 11.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.955 . . . . 0.0 110.355 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.4 tp -88.14 -29.54 20.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 47.3 t -46.1 116.32 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 109.31 10.59 23.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.29 135.45 33.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 1.5 mt-30 -106.38 138.69 42.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 110.285 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 13' ' ' ILE . 18.3 m -99.49 170.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.358 -0.839 . . . . 0.0 110.114 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.631 ' C ' HG21 ' A' ' 13' ' ' ILE . 25.9 t30 -110.67 -4.85 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' N ' HG21 ' A' ' 13' ' ' ILE . 6.0 mtt180 -129.05 126.43 39.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.43 143.19 56.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.325 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 53' ' ' THR . 80.9 t -129.97 135.7 27.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -70.09 -173.78 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.961 1.506 . . . . 0.0 110.427 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -43.05 164.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.955 179.994 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.726 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 51.82 61.31 6.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.963 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 53.5 m -84.39 87.72 7.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -1.093 . . . . 0.0 110.628 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.5 m -71.83 121.17 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.634 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -61.37 114.43 3.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.83 -179.276 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.657 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.8 mtm -113.67 156.72 43.18 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.0 1.02 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.97 1.511 . . . . 0.0 110.669 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' MET . 33.7 p30 -91.88 -21.88 20.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.018 . . . . 0.0 110.74 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 44.8 mtt -112.0 -7.75 14.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 56' ' ' MET . 10.8 t -101.14 91.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.082 -1.011 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -48.85 39.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -95.04 74.37 3.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.043 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 1.02 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -54.12 -165.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.87 . . . . 0.0 110.549 -179.793 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -104.99 -172.39 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.09 66.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.356 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -114.87 114.44 3.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 m -88.56 59.44 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -1.14 . . . . 0.0 110.062 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -106.71 -40.28 5.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.15 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 171.9 -59.25 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.129 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -72.93 55.6 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.974 1.513 . . . . 0.0 110.461 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.77 57.8 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -45.56 10.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -1.148 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.196 0.522 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.56 138.59 39.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -121.98 162.72 20.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.466 HG12 HD23 ' A' ' 55' ' ' LEU . 53.0 t -72.97 102.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.496 HG21 HG12 ' A' ' 27' ' ' VAL . 14.3 t -113.7 103.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -46.67 121.67 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 m120 -72.96 -64.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.877 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.416 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tp60 -81.58 149.13 28.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 110.227 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -59.54 133.62 56.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.956 179.863 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.803 HD12 ' SD ' ' A' ' 21' ' ' MET . 13.1 mm -121.75 136.08 25.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.73 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.058 1.557 . . . . 0.0 110.191 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.035 HG22 HG23 ' A' ' 45' ' ' VAL . 4.2 pt -120.1 -174.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -0.994 . . . . 0.0 110.485 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m120 56.53 16.54 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.06 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 19.1 m -123.05 154.33 38.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.958 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -77.03 163.77 26.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.405 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -111.63 122.62 48.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 179.93 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.1 170.96 7.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -67.24 -54.7 18.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.324 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.952 ' O ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -51.27 -21.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.803 ' SD ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -80.97 -48.38 12.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 9.4 ptt? -110.98 141.09 44.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -0.961 . . . . 0.0 110.191 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 21.0 mmtt -120.92 172.63 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.91 92.74 7.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.248 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.74 141.37 32.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -84.29 76.92 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 HG21 ' A' ' 6' ' ' VAL . 10.1 p -133.71 150.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.128 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -111.39 161.01 27.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.74 153.29 99.09 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.704 -2.207 . . . . 0.0 110.479 -0.207 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.5 ptt? -80.48 125.87 30.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.48 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -90.54 -100.71 1.17 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -109.06 131.67 21.66 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 110.137 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.21 177.84 6.75 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.698 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . -92.56 24.15 3.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.92 -77.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 pm0 -78.18 55.19 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.057 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.904 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -70.73 -30.5 1.79 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.376 -0.827 . . . . 0.0 111.764 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.904 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.5 Cg_endo -78.73 -4.46 14.07 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 122.686 0.835 . . . . 0.0 110.047 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 1.8 m120 -112.52 -37.95 4.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.99 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -76.25 -44.39 37.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.1 t -45.71 109.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 122.76 6.75 7.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.543 ' CE ' ' HG3' ' A' ' 64' ' ' GLU . 1.6 ttt -91.69 157.54 16.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.168 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' THR . 42.5 mt-30 -110.14 136.26 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.035 HG23 HG22 ' A' ' 13' ' ' ILE . 15.9 m -88.64 171.63 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.53 -15.85 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.0 111.255 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.6 ptm85 -128.16 150.73 49.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.88 -1.137 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.53 156.44 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 110.752 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.998 HG13 HG21 ' A' ' 53' ' ' THR . 91.6 t -130.17 127.55 22.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.57 -168.96 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.832 1.438 . . . . 0.0 110.509 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -80.17 155.95 27.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.188 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.66 43.94 6.64 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.998 HG21 HG13 ' A' ' 49' ' ' VAL . 84.9 m -86.33 128.28 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -69.39 141.23 54.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.78 110.4 2.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.481 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -109.42 159.93 29.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 46.2 Cg_endo -73.97 0.12 8.76 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.089 1.573 . . . . 0.0 110.648 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD1' ' CG ' ' A' ' 59' ' ' MET . 1.3 p30 -91.7 -26.2 18.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.653 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.818 ' O ' HG12 ' A' ' 45' ' ' VAL . 3.4 mtt -97.2 32.31 2.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 110.077 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.47 125.97 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.552 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -75.39 -80.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 109.84 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 8.0 p30 -100.74 101.44 12.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -45.78 167.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.799 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 40' ' ' LEU . 2.1 mp0 -83.05 -68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.94 -30.47 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.46 51.99 23.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 68' ' ' THR . 38.6 m -72.23 -89.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.087 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -94.17 5.46 51.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 179.766 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -111.27 -178.44 0.54 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 44.7 Cg_endo -72.86 117.4 5.11 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.917 1.482 . . . . 0.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.6 48.78 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' LEU . 2.1 tp -89.84 130.4 36.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.956 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 25' ' ' GLU . . . -76.9 150.77 35.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 40.4 t -116.53 164.56 14.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.3 t -92.54 102.36 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.347 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.4 t -123.71 121.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -70.21 138.85 52.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.115 -0.99 . . . . 0.0 109.998 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -72.45 -52.49 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 20.7 tt0 -82.2 162.71 22.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.75 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -67.63 142.97 56.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.466 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' CB ' ' A' ' 7' ' ' ALA . 14.7 mt -131.25 127.34 21.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.219 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.69 -159.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.79 1.416 . . . . 0.0 110.037 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 45' ' ' VAL . 36.1 pt -112.44 -165.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.115 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.578 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 39.9 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 110.412 -179.787 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 47.7 m -130.38 136.6 49.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.55 130.62 34.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -103.34 161.48 13.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -130.07 -175.6 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.629 HD21 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -51.88 -34.28 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -50.06 -60.01 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.76 30.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.317 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.96 115.32 21.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.297 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.81 124.81 45.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.917 . . . . 0.0 110.215 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.96 97.22 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 26.6 pt-20 -113.13 157.86 21.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 23.0 t -98.51 57.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -126.06 154.65 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 62.7 p -79.14 158.95 73.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.48 176.67 42.57 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.722 -2.199 . . . . 0.0 110.5 -0.167 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.3 mtt -77.13 -107.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.209 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.72 -129.37 9.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.04 132.45 22.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.83 -158.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.962 1.506 . . . . 0.0 110.304 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.09 30.92 7.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.433 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -77.41 -15.92 59.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.033 -1.042 . . . . 0.0 109.605 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.927 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.3 mp0 -105.02 24.66 11.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.574 -0.704 . . . . 0.0 109.966 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.4 mm -41.7 -53.5 7.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.701 -179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -71.24 -4.65 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.564 1.297 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.32 -36.23 4.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' HB2' ' A' ' 36' ' ' GLU . 2.7 mp -79.8 -42.47 24.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.259 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.7 t -42.18 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.367 -0.833 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.67 -6.5 13.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.51 148.96 30.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -1.202 . . . . 0.0 110.207 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' THR . 31.5 mt-30 -109.36 172.25 6.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 13' ' ' ILE . 4.8 m -119.53 172.54 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.471 ' O ' HG21 ' A' ' 13' ' ' ILE . 4.8 t-20 -111.16 -12.81 14.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' CD ' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -123.88 140.61 52.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.34 144.34 27.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 110.083 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.894 HG11 ' HA ' ' A' ' 53' ' ' THR . 34.1 t -130.41 130.23 22.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.1 Cg_endo -77.01 99.77 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.174 1.618 . . . . 0.0 110.331 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 58.4 136.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 110.597 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.33 75.79 0.34 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.894 ' HA ' HG11 ' A' ' 49' ' ' VAL . 23.4 p -96.63 96.37 8.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.428 HG21 ' HG2' ' A' ' 29' ' ' PRO . 9.1 m -63.47 136.43 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.273 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.957 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -79.52 103.96 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 110.123 179.973 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.0 ptp -109.48 143.58 28.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.031 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 47.4 Cg_endo -74.25 0.29 8.68 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.035 1.545 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' HB3' ' SD ' ' A' ' 56' ' ' MET . 50.4 t0 -83.09 -47.2 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.43 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG3' ' CD ' ' A' ' 47' ' ' ARG . 25.7 mmt -99.58 47.52 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.341 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 56' ' ' MET . 36.1 t -126.51 91.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.091 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 62' ' ' ASN . 28.9 pttt -71.42 -32.18 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 61' ' ' LYS . 61.1 t30 -96.29 52.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -44.59 152.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.48 -125.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 66' ' ' GLY . 44.4 m-20 -59.34 -43.67 92.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.139 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 46.22 96.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -96.4 -7.35 35.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -96.59 -161.56 0.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -41.11 -55.94 4.56 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 179.97 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -73.88 153.5 47.76 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.963 1.507 . . . . 0.0 110.437 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.449 ' HA2' ' HA3' ' A' ' 66' ' ' GLY . . . 176.24 -57.05 0.11 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -154.06 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -1.126 . . . . 0.0 110.174 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.201 0.524 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.433 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -87.79 113.59 23.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.895 . . . . 0.0 110.215 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -88.52 129.76 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 5.0 t -78.13 125.69 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.273 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 54' ' ' THR . 15.2 t -118.39 118.68 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.96 . . . . 0.0 110.281 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -44.97 117.58 1.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.5 t30 -73.58 -52.76 12.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 tp60 -95.2 148.03 22.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.2 tt -59.62 119.77 8.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 9' ' ' GLN . 1.0 OUTLIER -129.74 134.33 26.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.2 Cg_endo -72.96 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.963 1.507 . . . . 0.0 110.124 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 14' ' ' ASN . 3.1 mt -146.9 -171.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.212 -0.93 . . . . 0.0 109.99 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.667 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.6 p-10 36.26 48.83 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.63 . . . . 0.0 110.999 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -123.93 103.34 8.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 110.154 179.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -65.53 144.44 57.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mp -98.64 140.48 32.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.3 p -129.34 84.5 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.637 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' MET . 7.7 tp 52.15 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.332 -0.855 . . . . 0.0 110.808 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' THR . 3.3 mt -41.41 -53.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.634 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 mtt -65.58 -13.09 58.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.26 119.87 39.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.26 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 19.9 mmtm -118.86 90.83 3.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.96 95.04 2.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.433 HG22 ' CA ' ' A' ' 3' ' ' ALA . 28.9 t -78.69 71.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 28' ' ' THR . 63.6 t -142.07 161.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -75.29 151.89 85.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -77.19 -174.93 15.72 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.558 -2.268 . . . . 0.0 110.455 -0.229 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.2 mpt? -76.63 -109.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.919 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 97.52 -145.29 17.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 HD12 ' A' ' 55' ' ' LEU . 23.3 mm -74.52 112.3 16.75 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.344 -1.092 . . . . 0.0 110.398 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.714 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.7 Cg_endo -75.14 -1.86 11.8 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.928 1.488 . . . . 0.0 110.303 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 33' ' ' PRO . . . 69.49 24.64 5.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.82 -44.93 63.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 61.0 mm-40 -99.4 67.43 1.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.89 HG22 ' HD3' ' A' ' 38' ' ' PRO . 1.9 tp -70.08 -30.97 2.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 112.137 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HD3' HG22 ' A' ' 37' ' ' ILE . 45.2 Cg_endo -74.59 -8.25 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 N-CA-C 109.93 -0.835 . . . . 0.0 109.93 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -114.18 -31.1 6.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.368 -0.833 . . . . 0.0 109.529 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.1 tp -69.82 -36.99 76.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 110.059 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 37' ' ' ILE . 22.7 t -43.53 103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.6 24.52 7.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.649 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.4 ttm -95.92 138.97 32.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -1.093 . . . . 0.0 110.241 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 50.2 mt-30 -106.72 151.45 25.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.7 m -95.91 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.06 16.71 20.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.628 ' N ' HG23 ' A' ' 13' ' ' ILE . 20.8 mtt180 -144.1 161.96 37.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.38 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -72.52 134.95 45.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 21.3 t -128.65 128.25 23.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.63 -158.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.825 1.434 . . . . 0.0 110.445 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -87.37 155.31 20.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 110.822 -179.438 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.502 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 41.57 40.67 2.94 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.2 m -96.97 125.2 41.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.556 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 m -63.47 108.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -70.38 122.93 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 110.514 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.442 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 7.6 mtt -100.48 171.23 5.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 109.923 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 45.4 Cg_endo -73.04 -0.65 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.905 1.476 . . . . 0.0 110.55 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.93 -43.65 52.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.323 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' HB2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -92.13 60.7 3.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.259 -179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 63' ' ' TYR . 25.4 t -130.16 95.57 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -94.49 82.51 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.835 ' CD2' HG11 ' A' ' 60' ' ' VAL . 7.8 t80 -62.31 139.34 58.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.75 -56.64 4.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -96.05 83.17 3.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 70' ' ' PRO . . . -109.4 91.66 0.66 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -107.6 -38.75 5.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -1.142 . . . . 0.0 110.303 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 81.9 p -93.24 -137.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.79 -58.53 3.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.549 -179.798 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -71.07 118.49 5.72 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.907 1.477 . . . . 0.0 110.563 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.3 13.48 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -178.4 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.311 0.577 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.18 125.8 25.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.931 . . . . 0.0 110.356 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 p -121.76 149.78 42.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.82 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 56.0 t -83.13 113.0 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 54' ' ' THR . 5.1 t -121.09 104.59 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.065 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.54 131.53 3.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.412 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -88.75 -63.49 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -73.16 141.72 47.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.067 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -59.35 131.11 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mt -122.96 140.1 32.74 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.56 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.087 1.572 . . . . 0.0 110.366 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.3 mt -110.63 -175.77 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.7 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.3 p-10 39.35 29.98 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.613 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 13' ' ' ILE . 52.4 m -122.02 133.34 54.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.11 151.93 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.233 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 43' ' ' MET . 1.4 pp -119.96 157.05 29.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.56 159.06 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -50.06 -43.34 51.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.533 ' N ' HD23 ' A' ' 19' ' ' LEU . 17.8 mt -53.97 -29.98 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 mtt -85.77 -21.28 28.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.504 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.94 106.66 17.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.442 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -106.17 118.13 35.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.55 109.92 14.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.143 -0.973 . . . . 0.0 110.306 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.18 152.16 25.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.4 t -90.69 63.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 26' ' ' VAL . 11.5 m -147.75 -178.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -94.84 162.15 26.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.61 165.41 85.73 Favored 'Cis proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.404 -0.195 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -61.66 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 -149.28 28.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.719 HD13 ' OH ' ' A' ' 63' ' ' TYR . 4.9 mt -104.28 136.74 19.14 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.04 -159.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.999 1.526 . . . . 0.0 110.377 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -116.53 46.61 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.444 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 6.2 pt-20 -74.27 -27.04 60.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.11 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 6.9 mm-40 -104.55 36.18 2.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.679 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.9 mm -54.79 -51.1 81.93 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 110.8 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -71.02 -5.1 16.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.389 1.205 . . . . 0.0 110.715 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 63.1 m-80 -114.2 -50.18 2.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.367 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -68.27 -35.21 77.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 17.2 t -53.74 122.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.96 -14.91 31.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.594 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -85.0 159.78 20.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.146 . . . . 0.0 110.161 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -105.42 178.3 4.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.5 m -116.78 173.01 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 59' ' ' MET . 59.2 t30 -111.06 -9.04 14.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -130.56 172.06 12.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -0.923 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -76.09 151.55 37.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 53' ' ' THR . 37.3 t -127.95 108.0 20.13 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.801 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.9 Cg_endo -71.61 -165.26 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.032 1.543 . . . . 0.0 110.461 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.6 150.08 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.404 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.12 49.19 24.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.48 ' CB ' HG13 ' A' ' 49' ' ' VAL . 16.7 m -91.69 120.09 32.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.473 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.7 t -61.13 149.38 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -68.38 105.73 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtm -110.34 139.35 21.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 110.277 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 46.5 Cg_endo -73.9 -4.11 14.88 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.989 1.521 . . . . 0.0 110.631 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.91 -20.85 48.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' ASN . 3.8 mtt -105.23 12.37 31.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.232 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . 21.3 t -106.44 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 46' ' ' ASN . 73.0 mttt -43.9 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.091 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 63' ' ' TYR . 4.1 m120 -100.78 104.43 15.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.088 -1.007 . . . . 0.0 110.085 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.719 ' OH ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -44.33 165.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.956 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 2.4 mm-40 -64.36 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.116 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -48.75 79.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.82 -22.64 16.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 30.2 2.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 110.183 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' SER . 20.7 m -100.73 -60.0 1.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER 173.27 -59.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.203 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.17 90.99 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.887 1.467 . . . . 0.0 110.373 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.44 120.32 0.76 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -28.13 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -1.164 . . . . 0.0 110.319 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.219 0.533 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.35 143.1 24.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -119.38 125.89 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.971 ' O ' HD23 ' A' ' 55' ' ' LEU . 53.8 t -65.97 124.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.295 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' C ' ' A' ' 53' ' ' THR . 25.6 t -116.99 123.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -46.57 134.89 9.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.258 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.42 ' CG ' ' HE2' ' A' ' 23' ' ' LYS . 57.3 t30 -90.37 -69.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.4 144.54 30.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -62.92 135.82 57.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.063 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.535 HG22 HG21 ' A' ' 15' ' ' THR . 1.4 pt -124.9 119.72 25.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' ILE . 45.4 Cg_endo -72.09 57.79 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.847 1.446 . . . . 0.0 110.251 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.8 mt 49.64 179.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.705 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' H ' HG22 ' A' ' 13' ' ' ILE . 5.0 m120 43.76 26.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 110.241 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.535 HG21 HG22 ' A' ' 11' ' ' ILE . 17.8 m -119.92 103.05 9.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.862 . . . . 0.0 110.1 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . . . -57.86 152.89 15.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 110.405 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.849 HD11 HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -112.93 156.35 23.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.835 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.646 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -128.76 -169.83 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 7.7 mp -64.55 -46.83 81.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.14 -20.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.05 3.61 54.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.938 ' SD ' HG11 ' A' ' 5' ' ' VAL . 1.7 mmm -112.47 106.18 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' CG ' ' A' ' 8' ' ' ASN . 6.9 mtmt -105.98 115.33 30.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.03 98.07 4.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.9 142.05 46.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 26' ' ' VAL . 56.0 t -88.0 85.84 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 110.18 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.52 153.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.4 p -91.69 157.6 41.52 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.89 -172.7 11.34 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.486 -0.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 ptp -82.4 -151.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.334 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 154.69 -127.46 2.1 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 20.1 mm -91.12 108.86 31.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.279 -1.13 . . . . 0.0 110.277 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 31' ' ' GLY . 50.2 Cg_endo -76.5 50.41 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.936 1.492 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 45.67 24.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.33 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.676 ' OE1' HG21 ' A' ' 67' ' ' THR . 36.1 tt0 -77.01 -33.81 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.88 39.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.906 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 2.4 mm -54.75 -57.2 20.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.77 -1.78 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.652 1.343 . . . . 0.0 110.744 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.94 -51.21 2.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.396 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.22 -39.79 78.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 18' ' ' THR . 58.4 t -52.6 103.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.223 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -35.1 2.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.51 159.58 18.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -1.123 . . . . 0.0 110.286 -179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.551 ' HG3' ' CA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -110.26 -169.28 1.44 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.821 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 13' ' ' ILE . 3.7 m -120.19 172.24 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.19 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 2.8 m120 -111.18 0.47 16.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.411 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -123.31 142.54 50.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -62.2 129.14 39.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 HG21 ' A' ' 53' ' ' THR . 54.6 t -121.12 123.67 27.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.606 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.05 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.849 1.447 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -86.5 144.09 27.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 61.31 39.92 97.89 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.859 HG21 HG13 ' A' ' 49' ' ' VAL . 79.5 m -88.75 145.73 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -1.174 . . . . 0.0 110.106 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.3 m -72.45 143.97 48.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.7 mm? -69.93 80.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.419 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -94.06 143.82 27.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.915 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.19 -1.42 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.96 1.505 . . . . 0.0 110.377 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 18.7 p-10 -70.44 -12.01 61.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.28 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -108.75 -25.06 11.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.83 105.56 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.181 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -63.11 1.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.196 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' TYR . 52.7 m-20 -95.04 86.41 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.37 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -44.46 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 0.0 110.168 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 43' ' ' MET . 33.4 mm-40 -79.93 -97.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.56 -32.14 18.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 0.0 110.223 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' CA ' ' HA3' ' A' ' 71' ' ' GLY . . . 102.85 105.02 2.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.676 HG21 ' OE1' ' A' ' 35' ' ' GLU . 1.7 m -107.69 -54.76 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -1.133 . . . . 0.0 110.436 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.432 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 60.8 p -101.98 -157.18 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -44.63 -57.27 6.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -71.49 79.93 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.999 1.526 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA3' ' CA ' ' A' ' 66' ' ' GLY . . . -173.67 47.88 0.15 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -94.24 -40.9 9.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.31 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.197 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 mttp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.212 0.529 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.7 138.05 31.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -120.42 146.91 45.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.237 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 45.0 t -77.39 111.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.38 124.5 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -69.5 119.89 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.838 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.9 p30 -74.97 -43.57 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -96.56 135.64 38.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.182 179.887 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.827 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.98 153.82 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.674 -179.728 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.772 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -130.45 126.8 22.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.995 . . . . 0.0 110.07 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.6 Cg_endo -76.85 47.97 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.831 1.437 . . . . 0.0 110.82 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.578 HD11 ' H ' ' A' ' 48' ' ' ALA . 2.2 mt 51.72 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 44.98 31.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -126.32 105.17 8.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.95 138.85 42.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.212 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -92.26 139.49 30.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.8 OUTLIER -108.16 167.92 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 19' ' ' LEU . 6.1 tt -58.84 -42.78 90.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.947 . . . . 0.0 110.266 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 21' ' ' MET . 18.1 pt -67.03 -41.37 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.911 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.515 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.774 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.495 ' CG ' ' O ' ' A' ' 22' ' ' MET . 6.0 ptt? -115.38 123.8 49.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -121.15 159.94 24.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.0 101.78 13.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.362 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -113.07 136.91 52.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 54.9 t -91.64 88.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.99 -173.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 29' ' ' PRO . 23.9 m -116.31 146.03 36.4 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 110.013 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.707 ' HA ' HG23 ' A' ' 28' ' ' THR . 50.2 Cg_endo -75.58 -178.51 23.9 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.788 -2.172 . . . . 0.0 110.509 -0.174 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -159.51 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.14 -148.48 10.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.1 mt -85.11 131.48 48.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.294 -1.121 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.26 178.99 5.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.63 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -98.48 25.79 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 18.2 pt-20 -76.96 -18.68 58.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 10.2 mm-40 -104.85 48.81 0.83 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.286 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -54.53 -50.59 84.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.943 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.53 -0.58 9.93 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.818 1.43 . . . . 0.0 110.703 -179.594 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.29 -28.03 7.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.932 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.732 HD21 ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -89.13 -38.09 14.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 110.371 -179.857 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 37' ' ' ILE . 54.9 t -49.08 91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.919 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.64 28.39 1.59 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.446 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -98.93 131.5 44.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -1.182 . . . . 0.0 110.256 179.957 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -109.46 126.77 53.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.2 m -83.71 168.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HA ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 t30 -110.96 1.64 17.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -134.84 133.65 39.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.578 ' H ' HD11 ' A' ' 13' ' ' ILE . . . -50.55 140.58 13.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.336 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.086 HG13 HG21 ' A' ' 53' ' ' THR . 55.1 t -130.09 135.94 28.25 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.071 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.2 Cg_endo -72.13 -173.26 1.04 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.717 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -76.5 162.36 27.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.91 . . . . 0.0 110.536 -179.717 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.24 44.67 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.086 HG21 HG13 ' A' ' 49' ' ' VAL . 82.1 m -96.43 119.86 35.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -1.212 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.486 HG21 ' O ' ' A' ' 29' ' ' PRO . 22.3 p -54.75 127.3 27.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.732 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -61.68 113.34 2.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.177 -179.933 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.0 ptp -106.99 151.69 40.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.46 1.59 7.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.135 1.597 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' CE ' ' A' ' 59' ' ' MET . 1.8 t70 -76.71 -43.88 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 110.558 -179.752 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 9.2 mmt -105.5 63.54 0.69 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.361 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.2 t -130.17 99.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -61.02 -71.62 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -90.8 75.37 6.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.118 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 25.6 t80 -51.71 145.36 9.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.381 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' N ' ' HE3' ' A' ' 43' ' ' MET . 7.4 pm0 -64.42 -141.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.18 78.24 0.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.85 100.05 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -81.6 4.51 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -1.162 . . . . 0.0 110.248 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -76.67 -160.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.965 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -42.4 -56.42 5.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.301 179.867 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -72.46 162.49 41.29 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.972 1.512 . . . . 0.0 110.493 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.64 61.58 0.62 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.25 -44.82 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.0 110.254 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.182 179.982 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.258 0.551 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 164.97 19.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -123.17 158.6 30.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.77 114.72 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG22 HG22 ' A' ' 54' ' ' THR . 4.2 t -126.49 122.09 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -56.67 127.62 32.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.45 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 24.2 t-20 -77.45 -48.68 16.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.09 158.29 15.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.132 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.02 132.49 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 7' ' ' ALA . 1.1 mp -117.65 122.67 30.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 46.0 Cg_endo -71.57 -95.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.749 1.394 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -162.02 -173.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.095 179.527 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER 40.21 31.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 110.612 -179.813 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 11' ' ' ILE . 5.7 t -124.11 138.2 54.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -71.55 154.97 41.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 11' ' ' ILE . 51.3 mt -120.97 104.42 9.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.886 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.46 HG23 HG13 ' A' ' 41' ' ' VAL . 3.4 m -96.81 167.89 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.978 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.96 -25.15 67.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.6 mt -69.63 -19.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.6 ttp -97.73 -20.88 17.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HA ' ' A' ' 7' ' ' ALA . 1.4 mtt -118.91 143.51 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.112 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.75 172.09 7.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.07 102.05 14.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.3 tp10 -112.03 128.58 56.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.5 p -91.95 77.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.38 166.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.18 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.9 t -92.83 144.83 29.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' HG21 ' A' ' 54' ' ' THR . 49.4 Cg_endo -75.55 157.21 99.12 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.416 -0.248 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.3 mtt -72.79 -26.25 61.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.77 -132.02 43.99 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.875 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.8 mt -106.28 134.79 19.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.287 -1.125 . . . . 0.0 110.223 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -170.52 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.942 1.496 . . . . 0.0 110.407 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.47 46.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.272 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.05 -40.07 54.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.903 ' HB2' HD12 ' A' ' 40' ' ' LEU . 14.9 mm-40 -104.91 31.2 4.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.981 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -42.68 -54.27 8.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.4 Cg_endo -71.53 -2.22 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.615 1.323 . . . . 0.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.02 -32.15 6.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.894 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -85.55 -24.6 27.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.351 -179.848 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.8 t -42.58 119.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.2 8.78 28.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD23 ' A' ' 40' ' ' LEU . 18.9 ttp -72.34 134.66 45.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -1.194 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mt-30 -110.01 125.59 53.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 17' ' ' LEU . 3.7 m -79.99 154.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 110.141 179.851 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -108.26 10.1 27.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.405 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.57 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.52 137.44 26.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -45.06 128.19 7.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.018 HG13 HG21 ' A' ' 53' ' ' THR . 47.5 t -111.85 134.75 21.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.56 ' C ' ' HG1' ' A' ' 53' ' ' THR . 47.6 Cg_endo -74.12 -171.57 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.023 1.539 . . . . 0.0 110.477 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.31 164.01 22.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 110.281 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 43.43 30.32 1.31 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.018 HG21 HG13 ' A' ' 49' ' ' VAL . 72.9 m -76.15 104.16 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -1.196 . . . . 0.0 110.401 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -52.39 153.69 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.053 179.808 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.875 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -62.16 100.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.314 -179.841 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.7 mtm -113.55 145.34 33.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.435 -0.791 . . . . 0.0 110.287 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.62 0.18 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.001 1.527 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.97 -55.36 14.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' A' ' 47' ' ' ARG . 46.8 mtt -103.35 40.72 1.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 110.431 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 93.6 t -130.47 133.34 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -142.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.417 ' C ' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-20 -76.39 79.61 3.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 110.297 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CD2' ' N ' ' A' ' 64' ' ' GLU . 18.0 p90 -84.62 -167.96 2.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.501 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 47.5 tp10 -71.94 76.79 0.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 70' ' ' PRO . 10.1 t0 -99.31 -64.74 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.46 -126.94 1.06 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.534 ' HA ' HD23 ' A' ' 72' ' ' LEU . 15.8 m -108.92 -70.72 0.79 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 110.477 -179.77 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -18.29 59.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.51 -179.16 0.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.956 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -72.55 84.67 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.958 1.504 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -165.7 -36.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -67.7 113.76 5.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.144 . . . . 0.0 110.252 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.3 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.143 179.949 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.232 0.539 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.01 138.26 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.3 p -123.74 157.5 33.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.655 HG12 HD23 ' A' ' 55' ' ' LEU . 61.6 t -80.1 124.28 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -129.2 107.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 179.975 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -46.65 116.18 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 51' ' ' LEU . 52.6 t30 -77.79 -46.52 21.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.15 136.22 33.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 10' ' ' LEU . 1.7 pt? -78.12 131.68 37.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.34 -179.891 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.534 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 10.4 pt -128.9 155.73 79.06 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.872 . . . . 0.0 109.989 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.0 Cg_endo -72.85 -96.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.89 1.468 . . . . 0.0 110.159 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.563 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -152.24 172.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.961 -1.087 . . . . 0.0 109.889 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.81 21.38 5.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 110.353 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -97.91 117.07 31.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.03 157.55 5.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 41' ' ' VAL . 30.1 mt -98.43 111.16 23.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 p -95.41 155.91 16.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -28.08 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.378 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mt -68.64 -36.88 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.922 . . . . 0.0 110.235 -179.913 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 42.3 mtp -88.74 11.82 16.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.612 ' HA ' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -112.35 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -109.59 112.83 25.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.18 105.53 3.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.326 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -109.68 155.37 21.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.157 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 26' ' ' VAL . 10.8 t -91.65 24.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 28' ' ' THR . 31.7 t -95.68 148.38 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -77.34 168.25 29.55 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.955 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.568 ' CG ' HG21 ' A' ' 54' ' ' THR . 48.8 Cg_endo -73.77 -170.58 7.97 Favored 'Cis proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.624 -2.24 . . . . 0.0 110.417 -0.134 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 31' ' ' GLY . 5.3 ptt? -76.56 -34.82 58.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.248 180.0 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 45.56 -131.45 9.42 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.26 137.35 21.49 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.276 179.994 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 -166.86 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.008 1.531 . . . . 0.0 110.479 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.804 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -116.84 33.83 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -41.35 85.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 73.4 mm-40 -104.78 32.53 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.804 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.3 mm -42.88 -51.32 12.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.599 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -72.04 -1.4 9.97 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.483 1.254 . . . . 0.0 110.681 -179.776 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.75 -38.08 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 179.933 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -75.26 -34.12 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.911 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 37' ' ' ILE . 21.6 t -46.96 139.61 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -11.69 54.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.4 tpp -82.01 132.52 35.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.116 . . . . 0.0 110.209 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -92.94 -179.41 5.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.17 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.0 m -118.42 163.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.343 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 5.6 t-20 -111.19 3.42 18.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.542 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.7 mmt180 -139.18 -176.75 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 0.0 110.41 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -79.8 140.83 36.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.25 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 53' ' ' THR . 4.5 t -119.28 116.49 33.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.336 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -76.89 152.01 35.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.45 42.01 25.81 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.685 HG21 HG13 ' A' ' 49' ' ' VAL . 61.4 m -82.36 115.02 21.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.568 HG21 ' CG ' ' A' ' 29' ' ' PRO . 11.2 t -54.74 155.63 4.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -71.98 103.63 3.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.924 . . . . 0.0 110.229 179.971 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.483 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -112.17 145.14 32.2 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.997 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -12.24 25.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.982 1.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -62.17 -56.76 15.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.288 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.529 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 5.9 mtt -93.45 39.81 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 56' ' ' MET . 53.3 t -130.44 126.87 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 110.233 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -161.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 110.056 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.557 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 27.3 p-10 -69.2 79.81 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 3.4 p90 -82.2 -170.11 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -63.76 145.46 55.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.075 -1.016 . . . . 0.0 111.205 -178.679 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 10.3 t0 -98.17 79.06 2.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.577 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.22 -87.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.259 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -52.39 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.793 -179.286 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 21.2 p -69.72 -174.07 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.611 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 6.5 t -119.02 41.16 0.39 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 111.564 -179.456 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 69' ' ' SER . 43.8 Cg_endo -72.33 -169.44 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.569 1.299 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 66.5 33.79 85.74 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -70.01 -43.98 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -1.158 . . . . 0.0 110.205 179.935 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.277 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.214 0.531 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -85.38 151.24 24.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.99 135.7 54.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 22' ' ' MET . 94.7 t -78.88 121.82 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.2 t -127.59 116.66 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.104 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -67.16 122.35 17.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.133 179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -78.11 -42.29 32.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.429 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -88.05 143.53 27.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.263 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.6 tt -63.92 143.93 57.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 mt -130.38 112.53 16.77 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.278 -0.889 . . . . 0.0 110.401 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.35 59.56 5.45 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.787 1.414 . . . . 0.0 110.408 179.615 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 42.3 pt 38.19 -163.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.834 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 42.46 27.75 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.821 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.3 m -140.93 121.32 14.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.18 171.31 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.917 . . . . 0.0 110.161 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mt -113.8 138.03 50.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -124.47 -179.67 4.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.262 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.19 -53.53 16.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.36 -15.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.229 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtt -82.45 -47.02 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.539 ' HG3' HG13 ' A' ' 5' ' ' VAL . 1.7 ptt? -119.91 149.42 42.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -111.9 169.33 8.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.03 92.29 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.213 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.52 137.64 50.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 26' ' ' VAL . 76.3 t -90.73 60.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 28' ' ' THR . 55.3 t -132.7 170.23 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.854 HG22 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -79.93 151.86 73.85 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.998 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.854 ' HA ' HG22 ' A' ' 28' ' ' THR . 48.8 Cg_endo -75.69 178.95 32.65 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.678 -2.217 . . . . 0.0 110.535 -0.227 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -74.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.89 -166.88 53.09 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.772 HD11 ' OH ' ' A' ' 63' ' ' TYR . 16.2 mm -63.19 133.64 95.52 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.155 -1.203 . . . . 0.0 110.005 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 43.6 Cg_endo -72.75 -174.5 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.851 1.448 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.57 23.41 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.731 -179.496 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -77.33 -19.08 56.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.11 10.03 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.789 . . . . 0.0 110.116 -179.52 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.8 mm -41.9 -55.33 6.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 110.552 -179.79 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.51 -4.55 14.76 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.584 1.307 . . . . 0.0 110.72 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.8 m120 -114.18 -25.96 8.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 110.457 -179.835 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -91.27 -25.29 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.863 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 37' ' ' ILE . 33.1 t -42.99 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.01 15.15 4.83 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.423 ' HE3' ' HG2' ' A' ' 64' ' ' GLU . 36.3 tpp -87.75 136.5 32.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -1.169 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -102.54 149.09 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 6.2 m -113.6 161.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -111.32 -1.82 15.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 3.5 mtt180 -115.12 137.98 51.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.253 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.53 145.13 1.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.333 -179.516 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.066 ' CG1' HG21 ' A' ' 53' ' ' THR . 2.8 t -126.05 110.82 24.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.086 -179.778 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' O ' ' HB ' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -176.34 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.929 1.489 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' LEU . 1.6 mp -71.45 157.23 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.046 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.82 32.21 1.33 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.8 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.104 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -69.16 138.44 54.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.463 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 12.6 t -85.21 142.28 29.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.611 179.255 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 mm? -61.67 117.94 6.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.1 mtt -111.99 150.02 41.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.922 . . . . 0.0 110.338 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 -16.83 24.31 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.021 1.537 . . . . 0.0 110.364 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.73 -16.31 42.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.472 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 mtm -111.78 38.24 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.957 . . . . 0.0 110.182 -179.917 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.575 HG11 ' CE1' ' A' ' 63' ' ' TYR . 77.5 t -130.33 114.91 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.07 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -57.12 -99.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.374 -179.725 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 62' ' ' ASN . 22.0 p-10 -100.34 96.98 7.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.99 -1.068 . . . . 0.0 110.182 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -49.24 146.7 3.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 110.26 179.936 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 72.9 mm-40 -76.72 -56.05 4.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 42.0 p-10 -84.22 55.13 3.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.029 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.44 67.54 3.69 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -93.49 -20.27 20.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.054 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.52 -158.81 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.93 -55.78 4.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.899 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.5 Cg_endo -73.53 138.13 26.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.019 1.536 . . . . 0.0 110.395 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -25.98 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.18 27.13 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.232 179.989 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.253 0.549 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.26 130.88 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 159.67 15.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.15 127.38 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.249 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.3 t -124.44 127.32 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB3' ' H ' ' A' ' 53' ' ' THR . . . -45.56 127.79 7.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.19 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 28.0 t30 -89.57 -58.22 2.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.204 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -91.88 145.65 24.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 10' ' ' LEU . 2.0 tt -64.2 109.64 1.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 pt -123.6 137.36 28.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.069 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.014 1.534 . . . . 0.0 110.14 179.845 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.752 HG22 HG23 ' A' ' 45' ' ' VAL . 2.0 pt -146.41 -164.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.128 -0.982 . . . . 0.0 110.197 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER 40.37 27.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 0.0 110.561 -179.899 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.3 m -116.61 111.71 20.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -62.88 133.99 55.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.771 HD22 ' SD ' ' A' ' 22' ' ' MET . 47.9 mt -81.18 145.64 30.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 110.061 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -129.93 137.5 50.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 110.322 179.915 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.6 tt -43.76 -43.67 6.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.516 ' N ' HD23 ' A' ' 19' ' ' LEU . 8.1 mt -67.55 -21.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.358 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -97.54 -23.36 16.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.771 ' SD ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -116.42 120.0 37.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.34 147.95 27.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 110.164 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.0 116.41 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.32 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.33 151.2 30.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.37 78.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.288 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.8 149.91 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.141 179.931 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.6 p -97.7 159.96 29.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.85 152.88 97.42 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.439 -0.191 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.06 127.2 32.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.834 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.9 -110.66 3.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.786 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.838 HG13 HD22 ' A' ' 55' ' ' LEU . 8.5 mm -86.03 114.69 58.51 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.107 . . . . 0.0 110.628 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.51 -161.57 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.449 179.678 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -109.76 27.79 9.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.23 -38.24 51.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.958 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 65' ' ' ASP . 48.0 mm-40 -94.12 32.68 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.133 -0.979 . . . . 0.0 110.943 -179.288 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -43.65 -51.72 15.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.963 -1.085 . . . . 0.0 110.4 179.722 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -73.23 -11.39 24.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.732 1.385 . . . . 0.0 110.996 -179.427 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -105.66 -46.43 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.099 179.835 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' HG21 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -62.2 -43.98 97.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.202 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 37' ' ' ILE . 39.9 t -43.61 119.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.993 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.91 16.02 46.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.497 ' HE1' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ttm -83.91 135.09 34.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -1.147 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -106.92 124.83 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.752 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -85.08 158.55 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -103.73 -3.57 24.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.124 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.545 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 10.2 mtt180 -123.28 155.66 36.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.7 58.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.425 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG13 ' HB ' ' A' ' 53' ' ' THR . 28.2 t -127.86 113.61 20.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 179.893 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 -162.9 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.946 1.498 . . . . 0.0 110.6 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.32 155.98 28.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.968 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.5 45.82 6.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.591 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 87.4 m -94.02 100.07 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.157 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' MET . 23.8 m -44.91 123.77 4.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.838 HD22 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.97 115.47 4.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.949 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 54' ' ' THR . 19.8 mtp -112.25 164.24 15.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.48 -0.763 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 49.7 Cg_endo -76.37 6.5 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.08 1.568 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -42.16 11.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.07 -1.019 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -100.22 52.6 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 -179.9 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 17.4 t -129.97 123.42 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.898 . . . . 0.0 110.22 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -73.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -100.52 93.31 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.351 -179.896 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.497 ' HA ' ' HE1' ' A' ' 43' ' ' MET . 96.3 m-85 -52.64 151.9 4.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' HD12 ' A' ' 40' ' ' LEU . 1.5 mp0 -68.44 -70.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.148 179.865 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 33.2 p-10 -84.49 94.89 8.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.938 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 71' ' ' GLY . . . -85.67 38.39 3.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.4 m -107.81 -16.5 14.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.96 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.445 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 61.6 p -100.58 -140.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.511 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -75.65 -56.94 1.67 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 -179.828 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.8 Cg_endo -72.97 73.21 3.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.919 1.484 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . -130.81 0.65 5.42 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.21 137.74 34.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.242 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.496 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -61.62 124.55 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 t -82.93 173.2 12.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.172 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.23 108.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.1 t -123.78 107.4 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -58.68 121.62 11.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 3.5 m-20 -72.65 -55.34 7.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.73 156.45 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.746 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' HG ' ' HA ' ' A' ' 50' ' ' PRO . 8.0 tt -70.31 124.41 24.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 9' ' ' GLN . 22.0 mm -124.0 113.19 28.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -73.82 -92.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.0 110.404 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.871 HG22 HG23 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -161.89 -177.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.108 -0.995 . . . . 0.0 110.291 179.99 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 50.74 21.74 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.5 m -124.5 113.34 17.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.085 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.662 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.66 152.79 8.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.126 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -96.76 138.62 34.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -167.02 1.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.276 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.68 -63.36 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.295 -179.954 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -49.09 -24.93 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 110.194 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.93 3.72 40.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.7 mtt -116.37 118.37 32.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.916 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.0 160.07 23.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.092 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -105.08 83.03 1.92 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.34 135.83 44.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -94.38 77.83 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.839 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.7 120.03 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.2 p -83.25 150.39 60.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 110.152 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.82 129.89 19.93 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.483 -0.151 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -71.25 118.37 13.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -102.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.0 mt -118.15 137.62 24.73 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.238 -1.154 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -162.68 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.12 1.589 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -107.69 45.63 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.92 -35.58 67.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 mm-40 -104.97 35.29 2.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.817 . . . . 0.0 109.872 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -40.5 -52.17 6.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -71.39 -9.49 25.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.594 1.313 . . . . 0.0 110.766 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -106.25 -25.62 11.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.087 179.715 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -94.6 -40.36 9.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.83 . . . . 0.0 110.26 179.996 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -45.08 107.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.662 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.42 18.26 7.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.526 ' HE2' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -96.82 147.61 23.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -104.16 148.73 25.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.871 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -111.27 161.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -109.44 17.74 21.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.608 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -136.44 128.01 28.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.39 179.889 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -62.19 130.17 44.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.086 HG11 HG23 ' A' ' 53' ' ' THR . 9.1 t -128.67 128.17 23.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -73.77 -166.06 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.314 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.66 126.75 26.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.954 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 90.15 73.72 1.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.086 HG23 HG11 ' A' ' 49' ' ' VAL . 68.9 m -92.06 99.1 11.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -1.127 . . . . 0.0 110.326 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 56' ' ' MET . 41.1 p -64.58 132.37 49.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.93 85.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.112 179.935 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 54' ' ' THR . 4.2 mtt -103.33 142.9 25.53 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.25 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -75.2 2.78 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.078 1.567 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.13 -20.8 21.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.355 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.7 mtm -108.36 -6.86 16.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.445 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 63' ' ' TYR . 85.6 t -93.95 107.69 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -77.42 -60.68 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.1 t-20 -95.68 74.4 3.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.334 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -54.48 163.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.158 179.937 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.666 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -65.04 -178.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.108 179.892 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLY . 1.4 m-20 -59.75 -58.2 9.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.4 131.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 m -88.86 -62.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 14.6 t -108.7 51.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -154.32 -178.83 0.94 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.878 . . . . 0.0 110.0 179.904 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -72.93 103.06 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.909 1.478 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 72' ' ' LEU . . . -171.89 56.25 0.17 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 72' ' ' LEU . 4.0 mm? -103.91 85.42 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -1.129 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.293 0.568 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.29 159.0 18.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.16 179.933 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -122.47 145.81 47.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.823 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 58.6 t -79.95 112.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 52' ' ' GLY . 6.1 t -118.63 132.49 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 0.0 110.158 -179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.102 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.15 130.29 35.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.278 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 39.5 t30 -80.02 -69.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG3' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -65.78 130.85 44.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 179.85 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 51' ' ' LEU . 2.0 pt? -62.26 133.0 54.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.58 -179.716 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.729 HG13 HG23 ' A' ' 49' ' ' VAL . 1.3 pt -130.13 134.77 26.5 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.1 Cg_endo -73.68 168.78 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.935 1.492 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -46.66 174.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' OD1' HD13 ' A' ' 13' ' ' ILE . 6.9 m120 60.35 -152.4 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 58.49 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.92 . . . . 0.0 110.057 -179.835 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -56.28 154.02 8.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.43 144.14 26.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.2 OUTLIER -124.86 155.22 39.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 110.31 -179.934 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.769 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.0 tt -68.07 -46.35 71.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.962 ' O ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.72 -14.63 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.943 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.459 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -87.85 -47.34 8.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.265 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.992 ' HE3' ' HB2' ' A' ' 7' ' ' ALA . 20.1 mtp -97.36 142.14 29.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -108.46 167.65 9.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.046 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.69 106.81 18.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.43 144.42 32.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 45.7 t -97.1 66.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.207 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.06 -166.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 35.3 p -118.13 160.14 40.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.873 . . . . 0.0 110.132 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 50.5 Cg_endo -77.13 145.18 80.24 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.47 -0.137 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -76.1 75.24 2.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.957 179.742 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.08 -119.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.988 HG13 HD12 ' A' ' 55' ' ' LEU . 10.2 mm -82.49 115.14 56.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.446 -1.032 . . . . 0.0 110.47 -179.619 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 49.0 Cg_endo -75.64 50.21 2.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.95 1.5 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.823 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 41.82 29.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -42.98 99.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 110.457 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 59.3 mm-40 -104.16 34.08 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -42.77 -54.57 8.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -71.7 -4.56 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.639 1.336 . . . . 0.0 110.676 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.03 -21.58 10.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.874 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.507 ' CD1' ' HE2' ' A' ' 43' ' ' MET . 16.0 tp -92.1 -40.1 11.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 37' ' ' ILE . 75.0 t -44.53 115.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 110.184 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.53 14.96 24.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.538 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 5.0 ttp -104.45 157.94 16.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -106.75 141.4 38.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 13' ' ' ILE . 26.4 m -90.22 164.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.49 10.7 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.172 179.871 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.69 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -153.17 124.71 7.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.022 179.996 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -52.74 150.09 5.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.827 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -128.22 137.85 31.74 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.18 -168.79 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.99 1.521 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -70.14 155.59 40.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 110.06 179.864 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 44.36 40.71 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.102 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.2 t -78.37 130.11 35.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 110.326 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 t -78.05 145.04 36.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.988 HD12 HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.15 107.37 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -106.64 146.46 33.11 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 179.988 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.28 -0.77 10.06 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.428 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.94 -20.27 26.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.615 ' SD ' HG13 ' A' ' 49' ' ' VAL . 4.1 mtt -112.45 32.82 5.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.923 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 11.8 t -121.09 118.95 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.031 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -86.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.857 . . . . 0.0 110.271 -179.785 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.95 89.57 7.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -45.11 160.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CE ' ' A' ' 43' ' ' MET . 1.3 mp0 -103.97 -47.96 4.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.14 85.6 3.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 72.57 0.53 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 14.1 m -84.53 54.65 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 69' ' ' SER . 58.1 p -106.27 -89.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.79 -57.97 2.32 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -72.52 -3.02 12.67 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.904 1.476 . . . . 0.0 110.321 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 67' ' ' THR . . . -108.62 128.37 9.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -15.36 16.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 -179.932 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.311 0.577 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.3 135.78 33.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -105.84 144.72 32.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.912 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 34' ' ' ALA . 29.9 m -76.31 130.05 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.253 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 54' ' ' THR . 12.4 t -129.57 118.06 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.61 116.94 2.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.148 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 5.1 p-10 -75.07 -43.8 51.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 43.2 tt0 -97.12 150.96 20.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.9 tt -63.88 105.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 109.89 179.769 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 7.9 mm -99.5 139.37 20.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.516 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.6 -157.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.124 1.592 . . . . 0.0 110.201 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.26 -165.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.008 179.715 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.4 p30 38.45 32.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.6 m -133.39 142.98 48.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.341 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -75.27 148.83 39.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 45' ' ' VAL . 39.1 mt -105.88 151.36 24.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -115.05 -170.58 1.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.16 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.99 -49.45 45.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.856 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' HG2' ' A' ' 21' ' ' MET . 3.4 pt -55.36 -18.98 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.201 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.441 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.5 mmm -90.57 9.38 29.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.27 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.73 ' CE ' HD23 ' A' ' 40' ' ' LEU . 33.6 mtp -123.3 122.83 39.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -117.16 114.04 23.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.259 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.75 83.89 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.47 126.09 42.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 73.0 t -86.42 79.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 28' ' ' THR . 9.6 p -147.6 169.57 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.968 . . . . 0.0 110.368 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -117.21 150.16 45.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.982 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.554 ' O ' HG21 ' A' ' 54' ' ' THR . 48.2 Cg_endo -75.48 134.73 37.14 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.679 -2.217 . . . . 0.0 110.395 -0.132 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 30' ' ' MET . 1.1 ptt? -80.83 136.93 36.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.552 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -89.9 -116.35 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 55' ' ' LEU . 9.9 mm -81.24 136.28 49.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.281 -1.129 . . . . 0.0 109.802 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.3 Cg_endo -74.05 4.88 3.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.965 1.508 . . . . 0.0 111.238 -179.478 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.967 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . 68.12 18.4 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -11.43 59.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 179.642 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -105.04 28.27 7.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 110.324 -179.375 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.8 mm -42.19 -53.34 8.79 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.566 -179.852 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.23 -5.07 16.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.61 1.321 . . . . 0.0 110.81 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 8.4 m-80 -114.03 -49.02 2.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.973 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.73 HD23 ' CE ' ' A' ' 22' ' ' MET . 2.3 tp -66.69 -39.97 88.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 38.9 t -50.87 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 116.96 24.57 3.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.655 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.8 ppp? -104.53 154.58 19.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -1.169 . . . . 0.0 110.265 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -109.39 123.86 50.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 13' ' ' ILE . 33.3 m -77.76 165.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' MET . 44.5 t30 -110.35 -12.28 14.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.139 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.8 mtp85 -120.32 146.57 45.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 149.86 15.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 53' ' ' THR . 38.5 t -126.13 112.52 24.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.1 Cg_endo -72.72 -167.78 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.852 1.448 . . . . 0.0 110.522 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -73.64 149.04 42.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.82 53.21 6.38 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 49' ' ' VAL . 84.6 m -96.52 122.16 39.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.591 ' N ' HG13 ' A' ' 6' ' ' VAL . 1.3 m -64.14 123.37 18.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.863 . . . . 0.0 110.135 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 32' ' ' ILE . 1.3 tt -62.03 113.01 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.064 179.895 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.5 mtt -111.63 162.57 20.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.52 0.74 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.044 1.55 . . . . 0.0 110.435 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.79 -23.98 22.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -98.87 1.0 45.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 179.87 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.655 HG13 ' CE ' ' A' ' 43' ' ' MET . 7.1 t -91.5 116.47 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -80.18 -72.73 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.918 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 73' ' ' LYS . 65.0 m-80 -100.22 87.86 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.409 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.99 144.58 28.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . 8.7 mm-40 -83.23 -95.79 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.986 . . . . 0.0 110.352 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 13.8 t70 -94.45 82.95 4.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.99 93.1 0.28 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -74.36 -39.68 62.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 32.36 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.22 -179.6 1.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.6 Cg_endo -72.36 174.97 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.887 1.467 . . . . 0.0 110.56 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.24 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -65.73 153.16 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -1.177 . . . . 0.0 110.317 -179.853 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.269 0.557 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.52 135.35 51.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -112.53 148.8 33.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.929 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 29.3 t -73.58 107.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.1 t -107.53 102.18 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.05 130.28 21.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.228 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -57.97 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.136 -179.942 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' CD ' ' SD ' ' A' ' 21' ' ' MET . 4.6 pt20 -81.44 162.08 23.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.188 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.7 tt -86.48 149.18 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.036 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.522 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 13.1 pt -129.79 127.91 22.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 110.399 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.53 54.01 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.033 1.544 . . . . 0.0 110.38 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER 47.44 -177.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 -179.902 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 7.1 m-20 41.15 28.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 13' ' ' ILE . 54.0 m -118.36 114.4 22.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.19 128.44 35.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.051 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mt -83.03 143.19 30.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -122.21 176.42 5.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 19' ' ' LEU . 7.2 tt -68.32 -44.86 74.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.279 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.503 HG13 ' N ' ' A' ' 21' ' ' MET . 4.7 pt -60.03 -22.51 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.503 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -95.88 -21.62 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.954 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.475 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mtm -108.39 108.0 18.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -111.68 139.59 47.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.955 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.75 84.99 6.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 179.985 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 148.55 28.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.34 93.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 0.0 110.085 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 28' ' ' THR . 94.9 t -131.01 161.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 29' ' ' PRO . 28.8 m -114.51 145.74 34.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 -179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.666 ' O ' HG21 ' A' ' 54' ' ' THR . 50.5 Cg_endo -80.29 147.65 76.29 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.716 -2.202 . . . . 0.0 110.42 -0.445 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -68.2 68.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -42.17 -83.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.835 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 55' ' ' LEU . 4.8 mt -135.27 142.84 43.11 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.0 110.224 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.7 Cg_endo -72.36 -159.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.332 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.817 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -115.57 40.01 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.96 -29.86 64.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -102.9 24.58 10.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.1 mm -45.19 -53.32 17.56 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.6 Cg_endo -71.02 -6.43 19.2 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.505 1.266 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.27 -27.08 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.116 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 36' ' ' GLU . 1.1 mp -88.97 -26.46 21.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.081 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 53.3 t -51.46 99.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.08 2.59 12.38 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.598 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.0 tmm? -94.86 143.75 26.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -1.187 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 49.3 mt-30 -106.45 134.0 50.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 13' ' ' ILE . 17.8 m -77.48 154.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.171 179.866 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -97.75 1.49 48.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -132.59 142.41 49.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -56.96 136.76 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.45 -179.76 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 53' ' ' THR . 45.5 t -124.29 120.71 26.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.955 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.772 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.65 -161.26 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.973 1.512 . . . . 0.0 110.647 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 52' ' ' GLY . 2.4 mp -81.04 160.11 24.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.335 -0.853 . . . . 0.0 110.471 -179.658 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 43.37 49.5 6.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.037 HG21 HG13 ' A' ' 49' ' ' VAL . 39.7 m -96.75 106.37 18.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -1.152 . . . . 0.0 110.081 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 ' O ' ' A' ' 29' ' ' PRO . 5.6 m -50.35 147.98 3.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -65.07 108.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.115 179.925 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.41 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -110.07 150.31 41.28 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.981 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.08 0.44 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.051 1.553 . . . . 0.0 110.58 -179.981 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.15 -50.89 7.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.515 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.74 47.65 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.84 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' CE ' ' A' ' 43' ' ' MET . 19.5 t -127.88 109.85 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -82.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.255 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -91.86 88.58 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.856 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.74 139.0 57.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 179.922 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG3' HD12 ' A' ' 40' ' ' LEU . 4.7 mm-40 -87.9 -92.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.01 82.75 3.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.0 110.398 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.74 94.28 0.25 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.18 18.15 21.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -1.146 . . . . 0.0 110.266 -179.887 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 69' ' ' SER . 88.0 m -100.41 -33.91 10.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.05 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 173.25 -56.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.995 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -73.14 85.68 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.928 1.489 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.3 70.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.64 -32.63 72.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -1.165 . . . . 0.0 110.328 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 tptt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.257 179.992 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.235 0.541 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.41 156.99 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.219 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.84 161.27 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.253 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 55' ' ' LEU . 39.4 t -79.04 121.42 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.093 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -125.42 107.59 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.9 111.09 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 51.1 t30 -74.91 -59.91 2.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -72.18 139.43 48.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.67 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.98 132.58 51.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 179.919 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.88 ' HB ' HG21 ' A' ' 15' ' ' THR . 1.6 pt -130.13 110.89 16.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -74.82 69.69 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.93 1.49 . . . . 0.0 110.43 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.7 pt 39.0 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 45.9 29.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.88 HG21 ' HB ' ' A' ' 11' ' ' ILE . 5.1 t -131.0 130.32 43.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 110.135 -179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 142.68 53.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.179 -179.91 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 40' ' ' LEU . 5.5 mt -77.79 124.72 28.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 110.27 -179.92 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.443 ' HB ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.94 172.04 8.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.993 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 ' CG2' ' A' ' 41' ' ' VAL . 17.5 mt -77.23 -30.99 54.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 21' ' ' MET . 6.3 pt -62.62 -25.55 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.538 ' CE ' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -97.38 -14.06 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.588 ' HG3' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.04 126.28 32.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 12.7 mttt -111.55 124.06 51.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.21 10.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.406 ' HG2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -110.92 150.08 29.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 179.964 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 26' ' ' VAL . 61.3 t -81.68 4.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG2' ' A' ' 25' ' ' GLU . 41.1 t -53.47 130.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.21 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -84.8 168.27 21.91 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.813 ' O ' HG21 ' A' ' 54' ' ' THR . 48.0 Cg_endo -73.76 156.69 99.61 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.428 -0.191 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' GLY . 5.5 mtt -76.34 83.23 3.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.69 -116.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' OH ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -110.48 139.9 22.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.219 -1.165 . . . . 0.0 109.948 179.946 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 32' ' ' ILE . 46.7 Cg_endo -73.9 168.7 24.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.553 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.699 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . -84.14 47.1 1.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -77.15 -27.06 53.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.797 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -104.72 45.34 0.97 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 111.023 -179.406 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.699 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -63.05 -51.43 70.46 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.008 179.637 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.9 Cg_endo -75.08 -5.4 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.755 1.398 . . . . 0.0 110.722 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 4.7 m120 -114.77 -35.3 4.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.591 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD2' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -87.51 -38.9 15.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.799 -179.46 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' CG2' HD21 ' A' ' 19' ' ' LEU . 9.1 t -41.93 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.9 -7.3 6.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.652 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.54 131.0 35.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -1.089 . . . . 0.0 110.194 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 15' ' ' THR . 15.2 mt-30 -99.33 151.39 21.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.961 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.1 m -99.92 161.78 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -111.18 0.29 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -114.39 135.85 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 110.042 -179.858 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -55.8 123.15 13.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.325 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CB ' ' A' ' 53' ' ' THR . 19.7 t -109.99 125.47 31.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 179.605 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -72.67 -167.63 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.858 1.452 . . . . 0.0 110.512 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -81.53 155.28 25.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.231 -179.9 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 45.29 44.61 10.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' HG13 ' A' ' 49' ' ' VAL . 43.6 m -90.61 122.58 33.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -1.174 . . . . 0.0 110.203 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.813 HG21 ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -54.69 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.987 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD12 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -80.04 106.5 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.194 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -113.1 143.27 28.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 179.822 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.36 1.46 7.34 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.951 1.5 . . . . 0.0 110.634 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.84 -15.55 44.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.812 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HG2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -99.47 -21.43 15.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.52 120.75 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.311 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.95 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 179.879 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 22.6 p-10 -92.06 87.79 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.103 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.751 ' OH ' HG21 ' A' ' 32' ' ' ILE . 2.7 t80 -45.45 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' HG3' ' C ' ' A' ' 39' ' ' ASN . 1.5 tm-20 -66.91 -60.14 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' ' OG1' ' A' ' 67' ' ' THR . 2.0 m-20 -65.97 -49.89 66.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.62 2.54 78.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -90.16 4.65 49.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -1.19 . . . . 0.0 110.203 -179.934 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -98.4 -150.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.953 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.57 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -61.03 -60.17 11.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.04 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 47.2 Cg_endo -72.67 140.06 31.93 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.533 . . . . 0.0 110.201 179.714 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.67 48.68 0.55 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.04 -170.7 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -1.157 . . . . 0.0 110.239 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.162 0.505 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -66.59 115.65 6.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.27 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 6' ' ' VAL . 18.3 p -123.88 148.82 46.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.156 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 76.2 t -62.48 116.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 110.207 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -121.03 105.91 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -42.62 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -75.69 -70.85 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' O ' HG12 ' A' ' 11' ' ' ILE . 13.0 tp60 -65.04 143.35 57.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.8 114.08 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 1.5 pt -128.78 128.32 23.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.78 -158.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.87 1.458 . . . . 0.0 109.788 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 45' ' ' VAL . 44.5 pt -98.98 -170.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.069 -1.019 . . . . 0.0 110.194 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 49.41 20.31 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.489 -0.757 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -118.71 102.13 8.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.007 -1.058 . . . . 0.0 109.928 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.74 124.12 15.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.353 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.9 mt -94.13 163.4 13.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' CG1' ' A' ' 20' ' ' ILE . 67.4 p -130.51 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 110.027 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.0 -42.62 66.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.03 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CG1' ' OG1' ' A' ' 18' ' ' THR . 2.6 pt -58.62 -26.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.106 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.0 mtt -94.46 15.98 16.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.485 ' HE3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.59 111.6 16.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -119.38 114.45 22.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.61 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.182 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.24 152.53 28.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.185 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 26' ' ' VAL . 81.3 t -95.33 82.8 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.224 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.09 157.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.0 t -95.82 148.91 35.31 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.074 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -75.87 -165.18 4.13 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.729 -2.196 . . . . 0.0 110.541 -0.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.86 -19.53 51.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 30' ' ' MET . . . 45.95 -143.17 4.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -97.49 125.29 45.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -1.162 . . . . 0.0 110.066 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.03 -161.5 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.846 1.445 . . . . 0.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.92 17.79 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -56.79 -36.64 70.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 109.971 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 10.1 pt-20 -104.58 35.98 2.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 110.286 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.74 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 4.0 mm -55.57 -54.96 45.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.243 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -70.5 -4.15 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.636 1.335 . . . . 0.0 110.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.0 m-20 -109.36 -25.25 10.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.485 HD23 ' HE3' ' A' ' 22' ' ' MET . 5.3 tp -84.85 -29.32 25.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.29 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 37' ' ' ILE . 36.7 t -42.88 104.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 103.85 29.45 5.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 tpp -97.8 140.76 31.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 110.273 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.98 121.73 44.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.045 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' ILE . 10.4 m -80.7 166.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 110.304 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB2' ' CD ' ' A' ' 61' ' ' LYS . 11.7 t-20 -111.58 -4.75 14.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -125.17 132.78 52.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.848 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' ARG . . . -46.8 135.8 8.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.366 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' A' ' 53' ' ' THR . 76.6 t -116.86 113.95 39.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.72 -169.54 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.901 1.474 . . . . 0.0 110.382 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -71.84 148.78 45.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.75 53.49 6.2 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.675 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 99.8 m -96.51 120.95 37.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.278 -1.131 . . . . 0.0 110.253 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 128.05 35.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.728 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -62.5 115.8 4.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 110.184 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.0 mtt -110.2 157.98 36.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -3.3 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.61 -10.24 41.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' CG ' ' A' ' 47' ' ' ARG . 7.0 mtm -112.22 35.59 3.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.09 111.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.304 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' CD ' ' HB2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -69.51 -71.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.147 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 7.2 p30 -96.79 86.69 4.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.115 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.86 120.52 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.29 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.3 mm-40 -75.51 -81.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.189 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.0 m-20 -89.04 69.28 8.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.56 82.69 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 67' ' ' THR . 36.6 m -85.06 9.7 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -1.17 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.3 t -69.93 -21.99 63.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.922 . . . . 0.0 110.154 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.571 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -175.83 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.571 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -72.65 59.86 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.444 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.74 35.31 5.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.13 -41.26 10.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -1.142 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.235 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -68.47 142.21 55.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.63 131.77 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.63 145.32 40.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.129 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 59.3 t -73.68 133.53 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.79 121.18 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.04 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.24 130.41 19.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t30 -86.68 -68.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -82.73 139.18 33.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -68.49 132.62 47.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 111.08 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -130.82 154.78 81.98 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 109.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.19 -96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.935 1.492 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.2 mt -153.28 -174.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.852 -1.155 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 41.39 32.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.417 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 7.2 m -112.42 129.89 56.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -67.45 158.7 31.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -125.84 135.45 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.294 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.574 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -123.24 173.38 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 20' ' ' ILE . 5.2 tt -56.34 -56.71 17.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.7 mp -52.46 -19.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' THR . 24.4 mmm -88.31 -46.61 9.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 22' ' ' MET . 2.8 ptm -116.44 135.64 53.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -117.29 166.58 12.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.171 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.37 103.37 15.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -112.94 156.82 22.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.169 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.95 91.03 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.153 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.56 148.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -99.18 167.09 11.81 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.11 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.6 Cg_endo -73.86 163.58 89.6 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.401 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.39 93.3 3.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.415 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -81.97 -111.62 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.967 HG23 ' OE2' ' A' ' 36' ' ' GLU . 14.7 mm -91.44 113.6 59.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.337 -1.096 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.71 -174.84 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.944 1.497 . . . . 0.0 110.478 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -87.13 17.88 3.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -76.62 -53.96 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.967 ' OE2' HG23 ' A' ' 32' ' ' ILE . 19.3 pt-20 -92.39 33.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.743 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.2 mm -62.34 -52.71 64.25 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 110.049 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -72.3 -1.96 10.96 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.651 1.342 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.7 m120 -112.45 -32.06 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HG21 ' A' ' 32' ' ' ILE . 1.1 tp -86.72 -39.86 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 0.0 110.131 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 18' ' ' THR . 32.4 t -50.39 127.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.221 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.71 28.89 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.2 mtm -100.01 159.4 15.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 16.2 mp0 -109.95 165.95 11.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.0 m -101.63 165.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER -111.13 16.32 21.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.278 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 13' ' ' ILE . 5.3 mmt180 -143.92 176.63 9.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -80.41 134.71 36.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.487 HG13 HG21 ' A' ' 53' ' ' THR . 15.2 t -124.24 108.59 29.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 110.049 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -72.72 -163.14 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.976 1.514 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -78.45 156.83 29.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.32 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.02 32.87 1.59 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.529 ' OG1' ' CD ' ' A' ' 50' ' ' PRO . 18.3 m -75.0 112.46 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 110.315 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.406 ' HB ' ' CE ' ' A' ' 56' ' ' MET . 20.2 m -48.13 131.23 16.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.853 . . . . 0.0 109.978 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.566 HD12 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.84 100.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.406 ' CE ' ' HB ' ' A' ' 54' ' ' THR . 1.8 mtt -101.46 139.14 20.16 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.0 2.65 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.995 1.524 . . . . 0.0 110.592 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.36 -28.71 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' ASN . 9.2 mtm -95.3 -2.87 48.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.08 127.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -64.99 -92.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.396 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 17.9 p-10 -95.78 90.65 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.17 -0.956 . . . . 0.0 110.197 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.7 t80 -44.92 157.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 10.2 mm-40 -80.79 -80.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.36 33.12 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.09 90.47 0.55 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -96.94 17.53 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.191 . . . . 0.0 110.143 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' CB ' ' A' ' 69' ' ' SER . 9.2 t -77.15 0.73 20.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 110.302 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.528 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 172.99 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.207 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -72.65 172.07 15.95 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.989 1.521 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -34.42 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -77.06 98.42 5.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -1.124 . . . . 0.0 110.228 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 1' ' ' ASN . 52.4 p-10 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.274 0.559 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' CD ' ' HB3' ' A' ' 33' ' ' PRO . 9.4 ptpp? -95.79 160.82 14.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -83.3 174.49 10.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -120.6 165.3 15.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.134 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 97.1 t -92.63 95.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.468 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.8 t -119.12 127.12 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.827 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -80.66 144.49 32.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.462 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 t-20 -77.06 -66.42 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 109.686 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.16 148.78 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -59.33 148.33 32.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -0.954 . . . . 0.0 110.061 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.22 138.01 30.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.89 -159.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.067 1.561 . . . . 0.0 110.258 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.059 HD11 ' HB2' ' A' ' 48' ' ' ALA . 1.6 mp -123.16 173.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 13' ' ' ILE . 11.0 m-20 59.25 19.92 8.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -118.08 151.41 37.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 165.97 21.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.729 HD11 ' CG1' ' A' ' 45' ' ' VAL . 38.8 mt -121.56 117.86 27.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.98 165.05 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.2 -33.69 58.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.274 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.1 mm -55.51 -41.12 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.389 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.92 8.91 43.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.97 124.4 42.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.98 144.18 48.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.999 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.6 94.63 5.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.03 154.53 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 9.2 t -92.15 39.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.158 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.12 159.1 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 11.1 p -81.89 163.13 54.92 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.1 Cg_endo -74.19 178.78 32.18 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.625 -0.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 4' ' ' SER . 1.9 mtt -77.84 -68.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.7 -128.75 18.12 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -103.67 137.1 19.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.159 -1.201 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' CD ' ' A' ' 2' ' ' LYS . 44.8 Cg_endo -72.07 177.72 6.81 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.973 1.512 . . . . 0.0 110.43 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.12 23.96 6.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.303 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -18.78 57.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 109.47 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -105.17 10.81 33.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.3 mm -41.99 -54.44 7.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.697 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -70.04 -3.84 13.01 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.529 1.278 . . . . 0.0 110.737 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLU . 90.4 m-20 -114.15 -36.95 4.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.738 HD12 ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -78.78 -42.14 28.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.2 t -42.63 121.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.255 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.71 1.04 27.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.497 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.6 ttm -99.84 149.77 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -1.178 . . . . 0.0 110.12 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -100.8 159.83 14.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.729 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.7 m -102.45 163.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.43 -9.62 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -136.27 155.69 49.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.938 . . . . 0.0 110.183 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.059 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -86.17 144.12 27.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.709 HG11 HG23 ' A' ' 53' ' ' THR . 38.2 t -130.2 140.35 38.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.0 Cg_endo -73.4 -175.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.083 1.57 . . . . 0.0 110.391 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -44.25 169.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.905 . . . . 0.0 110.286 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 44.11 52.19 7.07 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.827 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 2.2 m -75.36 94.58 3.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -1.109 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.578 HG21 ' HG2' ' A' ' 29' ' ' PRO . 6.6 t -68.11 148.75 50.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.086 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -70.24 105.64 3.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.342 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.54 155.45 44.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.163 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' ' HG2' ' A' ' 56' ' ' MET . 45.9 Cg_endo -73.24 -5.98 18.1 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.012 1.532 . . . . 0.0 110.489 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.3 -45.81 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.548 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -94.52 49.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 98.9 t -130.11 83.94 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -67.35 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -99.59 88.63 3.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.246 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 3.2 t80 -44.33 141.06 1.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.738 ' OE1' HD12 ' A' ' 40' ' ' LEU . 3.4 pt-20 -64.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.352 -0.843 . . . . 0.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 13.9 p-10 -61.91 84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 70' ' ' PRO . . . -86.04 71.76 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 67' ' ' THR . 93.7 m -79.63 5.14 13.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -1.177 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -100.46 -104.22 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -96.22 -66.05 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.884 -1.135 . . . . 0.0 110.493 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.6 Cg_endo -72.64 126.25 11.29 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.508 1.268 . . . . 0.0 110.425 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.85 94.34 0.14 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.4 -48.1 51.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -1.159 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.22 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.24 0.543 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -96.23 151.14 19.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -53.54 121.48 7.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.157 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -90.91 150.37 21.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 55' ' ' LEU . 54.2 t -77.8 114.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 5.8 t -125.89 95.0 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -48.58 128.94 15.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.58 -80.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 110.022 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -58.98 160.07 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.822 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -90.25 140.57 29.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -131.42 140.03 37.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.44 -0.788 . . . . 0.0 110.03 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.4 163.37 37.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.961 1.506 . . . . 0.0 110.211 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 45' ' ' VAL . 3.9 pt -71.7 -177.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.0 m120 60.29 16.39 6.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.285 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 140.2 50.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.19 152.71 44.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.791 HD11 ' CG1' ' A' ' 45' ' ' VAL . 6.9 mt -105.38 138.36 41.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 77.8 p -115.12 153.91 29.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' MET . 13.0 pt -64.81 -20.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 7.6 mtm -97.69 -7.55 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 37' ' ' ILE . 1.4 mmm -96.26 105.49 17.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HD2' ' OD1' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -96.24 141.29 29.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.875 . . . . 0.0 110.311 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -90.62 89.99 7.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.268 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.62 120.12 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.097 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' C ' HG13 ' A' ' 27' ' ' VAL . 94.2 t -68.87 79.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.0 m -151.28 170.22 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.912 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -93.31 165.83 17.49 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.274 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.5 Cg_endo -74.97 167.24 81.01 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.357 -0.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.34 68.89 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.268 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.57 -130.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.596 HG21 ' CD ' ' A' ' 36' ' ' GLU . 2.0 mt -97.33 126.45 41.75 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.165 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.56 50.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.924 1.486 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . 45.93 26.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -69.91 -45.73 66.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' CD ' HG21 ' A' ' 32' ' ' ILE . 1.4 pt-20 -95.25 28.39 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.109 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.3 mm -47.09 -55.02 16.89 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -71.0 -2.74 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.569 1.299 . . . . 0.0 110.542 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 83.9 m-20 -109.48 -31.45 7.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.33 -31.85 15.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.505 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.4 t -43.69 110.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.32 4.45 27.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.5 ' HE3' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -100.23 152.83 19.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -1.219 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.81 154.85 18.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.893 . . . . 0.0 110.232 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.791 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.9 m -102.28 167.02 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' MET . 9.3 t30 -111.1 -11.4 14.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 3.7 mtt-85 -116.18 133.13 56.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 13' ' ' ILE . . . -51.48 124.98 13.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.518 HG13 ' CG2' ' A' ' 53' ' ' THR . 61.9 t -99.07 109.89 55.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.15 -165.02 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.957 1.504 . . . . 0.0 110.424 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -75.56 150.91 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.421 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.5 44.03 11.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' HG13 ' A' ' 49' ' ' VAL . 88.2 m -89.35 122.19 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.01 138.92 57.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 109.993 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -66.45 106.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 110.241 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.401 ' SD ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -106.15 152.58 40.46 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.41 -0.806 . . . . 0.0 110.344 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 56' ' ' MET . 48.0 Cg_endo -74.49 -0.68 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.563 . . . . 0.0 110.583 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.71 -13.9 38.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 7.8 mtt -104.24 -2.57 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.5 HG13 ' HE3' ' A' ' 43' ' ' MET . 28.4 t -100.96 106.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -80.81 78.0 7.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 11.2 t80 -46.13 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -99.41 -86.14 0.38 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.16 80.1 2.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.58 98.35 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 10.26 38.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.348 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.633 HG22 ' N ' ' A' ' 69' ' ' SER . 18.0 m -73.36 -91.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.633 ' N ' HG22 ' A' ' 68' ' ' THR . 0.6 OUTLIER -77.78 -56.13 1.15 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.175 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 69' ' ' SER . 49.5 Cg_endo -76.29 52.64 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.034 1.544 . . . . 0.0 110.297 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.92 72.61 0.54 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.82 17.58 22.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -1.174 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' NZ ' ' CB ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.219 0.533 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -83.81 159.34 21.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 0.0 110.186 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -70.06 137.35 51.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -97.87 157.06 16.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -87.83 104.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' C ' ' A' ' 52' ' ' GLY . 20.3 t -93.32 114.87 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -42.26 126.73 3.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.152 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.545 ' O ' HD23 ' A' ' 51' ' ' LEU . 50.8 t30 -82.46 -73.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.466 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -65.54 140.29 58.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 10' ' ' LEU . 4.2 tt -72.15 126.21 29.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 4.0 pt -130.67 151.05 78.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.966 ' O ' HD13 ' A' ' 13' ' ' ILE . 47.6 Cg_endo -73.69 -95.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.399 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 12' ' ' PRO . 6.2 mm -142.0 163.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 11.8 m120 42.26 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.261 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 88.3 m -154.32 123.18 6.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 110.237 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.73 144.64 21.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 17' ' ' LEU . 3.6 mt -107.63 143.36 36.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.404 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' HG12 ' A' ' 20' ' ' ILE . 1.1 p -116.56 167.13 11.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.35 -21.85 62.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 8.2 pt -73.8 -18.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' ' HB3' ' A' ' 9' ' ' GLN . 2.4 mtt -97.74 21.15 10.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 110.036 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.93 122.27 43.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.1 mmmt -119.11 127.3 53.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.7 74.85 6.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -107.95 118.46 36.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.38 72.56 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.182 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 m -135.69 -173.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 110.182 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 12.2 t -103.86 149.41 37.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.83 167.48 79.87 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.319 -0.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -82.6 81.3 8.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.3 -157.97 0.03 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -75.51 140.04 71.67 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.366 -1.079 . . . . 0.0 110.298 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.12 -168.48 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.1 1.579 . . . . 0.0 110.648 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -106.8 -5.54 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -24.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mm-40 -104.89 47.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.578 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.3 mm -60.74 -53.91 59.72 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 110.339 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.4 Cg_endo -73.05 -5.23 16.83 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.829 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -114.25 -30.82 6.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 0.0 110.372 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 55' ' ' LEU . 7.3 tp -82.06 -50.1 9.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 37' ' ' ILE . 96.9 t -44.46 114.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.16 11.45 18.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 64' ' ' GLU . 4.2 ttm -97.9 143.84 28.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.6 mt-30 -104.31 112.8 25.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.226 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' ASN . 17.6 m -76.84 152.39 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.494 ' HA ' HG22 ' A' ' 13' ' ' ILE . 9.0 t30 -109.95 42.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' NE ' HG13 ' A' ' 49' ' ' VAL . 4.1 ptm180 -141.23 156.29 45.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.95 . . . . 0.0 110.246 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -86.35 116.73 24.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.095 HG12 HG21 ' A' ' 53' ' ' THR . 2.7 m -115.22 112.02 44.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 46.9 Cg_endo -73.77 54.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.1 1.579 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 67.82 151.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 110.861 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.41 38.04 6.69 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.095 HG21 HG12 ' A' ' 49' ' ' VAL . 5.8 m -96.87 141.51 29.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.249 . . . . 0.0 110.225 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.8 HG21 ' HG2' ' A' ' 29' ' ' PRO . 10.1 t -70.42 131.77 44.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.596 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.35 122.93 17.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.302 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.15 135.31 19.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.468 ' HA ' HG21 ' A' ' 60' ' ' VAL . 49.2 Cg_endo -76.47 -24.24 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.101 1.579 . . . . 0.0 111.365 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' MET . 10.5 p-10 -63.64 -37.21 86.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.529 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.7 mmt -99.52 57.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.007 . . . . 0.0 110.003 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 57' ' ' PRO . 77.6 t -124.45 128.71 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 58.5 m-80 -96.09 100.48 12.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.471 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 2.7 t80 -45.43 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -98.43 -155.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 65' ' ' ASP . 27.1 t0 -59.9 79.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -136.25 81.4 0.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 24.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 69' ' ' SER . 66.7 m -86.3 -97.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.548 ' N ' HG22 ' A' ' 68' ' ' THR . 0.4 OUTLIER -80.74 -59.02 0.51 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.024 -1.047 . . . . 0.0 110.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.7 Cg_endo -73.72 -164.2 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.825 1.434 . . . . 0.0 110.58 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.58 -2.64 5.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -75.06 67.13 1.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 63' ' ' TYR . 2.5 mttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.309 0.576 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -80.97 151.34 28.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 110.163 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.19 120.65 12.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.298 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.5 t -97.44 148.21 23.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.08 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 22' ' ' MET . 53.7 t -71.32 109.68 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 110.289 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 54' ' ' THR . 10.7 t -124.16 120.27 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.093 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.911 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.92 130.23 39.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.612 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.2 m-80 -75.25 -23.52 57.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -96.4 155.33 16.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -80.69 127.6 32.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' SD ' ' A' ' 21' ' ' MET . 6.2 pt -129.06 106.87 17.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -72.98 157.35 51.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.53 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.739 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -44.71 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 30.2 m-20 57.39 59.06 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m -160.41 119.24 2.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.11 165.05 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.58 HD11 HG12 ' A' ' 45' ' ' VAL . 15.8 mt -122.5 111.8 17.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 17.6 p -89.13 139.78 30.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.097 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HA ' ' CG ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -50.69 -30.82 14.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.252 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 18' ' ' THR . 9.6 pt -71.15 -13.47 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.553 ' SD ' HG21 ' A' ' 11' ' ' ILE . 7.6 ttm -97.67 -10.41 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.557 ' HE3' HG22 ' A' ' 41' ' ' VAL . 5.5 ptp -117.3 123.23 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -121.11 147.51 45.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.29 96.39 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -109.83 142.96 40.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.177 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -94.74 81.06 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 110.126 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 28' ' ' THR . 8.6 p -126.63 166.52 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.256 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.8 t -114.47 149.24 41.86 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.33 164.37 88.39 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.771 -2.179 . . . . 0.0 110.523 -0.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.2 mtt -81.74 -150.64 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.402 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.8 -99.31 0.15 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 1.7 mt -118.63 132.33 23.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.124 -1.221 . . . . 0.0 109.636 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.66 -175.21 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.847 1.446 . . . . 0.0 110.359 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -86.97 21.88 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 110.299 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -43.83 74.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.479 ' OE2' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -95.22 35.01 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.88 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.6 mm -62.85 -53.25 57.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.925 . . . . 0.0 110.435 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.31 -3.07 12.23 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.581 1.306 . . . . 0.0 110.496 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -103.13 -32.49 9.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.479 HD13 ' OE2' ' A' ' 36' ' ' GLU . 4.0 tp -88.66 -31.69 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 37' ' ' ILE . 46.0 t -45.51 139.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 110.316 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.08 -32.46 5.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.2 ttp -74.91 144.78 43.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -178.43 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.617 HG23 ' HA ' ' A' ' 13' ' ' ILE . 3.3 m -119.08 164.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.074 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.8 t-20 -110.94 -8.58 14.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 110.768 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -130.05 114.86 16.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -0.992 . . . . 0.0 110.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -54.56 138.16 41.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 0.0 110.402 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 4.9 t -130.4 136.61 29.25 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.84 . . . . 0.0 110.15 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.925 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.13 179.84 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.343 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -41.87 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.209 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 54.15 51.76 48.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.911 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 59.8 p -70.63 96.73 1.24 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -1.119 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.593 ' HA ' HG22 ' A' ' 6' ' ' VAL . 15.5 m -55.35 125.87 22.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.074 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 5' ' ' VAL . 4.7 tp -61.93 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.526 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.12 167.46 9.22 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.8 Cg_endo -74.6 2.1 6.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.06 1.558 . . . . 0.0 110.592 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -75.05 -69.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.533 ' CA ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -84.12 62.02 6.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.959 . . . . 0.0 110.578 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 56' ' ' MET . 9.8 t -130.08 124.48 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.36 -94.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.395 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 80.3 m-20 -100.51 100.42 11.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.246 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -46.96 116.59 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -65.38 -79.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.34 88.31 7.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.86 77.13 0.32 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.2 m -82.11 -11.57 58.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -1.15 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -88.95 -143.71 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.528 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -53.31 -57.22 17.71 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.6 128.32 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.939 1.494 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.11 38.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 97.34 5.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -1.131 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.147 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -97.22 154.2 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.199 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . . . -62.49 131.86 50.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.24 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.13 136.51 34.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.117 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 96.6 t -70.19 118.06 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 4' ' ' SER . 4.4 t -121.53 107.96 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.947 . . . . 0.0 110.235 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -51.35 120.1 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.907 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -79.59 -42.3 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.458 ' O ' HG12 ' A' ' 11' ' ' ILE . 40.8 tp60 -91.12 141.26 29.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.776 ' O ' HD23 ' A' ' 10' ' ' LEU . 3.0 tt -60.42 113.64 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 9' ' ' GLN . 12.6 mm -106.21 131.83 21.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.24 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.87 -163.26 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.825 1.434 . . . . 0.0 110.192 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.687 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.6 mt -106.94 -174.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 109.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.521 ' H ' HG22 ' A' ' 13' ' ' ILE . 2.7 m-20 52.26 19.41 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -117.5 155.39 29.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -81.1 156.69 25.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 12.8 mt -100.3 116.22 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' HG22 ' A' ' 20' ' ' ILE . 25.3 p -101.14 126.73 47.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -46.68 -40.74 13.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 tt -43.42 -42.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.593 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -93.35 11.77 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 110.354 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 28.8 mtm -123.99 112.28 17.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.0 153.88 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 3' ' ' ALA . . . -88.31 99.38 12.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -112.95 127.15 56.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -68.84 81.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 28' ' ' THR . 83.8 t -131.8 162.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -100.28 150.18 36.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -75.95 -169.43 7.54 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.393 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 4' ' ' SER . 8.8 ptp -74.18 -29.51 61.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 44.68 -145.52 2.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.972 HD12 ' OH ' ' A' ' 63' ' ' TYR . 42.3 mm -83.32 115.32 58.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.14 . . . . 0.0 110.073 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 46.3 Cg_endo -72.15 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.894 1.471 . . . . 0.0 110.507 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -94.0 23.97 4.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.9 mm-40 -76.95 -49.67 15.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.841 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE2' ' CG ' ' A' ' 65' ' ' ASP . 3.1 mm-40 -100.39 37.8 1.62 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.823 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.969 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -63.96 -54.03 43.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.7 Cg_endo -72.01 -2.14 11.08 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.694 1.365 . . . . 0.0 110.294 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 5.1 m120 -106.95 -41.72 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' MET . 2.9 tp -74.5 -24.88 59.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 37' ' ' ILE . 34.6 t -45.7 99.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.78 11.9 21.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 53.5 tpp -81.43 155.12 26.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -1.188 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.7 157.83 16.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 110.252 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 13' ' ' ILE . 2.7 p -118.76 159.97 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' C ' HG21 ' A' ' 13' ' ' ILE . 35.4 t-20 -110.67 -13.76 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' H ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -118.02 174.74 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 0.0 110.145 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -85.53 149.04 25.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.589 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 53' ' ' THR . 54.2 t -128.24 107.5 19.57 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.833 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' C ' ' HG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -71.93 -160.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.966 1.509 . . . . 0.0 110.694 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.17 153.81 31.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.429 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.9 43.64 5.41 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.658 ' HB ' HG13 ' A' ' 49' ' ' VAL . 40.1 m -89.84 119.5 30.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -1.136 . . . . 0.0 110.328 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.9 141.26 58.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -66.05 115.45 6.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.279 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.57 138.58 21.52 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.71 -0.05 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.341 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -84.05 -20.71 32.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.892 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.502 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 22.0 mtt -99.67 -15.16 18.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.99 111.93 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 110.054 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -73.48 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.58 97.12 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.189 -0.945 . . . . 0.0 110.304 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.972 ' OH ' HD12 ' A' ' 32' ' ' ILE . 2.4 t80 -62.4 152.41 34.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.465 ' OE2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -71.78 -53.28 13.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 110.385 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' CG ' ' OE2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -60.19 -42.31 94.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.413 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' CA ' ' HA2' ' A' ' 71' ' ' GLY . . . 48.92 83.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 68' ' ' THR . 34.2 m -89.01 -87.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.336 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' THR . 1.3 p -110.16 -92.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 110.52 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.549 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -49.97 -53.79 39.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.4 Cg_endo -74.61 2.09 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.906 1.477 . . . . 0.0 110.74 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' ' CA ' ' A' ' 66' ' ' GLY . . . -56.45 -56.98 21.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 156.85 18.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.195 . . . . 0.0 110.277 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.119 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.236 0.541 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 116.4 28.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.43 169.65 12.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -122.52 169.8 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.568 ' O ' HD23 ' A' ' 55' ' ' LEU . 21.8 t -94.27 110.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' HA2' ' A' ' 52' ' ' GLY . 15.3 t -116.52 114.04 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.045 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -52.94 127.68 24.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -0.949 . . . . 0.0 110.041 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 39.6 t30 -74.57 -55.12 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.543 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -91.24 148.18 22.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.497 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 10' ' ' LEU . 9.0 tt -61.32 128.47 36.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.889 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -101.4 123.6 44.02 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.2 Cg_endo -78.4 47.34 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.874 1.46 . . . . 0.0 110.78 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.3 mt 49.91 177.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.17 -0.956 . . . . 0.0 110.387 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 13' ' ' ILE . 5.9 m-20 45.42 36.17 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.448 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 16.4 m -132.53 119.69 20.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.02 159.29 5.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.3 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 23.6 mt -103.17 134.8 45.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.61 -168.75 1.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.47 -45.14 73.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.511 HD12 ' SD ' ' A' ' 21' ' ' MET . 5.9 pt -55.41 -28.26 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.01 11.47 33.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.479 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -115.12 109.75 18.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -114.36 122.94 48.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.302 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.09 79.93 9.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.98 129.07 46.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 26' ' ' VAL . 49.4 t -76.65 55.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.68 155.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.477 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -93.42 165.15 18.86 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.63 ' O ' HG21 ' A' ' 54' ' ' THR . 47.4 Cg_endo -74.92 159.87 97.36 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.493 -0.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -53.58 56.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.19 -113.36 5.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.911 HD12 HD12 ' A' ' 55' ' ' LEU . 8.3 mt -127.67 127.36 24.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.163 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -175.8 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.883 1.464 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.636 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -98.94 26.38 5.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -62.38 -38.99 91.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -102.09 45.94 0.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.0 110.321 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.636 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -57.14 -42.52 96.67 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.5 Cg_endo -78.0 -7.13 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.529 1.278 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 1.3 m-20 -111.36 -36.49 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 47.6 tp -79.86 -38.63 32.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 23.0 t -52.21 141.57 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.26 -18.72 55.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 4.9 ttp -81.23 132.08 35.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -1.198 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -89.91 147.59 23.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.122 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 7.3 m -87.34 156.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -98.83 -5.95 30.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.344 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -127.94 163.08 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.159 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -82.21 135.79 35.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.664 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.828 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -119.83 124.99 27.62 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 109.781 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.41 -177.77 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.856 1.451 . . . . 0.0 110.55 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.14 143.41 56.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.328 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 56.93 47.35 87.57 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.045 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 4.9 t -86.08 113.54 22.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -1.145 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.63 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.4 m -55.04 143.36 27.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.033 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -61.83 101.32 0.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.169 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -108.5 148.61 38.03 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 60' ' ' VAL . 47.9 Cg_endo -74.02 1.88 6.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.99 1.521 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -52.81 7.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.54 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -87.32 45.67 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.4 t -123.96 133.12 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -91.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.9 104.42 15.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.35 155.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.9 mm-40 -103.57 -96.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.64 52.34 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 110.346 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.67 60.08 0.51 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -82.3 59.38 4.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' SER . 33.6 m -96.67 -89.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.48 -56.65 3.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.134 -0.979 . . . . 0.0 110.112 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -73.55 -166.32 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.044 1.55 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.14 173.56 40.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.16 175.2 6.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.193 -1.181 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.253 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.317 0.58 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -64.34 -177.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -86.4 142.59 28.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.272 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.4 p -97.03 169.23 9.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.071 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 24.8 t -86.74 88.93 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.1 t -106.55 121.9 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.132 -0.98 . . . . 0.0 109.868 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.999 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.73 143.8 32.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.443 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 48.7 t30 -73.82 -72.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -62.71 148.6 46.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.074 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.025 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -60.3 159.37 10.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.932 ' N ' HD22 ' A' ' 10' ' ' LEU . 1.8 pt -130.95 117.99 17.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.694 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 51.3 Cg_endo -80.45 50.57 3.59 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.834 1.439 . . . . 0.0 110.19 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 23.4 pt 39.18 -164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.615 -0.678 . . . . 0.0 110.755 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' ILE . 15.1 p30 37.88 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.568 -0.708 . . . . 0.0 110.781 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.4 m -138.45 118.67 13.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.62 155.19 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 109.992 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.39 127.0 53.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.4 OUTLIER -100.87 150.74 22.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.696 ' C ' HD23 ' A' ' 19' ' ' LEU . 7.5 tt -42.67 -49.53 5.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 3.6 mt -63.54 -24.78 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -84.55 -19.39 33.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.615 ' CE ' HD11 ' A' ' 37' ' ' ILE . 1.8 ptm -116.48 136.69 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.88 131.04 55.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.942 . . . . 0.0 110.2 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -74.77 97.18 3.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 139.42 40.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 3' ' ' ALA . 23.5 t -95.37 81.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.176 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -161.82 154.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 110.043 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.4 t -74.65 150.24 86.49 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 110.155 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.42 161.91 93.61 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.693 -2.211 . . . . 0.0 110.481 -0.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -82.65 -81.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.386 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.77 -122.54 7.44 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' HG ' ' A' ' 55' ' ' LEU . 5.5 mt -123.95 139.12 31.8 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.106 -1.232 . . . . 0.0 109.919 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.1 1.579 . . . . 0.0 110.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -108.25 41.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -65.09 -21.92 66.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.987 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 64' ' ' GLU . 4.8 mm-40 -105.32 35.5 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.785 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.7 mm -40.62 -54.94 4.78 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.531 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.39 -6.8 19.95 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.632 1.333 . . . . 0.0 110.889 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 m-20 -114.25 -18.87 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.128 -0.983 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -102.07 -34.7 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.6 t -42.69 103.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 125.12 9.38 5.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.63 144.92 26.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -1.174 . . . . 0.0 110.12 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 3.6 mt-30 -109.75 168.16 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 11' ' ' ILE . 12.4 m -116.09 174.79 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 -7.3 14.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.426 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.497 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -125.4 119.21 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.182 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -68.33 145.03 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.398 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 53' ' ' THR . 23.7 t -129.42 139.79 36.73 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 110.178 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.66 89.68 0.97 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.304 1.686 . . . . 0.0 110.713 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 55.25 160.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.395 -0.816 . . . . 0.0 110.73 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 41.37 65.95 1.04 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.999 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.3 t -91.83 113.52 25.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.096 -1.238 . . . . 0.0 110.015 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 30' ' ' MET . 1.5 m -73.68 121.96 21.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.82 106.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.733 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.682 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.8 mtt -112.92 156.94 41.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.57 -2.98 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.076 1.566 . . . . 0.0 110.485 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.45 -30.41 16.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 7.5 mmt -99.16 0.31 43.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.068 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 56' ' ' MET . 55.8 t -91.36 102.23 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CD ' ' OXT' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -67.36 -58.98 3.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.042 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 14.5 p-10 -100.59 80.11 2.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' OG ' ' A' ' 69' ' ' SER . 1.6 t80 -46.49 146.12 1.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.9 . . . . 0.0 110.464 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -70.41 -175.28 0.99 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.235 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -60.03 -57.74 11.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.97 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 50.68 179.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -107.61 -60.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 0.0 110.052 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 68' ' ' THR . 8.3 t -102.71 55.61 0.77 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.931 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -95.67 -177.91 0.71 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 110.303 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 43.6 Cg_endo -72.55 -89.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.481 . . . . 0.0 110.341 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.76 -15.68 3.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.51 130.66 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 110.138 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.492 ' OXT' ' CD ' ' A' ' 61' ' ' LYS . 4.0 mptt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.238 0.542 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -88.07 154.52 20.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 110.144 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -55.98 135.9 52.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.142 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 30' ' ' MET . 46.5 t -113.31 160.24 18.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.295 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 53.3 t -92.02 97.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 54' ' ' THR . 14.9 t -117.44 125.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.57 137.1 45.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.581 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.6 t-20 -73.6 -44.49 56.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 110.248 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 14.6 tt0 -88.28 152.81 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -64.21 152.14 41.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -129.84 133.9 25.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.16 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.92 1.484 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.614 HG23 HG23 ' A' ' 45' ' ' VAL . 2.3 mt -116.17 170.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -0.915 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.16 11.75 4.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.3 m -115.79 140.83 48.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 110.298 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -62.16 163.22 8.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.21 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 45' ' ' VAL . 9.1 mt -112.03 120.79 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.135 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.413 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -100.11 130.93 46.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -46.29 -40.75 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 19' ' ' LEU . 64.3 mt -46.91 -36.71 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 62.4 mtp -86.61 -19.01 29.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.273 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.2 mtm -102.05 127.56 48.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.223 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.9 mtpt -114.6 170.76 8.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.42 94.45 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.2 131.71 55.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 3' ' ' ALA . 32.4 t -78.66 87.63 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.99 149.41 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.6 t -102.5 149.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.066 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.72 133.51 31.65 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.741 -2.191 . . . . 0.0 110.516 -0.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ILE . 3.9 ptp -60.21 -29.63 68.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 57.8 -85.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 55' ' ' LEU . 3.8 mt -132.74 127.67 20.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.188 -1.184 . . . . 0.0 110.202 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.28 -160.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.885 1.466 . . . . 0.0 110.405 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -100.51 28.79 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.301 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -46.08 37.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.42 24.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.7 mm -50.94 -53.1 51.4 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.844 . . . . 0.0 110.565 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -70.78 -1.13 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.53 1.279 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' O ' ' CD ' ' A' ' 64' ' ' GLU . 35.3 m120 -113.5 -46.01 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -0.97 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -78.78 -35.4 44.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.472 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 t -44.29 107.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.045 -1.034 . . . . 0.0 110.034 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 113.76 12.28 11.67 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.1 mmm -94.49 160.69 14.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.164 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.21 147.14 34.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 17' ' ' LEU . 4.5 m -102.37 166.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 47' ' ' ARG . 55.6 p30 -101.59 -11.95 18.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.22 -0.925 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 63.4 mtt180 -130.99 156.96 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -86.05 141.53 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 110.279 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG22 ' SD ' ' A' ' 59' ' ' MET . 6.7 t -121.63 132.85 24.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' O ' HG22 ' A' ' 53' ' ' THR . 44.8 Cg_endo -71.9 -172.96 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.885 1.466 . . . . 0.0 110.339 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -46.36 155.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 55.89 59.99 9.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.797 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 38.8 p -78.34 95.24 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -1.077 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 6' ' ' VAL . 7.0 m -62.88 133.85 55.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.37 96.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.219 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mmm -112.65 153.64 44.96 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.155 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.23 3.16 6.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.944 1.497 . . . . 0.0 110.559 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -39.11 36.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.482 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.605 ' SD ' HG22 ' A' ' 49' ' ' VAL . 5.9 mtm -111.82 60.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.342 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG13 ' CE ' ' A' ' 43' ' ' MET . 83.9 t -129.49 104.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -81.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.518 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -93.04 93.17 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.422 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -47.76 150.22 1.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 39' ' ' ASN . 71.8 mm-40 -80.1 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.02 82.2 8.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.6 65.4 3.96 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -30.3 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -1.114 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 56.8 p -110.44 -129.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -73.73 -54.26 3.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.949 -1.094 . . . . 0.0 111.041 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 69' ' ' SER . 42.8 Cg_endo -69.2 59.79 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.693 1.365 . . . . 0.0 110.924 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -133.04 -2.37 3.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.26 135.01 46.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 0.0 110.424 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.193 179.918 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 160.04 26.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.256 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.93 156.89 36.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.44 149.39 42.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 34' ' ' ALA . 73.7 t -75.0 97.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.0 t -108.25 123.89 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.207 -0.933 . . . . 0.0 110.153 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -57.79 141.07 50.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.35 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t-20 -80.19 -67.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.845 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.415 ' O ' HG12 ' A' ' 11' ' ' ILE . 50.3 tt0 -87.54 155.33 20.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.819 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -59.36 141.11 55.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 110.201 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.769 ' H ' HG23 ' A' ' 49' ' ' VAL . 10.8 mm -130.55 144.9 55.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 110.058 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 44.2 Cg_endo -71.37 -170.94 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.947 1.498 . . . . 0.0 110.261 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 47' ' ' ARG . 6.2 mt -107.27 167.47 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.92 . . . . 0.0 110.023 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 54.72 26.18 7.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.185 -0.947 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -113.72 141.33 47.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.923 . . . . 0.0 110.217 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 104.96 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -87.27 162.79 17.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.356 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.29 163.21 23.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.99 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -57.24 -28.66 63.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG13 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.1 -17.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.67 -10.14 25.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.572 ' CE ' HD13 ' A' ' 17' ' ' LEU . 3.3 mtt -123.27 139.34 54.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.46 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -112.24 170.08 8.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.016 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.18 6.31 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 141.63 46.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.66 82.02 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.63 155.18 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 110.127 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.2 p -111.85 159.86 31.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.263 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -76.17 132.24 26.87 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.511 -2.287 . . . . 0.0 110.477 -0.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.78 153.44 29.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -120.57 -71.4 0.31 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 57' ' ' PRO . 3.1 mt -136.2 137.93 25.94 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.3 Cg_endo -73.07 -162.97 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.067 1.562 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -111.49 38.63 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -31.46 69.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 33.2 mm-40 -101.74 30.36 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.982 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.9 mm -44.89 -54.19 13.86 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -70.99 -5.77 17.71 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.632 1.333 . . . . 0.0 110.441 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.584 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 1.4 m-20 -108.46 -24.83 11.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 110.127 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -93.74 -12.86 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 109.967 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 37' ' ' ILE . 41.5 t -46.79 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.37 24.12 9.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.94 137.49 36.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.996 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 3.5 mt-30 -96.57 116.49 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.158 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.99 167.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.095 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 17.8 t30 -110.84 2.38 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HG2' ' CB ' ' A' ' 59' ' ' MET . 9.3 ptm180 -136.63 155.93 49.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.418 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -79.42 113.34 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.865 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.012 HG12 HG21 ' A' ' 53' ' ' THR . 19.1 m -81.87 112.33 34.05 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 48.2 Cg_endo -73.6 53.05 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.887 1.467 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER 66.82 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.496 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.22 49.11 14.93 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.012 HG21 HG12 ' A' ' 49' ' ' VAL . 11.3 m -96.83 123.71 40.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 142.63 58.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 110.165 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.22 120.74 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.482 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 46.5 mmm -112.7 137.49 21.75 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.8 Cg_endo -74.2 -7.39 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.62 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -52.49 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.488 ' CB ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 mpt? -87.78 62.12 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.329 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 56' ' ' MET . 28.8 t -128.57 106.47 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.171 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 9.4 mmtt -49.92 -84.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.79 91.79 8.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -48.66 135.82 14.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 8.2 pm0 -78.41 -37.81 43.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -0.939 . . . . 0.0 110.53 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 24.9 t70 -84.39 99.99 11.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.89 31.12 4.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -99.78 -64.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -108.82 -14.35 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.597 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -70.27 -171.47 0.16 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 47.3 Cg_endo -77.52 -4.83 15.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.778 1.409 . . . . 0.0 110.497 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.57 40.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.37 158.88 15.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 110.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.307 0.575 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -67.09 137.03 56.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.202 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 114.13 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -95.08 147.55 23.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.666 ' CG1' HD23 ' A' ' 55' ' ' LEU . 53.0 t -79.57 120.11 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 110.181 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.686 HG13 ' N ' ' A' ' 54' ' ' THR . 6.4 t -126.53 110.19 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.264 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -54.73 135.02 47.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.69 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -87.42 -71.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 2.2 pt20 -58.44 144.8 40.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -71.42 126.6 30.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.519 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -126.38 144.21 48.61 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.202 -0.936 . . . . 0.0 110.363 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.91 -158.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.982 1.517 . . . . 0.0 110.349 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.698 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.8 mt -95.74 -172.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.698 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.5 OUTLIER 39.86 30.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -104.83 115.81 30.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -64.25 98.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.591 HD11 HD23 ' A' ' 40' ' ' LEU . 1.7 pp -70.4 152.62 43.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.7 p -130.17 -160.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.3 mp -77.05 -43.11 35.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pt -69.18 -16.88 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -97.37 -12.73 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.33 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.554 ' HG3' HD13 ' A' ' 17' ' ' LEU . 39.3 mmm -124.13 107.46 11.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.153 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 21.9 mttt -99.22 144.18 28.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.76 98.56 11.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.4 mp0 -113.24 143.51 44.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 2' ' ' LYS . 8.1 p -96.75 62.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.92 -174.51 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 0.0 110.39 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.8 t -100.34 150.86 37.3 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.103 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 51.0 Cg_endo -81.84 153.74 78.65 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.689 -2.213 . . . . 0.0 110.563 -0.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -82.66 159.78 22.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.866 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -113.31 0.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -99.99 141.41 22.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 44.4 Cg_endo -71.43 -164.05 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.004 1.528 . . . . 0.0 110.466 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -116.91 27.29 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.925 . . . . 0.0 110.376 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.487 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -74.46 -17.13 60.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.246 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 pm0 -102.68 1.41 34.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.889 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -41.32 -54.56 5.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.496 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -70.5 -8.11 22.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.647 1.341 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.0 m120 -114.39 -18.61 11.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.067 -1.021 . . . . 0.0 110.501 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.591 HD23 HD11 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -102.4 -26.71 13.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.582 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 37' ' ' ILE . 10.6 t -42.63 127.96 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.97 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.25 -0.65 47.07 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -87.53 152.24 22.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -1.123 . . . . 0.0 110.139 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -99.72 174.73 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 13' ' ' ILE . 1.6 p -113.43 163.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 1.2 m-20 -102.81 -29.34 11.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 110.611 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 17.2 mtp180 -121.74 164.99 16.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.548 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -57.56 150.1 19.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 0.0 110.508 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.119 ' CG1' HG21 ' A' ' 53' ' ' THR . 80.5 t -127.88 107.27 20.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.056 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.72 -171.94 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.06 1.558 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -73.89 160.69 31.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.867 . . . . 0.0 110.184 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.54 46.92 7.19 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.119 HG21 ' CG1' ' A' ' 49' ' ' VAL . 8.1 t -92.38 104.87 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.686 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -51.54 157.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.93 112.0 2.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.474 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 3.0 tpt -112.51 127.58 26.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.91 -20.55 19.5 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.857 1.451 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -65.84 -23.1 66.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 45' ' ' VAL . 33.0 mtm -113.51 49.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 61.5 t -127.09 139.53 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' CE ' ' A' ' 43' ' ' MET . 37.3 t30 -90.34 92.66 9.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 86.3 m-85 -44.69 149.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -94.58 -47.21 6.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.89 95.39 10.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.58 5.34 83.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -9.69 47.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.0 110.176 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 3.2 p -106.04 -178.56 3.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.282 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -50.76 -56.0 22.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.467 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.2 Cg_endo -72.21 112.54 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.916 1.482 . . . . 0.0 110.522 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.29 49.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 72' ' ' LEU . 11.3 mt -80.93 -2.71 48.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -1.115 . . . . 0.0 110.329 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.252 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.312 0.577 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 162.75 12.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -65.01 126.79 29.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 14.4 t -95.01 166.44 11.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.156 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ILE . 15.0 t -85.54 110.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' GLU . 3.9 t -111.32 113.2 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.088 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.09 128.78 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.695 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.2 t-20 -80.59 -55.69 4.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.02 177.69 6.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.068 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.9 tt -99.65 130.53 45.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.786 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -126.8 133.17 24.74 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -73.15 56.96 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.983 1.517 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 mt 45.66 -172.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.076 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.6 m-20 43.63 63.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.114 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 m -159.61 119.09 2.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.4 85.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 43' ' ' MET . 1.2 pp -50.71 155.29 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.5 OUTLIER -130.01 159.91 35.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.178 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.1 tt -59.72 -48.42 81.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.821 ' N ' HD23 ' A' ' 19' ' ' LEU . 88.3 mt -57.7 -31.6 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.233 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -86.19 -26.15 25.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 18' ' ' THR . 15.9 mmt -110.91 131.2 55.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -107.41 165.33 11.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.67 99.97 9.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.2 tt0 -104.57 135.47 45.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.191 -0.943 . . . . 0.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 3' ' ' ALA . 12.2 t -85.38 71.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.9 t -133.07 160.4 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.4 t -88.13 152.22 50.21 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -77.77 160.31 93.05 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.546 -0.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtm -82.68 101.13 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.65 -119.9 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.582 ' CD1' HD12 ' A' ' 55' ' ' LEU . 1.8 mt -99.59 129.31 29.19 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 110.02 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 178.38 5.82 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.889 1.468 . . . . 0.0 110.761 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.747 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -79.3 2.79 20.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.378 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 34' ' ' ALA . 8.3 tt0 -43.58 -39.86 3.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -104.92 39.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.233 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.747 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -55.99 -54.56 50.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 110.233 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -70.61 -4.48 14.68 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.661 1.348 . . . . 0.0 110.45 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -111.45 -31.18 7.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.139 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -73.5 -39.61 64.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.141 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 41' ' ' VAL . 24.4 t -45.24 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.113 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 119.57 19.27 4.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.499 ' CE ' HG11 ' A' ' 60' ' ' VAL . 2.0 ttt -98.5 144.34 27.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -1.095 . . . . 0.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.83 146.53 28.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.162 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 13' ' ' ILE . 7.5 m -104.87 153.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.08 28.71 8.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 8.8 ptt180 -151.21 137.93 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -48.95 130.86 18.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.926 HG13 ' HB ' ' A' ' 53' ' ' THR . 9.9 t -117.32 106.86 46.17 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.98 -168.14 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.539 . . . . 0.0 110.398 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -70.37 136.82 50.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 60.98 52.67 50.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.926 ' HB ' HG13 ' A' ' 49' ' ' VAL . 63.3 m -96.49 124.87 40.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -1.119 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 54' ' ' THR . 4.8 t -68.45 149.84 48.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.142 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.12 111.34 12.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.336 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtt -104.8 133.01 20.38 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . 50.0 Cg_endo -76.99 6.23 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.948 1.499 . . . . 0.0 110.677 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 -42.19 21.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.055 -1.028 . . . . 0.0 110.521 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.551 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 3.2 mmt -110.54 67.28 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.6 t -126.25 122.36 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.867 . . . . 0.0 110.141 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.3 -77.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.09 105.62 17.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 70' ' ' PRO . 59.1 m-85 -67.26 155.61 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 110.223 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -104.54 -65.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.9 -43.91 67.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.02 90.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 68' ' ' THR . 6.6 m -105.07 -83.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.213 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 67' ' ' THR . 59.0 m -106.96 -80.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -51.8 -61.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.1 Cg_endo -71.13 154.6 62.1 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.814 1.428 . . . . 0.0 110.428 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.88 162.38 31.23 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 109.94 4.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -1.105 . . . . 0.0 110.216 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.305 0.574 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 26' ' ' VAL . 21.4 mmtt -90.59 -16.93 27.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -47.88 112.44 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -102.15 148.21 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.016 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 59.4 t -72.86 104.33 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.173 -0.954 . . . . 0.0 110.269 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -107.97 105.87 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.048 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.56 115.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -72.75 -62.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.056 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -86.61 152.43 22.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.3 tt -59.34 142.26 52.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 11' ' ' ILE . 35.2 mm -123.04 139.18 31.01 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 -162.11 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.024 1.539 . . . . 0.0 110.329 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 6.5 mt -116.55 157.82 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 64.31 38.26 8.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 6.1 m -132.49 138.4 47.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -61.89 158.72 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.2 mt -110.01 148.16 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -129.96 132.23 46.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.767 HD23 HG21 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -49.41 -31.28 9.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' CG1' ' HB ' ' A' ' 18' ' ' THR . 13.4 pt -69.51 -16.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 109.985 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.84 -15.65 22.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 110.073 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -121.64 119.66 32.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.29 164.55 14.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -94.75 115.63 27.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -111.28 124.88 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 2' ' ' LYS . 16.5 t -90.17 65.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.55 -173.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -111.94 153.0 44.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.086 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.33 161.93 92.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.432 -0.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.3 mtp -82.82 92.01 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.64 -144.73 0.28 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -79.63 136.24 55.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.325 -1.103 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.51 -174.26 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.002 1.527 . . . . 0.0 110.644 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.666 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -112.32 17.34 19.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.316 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -34.03 77.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.136 -0.977 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.5 mm-40 -89.24 26.41 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.666 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.96 -40.81 81.22 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.0 111.217 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.5 Cg_endo -74.81 -18.54 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.315 1.166 . . . . 0.0 111.256 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -114.31 -11.75 12.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 110.272 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.598 HD12 ' CD ' ' A' ' 64' ' ' GLU . 9.3 tt -102.42 -44.01 5.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 HD23 ' A' ' 19' ' ' LEU . 33.3 t -41.8 148.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.434 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -16.3 61.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.6 mtp -73.27 157.01 37.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -1.107 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' THR . 4.4 mp0 -110.05 170.34 8.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.8 m -109.5 166.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 110.252 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.92 -4.23 18.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' HD13 ' A' ' 13' ' ' ILE . 3.4 mtp180 -143.18 168.45 19.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.192 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -78.11 139.24 39.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.899 HG13 HG21 ' A' ' 53' ' ' THR . 88.8 t -112.04 127.28 27.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.84 . . . . 0.0 110.164 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.06 -171.88 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.841 1.442 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' A' ' 10' ' ' LEU . 2.1 mp -74.97 153.13 38.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.502 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 42.69 53.33 5.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.899 HG21 HG13 ' A' ' 49' ' ' VAL . 83.0 m -96.97 109.57 22.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.26 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 148.51 2.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.885 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.0 102.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.973 . . . . 0.0 110.211 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.1 mmt -111.35 149.63 40.89 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 Cg_endo -75.66 4.07 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.975 1.513 . . . . 0.0 110.798 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.32 -42.16 62.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 110.644 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.12 55.15 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.2 t -130.28 102.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -66.88 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.06 86.87 6.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 27.8 m-85 -44.29 155.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.598 ' CD ' HD12 ' A' ' 40' ' ' LEU . 1.4 pt-20 -76.38 -158.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 110.342 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 4.1 m-20 -68.6 73.35 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -111.68 92.53 0.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 67' ' ' THR . 85.6 m -97.39 21.71 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.3 p -97.43 -15.06 20.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.087 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.59 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -173.54 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.046 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.0 Cg_endo -72.24 169.76 20.78 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.854 1.449 . . . . 0.0 110.227 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.35 56.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.15 75.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.087 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.238 0.542 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -92.92 170.4 9.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.126 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.95 127.65 35.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -102.24 137.34 40.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' ILE . 15.9 m -78.22 129.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 54' ' ' THR . 11.4 t -122.13 131.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.712 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.69 129.31 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.89 -70.82 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -80.0 160.85 25.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.9 tt -77.98 130.97 37.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 49' ' ' VAL . 4.4 mt -116.59 113.54 40.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.151 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.852 ' C ' HD13 ' A' ' 13' ' ' ILE . 46.9 Cg_endo -73.25 66.12 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.83 1.437 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.852 HD13 ' C ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 32.78 -161.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.534 0.683 . . . . 0.0 111.696 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 18.4 m-20 36.52 42.17 0.19 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -147.72 124.53 11.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.58 7.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.812 . . . . 0.0 110.02 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 45' ' ' VAL . 60.7 mt -62.33 133.46 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.68 155.78 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -67.79 -29.1 68.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.345 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 21' ' ' MET . 1.4 pt -65.15 -19.67 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 110.139 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.523 ' N ' HG13 ' A' ' 20' ' ' ILE . 3.2 mtm -97.98 -2.25 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.9 118.57 32.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.272 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.6 pttt -114.81 142.27 46.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.56 96.32 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.957 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -112.2 133.93 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 3' ' ' ALA . 18.2 t -90.71 87.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.194 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG13 ' C ' ' A' ' 26' ' ' VAL . 18.1 m -148.76 -167.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.384 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.6 t -118.71 153.44 52.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 110.236 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -77.2 160.63 94.11 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.446 -0.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.1 mmm -82.62 71.27 9.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.154 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -55.96 -108.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.713 ' O ' HG22 ' A' ' 5' ' ' VAL . 2.6 mt -113.12 136.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -162.0 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.928 1.488 . . . . 0.0 110.352 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -93.69 32.91 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -56.86 4.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 15.5 mm-40 -88.67 33.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.43 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.9 mm -60.04 -54.71 52.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.0 Cg_endo -71.39 -8.85 24.2 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.262 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.99 -47.71 4.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 0.0 110.14 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -68.3 -41.25 81.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -54.78 119.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.7 -8.26 10.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.535 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.4 ttm -100.78 162.25 13.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -1.115 . . . . 0.0 110.218 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -109.86 138.2 46.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 17' ' ' LEU . 12.6 m -91.48 154.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -104.61 -2.73 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 4.2 mtt180 -113.14 131.35 55.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.002 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.86 132.27 9.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.384 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.641 HG13 ' CB ' ' A' ' 53' ' ' THR . 55.8 t -113.17 102.4 54.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 110.058 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.4 Cg_endo -72.03 -167.13 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.543 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.58 138.54 40.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.24 34.93 91.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.2 m -73.5 97.87 2.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -44.98 137.9 3.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.22 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.24 98.66 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.429 ' CG ' ' HG3' ' A' ' 59' ' ' MET . 2.9 ptm -113.11 146.5 35.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.53 -5.44 17.15 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.541 . . . . 0.0 110.458 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -76.99 -25.48 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.295 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' CB ' ' A' ' 47' ' ' ARG . 11.0 mtt -108.21 41.53 1.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG13 ' CE ' ' A' ' 43' ' ' MET . 49.7 t -130.26 104.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 19.2 tptm -69.16 -60.35 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -98.37 71.57 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 13.1 t80 -53.36 158.47 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mm-40 -87.84 -65.63 1.0 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.36 85.21 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.65 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.91 17.86 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.171 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -80.22 -137.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.8 -55.98 4.22 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.594 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.35 -163.89 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.912 1.48 . . . . 0.0 110.457 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.7 87.79 0.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.678 ' O ' HD23 ' A' ' 72' ' ' LEU . 8.9 tt -85.49 -7.68 58.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 110.342 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.227 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.253 0.549 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -93.37 142.65 27.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.69 126.55 29.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' GLU . 3.5 t -95.86 -178.48 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 55' ' ' LEU . 77.3 t -89.18 119.9 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.413 HG12 ' C ' ' A' ' 52' ' ' GLY . 3.5 t -126.82 101.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.219 -0.926 . . . . 0.0 110.165 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -47.15 116.48 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.106 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -79.66 -63.65 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.05 135.55 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.309 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.615 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.0 tt -60.45 142.06 55.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD13 HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -130.1 116.69 17.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.581 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.84 59.71 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.849 1.447 . . . . 0.0 110.1 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 13.9 pt 39.92 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.661 . . . . 0.0 110.727 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 13' ' ' ILE . 3.8 m120 40.34 47.25 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.467 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -156.71 110.36 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.825 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.56 118.12 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 22' ' ' MET . 5.9 mt -75.92 128.48 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -171.15 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.132 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.66 -45.96 67.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.119 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.31 -9.24 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -28.89 21.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE3' HD13 ' A' ' 17' ' ' LEU . 1.4 mmt -118.92 143.26 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 8' ' ' ASN . 8.5 mttt -115.68 166.68 11.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.735 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -100.33 79.1 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.82 152.99 20.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -90.08 14.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 25' ' ' GLU . 22.8 t -62.36 142.44 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -88.14 163.82 35.7 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.136 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.79 174.17 53.79 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.608 -2.246 . . . . 0.0 110.42 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.61 86.95 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 54' ' ' THR . . . -68.49 -150.75 0.3 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -76.26 137.59 68.28 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.361 -1.082 . . . . 0.0 110.063 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 170.56 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.955 1.503 . . . . 0.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.037 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -94.07 38.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.863 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -25.54 53.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.119 -0.988 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.77 ' CB ' HD23 ' A' ' 40' ' ' LEU . 7.6 mm-40 -105.09 41.97 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.63 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.037 HD11 ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -44.78 -50.18 25.62 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.89 -11.99 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.632 1.332 . . . . 0.0 110.619 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.89 -30.6 11.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.77 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -83.11 -47.07 12.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.105 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 31.4 t -43.22 104.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.056 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.825 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.07 11.98 11.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.4 ttm -83.37 134.33 34.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 144.8 31.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 14.4 m -119.11 160.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -110.85 0.63 17.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 0.0 110.359 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -120.02 122.3 40.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 110.366 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -47.12 140.61 4.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.34 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.881 HG13 HG21 ' A' ' 53' ' ' THR . 12.0 t -124.84 130.36 24.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.3 Cg_endo -69.6 -174.38 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.944 1.497 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -79.69 154.67 28.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 48.66 43.67 29.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.881 HG21 HG13 ' A' ' 49' ' ' VAL . 55.4 m -92.02 134.18 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -1.154 . . . . 0.0 110.266 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.438 ' CG2' ' HA3' ' A' ' 31' ' ' GLY . 7.6 m -67.38 141.24 57.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.095 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -61.93 99.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 mtp -102.83 142.51 24.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 49.3 Cg_endo -75.31 2.59 6.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.013 1.533 . . . . 0.0 110.593 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.11 -32.47 24.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.133 -0.979 . . . . 0.0 110.521 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 mtt -96.31 3.49 52.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 110.393 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.68 82.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.324 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 51.7 pttt -59.53 -37.11 77.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TYR . 18.5 p30 -100.45 74.2 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 109.852 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.539 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -46.13 175.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.51 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.601 ' HG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.12 -152.82 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.028 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 11.9 t70 -58.77 83.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.798 -1.189 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -123.74 112.98 1.96 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 31.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -1.189 . . . . 0.0 110.471 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -106.63 -23.4 12.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.6 -61.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.65 150.39 56.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.921 1.485 . . . . 0.0 110.579 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.05 -48.51 0.37 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 72' ' ' LEU . 2.0 mm? -81.44 125.03 29.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.331 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 pttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.151 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.495 ' CE ' ' HB3' ' A' ' 33' ' ' PRO . 12.6 pttt -71.07 153.56 42.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -63.1 138.64 58.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.2 t -103.46 -174.48 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 22' ' ' MET . 59.3 t -92.14 123.59 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.3 t -125.86 118.47 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.43 138.99 44.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.103 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 33.0 t30 -90.8 -62.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.287 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -77.36 162.43 27.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.21 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.714 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.2 tt -93.06 130.78 38.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.112 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 26.3 pt -130.03 137.87 31.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.49 71.88 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.067 1.561 . . . . 0.0 110.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.67 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.7 mt 54.65 -172.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.67 ' H ' HG22 ' A' ' 13' ' ' ILE . 49.7 m-80 42.13 -141.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 14' ' ' ASN . 42.6 m 57.48 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.27 132.28 47.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 110.065 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -75.46 143.89 42.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.5 p -123.46 160.07 27.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.217 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.742 ' C ' HD23 ' A' ' 19' ' ' LEU . 4.8 tt -67.58 -34.6 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.287 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' N ' HD23 ' A' ' 19' ' ' LEU . 2.3 mp -59.08 -36.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.4 mtm -93.76 6.88 46.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.374 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.567 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -98.97 123.56 43.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 147.71 34.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -105.7 75.91 1.16 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.161 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.81 20.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -81.65 91.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.181 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.31 154.92 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -113.13 150.02 42.31 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -76.67 171.09 69.83 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.678 -2.218 . . . . 0.0 110.433 -0.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -80.61 81.43 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.03 -112.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 55' ' ' LEU . 1.6 mt -103.87 138.89 19.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 110.153 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HB3' ' CE ' ' A' ' 2' ' ' LYS . 45.7 Cg_endo -73.19 -177.22 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.117 1.588 . . . . 0.0 110.394 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.784 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -95.82 20.99 9.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -76.61 -36.88 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.406 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -92.49 27.35 2.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 110.481 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -58.76 -48.75 96.26 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -77.0 -5.62 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.801 1.422 . . . . 0.0 110.44 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 17.9 m120 -114.29 -20.01 11.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.341 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -97.46 -38.63 9.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.283 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.1 t -43.63 123.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.331 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.625 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.59 -4.83 23.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.63 152.91 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -1.135 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 51.7 mt-30 -103.75 145.36 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.106 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.9 m -91.98 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.105 -0.997 . . . . 0.0 110.256 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 13' ' ' ILE . 1.7 m-20 -111.12 -9.03 14.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 11.6 ptm180 -119.22 171.59 8.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.341 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.39 123.67 27.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.815 . . . . 0.0 110.413 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 53' ' ' THR . 72.2 t -107.85 96.0 16.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.952 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.444 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.5 Cg_endo -71.97 -165.23 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -69.25 141.17 54.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 55.56 49.43 65.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.743 ' HB ' HG13 ' A' ' 49' ' ' VAL . 52.7 m -92.65 134.74 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 144.15 51.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.43 105.98 8.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.469 ' HG2' ' HB2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -96.85 129.66 32.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.6 Cg_endo -75.01 1.89 7.24 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.928 1.489 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HB2' ' HG2' ' A' ' 56' ' ' MET . 70.4 m-20 -81.46 -70.34 0.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 4.4 mmt -72.94 66.35 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.515 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 57' ' ' PRO . 62.0 t -126.64 128.93 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -96.78 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -0.939 . . . . 0.0 110.475 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' MET . 47.4 t30 -82.11 85.99 6.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.989 -1.07 . . . . 0.0 110.23 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.435 ' HB3' ' CA ' ' A' ' 71' ' ' GLY . 40.4 t80 -48.69 169.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.07 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 1.5 tt0 -64.67 -133.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.977 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -36.38 75.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 71' ' ' GLY . . . 62.04 55.52 27.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 0.08 51.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.583 HG23 ' HD2' ' A' ' 70' ' ' PRO . 14.8 t -110.03 -28.69 8.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.5 -61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.08 -1.012 . . . . 0.0 110.825 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 68' ' ' THR . 44.2 Cg_endo -70.57 -175.49 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.904 1.476 . . . . 0.0 110.768 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 85.21 44.34 6.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -98.55 63.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.171 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.8 p30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.266 0.555 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.53 -161.34 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.243 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -73.04 132.18 43.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -110.08 160.76 16.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG13 ' HB3' ' A' ' 22' ' ' MET . 67.8 t -89.44 113.72 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 23.4 t -111.68 113.34 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -54.25 118.89 4.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -76.27 -75.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -63.39 144.0 57.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.127 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.5 136.17 57.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 10.2 mt -125.02 131.59 24.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.55 -157.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.782 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.93 -179.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 40.95 27.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.197 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 13' ' ' ILE . 7.7 m -126.68 114.51 18.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.136 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.31 148.56 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 157.67 45.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -102.58 169.83 8.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.72 -10.58 53.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.115 ' N ' HD13 ' A' ' 19' ' ' LEU . 34.4 mm -69.82 -21.73 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.768 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.8 mtp -98.1 10.36 40.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.309 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.545 ' HB3' HG13 ' A' ' 5' ' ' VAL . 3.6 mtp -117.69 138.81 51.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -117.11 167.05 11.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 110.121 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.45 95.21 5.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.922 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 128.35 55.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 3' ' ' ALA . 5.2 t -91.99 58.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.97 160.06 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.4 t -74.9 149.39 85.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -75.72 169.83 73.44 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.668 -2.222 . . . . 0.0 110.398 -0.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.4 -142.25 19.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.948 ' HB ' HD13 ' A' ' 55' ' ' LEU . 2.9 mt -100.83 134.06 20.72 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.121 -1.223 . . . . 0.0 110.177 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.68 -166.28 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.908 1.478 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -98.82 34.04 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.37 -39.93 62.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.928 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HB2' HD13 ' A' ' 40' ' ' LEU . 63.7 mm-40 -103.45 32.38 3.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.6 mm -53.04 -46.91 97.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.3 Cg_endo -73.88 -1.17 10.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.486 1.256 . . . . 0.0 110.447 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.73 -37.97 4.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.897 . . . . 0.0 110.101 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.3 -41.6 27.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.7 t -44.66 125.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.92 9.09 59.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 64' ' ' GLU . 23.4 ttt -101.35 158.34 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.18 . . . . 0.0 110.245 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 158.38 18.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' MET . 26.8 m -107.09 168.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -110.76 5.78 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.301 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 10.2 mmt85 -138.09 135.53 35.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.74 146.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.367 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.837 HG13 HG21 ' A' ' 53' ' ' THR . 95.2 t -129.97 120.84 19.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.713 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.6 Cg_endo -73.48 -160.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.871 1.458 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -85.32 157.13 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.83 39.47 4.9 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.837 HG21 HG13 ' A' ' 49' ' ' VAL . 95.8 m -85.25 109.17 18.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -1.105 . . . . 0.0 110.399 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.9 m -47.41 149.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.948 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.1 103.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -97.85 133.89 22.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.133 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 46.4 Cg_endo -73.05 -34.88 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.955 1.503 . . . . 0.0 110.66 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 10.6 p-10 -57.18 -17.08 9.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 0.0 110.552 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 6.8 mtt -108.85 25.27 11.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.41 129.22 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.314 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -69.42 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -78.08 83.99 4.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 57' ' ' PRO . 88.8 m-85 -44.26 129.21 6.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 40' ' ' LEU . 2.9 mp0 -92.27 -37.47 12.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 17.5 p-10 -67.33 97.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.66 147.99 12.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 68' ' ' THR . 51.8 m -81.01 -92.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -1.149 . . . . 0.0 110.197 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' THR . 18.3 m -110.16 107.64 17.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.132 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.558 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 172.2 -58.98 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -73.01 -22.41 19.57 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.021 1.537 . . . . 0.0 110.503 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.68 159.79 13.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.07 -6.95 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.165 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.349 0.595 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.85 140.17 38.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -63.0 148.31 48.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.2 p -103.8 161.1 14.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.97 101.67 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.38 107.17 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -62.61 116.84 5.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 1.1 t-20 -79.92 -57.51 3.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 110.063 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 1.2 tp-100 -59.93 117.92 5.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.594 ' HB3' HD12 ' A' ' 51' ' ' LEU . 1.7 pt? -62.08 129.21 39.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 HG21 ' A' ' 15' ' ' THR . 4.7 pt -130.06 146.04 59.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 0.0 109.941 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 45.1 Cg_endo -71.78 -94.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.0 110.158 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 45' ' ' VAL . 1.5 mt -152.01 -179.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.038 . . . . 0.0 109.972 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' H ' HG22 ' A' ' 13' ' ' ILE . 11.4 m-80 51.75 21.12 1.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.795 HG21 HD12 ' A' ' 11' ' ' ILE . 8.0 t -99.75 128.65 45.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.44 100.62 4.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.065 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' MET . 3.8 mt -49.0 124.24 8.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.276 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.33 158.01 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tt -49.6 -46.01 48.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.437 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.7 mt -51.4 -47.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -78.67 -25.2 44.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.43 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 20.8 mtm -85.35 110.51 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.34 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.29 151.16 25.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 95.76 7.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.23 123.49 50.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.134 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 3' ' ' ALA . 3.9 t -77.47 98.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.53 139.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.2 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -77.68 151.59 80.02 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.5 Cg_endo -75.52 156.34 99.29 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.433 -0.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -82.56 86.4 6.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -144.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.1 mt -72.56 130.45 85.7 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 109.966 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.54 -179.44 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.984 1.518 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -94.2 2.15 55.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.6 -21.72 7.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HB2' HD13 ' A' ' 40' ' ' LEU . 7.1 mm-40 -104.64 23.5 13.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.418 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -42.27 -53.02 9.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.3 Cg_endo -72.01 -6.0 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.641 1.337 . . . . 0.0 110.757 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLU . 5.7 m-80 -113.84 -20.25 11.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.6 mp -85.85 -43.88 12.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.6 t -44.8 122.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.11 37.19 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.467 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.64 136.95 34.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 110.181 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -106.7 129.27 54.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -84.88 163.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -111.3 5.46 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 27.3 mtt180 -144.03 167.55 22.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -68.54 144.68 54.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.598 HG13 ' CB ' ' A' ' 53' ' ' THR . 30.2 t -126.52 126.07 24.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.24 -176.67 2.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.521 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.91 137.96 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 60.68 51.15 60.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.598 ' CB ' HG13 ' A' ' 49' ' ' VAL . 96.5 m -96.3 129.52 43.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -1.128 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 m -66.54 136.39 55.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.36 105.67 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -109.39 154.59 42.15 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.855 . . . . 0.0 110.1 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.4 1.6 7.21 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.002 1.527 . . . . 0.0 110.56 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -45.57 31.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.428 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.508 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 14.6 mtm -107.58 57.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.351 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 56' ' ' MET . 98.8 t -125.03 84.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 14.7 tptm -52.85 -65.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -99.59 86.39 3.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.882 . . . . 0.0 110.218 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.56 150.34 12.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.472 ' CD ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -73.75 -162.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 44.3 p-10 -73.0 75.11 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.32 127.86 4.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -77.18 55.93 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -1.099 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 171.37 8.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -45.77 -55.69 12.03 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 110.455 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -73.42 88.48 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.925 1.487 . . . . 0.0 110.436 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.79 37.46 1.86 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 73.06 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.244 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.131 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.214 0.531 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 16.96 9.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.906 . . . . 0.0 110.221 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.97 111.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.2 t -99.75 164.88 11.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 32' ' ' ILE . 32.2 t -73.05 117.91 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG12 ' HA2' ' A' ' 52' ' ' GLY . 17.0 t -127.34 99.35 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.737 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -59.28 141.34 54.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.945 . . . . 0.0 110.2 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.85 -63.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.21 145.12 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.009 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -59.55 150.0 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 11' ' ' ILE . 17.3 mt -130.13 137.54 31.1 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.04 166.32 30.37 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.498 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.603 HG22 HG23 ' A' ' 45' ' ' VAL . 11.2 pt -81.49 175.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 58.23 16.77 4.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.406 ' C ' ' HG2' ' A' ' 44' ' ' GLN . 1.6 m -125.12 105.94 9.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.32 122.63 14.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.75 155.46 23.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.912 . . . . 0.0 110.392 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 22' ' ' MET . 1.7 m -106.69 169.83 8.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 22' ' ' MET . 1.5 pp -65.0 -33.1 75.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.462 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.54 -20.34 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.173 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.99 -14.99 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.533 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.494 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.69 127.68 51.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.96 . . . . 0.0 110.495 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.4 mttt -121.07 179.37 4.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.985 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.89 99.36 9.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.21 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 tp10 -101.8 145.33 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.0 t -90.4 76.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 155.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.6 t -101.37 150.01 36.83 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.151 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.19 176.29 44.42 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.708 -2.205 . . . . 0.0 110.513 -0.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -73.55 -139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 30' ' ' MET . . . 151.89 -117.01 0.79 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.971 HD12 HD12 ' A' ' 55' ' ' LEU . 2.9 mt -110.56 118.97 47.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 50.1 Cg_endo -75.26 5.08 4.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.852 1.448 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . 71.92 20.69 4.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.457 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.0 -26.51 4.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.006 -1.059 . . . . 0.0 109.729 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 43.3 mm-40 -105.16 60.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.851 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -56.89 -41.48 91.57 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 111.058 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -75.69 -9.74 19.9 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.288 1.152 . . . . 0.0 110.508 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -114.47 -26.88 7.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD12 ' OE1' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.44 -45.6 15.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.329 -0.857 . . . . 0.0 110.398 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 40' ' ' LEU . 20.3 t -42.22 115.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.605 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.93 0.27 25.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.25 136.98 48.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -1.16 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 26.8 mt-30 -110.1 163.9 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 13' ' ' ILE . 7.2 m -120.54 170.29 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 47.7 p-10 -110.81 -8.73 14.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 1.8 mtt180 -126.33 121.21 31.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -48.23 140.44 7.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 53' ' ' THR . 67.2 t -127.46 135.14 26.99 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -73.13 -161.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.79 168.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.15 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.698 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 46.8 80.89 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.794 HG23 HG11 ' A' ' 49' ' ' VAL . 64.0 m -94.31 90.54 6.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.114 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 5.6 m -66.88 133.1 49.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.234 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.971 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.44 88.63 0.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.3 mtm -111.82 164.27 15.54 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.33 10.15 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -54.44 5.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.805 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 36.5 mtt -113.04 69.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.853 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 63' ' ' TYR . 12.8 t -130.31 103.4 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.044 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 46' ' ' ASN . 5.6 mtpt -55.6 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.277 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.88 84.0 4.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 110.352 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 70' ' ' PRO . 2.1 t80 -46.57 144.89 2.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' OE1' HD12 ' A' ' 40' ' ' LEU . 1.9 pt-20 -68.64 -151.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.25 -0.906 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.3 m-20 -59.39 -46.4 88.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.67 146.96 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -87.42 -30.91 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -1.184 . . . . 0.0 110.079 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -93.06 23.46 4.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.15 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.602 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 4.3 t 54.55 44.12 1.64 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 111.001 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -74.26 103.54 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.692 1.364 . . . . 0.0 110.415 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.02 128.47 3.56 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -77.41 -21.46 53.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.31 0.576 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.48 ' HE3' ' SD ' ' A' ' 30' ' ' MET . 3.2 ptpt -70.97 146.92 49.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.33 36.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -106.28 152.99 22.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 36.8 t -87.44 96.1 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.329 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG12 ' C ' ' A' ' 52' ' ' GLY . 2.9 t -107.04 112.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.037 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.007 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -62.72 136.82 58.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.72 -54.91 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -83.21 146.27 28.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.9 pt? -63.57 145.85 54.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' VAL . 6.6 mt -130.37 136.3 28.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.51 -162.43 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.934 1.491 . . . . 0.0 110.273 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.7 mt -104.3 -173.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.693 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.0 OUTLIER 40.08 28.11 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 110.571 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 13' ' ' ILE . 25.6 m -120.57 121.64 38.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.247 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -57.17 162.66 2.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 110.14 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mt -121.13 144.79 48.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -116.95 169.17 9.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.2 tt -60.66 -50.26 74.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.622 ' N ' HD23 ' A' ' 19' ' ' LEU . 58.0 mt -55.39 -38.74 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -13.89 60.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.41 112.01 20.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.6 mttt -106.0 145.0 31.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -94.0 102.63 14.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 4' ' ' SER . 41.6 tt0 -108.16 133.56 52.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.8 t -85.71 74.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 m -143.41 -173.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.2 t -109.52 150.66 41.49 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.153 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -76.16 168.11 78.21 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.613 -2.244 . . . . 0.0 110.465 -0.272 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.48 ' SD ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -76.95 -112.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.098 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.79 -134.58 10.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.8 mt -99.12 125.69 40.75 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -1.122 . . . . 0.0 110.03 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.29 -170.96 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.931 1.49 . . . . 0.0 110.547 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.17 16.76 17.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -47.76 84.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 mm-40 -89.36 47.78 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.108 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 5.9 tp -69.79 -30.68 2.14 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 111.719 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.4 Cg_endo -80.15 -7.93 14.13 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 122.813 0.901 . . . . 0.0 109.928 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -108.55 -35.14 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -79.63 -44.5 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 110.049 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 29.2 t -48.57 103.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 110.013 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.17 -0.55 19.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.567 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.52 157.09 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 110.053 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB2' ' HG3' ' A' ' 61' ' ' LYS . 41.4 mt-30 -109.54 171.13 7.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.332 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.55 HG13 HD11 ' A' ' 17' ' ' LEU . 11.7 m -116.93 156.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -103.5 5.06 36.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.4 mtt180 -136.39 159.91 40.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 150.59 48.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.13 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.954 ' CG1' HG21 ' A' ' 53' ' ' THR . 21.8 t -129.31 111.66 18.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -164.19 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.886 1.466 . . . . 0.0 110.432 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 3.2 mp -79.38 163.58 24.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.066 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.21 28.97 0.91 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.007 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -65.14 124.52 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.391 -1.064 . . . . 0.0 110.417 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 140.52 40.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.66 101.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.106 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtt -111.55 153.81 44.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.989 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.4 -0.26 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.958 1.504 . . . . 0.0 110.493 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.31 -46.82 21.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 110.319 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 1.4 mpt? -97.92 50.0 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG13 ' CE ' ' A' ' 43' ' ' MET . 39.4 t -121.4 103.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.905 . . . . 0.0 110.17 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -50.27 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 17.1 p-10 -95.57 92.25 6.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.945 . . . . 0.0 110.246 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -44.69 135.73 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.278 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 77.8 mm-40 -88.12 -75.5 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.68 76.84 2.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.82 52.9 0.63 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 p -90.01 25.56 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -1.138 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 p -101.95 -11.76 18.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.561 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -178.64 -59.76 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.11 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.3 Cg_endo -72.74 -90.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.0 -79.86 1.13 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.59 86.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -1.091 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.214 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.276 0.56 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -67.33 175.82 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.54 141.72 28.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -121.29 153.79 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG11 ' SD ' ' A' ' 22' ' ' MET . 25.3 t -87.44 127.49 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.272 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 54' ' ' THR . 11.9 t -130.09 121.63 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.89 142.15 6.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 10.1 t-20 -89.09 -59.33 2.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -97.07 148.26 23.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.702 HD23 ' C ' ' A' ' 10' ' ' LEU . 7.7 tt -64.75 131.84 47.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 10' ' ' LEU . 7.6 pt -130.18 130.28 23.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 0.0 110.644 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.3 Cg_endo -74.86 71.03 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.941 1.495 . . . . 0.0 109.841 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 32.4 pt 39.39 -164.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.732 -0.605 . . . . 0.0 110.692 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER 65.56 -62.31 0.23 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -58.36 106.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.349 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.78 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.179 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -106.75 129.4 54.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.28 -0.887 . . . . 0.0 110.095 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -125.75 156.12 39.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 110.349 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -46.25 -62.49 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mt -59.82 -13.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.462 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -91.53 -47.38 7.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.435 ' SD ' HG11 ' A' ' 5' ' ' VAL . 17.5 ptt? -104.84 148.26 26.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -120.17 160.76 22.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.86 103.2 14.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.25 137.58 50.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 52.2 t -96.42 80.41 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.258 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 28' ' ' THR . 14.0 p -174.2 168.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.511 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -82.9 151.75 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -75.89 133.13 29.93 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.602 -0.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.403 ' C ' ' HG1' ' A' ' 54' ' ' THR . 19.5 mtp -82.46 175.29 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.88 -132.77 1.4 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -90.23 136.85 28.17 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.213 -1.169 . . . . 0.0 109.924 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.56 -170.79 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.003 1.528 . . . . 0.0 110.676 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.75 31.73 5.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.275 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -48.04 82.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.016 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 74.3 mm-40 -100.0 65.65 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 8.7 tp -70.62 -29.87 1.65 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 111.929 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.0 Cg_endo -78.01 -7.19 16.26 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.704 0.844 . . . . 0.0 109.944 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.27 -19.6 11.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -88.34 -40.96 13.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.161 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 37' ' ' ILE . 90.8 t -46.53 105.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.54 10.0 8.91 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.21 121.48 23.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.46 148.47 22.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.1 m -117.98 155.87 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.11 5.05 19.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 66.4 mtt-85 -120.99 127.0 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.233 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.78 133.44 8.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 110.496 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.958 HG13 HG21 ' A' ' 53' ' ' THR . 24.8 t -117.9 121.54 31.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -72.6 -174.93 1.62 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.96 1.505 . . . . 0.0 110.513 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.89 156.16 39.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.556 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.83 44.77 18.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.958 HG21 HG13 ' A' ' 49' ' ' VAL . 4.9 m -93.47 114.64 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.147 . . . . 0.0 110.126 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.589 ' N ' HG13 ' A' ' 6' ' ' VAL . 2.4 t -57.79 144.15 39.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -64.11 108.85 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.515 ' CG ' ' HD2' ' A' ' 57' ' ' PRO . 20.7 ttm -103.18 145.62 30.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.515 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 47.0 Cg_endo -74.13 -0.5 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.075 1.566 . . . . 0.0 110.613 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -41.35 13.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.16 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 8.9 mtm -90.9 45.38 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 56' ' ' MET . 3.0 t -129.96 126.03 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.107 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -74.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -100.05 104.25 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -47.22 176.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.331 -0.855 . . . . 0.0 110.334 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -144.51 0.05 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.101 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 8.1 p-10 -75.18 80.37 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.75 97.48 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -101.65 39.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -1.111 . . . . 0.0 110.406 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -72.76 -11.83 60.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.955 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -177.31 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 48.3 Cg_endo -73.61 98.12 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.715 1.376 . . . . 0.0 110.399 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.43 -31.25 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -65.54 96.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -1.181 . . . . 0.0 110.287 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.127 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.241 0.543 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 175.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.72 128.68 35.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' MET . 3.7 p -116.12 145.48 43.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.151 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 39.2 t -86.48 135.24 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -129.47 124.37 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -57.46 115.52 2.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.85 -51.88 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 110.19 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -84.32 142.7 30.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.173 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -74.11 127.94 34.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.2 pt -130.49 119.91 18.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.53 64.66 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.881 1.464 . . . . 0.0 110.544 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.4 pt 39.32 -164.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' ILE . 71.6 m-20 40.8 32.29 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.885 . . . . 0.0 110.456 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 m -145.53 107.2 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.144 -0.973 . . . . 0.0 110.339 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' CA ' ' HG2' ' A' ' 44' ' ' GLN . . . -59.59 163.84 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.06 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.883 HD13 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -141.12 157.71 44.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -119.42 -157.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.845 . . . . 0.0 110.188 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.1 mp -69.27 -62.28 1.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -47.52 -23.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.348 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -72.34 -57.32 4.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.091 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.883 ' HG3' HD13 ' A' ' 17' ' ' LEU . 1.4 mtt -107.88 141.11 39.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.22 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.08 108.35 19.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.338 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.04 145.1 41.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 80.3 t -86.86 97.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -168.04 154.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.211 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -77.78 159.15 77.09 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.44 -163.68 3.31 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.72 -2.2 . . . . 0.0 110.547 -0.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 4' ' ' SER . 9.3 mtt -81.82 -73.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.31 -144.1 33.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -103.56 130.76 22.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 110.142 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 -172.3 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.327 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.025 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -97.7 32.33 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -76.83 -28.81 55.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.92 40.78 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.025 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.66 -51.91 77.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.6 Cg_endo -73.43 -1.81 11.21 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.741 1.39 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 89.8 m-20 -114.26 -42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.227 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' MET . 66.7 tp -73.42 -42.07 62.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.4 t -46.8 116.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.35 10.89 50.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 ttt -104.64 147.73 27.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.535 ' HG2' ' CA ' ' A' ' 16' ' ' ALA . 44.1 mt-30 -110.06 164.53 12.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.281 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 8.4 m -115.66 164.33 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.98 -1.45 16.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 14.5 mtt180 -118.22 131.58 56.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.12 127.28 8.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.56 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 53' ' ' THR . 22.4 t -116.15 108.75 45.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -73.37 -176.09 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.987 1.519 . . . . 0.0 110.466 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.05 134.34 48.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 70.42 46.28 49.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.739 ' CB ' HG13 ' A' ' 49' ' ' VAL . 67.1 m -96.63 113.82 25.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -1.153 . . . . 0.0 110.386 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 53.1 m -54.52 142.51 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.304 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.11 100.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.44 ' HB2' ' HG3' ' A' ' 59' ' ' MET . 2.9 mmt -98.47 139.08 20.91 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 -2.26 11.84 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.059 1.557 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.35 -37.79 14.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.519 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -73.05 -14.2 61.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 25.4 t -85.35 118.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.32 -74.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' CE ' ' A' ' 43' ' ' MET . 71.6 m-20 -100.58 93.48 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE1' ' OG1' ' A' ' 67' ' ' THR . 9.4 t80 -46.65 165.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 23.6 mm-40 -89.8 -171.37 3.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 63.75 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.143 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.04 -71.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 63' ' ' TYR . 2.2 m -79.76 108.82 13.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 68' ' ' THR . 5.3 t -72.1 69.2 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.576 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -171.68 -62.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.383 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.51 65.08 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.833 1.438 . . . . 0.0 110.432 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.09 97.41 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.74 -55.31 3.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 110.159 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.154 179.96 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.261 0.553 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 131.45 49.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.73 154.11 22.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 7.3 p -121.41 168.29 11.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.8 t -88.38 117.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 0.0 110.279 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.64 123.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -52.61 118.99 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -74.54 -68.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -89.27 147.0 24.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' N ' HD23 ' A' ' 10' ' ' LEU . 1.8 pt? -67.74 134.19 50.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.291 -0.881 . . . . 0.0 110.512 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.479 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.0 pt -120.38 156.12 55.66 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.339 -0.851 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.59 -158.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.07 1.563 . . . . 0.0 109.991 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.5 mt -103.25 166.73 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.878 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER 58.99 25.84 14.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.359 179.953 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -102.93 124.26 48.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -63.12 157.36 22.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.645 HD12 ' CB ' ' A' ' 43' ' ' MET . 2.5 mt -93.81 131.65 38.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' SD ' ' A' ' 22' ' ' MET . 1.1 p -116.8 172.92 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.163 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.45 -55.57 15.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' MET . 5.8 pt -48.32 -24.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 4.6 mtt -97.55 3.9 50.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -117.34 96.47 5.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -112.8 127.05 56.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -80.05 99.3 7.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.211 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.19 139.44 46.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.892 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -79.64 93.69 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.1 146.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.504 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.9 t -87.86 149.43 45.78 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.233 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.89 176.14 45.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.691 -2.212 . . . . 0.0 110.503 -0.135 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' SER . 3.2 mtp -75.87 -57.86 3.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.318 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.75 -145.67 35.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 55' ' ' LEU . 2.3 mt -88.3 124.86 65.5 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -1.208 . . . . 0.0 109.928 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.83 -163.48 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.465 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -103.15 25.48 9.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -38.99 69.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' OE2' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.76 38.77 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.877 ' O ' HG23 ' A' ' 41' ' ' VAL . 8.6 mm -65.98 -45.24 63.52 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.6 Cg_endo -75.38 0.75 8.69 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.513 1.27 . . . . 0.0 110.456 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 3.6 t-20 -111.18 -33.95 6.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -83.13 -29.6 28.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.9 t -43.1 116.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 110.73 7.54 25.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.645 ' CB ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -94.55 132.64 39.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 110.298 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -93.73 150.08 20.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 9.6 m -87.72 174.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -102.93 -25.49 13.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.576 -179.67 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 7.6 ptm180 -135.05 179.88 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.209 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -70.47 149.9 46.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.631 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 53' ' ' THR . 19.5 t -127.92 124.79 23.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.874 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.48 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.961 1.506 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 1.1 mp -90.61 166.43 13.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.42 33.1 2.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.793 HG21 HG13 ' A' ' 49' ' ' VAL . 92.3 m -78.13 98.44 5.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -1.175 . . . . 0.0 110.075 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.0 m -44.84 148.33 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.84 88.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.163 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 156.04 43.68 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.059 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' CB ' ' HB3' ' A' ' 70' ' ' PRO . 45.3 Cg_endo -72.34 -0.54 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.925 1.487 . . . . 0.0 110.598 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -52.01 65.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.75 ' SD ' HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -109.99 33.07 4.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 63' ' ' TYR . 12.4 t -128.59 109.47 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.541 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 11.1 ptmt -65.8 -149.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 109.835 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 62.6 t30 -64.88 84.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 109.92 179.665 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 60' ' ' VAL . 36.5 p90 -83.45 -159.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 55.8 mm-40 -63.44 -124.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 8.3 p-10 -58.61 94.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 110.63 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 63' ' ' TYR . . . -149.14 54.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -107.93 -12.92 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -1.133 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' A' ' 69' ' ' SER . 6.0 t -70.74 -6.01 34.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.589 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER 174.57 -62.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -72.37 -158.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 110.137 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 62' ' ' ASN . . . 86.32 -83.94 1.59 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.6 mm? -65.93 143.52 57.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 tttp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.261 -179.904 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.292 0.568 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.23 172.73 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.32 115.21 7.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.8 t -102.66 141.46 35.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' HB ' HD21 ' A' ' 55' ' ' LEU . 23.5 t -73.25 105.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.726 HG12 ' HA2' ' A' ' 52' ' ' GLY . 18.0 t -123.62 117.7 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.211 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -71.87 144.56 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.091 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 17.7 t-20 -83.49 -52.81 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 110.503 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.49 142.5 32.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 110.358 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.747 HD23 ' C ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -60.38 138.57 57.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.091 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HB1' ' A' ' 7' ' ' ALA . 4.0 mt -129.33 133.76 25.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.16 -179.13 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.971 1.511 . . . . 0.0 110.395 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.861 HG22 HG23 ' A' ' 45' ' ' VAL . 2.6 pt -93.67 -174.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.63 16.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -130.58 118.33 20.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.069 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.9 160.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 11' ' ' ILE . 6.2 mt -118.7 145.26 45.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -119.89 -166.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 110.281 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 19' ' ' LEU . 27.9 mt -76.61 -52.32 9.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mt -50.37 -21.76 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.163 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.65 -44.83 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -108.22 120.13 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.266 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -111.11 165.88 11.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 98.42 8.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.01 160.1 17.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.11 50.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 t -117.22 166.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 48.2 p -81.99 159.75 64.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -74.83 -167.49 5.65 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.536 -0.143 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' SER . 51.6 mtp -81.64 -46.47 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.474 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.73 -156.35 0.43 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.02 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.6 mt -90.5 142.22 27.94 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.22 -1.164 . . . . 0.0 110.409 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 47.4 Cg_endo -73.56 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.086 1.571 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -107.4 42.63 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.174 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.61 -42.43 51.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -103.26 36.91 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -53.04 -54.08 48.22 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.469 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.1 Cg_endo -70.9 -5.88 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.702 1.369 . . . . 0.0 110.709 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -114.13 -19.05 11.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.955 . . . . 0.0 110.355 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.4 tp -88.14 -29.54 20.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 47.3 t -46.1 116.32 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 109.31 10.59 23.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.29 135.45 33.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 1.5 mt-30 -106.38 138.69 42.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 110.285 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 13' ' ' ILE . 18.3 m -99.49 170.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.358 -0.839 . . . . 0.0 110.114 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.631 ' C ' HG21 ' A' ' 13' ' ' ILE . 25.9 t30 -110.67 -4.85 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' N ' HG21 ' A' ' 13' ' ' ILE . 6.0 mtt180 -129.05 126.43 39.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.43 143.19 56.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.325 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 53' ' ' THR . 80.9 t -129.97 135.7 27.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -70.09 -173.78 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.961 1.506 . . . . 0.0 110.427 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -43.05 164.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.955 179.994 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.726 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 51.82 61.31 6.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.963 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 53.5 m -84.39 87.72 7.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -1.093 . . . . 0.0 110.628 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.5 m -71.83 121.17 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.634 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -61.37 114.43 3.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.83 -179.276 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.657 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.8 mtm -113.67 156.72 43.18 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.0 1.02 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.97 1.511 . . . . 0.0 110.669 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' MET . 33.7 p30 -91.88 -21.88 20.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.018 . . . . 0.0 110.74 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 44.8 mtt -112.0 -7.75 14.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 56' ' ' MET . 10.8 t -101.14 91.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.082 -1.011 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -48.85 39.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -95.04 74.37 3.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.043 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 1.02 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -54.12 -165.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.87 . . . . 0.0 110.549 -179.793 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -104.99 -172.39 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.09 66.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.356 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -114.87 114.44 3.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 m -88.56 59.44 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -1.14 . . . . 0.0 110.062 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -106.71 -40.28 5.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.15 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 171.9 -59.25 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.129 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -72.93 55.6 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.974 1.513 . . . . 0.0 110.461 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.77 57.8 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -45.56 10.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -1.148 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.247 0.546 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -87.01 136.08 33.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.211 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.56 138.59 39.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -121.98 162.72 20.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.466 HG12 HD23 ' A' ' 55' ' ' LEU . 53.0 t -72.97 102.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.496 HG21 HG12 ' A' ' 27' ' ' VAL . 14.3 t -113.7 103.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -46.67 121.67 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 m120 -72.96 -64.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.877 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tp60 -81.58 149.13 28.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 110.227 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -59.54 133.62 56.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.956 179.863 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.803 HD12 ' SD ' ' A' ' 21' ' ' MET . 13.1 mm -121.75 136.08 25.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.73 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.058 1.557 . . . . 0.0 110.191 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.035 HG22 HG23 ' A' ' 45' ' ' VAL . 4.2 pt -120.1 -174.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -0.994 . . . . 0.0 110.485 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m120 56.53 16.54 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.06 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 19.1 m -123.05 154.33 38.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.958 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -77.03 163.77 26.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.405 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -111.63 122.62 48.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 179.93 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.1 170.96 7.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -67.24 -54.7 18.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.324 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.952 ' O ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -51.27 -21.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.803 ' SD ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -80.97 -48.38 12.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 9.4 ptt? -110.98 141.09 44.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -0.961 . . . . 0.0 110.191 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 21.0 mmtt -120.92 172.63 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.91 92.74 7.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.248 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.74 141.37 32.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -84.29 76.92 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 HG21 ' A' ' 6' ' ' VAL . 10.1 p -133.71 150.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.128 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -111.39 161.01 27.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.74 153.29 99.09 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.704 -2.207 . . . . 0.0 110.479 -0.207 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.5 ptt? -80.48 125.87 30.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.48 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -90.54 -100.71 1.17 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -109.06 131.67 21.66 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 110.137 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.21 177.84 6.75 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.698 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . -92.56 24.15 3.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.92 -77.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 pm0 -78.18 55.19 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.057 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.904 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -70.73 -30.5 1.79 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.376 -0.827 . . . . 0.0 111.764 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.904 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.5 Cg_endo -78.73 -4.46 14.07 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 122.686 0.835 . . . . 0.0 110.047 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 1.8 m120 -112.52 -37.95 4.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.99 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -76.25 -44.39 37.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.1 t -45.71 109.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 122.76 6.75 7.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.543 ' CE ' ' HG3' ' A' ' 64' ' ' GLU . 1.6 ttt -91.69 157.54 16.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.168 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' THR . 42.5 mt-30 -110.14 136.26 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.035 HG23 HG22 ' A' ' 13' ' ' ILE . 15.9 m -88.64 171.63 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.53 -15.85 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.0 111.255 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.6 ptm85 -128.16 150.73 49.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.88 -1.137 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.53 156.44 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 110.752 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.998 HG13 HG21 ' A' ' 53' ' ' THR . 91.6 t -130.17 127.55 22.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.57 -168.96 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.832 1.438 . . . . 0.0 110.509 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -80.17 155.95 27.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.188 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.66 43.94 6.64 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.998 HG21 HG13 ' A' ' 49' ' ' VAL . 84.9 m -86.33 128.28 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -69.39 141.23 54.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.78 110.4 2.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.481 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -109.42 159.93 29.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 46.2 Cg_endo -73.97 0.12 8.76 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.089 1.573 . . . . 0.0 110.648 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD1' ' CG ' ' A' ' 59' ' ' MET . 1.3 p30 -91.7 -26.2 18.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.653 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.818 ' O ' HG12 ' A' ' 45' ' ' VAL . 3.4 mtt -97.2 32.31 2.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 110.077 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.47 125.97 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.552 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -75.39 -80.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 109.84 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 8.0 p30 -100.74 101.44 12.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -45.78 167.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.799 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 40' ' ' LEU . 2.1 mp0 -83.05 -68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.94 -30.47 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.46 51.99 23.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 68' ' ' THR . 38.6 m -72.23 -89.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.087 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -94.17 5.46 51.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 179.766 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -111.27 -178.44 0.54 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 44.7 Cg_endo -72.86 117.4 5.11 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.917 1.482 . . . . 0.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.6 48.78 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' LEU . 2.1 tp -89.84 130.4 36.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.956 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.314 0.578 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -102.26 170.35 8.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 25' ' ' GLU . . . -76.9 150.77 35.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 40.4 t -116.53 164.56 14.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.3 t -92.54 102.36 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.347 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.4 t -123.71 121.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -70.21 138.85 52.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.115 -0.99 . . . . 0.0 109.998 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -72.45 -52.49 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 20.7 tt0 -82.2 162.71 22.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.75 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -67.63 142.97 56.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.466 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' CB ' ' A' ' 7' ' ' ALA . 14.7 mt -131.25 127.34 21.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.219 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.69 -159.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.79 1.416 . . . . 0.0 110.037 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 45' ' ' VAL . 36.1 pt -112.44 -165.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.115 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.578 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 39.9 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 110.412 -179.787 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 47.7 m -130.38 136.6 49.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.55 130.62 34.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -103.34 161.48 13.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -130.07 -175.6 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.629 HD21 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -51.88 -34.28 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -50.06 -60.01 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.76 30.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.317 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.96 115.32 21.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.297 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.81 124.81 45.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.917 . . . . 0.0 110.215 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.96 97.22 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 26.6 pt-20 -113.13 157.86 21.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 23.0 t -98.51 57.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -126.06 154.65 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 62.7 p -79.14 158.95 73.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.48 176.67 42.57 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.722 -2.199 . . . . 0.0 110.5 -0.167 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.3 mtt -77.13 -107.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.209 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.72 -129.37 9.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.04 132.45 22.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.83 -158.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.962 1.506 . . . . 0.0 110.304 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.09 30.92 7.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.433 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -77.41 -15.92 59.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.033 -1.042 . . . . 0.0 109.605 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.927 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.3 mp0 -105.02 24.66 11.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.574 -0.704 . . . . 0.0 109.966 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.4 mm -41.7 -53.5 7.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.701 -179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -71.24 -4.65 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.564 1.297 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.32 -36.23 4.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' HB2' ' A' ' 36' ' ' GLU . 2.7 mp -79.8 -42.47 24.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.259 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.7 t -42.18 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.367 -0.833 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.67 -6.5 13.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.51 148.96 30.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -1.202 . . . . 0.0 110.207 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' THR . 31.5 mt-30 -109.36 172.25 6.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 13' ' ' ILE . 4.8 m -119.53 172.54 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.471 ' O ' HG21 ' A' ' 13' ' ' ILE . 4.8 t-20 -111.16 -12.81 14.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' CD ' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -123.88 140.61 52.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.34 144.34 27.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 110.083 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.894 HG11 ' HA ' ' A' ' 53' ' ' THR . 34.1 t -130.41 130.23 22.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.1 Cg_endo -77.01 99.77 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.174 1.618 . . . . 0.0 110.331 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 58.4 136.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 110.597 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.33 75.79 0.34 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.894 ' HA ' HG11 ' A' ' 49' ' ' VAL . 23.4 p -96.63 96.37 8.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.428 HG21 ' HG2' ' A' ' 29' ' ' PRO . 9.1 m -63.47 136.43 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.273 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.957 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -79.52 103.96 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 110.123 179.973 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.0 ptp -109.48 143.58 28.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.031 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 47.4 Cg_endo -74.25 0.29 8.68 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.035 1.545 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' HB3' ' SD ' ' A' ' 56' ' ' MET . 50.4 t0 -83.09 -47.2 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.43 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG3' ' CD ' ' A' ' 47' ' ' ARG . 25.7 mmt -99.58 47.52 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.341 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 56' ' ' MET . 36.1 t -126.51 91.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.091 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 62' ' ' ASN . 28.9 pttt -71.42 -32.18 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 61' ' ' LYS . 61.1 t30 -96.29 52.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -44.59 152.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.48 -125.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 66' ' ' GLY . 44.4 m-20 -59.34 -43.67 92.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.139 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 46.22 96.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -96.4 -7.35 35.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -96.59 -161.56 0.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -41.11 -55.94 4.56 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 179.97 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -73.88 153.5 47.76 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.963 1.507 . . . . 0.0 110.437 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.449 ' HA2' ' HA3' ' A' ' 66' ' ' GLY . . . 176.24 -57.05 0.11 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -154.06 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -1.126 . . . . 0.0 110.174 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.6 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.37 152.49 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.433 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -87.79 113.59 23.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.895 . . . . 0.0 110.215 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -88.52 129.76 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 5.0 t -78.13 125.69 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.273 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 54' ' ' THR . 15.2 t -118.39 118.68 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.96 . . . . 0.0 110.281 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -44.97 117.58 1.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.5 t30 -73.58 -52.76 12.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 tp60 -95.2 148.03 22.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.2 tt -59.62 119.77 8.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 9' ' ' GLN . 1.0 OUTLIER -129.74 134.33 26.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.2 Cg_endo -72.96 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.963 1.507 . . . . 0.0 110.124 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 14' ' ' ASN . 3.1 mt -146.9 -171.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.212 -0.93 . . . . 0.0 109.99 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.667 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.6 p-10 36.26 48.83 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.63 . . . . 0.0 110.999 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -123.93 103.34 8.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 110.154 179.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -65.53 144.44 57.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mp -98.64 140.48 32.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.3 p -129.34 84.5 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.637 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' MET . 7.7 tp 52.15 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.332 -0.855 . . . . 0.0 110.808 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' THR . 3.3 mt -41.41 -53.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.634 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 mtt -65.58 -13.09 58.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.26 119.87 39.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.26 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 19.9 mmtm -118.86 90.83 3.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.96 95.04 2.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.433 HG22 ' CA ' ' A' ' 3' ' ' ALA . 28.9 t -78.69 71.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 28' ' ' THR . 63.6 t -142.07 161.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -75.29 151.89 85.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -77.19 -174.93 15.72 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.558 -2.268 . . . . 0.0 110.455 -0.229 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.2 mpt? -76.63 -109.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.919 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 97.52 -145.29 17.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 HD12 ' A' ' 55' ' ' LEU . 23.3 mm -74.52 112.3 16.75 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.344 -1.092 . . . . 0.0 110.398 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.714 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.7 Cg_endo -75.14 -1.86 11.8 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.928 1.488 . . . . 0.0 110.303 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 33' ' ' PRO . . . 69.49 24.64 5.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.82 -44.93 63.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 61.0 mm-40 -99.4 67.43 1.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.89 HG22 ' HD3' ' A' ' 38' ' ' PRO . 1.9 tp -70.08 -30.97 2.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 112.137 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HD3' HG22 ' A' ' 37' ' ' ILE . 45.2 Cg_endo -74.59 -8.25 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 N-CA-C 109.93 -0.835 . . . . 0.0 109.93 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -114.18 -31.1 6.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.368 -0.833 . . . . 0.0 109.529 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.1 tp -69.82 -36.99 76.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 110.059 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 37' ' ' ILE . 22.7 t -43.53 103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.6 24.52 7.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.649 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.4 ttm -95.92 138.97 32.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -1.093 . . . . 0.0 110.241 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 50.2 mt-30 -106.72 151.45 25.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.7 m -95.91 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.06 16.71 20.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' N ' HG23 ' A' ' 13' ' ' ILE . 20.8 mtt180 -144.1 161.96 37.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.38 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -72.52 134.95 45.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 21.3 t -128.65 128.25 23.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.63 -158.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.825 1.434 . . . . 0.0 110.445 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -87.37 155.31 20.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 110.822 -179.438 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.502 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 41.57 40.67 2.94 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.2 m -96.97 125.2 41.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.556 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 m -63.47 108.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -70.38 122.93 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 110.514 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.442 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 7.6 mtt -100.48 171.23 5.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 109.923 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 45.4 Cg_endo -73.04 -0.65 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.905 1.476 . . . . 0.0 110.55 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.93 -43.65 52.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.323 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' HB2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -92.13 60.7 3.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.259 -179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 63' ' ' TYR . 25.4 t -130.16 95.57 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -94.49 82.51 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.835 ' CD2' HG11 ' A' ' 60' ' ' VAL . 7.8 t80 -62.31 139.34 58.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.75 -56.64 4.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -96.05 83.17 3.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 70' ' ' PRO . . . -109.4 91.66 0.66 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -107.6 -38.75 5.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -1.142 . . . . 0.0 110.303 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 81.9 p -93.24 -137.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.79 -58.53 3.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.549 -179.798 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -71.07 118.49 5.72 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.907 1.477 . . . . 0.0 110.563 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.3 13.48 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -178.4 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.218 0.532 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.88 133.22 41.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.18 125.8 25.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.931 . . . . 0.0 110.356 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 p -121.76 149.78 42.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.82 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 56.0 t -83.13 113.0 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 54' ' ' THR . 5.1 t -121.09 104.59 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.065 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.54 131.53 3.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.412 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -88.75 -63.49 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -73.16 141.72 47.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.067 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -59.35 131.11 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mt -122.96 140.1 32.74 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.56 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.087 1.572 . . . . 0.0 110.366 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.3 mt -110.63 -175.77 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.7 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.3 p-10 39.35 29.98 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.613 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 13' ' ' ILE . 52.4 m -122.02 133.34 54.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.11 151.93 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.233 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 43' ' ' MET . 1.4 pp -119.96 157.05 29.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.56 159.06 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -50.06 -43.34 51.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.533 ' N ' HD23 ' A' ' 19' ' ' LEU . 17.8 mt -53.97 -29.98 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 mtt -85.77 -21.28 28.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.504 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.94 106.66 17.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.442 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -106.17 118.13 35.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.55 109.92 14.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.143 -0.973 . . . . 0.0 110.306 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.18 152.16 25.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.4 t -90.69 63.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 26' ' ' VAL . 11.5 m -147.75 -178.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -94.84 162.15 26.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.61 165.41 85.73 Favored 'Cis proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.404 -0.195 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -61.66 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 -149.28 28.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.719 HD13 ' OH ' ' A' ' 63' ' ' TYR . 4.9 mt -104.28 136.74 19.14 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.04 -159.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.999 1.526 . . . . 0.0 110.377 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -116.53 46.61 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.444 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 6.2 pt-20 -74.27 -27.04 60.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.11 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 6.9 mm-40 -104.55 36.18 2.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.679 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.9 mm -54.79 -51.1 81.93 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 110.8 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -71.02 -5.1 16.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.389 1.205 . . . . 0.0 110.715 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 63.1 m-80 -114.2 -50.18 2.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.367 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -68.27 -35.21 77.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 17.2 t -53.74 122.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.96 -14.91 31.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.594 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -85.0 159.78 20.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.146 . . . . 0.0 110.161 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -105.42 178.3 4.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.5 m -116.78 173.01 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 59' ' ' MET . 59.2 t30 -111.06 -9.04 14.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -130.56 172.06 12.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -0.923 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -76.09 151.55 37.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 53' ' ' THR . 37.3 t -127.95 108.0 20.13 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.801 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.9 Cg_endo -71.61 -165.26 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.032 1.543 . . . . 0.0 110.461 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.6 150.08 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.404 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.12 49.19 24.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.48 ' CB ' HG13 ' A' ' 49' ' ' VAL . 16.7 m -91.69 120.09 32.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.473 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.7 t -61.13 149.38 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -68.38 105.73 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtm -110.34 139.35 21.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 110.277 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 46.5 Cg_endo -73.9 -4.11 14.88 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.989 1.521 . . . . 0.0 110.631 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.91 -20.85 48.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' ASN . 3.8 mtt -105.23 12.37 31.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.232 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . 21.3 t -106.44 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 46' ' ' ASN . 73.0 mttt -43.9 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.091 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 63' ' ' TYR . 4.1 m120 -100.78 104.43 15.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.088 -1.007 . . . . 0.0 110.085 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.719 ' OH ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -44.33 165.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.956 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 2.4 mm-40 -64.36 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.116 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -48.75 79.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.82 -22.64 16.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 30.2 2.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 110.183 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' SER . 20.7 m -100.73 -60.0 1.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER 173.27 -59.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.203 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.17 90.99 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.887 1.467 . . . . 0.0 110.373 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.44 120.32 0.76 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -28.13 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -1.164 . . . . 0.0 110.319 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.326 0.584 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.38 131.97 47.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.35 143.1 24.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -119.38 125.89 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.971 ' O ' HD23 ' A' ' 55' ' ' LEU . 53.8 t -65.97 124.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.295 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' C ' ' A' ' 53' ' ' THR . 25.6 t -116.99 123.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -46.57 134.89 9.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.258 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' CG ' ' HE2' ' A' ' 23' ' ' LYS . 57.3 t30 -90.37 -69.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.4 144.54 30.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -62.92 135.82 57.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.063 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.535 HG22 HG21 ' A' ' 15' ' ' THR . 1.4 pt -124.9 119.72 25.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' ILE . 45.4 Cg_endo -72.09 57.79 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.847 1.446 . . . . 0.0 110.251 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.8 mt 49.64 179.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.705 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' H ' HG22 ' A' ' 13' ' ' ILE . 5.0 m120 43.76 26.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 110.241 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.535 HG21 HG22 ' A' ' 11' ' ' ILE . 17.8 m -119.92 103.05 9.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.862 . . . . 0.0 110.1 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . . . -57.86 152.89 15.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 110.405 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.849 HD11 HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -112.93 156.35 23.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.835 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.646 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -128.76 -169.83 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 7.7 mp -64.55 -46.83 81.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.14 -20.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.05 3.61 54.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.938 ' SD ' HG11 ' A' ' 5' ' ' VAL . 1.7 mmm -112.47 106.18 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' CG ' ' A' ' 8' ' ' ASN . 6.9 mtmt -105.98 115.33 30.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.03 98.07 4.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.9 142.05 46.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 26' ' ' VAL . 56.0 t -88.0 85.84 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 110.18 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.52 153.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.4 p -91.69 157.6 41.52 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.89 -172.7 11.34 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.486 -0.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 ptp -82.4 -151.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.334 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 154.69 -127.46 2.1 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 20.1 mm -91.12 108.86 31.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.279 -1.13 . . . . 0.0 110.277 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 31' ' ' GLY . 50.2 Cg_endo -76.5 50.41 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.936 1.492 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 45.67 24.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.33 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' OE1' HG21 ' A' ' 67' ' ' THR . 36.1 tt0 -77.01 -33.81 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.88 39.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.906 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 2.4 mm -54.75 -57.2 20.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.77 -1.78 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.652 1.343 . . . . 0.0 110.744 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.94 -51.21 2.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.396 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.22 -39.79 78.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 18' ' ' THR . 58.4 t -52.6 103.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.223 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -35.1 2.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.51 159.58 18.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -1.123 . . . . 0.0 110.286 -179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.551 ' HG3' ' CA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -110.26 -169.28 1.44 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.821 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 13' ' ' ILE . 3.7 m -120.19 172.24 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.19 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 2.8 m120 -111.18 0.47 16.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.411 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -123.31 142.54 50.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -62.2 129.14 39.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 HG21 ' A' ' 53' ' ' THR . 54.6 t -121.12 123.67 27.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.606 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.05 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.849 1.447 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -86.5 144.09 27.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 61.31 39.92 97.89 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.859 HG21 HG13 ' A' ' 49' ' ' VAL . 79.5 m -88.75 145.73 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -1.174 . . . . 0.0 110.106 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.3 m -72.45 143.97 48.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.7 mm? -69.93 80.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.419 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -94.06 143.82 27.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.915 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.19 -1.42 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.96 1.505 . . . . 0.0 110.377 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 18.7 p-10 -70.44 -12.01 61.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.28 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -108.75 -25.06 11.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.83 105.56 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.181 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -63.11 1.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.196 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' TYR . 52.7 m-20 -95.04 86.41 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.37 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -44.46 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 0.0 110.168 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 43' ' ' MET . 33.4 mm-40 -79.93 -97.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.56 -32.14 18.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 0.0 110.223 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' CA ' ' HA3' ' A' ' 71' ' ' GLY . . . 102.85 105.02 2.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.676 HG21 ' OE1' ' A' ' 35' ' ' GLU . 1.7 m -107.69 -54.76 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -1.133 . . . . 0.0 110.436 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.432 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 60.8 p -101.98 -157.18 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -44.63 -57.27 6.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -71.49 79.93 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.999 1.526 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA3' ' CA ' ' A' ' 66' ' ' GLY . . . -173.67 47.88 0.15 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -94.24 -40.9 9.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.31 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.197 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -80.58 -172.96 3.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.7 138.05 31.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -120.42 146.91 45.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.237 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 45.0 t -77.39 111.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.38 124.5 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -69.5 119.89 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.838 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.9 p30 -74.97 -43.57 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -96.56 135.64 38.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.182 179.887 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.827 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.98 153.82 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.674 -179.728 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.772 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -130.45 126.8 22.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.995 . . . . 0.0 110.07 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.6 Cg_endo -76.85 47.97 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.831 1.437 . . . . 0.0 110.82 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.578 HD11 ' H ' ' A' ' 48' ' ' ALA . 2.2 mt 51.72 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 44.98 31.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -126.32 105.17 8.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.95 138.85 42.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.212 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -92.26 139.49 30.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.8 OUTLIER -108.16 167.92 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 19' ' ' LEU . 6.1 tt -58.84 -42.78 90.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.947 . . . . 0.0 110.266 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 21' ' ' MET . 18.1 pt -67.03 -41.37 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.911 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.515 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.774 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.495 ' CG ' ' O ' ' A' ' 22' ' ' MET . 6.0 ptt? -115.38 123.8 49.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -121.15 159.94 24.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.0 101.78 13.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.362 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -113.07 136.91 52.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 54.9 t -91.64 88.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.99 -173.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 29' ' ' PRO . 23.9 m -116.31 146.03 36.4 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 110.013 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.707 ' HA ' HG23 ' A' ' 28' ' ' THR . 50.2 Cg_endo -75.58 -178.51 23.9 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.788 -2.172 . . . . 0.0 110.509 -0.174 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -159.51 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.14 -148.48 10.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.1 mt -85.11 131.48 48.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.294 -1.121 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.26 178.99 5.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.63 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -98.48 25.79 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 18.2 pt-20 -76.96 -18.68 58.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 10.2 mm-40 -104.85 48.81 0.83 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.286 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -54.53 -50.59 84.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.943 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.53 -0.58 9.93 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.818 1.43 . . . . 0.0 110.703 -179.594 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.29 -28.03 7.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.932 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.732 HD21 ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -89.13 -38.09 14.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 110.371 -179.857 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 37' ' ' ILE . 54.9 t -49.08 91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.919 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.64 28.39 1.59 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.446 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -98.93 131.5 44.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -1.182 . . . . 0.0 110.256 179.957 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -109.46 126.77 53.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.2 m -83.71 168.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HA ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 t30 -110.96 1.64 17.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -134.84 133.65 39.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.578 ' H ' HD11 ' A' ' 13' ' ' ILE . . . -50.55 140.58 13.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.336 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.086 HG13 HG21 ' A' ' 53' ' ' THR . 55.1 t -130.09 135.94 28.25 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.071 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.2 Cg_endo -72.13 -173.26 1.04 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.717 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -76.5 162.36 27.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.91 . . . . 0.0 110.536 -179.717 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.24 44.67 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.086 HG21 HG13 ' A' ' 49' ' ' VAL . 82.1 m -96.43 119.86 35.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -1.212 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.486 HG21 ' O ' ' A' ' 29' ' ' PRO . 22.3 p -54.75 127.3 27.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.732 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -61.68 113.34 2.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.177 -179.933 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.0 ptp -106.99 151.69 40.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.46 1.59 7.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.135 1.597 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' CE ' ' A' ' 59' ' ' MET . 1.8 t70 -76.71 -43.88 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 110.558 -179.752 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 9.2 mmt -105.5 63.54 0.69 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.361 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.2 t -130.17 99.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -61.02 -71.62 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -90.8 75.37 6.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.118 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 25.6 t80 -51.71 145.36 9.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.381 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' N ' ' HE3' ' A' ' 43' ' ' MET . 7.4 pm0 -64.42 -141.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.18 78.24 0.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.85 100.05 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -81.6 4.51 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -1.162 . . . . 0.0 110.248 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -76.67 -160.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.965 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -42.4 -56.42 5.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.301 179.867 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -72.46 162.49 41.29 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.972 1.512 . . . . 0.0 110.493 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.64 61.58 0.62 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.25 -44.82 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.0 110.254 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.182 179.982 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.284 0.564 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 128.35 35.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 164.97 19.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -123.17 158.6 30.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.77 114.72 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG22 HG22 ' A' ' 54' ' ' THR . 4.2 t -126.49 122.09 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -56.67 127.62 32.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.45 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 24.2 t-20 -77.45 -48.68 16.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.09 158.29 15.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.132 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.02 132.49 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 7' ' ' ALA . 1.1 mp -117.65 122.67 30.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 46.0 Cg_endo -71.57 -95.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.749 1.394 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -162.02 -173.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.095 179.527 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER 40.21 31.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 110.612 -179.813 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 11' ' ' ILE . 5.7 t -124.11 138.2 54.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -71.55 154.97 41.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 11' ' ' ILE . 51.3 mt -120.97 104.42 9.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.886 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.46 HG23 HG13 ' A' ' 41' ' ' VAL . 3.4 m -96.81 167.89 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.978 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.96 -25.15 67.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.6 mt -69.63 -19.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.6 ttp -97.73 -20.88 17.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HA ' ' A' ' 7' ' ' ALA . 1.4 mtt -118.91 143.51 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.112 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.75 172.09 7.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.07 102.05 14.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.3 tp10 -112.03 128.58 56.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.5 p -91.95 77.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.38 166.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.18 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.9 t -92.83 144.83 29.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' HG21 ' A' ' 54' ' ' THR . 49.4 Cg_endo -75.55 157.21 99.12 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.416 -0.248 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.3 mtt -72.79 -26.25 61.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.77 -132.02 43.99 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.875 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.8 mt -106.28 134.79 19.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.287 -1.125 . . . . 0.0 110.223 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -170.52 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.942 1.496 . . . . 0.0 110.407 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.47 46.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.272 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.05 -40.07 54.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.903 ' HB2' HD12 ' A' ' 40' ' ' LEU . 14.9 mm-40 -104.91 31.2 4.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.981 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -42.68 -54.27 8.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.4 Cg_endo -71.53 -2.22 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.615 1.323 . . . . 0.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.473 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.02 -32.15 6.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.894 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -85.55 -24.6 27.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.351 -179.848 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.8 t -42.58 119.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.2 8.78 28.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD23 ' A' ' 40' ' ' LEU . 18.9 ttp -72.34 134.66 45.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -1.194 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mt-30 -110.01 125.59 53.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 17' ' ' LEU . 3.7 m -79.99 154.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 110.141 179.851 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -108.26 10.1 27.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.405 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.57 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.52 137.44 26.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -45.06 128.19 7.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.018 HG13 HG21 ' A' ' 53' ' ' THR . 47.5 t -111.85 134.75 21.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.56 ' C ' ' HG1' ' A' ' 53' ' ' THR . 47.6 Cg_endo -74.12 -171.57 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.023 1.539 . . . . 0.0 110.477 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.31 164.01 22.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 110.281 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 43.43 30.32 1.31 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.018 HG21 HG13 ' A' ' 49' ' ' VAL . 72.9 m -76.15 104.16 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -1.196 . . . . 0.0 110.401 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -52.39 153.69 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.053 179.808 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.875 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -62.16 100.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.314 -179.841 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.7 mtm -113.55 145.34 33.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.435 -0.791 . . . . 0.0 110.287 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.62 0.18 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.001 1.527 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.97 -55.36 14.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' A' ' 47' ' ' ARG . 46.8 mtt -103.35 40.72 1.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 110.431 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 93.6 t -130.47 133.34 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -142.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' C ' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-20 -76.39 79.61 3.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 110.297 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CD2' ' N ' ' A' ' 64' ' ' GLU . 18.0 p90 -84.62 -167.96 2.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 47.5 tp10 -71.94 76.79 0.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 70' ' ' PRO . 10.1 t0 -99.31 -64.74 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.46 -126.94 1.06 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.534 ' HA ' HD23 ' A' ' 72' ' ' LEU . 15.8 m -108.92 -70.72 0.79 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 110.477 -179.77 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -18.29 59.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.51 -179.16 0.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.956 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -72.55 84.67 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.958 1.504 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -165.7 -36.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -67.7 113.76 5.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.144 . . . . 0.0 110.252 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.3 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.143 179.949 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.195 0.521 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 140.97 58.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.01 138.26 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.3 p -123.74 157.5 33.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.655 HG12 HD23 ' A' ' 55' ' ' LEU . 61.6 t -80.1 124.28 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -129.2 107.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 179.975 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -46.65 116.18 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 51' ' ' LEU . 52.6 t30 -77.79 -46.52 21.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.15 136.22 33.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 10' ' ' LEU . 1.7 pt? -78.12 131.68 37.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.34 -179.891 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.534 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 10.4 pt -128.9 155.73 79.06 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.872 . . . . 0.0 109.989 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.0 Cg_endo -72.85 -96.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.89 1.468 . . . . 0.0 110.159 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.563 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -152.24 172.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.961 -1.087 . . . . 0.0 109.889 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.81 21.38 5.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 110.353 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -97.91 117.07 31.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.03 157.55 5.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 41' ' ' VAL . 30.1 mt -98.43 111.16 23.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 p -95.41 155.91 16.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -28.08 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.378 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mt -68.64 -36.88 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.922 . . . . 0.0 110.235 -179.913 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 42.3 mtp -88.74 11.82 16.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.612 ' HA ' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -112.35 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -109.59 112.83 25.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.18 105.53 3.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.326 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -109.68 155.37 21.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.157 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 26' ' ' VAL . 10.8 t -91.65 24.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 28' ' ' THR . 31.7 t -95.68 148.38 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -77.34 168.25 29.55 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.955 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' CG ' HG21 ' A' ' 54' ' ' THR . 48.8 Cg_endo -73.77 -170.58 7.97 Favored 'Cis proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.624 -2.24 . . . . 0.0 110.417 -0.134 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 31' ' ' GLY . 5.3 ptt? -76.56 -34.82 58.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.248 180.0 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 45.56 -131.45 9.42 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.26 137.35 21.49 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.276 179.994 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 -166.86 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.008 1.531 . . . . 0.0 110.479 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.804 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -116.84 33.83 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -41.35 85.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 73.4 mm-40 -104.78 32.53 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.804 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.3 mm -42.88 -51.32 12.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.599 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -72.04 -1.4 9.97 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.483 1.254 . . . . 0.0 110.681 -179.776 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.75 -38.08 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 179.933 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -75.26 -34.12 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.911 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 37' ' ' ILE . 21.6 t -46.96 139.61 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -11.69 54.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.4 tpp -82.01 132.52 35.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.116 . . . . 0.0 110.209 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -92.94 -179.41 5.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.17 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.0 m -118.42 163.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.343 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 5.6 t-20 -111.19 3.42 18.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.542 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.7 mmt180 -139.18 -176.75 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 0.0 110.41 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -79.8 140.83 36.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.25 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 53' ' ' THR . 4.5 t -119.28 116.49 33.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.336 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -76.89 152.01 35.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.45 42.01 25.81 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.685 HG21 HG13 ' A' ' 49' ' ' VAL . 61.4 m -82.36 115.02 21.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.568 HG21 ' CG ' ' A' ' 29' ' ' PRO . 11.2 t -54.74 155.63 4.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -71.98 103.63 3.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.924 . . . . 0.0 110.229 179.971 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.483 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -112.17 145.14 32.2 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.997 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -12.24 25.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.982 1.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -62.17 -56.76 15.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.288 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.529 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 5.9 mtt -93.45 39.81 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 56' ' ' MET . 53.3 t -130.44 126.87 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 110.233 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -161.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 110.056 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.557 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 27.3 p-10 -69.2 79.81 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 3.4 p90 -82.2 -170.11 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -63.76 145.46 55.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.075 -1.016 . . . . 0.0 111.205 -178.679 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 10.3 t0 -98.17 79.06 2.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.577 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.22 -87.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.259 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -52.39 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.793 -179.286 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 21.2 p -69.72 -174.07 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.611 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 6.5 t -119.02 41.16 0.39 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 111.564 -179.456 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 69' ' ' SER . 43.8 Cg_endo -72.33 -169.44 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.569 1.299 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 66.5 33.79 85.74 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -70.01 -43.98 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -1.158 . . . . 0.0 110.205 179.935 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.277 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.235 0.541 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -99.17 170.71 8.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -85.38 151.24 24.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.99 135.7 54.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 22' ' ' MET . 94.7 t -78.88 121.82 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.2 t -127.59 116.66 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.104 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -67.16 122.35 17.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.133 179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -78.11 -42.29 32.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.429 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -88.05 143.53 27.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.263 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.6 tt -63.92 143.93 57.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 mt -130.38 112.53 16.77 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.278 -0.889 . . . . 0.0 110.401 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.35 59.56 5.45 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.787 1.414 . . . . 0.0 110.408 179.615 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 42.3 pt 38.19 -163.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.834 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 42.46 27.75 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.821 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.3 m -140.93 121.32 14.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.18 171.31 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.917 . . . . 0.0 110.161 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mt -113.8 138.03 50.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -124.47 -179.67 4.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.262 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.19 -53.53 16.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.36 -15.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.229 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtt -82.45 -47.02 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.539 ' HG3' HG13 ' A' ' 5' ' ' VAL . 1.7 ptt? -119.91 149.42 42.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -111.9 169.33 8.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.03 92.29 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.213 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.52 137.64 50.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 26' ' ' VAL . 76.3 t -90.73 60.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 28' ' ' THR . 55.3 t -132.7 170.23 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.854 HG22 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -79.93 151.86 73.85 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.998 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.854 ' HA ' HG22 ' A' ' 28' ' ' THR . 48.8 Cg_endo -75.69 178.95 32.65 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.678 -2.217 . . . . 0.0 110.535 -0.227 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -74.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.89 -166.88 53.09 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.772 HD11 ' OH ' ' A' ' 63' ' ' TYR . 16.2 mm -63.19 133.64 95.52 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.155 -1.203 . . . . 0.0 110.005 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 43.6 Cg_endo -72.75 -174.5 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.851 1.448 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.57 23.41 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.731 -179.496 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -77.33 -19.08 56.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.11 10.03 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.789 . . . . 0.0 110.116 -179.52 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.8 mm -41.9 -55.33 6.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 110.552 -179.79 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.51 -4.55 14.76 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.584 1.307 . . . . 0.0 110.72 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.8 m120 -114.18 -25.96 8.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 110.457 -179.835 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -91.27 -25.29 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.863 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 37' ' ' ILE . 33.1 t -42.99 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.01 15.15 4.83 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.423 ' HE3' ' HG2' ' A' ' 64' ' ' GLU . 36.3 tpp -87.75 136.5 32.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -1.169 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -102.54 149.09 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 6.2 m -113.6 161.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -111.32 -1.82 15.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 3.5 mtt180 -115.12 137.98 51.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.253 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.53 145.13 1.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.333 -179.516 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.066 ' CG1' HG21 ' A' ' 53' ' ' THR . 2.8 t -126.05 110.82 24.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.086 -179.778 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' O ' ' HB ' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -176.34 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.929 1.489 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' LEU . 1.6 mp -71.45 157.23 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.046 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.82 32.21 1.33 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.8 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.104 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -69.16 138.44 54.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.463 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 12.6 t -85.21 142.28 29.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.611 179.255 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 mm? -61.67 117.94 6.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.1 mtt -111.99 150.02 41.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.922 . . . . 0.0 110.338 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 -16.83 24.31 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.021 1.537 . . . . 0.0 110.364 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.73 -16.31 42.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.472 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 mtm -111.78 38.24 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.957 . . . . 0.0 110.182 -179.917 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.575 HG11 ' CE1' ' A' ' 63' ' ' TYR . 77.5 t -130.33 114.91 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.07 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -57.12 -99.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.374 -179.725 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 62' ' ' ASN . 22.0 p-10 -100.34 96.98 7.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.99 -1.068 . . . . 0.0 110.182 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -49.24 146.7 3.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 110.26 179.936 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 72.9 mm-40 -76.72 -56.05 4.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 42.0 p-10 -84.22 55.13 3.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.029 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.44 67.54 3.69 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -93.49 -20.27 20.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.054 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.52 -158.81 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.93 -55.78 4.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.899 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.5 Cg_endo -73.53 138.13 26.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.019 1.536 . . . . 0.0 110.395 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -25.98 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.18 27.13 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.232 179.989 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.21 0.528 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 144.24 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.26 130.88 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 159.67 15.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.15 127.38 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.249 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.3 t -124.44 127.32 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB3' ' H ' ' A' ' 53' ' ' THR . . . -45.56 127.79 7.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.19 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 28.0 t30 -89.57 -58.22 2.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.204 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -91.88 145.65 24.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 10' ' ' LEU . 2.0 tt -64.2 109.64 1.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 pt -123.6 137.36 28.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.069 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.014 1.534 . . . . 0.0 110.14 179.845 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.752 HG22 HG23 ' A' ' 45' ' ' VAL . 2.0 pt -146.41 -164.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.128 -0.982 . . . . 0.0 110.197 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER 40.37 27.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 0.0 110.561 -179.899 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.3 m -116.61 111.71 20.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -62.88 133.99 55.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.771 HD22 ' SD ' ' A' ' 22' ' ' MET . 47.9 mt -81.18 145.64 30.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 110.061 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -129.93 137.5 50.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 110.322 179.915 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.6 tt -43.76 -43.67 6.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.516 ' N ' HD23 ' A' ' 19' ' ' LEU . 8.1 mt -67.55 -21.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.358 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -97.54 -23.36 16.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.771 ' SD ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -116.42 120.0 37.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.34 147.95 27.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 110.164 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.0 116.41 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.32 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.33 151.2 30.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.37 78.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.288 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.8 149.91 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.141 179.931 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.6 p -97.7 159.96 29.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.85 152.88 97.42 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.439 -0.191 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.06 127.2 32.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.834 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.9 -110.66 3.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.786 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.838 HG13 HD22 ' A' ' 55' ' ' LEU . 8.5 mm -86.03 114.69 58.51 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.107 . . . . 0.0 110.628 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.51 -161.57 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.449 179.678 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -109.76 27.79 9.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.23 -38.24 51.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.958 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 65' ' ' ASP . 48.0 mm-40 -94.12 32.68 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.133 -0.979 . . . . 0.0 110.943 -179.288 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -43.65 -51.72 15.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.963 -1.085 . . . . 0.0 110.4 179.722 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -73.23 -11.39 24.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.732 1.385 . . . . 0.0 110.996 -179.427 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -105.66 -46.43 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.099 179.835 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' HG21 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -62.2 -43.98 97.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.202 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 37' ' ' ILE . 39.9 t -43.61 119.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.993 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.91 16.02 46.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.497 ' HE1' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ttm -83.91 135.09 34.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -1.147 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -106.92 124.83 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.752 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -85.08 158.55 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -103.73 -3.57 24.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.124 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.545 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 10.2 mtt180 -123.28 155.66 36.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.7 58.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.425 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG13 ' HB ' ' A' ' 53' ' ' THR . 28.2 t -127.86 113.61 20.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 179.893 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 -162.9 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.946 1.498 . . . . 0.0 110.6 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.32 155.98 28.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.968 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.5 45.82 6.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.591 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 87.4 m -94.02 100.07 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.157 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' MET . 23.8 m -44.91 123.77 4.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.838 HD22 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.97 115.47 4.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.949 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 54' ' ' THR . 19.8 mtp -112.25 164.24 15.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.48 -0.763 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 49.7 Cg_endo -76.37 6.5 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.08 1.568 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -42.16 11.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.07 -1.019 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -100.22 52.6 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 -179.9 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 17.4 t -129.97 123.42 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.898 . . . . 0.0 110.22 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -73.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -100.52 93.31 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.351 -179.896 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.497 ' HA ' ' HE1' ' A' ' 43' ' ' MET . 96.3 m-85 -52.64 151.9 4.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' HD12 ' A' ' 40' ' ' LEU . 1.5 mp0 -68.44 -70.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.148 179.865 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 33.2 p-10 -84.49 94.89 8.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.938 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 71' ' ' GLY . . . -85.67 38.39 3.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.4 m -107.81 -16.5 14.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.96 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.445 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 61.6 p -100.58 -140.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.511 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -75.65 -56.94 1.67 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 -179.828 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.8 Cg_endo -72.97 73.21 3.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.919 1.484 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . -130.81 0.65 5.42 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.21 137.74 34.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.242 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.544 ' HB2' HG11 ' A' ' 26' ' ' VAL . 14.1 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.297 0.57 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 117.22 19.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.496 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -61.62 124.55 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 t -82.93 173.2 12.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.172 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.23 108.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.1 t -123.78 107.4 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -58.68 121.62 11.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 3.5 m-20 -72.65 -55.34 7.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.73 156.45 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.746 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' HG ' ' HA ' ' A' ' 50' ' ' PRO . 8.0 tt -70.31 124.41 24.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 9' ' ' GLN . 22.0 mm -124.0 113.19 28.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -73.82 -92.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.0 110.404 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.871 HG22 HG23 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -161.89 -177.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.108 -0.995 . . . . 0.0 110.291 179.99 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 50.74 21.74 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.5 m -124.5 113.34 17.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.085 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.662 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.66 152.79 8.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.126 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -96.76 138.62 34.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -167.02 1.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.276 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.68 -63.36 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.295 -179.954 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -49.09 -24.93 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 110.194 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.93 3.72 40.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.7 mtt -116.37 118.37 32.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.916 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.0 160.07 23.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.092 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -105.08 83.03 1.92 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.34 135.83 44.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 1' ' ' ASN . 18.8 t -94.38 77.83 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.839 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.7 120.03 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.2 p -83.25 150.39 60.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 110.152 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.82 129.89 19.93 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.483 -0.151 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -71.25 118.37 13.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -102.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.0 mt -118.15 137.62 24.73 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.238 -1.154 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -162.68 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.12 1.589 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -107.69 45.63 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.92 -35.58 67.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 mm-40 -104.97 35.29 2.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.817 . . . . 0.0 109.872 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -40.5 -52.17 6.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -71.39 -9.49 25.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.594 1.313 . . . . 0.0 110.766 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -106.25 -25.62 11.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.087 179.715 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -94.6 -40.36 9.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.83 . . . . 0.0 110.26 179.996 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -45.08 107.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.662 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.42 18.26 7.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.526 ' HE2' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -96.82 147.61 23.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -104.16 148.73 25.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.871 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -111.27 161.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -109.44 17.74 21.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.608 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -136.44 128.01 28.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.39 179.889 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -62.19 130.17 44.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.086 HG11 HG23 ' A' ' 53' ' ' THR . 9.1 t -128.67 128.17 23.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -73.77 -166.06 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.314 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.66 126.75 26.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.954 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 90.15 73.72 1.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.086 HG23 HG11 ' A' ' 49' ' ' VAL . 68.9 m -92.06 99.1 11.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -1.127 . . . . 0.0 110.326 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 56' ' ' MET . 41.1 p -64.58 132.37 49.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.93 85.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.112 179.935 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 54' ' ' THR . 4.2 mtt -103.33 142.9 25.53 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.25 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -75.2 2.78 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.078 1.567 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.13 -20.8 21.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.355 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.7 mtm -108.36 -6.86 16.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.445 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 63' ' ' TYR . 85.6 t -93.95 107.69 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -77.42 -60.68 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.1 t-20 -95.68 74.4 3.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.334 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -54.48 163.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.158 179.937 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.666 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -65.04 -178.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.108 179.892 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLY . 1.4 m-20 -59.75 -58.2 9.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.4 131.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 m -88.86 -62.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 14.6 t -108.7 51.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -154.32 -178.83 0.94 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.878 . . . . 0.0 110.0 179.904 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -72.93 103.06 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.909 1.478 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 72' ' ' LEU . . . -171.89 56.25 0.17 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 72' ' ' LEU . 4.0 mm? -103.91 85.42 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -1.129 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.268 0.556 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -103.24 176.98 4.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.234 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.29 159.0 18.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.16 179.933 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -122.47 145.81 47.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.823 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 58.6 t -79.95 112.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 52' ' ' GLY . 6.1 t -118.63 132.49 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 0.0 110.158 -179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.102 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.15 130.29 35.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.278 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 39.5 t30 -80.02 -69.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG3' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -65.78 130.85 44.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 179.85 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 51' ' ' LEU . 2.0 pt? -62.26 133.0 54.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.58 -179.716 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.729 HG13 HG23 ' A' ' 49' ' ' VAL . 1.3 pt -130.13 134.77 26.5 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.1 Cg_endo -73.68 168.78 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.935 1.492 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -46.66 174.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' OD1' HD13 ' A' ' 13' ' ' ILE . 6.9 m120 60.35 -152.4 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 58.49 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.92 . . . . 0.0 110.057 -179.835 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -56.28 154.02 8.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.43 144.14 26.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.2 OUTLIER -124.86 155.22 39.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 110.31 -179.934 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.769 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.0 tt -68.07 -46.35 71.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.962 ' O ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.72 -14.63 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.943 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.459 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -87.85 -47.34 8.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.265 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.992 ' HE3' ' HB2' ' A' ' 7' ' ' ALA . 20.1 mtp -97.36 142.14 29.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -108.46 167.65 9.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.046 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.69 106.81 18.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.43 144.42 32.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 45.7 t -97.1 66.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.207 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.06 -166.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 35.3 p -118.13 160.14 40.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.873 . . . . 0.0 110.132 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 50.5 Cg_endo -77.13 145.18 80.24 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.47 -0.137 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -76.1 75.24 2.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.957 179.742 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.08 -119.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.988 HG13 HD12 ' A' ' 55' ' ' LEU . 10.2 mm -82.49 115.14 56.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.446 -1.032 . . . . 0.0 110.47 -179.619 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 49.0 Cg_endo -75.64 50.21 2.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.95 1.5 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.823 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 41.82 29.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -42.98 99.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 110.457 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 59.3 mm-40 -104.16 34.08 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -42.77 -54.57 8.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -71.7 -4.56 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.639 1.336 . . . . 0.0 110.676 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.03 -21.58 10.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.874 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' CD1' ' HE2' ' A' ' 43' ' ' MET . 16.0 tp -92.1 -40.1 11.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 37' ' ' ILE . 75.0 t -44.53 115.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 110.184 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.53 14.96 24.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.538 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 5.0 ttp -104.45 157.94 16.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -106.75 141.4 38.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 13' ' ' ILE . 26.4 m -90.22 164.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.49 10.7 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.172 179.871 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.69 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -153.17 124.71 7.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.022 179.996 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -52.74 150.09 5.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.827 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -128.22 137.85 31.74 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.18 -168.79 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.99 1.521 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -70.14 155.59 40.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 110.06 179.864 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 44.36 40.71 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.102 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.2 t -78.37 130.11 35.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 110.326 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 t -78.05 145.04 36.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.988 HD12 HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.15 107.37 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -106.64 146.46 33.11 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 179.988 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.28 -0.77 10.06 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.428 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.94 -20.27 26.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.615 ' SD ' HG13 ' A' ' 49' ' ' VAL . 4.1 mtt -112.45 32.82 5.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.923 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 11.8 t -121.09 118.95 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.031 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -86.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.857 . . . . 0.0 110.271 -179.785 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.95 89.57 7.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -45.11 160.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CE ' ' A' ' 43' ' ' MET . 1.3 mp0 -103.97 -47.96 4.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.14 85.6 3.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 72.57 0.53 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 14.1 m -84.53 54.65 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 69' ' ' SER . 58.1 p -106.27 -89.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.79 -57.97 2.32 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -72.52 -3.02 12.67 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.904 1.476 . . . . 0.0 110.321 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 67' ' ' THR . . . -108.62 128.37 9.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -15.36 16.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 -179.932 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.255 0.55 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 148.45 51.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.3 135.78 33.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -105.84 144.72 32.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.912 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 34' ' ' ALA . 29.9 m -76.31 130.05 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.253 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 54' ' ' THR . 12.4 t -129.57 118.06 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.61 116.94 2.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.148 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 5.1 p-10 -75.07 -43.8 51.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 43.2 tt0 -97.12 150.96 20.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.9 tt -63.88 105.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 109.89 179.769 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 7.9 mm -99.5 139.37 20.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.516 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.6 -157.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.124 1.592 . . . . 0.0 110.201 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.26 -165.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.008 179.715 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.4 p30 38.45 32.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.6 m -133.39 142.98 48.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.341 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -75.27 148.83 39.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 45' ' ' VAL . 39.1 mt -105.88 151.36 24.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -115.05 -170.58 1.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.16 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.99 -49.45 45.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.856 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' HG2' ' A' ' 21' ' ' MET . 3.4 pt -55.36 -18.98 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.201 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.441 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.5 mmm -90.57 9.38 29.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.27 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.73 ' CE ' HD23 ' A' ' 40' ' ' LEU . 33.6 mtp -123.3 122.83 39.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -117.16 114.04 23.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.259 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.75 83.89 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.47 126.09 42.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 73.0 t -86.42 79.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 28' ' ' THR . 9.6 p -147.6 169.57 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.968 . . . . 0.0 110.368 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -117.21 150.16 45.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.982 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.554 ' O ' HG21 ' A' ' 54' ' ' THR . 48.2 Cg_endo -75.48 134.73 37.14 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.679 -2.217 . . . . 0.0 110.395 -0.132 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 30' ' ' MET . 1.1 ptt? -80.83 136.93 36.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.552 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -89.9 -116.35 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 55' ' ' LEU . 9.9 mm -81.24 136.28 49.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.281 -1.129 . . . . 0.0 109.802 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.3 Cg_endo -74.05 4.88 3.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.965 1.508 . . . . 0.0 111.238 -179.478 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.967 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . 68.12 18.4 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -11.43 59.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 179.642 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -105.04 28.27 7.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 110.324 -179.375 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.8 mm -42.19 -53.34 8.79 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.566 -179.852 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.23 -5.07 16.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.61 1.321 . . . . 0.0 110.81 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 8.4 m-80 -114.03 -49.02 2.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.973 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.73 HD23 ' CE ' ' A' ' 22' ' ' MET . 2.3 tp -66.69 -39.97 88.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 38.9 t -50.87 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 116.96 24.57 3.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.655 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.8 ppp? -104.53 154.58 19.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -1.169 . . . . 0.0 110.265 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -109.39 123.86 50.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 13' ' ' ILE . 33.3 m -77.76 165.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' MET . 44.5 t30 -110.35 -12.28 14.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.139 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.8 mtp85 -120.32 146.57 45.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 149.86 15.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 53' ' ' THR . 38.5 t -126.13 112.52 24.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.1 Cg_endo -72.72 -167.78 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.852 1.448 . . . . 0.0 110.522 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -73.64 149.04 42.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.82 53.21 6.38 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 49' ' ' VAL . 84.6 m -96.52 122.16 39.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.591 ' N ' HG13 ' A' ' 6' ' ' VAL . 1.3 m -64.14 123.37 18.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.863 . . . . 0.0 110.135 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 32' ' ' ILE . 1.3 tt -62.03 113.01 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.064 179.895 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.5 mtt -111.63 162.57 20.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.52 0.74 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.044 1.55 . . . . 0.0 110.435 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.79 -23.98 22.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -98.87 1.0 45.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 179.87 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.655 HG13 ' CE ' ' A' ' 43' ' ' MET . 7.1 t -91.5 116.47 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -80.18 -72.73 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.918 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 73' ' ' LYS . 65.0 m-80 -100.22 87.86 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.409 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.99 144.58 28.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . 8.7 mm-40 -83.23 -95.79 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.986 . . . . 0.0 110.352 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 13.8 t70 -94.45 82.95 4.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.99 93.1 0.28 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -74.36 -39.68 62.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 32.36 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.22 -179.6 1.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.6 Cg_endo -72.36 174.97 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.887 1.467 . . . . 0.0 110.56 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.24 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -65.73 153.16 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -1.177 . . . . 0.0 110.317 -179.853 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.251 0.548 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.79 128.97 35.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.288 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.52 135.35 51.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -112.53 148.8 33.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.929 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 29.3 t -73.58 107.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.1 t -107.53 102.18 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.05 130.28 21.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.228 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -57.97 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.136 -179.942 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' CD ' ' SD ' ' A' ' 21' ' ' MET . 4.6 pt20 -81.44 162.08 23.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.188 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.7 tt -86.48 149.18 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.036 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.522 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 13.1 pt -129.79 127.91 22.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 110.399 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.53 54.01 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.033 1.544 . . . . 0.0 110.38 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER 47.44 -177.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 -179.902 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 7.1 m-20 41.15 28.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 13' ' ' ILE . 54.0 m -118.36 114.4 22.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.19 128.44 35.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.051 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mt -83.03 143.19 30.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -122.21 176.42 5.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 19' ' ' LEU . 7.2 tt -68.32 -44.86 74.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.279 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.503 HG13 ' N ' ' A' ' 21' ' ' MET . 4.7 pt -60.03 -22.51 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.503 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -95.88 -21.62 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.954 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.475 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mtm -108.39 108.0 18.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -111.68 139.59 47.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.955 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.75 84.99 6.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 179.985 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 148.55 28.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.34 93.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 0.0 110.085 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 28' ' ' THR . 94.9 t -131.01 161.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 29' ' ' PRO . 28.8 m -114.51 145.74 34.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 -179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' O ' HG21 ' A' ' 54' ' ' THR . 50.5 Cg_endo -80.29 147.65 76.29 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.716 -2.202 . . . . 0.0 110.42 -0.445 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -68.2 68.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -42.17 -83.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.835 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 55' ' ' LEU . 4.8 mt -135.27 142.84 43.11 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.0 110.224 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.7 Cg_endo -72.36 -159.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.332 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.817 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -115.57 40.01 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.96 -29.86 64.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -102.9 24.58 10.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.1 mm -45.19 -53.32 17.56 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.6 Cg_endo -71.02 -6.43 19.2 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.505 1.266 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.27 -27.08 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.116 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 36' ' ' GLU . 1.1 mp -88.97 -26.46 21.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.081 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 53.3 t -51.46 99.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.08 2.59 12.38 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.598 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.0 tmm? -94.86 143.75 26.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -1.187 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 49.3 mt-30 -106.45 134.0 50.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 13' ' ' ILE . 17.8 m -77.48 154.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.171 179.866 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -97.75 1.49 48.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -132.59 142.41 49.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -56.96 136.76 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.45 -179.76 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 53' ' ' THR . 45.5 t -124.29 120.71 26.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.955 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.772 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.65 -161.26 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.973 1.512 . . . . 0.0 110.647 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 52' ' ' GLY . 2.4 mp -81.04 160.11 24.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.335 -0.853 . . . . 0.0 110.471 -179.658 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 43.37 49.5 6.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.037 HG21 HG13 ' A' ' 49' ' ' VAL . 39.7 m -96.75 106.37 18.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -1.152 . . . . 0.0 110.081 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 ' O ' ' A' ' 29' ' ' PRO . 5.6 m -50.35 147.98 3.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -65.07 108.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.115 179.925 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.41 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -110.07 150.31 41.28 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.981 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.08 0.44 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.051 1.553 . . . . 0.0 110.58 -179.981 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.15 -50.89 7.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.515 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.74 47.65 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.84 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' CE ' ' A' ' 43' ' ' MET . 19.5 t -127.88 109.85 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -82.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.255 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -91.86 88.58 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.856 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.74 139.0 57.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 179.922 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG3' HD12 ' A' ' 40' ' ' LEU . 4.7 mm-40 -87.9 -92.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.01 82.75 3.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.0 110.398 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.74 94.28 0.25 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.18 18.15 21.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -1.146 . . . . 0.0 110.266 -179.887 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 69' ' ' SER . 88.0 m -100.41 -33.91 10.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.05 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 173.25 -56.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.995 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -73.14 85.68 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.928 1.489 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.3 70.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.64 -32.63 72.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -1.165 . . . . 0.0 110.328 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 tptt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.257 179.992 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.169 0.509 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.64 129.12 44.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.161 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.41 156.99 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.219 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.84 161.27 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.253 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 55' ' ' LEU . 39.4 t -79.04 121.42 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.093 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -125.42 107.59 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.9 111.09 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 51.1 t30 -74.91 -59.91 2.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -72.18 139.43 48.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.67 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.98 132.58 51.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 179.919 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.88 ' HB ' HG21 ' A' ' 15' ' ' THR . 1.6 pt -130.13 110.89 16.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -74.82 69.69 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.93 1.49 . . . . 0.0 110.43 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.7 pt 39.0 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 45.9 29.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.88 HG21 ' HB ' ' A' ' 11' ' ' ILE . 5.1 t -131.0 130.32 43.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 110.135 -179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 142.68 53.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.179 -179.91 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 40' ' ' LEU . 5.5 mt -77.79 124.72 28.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 110.27 -179.92 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.443 ' HB ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.94 172.04 8.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.993 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 ' CG2' ' A' ' 41' ' ' VAL . 17.5 mt -77.23 -30.99 54.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 21' ' ' MET . 6.3 pt -62.62 -25.55 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.538 ' CE ' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -97.38 -14.06 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.588 ' HG3' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.04 126.28 32.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 12.7 mttt -111.55 124.06 51.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.21 10.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.406 ' HG2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -110.92 150.08 29.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 179.964 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 26' ' ' VAL . 61.3 t -81.68 4.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG2' ' A' ' 25' ' ' GLU . 41.1 t -53.47 130.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.21 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -84.8 168.27 21.91 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.813 ' O ' HG21 ' A' ' 54' ' ' THR . 48.0 Cg_endo -73.76 156.69 99.61 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.428 -0.191 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' GLY . 5.5 mtt -76.34 83.23 3.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.69 -116.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' OH ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -110.48 139.9 22.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.219 -1.165 . . . . 0.0 109.948 179.946 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 32' ' ' ILE . 46.7 Cg_endo -73.9 168.7 24.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.553 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.699 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . -84.14 47.1 1.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -77.15 -27.06 53.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.797 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -104.72 45.34 0.97 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 111.023 -179.406 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.699 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -63.05 -51.43 70.46 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.008 179.637 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.9 Cg_endo -75.08 -5.4 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.755 1.398 . . . . 0.0 110.722 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 4.7 m120 -114.77 -35.3 4.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.591 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD2' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -87.51 -38.9 15.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.799 -179.46 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' CG2' HD21 ' A' ' 19' ' ' LEU . 9.1 t -41.93 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.9 -7.3 6.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.652 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.54 131.0 35.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -1.089 . . . . 0.0 110.194 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 15' ' ' THR . 15.2 mt-30 -99.33 151.39 21.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.961 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.1 m -99.92 161.78 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -111.18 0.29 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -114.39 135.85 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 110.042 -179.858 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -55.8 123.15 13.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.325 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CB ' ' A' ' 53' ' ' THR . 19.7 t -109.99 125.47 31.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 179.605 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -72.67 -167.63 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.858 1.452 . . . . 0.0 110.512 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -81.53 155.28 25.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.231 -179.9 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 45.29 44.61 10.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' HG13 ' A' ' 49' ' ' VAL . 43.6 m -90.61 122.58 33.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -1.174 . . . . 0.0 110.203 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.813 HG21 ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -54.69 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.987 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD12 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -80.04 106.5 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.194 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -113.1 143.27 28.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 179.822 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.36 1.46 7.34 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.951 1.5 . . . . 0.0 110.634 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.84 -15.55 44.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.812 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HG2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -99.47 -21.43 15.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.52 120.75 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.311 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.95 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 179.879 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 22.6 p-10 -92.06 87.79 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.103 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.751 ' OH ' HG21 ' A' ' 32' ' ' ILE . 2.7 t80 -45.45 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' HG3' ' C ' ' A' ' 39' ' ' ASN . 1.5 tm-20 -66.91 -60.14 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' ' OG1' ' A' ' 67' ' ' THR . 2.0 m-20 -65.97 -49.89 66.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.62 2.54 78.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -90.16 4.65 49.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -1.19 . . . . 0.0 110.203 -179.934 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -98.4 -150.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.953 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.57 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -61.03 -60.17 11.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.04 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 47.2 Cg_endo -72.67 140.06 31.93 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.533 . . . . 0.0 110.201 179.714 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.67 48.68 0.55 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.04 -170.7 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -1.157 . . . . 0.0 110.239 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.271 0.558 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.27 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 6' ' ' VAL . 18.3 p -123.88 148.82 46.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.156 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 76.2 t -62.48 116.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 110.207 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -121.03 105.91 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -42.62 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -75.69 -70.85 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.441 ' O ' HG12 ' A' ' 11' ' ' ILE . 13.0 tp60 -65.04 143.35 57.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.8 114.08 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 1.5 pt -128.78 128.32 23.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.78 -158.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.87 1.458 . . . . 0.0 109.788 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 45' ' ' VAL . 44.5 pt -98.98 -170.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.069 -1.019 . . . . 0.0 110.194 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 2.6 p30 49.41 20.31 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.489 -0.757 . . . . 0.0 110.735 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -118.71 102.13 8.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.007 -1.058 . . . . 0.0 109.928 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.74 124.12 15.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.353 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.9 mt -94.13 163.4 13.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' CG1' ' A' ' 20' ' ' ILE . 67.4 p -130.51 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 110.027 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.0 -42.62 66.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.03 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CG1' ' OG1' ' A' ' 18' ' ' THR . 2.6 pt -58.62 -26.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.106 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.0 mtt -94.46 15.98 16.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.485 ' HE3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.59 111.6 16.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -119.38 114.45 22.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.61 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.182 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.24 152.53 28.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.185 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 26' ' ' VAL . 81.3 t -95.33 82.8 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.224 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.09 157.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.0 t -95.82 148.91 35.31 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.074 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -75.87 -165.18 4.13 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.729 -2.196 . . . . 0.0 110.541 -0.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.86 -19.53 51.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 30' ' ' MET . . . 45.95 -143.17 4.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -97.49 125.29 45.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -1.162 . . . . 0.0 110.066 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.03 -161.5 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.846 1.445 . . . . 0.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.92 17.79 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -56.79 -36.64 70.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 109.971 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 10.1 pt-20 -104.58 35.98 2.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 110.286 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.74 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 4.0 mm -55.57 -54.96 45.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.243 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -70.5 -4.15 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.636 1.335 . . . . 0.0 110.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.0 m-20 -109.36 -25.25 10.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.485 HD23 ' HE3' ' A' ' 22' ' ' MET . 5.3 tp -84.85 -29.32 25.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.29 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 37' ' ' ILE . 36.7 t -42.88 104.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 103.85 29.45 5.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 tpp -97.8 140.76 31.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 110.273 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.98 121.73 44.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.045 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' ILE . 10.4 m -80.7 166.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 110.304 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB2' ' CD ' ' A' ' 61' ' ' LYS . 11.7 t-20 -111.58 -4.75 14.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -125.17 132.78 52.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.848 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' ARG . . . -46.8 135.8 8.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.366 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' A' ' 53' ' ' THR . 76.6 t -116.86 113.95 39.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.72 -169.54 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.901 1.474 . . . . 0.0 110.382 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -71.84 148.78 45.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.75 53.49 6.2 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.675 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 99.8 m -96.51 120.95 37.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.278 -1.131 . . . . 0.0 110.253 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 128.05 35.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.728 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -62.5 115.8 4.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 110.184 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.0 mtt -110.2 157.98 36.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -3.3 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.61 -10.24 41.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' CG ' ' A' ' 47' ' ' ARG . 7.0 mtm -112.22 35.59 3.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.09 111.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.304 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' CD ' ' HB2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -69.51 -71.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.147 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 7.2 p30 -96.79 86.69 4.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.115 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.86 120.52 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.29 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.3 mm-40 -75.51 -81.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.189 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.0 m-20 -89.04 69.28 8.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.56 82.69 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 67' ' ' THR . 36.6 m -85.06 9.7 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -1.17 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.3 t -69.93 -21.99 63.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.922 . . . . 0.0 110.154 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.571 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -175.83 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.571 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -72.65 59.86 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.444 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.74 35.31 5.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.13 -41.26 10.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -1.142 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.235 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tttm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.221 0.534 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.63 131.77 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.63 145.32 40.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.129 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 59.3 t -73.68 133.53 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.79 121.18 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.04 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.24 130.41 19.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t30 -86.68 -68.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -82.73 139.18 33.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -68.49 132.62 47.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 111.08 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -130.82 154.78 81.98 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 109.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.19 -96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.935 1.492 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.2 mt -153.28 -174.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.852 -1.155 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 41.39 32.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.417 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 7.2 m -112.42 129.89 56.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -67.45 158.7 31.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -125.84 135.45 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.294 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.574 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -123.24 173.38 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 20' ' ' ILE . 5.2 tt -56.34 -56.71 17.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.7 mp -52.46 -19.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' THR . 24.4 mmm -88.31 -46.61 9.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 22' ' ' MET . 2.8 ptm -116.44 135.64 53.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -117.29 166.58 12.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.171 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.37 103.37 15.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -112.94 156.82 22.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.169 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.95 91.03 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.153 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.56 148.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -99.18 167.09 11.81 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.11 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.6 Cg_endo -73.86 163.58 89.6 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.401 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.39 93.3 3.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.415 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -81.97 -111.62 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.967 HG23 ' OE2' ' A' ' 36' ' ' GLU . 14.7 mm -91.44 113.6 59.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.337 -1.096 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.71 -174.84 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.944 1.497 . . . . 0.0 110.478 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -87.13 17.88 3.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -76.62 -53.96 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.967 ' OE2' HG23 ' A' ' 32' ' ' ILE . 19.3 pt-20 -92.39 33.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.743 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.2 mm -62.34 -52.71 64.25 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 110.049 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -72.3 -1.96 10.96 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.651 1.342 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 8.8 m-80 -112.45 -32.06 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.1 tp -86.72 -39.86 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 0.0 110.131 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 18' ' ' THR . 32.4 t -50.39 127.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.221 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.71 28.89 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.2 mtm -100.01 159.4 15.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 16.2 mp0 -109.95 165.95 11.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.0 m -101.63 165.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' MET . 26.3 t-20 -111.13 16.32 21.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.278 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 13' ' ' ILE . 5.3 mmt180 -143.92 176.63 9.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -80.41 134.71 36.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.487 HG13 HG21 ' A' ' 53' ' ' THR . 15.2 t -124.24 108.59 29.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 110.049 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -72.72 -163.14 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.976 1.514 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -78.45 156.83 29.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.32 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.02 32.87 1.59 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.529 ' OG1' ' CD ' ' A' ' 50' ' ' PRO . 18.3 m -75.0 112.46 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 110.315 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.406 ' HB ' ' CE ' ' A' ' 56' ' ' MET . 20.2 m -48.13 131.23 16.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.853 . . . . 0.0 109.978 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.566 HD12 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.84 100.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.406 ' CE ' ' HB ' ' A' ' 54' ' ' THR . 1.8 mtt -101.46 139.14 20.16 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.0 2.65 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.995 1.524 . . . . 0.0 110.592 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.36 -28.71 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' ASN . 9.2 mtm -95.3 -2.87 48.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.08 127.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -64.99 -92.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.396 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 17.9 p-10 -95.78 90.65 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.17 -0.956 . . . . 0.0 110.197 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.7 t80 -44.92 157.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 10.2 mm-40 -80.79 -80.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.36 33.12 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.09 90.47 0.55 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -96.94 17.53 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.191 . . . . 0.0 110.143 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' CB ' ' A' ' 69' ' ' SER . 9.2 t -77.15 0.73 20.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 110.302 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.528 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 172.99 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.207 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -72.65 172.07 15.95 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.989 1.521 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -34.42 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -77.06 98.42 5.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -1.124 . . . . 0.0 110.228 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.532 ' CD ' ' HB3' ' A' ' 33' ' ' PRO . 9.4 ptpp? . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.267 0.556 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -83.3 174.49 10.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -120.6 165.3 15.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.134 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 97.1 t -92.63 95.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.468 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.8 t -119.12 127.12 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.827 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -80.66 144.49 32.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.462 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 t-20 -77.06 -66.42 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 109.686 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.16 148.78 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -59.33 148.33 32.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -0.954 . . . . 0.0 110.061 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.22 138.01 30.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.89 -159.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.067 1.561 . . . . 0.0 110.258 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.059 HD11 ' HB2' ' A' ' 48' ' ' ALA . 1.6 mp -123.16 173.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 13' ' ' ILE . 3.6 m120 59.25 19.92 8.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -118.08 151.41 37.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 165.97 21.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.729 HD11 ' CG1' ' A' ' 45' ' ' VAL . 38.8 mt -121.56 117.86 27.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.98 165.05 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.2 -33.69 58.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.274 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.1 mm -55.51 -41.12 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.389 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.92 8.91 43.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.97 124.4 42.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.98 144.18 48.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.999 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.6 94.63 5.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.03 154.53 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 9.2 t -92.15 39.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.158 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.12 159.1 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 11.1 p -81.89 163.13 54.92 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.1 Cg_endo -74.19 178.78 32.18 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.625 -0.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 4' ' ' SER . 1.9 mtt -77.84 -68.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.7 -128.75 18.12 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -103.67 137.1 19.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.159 -1.201 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' CD ' ' A' ' 2' ' ' LYS . 44.8 Cg_endo -72.07 177.72 6.81 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.973 1.512 . . . . 0.0 110.43 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.12 23.96 6.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.303 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -18.78 57.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 109.47 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -105.17 10.81 33.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.3 mm -41.99 -54.44 7.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.697 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -70.04 -3.84 13.01 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.529 1.278 . . . . 0.0 110.737 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLU . 90.4 m-20 -114.15 -36.95 4.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.738 HD12 ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -78.78 -42.14 28.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.2 t -42.63 121.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.255 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.71 1.04 27.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.497 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.6 ttm -99.84 149.77 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -1.178 . . . . 0.0 110.12 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -100.8 159.83 14.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.729 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.7 m -102.45 163.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.43 -9.62 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -136.27 155.69 49.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.938 . . . . 0.0 110.183 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.059 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -86.17 144.12 27.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.709 HG11 HG23 ' A' ' 53' ' ' THR . 38.2 t -130.2 140.35 38.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.0 Cg_endo -73.4 -175.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.083 1.57 . . . . 0.0 110.391 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -44.25 169.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.905 . . . . 0.0 110.286 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 44.11 52.19 7.07 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.827 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 2.2 m -75.36 94.58 3.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -1.109 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.578 HG21 ' HG2' ' A' ' 29' ' ' PRO . 6.6 t -68.11 148.75 50.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.086 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -70.24 105.64 3.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.342 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.54 155.45 44.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.163 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' ' HG2' ' A' ' 56' ' ' MET . 45.9 Cg_endo -73.24 -5.98 18.1 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.012 1.532 . . . . 0.0 110.489 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.3 -45.81 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.548 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -94.52 49.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 98.9 t -130.11 83.94 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -67.35 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -99.59 88.63 3.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.246 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 3.2 t80 -44.33 141.06 1.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.738 ' OE1' HD12 ' A' ' 40' ' ' LEU . 3.4 pt-20 -64.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.352 -0.843 . . . . 0.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 13.9 p-10 -61.91 84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 70' ' ' PRO . . . -86.04 71.76 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 67' ' ' THR . 93.7 m -79.63 5.14 13.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -1.177 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -100.46 -104.22 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -96.22 -66.05 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.884 -1.135 . . . . 0.0 110.493 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.6 Cg_endo -72.64 126.25 11.29 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.508 1.268 . . . . 0.0 110.425 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.85 94.34 0.14 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.4 -48.1 51.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -1.159 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.22 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.235 0.541 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -53.54 121.48 7.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.157 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -90.91 150.37 21.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 55' ' ' LEU . 54.2 t -77.8 114.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 5.8 t -125.89 95.0 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -48.58 128.94 15.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.58 -80.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 110.022 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -58.98 160.07 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.822 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -90.25 140.57 29.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -131.42 140.03 37.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.44 -0.788 . . . . 0.0 110.03 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.4 163.37 37.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.961 1.506 . . . . 0.0 110.211 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 45' ' ' VAL . 3.9 pt -71.7 -177.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.505 HD22 HD12 ' A' ' 13' ' ' ILE . 2.1 m-80 60.29 16.39 6.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.285 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 140.2 50.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.19 152.71 44.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.791 HD11 ' CG1' ' A' ' 45' ' ' VAL . 6.9 mt -105.38 138.36 41.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 77.8 p -115.12 153.91 29.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' MET . 13.0 pt -64.81 -20.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 7.6 mtm -97.69 -7.55 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 37' ' ' ILE . 1.4 mmm -96.26 105.49 17.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HD2' ' OD1' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -96.24 141.29 29.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.875 . . . . 0.0 110.311 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -90.62 89.99 7.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.268 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.62 120.12 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.097 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' C ' HG13 ' A' ' 27' ' ' VAL . 94.2 t -68.87 79.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.0 m -151.28 170.22 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.912 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -93.31 165.83 17.49 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.274 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.5 Cg_endo -74.97 167.24 81.01 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.357 -0.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.34 68.89 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.268 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.57 -130.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.596 HG21 ' CD ' ' A' ' 36' ' ' GLU . 2.0 mt -97.33 126.45 41.75 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.165 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.56 50.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.924 1.486 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . 45.93 26.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -69.91 -45.73 66.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' CD ' HG21 ' A' ' 32' ' ' ILE . 1.4 pt-20 -95.25 28.39 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.109 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.3 mm -47.09 -55.02 16.89 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -71.0 -2.74 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.569 1.299 . . . . 0.0 110.542 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 83.9 m-20 -109.48 -31.45 7.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.33 -31.85 15.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.505 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.4 t -43.69 110.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.32 4.45 27.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.5 ' HE3' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -100.23 152.83 19.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -1.219 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.81 154.85 18.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.893 . . . . 0.0 110.232 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.791 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.9 m -102.28 167.02 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' MET . 9.3 t30 -111.1 -11.4 14.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 3.7 mtt-85 -116.18 133.13 56.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 13' ' ' ILE . . . -51.48 124.98 13.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.518 HG13 ' CG2' ' A' ' 53' ' ' THR . 61.9 t -99.07 109.89 55.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.15 -165.02 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.957 1.504 . . . . 0.0 110.424 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -75.56 150.91 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.421 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.5 44.03 11.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' HG13 ' A' ' 49' ' ' VAL . 88.2 m -89.35 122.19 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.01 138.92 57.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 109.993 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -66.45 106.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 110.241 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.401 ' SD ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -106.15 152.58 40.46 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.41 -0.806 . . . . 0.0 110.344 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 56' ' ' MET . 48.0 Cg_endo -74.49 -0.68 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.563 . . . . 0.0 110.583 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.71 -13.9 38.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 7.8 mtt -104.24 -2.57 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG13 ' HE3' ' A' ' 43' ' ' MET . 28.4 t -100.96 106.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -80.81 78.0 7.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.442 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 11.2 t80 -46.13 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -99.41 -86.14 0.38 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.16 80.1 2.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.58 98.35 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 10.26 38.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.348 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.633 HG22 ' N ' ' A' ' 69' ' ' SER . 18.0 m -73.36 -91.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.633 ' N ' HG22 ' A' ' 68' ' ' THR . 0.6 OUTLIER -77.78 -56.13 1.15 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.175 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 69' ' ' SER . 49.5 Cg_endo -76.29 52.64 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.034 1.544 . . . . 0.0 110.297 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.92 72.61 0.54 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.82 17.58 22.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -1.174 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' CB ' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.201 0.524 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.447 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -70.06 137.35 51.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -97.87 157.06 16.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -87.83 104.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' C ' ' A' ' 52' ' ' GLY . 20.3 t -93.32 114.87 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -42.26 126.73 3.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.152 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.545 ' O ' HD23 ' A' ' 51' ' ' LEU . 50.8 t30 -82.46 -73.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.466 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -65.54 140.29 58.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.748 ' C ' HD23 ' A' ' 10' ' ' LEU . 4.2 tt -72.15 126.21 29.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 4.0 pt -130.67 151.05 78.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.966 ' O ' HD13 ' A' ' 13' ' ' ILE . 47.6 Cg_endo -73.69 -95.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.399 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 12' ' ' PRO . 6.2 mm -142.0 163.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 16.2 m-80 42.26 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.261 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 88.3 m -154.32 123.18 6.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 110.237 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.73 144.64 21.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 17' ' ' LEU . 3.6 mt -107.63 143.36 36.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.404 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' HG12 ' A' ' 20' ' ' ILE . 1.1 p -116.56 167.13 11.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.35 -21.85 62.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.523 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 8.2 pt -73.8 -18.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' ' HB3' ' A' ' 9' ' ' GLN . 2.4 mtt -97.74 21.15 10.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 110.036 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.93 122.27 43.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.1 mmmt -119.11 127.3 53.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.7 74.85 6.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -107.95 118.46 36.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.38 72.56 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.182 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 m -135.69 -173.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 110.182 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 12.2 t -103.86 149.41 37.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.83 167.48 79.87 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.319 -0.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -82.6 81.3 8.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.3 -157.97 0.03 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -75.51 140.04 71.67 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.366 -1.079 . . . . 0.0 110.298 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.12 -168.48 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.1 1.579 . . . . 0.0 110.648 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -106.8 -5.54 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -24.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mm-40 -104.89 47.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.578 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.3 mm -60.74 -53.91 59.72 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 110.339 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.4 Cg_endo -73.05 -5.23 16.83 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.829 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -114.25 -30.82 6.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 0.0 110.372 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 55' ' ' LEU . 7.3 tp -82.06 -50.1 9.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 37' ' ' ILE . 96.9 t -44.46 114.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.16 11.45 18.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 64' ' ' GLU . 4.2 ttm -97.9 143.84 28.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.6 mt-30 -104.31 112.8 25.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.226 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' ASN . 17.6 m -76.84 152.39 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.494 ' HA ' HG22 ' A' ' 13' ' ' ILE . 24.4 t-20 -109.95 42.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' NE ' HG13 ' A' ' 49' ' ' VAL . 4.1 ptm180 -141.23 156.29 45.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.95 . . . . 0.0 110.246 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -86.35 116.73 24.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.095 HG12 HG21 ' A' ' 53' ' ' THR . 2.7 m -115.22 112.02 44.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 46.9 Cg_endo -73.77 54.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.1 1.579 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 67.82 151.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 110.861 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.41 38.04 6.69 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.095 HG21 HG12 ' A' ' 49' ' ' VAL . 5.8 m -96.87 141.51 29.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.249 . . . . 0.0 110.225 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.8 HG21 ' HG2' ' A' ' 29' ' ' PRO . 10.1 t -70.42 131.77 44.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.596 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.35 122.93 17.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.302 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.15 135.31 19.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.468 ' HA ' HG21 ' A' ' 60' ' ' VAL . 49.2 Cg_endo -76.47 -24.24 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.101 1.579 . . . . 0.0 111.365 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' MET . 10.5 p-10 -63.64 -37.21 86.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.529 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.7 mmt -99.52 57.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.007 . . . . 0.0 110.003 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 57' ' ' PRO . 77.6 t -124.45 128.71 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 58.5 m-80 -96.09 100.48 12.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.471 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 2.7 t80 -45.43 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -98.43 -155.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 65' ' ' ASP . 27.1 t0 -59.9 79.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -136.25 81.4 0.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 24.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 69' ' ' SER . 66.7 m -86.3 -97.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.548 ' N ' HG22 ' A' ' 68' ' ' THR . 0.4 OUTLIER -80.74 -59.02 0.51 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.024 -1.047 . . . . 0.0 110.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.7 Cg_endo -73.72 -164.2 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.825 1.434 . . . . 0.0 110.58 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.58 -2.64 5.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -75.06 67.13 1.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 63' ' ' TYR . 2.5 mttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 tptp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.204 0.526 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.19 120.65 12.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.298 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.5 t -97.44 148.21 23.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.08 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 22' ' ' MET . 53.7 t -71.32 109.68 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 110.289 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 54' ' ' THR . 10.7 t -124.16 120.27 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.093 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.911 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.92 130.23 39.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.612 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.2 m-80 -75.25 -23.52 57.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -96.4 155.33 16.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -80.69 127.6 32.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' SD ' ' A' ' 21' ' ' MET . 6.2 pt -129.06 106.87 17.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -72.98 157.35 51.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.53 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.739 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -44.71 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.1 m120 57.39 59.06 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m -160.41 119.24 2.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.11 165.05 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.58 HD11 HG12 ' A' ' 45' ' ' VAL . 15.8 mt -122.5 111.8 17.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 17.6 p -89.13 139.78 30.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.097 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HA ' ' CG ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -50.69 -30.82 14.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.252 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 18' ' ' THR . 9.6 pt -71.15 -13.47 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.553 ' SD ' HG21 ' A' ' 11' ' ' ILE . 7.6 ttm -97.67 -10.41 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.557 ' HE3' HG22 ' A' ' 41' ' ' VAL . 5.5 ptp -117.3 123.23 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -121.11 147.51 45.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.29 96.39 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -109.83 142.96 40.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.177 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -94.74 81.06 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 110.126 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 28' ' ' THR . 8.6 p -126.63 166.52 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.256 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.8 t -114.47 149.24 41.86 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.33 164.37 88.39 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.771 -2.179 . . . . 0.0 110.523 -0.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.2 mtt -81.74 -150.64 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.402 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.8 -99.31 0.15 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 1.7 mt -118.63 132.33 23.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.124 -1.221 . . . . 0.0 109.636 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.66 -175.21 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.847 1.446 . . . . 0.0 110.359 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -86.97 21.88 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 110.299 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -43.83 74.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.479 ' OE2' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -95.22 35.01 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.88 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.6 mm -62.85 -53.25 57.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.925 . . . . 0.0 110.435 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.31 -3.07 12.23 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.581 1.306 . . . . 0.0 110.496 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -103.13 -32.49 9.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.479 HD13 ' OE2' ' A' ' 36' ' ' GLU . 4.0 tp -88.66 -31.69 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 37' ' ' ILE . 46.0 t -45.51 139.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 110.316 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.08 -32.46 5.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.2 ttp -74.91 144.78 43.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -178.43 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.617 HG23 ' HA ' ' A' ' 13' ' ' ILE . 3.3 m -119.08 164.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.074 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.8 t-20 -110.94 -8.58 14.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 110.768 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -130.05 114.86 16.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -0.992 . . . . 0.0 110.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -54.56 138.16 41.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 0.0 110.402 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 4.9 t -130.4 136.61 29.25 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.84 . . . . 0.0 110.15 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.925 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.13 179.84 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.343 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -41.87 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.209 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 54.15 51.76 48.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.911 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 59.8 p -70.63 96.73 1.24 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -1.119 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.593 ' HA ' HG22 ' A' ' 6' ' ' VAL . 15.5 m -55.35 125.87 22.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.074 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 5' ' ' VAL . 4.7 tp -61.93 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.526 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.12 167.46 9.22 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.8 Cg_endo -74.6 2.1 6.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.06 1.558 . . . . 0.0 110.592 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -75.05 -69.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.533 ' CA ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -84.12 62.02 6.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.959 . . . . 0.0 110.578 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 56' ' ' MET . 9.8 t -130.08 124.48 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.36 -94.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.395 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 80.3 m-20 -100.51 100.42 11.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.246 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -46.96 116.59 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -65.38 -79.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.34 88.31 7.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.86 77.13 0.32 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.2 m -82.11 -11.57 58.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -1.15 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -88.95 -143.71 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.528 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -53.31 -57.22 17.71 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.6 128.32 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.939 1.494 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.11 38.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 97.34 5.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -1.131 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.147 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.557 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . . . -62.49 131.86 50.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.24 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.13 136.51 34.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.117 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 96.6 t -70.19 118.06 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 4' ' ' SER . 4.4 t -121.53 107.96 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.947 . . . . 0.0 110.235 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -51.35 120.1 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.907 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -79.59 -42.3 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.458 ' O ' HG12 ' A' ' 11' ' ' ILE . 40.8 tp60 -91.12 141.26 29.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 10' ' ' LEU . 3.0 tt -60.42 113.64 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 9' ' ' GLN . 12.6 mm -106.21 131.83 21.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.24 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.87 -163.26 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.825 1.434 . . . . 0.0 110.192 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.687 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.6 mt -106.94 -174.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 109.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.521 ' H ' HG22 ' A' ' 13' ' ' ILE . 2.7 m-20 52.26 19.41 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -117.5 155.39 29.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -81.1 156.69 25.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 12.8 mt -100.3 116.22 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' HG22 ' A' ' 20' ' ' ILE . 25.3 p -101.14 126.73 47.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -46.68 -40.74 13.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.593 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 tt -43.42 -42.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.593 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -93.35 11.77 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 110.354 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 28.8 mtm -123.99 112.28 17.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.0 153.88 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 3' ' ' ALA . . . -88.31 99.38 12.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -112.95 127.15 56.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -68.84 81.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 28' ' ' THR . 83.8 t -131.8 162.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -100.28 150.18 36.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -75.95 -169.43 7.54 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.393 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 4' ' ' SER . 8.8 ptp -74.18 -29.51 61.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 44.68 -145.52 2.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.972 HD12 ' OH ' ' A' ' 63' ' ' TYR . 42.3 mm -83.32 115.32 58.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.14 . . . . 0.0 110.073 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 46.3 Cg_endo -72.15 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.894 1.471 . . . . 0.0 110.507 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -94.0 23.97 4.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.9 mm-40 -76.95 -49.67 15.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.841 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE2' ' CG ' ' A' ' 65' ' ' ASP . 3.1 mm-40 -100.39 37.8 1.62 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.823 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.969 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -63.96 -54.03 43.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.7 Cg_endo -72.01 -2.14 11.08 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.694 1.365 . . . . 0.0 110.294 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' OD1' ' OE2' ' A' ' 64' ' ' GLU . 17.1 m-80 -106.95 -41.72 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' MET . 2.9 tp -74.5 -24.88 59.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 37' ' ' ILE . 34.6 t -45.7 99.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.78 11.9 21.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 53.5 tpp -81.43 155.12 26.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -1.188 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.7 157.83 16.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 110.252 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 13' ' ' ILE . 2.7 p -118.76 159.97 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' C ' HG21 ' A' ' 13' ' ' ILE . 35.4 t-20 -110.67 -13.76 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' H ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -118.02 174.74 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 0.0 110.145 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -85.53 149.04 25.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.589 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 53' ' ' THR . 54.2 t -128.24 107.5 19.57 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.833 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' C ' ' HG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -71.93 -160.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.966 1.509 . . . . 0.0 110.694 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.17 153.81 31.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.429 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.9 43.64 5.41 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.658 ' HB ' HG13 ' A' ' 49' ' ' VAL . 40.1 m -89.84 119.5 30.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -1.136 . . . . 0.0 110.328 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.9 141.26 58.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -66.05 115.45 6.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.279 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.57 138.58 21.52 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.71 -0.05 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.341 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -84.05 -20.71 32.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.892 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.502 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 22.0 mtt -99.67 -15.16 18.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.99 111.93 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 110.054 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -73.48 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.58 97.12 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.189 -0.945 . . . . 0.0 110.304 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.972 ' OH ' HD12 ' A' ' 32' ' ' ILE . 2.4 t80 -62.4 152.41 34.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -71.78 -53.28 13.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 110.385 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' CG ' ' OE2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -60.19 -42.31 94.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.413 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' CA ' ' HA2' ' A' ' 71' ' ' GLY . . . 48.92 83.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 68' ' ' THR . 34.2 m -89.01 -87.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.336 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' THR . 1.3 p -110.16 -92.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 110.52 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.549 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -49.97 -53.79 39.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.4 Cg_endo -74.61 2.09 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.906 1.477 . . . . 0.0 110.74 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' ' CA ' ' A' ' 66' ' ' GLY . . . -56.45 -56.98 21.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 156.85 18.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.195 . . . . 0.0 110.277 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.119 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.2 0.524 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.43 169.65 12.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -122.52 169.8 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.568 ' O ' HD23 ' A' ' 55' ' ' LEU . 21.8 t -94.27 110.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' HA2' ' A' ' 52' ' ' GLY . 15.3 t -116.52 114.04 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.045 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -52.94 127.68 24.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -0.949 . . . . 0.0 110.041 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 39.6 t30 -74.57 -55.12 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.543 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -91.24 148.18 22.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.497 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.644 ' C ' HD23 ' A' ' 10' ' ' LEU . 9.0 tt -61.32 128.47 36.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.889 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -101.4 123.6 44.02 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.2 Cg_endo -78.4 47.34 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.874 1.46 . . . . 0.0 110.78 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.3 mt 49.91 177.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.17 -0.956 . . . . 0.0 110.387 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 13' ' ' ILE . 5.9 m-20 45.42 36.17 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.448 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 16.4 m -132.53 119.69 20.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.02 159.29 5.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.3 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 23.6 mt -103.17 134.8 45.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.61 -168.75 1.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.47 -45.14 73.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.511 HD12 ' SD ' ' A' ' 21' ' ' MET . 5.9 pt -55.41 -28.26 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.01 11.47 33.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.479 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -115.12 109.75 18.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -114.36 122.94 48.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.302 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.09 79.93 9.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.98 129.07 46.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 26' ' ' VAL . 49.4 t -76.65 55.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.68 155.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.477 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -93.42 165.15 18.86 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.63 ' O ' HG21 ' A' ' 54' ' ' THR . 47.4 Cg_endo -74.92 159.87 97.36 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.493 -0.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -53.58 56.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.19 -113.36 5.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.911 HD12 HD12 ' A' ' 55' ' ' LEU . 8.3 mt -127.67 127.36 24.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.163 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -175.8 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.883 1.464 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.636 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -98.94 26.38 5.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -62.38 -38.99 91.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -102.09 45.94 0.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.0 110.321 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.636 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -57.14 -42.52 96.67 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.5 Cg_endo -78.0 -7.13 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.529 1.278 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 1.3 m-20 -111.36 -36.49 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 47.6 tp -79.86 -38.63 32.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 23.0 t -52.21 141.57 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.26 -18.72 55.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 4.9 ttp -81.23 132.08 35.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -1.198 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -89.91 147.59 23.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.122 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 7.3 m -87.34 156.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -98.83 -5.95 30.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.344 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -127.94 163.08 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.159 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -82.21 135.79 35.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.664 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.828 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -119.83 124.99 27.62 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 109.781 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.41 -177.77 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.856 1.451 . . . . 0.0 110.55 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.14 143.41 56.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.328 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 56.93 47.35 87.57 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.045 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 4.9 t -86.08 113.54 22.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -1.145 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.63 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.4 m -55.04 143.36 27.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.033 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -61.83 101.32 0.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.169 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -108.5 148.61 38.03 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 60' ' ' VAL . 47.9 Cg_endo -74.02 1.88 6.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.99 1.521 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -52.81 7.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.54 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -87.32 45.67 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.4 t -123.96 133.12 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -91.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.9 104.42 15.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.35 155.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.9 mm-40 -103.57 -96.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.64 52.34 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 110.346 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.67 60.08 0.51 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -82.3 59.38 4.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' SER . 33.6 m -96.67 -89.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.48 -56.65 3.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.134 -0.979 . . . . 0.0 110.112 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -73.55 -166.32 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.044 1.55 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.14 173.56 40.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.16 175.2 6.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.193 -1.181 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.253 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.253 0.549 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -86.4 142.59 28.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.272 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.4 p -97.03 169.23 9.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.071 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 24.8 t -86.74 88.93 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.1 t -106.55 121.9 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.132 -0.98 . . . . 0.0 109.868 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.999 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.73 143.8 32.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.443 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 7.4 t-20 -73.82 -72.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -62.71 148.6 46.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.074 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.025 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -60.3 159.37 10.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.932 ' N ' HD22 ' A' ' 10' ' ' LEU . 1.8 pt -130.95 117.99 17.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.694 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 51.3 Cg_endo -80.45 50.57 3.59 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.834 1.439 . . . . 0.0 110.19 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 23.4 pt 39.18 -164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.615 -0.678 . . . . 0.0 110.755 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' ND2' HG13 ' A' ' 13' ' ' ILE . 15.1 p30 37.88 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.568 -0.708 . . . . 0.0 110.781 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.4 m -138.45 118.67 13.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.62 155.19 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 109.992 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.39 127.0 53.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.4 OUTLIER -100.87 150.74 22.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 19' ' ' LEU . 7.5 tt -42.67 -49.53 5.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 3.6 mt -63.54 -24.78 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -84.55 -19.39 33.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.615 ' CE ' HD11 ' A' ' 37' ' ' ILE . 1.8 ptm -116.48 136.69 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.88 131.04 55.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.942 . . . . 0.0 110.2 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -74.77 97.18 3.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 139.42 40.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 3' ' ' ALA . 23.5 t -95.37 81.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.176 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -161.82 154.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 110.043 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.4 t -74.65 150.24 86.49 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 110.155 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.42 161.91 93.61 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.693 -2.211 . . . . 0.0 110.481 -0.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -82.65 -81.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.386 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.77 -122.54 7.44 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' HG ' ' A' ' 55' ' ' LEU . 5.5 mt -123.95 139.12 31.8 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.106 -1.232 . . . . 0.0 109.919 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.1 1.579 . . . . 0.0 110.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -108.25 41.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -65.09 -21.92 66.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.987 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 64' ' ' GLU . 4.8 mm-40 -105.32 35.5 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.785 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.7 mm -40.62 -54.94 4.78 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.531 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.39 -6.8 19.95 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.632 1.333 . . . . 0.0 110.889 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 m-20 -114.25 -18.87 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.128 -0.983 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -102.07 -34.7 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.6 t -42.69 103.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 125.12 9.38 5.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.63 144.92 26.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -1.174 . . . . 0.0 110.12 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 3.6 mt-30 -109.75 168.16 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 11' ' ' ILE . 12.4 m -116.09 174.79 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 -7.3 14.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.426 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.497 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -125.4 119.21 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.182 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -68.33 145.03 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.398 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 53' ' ' THR . 23.7 t -129.42 139.79 36.73 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 110.178 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.66 89.68 0.97 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.304 1.686 . . . . 0.0 110.713 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 55.25 160.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.395 -0.816 . . . . 0.0 110.73 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 41.37 65.95 1.04 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.999 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.3 t -91.83 113.52 25.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.096 -1.238 . . . . 0.0 110.015 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 30' ' ' MET . 1.5 m -73.68 121.96 21.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.82 106.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.733 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.682 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.8 mtt -112.92 156.94 41.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.57 -2.98 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.076 1.566 . . . . 0.0 110.485 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.45 -30.41 16.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 7.5 mmt -99.16 0.31 43.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.068 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 56' ' ' MET . 55.8 t -91.36 102.23 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CD ' ' OXT' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -67.36 -58.98 3.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.042 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 14.5 p-10 -100.59 80.11 2.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' OG ' ' A' ' 69' ' ' SER . 1.6 t80 -46.49 146.12 1.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.9 . . . . 0.0 110.464 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -70.41 -175.28 0.99 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.235 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -60.03 -57.74 11.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.97 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 50.68 179.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -107.61 -60.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 0.0 110.052 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 68' ' ' THR . 8.3 t -102.71 55.61 0.77 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.931 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -95.67 -177.91 0.71 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 110.303 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 43.6 Cg_endo -72.55 -89.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.481 . . . . 0.0 110.341 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.76 -15.68 3.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.51 130.66 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 110.138 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.492 ' OXT' ' CD ' ' A' ' 61' ' ' LYS . 4.0 mptt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.251 0.548 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -55.98 135.9 52.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.142 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 30' ' ' MET . 46.5 t -113.31 160.24 18.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.295 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 53.3 t -92.02 97.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 54' ' ' THR . 14.9 t -117.44 125.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.57 137.1 45.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.581 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.6 t-20 -73.6 -44.49 56.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 110.248 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.418 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 14.6 tt0 -88.28 152.81 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -64.21 152.14 41.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -129.84 133.9 25.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.16 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.92 1.484 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.614 HG23 HG23 ' A' ' 45' ' ' VAL . 2.3 mt -116.17 170.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -0.915 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.16 11.75 4.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.3 m -115.79 140.83 48.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 110.298 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -62.16 163.22 8.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.21 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 45' ' ' VAL . 9.1 mt -112.03 120.79 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.135 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.413 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -100.11 130.93 46.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -46.29 -40.75 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 19' ' ' LEU . 64.3 mt -46.91 -36.71 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 62.4 mtp -86.61 -19.01 29.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.273 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.2 mtm -102.05 127.56 48.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.223 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.9 mtpt -114.6 170.76 8.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.42 94.45 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.2 131.71 55.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 3' ' ' ALA . 32.4 t -78.66 87.63 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.99 149.41 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.6 t -102.5 149.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.066 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.72 133.51 31.65 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.741 -2.191 . . . . 0.0 110.516 -0.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ILE . 3.9 ptp -60.21 -29.63 68.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 57.8 -85.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 55' ' ' LEU . 3.8 mt -132.74 127.67 20.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.188 -1.184 . . . . 0.0 110.202 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.28 -160.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.885 1.466 . . . . 0.0 110.405 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -100.51 28.79 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.301 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -46.08 37.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.42 24.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.7 mm -50.94 -53.1 51.4 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.844 . . . . 0.0 110.565 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -70.78 -1.13 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.53 1.279 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' O ' ' CD ' ' A' ' 64' ' ' GLU . 35.3 m120 -113.5 -46.01 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -0.97 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -78.78 -35.4 44.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.472 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 t -44.29 107.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.045 -1.034 . . . . 0.0 110.034 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 113.76 12.28 11.67 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.1 mmm -94.49 160.69 14.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.164 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.21 147.14 34.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 17' ' ' LEU . 4.5 m -102.37 166.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 47' ' ' ARG . 55.6 p30 -101.59 -11.95 18.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.22 -0.925 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 63.4 mtt180 -130.99 156.96 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -86.05 141.53 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 110.279 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG22 ' SD ' ' A' ' 59' ' ' MET . 6.7 t -121.63 132.85 24.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' O ' HG22 ' A' ' 53' ' ' THR . 44.8 Cg_endo -71.9 -172.96 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.885 1.466 . . . . 0.0 110.339 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -46.36 155.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 55.89 59.99 9.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.797 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 38.8 p -78.34 95.24 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -1.077 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 6' ' ' VAL . 7.0 m -62.88 133.85 55.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.37 96.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.219 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mmm -112.65 153.64 44.96 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.155 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.23 3.16 6.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.944 1.497 . . . . 0.0 110.559 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -39.11 36.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.482 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.605 ' SD ' HG22 ' A' ' 49' ' ' VAL . 5.9 mtm -111.82 60.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.342 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG13 ' CE ' ' A' ' 43' ' ' MET . 83.9 t -129.49 104.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -81.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.518 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -93.04 93.17 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.422 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -47.76 150.22 1.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 39' ' ' ASN . 71.8 mm-40 -80.1 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.02 82.2 8.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.6 65.4 3.96 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -30.3 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -1.114 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 56.8 p -110.44 -129.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -73.73 -54.26 3.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.949 -1.094 . . . . 0.0 111.041 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 69' ' ' SER . 42.8 Cg_endo -69.2 59.79 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.693 1.365 . . . . 0.0 110.924 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -133.04 -2.37 3.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.26 135.01 46.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 0.0 110.424 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.193 179.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.277 0.56 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.93 156.89 36.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.44 149.39 42.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 34' ' ' ALA . 73.7 t -75.0 97.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.0 t -108.25 123.89 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.207 -0.933 . . . . 0.0 110.153 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -57.79 141.07 50.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.35 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t-20 -80.19 -67.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.845 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.415 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.1 tt0 -87.54 155.33 20.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.819 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -59.36 141.11 55.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 110.201 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.769 ' H ' HG23 ' A' ' 49' ' ' VAL . 10.8 mm -130.55 144.9 55.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 110.058 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 44.2 Cg_endo -71.37 -170.94 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.947 1.498 . . . . 0.0 110.261 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 47' ' ' ARG . 6.2 mt -107.27 167.47 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.92 . . . . 0.0 110.023 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 54.72 26.18 7.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.185 -0.947 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -113.72 141.33 47.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.923 . . . . 0.0 110.217 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 104.96 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -87.27 162.79 17.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.356 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.29 163.21 23.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.99 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -57.24 -28.66 63.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG13 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.1 -17.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.67 -10.14 25.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.572 ' CE ' HD13 ' A' ' 17' ' ' LEU . 3.3 mtt -123.27 139.34 54.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.46 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -112.24 170.08 8.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.016 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.18 6.31 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 141.63 46.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.66 82.02 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.63 155.18 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 110.127 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.2 p -111.85 159.86 31.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.263 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -76.17 132.24 26.87 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.511 -2.287 . . . . 0.0 110.477 -0.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.78 153.44 29.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -120.57 -71.4 0.31 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 57' ' ' PRO . 3.1 mt -136.2 137.93 25.94 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.452 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.3 Cg_endo -73.07 -162.97 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.067 1.562 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -111.49 38.63 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -31.46 69.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 33.2 mm-40 -101.74 30.36 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.982 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.9 mm -44.89 -54.19 13.86 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -70.99 -5.77 17.71 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.632 1.333 . . . . 0.0 110.441 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' OD1' ' OE1' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -108.46 -24.83 11.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 110.127 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -93.74 -12.86 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 109.967 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 37' ' ' ILE . 41.5 t -46.79 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.37 24.12 9.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.94 137.49 36.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.996 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 3.5 mt-30 -96.57 116.49 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.158 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.99 167.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.095 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 17.8 t30 -110.84 2.38 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HG2' ' CB ' ' A' ' 59' ' ' MET . 9.3 ptm180 -136.63 155.93 49.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.418 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -79.42 113.34 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.865 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.012 HG12 HG21 ' A' ' 53' ' ' THR . 19.1 m -81.87 112.33 34.05 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 48.2 Cg_endo -73.6 53.05 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.887 1.467 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER 66.82 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.496 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.22 49.11 14.93 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.012 HG21 HG12 ' A' ' 49' ' ' VAL . 11.3 m -96.83 123.71 40.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 142.63 58.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 110.165 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.22 120.74 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.482 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 46.5 mmm -112.7 137.49 21.75 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.8 Cg_endo -74.2 -7.39 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.62 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -52.49 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.488 ' CB ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 mpt? -87.78 62.12 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.329 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 56' ' ' MET . 28.8 t -128.57 106.47 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.171 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 9.4 mmtt -49.92 -84.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.79 91.79 8.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -48.66 135.82 14.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 8.2 pm0 -78.41 -37.81 43.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -0.939 . . . . 0.0 110.53 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 24.9 t70 -84.39 99.99 11.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.89 31.12 4.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -99.78 -64.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -108.82 -14.35 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.597 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -70.27 -171.47 0.16 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 47.3 Cg_endo -77.52 -4.83 15.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.778 1.409 . . . . 0.0 110.497 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.57 40.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.37 158.88 15.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 110.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 114.13 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -95.08 147.55 23.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.666 ' CG1' HD23 ' A' ' 55' ' ' LEU . 53.0 t -79.57 120.11 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 110.181 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.686 HG13 ' N ' ' A' ' 54' ' ' THR . 6.4 t -126.53 110.19 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.264 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -54.73 135.02 47.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.69 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -87.42 -71.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 2.2 pt20 -58.44 144.8 40.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -71.42 126.6 30.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.519 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -126.38 144.21 48.61 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.202 -0.936 . . . . 0.0 110.363 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.91 -158.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.982 1.517 . . . . 0.0 110.349 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.698 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.8 mt -95.74 -172.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.698 ' H ' HG22 ' A' ' 13' ' ' ILE . 9.9 p30 39.86 30.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -104.83 115.81 30.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -64.25 98.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.591 HD11 HD23 ' A' ' 40' ' ' LEU . 1.7 pp -70.4 152.62 43.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.7 p -130.17 -160.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.3 mp -77.05 -43.11 35.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pt -69.18 -16.88 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -97.37 -12.73 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.33 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.554 ' HG3' HD13 ' A' ' 17' ' ' LEU . 39.3 mmm -124.13 107.46 11.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.153 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 21.9 mttt -99.22 144.18 28.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.76 98.56 11.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.4 mp0 -113.24 143.51 44.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 2' ' ' LYS . 8.1 p -96.75 62.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.92 -174.51 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 0.0 110.39 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.8 t -100.34 150.86 37.3 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.103 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 51.0 Cg_endo -81.84 153.74 78.65 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.689 -2.213 . . . . 0.0 110.563 -0.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -82.66 159.78 22.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.866 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -113.31 0.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -99.99 141.41 22.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 44.4 Cg_endo -71.43 -164.05 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.004 1.528 . . . . 0.0 110.466 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -116.91 27.29 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.925 . . . . 0.0 110.376 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.487 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -74.46 -17.13 60.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.246 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 pm0 -102.68 1.41 34.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.889 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -41.32 -54.56 5.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.496 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -70.5 -8.11 22.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.647 1.341 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -114.39 -18.61 11.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.067 -1.021 . . . . 0.0 110.501 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.591 HD23 HD11 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -102.4 -26.71 13.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.582 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 37' ' ' ILE . 10.6 t -42.63 127.96 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.97 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.25 -0.65 47.07 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -87.53 152.24 22.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -1.123 . . . . 0.0 110.139 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -99.72 174.73 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 13' ' ' ILE . 1.6 p -113.43 163.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 1.2 m-20 -102.81 -29.34 11.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 110.611 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 17.2 mtp180 -121.74 164.99 16.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.548 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -57.56 150.1 19.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 0.0 110.508 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.119 ' CG1' HG21 ' A' ' 53' ' ' THR . 80.5 t -127.88 107.27 20.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.056 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.72 -171.94 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.06 1.558 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -73.89 160.69 31.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.867 . . . . 0.0 110.184 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.54 46.92 7.19 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.119 HG21 ' CG1' ' A' ' 49' ' ' VAL . 8.1 t -92.38 104.87 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.686 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -51.54 157.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.93 112.0 2.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.474 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 3.0 tpt -112.51 127.58 26.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.91 -20.55 19.5 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.857 1.451 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -65.84 -23.1 66.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 45' ' ' VAL . 33.0 mtm -113.51 49.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 61.5 t -127.09 139.53 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' CE ' ' A' ' 43' ' ' MET . 37.3 t30 -90.34 92.66 9.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 86.3 m-85 -44.69 149.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -94.58 -47.21 6.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.89 95.39 10.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.58 5.34 83.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -9.69 47.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.0 110.176 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 3.2 p -106.04 -178.56 3.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.282 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -50.76 -56.0 22.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.467 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.2 Cg_endo -72.21 112.54 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.916 1.482 . . . . 0.0 110.522 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.29 49.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 72' ' ' LEU . 11.3 mt -80.93 -2.71 48.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -1.115 . . . . 0.0 110.329 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.252 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -65.01 126.79 29.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 14.4 t -95.01 166.44 11.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.156 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ILE . 15.0 t -85.54 110.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' GLU . 3.9 t -111.32 113.2 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.088 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.09 128.78 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.695 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.2 t-20 -80.59 -55.69 4.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -91.02 177.69 6.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.068 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.9 tt -99.65 130.53 45.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.786 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -126.8 133.17 24.74 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -73.15 56.96 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.983 1.517 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 mt 45.66 -172.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.076 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.6 m-20 43.63 63.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.114 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 m -159.61 119.09 2.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.4 85.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 43' ' ' MET . 1.2 pp -50.71 155.29 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.5 OUTLIER -130.01 159.91 35.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.178 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.1 tt -59.72 -48.42 81.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.821 ' N ' HD23 ' A' ' 19' ' ' LEU . 88.3 mt -57.7 -31.6 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.233 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -86.19 -26.15 25.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 18' ' ' THR . 15.9 mmt -110.91 131.2 55.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -107.41 165.33 11.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.67 99.97 9.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.2 tt0 -104.57 135.47 45.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.191 -0.943 . . . . 0.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 3' ' ' ALA . 12.2 t -85.38 71.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.9 t -133.07 160.4 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.4 t -88.13 152.22 50.21 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -77.77 160.31 93.05 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.546 -0.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtm -82.68 101.13 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.65 -119.9 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.582 ' CD1' HD12 ' A' ' 55' ' ' LEU . 1.8 mt -99.59 129.31 29.19 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 110.02 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 178.38 5.82 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.889 1.468 . . . . 0.0 110.761 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.747 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -79.3 2.79 20.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.378 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 34' ' ' ALA . 8.3 tt0 -43.58 -39.86 3.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -104.92 39.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.233 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.747 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -55.99 -54.56 50.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 110.233 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -70.61 -4.48 14.68 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.661 1.348 . . . . 0.0 110.45 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -111.45 -31.18 7.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.139 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -73.5 -39.61 64.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.141 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 41' ' ' VAL . 24.4 t -45.24 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.113 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 119.57 19.27 4.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.499 ' CE ' HG11 ' A' ' 60' ' ' VAL . 2.0 ttt -98.5 144.34 27.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -1.095 . . . . 0.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.83 146.53 28.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.162 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 13' ' ' ILE . 7.5 m -104.87 153.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.08 28.71 8.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 8.8 ptt180 -151.21 137.93 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -48.95 130.86 18.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.926 HG13 ' HB ' ' A' ' 53' ' ' THR . 9.9 t -117.32 106.86 46.17 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.98 -168.14 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.539 . . . . 0.0 110.398 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -70.37 136.82 50.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 60.98 52.67 50.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.926 ' HB ' HG13 ' A' ' 49' ' ' VAL . 63.3 m -96.49 124.87 40.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -1.119 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 54' ' ' THR . 4.8 t -68.45 149.84 48.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.142 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.12 111.34 12.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.336 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtt -104.8 133.01 20.38 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . 50.0 Cg_endo -76.99 6.23 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.948 1.499 . . . . 0.0 110.677 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 -42.19 21.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.055 -1.028 . . . . 0.0 110.521 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.551 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 3.2 mmt -110.54 67.28 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.6 t -126.25 122.36 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.867 . . . . 0.0 110.141 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.3 -77.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.09 105.62 17.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 70' ' ' PRO . 59.1 m-85 -67.26 155.61 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 110.223 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -104.54 -65.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.9 -43.91 67.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.02 90.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 68' ' ' THR . 6.6 m -105.07 -83.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.213 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 67' ' ' THR . 59.0 m -106.96 -80.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -51.8 -61.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.1 Cg_endo -71.13 154.6 62.1 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.814 1.428 . . . . 0.0 110.428 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.88 162.38 31.23 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 109.94 4.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -1.105 . . . . 0.0 110.216 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 26' ' ' VAL . 21.4 mmtt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.432 0.634 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -47.88 112.44 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -102.15 148.21 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.016 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 34' ' ' ALA . 59.4 t -72.86 104.33 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.173 -0.954 . . . . 0.0 110.269 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -107.97 105.87 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.048 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.56 115.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -72.75 -62.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.056 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -86.61 152.43 22.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.3 tt -59.34 142.26 52.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 11' ' ' ILE . 35.2 mm -123.04 139.18 31.01 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 -162.11 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.024 1.539 . . . . 0.0 110.329 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 6.5 mt -116.55 157.82 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 64.31 38.26 8.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 6.1 m -132.49 138.4 47.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -61.89 158.72 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.2 mt -110.01 148.16 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -129.96 132.23 46.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.767 HD23 HG21 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -49.41 -31.28 9.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' CG1' ' HB ' ' A' ' 18' ' ' THR . 13.4 pt -69.51 -16.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 109.985 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.84 -15.65 22.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 110.073 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -121.64 119.66 32.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.29 164.55 14.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -94.75 115.63 27.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -111.28 124.88 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 2' ' ' LYS . 16.5 t -90.17 65.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.55 -173.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -111.94 153.0 44.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.086 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.33 161.93 92.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.432 -0.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.3 mtp -82.82 92.01 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.64 -144.73 0.28 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -79.63 136.24 55.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.325 -1.103 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.51 -174.26 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.002 1.527 . . . . 0.0 110.644 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.666 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -112.32 17.34 19.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.316 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -34.03 77.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.136 -0.977 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.5 mm-40 -89.24 26.41 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.666 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.96 -40.81 81.22 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.0 111.217 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.5 Cg_endo -74.81 -18.54 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.315 1.166 . . . . 0.0 111.256 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -114.31 -11.75 12.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 110.272 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.598 HD12 ' CD ' ' A' ' 64' ' ' GLU . 9.3 tt -102.42 -44.01 5.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 HD23 ' A' ' 19' ' ' LEU . 33.3 t -41.8 148.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.434 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -16.3 61.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.6 mtp -73.27 157.01 37.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -1.107 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' THR . 4.4 mp0 -110.05 170.34 8.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.8 m -109.5 166.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 110.252 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.92 -4.23 18.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' HD13 ' A' ' 13' ' ' ILE . 3.4 mtp180 -143.18 168.45 19.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.192 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -78.11 139.24 39.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.899 HG13 HG21 ' A' ' 53' ' ' THR . 88.8 t -112.04 127.28 27.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.84 . . . . 0.0 110.164 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.06 -171.88 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.841 1.442 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' A' ' 10' ' ' LEU . 2.1 mp -74.97 153.13 38.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.502 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 42.69 53.33 5.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.899 HG21 HG13 ' A' ' 49' ' ' VAL . 83.0 m -96.97 109.57 22.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.26 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 148.51 2.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.885 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.0 102.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.973 . . . . 0.0 110.211 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.1 mmt -111.35 149.63 40.89 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 Cg_endo -75.66 4.07 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.975 1.513 . . . . 0.0 110.798 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.32 -42.16 62.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 110.644 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.12 55.15 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.2 t -130.28 102.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -66.88 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.06 86.87 6.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 27.8 m-85 -44.29 155.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.598 ' CD ' HD12 ' A' ' 40' ' ' LEU . 1.4 pt-20 -76.38 -158.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 110.342 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.1 m-20 -68.6 73.35 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -111.68 92.53 0.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 67' ' ' THR . 85.6 m -97.39 21.71 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.3 p -97.43 -15.06 20.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.087 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.59 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -173.54 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.046 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.0 Cg_endo -72.24 169.76 20.78 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.854 1.449 . . . . 0.0 110.227 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.35 56.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.15 75.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.087 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.237 0.541 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.95 127.65 35.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -102.24 137.34 40.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' ILE . 15.9 m -78.22 129.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 54' ' ' THR . 11.4 t -122.13 131.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.712 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.69 129.31 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.89 -70.82 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -80.0 160.85 25.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.9 tt -77.98 130.97 37.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 49' ' ' VAL . 4.4 mt -116.59 113.54 40.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.151 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.852 ' C ' HD13 ' A' ' 13' ' ' ILE . 46.9 Cg_endo -73.25 66.12 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.83 1.437 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.852 HD13 ' C ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 32.78 -161.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.534 0.683 . . . . 0.0 111.696 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 5.1 m120 36.52 42.17 0.19 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -147.72 124.53 11.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.58 7.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.812 . . . . 0.0 110.02 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 45' ' ' VAL . 60.7 mt -62.33 133.46 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.68 155.78 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -67.79 -29.1 68.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.345 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 21' ' ' MET . 1.4 pt -65.15 -19.67 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 110.139 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.523 ' N ' HG13 ' A' ' 20' ' ' ILE . 3.2 mtm -97.98 -2.25 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.9 118.57 32.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.272 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.6 pttt -114.81 142.27 46.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.56 96.32 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.957 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -112.2 133.93 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 3' ' ' ALA . 18.2 t -90.71 87.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.194 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG13 ' C ' ' A' ' 26' ' ' VAL . 18.1 m -148.76 -167.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.384 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.6 t -118.71 153.44 52.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 110.236 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -77.2 160.63 94.11 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.446 -0.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.1 mmm -82.62 71.27 9.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.154 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -55.96 -108.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.713 ' O ' HG22 ' A' ' 5' ' ' VAL . 2.6 mt -113.12 136.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -162.0 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.928 1.488 . . . . 0.0 110.352 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -93.69 32.91 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -56.86 4.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 15.5 mm-40 -88.67 33.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.43 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.9 mm -60.04 -54.71 52.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.0 Cg_endo -71.39 -8.85 24.2 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.262 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.99 -47.71 4.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 0.0 110.14 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -68.3 -41.25 81.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -54.78 119.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.7 -8.26 10.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.535 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.4 ttm -100.78 162.25 13.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -1.115 . . . . 0.0 110.218 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -109.86 138.2 46.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 17' ' ' LEU . 12.6 m -91.48 154.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -104.61 -2.73 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 4.2 mtt180 -113.14 131.35 55.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.002 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.86 132.27 9.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.384 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.641 HG13 ' CB ' ' A' ' 53' ' ' THR . 55.8 t -113.17 102.4 54.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 110.058 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.4 Cg_endo -72.03 -167.13 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.543 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.58 138.54 40.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.24 34.93 91.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.2 m -73.5 97.87 2.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -44.98 137.9 3.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.22 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.24 98.66 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.429 ' CG ' ' HG3' ' A' ' 59' ' ' MET . 2.9 ptm -113.11 146.5 35.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.53 -5.44 17.15 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.541 . . . . 0.0 110.458 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -76.99 -25.48 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.295 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' CB ' ' A' ' 47' ' ' ARG . 11.0 mtt -108.21 41.53 1.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG13 ' CE ' ' A' ' 43' ' ' MET . 49.7 t -130.26 104.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 19.2 tptm -69.16 -60.35 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.454 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -98.37 71.57 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 13.1 t80 -53.36 158.47 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mm-40 -87.84 -65.63 1.0 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.36 85.21 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.65 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.91 17.86 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.171 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -80.22 -137.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.8 -55.98 4.22 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.594 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.35 -163.89 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.912 1.48 . . . . 0.0 110.457 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.7 87.79 0.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 72' ' ' LEU . 8.9 tt -85.49 -7.68 58.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 110.342 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.227 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.178 0.513 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.69 126.55 29.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' GLU . 3.5 t -95.86 -178.48 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 55' ' ' LEU . 77.3 t -89.18 119.9 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.413 HG12 ' C ' ' A' ' 52' ' ' GLY . 3.5 t -126.82 101.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.219 -0.926 . . . . 0.0 110.165 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -47.15 116.48 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.106 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -79.66 -63.65 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.05 135.55 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.309 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.615 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.0 tt -60.45 142.06 55.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.615 HD13 HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -130.1 116.69 17.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.581 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.84 59.71 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.849 1.447 . . . . 0.0 110.1 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 13.9 pt 39.92 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.661 . . . . 0.0 110.727 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 40.34 47.25 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.467 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -156.71 110.36 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.825 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.56 118.12 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 22' ' ' MET . 5.9 mt -75.92 128.48 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -171.15 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.132 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.66 -45.96 67.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.119 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.31 -9.24 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -28.89 21.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE3' HD13 ' A' ' 17' ' ' LEU . 1.4 mmt -118.92 143.26 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 8' ' ' ASN . 8.5 mttt -115.68 166.68 11.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.735 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -100.33 79.1 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.82 152.99 20.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -90.08 14.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 25' ' ' GLU . 22.8 t -62.36 142.44 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -88.14 163.82 35.7 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.136 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.79 174.17 53.79 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.608 -2.246 . . . . 0.0 110.42 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.61 86.95 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 54' ' ' THR . . . -68.49 -150.75 0.3 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -76.26 137.59 68.28 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.361 -1.082 . . . . 0.0 110.063 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 170.56 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.955 1.503 . . . . 0.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.037 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -94.07 38.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.863 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -25.54 53.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.119 -0.988 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.77 ' CB ' HD23 ' A' ' 40' ' ' LEU . 7.6 mm-40 -105.09 41.97 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.63 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.037 HD11 ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -44.78 -50.18 25.62 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.89 -11.99 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.632 1.332 . . . . 0.0 110.619 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.89 -30.6 11.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.77 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -83.11 -47.07 12.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.105 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 31.4 t -43.22 104.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.056 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.825 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.07 11.98 11.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.4 ttm -83.37 134.33 34.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 144.8 31.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 14.4 m -119.11 160.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -110.85 0.63 17.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 0.0 110.359 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -120.02 122.3 40.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 110.366 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -47.12 140.61 4.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.34 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.881 HG13 HG21 ' A' ' 53' ' ' THR . 12.0 t -124.84 130.36 24.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.3 Cg_endo -69.6 -174.38 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.944 1.497 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -79.69 154.67 28.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 48.66 43.67 29.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.881 HG21 HG13 ' A' ' 49' ' ' VAL . 55.4 m -92.02 134.18 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -1.154 . . . . 0.0 110.266 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.438 ' CG2' ' HA3' ' A' ' 31' ' ' GLY . 7.6 m -67.38 141.24 57.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.095 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -61.93 99.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 mtp -102.83 142.51 24.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 49.3 Cg_endo -75.31 2.59 6.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.013 1.533 . . . . 0.0 110.593 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.11 -32.47 24.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.133 -0.979 . . . . 0.0 110.521 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 mtt -96.31 3.49 52.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 110.393 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.68 82.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.324 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 51.7 pttt -59.53 -37.11 77.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TYR . 18.5 p30 -100.45 74.2 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 109.852 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.539 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -46.13 175.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.51 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.601 ' HG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.12 -152.82 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.028 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 11.9 t70 -58.77 83.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.798 -1.189 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -123.74 112.98 1.96 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 31.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -1.189 . . . . 0.0 110.471 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -106.63 -23.4 12.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.6 -61.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.65 150.39 56.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.921 1.485 . . . . 0.0 110.579 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.05 -48.51 0.37 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.0 mm? -81.44 125.03 29.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.331 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 pttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.151 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.495 ' CE ' ' HB3' ' A' ' 33' ' ' PRO . 12.6 pttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.265 0.555 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -63.1 138.64 58.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.2 t -103.46 -174.48 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 22' ' ' MET . 59.3 t -92.14 123.59 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.3 t -125.86 118.47 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.43 138.99 44.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.103 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 4.0 t-20 -90.8 -62.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.287 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -77.36 162.43 27.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.21 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.2 tt -93.06 130.78 38.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.112 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 26.3 pt -130.03 137.87 31.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.49 71.88 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.067 1.561 . . . . 0.0 110.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.67 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.7 mt 54.65 -172.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.67 ' H ' HG22 ' A' ' 13' ' ' ILE . 49.7 m-80 42.13 -141.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 14' ' ' ASN . 42.6 m 57.48 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.625 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.27 132.28 47.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 110.065 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -75.46 143.89 42.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.5 p -123.46 160.07 27.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.217 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 19' ' ' LEU . 4.8 tt -67.58 -34.6 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.287 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' N ' HD23 ' A' ' 19' ' ' LEU . 2.3 mp -59.08 -36.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.4 mtm -93.76 6.88 46.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.374 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.567 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -98.97 123.56 43.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 147.71 34.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -105.7 75.91 1.16 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.161 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.81 20.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -81.65 91.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.181 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.31 154.92 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -113.13 150.02 42.31 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -76.67 171.09 69.83 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.678 -2.218 . . . . 0.0 110.433 -0.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -80.61 81.43 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.03 -112.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 55' ' ' LEU . 1.6 mt -103.87 138.89 19.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 110.153 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HB3' ' CE ' ' A' ' 2' ' ' LYS . 45.7 Cg_endo -73.19 -177.22 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.117 1.588 . . . . 0.0 110.394 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.784 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -95.82 20.99 9.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -76.61 -36.88 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.406 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -92.49 27.35 2.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 110.481 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -58.76 -48.75 96.26 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -77.0 -5.62 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.801 1.422 . . . . 0.0 110.44 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 17.9 m120 -114.29 -20.01 11.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.341 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -97.46 -38.63 9.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.283 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.1 t -43.63 123.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.331 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.625 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.59 -4.83 23.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.63 152.91 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -1.135 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 51.7 mt-30 -103.75 145.36 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.106 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.9 m -91.98 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.105 -0.997 . . . . 0.0 110.256 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 13' ' ' ILE . 1.7 m-20 -111.12 -9.03 14.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 11.6 ptm180 -119.22 171.59 8.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.341 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.39 123.67 27.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.815 . . . . 0.0 110.413 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 53' ' ' THR . 72.2 t -107.85 96.0 16.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.952 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.444 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.5 Cg_endo -71.97 -165.23 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -69.25 141.17 54.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 55.56 49.43 65.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.743 ' HB ' HG13 ' A' ' 49' ' ' VAL . 52.7 m -92.65 134.74 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 144.15 51.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.43 105.98 8.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.469 ' HG2' ' HB2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -96.85 129.66 32.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.6 Cg_endo -75.01 1.89 7.24 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.928 1.489 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HB2' ' HG2' ' A' ' 56' ' ' MET . 70.4 m-20 -81.46 -70.34 0.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 4.4 mmt -72.94 66.35 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.515 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 57' ' ' PRO . 62.0 t -126.64 128.93 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -96.78 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -0.939 . . . . 0.0 110.475 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' MET . 47.4 t30 -82.11 85.99 6.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.989 -1.07 . . . . 0.0 110.23 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.435 ' HB3' ' CA ' ' A' ' 71' ' ' GLY . 40.4 t80 -48.69 169.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.07 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 1.5 tt0 -64.67 -133.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.977 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -36.38 75.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 71' ' ' GLY . . . 62.04 55.52 27.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 0.08 51.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.583 HG23 ' HD2' ' A' ' 70' ' ' PRO . 14.8 t -110.03 -28.69 8.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.5 -61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.08 -1.012 . . . . 0.0 110.825 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 68' ' ' THR . 44.2 Cg_endo -70.57 -175.49 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.904 1.476 . . . . 0.0 110.768 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 85.21 44.34 6.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -98.55 63.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.171 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.183 0.516 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -73.04 132.18 43.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -110.08 160.76 16.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG13 ' HB3' ' A' ' 22' ' ' MET . 67.8 t -89.44 113.72 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 23.4 t -111.68 113.34 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -54.25 118.89 4.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -76.27 -75.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -63.39 144.0 57.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.127 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.5 136.17 57.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 10.2 mt -125.02 131.59 24.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.55 -157.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.782 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.93 -179.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 8.8 p30 40.95 27.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.197 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 13' ' ' ILE . 7.7 m -126.68 114.51 18.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.136 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.31 148.56 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 157.67 45.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -102.58 169.83 8.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.72 -10.58 53.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.115 ' N ' HD13 ' A' ' 19' ' ' LEU . 34.4 mm -69.82 -21.73 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.768 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.8 mtp -98.1 10.36 40.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.309 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.545 ' HB3' HG13 ' A' ' 5' ' ' VAL . 3.6 mtp -117.69 138.81 51.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -117.11 167.05 11.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 110.121 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.45 95.21 5.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.922 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 128.35 55.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 3' ' ' ALA . 5.2 t -91.99 58.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.97 160.06 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.503 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.4 t -74.9 149.39 85.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -75.72 169.83 73.44 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.668 -2.222 . . . . 0.0 110.398 -0.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.4 -142.25 19.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.948 ' HB ' HD13 ' A' ' 55' ' ' LEU . 2.9 mt -100.83 134.06 20.72 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.121 -1.223 . . . . 0.0 110.177 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.68 -166.28 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.908 1.478 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -98.82 34.04 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.37 -39.93 62.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.928 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HB2' HD13 ' A' ' 40' ' ' LEU . 63.7 mm-40 -103.45 32.38 3.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.6 mm -53.04 -46.91 97.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.3 Cg_endo -73.88 -1.17 10.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.486 1.256 . . . . 0.0 110.447 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.73 -37.97 4.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.897 . . . . 0.0 110.101 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.3 -41.6 27.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.7 t -44.66 125.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.92 9.09 59.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 64' ' ' GLU . 23.4 ttt -101.35 158.34 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.18 . . . . 0.0 110.245 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 158.38 18.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' MET . 26.8 m -107.09 168.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -110.76 5.78 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.301 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 10.2 mmt85 -138.09 135.53 35.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.74 146.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.367 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.837 HG13 HG21 ' A' ' 53' ' ' THR . 95.2 t -129.97 120.84 19.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.713 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.6 Cg_endo -73.48 -160.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.871 1.458 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -85.32 157.13 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.83 39.47 4.9 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.837 HG21 HG13 ' A' ' 49' ' ' VAL . 95.8 m -85.25 109.17 18.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -1.105 . . . . 0.0 110.399 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.9 m -47.41 149.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.948 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.1 103.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -97.85 133.89 22.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.133 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 46.4 Cg_endo -73.05 -34.88 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.955 1.503 . . . . 0.0 110.66 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 10.6 p-10 -57.18 -17.08 9.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 0.0 110.552 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 6.8 mtt -108.85 25.27 11.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.41 129.22 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.314 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -69.42 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -78.08 83.99 4.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 57' ' ' PRO . 88.8 m-85 -44.26 129.21 6.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 40' ' ' LEU . 2.9 mp0 -92.27 -37.47 12.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 17.5 p-10 -67.33 97.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.66 147.99 12.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 68' ' ' THR . 51.8 m -81.01 -92.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -1.149 . . . . 0.0 110.197 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' THR . 18.3 m -110.16 107.64 17.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.132 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.558 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 172.2 -58.98 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -73.01 -22.41 19.57 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.021 1.537 . . . . 0.0 110.503 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.68 159.79 13.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.07 -6.95 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.165 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.251 0.548 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -63.0 148.31 48.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.2 p -103.8 161.1 14.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.97 101.67 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.38 107.17 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -62.61 116.84 5.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 1.1 t-20 -79.92 -57.51 3.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 110.063 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 1.2 tp-100 -59.93 117.92 5.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.594 ' HB3' HD12 ' A' ' 51' ' ' LEU . 1.7 pt? -62.08 129.21 39.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 HG21 ' A' ' 15' ' ' THR . 4.7 pt -130.06 146.04 59.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 0.0 109.941 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 45.1 Cg_endo -71.78 -94.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.0 110.158 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 45' ' ' VAL . 1.5 mt -152.01 -179.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.038 . . . . 0.0 109.972 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' H ' HG22 ' A' ' 13' ' ' ILE . 11.4 m-80 51.75 21.12 1.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.795 HG21 HD12 ' A' ' 11' ' ' ILE . 8.0 t -99.75 128.65 45.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.44 100.62 4.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.065 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' MET . 3.8 mt -49.0 124.24 8.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.276 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.33 158.01 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tt -49.6 -46.01 48.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.437 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.7 mt -51.4 -47.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -78.67 -25.2 44.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.43 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 20.8 mtm -85.35 110.51 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.34 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.29 151.16 25.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 95.76 7.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.23 123.49 50.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.134 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 3' ' ' ALA . 3.9 t -77.47 98.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.53 139.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.2 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -77.68 151.59 80.02 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.5 Cg_endo -75.52 156.34 99.29 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.433 -0.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -82.56 86.4 6.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -144.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.1 mt -72.56 130.45 85.7 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 109.966 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.54 -179.44 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.984 1.518 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -94.2 2.15 55.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.6 -21.72 7.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HB2' HD13 ' A' ' 40' ' ' LEU . 7.1 mm-40 -104.64 23.5 13.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.418 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -42.27 -53.02 9.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.3 Cg_endo -72.01 -6.0 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.641 1.337 . . . . 0.0 110.757 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' ND2' ' OD2' ' A' ' 65' ' ' ASP . 4.2 m120 -113.84 -20.25 11.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.6 mp -85.85 -43.88 12.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.6 t -44.8 122.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.11 37.19 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.467 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.64 136.95 34.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 110.181 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -106.7 129.27 54.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -84.88 163.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -111.3 5.46 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 27.3 mtt180 -144.03 167.55 22.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -68.54 144.68 54.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.598 HG13 ' CB ' ' A' ' 53' ' ' THR . 30.2 t -126.52 126.07 24.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.24 -176.67 2.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.521 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.91 137.96 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 60.68 51.15 60.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.598 ' CB ' HG13 ' A' ' 49' ' ' VAL . 96.5 m -96.3 129.52 43.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -1.128 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 m -66.54 136.39 55.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.36 105.67 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -109.39 154.59 42.15 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.855 . . . . 0.0 110.1 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.4 1.6 7.21 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.002 1.527 . . . . 0.0 110.56 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -45.57 31.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.428 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.508 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 14.6 mtm -107.58 57.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.351 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 56' ' ' MET . 98.8 t -125.03 84.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 14.7 tptm -52.85 -65.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -99.59 86.39 3.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.882 . . . . 0.0 110.218 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.56 150.34 12.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.472 ' CD ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -73.75 -162.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' ND2' ' A' ' 39' ' ' ASN . 44.3 p-10 -73.0 75.11 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.32 127.86 4.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -77.18 55.93 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -1.099 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 171.37 8.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -45.77 -55.69 12.03 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 110.455 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -73.42 88.48 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.925 1.487 . . . . 0.0 110.436 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.79 37.46 1.86 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 73.06 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.244 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.131 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.202 0.525 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.97 111.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.2 t -99.75 164.88 11.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 32' ' ' ILE . 32.2 t -73.05 117.91 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG12 ' HA2' ' A' ' 52' ' ' GLY . 17.0 t -127.34 99.35 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.737 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -59.28 141.34 54.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.945 . . . . 0.0 110.2 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.85 -63.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.21 145.12 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.009 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -59.55 150.0 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 11' ' ' ILE . 17.3 mt -130.13 137.54 31.1 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.04 166.32 30.37 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.498 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.603 HG22 HG23 ' A' ' 45' ' ' VAL . 11.2 pt -81.49 175.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 3.0 m120 58.23 16.77 4.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 110.22 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.406 ' C ' ' HG2' ' A' ' 44' ' ' GLN . 1.6 m -125.12 105.94 9.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.32 122.63 14.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.75 155.46 23.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.912 . . . . 0.0 110.392 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 22' ' ' MET . 1.7 m -106.69 169.83 8.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 22' ' ' MET . 1.5 pp -65.0 -33.1 75.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.462 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.54 -20.34 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.173 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.99 -14.99 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.533 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.494 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.69 127.68 51.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.96 . . . . 0.0 110.495 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.4 mttt -121.07 179.37 4.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.985 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.89 99.36 9.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.21 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 tp10 -101.8 145.33 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.0 t -90.4 76.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 155.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.6 t -101.37 150.01 36.83 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.151 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.19 176.29 44.42 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.708 -2.205 . . . . 0.0 110.513 -0.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -73.55 -139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 30' ' ' MET . . . 151.89 -117.01 0.79 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.971 HD12 HD12 ' A' ' 55' ' ' LEU . 2.9 mt -110.56 118.97 47.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 50.1 Cg_endo -75.26 5.08 4.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.852 1.448 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . 71.92 20.69 4.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.457 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.0 -26.51 4.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.006 -1.059 . . . . 0.0 109.729 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 43.3 mm-40 -105.16 60.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.851 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -56.89 -41.48 91.57 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 111.058 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -75.69 -9.74 19.9 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.288 1.152 . . . . 0.0 110.508 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -114.47 -26.88 7.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD12 ' OE1' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.44 -45.6 15.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.329 -0.857 . . . . 0.0 110.398 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 40' ' ' LEU . 20.3 t -42.22 115.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.605 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.93 0.27 25.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.25 136.98 48.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -1.16 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 26.8 mt-30 -110.1 163.9 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 13' ' ' ILE . 7.2 m -120.54 170.29 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 47.7 p-10 -110.81 -8.73 14.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 1.8 mtt180 -126.33 121.21 31.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -48.23 140.44 7.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 53' ' ' THR . 67.2 t -127.46 135.14 26.99 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -73.13 -161.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.79 168.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.15 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.698 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 46.8 80.89 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.794 HG23 HG11 ' A' ' 49' ' ' VAL . 64.0 m -94.31 90.54 6.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.114 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 5.6 m -66.88 133.1 49.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.234 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.971 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.44 88.63 0.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.3 mtm -111.82 164.27 15.54 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.33 10.15 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -54.44 5.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.805 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 36.5 mtt -113.04 69.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.853 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 63' ' ' TYR . 12.8 t -130.31 103.4 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.044 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 46' ' ' ASN . 5.6 mtpt -55.6 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.277 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.88 84.0 4.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 110.352 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 70' ' ' PRO . 2.1 t80 -46.57 144.89 2.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' OE1' HD12 ' A' ' 40' ' ' LEU . 1.9 pt-20 -68.64 -151.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.25 -0.906 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.3 m-20 -59.39 -46.4 88.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.67 146.96 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -87.42 -30.91 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -1.184 . . . . 0.0 110.079 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -93.06 23.46 4.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.15 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.602 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 4.3 t 54.55 44.12 1.64 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 111.001 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -74.26 103.54 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.692 1.364 . . . . 0.0 110.415 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.02 128.47 3.56 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -77.41 -21.46 53.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.48 ' HE3' ' SD ' ' A' ' 30' ' ' MET . 3.2 ptpt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.229 0.538 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.33 36.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -106.28 152.99 22.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 36.8 t -87.44 96.1 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.329 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG12 ' C ' ' A' ' 52' ' ' GLY . 2.9 t -107.04 112.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.037 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.007 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -62.72 136.82 58.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.72 -54.91 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -83.21 146.27 28.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.9 pt? -63.57 145.85 54.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' VAL . 6.6 mt -130.37 136.3 28.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.51 -162.43 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.934 1.491 . . . . 0.0 110.273 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.7 mt -104.3 -173.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.693 ' H ' HG22 ' A' ' 13' ' ' ILE . 9.4 p30 40.08 28.11 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 110.571 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 13' ' ' ILE . 25.6 m -120.57 121.64 38.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.247 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -57.17 162.66 2.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 110.14 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mt -121.13 144.79 48.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -116.95 169.17 9.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.2 tt -60.66 -50.26 74.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.622 ' N ' HD23 ' A' ' 19' ' ' LEU . 58.0 mt -55.39 -38.74 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -13.89 60.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.41 112.01 20.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.6 mttt -106.0 145.0 31.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -94.0 102.63 14.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 4' ' ' SER . 41.6 tt0 -108.16 133.56 52.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.8 t -85.71 74.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 m -143.41 -173.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.2 t -109.52 150.66 41.49 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.153 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -76.16 168.11 78.21 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.613 -2.244 . . . . 0.0 110.465 -0.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.48 ' SD ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -76.95 -112.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.098 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.79 -134.58 10.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.8 mt -99.12 125.69 40.75 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -1.122 . . . . 0.0 110.03 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.29 -170.96 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.931 1.49 . . . . 0.0 110.547 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.17 16.76 17.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -47.76 84.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 mm-40 -89.36 47.78 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.108 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 5.9 tp -69.79 -30.68 2.14 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 111.719 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.4 Cg_endo -80.15 -7.93 14.13 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 122.813 0.901 . . . . 0.0 109.928 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -108.55 -35.14 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -79.63 -44.5 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 110.049 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 29.2 t -48.57 103.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 110.013 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.17 -0.55 19.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.567 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.52 157.09 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 110.053 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB2' ' HG3' ' A' ' 61' ' ' LYS . 18.0 mt-30 -109.54 171.13 7.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.332 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.55 HG13 HD11 ' A' ' 17' ' ' LEU . 11.7 m -116.93 156.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -103.5 5.06 36.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.4 mtt180 -136.39 159.91 40.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 150.59 48.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.13 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.954 ' CG1' HG21 ' A' ' 53' ' ' THR . 21.8 t -129.31 111.66 18.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -164.19 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.886 1.466 . . . . 0.0 110.432 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 3.2 mp -79.38 163.58 24.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.066 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.21 28.97 0.91 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.007 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -65.14 124.52 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.391 -1.064 . . . . 0.0 110.417 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 140.52 40.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.66 101.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.106 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtt -111.55 153.81 44.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.989 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.4 -0.26 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.958 1.504 . . . . 0.0 110.493 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.31 -46.82 21.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 110.319 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 1.4 mpt? -97.92 50.0 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG13 ' CE ' ' A' ' 43' ' ' MET . 39.4 t -121.4 103.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.905 . . . . 0.0 110.17 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -50.27 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 17.1 p-10 -95.57 92.25 6.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.945 . . . . 0.0 110.246 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -44.69 135.73 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.278 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 77.8 mm-40 -88.12 -75.5 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.68 76.84 2.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.82 52.9 0.63 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 p -90.01 25.56 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -1.138 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 p -101.95 -11.76 18.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.561 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -178.64 -59.76 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.11 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.3 Cg_endo -72.74 -90.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.0 -79.86 1.13 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.59 86.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -1.091 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.214 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.54 141.72 28.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -121.29 153.79 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG11 ' SD ' ' A' ' 22' ' ' MET . 25.3 t -87.44 127.49 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.272 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 54' ' ' THR . 11.9 t -130.09 121.63 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.89 142.15 6.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 10.1 t-20 -89.09 -59.33 2.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -97.07 148.26 23.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.702 ' C ' HD23 ' A' ' 10' ' ' LEU . 7.7 tt -64.75 131.84 47.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 10' ' ' LEU . 7.6 pt -130.18 130.28 23.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 0.0 110.644 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.3 Cg_endo -74.86 71.03 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.941 1.495 . . . . 0.0 109.841 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 32.4 pt 39.39 -164.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.732 -0.605 . . . . 0.0 110.692 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER 65.56 -62.31 0.23 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -58.36 106.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.349 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.78 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.179 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -106.75 129.4 54.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.28 -0.887 . . . . 0.0 110.095 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -125.75 156.12 39.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 110.349 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -46.25 -62.49 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mt -59.82 -13.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.462 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -91.53 -47.38 7.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.435 ' SD ' HG11 ' A' ' 5' ' ' VAL . 17.5 ptt? -104.84 148.26 26.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -120.17 160.76 22.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.86 103.2 14.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.25 137.58 50.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 52.2 t -96.42 80.41 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.258 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 28' ' ' THR . 14.0 p -174.2 168.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.511 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -82.9 151.75 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -75.89 133.13 29.93 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.602 -0.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.403 ' C ' ' HG1' ' A' ' 54' ' ' THR . 19.5 mtp -82.46 175.29 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.88 -132.77 1.4 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -90.23 136.85 28.17 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.213 -1.169 . . . . 0.0 109.924 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.56 -170.79 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.003 1.528 . . . . 0.0 110.676 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.75 31.73 5.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.275 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -48.04 82.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.016 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 74.3 mm-40 -100.0 65.65 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 8.7 tp -70.62 -29.87 1.65 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 111.929 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.0 Cg_endo -78.01 -7.19 16.26 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.704 0.844 . . . . 0.0 109.944 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.27 -19.6 11.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -88.34 -40.96 13.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.161 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 37' ' ' ILE . 90.8 t -46.53 105.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.54 10.0 8.91 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.21 121.48 23.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.46 148.47 22.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.1 m -117.98 155.87 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.11 5.05 19.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 66.4 mtt-85 -120.99 127.0 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.233 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.78 133.44 8.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 110.496 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.958 HG13 HG21 ' A' ' 53' ' ' THR . 24.8 t -117.9 121.54 31.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -72.6 -174.93 1.62 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.96 1.505 . . . . 0.0 110.513 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.89 156.16 39.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.556 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.83 44.77 18.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.958 HG21 HG13 ' A' ' 49' ' ' VAL . 4.9 m -93.47 114.64 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.147 . . . . 0.0 110.126 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.589 ' N ' HG13 ' A' ' 6' ' ' VAL . 2.4 t -57.79 144.15 39.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -64.11 108.85 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.515 ' CG ' ' HD2' ' A' ' 57' ' ' PRO . 20.7 ttm -103.18 145.62 30.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.515 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 47.0 Cg_endo -74.13 -0.5 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.075 1.566 . . . . 0.0 110.613 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -41.35 13.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.16 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 8.9 mtm -90.9 45.38 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 56' ' ' MET . 3.0 t -129.96 126.03 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.107 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -74.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' TYR . 7.6 p30 -100.05 104.25 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -47.22 176.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.331 -0.855 . . . . 0.0 110.334 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -144.51 0.05 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.101 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 8.1 p-10 -75.18 80.37 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.75 97.48 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -101.65 39.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -1.111 . . . . 0.0 110.406 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -72.76 -11.83 60.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.955 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -177.31 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 48.3 Cg_endo -73.61 98.12 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.715 1.376 . . . . 0.0 110.399 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.43 -31.25 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -65.54 96.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -1.181 . . . . 0.0 110.287 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.127 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.72 128.68 35.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' MET . 3.7 p -116.12 145.48 43.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.151 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 39.2 t -86.48 135.24 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.46 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -129.47 124.37 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -57.46 115.52 2.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.85 -51.88 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 110.19 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -84.32 142.7 30.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.173 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -74.11 127.94 34.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.2 pt -130.49 119.91 18.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.53 64.66 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.881 1.464 . . . . 0.0 110.544 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.4 pt 39.32 -164.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' ILE . 71.6 m-20 40.8 32.29 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.885 . . . . 0.0 110.456 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 m -145.53 107.2 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.144 -0.973 . . . . 0.0 110.339 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' CA ' ' HG2' ' A' ' 44' ' ' GLN . . . -59.59 163.84 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.06 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.883 HD13 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -141.12 157.71 44.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -119.42 -157.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.845 . . . . 0.0 110.188 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.1 mp -69.27 -62.28 1.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -47.52 -23.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.348 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -72.34 -57.32 4.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.091 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.883 ' HG3' HD13 ' A' ' 17' ' ' LEU . 1.4 mtt -107.88 141.11 39.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.22 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.08 108.35 19.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.338 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.04 145.1 41.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 80.3 t -86.86 97.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -168.04 154.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.211 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -77.78 159.15 77.09 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.44 -163.68 3.31 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.72 -2.2 . . . . 0.0 110.547 -0.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 4' ' ' SER . 9.3 mtt -81.82 -73.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.31 -144.1 33.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -103.56 130.76 22.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 110.142 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 -172.3 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.327 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.025 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -97.7 32.33 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -76.83 -28.81 55.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.92 40.78 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.025 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.66 -51.91 77.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.6 Cg_endo -73.43 -1.81 11.21 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.741 1.39 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 89.8 m-20 -114.26 -42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.227 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' MET . 66.7 tp -73.42 -42.07 62.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.4 t -46.8 116.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.35 10.89 50.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 ttt -104.64 147.73 27.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.535 ' HG2' ' CA ' ' A' ' 16' ' ' ALA . 44.1 mt-30 -110.06 164.53 12.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.281 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 8.4 m -115.66 164.33 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.98 -1.45 16.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 14.5 mtt180 -118.22 131.58 56.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.12 127.28 8.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.56 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 53' ' ' THR . 22.4 t -116.15 108.75 45.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -73.37 -176.09 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.987 1.519 . . . . 0.0 110.466 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.05 134.34 48.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 70.42 46.28 49.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.739 ' CB ' HG13 ' A' ' 49' ' ' VAL . 67.1 m -96.63 113.82 25.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -1.153 . . . . 0.0 110.386 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 53.1 m -54.52 142.51 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.304 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.11 100.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.44 ' HB2' ' HG3' ' A' ' 59' ' ' MET . 2.9 mmt -98.47 139.08 20.91 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 -2.26 11.84 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.059 1.557 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.35 -37.79 14.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.519 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -73.05 -14.2 61.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 25.4 t -85.35 118.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.32 -74.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' CE ' ' A' ' 43' ' ' MET . 71.6 m-20 -100.58 93.48 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE1' ' OG1' ' A' ' 67' ' ' THR . 9.4 t80 -46.65 165.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 23.6 mm-40 -89.8 -171.37 3.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 63.75 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.143 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.04 -71.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 63' ' ' TYR . 2.2 m -79.76 108.82 13.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 68' ' ' THR . 5.3 t -72.1 69.2 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.576 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -171.68 -62.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.383 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.51 65.08 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.833 1.438 . . . . 0.0 110.432 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.09 97.41 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.74 -55.31 3.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 110.159 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.154 179.96 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.267 0.556 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.73 154.11 22.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 7.3 p -121.41 168.29 11.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.8 t -88.38 117.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 0.0 110.279 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.64 123.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -52.61 118.99 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -74.54 -68.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -89.27 147.0 24.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 10' ' ' LEU . 1.8 pt? -67.74 134.19 50.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.291 -0.881 . . . . 0.0 110.512 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.479 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.0 pt -120.38 156.12 55.66 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.339 -0.851 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.59 -158.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.07 1.563 . . . . 0.0 109.991 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.5 mt -103.25 166.73 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.878 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER 58.99 25.84 14.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.359 179.953 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -102.93 124.26 48.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.735 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -63.12 157.36 22.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.645 HD12 ' CB ' ' A' ' 43' ' ' MET . 2.5 mt -93.81 131.65 38.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' SD ' ' A' ' 22' ' ' MET . 1.1 p -116.8 172.92 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.163 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.45 -55.57 15.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' MET . 5.8 pt -48.32 -24.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 4.6 mtt -97.55 3.9 50.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -117.34 96.47 5.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -112.8 127.05 56.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -80.05 99.3 7.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.211 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.19 139.44 46.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.892 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -79.64 93.69 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.1 146.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.504 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.9 t -87.86 149.43 45.78 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.233 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.89 176.14 45.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.691 -2.212 . . . . 0.0 110.503 -0.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' SER . 3.2 mtp -75.87 -57.86 3.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.318 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.75 -145.67 35.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 55' ' ' LEU . 2.3 mt -88.3 124.86 65.5 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -1.208 . . . . 0.0 109.928 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.83 -163.48 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.465 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -103.15 25.48 9.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -38.99 69.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' OE2' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.76 38.77 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.877 ' O ' HG23 ' A' ' 41' ' ' VAL . 8.6 mm -65.98 -45.24 63.52 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.6 Cg_endo -75.38 0.75 8.69 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.513 1.27 . . . . 0.0 110.456 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 3.6 t-20 -111.18 -33.95 6.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -83.13 -29.6 28.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.9 t -43.1 116.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 110.73 7.54 25.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.645 ' CB ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -94.55 132.64 39.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 110.298 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.735 HE21 ' HB2' ' A' ' 16' ' ' ALA . 10.7 mp0 -93.73 150.08 20.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 9.6 m -87.72 174.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -102.93 -25.49 13.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.576 -179.67 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 7.6 ptm180 -135.05 179.88 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.209 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -70.47 149.9 46.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.631 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 53' ' ' THR . 19.5 t -127.92 124.79 23.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.874 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.48 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.961 1.506 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 1.1 mp -90.61 166.43 13.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.42 33.1 2.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.793 HG21 HG13 ' A' ' 49' ' ' VAL . 92.3 m -78.13 98.44 5.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -1.175 . . . . 0.0 110.075 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.0 m -44.84 148.33 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.84 88.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.163 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 156.04 43.68 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.059 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.48 ' CB ' ' HB3' ' A' ' 70' ' ' PRO . 45.3 Cg_endo -72.34 -0.54 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.925 1.487 . . . . 0.0 110.598 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -52.01 65.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.75 ' SD ' HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -109.99 33.07 4.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 63' ' ' TYR . 12.4 t -128.59 109.47 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.541 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 11.1 ptmt -65.8 -149.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 109.835 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 62.6 t30 -64.88 84.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 109.92 179.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 60' ' ' VAL . 36.5 p90 -83.45 -159.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 55.8 mm-40 -63.44 -124.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 8.3 p-10 -58.61 94.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 110.63 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 63' ' ' TYR . . . -149.14 54.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -107.93 -12.92 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -1.133 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' A' ' 69' ' ' SER . 6.0 t -70.74 -6.01 34.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.589 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER 174.57 -62.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -72.37 -158.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 110.137 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 62' ' ' ASN . . . 86.32 -83.94 1.59 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.6 mm? -65.93 143.52 57.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 tttp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.261 -179.904 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.233 0.54 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.32 115.21 7.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.8 t -102.66 141.46 35.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' HB ' HD21 ' A' ' 55' ' ' LEU . 23.5 t -73.25 105.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.726 HG12 ' HA2' ' A' ' 52' ' ' GLY . 18.0 t -123.62 117.7 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.211 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -71.87 144.56 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.091 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 17.7 t-20 -83.49 -52.81 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 110.503 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.49 142.5 32.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 110.358 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.747 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -60.38 138.57 57.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.091 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HB1' ' A' ' 7' ' ' ALA . 4.0 mt -129.33 133.76 25.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.16 -179.13 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.971 1.511 . . . . 0.0 110.395 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.861 HG22 HG23 ' A' ' 45' ' ' VAL . 2.6 pt -93.67 -174.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.63 16.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -130.58 118.33 20.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.069 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.9 160.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 11' ' ' ILE . 6.2 mt -118.7 145.26 45.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -119.89 -166.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 110.281 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 19' ' ' LEU . 27.9 mt -76.61 -52.32 9.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mt -50.37 -21.76 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.163 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.65 -44.83 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -108.22 120.13 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.266 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -111.11 165.88 11.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 98.42 8.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.01 160.1 17.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.11 50.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 t -117.22 166.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 48.2 p -81.99 159.75 64.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -74.83 -167.49 5.65 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.536 -0.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' SER . 51.6 mtp -81.64 -46.47 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.474 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.73 -156.35 0.43 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.02 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.6 mt -90.5 142.22 27.94 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.22 -1.164 . . . . 0.0 110.409 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 47.4 Cg_endo -73.56 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.086 1.571 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -107.4 42.63 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.174 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.61 -42.43 51.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -103.26 36.91 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -53.04 -54.08 48.22 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.469 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.1 Cg_endo -70.9 -5.88 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.702 1.369 . . . . 0.0 110.709 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.13 -19.05 11.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.955 . . . . 0.0 110.355 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.4 tp -88.14 -29.54 20.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 47.3 t -46.1 116.32 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 109.31 10.59 23.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.29 135.45 33.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 1.5 mt-30 -106.38 138.69 42.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 110.285 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 13' ' ' ILE . 18.3 m -99.49 170.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.358 -0.839 . . . . 0.0 110.114 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.631 ' C ' HG21 ' A' ' 13' ' ' ILE . 25.9 t30 -110.67 -4.85 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' N ' HG21 ' A' ' 13' ' ' ILE . 6.0 mtt180 -129.05 126.43 39.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.43 143.19 56.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.325 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 53' ' ' THR . 80.9 t -129.97 135.7 27.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -70.09 -173.78 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.961 1.506 . . . . 0.0 110.427 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -43.05 164.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.955 179.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.726 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 51.82 61.31 6.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.963 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 53.5 m -84.39 87.72 7.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -1.093 . . . . 0.0 110.628 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.5 m -71.83 121.17 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.634 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -61.37 114.43 3.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.83 -179.276 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.657 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.8 mtm -113.67 156.72 43.18 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.0 1.02 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.97 1.511 . . . . 0.0 110.669 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' MET . 33.7 p30 -91.88 -21.88 20.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.018 . . . . 0.0 110.74 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 44.8 mtt -112.0 -7.75 14.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 56' ' ' MET . 10.8 t -101.14 91.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.082 -1.011 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -48.85 39.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -95.04 74.37 3.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.043 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 1.02 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -54.12 -165.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.87 . . . . 0.0 110.549 -179.793 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -104.99 -172.39 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.09 66.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.356 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -114.87 114.44 3.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 m -88.56 59.44 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -1.14 . . . . 0.0 110.062 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -106.71 -40.28 5.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.15 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 171.9 -59.25 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.129 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -72.93 55.6 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.974 1.513 . . . . 0.0 110.461 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.77 57.8 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -45.56 10.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -1.148 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.196 0.522 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.56 138.59 39.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -121.98 162.72 20.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.466 HG12 HD23 ' A' ' 55' ' ' LEU . 53.0 t -72.97 102.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.496 HG21 HG12 ' A' ' 27' ' ' VAL . 14.3 t -113.7 103.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -46.67 121.67 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 m120 -72.96 -64.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.877 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.416 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tp60 -81.58 149.13 28.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 110.227 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -59.54 133.62 56.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.956 179.863 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.803 HD12 ' SD ' ' A' ' 21' ' ' MET . 13.1 mm -121.75 136.08 25.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.73 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.058 1.557 . . . . 0.0 110.191 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.035 HG22 HG23 ' A' ' 45' ' ' VAL . 4.2 pt -120.1 -174.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -0.994 . . . . 0.0 110.485 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m120 56.53 16.54 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.06 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 19.1 m -123.05 154.33 38.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.958 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -77.03 163.77 26.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.405 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -111.63 122.62 48.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 179.93 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.1 170.96 7.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -67.24 -54.7 18.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.324 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.952 HD13 ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -51.27 -21.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.803 ' SD ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -80.97 -48.38 12.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 9.4 ptt? -110.98 141.09 44.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -0.961 . . . . 0.0 110.191 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 21.0 mmtt -120.92 172.63 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.91 92.74 7.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.248 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.74 141.37 32.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -84.29 76.92 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 HG21 ' A' ' 6' ' ' VAL . 10.1 p -133.71 150.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.128 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -111.39 161.01 27.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.74 153.29 99.09 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.704 -2.207 . . . . 0.0 110.479 -0.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.5 ptt? -80.48 125.87 30.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.48 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -90.54 -100.71 1.17 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -109.06 131.67 21.66 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 110.137 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.21 177.84 6.75 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.698 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . -92.56 24.15 3.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.92 -77.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 pm0 -78.18 55.19 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.057 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.904 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -70.73 -30.5 1.79 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.376 -0.827 . . . . 0.0 111.764 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.904 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.5 Cg_endo -78.73 -4.46 14.07 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 122.686 0.835 . . . . 0.0 110.047 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 1.8 m120 -112.52 -37.95 4.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.99 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -76.25 -44.39 37.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.1 t -45.71 109.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 122.76 6.75 7.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.543 ' CE ' ' HG3' ' A' ' 64' ' ' GLU . 1.6 ttt -91.69 157.54 16.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.168 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' THR . 42.5 mt-30 -110.14 136.26 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.035 HG23 HG22 ' A' ' 13' ' ' ILE . 15.9 m -88.64 171.63 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.53 -15.85 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.0 111.255 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.6 ptm85 -128.16 150.73 49.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.88 -1.137 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.53 156.44 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 110.752 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.998 HG13 HG21 ' A' ' 53' ' ' THR . 91.6 t -130.17 127.55 22.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.57 -168.96 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.832 1.438 . . . . 0.0 110.509 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -80.17 155.95 27.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.188 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.66 43.94 6.64 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.998 HG21 HG13 ' A' ' 49' ' ' VAL . 84.9 m -86.33 128.28 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -69.39 141.23 54.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.78 110.4 2.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.481 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -109.42 159.93 29.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 46.2 Cg_endo -73.97 0.12 8.76 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.089 1.573 . . . . 0.0 110.648 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD1' ' CG ' ' A' ' 59' ' ' MET . 1.3 p30 -91.7 -26.2 18.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.653 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.818 ' O ' HG12 ' A' ' 45' ' ' VAL . 3.4 mtt -97.2 32.31 2.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 110.077 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.47 125.97 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.552 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -75.39 -80.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 109.84 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 8.0 p30 -100.74 101.44 12.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -45.78 167.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.799 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 40' ' ' LEU . 2.1 mp0 -83.05 -68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.94 -30.47 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.46 51.99 23.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 68' ' ' THR . 38.6 m -72.23 -89.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.087 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -94.17 5.46 51.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 179.766 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -111.27 -178.44 0.54 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 44.7 Cg_endo -72.86 117.4 5.11 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.917 1.482 . . . . 0.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.6 48.78 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' LEU . 2.1 tp -89.84 130.4 36.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.956 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 25' ' ' GLU . . . -76.9 150.77 35.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 40.4 t -116.53 164.56 14.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.3 t -92.54 102.36 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.347 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.4 t -123.71 121.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -70.21 138.85 52.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.115 -0.99 . . . . 0.0 109.998 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.45 -52.49 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 20.7 tt0 -82.2 162.71 22.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.75 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -67.63 142.97 56.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.466 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' CB ' ' A' ' 7' ' ' ALA . 14.7 mt -131.25 127.34 21.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.219 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.69 -159.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.79 1.416 . . . . 0.0 110.037 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 45' ' ' VAL . 36.1 pt -112.44 -165.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.115 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 p30 39.9 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 110.412 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 47.7 m -130.38 136.6 49.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.55 130.62 34.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -103.34 161.48 13.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -130.07 -175.6 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.629 HD21 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -51.88 -34.28 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -50.06 -60.01 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.76 30.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.317 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.96 115.32 21.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.297 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.81 124.81 45.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.917 . . . . 0.0 110.215 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.96 97.22 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 26.6 pt-20 -113.13 157.86 21.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 23.0 t -98.51 57.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -126.06 154.65 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 62.7 p -79.14 158.95 73.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.48 176.67 42.57 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.722 -2.199 . . . . 0.0 110.5 -0.167 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.3 mtt -77.13 -107.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.209 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.72 -129.37 9.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.04 132.45 22.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.83 -158.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.962 1.506 . . . . 0.0 110.304 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.09 30.92 7.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.433 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -77.41 -15.92 59.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.033 -1.042 . . . . 0.0 109.605 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.927 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.3 mp0 -105.02 24.66 11.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.574 -0.704 . . . . 0.0 109.966 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.4 mm -41.7 -53.5 7.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.701 -179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -71.24 -4.65 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.564 1.297 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.32 -36.23 4.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' HB2' ' A' ' 36' ' ' GLU . 2.7 mp -79.8 -42.47 24.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.259 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.7 t -42.18 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.367 -0.833 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.67 -6.5 13.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.51 148.96 30.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -1.202 . . . . 0.0 110.207 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' THR . 31.5 mt-30 -109.36 172.25 6.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 13' ' ' ILE . 4.8 m -119.53 172.54 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.471 ' O ' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -111.16 -12.81 14.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' CD ' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -123.88 140.61 52.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.34 144.34 27.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 110.083 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.894 HG11 ' HA ' ' A' ' 53' ' ' THR . 34.1 t -130.41 130.23 22.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.1 Cg_endo -77.01 99.77 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.174 1.618 . . . . 0.0 110.331 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 58.4 136.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 110.597 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.33 75.79 0.34 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.894 ' HA ' HG11 ' A' ' 49' ' ' VAL . 23.4 p -96.63 96.37 8.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.428 HG21 ' HG2' ' A' ' 29' ' ' PRO . 9.1 m -63.47 136.43 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.273 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.957 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -79.52 103.96 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 110.123 179.973 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.0 ptp -109.48 143.58 28.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.031 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 47.4 Cg_endo -74.25 0.29 8.68 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.035 1.545 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' HB3' ' SD ' ' A' ' 56' ' ' MET . 50.4 t0 -83.09 -47.2 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.43 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG3' ' CD ' ' A' ' 47' ' ' ARG . 25.7 mmt -99.58 47.52 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.341 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 56' ' ' MET . 36.1 t -126.51 91.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.091 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 62' ' ' ASN . 28.9 pttt -71.42 -32.18 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 61' ' ' LYS . 61.1 t30 -96.29 52.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -44.59 152.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.48 -125.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 66' ' ' GLY . 44.4 m-20 -59.34 -43.67 92.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.139 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 46.22 96.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -96.4 -7.35 35.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -96.59 -161.56 0.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -41.11 -55.94 4.56 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 179.97 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -73.88 153.5 47.76 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.963 1.507 . . . . 0.0 110.437 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.449 ' HA2' ' HA3' ' A' ' 66' ' ' GLY . . . 176.24 -57.05 0.11 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -154.06 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -1.126 . . . . 0.0 110.174 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.201 0.524 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.433 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -87.79 113.59 23.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.895 . . . . 0.0 110.215 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -88.52 129.76 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 5.0 t -78.13 125.69 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.273 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 54' ' ' THR . 15.2 t -118.39 118.68 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.96 . . . . 0.0 110.281 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -44.97 117.58 1.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.5 t30 -73.58 -52.76 12.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 tp60 -95.2 148.03 22.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.2 tt -59.62 119.77 8.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 9' ' ' GLN . 1.0 OUTLIER -129.74 134.33 26.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.2 Cg_endo -72.96 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.963 1.507 . . . . 0.0 110.124 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 14' ' ' ASN . 3.1 mt -146.9 -171.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.212 -0.93 . . . . 0.0 109.99 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.667 ' H ' HG22 ' A' ' 13' ' ' ILE . 9.9 p30 36.26 48.83 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.63 . . . . 0.0 110.999 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -123.93 103.34 8.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 110.154 179.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -65.53 144.44 57.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mp -98.64 140.48 32.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.3 p -129.34 84.5 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.637 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' MET . 7.7 tp 52.15 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.332 -0.855 . . . . 0.0 110.808 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' THR . 3.3 mt -41.41 -53.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.634 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 mtt -65.58 -13.09 58.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.26 119.87 39.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.26 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 19.9 mmtm -118.86 90.83 3.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.96 95.04 2.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.433 HG22 ' CA ' ' A' ' 3' ' ' ALA . 28.9 t -78.69 71.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 28' ' ' THR . 63.6 t -142.07 161.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -75.29 151.89 85.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -77.19 -174.93 15.72 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.558 -2.268 . . . . 0.0 110.455 -0.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.2 mpt? -76.63 -109.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.919 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 97.52 -145.29 17.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 HD12 ' A' ' 55' ' ' LEU . 23.3 mm -74.52 112.3 16.75 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.344 -1.092 . . . . 0.0 110.398 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.714 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.7 Cg_endo -75.14 -1.86 11.8 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.928 1.488 . . . . 0.0 110.303 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 33' ' ' PRO . . . 69.49 24.64 5.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.82 -44.93 63.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 61.0 mm-40 -99.4 67.43 1.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.89 HG22 ' HD3' ' A' ' 38' ' ' PRO . 1.9 tp -70.08 -30.97 2.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 112.137 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HD3' HG22 ' A' ' 37' ' ' ILE . 45.2 Cg_endo -74.59 -8.25 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 N-CA-C 109.93 -0.835 . . . . 0.0 109.93 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -114.18 -31.1 6.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.368 -0.833 . . . . 0.0 109.529 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.1 tp -69.82 -36.99 76.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 110.059 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 37' ' ' ILE . 22.7 t -43.53 103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.6 24.52 7.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.649 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.4 ttm -95.92 138.97 32.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -1.093 . . . . 0.0 110.241 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 44.7 mt-30 -106.72 151.45 25.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.7 m -95.91 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.06 16.71 20.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.628 ' N ' HG23 ' A' ' 13' ' ' ILE . 20.8 mtt180 -144.1 161.96 37.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.38 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -72.52 134.95 45.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 21.3 t -128.65 128.25 23.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.63 -158.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.825 1.434 . . . . 0.0 110.445 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -87.37 155.31 20.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 110.822 -179.438 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.502 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 41.57 40.67 2.94 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.2 m -96.97 125.2 41.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.556 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 m -63.47 108.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -70.38 122.93 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 110.514 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.442 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 7.6 mtt -100.48 171.23 5.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 109.923 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 45.4 Cg_endo -73.04 -0.65 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.905 1.476 . . . . 0.0 110.55 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.93 -43.65 52.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.323 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' HB2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -92.13 60.7 3.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.259 -179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 63' ' ' TYR . 25.4 t -130.16 95.57 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -94.49 82.51 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.835 ' CD2' HG11 ' A' ' 60' ' ' VAL . 7.8 t80 -62.31 139.34 58.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.75 -56.64 4.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -96.05 83.17 3.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 70' ' ' PRO . . . -109.4 91.66 0.66 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -107.6 -38.75 5.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -1.142 . . . . 0.0 110.303 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 81.9 p -93.24 -137.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.79 -58.53 3.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.549 -179.798 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -71.07 118.49 5.72 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.907 1.477 . . . . 0.0 110.563 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.3 13.48 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -178.4 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.311 0.577 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.18 125.8 25.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.931 . . . . 0.0 110.356 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 p -121.76 149.78 42.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.82 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 56.0 t -83.13 113.0 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 54' ' ' THR . 5.1 t -121.09 104.59 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.065 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.54 131.53 3.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.412 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -88.75 -63.49 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -73.16 141.72 47.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.067 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -59.35 131.11 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mt -122.96 140.1 32.74 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.56 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.087 1.572 . . . . 0.0 110.366 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.3 mt -110.63 -175.77 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.7 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 10.0 p30 39.35 29.98 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.613 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 13' ' ' ILE . 52.4 m -122.02 133.34 54.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.11 151.93 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.233 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 43' ' ' MET . 1.4 pp -119.96 157.05 29.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.56 159.06 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -50.06 -43.34 51.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.533 ' N ' HD23 ' A' ' 19' ' ' LEU . 17.8 mt -53.97 -29.98 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 mtt -85.77 -21.28 28.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.504 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.94 106.66 17.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.442 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -106.17 118.13 35.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.55 109.92 14.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.143 -0.973 . . . . 0.0 110.306 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.18 152.16 25.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.4 t -90.69 63.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 26' ' ' VAL . 11.5 m -147.75 -178.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -94.84 162.15 26.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.61 165.41 85.73 Favored 'Cis proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.404 -0.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -61.66 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 -149.28 28.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.719 HD13 ' OH ' ' A' ' 63' ' ' TYR . 4.9 mt -104.28 136.74 19.14 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.04 -159.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.999 1.526 . . . . 0.0 110.377 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -116.53 46.61 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.444 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 6.2 pt-20 -74.27 -27.04 60.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.11 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 6.9 mm-40 -104.55 36.18 2.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.679 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.9 mm -54.79 -51.1 81.93 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 110.8 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -71.02 -5.1 16.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.389 1.205 . . . . 0.0 110.715 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 63.1 m-80 -114.2 -50.18 2.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.367 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -68.27 -35.21 77.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 17.2 t -53.74 122.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.96 -14.91 31.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.594 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -85.0 159.78 20.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.146 . . . . 0.0 110.161 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -105.42 178.3 4.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.5 m -116.78 173.01 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 59' ' ' MET . 59.2 t30 -111.06 -9.04 14.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -130.56 172.06 12.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -0.923 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -76.09 151.55 37.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 53' ' ' THR . 37.3 t -127.95 108.0 20.13 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.801 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.9 Cg_endo -71.61 -165.26 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.032 1.543 . . . . 0.0 110.461 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.6 150.08 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.404 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.12 49.19 24.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.48 ' CB ' HG13 ' A' ' 49' ' ' VAL . 16.7 m -91.69 120.09 32.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.473 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.7 t -61.13 149.38 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -68.38 105.73 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtm -110.34 139.35 21.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 110.277 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 46.5 Cg_endo -73.9 -4.11 14.88 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.989 1.521 . . . . 0.0 110.631 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.91 -20.85 48.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' ASN . 3.8 mtt -105.23 12.37 31.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.232 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . 21.3 t -106.44 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 46' ' ' ASN . 73.0 mttt -43.9 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.091 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 63' ' ' TYR . 4.1 m120 -100.78 104.43 15.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.088 -1.007 . . . . 0.0 110.085 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.719 ' OH ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -44.33 165.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.956 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 2.4 mm-40 -64.36 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.116 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -48.75 79.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.82 -22.64 16.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 30.2 2.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 110.183 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' SER . 20.7 m -100.73 -60.0 1.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER 173.27 -59.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.203 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.17 90.99 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.887 1.467 . . . . 0.0 110.373 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.44 120.32 0.76 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -28.13 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -1.164 . . . . 0.0 110.319 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.219 0.533 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.35 143.1 24.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -119.38 125.89 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.971 ' O ' HD23 ' A' ' 55' ' ' LEU . 53.8 t -65.97 124.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.295 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' C ' ' A' ' 53' ' ' THR . 25.6 t -116.99 123.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -46.57 134.89 9.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.258 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.42 ' CG ' ' HE2' ' A' ' 23' ' ' LYS . 57.3 t30 -90.37 -69.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.4 144.54 30.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -62.92 135.82 57.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.063 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.535 HG22 HG21 ' A' ' 15' ' ' THR . 1.4 pt -124.9 119.72 25.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' ILE . 45.4 Cg_endo -72.09 57.79 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.847 1.446 . . . . 0.0 110.251 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.8 mt 49.64 179.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.705 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' H ' HG22 ' A' ' 13' ' ' ILE . 2.8 m-80 43.76 26.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 110.241 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.535 HG21 HG22 ' A' ' 11' ' ' ILE . 17.8 m -119.92 103.05 9.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.862 . . . . 0.0 110.1 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . . . -57.86 152.89 15.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 110.405 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.849 HD11 HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -112.93 156.35 23.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.835 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.646 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -128.76 -169.83 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 7.7 mp -64.55 -46.83 81.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.14 -20.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.05 3.61 54.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.938 ' SD ' HG11 ' A' ' 5' ' ' VAL . 1.7 mmm -112.47 106.18 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' CG ' ' A' ' 8' ' ' ASN . 6.9 mtmt -105.98 115.33 30.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.03 98.07 4.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.9 142.05 46.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 26' ' ' VAL . 56.0 t -88.0 85.84 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 110.18 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.52 153.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.4 p -91.69 157.6 41.52 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.89 -172.7 11.34 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.486 -0.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 ptp -82.4 -151.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.334 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 154.69 -127.46 2.1 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 20.1 mm -91.12 108.86 31.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.279 -1.13 . . . . 0.0 110.277 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 31' ' ' GLY . 50.2 Cg_endo -76.5 50.41 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.936 1.492 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 45.67 24.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.33 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.676 ' OE1' HG21 ' A' ' 67' ' ' THR . 36.1 tt0 -77.01 -33.81 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.88 39.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.906 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 2.4 mm -54.75 -57.2 20.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.77 -1.78 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.652 1.343 . . . . 0.0 110.744 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.94 -51.21 2.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.396 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.22 -39.79 78.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 18' ' ' THR . 58.4 t -52.6 103.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.223 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -35.1 2.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.51 159.58 18.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -1.123 . . . . 0.0 110.286 -179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.551 ' HG3' ' CA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -110.26 -169.28 1.44 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.821 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 13' ' ' ILE . 3.7 m -120.19 172.24 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.19 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 2.8 m120 -111.18 0.47 16.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.411 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -123.31 142.54 50.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -62.2 129.14 39.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 HG21 ' A' ' 53' ' ' THR . 54.6 t -121.12 123.67 27.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.606 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.05 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.849 1.447 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -86.5 144.09 27.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 61.31 39.92 97.89 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.859 HG21 HG13 ' A' ' 49' ' ' VAL . 79.5 m -88.75 145.73 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -1.174 . . . . 0.0 110.106 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.3 m -72.45 143.97 48.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.7 mm? -69.93 80.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.419 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -94.06 143.82 27.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.915 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.19 -1.42 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.96 1.505 . . . . 0.0 110.377 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 18.7 p-10 -70.44 -12.01 61.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.28 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -108.75 -25.06 11.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.83 105.56 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.181 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -63.11 1.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.196 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' TYR . 10.2 m120 -95.04 86.41 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.37 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -44.46 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 0.0 110.168 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 43' ' ' MET . 33.4 mm-40 -79.93 -97.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.56 -32.14 18.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 0.0 110.223 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' CA ' ' HA3' ' A' ' 71' ' ' GLY . . . 102.85 105.02 2.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.676 HG21 ' OE1' ' A' ' 35' ' ' GLU . 1.7 m -107.69 -54.76 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -1.133 . . . . 0.0 110.436 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.432 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 60.8 p -101.98 -157.18 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -44.63 -57.27 6.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -71.49 79.93 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.999 1.526 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA3' ' CA ' ' A' ' 66' ' ' GLY . . . -173.67 47.88 0.15 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -94.24 -40.9 9.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.31 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.197 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 mttp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.212 0.529 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.7 138.05 31.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -120.42 146.91 45.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.237 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 45.0 t -77.39 111.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.38 124.5 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -69.5 119.89 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.838 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.9 p-10 -74.97 -43.57 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -96.56 135.64 38.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.182 179.887 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.827 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.98 153.82 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.674 -179.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.772 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -130.45 126.8 22.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.995 . . . . 0.0 110.07 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.6 Cg_endo -76.85 47.97 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.831 1.437 . . . . 0.0 110.82 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.578 HD11 ' H ' ' A' ' 48' ' ' ALA . 2.2 mt 51.72 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 44.98 31.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -126.32 105.17 8.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.95 138.85 42.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.212 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -92.26 139.49 30.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.8 OUTLIER -108.16 167.92 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 19' ' ' LEU . 6.1 tt -58.84 -42.78 90.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.947 . . . . 0.0 110.266 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 21' ' ' MET . 18.1 pt -67.03 -41.37 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.911 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.515 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.774 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.495 ' O ' ' CG ' ' A' ' 22' ' ' MET . 6.0 ptt? -115.38 123.8 49.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -121.15 159.94 24.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.0 101.78 13.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.362 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -113.07 136.91 52.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 54.9 t -91.64 88.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.99 -173.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 29' ' ' PRO . 23.9 m -116.31 146.03 36.4 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 110.013 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.707 ' HA ' HG23 ' A' ' 28' ' ' THR . 50.2 Cg_endo -75.58 -178.51 23.9 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.788 -2.172 . . . . 0.0 110.509 -0.174 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -159.51 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.14 -148.48 10.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.1 mt -85.11 131.48 48.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.294 -1.121 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.26 178.99 5.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.63 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -98.48 25.79 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 18.2 pt-20 -76.96 -18.68 58.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 10.2 mm-40 -104.85 48.81 0.83 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.286 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -54.53 -50.59 84.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.943 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.53 -0.58 9.93 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.818 1.43 . . . . 0.0 110.703 -179.594 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.29 -28.03 7.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.932 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.732 HD21 ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -89.13 -38.09 14.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 110.371 -179.857 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 37' ' ' ILE . 54.9 t -49.08 91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.919 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.64 28.39 1.59 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.446 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -98.93 131.5 44.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -1.182 . . . . 0.0 110.256 179.957 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -109.46 126.77 53.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.2 m -83.71 168.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HA ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 t30 -110.96 1.64 17.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -134.84 133.65 39.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.578 ' H ' HD11 ' A' ' 13' ' ' ILE . . . -50.55 140.58 13.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.336 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.086 HG13 HG21 ' A' ' 53' ' ' THR . 55.1 t -130.09 135.94 28.25 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.071 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.2 Cg_endo -72.13 -173.26 1.04 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.717 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -76.5 162.36 27.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.91 . . . . 0.0 110.536 -179.717 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.24 44.67 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.086 HG21 HG13 ' A' ' 49' ' ' VAL . 82.1 m -96.43 119.86 35.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -1.212 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.486 HG21 ' O ' ' A' ' 29' ' ' PRO . 22.3 p -54.75 127.3 27.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.732 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -61.68 113.34 2.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.177 -179.933 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.0 ptp -106.99 151.69 40.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.46 1.59 7.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.135 1.597 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' CE ' ' A' ' 59' ' ' MET . 1.8 t70 -76.71 -43.88 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 110.558 -179.752 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 9.2 mmt -105.5 63.54 0.69 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.361 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.2 t -130.17 99.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -61.02 -71.62 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -90.8 75.37 6.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.118 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 25.6 t80 -51.71 145.36 9.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.381 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' N ' ' HE3' ' A' ' 43' ' ' MET . 7.4 pm0 -64.42 -141.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.18 78.24 0.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.85 100.05 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -81.6 4.51 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -1.162 . . . . 0.0 110.248 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -76.67 -160.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.965 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -42.4 -56.42 5.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.301 179.867 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -72.46 162.49 41.29 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.972 1.512 . . . . 0.0 110.493 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.64 61.58 0.62 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.25 -44.82 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.0 110.254 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.182 179.982 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.258 0.551 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 164.97 19.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -123.17 158.6 30.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.77 114.72 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG22 HG22 ' A' ' 54' ' ' THR . 4.2 t -126.49 122.09 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -56.67 127.62 32.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.45 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 24.2 t-20 -77.45 -48.68 16.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.09 158.29 15.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.132 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.02 132.49 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 7' ' ' ALA . 1.1 mp -117.65 122.67 30.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 46.0 Cg_endo -71.57 -95.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.749 1.394 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.775 HD13 HD22 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -162.02 -173.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.095 179.527 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.775 HD22 HD13 ' A' ' 13' ' ' ILE . 9.9 p30 40.21 31.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 11' ' ' ILE . 5.7 t -124.11 138.2 54.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -71.55 154.97 41.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 11' ' ' ILE . 51.3 mt -120.97 104.42 9.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.886 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.46 HG23 HG13 ' A' ' 41' ' ' VAL . 3.4 m -96.81 167.89 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.978 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.96 -25.15 67.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.6 mt -69.63 -19.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.6 ttp -97.73 -20.88 17.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HA ' ' A' ' 7' ' ' ALA . 1.4 mtt -118.91 143.51 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.112 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.75 172.09 7.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.07 102.05 14.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.3 tp10 -112.03 128.58 56.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.5 p -91.95 77.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.38 166.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.18 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.9 t -92.83 144.83 29.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' HG21 ' A' ' 54' ' ' THR . 49.4 Cg_endo -75.55 157.21 99.12 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.416 -0.248 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.3 mtt -72.79 -26.25 61.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.77 -132.02 43.99 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.875 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.8 mt -106.28 134.79 19.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.287 -1.125 . . . . 0.0 110.223 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -170.52 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.942 1.496 . . . . 0.0 110.407 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.47 46.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.272 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.05 -40.07 54.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.903 ' HB2' HD12 ' A' ' 40' ' ' LEU . 14.9 mm-40 -104.91 31.2 4.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.981 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -42.68 -54.27 8.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.4 Cg_endo -71.53 -2.22 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.615 1.323 . . . . 0.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.02 -32.15 6.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.894 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -85.55 -24.6 27.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.351 -179.848 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.8 t -42.58 119.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.2 8.78 28.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD23 ' A' ' 40' ' ' LEU . 18.9 ttp -72.34 134.66 45.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -1.194 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mt-30 -110.01 125.59 53.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 17' ' ' LEU . 3.7 m -79.99 154.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 110.141 179.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -108.26 10.1 27.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.405 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.57 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.52 137.44 26.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -45.06 128.19 7.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.018 HG13 HG21 ' A' ' 53' ' ' THR . 47.5 t -111.85 134.75 21.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.56 ' C ' ' HG1' ' A' ' 53' ' ' THR . 47.6 Cg_endo -74.12 -171.57 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.023 1.539 . . . . 0.0 110.477 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.31 164.01 22.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 110.281 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 43.43 30.32 1.31 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.018 HG21 HG13 ' A' ' 49' ' ' VAL . 72.9 m -76.15 104.16 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -1.196 . . . . 0.0 110.401 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -52.39 153.69 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.053 179.808 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.875 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -62.16 100.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.314 -179.841 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.7 mtm -113.55 145.34 33.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.435 -0.791 . . . . 0.0 110.287 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.62 0.18 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.001 1.527 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.97 -55.36 14.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' A' ' 47' ' ' ARG . 46.8 mtt -103.35 40.72 1.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 110.431 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 93.6 t -130.47 133.34 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -142.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.417 ' C ' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-20 -76.39 79.61 3.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 110.297 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CD2' ' N ' ' A' ' 64' ' ' GLU . 18.0 p90 -84.62 -167.96 2.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.501 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 47.5 tp10 -71.94 76.79 0.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 70' ' ' PRO . 10.1 t0 -99.31 -64.74 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.46 -126.94 1.06 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.534 ' HA ' HD23 ' A' ' 72' ' ' LEU . 15.8 m -108.92 -70.72 0.79 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 110.477 -179.77 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -18.29 59.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.51 -179.16 0.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.956 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -72.55 84.67 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.958 1.504 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -165.7 -36.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -67.7 113.76 5.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.144 . . . . 0.0 110.252 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.3 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.143 179.949 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.232 0.539 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.01 138.26 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.3 p -123.74 157.5 33.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.655 HG12 HD23 ' A' ' 55' ' ' LEU . 61.6 t -80.1 124.28 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -129.2 107.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 179.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -46.65 116.18 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 51' ' ' LEU . 52.6 t30 -77.79 -46.52 21.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.15 136.22 33.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 10' ' ' LEU . 1.7 pt? -78.12 131.68 37.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.34 -179.891 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.534 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 10.4 pt -128.9 155.73 79.06 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.872 . . . . 0.0 109.989 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.0 Cg_endo -72.85 -96.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.89 1.468 . . . . 0.0 110.159 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.563 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -152.24 172.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.961 -1.087 . . . . 0.0 109.889 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.81 21.38 5.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 110.353 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -97.91 117.07 31.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.03 157.55 5.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 41' ' ' VAL . 30.1 mt -98.43 111.16 23.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 p -95.41 155.91 16.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -28.08 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.378 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mt -68.64 -36.88 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.922 . . . . 0.0 110.235 -179.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 42.3 mtp -88.74 11.82 16.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.612 ' HA ' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -112.35 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -109.59 112.83 25.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.18 105.53 3.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.326 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -109.68 155.37 21.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.157 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 26' ' ' VAL . 10.8 t -91.65 24.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 28' ' ' THR . 31.7 t -95.68 148.38 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -77.34 168.25 29.55 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.955 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.568 ' CG ' HG21 ' A' ' 54' ' ' THR . 48.8 Cg_endo -73.77 -170.58 7.97 Favored 'Cis proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.624 -2.24 . . . . 0.0 110.417 -0.134 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 31' ' ' GLY . 5.3 ptt? -76.56 -34.82 58.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.248 180.0 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 45.56 -131.45 9.42 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.26 137.35 21.49 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.276 179.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 -166.86 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.008 1.531 . . . . 0.0 110.479 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.804 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -116.84 33.83 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -41.35 85.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 73.4 mm-40 -104.78 32.53 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.804 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.3 mm -42.88 -51.32 12.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.599 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -72.04 -1.4 9.97 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.483 1.254 . . . . 0.0 110.681 -179.776 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.75 -38.08 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 179.933 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -75.26 -34.12 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.911 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 37' ' ' ILE . 21.6 t -46.96 139.61 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -11.69 54.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.4 tpp -82.01 132.52 35.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.116 . . . . 0.0 110.209 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -92.94 -179.41 5.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.17 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.0 m -118.42 163.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.343 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -111.19 3.42 18.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.542 -179.91 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.7 mmt180 -139.18 -176.75 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 0.0 110.41 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -79.8 140.83 36.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.25 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 53' ' ' THR . 4.5 t -119.28 116.49 33.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.336 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -76.89 152.01 35.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.45 42.01 25.81 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.685 HG21 HG13 ' A' ' 49' ' ' VAL . 61.4 m -82.36 115.02 21.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.568 HG21 ' CG ' ' A' ' 29' ' ' PRO . 11.2 t -54.74 155.63 4.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -71.98 103.63 3.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.924 . . . . 0.0 110.229 179.971 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.483 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -112.17 145.14 32.2 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.997 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -12.24 25.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.982 1.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -62.17 -56.76 15.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.288 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.529 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 5.9 mtt -93.45 39.81 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 56' ' ' MET . 53.3 t -130.44 126.87 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 110.233 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -161.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 110.056 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.557 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 27.3 p-10 -69.2 79.81 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 3.4 p90 -82.2 -170.11 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -63.76 145.46 55.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.075 -1.016 . . . . 0.0 111.205 -178.679 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 10.3 t0 -98.17 79.06 2.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.577 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.22 -87.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.259 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -52.39 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.793 -179.286 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 21.2 p -69.72 -174.07 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.611 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 6.5 t -119.02 41.16 0.39 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 111.564 -179.456 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 69' ' ' SER . 43.8 Cg_endo -72.33 -169.44 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.569 1.299 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 66.5 33.79 85.74 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -70.01 -43.98 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -1.158 . . . . 0.0 110.205 179.935 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.277 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.214 0.531 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -85.38 151.24 24.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.99 135.7 54.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 22' ' ' MET . 94.7 t -78.88 121.82 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.2 t -127.59 116.66 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.104 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -67.16 122.35 17.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.133 179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -78.11 -42.29 32.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.429 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -88.05 143.53 27.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.263 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.6 tt -63.92 143.93 57.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 mt -130.38 112.53 16.77 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.278 -0.889 . . . . 0.0 110.401 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.35 59.56 5.45 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.787 1.414 . . . . 0.0 110.408 179.615 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 42.3 pt 38.19 -163.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.834 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 42.46 27.75 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.821 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.3 m -140.93 121.32 14.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.18 171.31 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.917 . . . . 0.0 110.161 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mt -113.8 138.03 50.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -124.47 -179.67 4.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.262 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.19 -53.53 16.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.36 -15.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.229 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtt -82.45 -47.02 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.539 ' HG3' HG13 ' A' ' 5' ' ' VAL . 1.7 ptt? -119.91 149.42 42.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -111.9 169.33 8.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.03 92.29 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.213 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.52 137.64 50.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 26' ' ' VAL . 76.3 t -90.73 60.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 28' ' ' THR . 55.3 t -132.7 170.23 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.854 HG22 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -79.93 151.86 73.85 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.998 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.854 ' HA ' HG22 ' A' ' 28' ' ' THR . 48.8 Cg_endo -75.69 178.95 32.65 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.678 -2.217 . . . . 0.0 110.535 -0.227 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -74.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.89 -166.88 53.09 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.772 HD11 ' OH ' ' A' ' 63' ' ' TYR . 16.2 mm -63.19 133.64 95.52 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.155 -1.203 . . . . 0.0 110.005 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 43.6 Cg_endo -72.75 -174.5 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.851 1.448 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.57 23.41 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.731 -179.496 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -77.33 -19.08 56.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.11 10.03 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.789 . . . . 0.0 110.116 -179.52 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.8 mm -41.9 -55.33 6.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 110.552 -179.79 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.51 -4.55 14.76 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.584 1.307 . . . . 0.0 110.72 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.8 m120 -114.18 -25.96 8.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 110.457 -179.835 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -91.27 -25.29 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.863 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 37' ' ' ILE . 33.1 t -42.99 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.01 15.15 4.83 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.423 ' HE3' ' HG2' ' A' ' 64' ' ' GLU . 36.3 tpp -87.75 136.5 32.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -1.169 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -102.54 149.09 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 6.2 m -113.6 161.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 2.3 t30 -111.32 -1.82 15.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 179.792 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 3.5 mtt180 -115.12 137.98 51.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.253 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.53 145.13 1.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.333 -179.516 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.066 ' CG1' HG21 ' A' ' 53' ' ' THR . 2.8 t -126.05 110.82 24.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.086 -179.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' O ' ' HB ' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -176.34 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.929 1.489 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' LEU . 1.6 mp -71.45 157.23 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.046 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.82 32.21 1.33 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.8 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.104 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -69.16 138.44 54.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.463 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 12.6 t -85.21 142.28 29.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.611 179.255 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 mm? -61.67 117.94 6.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.1 mtt -111.99 150.02 41.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.922 . . . . 0.0 110.338 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 -16.83 24.31 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.021 1.537 . . . . 0.0 110.364 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.73 -16.31 42.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.472 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 mtm -111.78 38.24 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.957 . . . . 0.0 110.182 -179.917 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.575 HG11 ' CE1' ' A' ' 63' ' ' TYR . 77.5 t -130.33 114.91 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.07 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -57.12 -99.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.374 -179.725 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 62' ' ' ASN . 22.0 p-10 -100.34 96.98 7.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.99 -1.068 . . . . 0.0 110.182 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -49.24 146.7 3.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 110.26 179.936 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 72.9 mm-40 -76.72 -56.05 4.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 42.0 p-10 -84.22 55.13 3.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.029 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.44 67.54 3.69 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -93.49 -20.27 20.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.054 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.52 -158.81 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.93 -55.78 4.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.899 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.5 Cg_endo -73.53 138.13 26.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.019 1.536 . . . . 0.0 110.395 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -25.98 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.18 27.13 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.232 179.989 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.253 0.549 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.26 130.88 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 159.67 15.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.15 127.38 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.249 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.3 t -124.44 127.32 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB3' ' H ' ' A' ' 53' ' ' THR . . . -45.56 127.79 7.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.19 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 28.0 t30 -89.57 -58.22 2.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.204 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -91.88 145.65 24.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.0 tt -64.2 109.64 1.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 pt -123.6 137.36 28.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.069 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.014 1.534 . . . . 0.0 110.14 179.845 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.752 HG22 HG23 ' A' ' 45' ' ' VAL . 2.0 pt -146.41 -164.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.128 -0.982 . . . . 0.0 110.197 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.8 p30 40.37 27.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 0.0 110.561 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.3 m -116.61 111.71 20.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -62.88 133.99 55.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.771 HD22 ' SD ' ' A' ' 22' ' ' MET . 47.9 mt -81.18 145.64 30.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 110.061 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -129.93 137.5 50.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 110.322 179.915 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.6 tt -43.76 -43.67 6.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.516 ' N ' HD23 ' A' ' 19' ' ' LEU . 8.1 mt -67.55 -21.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.358 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -97.54 -23.36 16.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.771 ' SD ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -116.42 120.0 37.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.34 147.95 27.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 110.164 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.0 116.41 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.32 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.33 151.2 30.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.37 78.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.288 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.8 149.91 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.141 179.931 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.6 p -97.7 159.96 29.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.85 152.88 97.42 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.439 -0.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.06 127.2 32.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.834 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.9 -110.66 3.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.786 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.838 HG13 HD22 ' A' ' 55' ' ' LEU . 8.5 mm -86.03 114.69 58.51 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.107 . . . . 0.0 110.628 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.51 -161.57 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.449 179.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -109.76 27.79 9.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.23 -38.24 51.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.958 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 65' ' ' ASP . 48.0 mm-40 -94.12 32.68 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.133 -0.979 . . . . 0.0 110.943 -179.288 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -43.65 -51.72 15.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.963 -1.085 . . . . 0.0 110.4 179.722 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -73.23 -11.39 24.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.732 1.385 . . . . 0.0 110.996 -179.427 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -105.66 -46.43 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.099 179.835 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' HG21 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -62.2 -43.98 97.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.202 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 37' ' ' ILE . 39.9 t -43.61 119.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.993 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.91 16.02 46.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.497 ' HE1' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ttm -83.91 135.09 34.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -1.147 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -106.92 124.83 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.752 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -85.08 158.55 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -103.73 -3.57 24.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.124 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.545 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 10.2 mtt180 -123.28 155.66 36.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.7 58.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.425 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG13 ' HB ' ' A' ' 53' ' ' THR . 28.2 t -127.86 113.61 20.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 179.893 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 -162.9 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.946 1.498 . . . . 0.0 110.6 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.32 155.98 28.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.968 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.5 45.82 6.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.591 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 87.4 m -94.02 100.07 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.157 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' MET . 23.8 m -44.91 123.77 4.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.838 HD22 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.97 115.47 4.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 54' ' ' THR . 19.8 mtp -112.25 164.24 15.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.48 -0.763 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 49.7 Cg_endo -76.37 6.5 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.08 1.568 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -42.16 11.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.07 -1.019 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -100.22 52.6 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 -179.9 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 17.4 t -129.97 123.42 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.898 . . . . 0.0 110.22 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -73.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 6.7 t-20 -100.52 93.31 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.497 ' HA ' ' HE1' ' A' ' 43' ' ' MET . 96.3 m-85 -52.64 151.9 4.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' HD12 ' A' ' 40' ' ' LEU . 1.5 mp0 -68.44 -70.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.148 179.865 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 33.2 p-10 -84.49 94.89 8.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.938 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 71' ' ' GLY . . . -85.67 38.39 3.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.4 m -107.81 -16.5 14.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.96 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.445 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 61.6 p -100.58 -140.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.511 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -75.65 -56.94 1.67 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 -179.828 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.8 Cg_endo -72.97 73.21 3.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.919 1.484 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . -130.81 0.65 5.42 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.21 137.74 34.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.242 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.496 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -61.62 124.55 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 t -82.93 173.2 12.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.172 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.23 108.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.1 t -123.78 107.4 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -58.68 121.62 11.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 3.5 m-20 -72.65 -55.34 7.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.73 156.45 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.746 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' HG ' ' HA ' ' A' ' 50' ' ' PRO . 8.0 tt -70.31 124.41 24.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 9' ' ' GLN . 22.0 mm -124.0 113.19 28.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -73.82 -92.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.0 110.404 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.871 HG22 HG23 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -161.89 -177.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.108 -0.995 . . . . 0.0 110.291 179.99 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 50.74 21.74 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.5 m -124.5 113.34 17.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.085 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.662 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.66 152.79 8.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.126 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -96.76 138.62 34.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -167.02 1.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.276 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.68 -63.36 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.295 -179.954 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -49.09 -24.93 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 110.194 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.93 3.72 40.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.7 mtt -116.37 118.37 32.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.0 160.07 23.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.092 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -105.08 83.03 1.92 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.34 135.83 44.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -94.38 77.83 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.7 120.03 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.2 p -83.25 150.39 60.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 110.152 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.82 129.89 19.93 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.483 -0.151 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -71.25 118.37 13.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -102.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.0 mt -118.15 137.62 24.73 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.238 -1.154 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -162.68 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.12 1.589 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -107.69 45.63 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.92 -35.58 67.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 mm-40 -104.97 35.29 2.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.817 . . . . 0.0 109.872 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -40.5 -52.17 6.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -71.39 -9.49 25.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.594 1.313 . . . . 0.0 110.766 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -106.25 -25.62 11.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.087 179.715 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -94.6 -40.36 9.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.83 . . . . 0.0 110.26 179.996 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -45.08 107.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.662 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.42 18.26 7.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.526 ' HE2' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -96.82 147.61 23.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -104.16 148.73 25.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.871 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -111.27 161.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -109.44 17.74 21.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.608 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -136.44 128.01 28.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.39 179.889 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -62.19 130.17 44.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.086 HG11 HG23 ' A' ' 53' ' ' THR . 9.1 t -128.67 128.17 23.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -73.77 -166.06 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.314 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.66 126.75 26.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.954 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 90.15 73.72 1.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.086 HG23 HG11 ' A' ' 49' ' ' VAL . 68.9 m -92.06 99.1 11.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -1.127 . . . . 0.0 110.326 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 56' ' ' MET . 41.1 p -64.58 132.37 49.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.93 85.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.112 179.935 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 54' ' ' THR . 4.2 mtt -103.33 142.9 25.53 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.25 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -75.2 2.78 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.078 1.567 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.13 -20.8 21.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.355 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.7 mtm -108.36 -6.86 16.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.445 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 63' ' ' TYR . 85.6 t -93.95 107.69 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -77.42 -60.68 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.1 t-20 -95.68 74.4 3.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.334 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -54.48 163.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.158 179.937 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.666 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -65.04 -178.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.108 179.892 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLY . 1.4 m-20 -59.75 -58.2 9.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.4 131.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 m -88.86 -62.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 14.6 t -108.7 51.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -154.32 -178.83 0.94 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.878 . . . . 0.0 110.0 179.904 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -72.93 103.06 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.909 1.478 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 72' ' ' LEU . . . -171.89 56.25 0.17 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' HA ' HD13 ' A' ' 72' ' ' LEU . 4.0 mm? -103.91 85.42 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -1.129 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.293 0.568 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.29 159.0 18.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.16 179.933 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -122.47 145.81 47.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.823 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 58.6 t -79.95 112.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 52' ' ' GLY . 6.1 t -118.63 132.49 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 0.0 110.158 -179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.102 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.15 130.29 35.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.278 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 39.5 t30 -80.02 -69.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG3' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -65.78 130.85 44.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 179.85 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 51' ' ' LEU . 2.0 pt? -62.26 133.0 54.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.58 -179.716 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.729 HG13 HG23 ' A' ' 49' ' ' VAL . 1.3 pt -130.13 134.77 26.5 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.1 Cg_endo -73.68 168.78 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.935 1.492 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -46.66 174.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' OD1' HD13 ' A' ' 13' ' ' ILE . 6.9 m120 60.35 -152.4 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 58.49 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.92 . . . . 0.0 110.057 -179.835 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -56.28 154.02 8.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.43 144.14 26.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.2 OUTLIER -124.86 155.22 39.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 110.31 -179.934 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.769 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.0 tt -68.07 -46.35 71.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.72 -14.63 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.943 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.459 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -87.85 -47.34 8.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.265 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.992 ' HE3' ' HB2' ' A' ' 7' ' ' ALA . 20.1 mtp -97.36 142.14 29.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -108.46 167.65 9.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.046 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.69 106.81 18.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.43 144.42 32.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 45.7 t -97.1 66.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.207 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.06 -166.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 35.3 p -118.13 160.14 40.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.873 . . . . 0.0 110.132 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 50.5 Cg_endo -77.13 145.18 80.24 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.47 -0.137 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -76.1 75.24 2.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.957 179.742 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.08 -119.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.988 HG13 HD12 ' A' ' 55' ' ' LEU . 10.2 mm -82.49 115.14 56.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.446 -1.032 . . . . 0.0 110.47 -179.619 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 49.0 Cg_endo -75.64 50.21 2.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.95 1.5 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.823 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 41.82 29.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -42.98 99.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 110.457 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 59.3 mm-40 -104.16 34.08 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -42.77 -54.57 8.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -71.7 -4.56 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.639 1.336 . . . . 0.0 110.676 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.03 -21.58 10.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.874 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.507 ' CD1' ' HE2' ' A' ' 43' ' ' MET . 16.0 tp -92.1 -40.1 11.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 37' ' ' ILE . 75.0 t -44.53 115.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 110.184 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.53 14.96 24.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.538 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 5.0 ttp -104.45 157.94 16.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -106.75 141.4 38.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 13' ' ' ILE . 26.4 m -90.22 164.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -110.49 10.7 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.172 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.69 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -153.17 124.71 7.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.022 179.996 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -52.74 150.09 5.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.827 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -128.22 137.85 31.74 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.18 -168.79 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.99 1.521 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -70.14 155.59 40.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 110.06 179.864 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 44.36 40.71 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.102 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.2 t -78.37 130.11 35.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 110.326 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 t -78.05 145.04 36.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.988 HD12 HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.15 107.37 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -106.64 146.46 33.11 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 179.988 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.28 -0.77 10.06 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.428 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.94 -20.27 26.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.615 ' SD ' HG13 ' A' ' 49' ' ' VAL . 4.1 mtt -112.45 32.82 5.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.923 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 11.8 t -121.09 118.95 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.031 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -86.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.857 . . . . 0.0 110.271 -179.785 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.95 89.57 7.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -45.11 160.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CE ' ' A' ' 43' ' ' MET . 1.3 mp0 -103.97 -47.96 4.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.14 85.6 3.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 72.57 0.53 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 14.1 m -84.53 54.65 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 69' ' ' SER . 58.1 p -106.27 -89.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.79 -57.97 2.32 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -72.52 -3.02 12.67 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.904 1.476 . . . . 0.0 110.321 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 67' ' ' THR . . . -108.62 128.37 9.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -15.36 16.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 -179.932 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.311 0.577 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.3 135.78 33.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -105.84 144.72 32.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.912 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 34' ' ' ALA . 29.9 m -76.31 130.05 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.253 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 54' ' ' THR . 12.4 t -129.57 118.06 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.61 116.94 2.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.148 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 5.1 p-10 -75.07 -43.8 51.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tt0 -97.12 150.96 20.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.9 tt -63.88 105.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 109.89 179.769 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 7.9 mm -99.5 139.37 20.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.516 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.6 -157.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.124 1.592 . . . . 0.0 110.201 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.745 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.26 -165.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.008 179.715 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.4 p30 38.45 32.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.6 m -133.39 142.98 48.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.341 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -75.27 148.83 39.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 45' ' ' VAL . 39.1 mt -105.88 151.36 24.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -115.05 -170.58 1.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.16 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.99 -49.45 45.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.856 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' HG2' ' A' ' 21' ' ' MET . 3.4 pt -55.36 -18.98 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.201 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.441 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.5 mmm -90.57 9.38 29.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.27 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.73 ' CE ' HD23 ' A' ' 40' ' ' LEU . 33.6 mtp -123.3 122.83 39.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -117.16 114.04 23.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.259 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.75 83.89 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.47 126.09 42.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 73.0 t -86.42 79.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 28' ' ' THR . 9.6 p -147.6 169.57 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.968 . . . . 0.0 110.368 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -117.21 150.16 45.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.982 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.554 ' O ' HG21 ' A' ' 54' ' ' THR . 48.2 Cg_endo -75.48 134.73 37.14 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.679 -2.217 . . . . 0.0 110.395 -0.132 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 30' ' ' MET . 1.1 ptt? -80.83 136.93 36.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.552 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -89.9 -116.35 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 55' ' ' LEU . 9.9 mm -81.24 136.28 49.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.281 -1.129 . . . . 0.0 109.802 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.3 Cg_endo -74.05 4.88 3.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.965 1.508 . . . . 0.0 111.238 -179.478 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.967 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . 68.12 18.4 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -11.43 59.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 179.642 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -105.04 28.27 7.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 110.324 -179.375 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.8 mm -42.19 -53.34 8.79 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.566 -179.852 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.23 -5.07 16.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.61 1.321 . . . . 0.0 110.81 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 8.4 m-80 -114.03 -49.02 2.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.973 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.73 HD23 ' CE ' ' A' ' 22' ' ' MET . 2.3 tp -66.69 -39.97 88.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 38.9 t -50.87 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 116.96 24.57 3.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.655 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.8 ppp? -104.53 154.58 19.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -1.169 . . . . 0.0 110.265 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -109.39 123.86 50.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 13' ' ' ILE . 33.3 m -77.76 165.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' MET . 44.5 t30 -110.35 -12.28 14.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.139 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.8 mtp85 -120.32 146.57 45.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 149.86 15.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 53' ' ' THR . 38.5 t -126.13 112.52 24.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.1 Cg_endo -72.72 -167.78 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.852 1.448 . . . . 0.0 110.522 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -73.64 149.04 42.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.82 53.21 6.38 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 49' ' ' VAL . 84.6 m -96.52 122.16 39.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.591 ' N ' HG13 ' A' ' 6' ' ' VAL . 1.3 m -64.14 123.37 18.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.863 . . . . 0.0 110.135 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 32' ' ' ILE . 1.3 tt -62.03 113.01 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.064 179.895 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.5 mtt -111.63 162.57 20.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.52 0.74 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.044 1.55 . . . . 0.0 110.435 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.79 -23.98 22.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -98.87 1.0 45.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 179.87 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.655 HG13 ' CE ' ' A' ' 43' ' ' MET . 7.1 t -91.5 116.47 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -80.18 -72.73 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.918 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 73' ' ' LYS . 65.0 m-80 -100.22 87.86 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.409 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.99 144.58 28.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . 8.7 mm-40 -83.23 -95.79 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.986 . . . . 0.0 110.352 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 13.8 t70 -94.45 82.95 4.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.99 93.1 0.28 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -74.36 -39.68 62.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 32.36 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.22 -179.6 1.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.6 Cg_endo -72.36 174.97 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.887 1.467 . . . . 0.0 110.56 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.24 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -65.73 153.16 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -1.177 . . . . 0.0 110.317 -179.853 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.269 0.557 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.52 135.35 51.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -112.53 148.8 33.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.929 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 29.3 t -73.58 107.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.1 t -107.53 102.18 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.05 130.28 21.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.228 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -57.97 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.136 -179.942 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' CD ' ' SD ' ' A' ' 21' ' ' MET . 4.6 pt20 -81.44 162.08 23.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.188 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.7 tt -86.48 149.18 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.036 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.522 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 13.1 pt -129.79 127.91 22.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 110.399 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.53 54.01 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.033 1.544 . . . . 0.0 110.38 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER 47.44 -177.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 -179.902 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 7.1 m-20 41.15 28.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 13' ' ' ILE . 54.0 m -118.36 114.4 22.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.19 128.44 35.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.051 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mt -83.03 143.19 30.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -122.21 176.42 5.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 19' ' ' LEU . 7.2 tt -68.32 -44.86 74.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.279 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.503 HG13 ' N ' ' A' ' 21' ' ' MET . 4.7 pt -60.03 -22.51 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.503 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -95.88 -21.62 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.954 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.475 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mtm -108.39 108.0 18.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -111.68 139.59 47.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.955 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.75 84.99 6.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 179.985 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 148.55 28.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.34 93.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 0.0 110.085 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 28' ' ' THR . 94.9 t -131.01 161.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 29' ' ' PRO . 28.8 m -114.51 145.74 34.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 -179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.666 ' O ' HG21 ' A' ' 54' ' ' THR . 50.5 Cg_endo -80.29 147.65 76.29 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.716 -2.202 . . . . 0.0 110.42 -0.445 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -68.2 68.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -42.17 -83.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.835 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 55' ' ' LEU . 4.8 mt -135.27 142.84 43.11 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.0 110.224 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.7 Cg_endo -72.36 -159.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.332 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.817 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -115.57 40.01 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.96 -29.86 64.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -102.9 24.58 10.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.1 mm -45.19 -53.32 17.56 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.6 Cg_endo -71.02 -6.43 19.2 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.505 1.266 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.27 -27.08 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.116 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 36' ' ' GLU . 1.1 mp -88.97 -26.46 21.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.081 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 53.3 t -51.46 99.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.08 2.59 12.38 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.598 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.0 tmm? -94.86 143.75 26.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -1.187 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 49.3 mt-30 -106.45 134.0 50.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 13' ' ' ILE . 17.8 m -77.48 154.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.171 179.866 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -97.75 1.49 48.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -132.59 142.41 49.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -56.96 136.76 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.45 -179.76 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 53' ' ' THR . 45.5 t -124.29 120.71 26.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.955 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.772 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.65 -161.26 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.973 1.512 . . . . 0.0 110.647 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 52' ' ' GLY . 2.4 mp -81.04 160.11 24.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.335 -0.853 . . . . 0.0 110.471 -179.658 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 43.37 49.5 6.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.037 HG21 HG13 ' A' ' 49' ' ' VAL . 39.7 m -96.75 106.37 18.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -1.152 . . . . 0.0 110.081 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 ' O ' ' A' ' 29' ' ' PRO . 5.6 m -50.35 147.98 3.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -65.07 108.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.115 179.925 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.41 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -110.07 150.31 41.28 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.981 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.08 0.44 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.051 1.553 . . . . 0.0 110.58 -179.981 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.15 -50.89 7.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.515 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.74 47.65 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.84 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' CE ' ' A' ' 43' ' ' MET . 19.5 t -127.88 109.85 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -82.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.255 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -91.86 88.58 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.856 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.74 139.0 57.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 179.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG3' HD12 ' A' ' 40' ' ' LEU . 4.7 mm-40 -87.9 -92.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.01 82.75 3.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.0 110.398 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.74 94.28 0.25 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.18 18.15 21.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -1.146 . . . . 0.0 110.266 -179.887 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 69' ' ' SER . 88.0 m -100.41 -33.91 10.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.05 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 173.25 -56.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.995 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -73.14 85.68 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.928 1.489 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.3 70.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.64 -32.63 72.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -1.165 . . . . 0.0 110.328 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 tptt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.257 179.992 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.235 0.541 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.41 156.99 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.219 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.84 161.27 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.253 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 55' ' ' LEU . 39.4 t -79.04 121.42 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.093 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -125.42 107.59 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.9 111.09 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 51.1 t30 -74.91 -59.91 2.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -72.18 139.43 48.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.67 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.98 132.58 51.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 179.919 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.88 ' HB ' HG21 ' A' ' 15' ' ' THR . 1.6 pt -130.13 110.89 16.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -74.82 69.69 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.93 1.49 . . . . 0.0 110.43 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.7 pt 39.0 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 45.9 29.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.88 HG21 ' HB ' ' A' ' 11' ' ' ILE . 5.1 t -131.0 130.32 43.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 110.135 -179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 142.68 53.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.179 -179.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 40' ' ' LEU . 5.5 mt -77.79 124.72 28.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 110.27 -179.92 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.443 ' HB ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.94 172.04 8.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.993 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 ' CG2' ' A' ' 41' ' ' VAL . 17.5 mt -77.23 -30.99 54.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 21' ' ' MET . 6.3 pt -62.62 -25.55 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.538 ' CE ' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -97.38 -14.06 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.588 ' HG3' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.04 126.28 32.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 12.7 mttt -111.55 124.06 51.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.21 10.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.406 ' HG2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -110.92 150.08 29.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 179.964 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 26' ' ' VAL . 61.3 t -81.68 4.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG2' ' A' ' 25' ' ' GLU . 41.1 t -53.47 130.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.21 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -84.8 168.27 21.91 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.813 ' O ' HG21 ' A' ' 54' ' ' THR . 48.0 Cg_endo -73.76 156.69 99.61 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.428 -0.191 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' GLY . 5.5 mtt -76.34 83.23 3.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.69 -116.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' OH ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -110.48 139.9 22.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.219 -1.165 . . . . 0.0 109.948 179.946 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 32' ' ' ILE . 46.7 Cg_endo -73.9 168.7 24.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.553 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.699 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . -84.14 47.1 1.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -77.15 -27.06 53.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.797 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -104.72 45.34 0.97 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 111.023 -179.406 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.699 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -63.05 -51.43 70.46 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.008 179.637 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.9 Cg_endo -75.08 -5.4 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.755 1.398 . . . . 0.0 110.722 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 3.9 m-80 -114.77 -35.3 4.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.591 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD2' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -87.51 -38.9 15.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.799 -179.46 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' CG2' HD21 ' A' ' 19' ' ' LEU . 9.1 t -41.93 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.9 -7.3 6.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.652 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.54 131.0 35.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -1.089 . . . . 0.0 110.194 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 15' ' ' THR . 15.2 mt-30 -99.33 151.39 21.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.961 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.1 m -99.92 161.78 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -111.18 0.29 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -114.39 135.85 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 110.042 -179.858 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -55.8 123.15 13.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.325 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CB ' ' A' ' 53' ' ' THR . 19.7 t -109.99 125.47 31.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 179.605 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -72.67 -167.63 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.858 1.452 . . . . 0.0 110.512 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -81.53 155.28 25.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.231 -179.9 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 45.29 44.61 10.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' HG13 ' A' ' 49' ' ' VAL . 43.6 m -90.61 122.58 33.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -1.174 . . . . 0.0 110.203 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.813 HG21 ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -54.69 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.987 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD12 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -80.04 106.5 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.194 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -113.1 143.27 28.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 179.822 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.36 1.46 7.34 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.951 1.5 . . . . 0.0 110.634 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.84 -15.55 44.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.812 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HG2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -99.47 -21.43 15.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.52 120.75 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.311 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.95 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 179.879 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 22.6 p-10 -92.06 87.79 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.103 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.751 ' OH ' HG21 ' A' ' 32' ' ' ILE . 2.7 t80 -45.45 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' HG3' ' C ' ' A' ' 39' ' ' ASN . 1.5 tm-20 -66.91 -60.14 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' ' OG1' ' A' ' 67' ' ' THR . 2.0 m-20 -65.97 -49.89 66.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.62 2.54 78.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -90.16 4.65 49.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -1.19 . . . . 0.0 110.203 -179.934 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -98.4 -150.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.953 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.57 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -61.03 -60.17 11.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.04 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 47.2 Cg_endo -72.67 140.06 31.93 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.533 . . . . 0.0 110.201 179.714 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.67 48.68 0.55 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.04 -170.7 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -1.157 . . . . 0.0 110.239 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.162 0.505 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -66.59 115.65 6.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.27 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 6' ' ' VAL . 18.3 p -123.88 148.82 46.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.156 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 76.2 t -62.48 116.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 110.207 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -121.03 105.91 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -42.62 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -75.69 -70.85 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' O ' HG12 ' A' ' 11' ' ' ILE . 13.0 tp60 -65.04 143.35 57.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.8 114.08 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 1.5 pt -128.78 128.32 23.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.78 -158.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.87 1.458 . . . . 0.0 109.788 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 45' ' ' VAL . 44.5 pt -98.98 -170.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.069 -1.019 . . . . 0.0 110.194 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 2.6 p30 49.41 20.31 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.489 -0.757 . . . . 0.0 110.735 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -118.71 102.13 8.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.007 -1.058 . . . . 0.0 109.928 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.74 124.12 15.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.353 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.9 mt -94.13 163.4 13.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' CG1' ' A' ' 20' ' ' ILE . 67.4 p -130.51 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 110.027 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.0 -42.62 66.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.03 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CG1' ' OG1' ' A' ' 18' ' ' THR . 2.6 pt -58.62 -26.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.106 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.0 mtt -94.46 15.98 16.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.485 ' HE3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.59 111.6 16.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -119.38 114.45 22.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.61 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.182 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.24 152.53 28.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.185 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 26' ' ' VAL . 81.3 t -95.33 82.8 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.224 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.09 157.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.0 t -95.82 148.91 35.31 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.074 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -75.87 -165.18 4.13 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.729 -2.196 . . . . 0.0 110.541 -0.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.86 -19.53 51.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 30' ' ' MET . . . 45.95 -143.17 4.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -97.49 125.29 45.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -1.162 . . . . 0.0 110.066 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.03 -161.5 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.846 1.445 . . . . 0.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.92 17.79 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -56.79 -36.64 70.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 109.971 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 10.1 pt-20 -104.58 35.98 2.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 110.286 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.74 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 4.0 mm -55.57 -54.96 45.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.243 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -70.5 -4.15 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.636 1.335 . . . . 0.0 110.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.0 m-20 -109.36 -25.25 10.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.485 HD23 ' HE3' ' A' ' 22' ' ' MET . 5.3 tp -84.85 -29.32 25.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.29 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 37' ' ' ILE . 36.7 t -42.88 104.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 103.85 29.45 5.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 tpp -97.8 140.76 31.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 110.273 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.98 121.73 44.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.045 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 13' ' ' ILE . 10.4 m -80.7 166.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 110.304 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB2' ' CD ' ' A' ' 61' ' ' LYS . 11.7 t-20 -111.58 -4.75 14.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -125.17 132.78 52.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.848 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' ARG . . . -46.8 135.8 8.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.366 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' A' ' 53' ' ' THR . 76.6 t -116.86 113.95 39.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.72 -169.54 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.901 1.474 . . . . 0.0 110.382 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -71.84 148.78 45.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.75 53.49 6.2 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.675 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 99.8 m -96.51 120.95 37.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.278 -1.131 . . . . 0.0 110.253 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 128.05 35.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.728 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -62.5 115.8 4.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 110.184 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.0 mtt -110.2 157.98 36.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 -3.3 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.61 -10.24 41.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' CG ' ' A' ' 47' ' ' ARG . 7.0 mtm -112.22 35.59 3.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.09 111.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.304 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' CD ' ' HB2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -69.51 -71.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.147 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 7.2 p30 -96.79 86.69 4.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.115 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.86 120.52 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.29 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.3 mm-40 -75.51 -81.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.189 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.0 m-20 -89.04 69.28 8.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.56 82.69 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 67' ' ' THR . 36.6 m -85.06 9.7 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -1.17 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.3 t -69.93 -21.99 63.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.922 . . . . 0.0 110.154 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.571 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -175.83 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.571 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -72.65 59.86 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.444 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.74 35.31 5.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.13 -41.26 10.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -1.142 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.235 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -68.47 142.21 55.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.63 131.77 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.63 145.32 40.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.129 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 59.3 t -73.68 133.53 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.79 121.18 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.04 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.24 130.41 19.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t30 -86.68 -68.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -82.73 139.18 33.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -68.49 132.62 47.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 111.08 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -130.82 154.78 81.98 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 109.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.0 Cg_endo -72.19 -96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.935 1.492 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.2 mt -153.28 -174.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.852 -1.155 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 41.39 32.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.417 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 7.2 m -112.42 129.89 56.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -67.45 158.7 31.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.182 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -125.84 135.45 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.294 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.574 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -123.24 173.38 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 20' ' ' ILE . 5.2 tt -56.34 -56.71 17.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.7 mp -52.46 -19.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' THR . 24.4 mmm -88.31 -46.61 9.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 22' ' ' MET . 2.8 ptm -116.44 135.64 53.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.281 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -117.29 166.58 12.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.171 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.37 103.37 15.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -112.94 156.82 22.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.169 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.95 91.03 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.153 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.56 148.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -99.18 167.09 11.81 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.11 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.6 Cg_endo -73.86 163.58 89.6 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.401 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.39 93.3 3.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 110.415 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -81.97 -111.62 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.967 HG23 ' OE2' ' A' ' 36' ' ' GLU . 14.7 mm -91.44 113.6 59.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.337 -1.096 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.71 -174.84 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.944 1.497 . . . . 0.0 110.478 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -87.13 17.88 3.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -76.62 -53.96 7.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.967 ' OE2' HG23 ' A' ' 32' ' ' ILE . 19.3 pt-20 -92.39 33.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.743 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.2 mm -62.34 -52.71 64.25 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 110.049 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -72.3 -1.96 10.96 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.651 1.342 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 8.8 m-80 -112.45 -32.06 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.1 tp -86.72 -39.86 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 0.0 110.131 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 18' ' ' THR . 32.4 t -50.39 127.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.221 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.71 28.89 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.2 mtm -100.01 159.4 15.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 16.2 mp0 -109.95 165.95 11.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.0 m -101.63 165.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' MET . 26.3 t-20 -111.13 16.32 21.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 110.278 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 13' ' ' ILE . 5.3 mmt180 -143.92 176.63 9.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -80.41 134.71 36.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.487 HG13 HG21 ' A' ' 53' ' ' THR . 15.2 t -124.24 108.59 29.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 110.049 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -72.72 -163.14 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.976 1.514 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -78.45 156.83 29.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.32 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.02 32.87 1.59 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.529 ' OG1' ' CD ' ' A' ' 50' ' ' PRO . 18.3 m -75.0 112.46 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 110.315 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.406 ' HB ' ' CE ' ' A' ' 56' ' ' MET . 20.2 m -48.13 131.23 16.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.853 . . . . 0.0 109.978 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.566 HD12 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.84 100.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.222 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.406 ' CE ' ' HB ' ' A' ' 54' ' ' THR . 1.8 mtt -101.46 139.14 20.16 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.0 2.65 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.995 1.524 . . . . 0.0 110.592 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.36 -28.71 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' ASN . 9.2 mtm -95.3 -2.87 48.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.08 127.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -64.99 -92.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.396 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 17.9 p-10 -95.78 90.65 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.17 -0.956 . . . . 0.0 110.197 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' A' ' 32' ' ' ILE . 2.7 t80 -44.92 157.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 10.2 mm-40 -80.79 -80.35 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.281 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.36 33.12 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.09 90.47 0.55 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -96.94 17.53 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.191 . . . . 0.0 110.143 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' CB ' ' A' ' 69' ' ' SER . 9.2 t -77.15 0.73 20.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 110.302 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.528 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 172.99 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.207 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -72.65 172.07 15.95 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.989 1.521 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -34.42 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -77.06 98.42 5.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -1.124 . . . . 0.0 110.228 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 1' ' ' ASN . 52.4 p-10 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.274 0.559 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' CD ' ' HB3' ' A' ' 33' ' ' PRO . 9.4 ptpp? -95.79 160.82 14.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -83.3 174.49 10.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -120.6 165.3 15.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.134 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 97.1 t -92.63 95.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.468 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.8 t -119.12 127.12 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.827 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -80.66 144.49 32.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.462 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 t-20 -77.06 -66.42 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 109.686 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.16 148.78 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -59.33 148.33 32.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -0.954 . . . . 0.0 110.061 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.22 138.01 30.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.89 -159.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.067 1.561 . . . . 0.0 110.258 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.059 HD11 ' HB2' ' A' ' 48' ' ' ALA . 1.6 mp -123.16 173.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 13' ' ' ILE . 3.6 m120 59.25 19.92 8.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -118.08 151.41 37.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 165.97 21.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.729 HD11 ' CG1' ' A' ' 45' ' ' VAL . 38.8 mt -121.56 117.86 27.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.98 165.05 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.2 -33.69 58.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.274 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.1 mm -55.51 -41.12 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.389 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.92 8.91 43.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.97 124.4 42.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.98 144.18 48.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.999 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.6 94.63 5.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.03 154.53 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 9.2 t -92.15 39.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.158 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.12 159.1 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 11.1 p -81.89 163.13 54.92 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.1 Cg_endo -74.19 178.78 32.18 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.625 -0.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 4' ' ' SER . 1.9 mtt -77.84 -68.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.7 -128.75 18.12 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.0 mt -103.67 137.1 19.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.159 -1.201 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' CD ' ' A' ' 2' ' ' LYS . 44.8 Cg_endo -72.07 177.72 6.81 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.973 1.512 . . . . 0.0 110.43 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.12 23.96 6.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.303 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -18.78 57.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 109.47 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -105.17 10.81 33.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.3 mm -41.99 -54.44 7.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.697 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -70.04 -3.84 13.01 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.529 1.278 . . . . 0.0 110.737 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' GLU . 90.4 m-20 -114.15 -36.95 4.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.738 HD12 ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -78.78 -42.14 28.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.2 t -42.63 121.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.255 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.71 1.04 27.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.497 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.6 ttm -99.84 149.77 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -1.178 . . . . 0.0 110.12 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -100.8 159.83 14.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.729 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.7 m -102.45 163.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.43 -9.62 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -136.27 155.69 49.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.938 . . . . 0.0 110.183 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.059 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -86.17 144.12 27.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.709 HG11 HG23 ' A' ' 53' ' ' THR . 38.2 t -130.2 140.35 38.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.093 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.0 Cg_endo -73.4 -175.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.083 1.57 . . . . 0.0 110.391 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -44.25 169.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.905 . . . . 0.0 110.286 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 44.11 52.19 7.07 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.827 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 2.2 m -75.36 94.58 3.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -1.109 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.578 HG21 ' HG2' ' A' ' 29' ' ' PRO . 6.6 t -68.11 148.75 50.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.086 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -70.24 105.64 3.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.342 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.54 155.45 44.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.163 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' ' HG2' ' A' ' 56' ' ' MET . 45.9 Cg_endo -73.24 -5.98 18.1 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.012 1.532 . . . . 0.0 110.489 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.3 -45.81 14.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.548 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -94.52 49.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 98.9 t -130.11 83.94 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -67.35 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -99.59 88.63 3.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.246 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 3.2 t80 -44.33 141.06 1.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.738 ' OE1' HD12 ' A' ' 40' ' ' LEU . 3.4 pt-20 -64.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.352 -0.843 . . . . 0.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 13.9 p-10 -61.91 84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 70' ' ' PRO . . . -86.04 71.76 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 67' ' ' THR . 93.7 m -79.63 5.14 13.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -1.177 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -100.46 -104.22 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -96.22 -66.05 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.884 -1.135 . . . . 0.0 110.493 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.6 Cg_endo -72.64 126.25 11.29 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.508 1.268 . . . . 0.0 110.425 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.85 94.34 0.14 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.4 -48.1 51.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -1.159 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.22 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.24 0.543 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -96.23 151.14 19.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -53.54 121.48 7.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.157 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -90.91 150.37 21.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 55' ' ' LEU . 54.2 t -77.8 114.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 5.8 t -125.89 95.0 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -48.58 128.94 15.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.58 -80.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 110.022 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -58.98 160.07 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.822 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -90.25 140.57 29.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -131.42 140.03 37.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.44 -0.788 . . . . 0.0 110.03 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.4 163.37 37.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.961 1.506 . . . . 0.0 110.211 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 45' ' ' VAL . 3.9 pt -71.7 -177.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.505 HD22 HD12 ' A' ' 13' ' ' ILE . 2.1 m-80 60.29 16.39 6.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.285 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 140.2 50.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.19 152.71 44.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.791 HD11 ' CG1' ' A' ' 45' ' ' VAL . 6.9 mt -105.38 138.36 41.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 77.8 p -115.12 153.91 29.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -30.36 70.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' MET . 13.0 pt -64.81 -20.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 7.6 mtm -97.69 -7.55 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 37' ' ' ILE . 1.4 mmm -96.26 105.49 17.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HD2' ' OD1' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -96.24 141.29 29.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.875 . . . . 0.0 110.311 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -90.62 89.99 7.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.268 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.62 120.12 40.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.097 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' C ' HG13 ' A' ' 27' ' ' VAL . 94.2 t -68.87 79.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.0 m -151.28 170.22 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.912 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -93.31 165.83 17.49 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.274 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.5 Cg_endo -74.97 167.24 81.01 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.357 -0.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.34 68.89 2.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.268 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.57 -130.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.596 HG21 ' CD ' ' A' ' 36' ' ' GLU . 2.0 mt -97.33 126.45 41.75 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.165 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.56 50.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.924 1.486 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . 45.93 26.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -69.91 -45.73 66.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' CD ' HG21 ' A' ' 32' ' ' ILE . 1.4 pt-20 -95.25 28.39 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.109 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.3 mm -47.09 -55.02 16.89 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -71.0 -2.74 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.569 1.299 . . . . 0.0 110.542 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 83.9 m-20 -109.48 -31.45 7.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.33 -31.85 15.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.505 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.4 t -43.69 110.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.32 4.45 27.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.5 ' HE3' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -100.23 152.83 19.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -1.219 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.81 154.85 18.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.893 . . . . 0.0 110.232 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.791 ' CG1' HD11 ' A' ' 17' ' ' LEU . 5.9 m -102.28 167.02 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' MET . 9.3 t30 -111.1 -11.4 14.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 3.7 mtt-85 -116.18 133.13 56.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 13' ' ' ILE . . . -51.48 124.98 13.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.518 HG13 ' CG2' ' A' ' 53' ' ' THR . 61.9 t -99.07 109.89 55.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.15 -165.02 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.957 1.504 . . . . 0.0 110.424 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -75.56 150.91 37.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.421 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.5 44.03 11.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' HG13 ' A' ' 49' ' ' VAL . 88.2 m -89.35 122.19 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.01 138.92 57.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 109.993 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -66.45 106.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 110.241 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.401 ' SD ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -106.15 152.58 40.46 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.41 -0.806 . . . . 0.0 110.344 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 56' ' ' MET . 48.0 Cg_endo -74.49 -0.68 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.563 . . . . 0.0 110.583 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.71 -13.9 38.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 7.8 mtt -104.24 -2.57 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.5 HG13 ' HE3' ' A' ' 43' ' ' MET . 28.4 t -100.96 106.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -80.81 78.0 7.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.306 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 11.2 t80 -46.13 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -99.41 -86.14 0.38 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.16 80.1 2.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.58 98.35 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 10.26 38.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -1.212 . . . . 0.0 110.348 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.633 HG22 ' N ' ' A' ' 69' ' ' SER . 18.0 m -73.36 -91.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.633 ' N ' HG22 ' A' ' 68' ' ' THR . 0.6 OUTLIER -77.78 -56.13 1.15 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.175 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 69' ' ' SER . 49.5 Cg_endo -76.29 52.64 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.034 1.544 . . . . 0.0 110.297 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.92 72.61 0.54 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.82 17.58 22.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -1.174 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' CB ' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.219 0.533 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -83.81 159.34 21.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 0.0 110.186 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -70.06 137.35 51.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -97.87 157.06 16.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -87.83 104.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' C ' ' A' ' 52' ' ' GLY . 20.3 t -93.32 114.87 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -42.26 126.73 3.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.152 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.545 ' O ' HD23 ' A' ' 51' ' ' LEU . 50.8 t30 -82.46 -73.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.276 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.466 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -65.54 140.29 58.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.748 ' C ' HD23 ' A' ' 10' ' ' LEU . 4.2 tt -72.15 126.21 29.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 4.0 pt -130.67 151.05 78.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.966 ' O ' HD13 ' A' ' 13' ' ' ILE . 47.6 Cg_endo -73.69 -95.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.399 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 12' ' ' PRO . 6.2 mm -142.0 163.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 110.05 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 16.2 m-80 42.26 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.261 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 88.3 m -154.32 123.18 6.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 110.237 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.73 144.64 21.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 17' ' ' LEU . 3.6 mt -107.63 143.36 36.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 110.404 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' HG12 ' A' ' 20' ' ' ILE . 1.1 p -116.56 167.13 11.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.35 -21.85 62.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 8.2 pt -73.8 -18.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.808 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' ' HB3' ' A' ' 9' ' ' GLN . 2.4 mtt -97.74 21.15 10.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 110.036 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.93 122.27 43.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.1 mmmt -119.11 127.3 53.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.7 74.85 6.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -107.95 118.46 36.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.38 72.56 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.182 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 m -135.69 -173.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 110.182 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 12.2 t -103.86 149.41 37.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.83 167.48 79.87 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.319 -0.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -82.6 81.3 8.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.3 -157.97 0.03 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -75.51 140.04 71.67 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.366 -1.079 . . . . 0.0 110.298 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.12 -168.48 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.1 1.579 . . . . 0.0 110.648 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -106.8 -5.54 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -24.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mm-40 -104.89 47.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.578 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.3 mm -60.74 -53.91 59.72 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 110.339 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.4 Cg_endo -73.05 -5.23 16.83 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.829 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -114.25 -30.82 6.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 0.0 110.372 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 55' ' ' LEU . 7.3 tp -82.06 -50.1 9.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 37' ' ' ILE . 96.9 t -44.46 114.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.16 11.45 18.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 64' ' ' GLU . 4.2 ttm -97.9 143.84 28.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.6 mt-30 -104.31 112.8 25.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.226 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' ASN . 17.6 m -76.84 152.39 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.494 ' HA ' HG22 ' A' ' 13' ' ' ILE . 24.4 t-20 -109.95 42.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' NE ' HG13 ' A' ' 49' ' ' VAL . 4.1 ptm180 -141.23 156.29 45.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.95 . . . . 0.0 110.246 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -86.35 116.73 24.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.095 HG12 HG21 ' A' ' 53' ' ' THR . 2.7 m -115.22 112.02 44.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 46.9 Cg_endo -73.77 54.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.1 1.579 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 67.82 151.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 110.861 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 45.41 38.04 6.69 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.095 HG21 HG12 ' A' ' 49' ' ' VAL . 5.8 m -96.87 141.51 29.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.249 . . . . 0.0 110.225 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.8 HG21 ' HG2' ' A' ' 29' ' ' PRO . 10.1 t -70.42 131.77 44.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.596 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.35 122.93 17.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.302 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.15 135.31 19.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.468 ' HA ' HG21 ' A' ' 60' ' ' VAL . 49.2 Cg_endo -76.47 -24.24 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.101 1.579 . . . . 0.0 111.365 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' MET . 10.5 p-10 -63.64 -37.21 86.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.529 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.7 mmt -99.52 57.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.007 . . . . 0.0 110.003 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 57' ' ' PRO . 77.6 t -124.45 128.71 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 58.5 m-80 -96.09 100.48 12.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.471 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 2.7 t80 -45.43 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -98.43 -155.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 65' ' ' ASP . 27.1 t0 -59.9 79.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -136.25 81.4 0.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 24.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 69' ' ' SER . 66.7 m -86.3 -97.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.548 ' N ' HG22 ' A' ' 68' ' ' THR . 0.4 OUTLIER -80.74 -59.02 0.51 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.024 -1.047 . . . . 0.0 110.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.7 Cg_endo -73.72 -164.2 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.825 1.434 . . . . 0.0 110.58 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.58 -2.64 5.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -75.06 67.13 1.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 63' ' ' TYR . 2.5 mttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.309 0.576 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -80.97 151.34 28.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 110.163 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.19 120.65 12.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.298 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.5 t -97.44 148.21 23.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.08 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 22' ' ' MET . 53.7 t -71.32 109.68 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 110.289 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 54' ' ' THR . 10.7 t -124.16 120.27 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.093 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.911 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.92 130.23 39.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.612 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.2 m-80 -75.25 -23.52 57.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -96.4 155.33 16.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -80.69 127.6 32.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' SD ' ' A' ' 21' ' ' MET . 6.2 pt -129.06 106.87 17.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -72.98 157.35 51.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.006 1.53 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.739 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -44.71 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 2.1 m120 57.39 59.06 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m -160.41 119.24 2.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.11 165.05 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.58 HD11 HG12 ' A' ' 45' ' ' VAL . 15.8 mt -122.5 111.8 17.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 17.6 p -89.13 139.78 30.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.097 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HA ' ' CG ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -50.69 -30.82 14.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.252 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 18' ' ' THR . 9.6 pt -71.15 -13.47 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.553 ' SD ' HG21 ' A' ' 11' ' ' ILE . 7.6 ttm -97.67 -10.41 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.557 ' HE3' HG22 ' A' ' 41' ' ' VAL . 5.5 ptp -117.3 123.23 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -121.11 147.51 45.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.29 96.39 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -109.83 142.96 40.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.177 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -94.74 81.06 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.948 . . . . 0.0 110.126 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 28' ' ' THR . 8.6 p -126.63 166.52 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.256 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.8 t -114.47 149.24 41.86 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.33 164.37 88.39 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.771 -2.179 . . . . 0.0 110.523 -0.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.2 mtt -81.74 -150.64 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.402 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.8 -99.31 0.15 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 1.7 mt -118.63 132.33 23.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.124 -1.221 . . . . 0.0 109.636 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.66 -175.21 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.847 1.446 . . . . 0.0 110.359 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -86.97 21.88 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 110.299 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -43.83 74.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.479 ' OE2' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -95.22 35.01 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.88 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.6 mm -62.85 -53.25 57.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.925 . . . . 0.0 110.435 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.31 -3.07 12.23 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.581 1.306 . . . . 0.0 110.496 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -103.13 -32.49 9.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.479 HD13 ' OE2' ' A' ' 36' ' ' GLU . 4.0 tp -88.66 -31.69 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 37' ' ' ILE . 46.0 t -45.51 139.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 110.316 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.08 -32.46 5.65 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.2 ttp -74.91 144.78 43.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -178.43 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.617 HG23 ' HA ' ' A' ' 13' ' ' ILE . 3.3 m -119.08 164.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.074 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' C ' HG22 ' A' ' 13' ' ' ILE . 1.8 t-20 -110.94 -8.58 14.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 110.768 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -130.05 114.86 16.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -0.992 . . . . 0.0 110.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -54.56 138.16 41.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 0.0 110.402 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 53' ' ' THR . 4.9 t -130.4 136.61 29.25 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.84 . . . . 0.0 110.15 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.925 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.13 179.84 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.343 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -41.87 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.209 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 54.15 51.76 48.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.911 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 59.8 p -70.63 96.73 1.24 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -1.119 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.593 ' HA ' HG22 ' A' ' 6' ' ' VAL . 15.5 m -55.35 125.87 22.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.074 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 5' ' ' VAL . 4.7 tp -61.93 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.526 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.12 167.46 9.22 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.8 Cg_endo -74.6 2.1 6.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.06 1.558 . . . . 0.0 110.592 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -75.05 -69.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.533 ' CA ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -84.12 62.02 6.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.959 . . . . 0.0 110.578 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 56' ' ' MET . 9.8 t -130.08 124.48 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.36 -94.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.395 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 80.3 m-20 -100.51 100.42 11.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.246 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -46.96 116.59 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 8.9 mm-40 -65.38 -79.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.34 88.31 7.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.86 77.13 0.32 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.2 m -82.11 -11.57 58.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -1.15 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -88.95 -143.71 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.528 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -53.31 -57.22 17.71 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.225 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.6 128.32 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.939 1.494 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.11 38.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 97.34 5.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -1.131 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.147 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -97.22 154.2 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.199 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . . . -62.49 131.86 50.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.24 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.13 136.51 34.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.117 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 96.6 t -70.19 118.06 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 4' ' ' SER . 4.4 t -121.53 107.96 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.947 . . . . 0.0 110.235 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -51.35 120.1 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.907 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -79.59 -42.3 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.458 ' O ' HG12 ' A' ' 11' ' ' ILE . 40.8 tp60 -91.12 141.26 29.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 10' ' ' LEU . 3.0 tt -60.42 113.64 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 9' ' ' GLN . 12.6 mm -106.21 131.83 21.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.24 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.87 -163.26 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.825 1.434 . . . . 0.0 110.192 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.687 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.6 mt -106.94 -174.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 109.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.521 ' H ' HG22 ' A' ' 13' ' ' ILE . 2.7 m-20 52.26 19.41 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -117.5 155.39 29.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -81.1 156.69 25.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 12.8 mt -100.3 116.22 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' HG22 ' A' ' 20' ' ' ILE . 25.3 p -101.14 126.73 47.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -46.68 -40.74 13.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 tt -43.42 -42.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.593 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -93.35 11.77 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 110.354 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 28.8 mtm -123.99 112.28 17.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.0 153.88 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 3' ' ' ALA . . . -88.31 99.38 12.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -112.95 127.15 56.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -68.84 81.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 28' ' ' THR . 83.8 t -131.8 162.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -100.28 150.18 36.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -75.95 -169.43 7.54 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.393 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 4' ' ' SER . 8.8 ptp -74.18 -29.51 61.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' MET . . . 44.68 -145.52 2.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.972 HD12 ' OH ' ' A' ' 63' ' ' TYR . 42.3 mm -83.32 115.32 58.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.14 . . . . 0.0 110.073 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 46.3 Cg_endo -72.15 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.894 1.471 . . . . 0.0 110.507 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -94.0 23.97 4.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.132 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.9 mm-40 -76.95 -49.67 15.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.841 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE2' ' CG ' ' A' ' 65' ' ' ASP . 3.1 mm-40 -100.39 37.8 1.62 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.823 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.969 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -63.96 -54.03 43.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.7 Cg_endo -72.01 -2.14 11.08 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.694 1.365 . . . . 0.0 110.294 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' OD1' ' OE2' ' A' ' 64' ' ' GLU . 17.1 m-80 -106.95 -41.72 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' MET . 2.9 tp -74.5 -24.88 59.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 37' ' ' ILE . 34.6 t -45.7 99.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.78 11.9 21.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 53.5 tpp -81.43 155.12 26.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -1.188 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.7 157.83 16.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 110.252 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 13' ' ' ILE . 2.7 p -118.76 159.97 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' C ' HG21 ' A' ' 13' ' ' ILE . 35.4 t-20 -110.67 -13.76 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' H ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -118.02 174.74 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 0.0 110.145 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -85.53 149.04 25.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.589 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 53' ' ' THR . 54.2 t -128.24 107.5 19.57 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.833 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' C ' ' HG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -71.93 -160.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.966 1.509 . . . . 0.0 110.694 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.17 153.81 31.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.429 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.9 43.64 5.41 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.658 ' HB ' HG13 ' A' ' 49' ' ' VAL . 40.1 m -89.84 119.5 30.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -1.136 . . . . 0.0 110.328 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.9 141.26 58.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -66.05 115.45 6.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.279 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.57 138.58 21.52 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.71 -0.05 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.341 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -84.05 -20.71 32.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.892 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.502 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 22.0 mtt -99.67 -15.16 18.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.99 111.93 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 110.054 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -73.48 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.58 97.12 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.189 -0.945 . . . . 0.0 110.304 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.972 ' OH ' HD12 ' A' ' 32' ' ' ILE . 2.4 t80 -62.4 152.41 34.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -71.78 -53.28 13.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 110.385 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' CG ' ' OE2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -60.19 -42.31 94.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.413 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' CA ' ' HA2' ' A' ' 71' ' ' GLY . . . 48.92 83.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 68' ' ' THR . 34.2 m -89.01 -87.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.336 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' THR . 1.3 p -110.16 -92.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 110.52 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.549 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -49.97 -53.79 39.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.4 Cg_endo -74.61 2.09 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.906 1.477 . . . . 0.0 110.74 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' ' CA ' ' A' ' 66' ' ' GLY . . . -56.45 -56.98 21.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 156.85 18.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.195 . . . . 0.0 110.277 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.119 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.236 0.541 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 116.4 28.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.43 169.65 12.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -122.52 169.8 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.568 ' O ' HD23 ' A' ' 55' ' ' LEU . 21.8 t -94.27 110.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' HA2' ' A' ' 52' ' ' GLY . 15.3 t -116.52 114.04 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.193 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.045 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -52.94 127.68 24.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -0.949 . . . . 0.0 110.041 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 39.6 t30 -74.57 -55.12 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.543 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -91.24 148.18 22.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.497 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.644 ' C ' HD23 ' A' ' 10' ' ' LEU . 9.0 tt -61.32 128.47 36.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.889 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 49' ' ' VAL . 2.4 mt -101.4 123.6 44.02 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.2 Cg_endo -78.4 47.34 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.874 1.46 . . . . 0.0 110.78 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.3 mt 49.91 177.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.17 -0.956 . . . . 0.0 110.387 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 13' ' ' ILE . 5.9 m-20 45.42 36.17 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.448 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 16.4 m -132.53 119.69 20.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.02 159.29 5.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.3 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 23.6 mt -103.17 134.8 45.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.61 -168.75 1.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.47 -45.14 73.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.227 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.511 HD12 ' SD ' ' A' ' 21' ' ' MET . 5.9 pt -55.41 -28.26 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.01 11.47 33.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.479 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -115.12 109.75 18.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -114.36 122.94 48.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.302 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.09 79.93 9.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.98 129.07 46.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 26' ' ' VAL . 49.4 t -76.65 55.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.68 155.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.477 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -93.42 165.15 18.86 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.63 ' O ' HG21 ' A' ' 54' ' ' THR . 47.4 Cg_endo -74.92 159.87 97.36 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.493 -0.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -53.58 56.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.19 -113.36 5.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.911 HD12 HD12 ' A' ' 55' ' ' LEU . 8.3 mt -127.67 127.36 24.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.163 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -175.8 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.883 1.464 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.636 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -98.94 26.38 5.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -62.38 -38.99 91.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -102.09 45.94 0.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.0 110.321 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.636 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -57.14 -42.52 96.67 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.5 Cg_endo -78.0 -7.13 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.529 1.278 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 1.3 m-20 -111.36 -36.49 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 47.6 tp -79.86 -38.63 32.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 23.0 t -52.21 141.57 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.26 -18.72 55.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 4.9 ttp -81.23 132.08 35.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -1.198 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -89.91 147.59 23.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.122 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 7.3 m -87.34 156.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -98.83 -5.95 30.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.344 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -127.94 163.08 25.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.159 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -82.21 135.79 35.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.664 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.828 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -119.83 124.99 27.62 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 109.781 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.41 -177.77 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.856 1.451 . . . . 0.0 110.55 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.14 143.41 56.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.328 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 56.93 47.35 87.57 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.045 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 4.9 t -86.08 113.54 22.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -1.145 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.63 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.4 m -55.04 143.36 27.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.033 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -61.83 101.32 0.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.169 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -108.5 148.61 38.03 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 60' ' ' VAL . 47.9 Cg_endo -74.02 1.88 6.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.99 1.521 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -52.81 7.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.54 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -87.32 45.67 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.4 t -123.96 133.12 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -91.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.9 104.42 15.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.35 155.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 49.9 mm-40 -103.57 -96.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.64 52.34 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.06 -1.025 . . . . 0.0 110.346 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.67 60.08 0.51 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -82.3 59.38 4.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' SER . 33.6 m -96.67 -89.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.48 -56.65 3.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.134 -0.979 . . . . 0.0 110.112 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -73.55 -166.32 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.044 1.55 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.14 173.56 40.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.16 175.2 6.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.193 -1.181 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.253 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.317 0.58 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -64.34 -177.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -86.4 142.59 28.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.272 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.4 p -97.03 169.23 9.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.071 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 24.8 t -86.74 88.93 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.1 t -106.55 121.9 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.132 -0.98 . . . . 0.0 109.868 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.999 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.73 143.8 32.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.443 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 7.4 t-20 -73.82 -72.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -62.71 148.6 46.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.074 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.025 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -60.3 159.37 10.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.932 ' N ' HD22 ' A' ' 10' ' ' LEU . 1.8 pt -130.95 117.99 17.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.694 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 51.3 Cg_endo -80.45 50.57 3.59 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.834 1.439 . . . . 0.0 110.19 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 23.4 pt 39.18 -164.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.615 -0.678 . . . . 0.0 110.755 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' ND2' HG13 ' A' ' 13' ' ' ILE . 15.1 p30 37.88 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.568 -0.708 . . . . 0.0 110.781 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.4 m -138.45 118.67 13.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.62 155.19 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 109.992 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.39 127.0 53.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.4 OUTLIER -100.87 150.74 22.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 19' ' ' LEU . 7.5 tt -42.67 -49.53 5.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 3.6 mt -63.54 -24.78 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -84.55 -19.39 33.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.615 ' CE ' HD11 ' A' ' 37' ' ' ILE . 1.8 ptm -116.48 136.69 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.88 131.04 55.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.942 . . . . 0.0 110.2 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -74.77 97.18 3.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 139.42 40.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 3' ' ' ALA . 23.5 t -95.37 81.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.176 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -161.82 154.99 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 110.043 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.4 t -74.65 150.24 86.49 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 110.155 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.42 161.91 93.61 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.693 -2.211 . . . . 0.0 110.481 -0.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -82.65 -81.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.386 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.77 -122.54 7.44 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' HG ' ' A' ' 55' ' ' LEU . 5.5 mt -123.95 139.12 31.8 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.106 -1.232 . . . . 0.0 109.919 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.1 1.579 . . . . 0.0 110.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -108.25 41.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -65.09 -21.92 66.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.987 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 64' ' ' GLU . 4.8 mm-40 -105.32 35.5 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.785 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.7 mm -40.62 -54.94 4.78 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.531 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.39 -6.8 19.95 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.632 1.333 . . . . 0.0 110.889 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 m-20 -114.25 -18.87 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.128 -0.983 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -102.07 -34.7 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.6 t -42.69 103.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 125.12 9.38 5.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.63 144.92 26.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -1.174 . . . . 0.0 110.12 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 3.6 mt-30 -109.75 168.16 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 11' ' ' ILE . 12.4 m -116.09 174.79 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 -7.3 14.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.426 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.497 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -125.4 119.21 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.182 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -68.33 145.03 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.0 110.398 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 53' ' ' THR . 23.7 t -129.42 139.79 36.73 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 110.178 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.9 Cg_endo -73.66 89.68 0.97 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.304 1.686 . . . . 0.0 110.713 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 55.25 160.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.395 -0.816 . . . . 0.0 110.73 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 41.37 65.95 1.04 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.999 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.3 t -91.83 113.52 25.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.096 -1.238 . . . . 0.0 110.015 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 30' ' ' MET . 1.5 m -73.68 121.96 21.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.82 106.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.733 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.682 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.8 mtt -112.92 156.94 41.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.57 -2.98 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.076 1.566 . . . . 0.0 110.485 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.45 -30.41 16.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 7.5 mmt -99.16 0.31 43.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.068 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 56' ' ' MET . 55.8 t -91.36 102.23 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CD ' ' OXT' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -67.36 -58.98 3.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.042 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 14.5 p-10 -100.59 80.11 2.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' OG ' ' A' ' 69' ' ' SER . 1.6 t80 -46.49 146.12 1.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.9 . . . . 0.0 110.464 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -70.41 -175.28 0.99 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.235 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -60.03 -57.74 11.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.97 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 50.68 179.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -107.61 -60.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 0.0 110.052 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 68' ' ' THR . 8.3 t -102.71 55.61 0.77 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.931 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -95.67 -177.91 0.71 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 110.303 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 43.6 Cg_endo -72.55 -89.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.481 . . . . 0.0 110.341 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.76 -15.68 3.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.51 130.66 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 110.138 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.492 ' OXT' ' CD ' ' A' ' 61' ' ' LYS . 4.0 mptt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.238 0.542 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -88.07 154.52 20.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 110.144 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -55.98 135.9 52.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.142 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 30' ' ' MET . 46.5 t -113.31 160.24 18.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.295 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 53.3 t -92.02 97.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 54' ' ' THR . 14.9 t -117.44 125.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -72.57 137.1 45.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.581 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.6 t-20 -73.6 -44.49 56.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 110.248 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 14.6 tt0 -88.28 152.81 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.251 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -64.21 152.14 41.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -129.84 133.9 25.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.16 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.92 1.484 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.614 HG23 HG23 ' A' ' 45' ' ' VAL . 2.3 mt -116.17 170.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -0.915 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.16 11.75 4.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.3 m -115.79 140.83 48.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 110.298 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -62.16 163.22 8.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.21 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 45' ' ' VAL . 9.1 mt -112.03 120.79 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.135 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.413 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -100.11 130.93 46.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -46.29 -40.75 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.894 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.618 ' N ' HD23 ' A' ' 19' ' ' LEU . 64.3 mt -46.91 -36.71 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 62.4 mtp -86.61 -19.01 29.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 110.273 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.2 mtm -102.05 127.56 48.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.223 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.9 mtpt -114.6 170.76 8.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.142 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.42 94.45 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.2 131.71 55.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 3' ' ' ALA . 32.4 t -78.66 87.63 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.99 149.41 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 10.6 t -102.5 149.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.066 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -75.72 133.51 31.65 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.741 -2.191 . . . . 0.0 110.516 -0.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ILE . 3.9 ptp -60.21 -29.63 68.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 57.8 -85.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 55' ' ' LEU . 3.8 mt -132.74 127.67 20.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.188 -1.184 . . . . 0.0 110.202 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.28 -160.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.885 1.466 . . . . 0.0 110.405 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -100.51 28.79 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.301 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -46.08 37.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.42 24.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.7 mm -50.94 -53.1 51.4 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.844 . . . . 0.0 110.565 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.0 Cg_endo -70.78 -1.13 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.53 1.279 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' O ' ' CD ' ' A' ' 64' ' ' GLU . 35.3 m120 -113.5 -46.01 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -0.97 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -78.78 -35.4 44.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.472 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 t -44.29 107.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.045 -1.034 . . . . 0.0 110.034 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 113.76 12.28 11.67 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.1 mmm -94.49 160.69 14.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.164 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.21 147.14 34.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 17' ' ' LEU . 4.5 m -102.37 166.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 47' ' ' ARG . 55.6 p30 -101.59 -11.95 18.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.22 -0.925 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 63.4 mtt180 -130.99 156.96 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 110.22 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -86.05 141.53 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 110.279 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG22 ' SD ' ' A' ' 59' ' ' MET . 6.7 t -121.63 132.85 24.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' O ' HG22 ' A' ' 53' ' ' THR . 44.8 Cg_endo -71.9 -172.96 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.885 1.466 . . . . 0.0 110.339 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -46.36 155.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 55.89 59.99 9.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.797 ' OG1' ' HB3' ' A' ' 7' ' ' ALA . 38.8 p -78.34 95.24 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -1.077 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 6' ' ' VAL . 7.0 m -62.88 133.85 55.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.37 96.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.219 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mmm -112.65 153.64 44.96 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.155 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.23 3.16 6.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.944 1.497 . . . . 0.0 110.559 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -39.11 36.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.482 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.605 ' SD ' HG22 ' A' ' 49' ' ' VAL . 5.9 mtm -111.82 60.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.342 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG13 ' CE ' ' A' ' 43' ' ' MET . 83.9 t -129.49 104.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -81.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.518 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -93.04 93.17 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.422 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -47.76 150.22 1.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 39' ' ' ASN . 71.8 mm-40 -80.1 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.02 82.2 8.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 71' ' ' GLY . . . -85.6 65.4 3.96 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -30.3 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -1.114 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 56.8 p -110.44 -129.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -73.73 -54.26 3.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.949 -1.094 . . . . 0.0 111.041 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 69' ' ' SER . 42.8 Cg_endo -69.2 59.79 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.693 1.365 . . . . 0.0 110.924 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 66' ' ' GLY . . . -133.04 -2.37 3.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.26 135.01 46.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 0.0 110.424 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.193 179.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 160.04 26.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.256 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.93 156.89 36.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.44 149.39 42.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 34' ' ' ALA . 73.7 t -75.0 97.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.0 t -108.25 123.89 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.207 -0.933 . . . . 0.0 110.153 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -57.79 141.07 50.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.35 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t-20 -80.19 -67.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.845 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.415 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.1 tt0 -87.54 155.33 20.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.819 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -59.36 141.11 55.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 110.201 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.769 ' H ' HG23 ' A' ' 49' ' ' VAL . 10.8 mm -130.55 144.9 55.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 110.058 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 44.2 Cg_endo -71.37 -170.94 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.947 1.498 . . . . 0.0 110.261 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 47' ' ' ARG . 6.2 mt -107.27 167.47 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.92 . . . . 0.0 110.023 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 54.72 26.18 7.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.185 -0.947 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -113.72 141.33 47.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.923 . . . . 0.0 110.217 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.28 104.96 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -87.27 162.79 17.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.356 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.29 163.21 23.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.99 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -57.24 -28.66 63.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG13 ' CD1' ' A' ' 19' ' ' LEU . 3.2 mt -69.1 -17.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.67 -10.14 25.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.572 ' CE ' HD13 ' A' ' 17' ' ' LEU . 3.3 mtt -123.27 139.34 54.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.46 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -112.24 170.08 8.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.016 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.18 6.31 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 141.63 46.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.66 82.02 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.63 155.18 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 110.127 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.2 p -111.85 159.86 31.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.263 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.4 Cg_endo -76.17 132.24 26.87 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.511 -2.287 . . . . 0.0 110.477 -0.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.78 153.44 29.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -120.57 -71.4 0.31 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 57' ' ' PRO . 3.1 mt -136.2 137.93 25.94 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.3 Cg_endo -73.07 -162.97 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.067 1.562 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -111.49 38.63 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -31.46 69.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 64' ' ' GLU . 33.2 mm-40 -101.74 30.36 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.982 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.9 mm -44.89 -54.19 13.86 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -70.99 -5.77 17.71 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.632 1.333 . . . . 0.0 110.441 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' OD1' ' OE1' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -108.46 -24.83 11.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 110.127 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.2 OUTLIER -93.74 -12.86 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 109.967 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 37' ' ' ILE . 41.5 t -46.79 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.37 24.12 9.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.94 137.49 36.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.996 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 3.5 mt-30 -96.57 116.49 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.158 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.99 167.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.095 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 17.8 t30 -110.84 2.38 18.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HG2' ' CB ' ' A' ' 59' ' ' MET . 9.3 ptm180 -136.63 155.93 49.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.418 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -79.42 113.34 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.865 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.012 HG12 HG21 ' A' ' 53' ' ' THR . 19.1 m -81.87 112.33 34.05 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 51' ' ' LEU . 48.2 Cg_endo -73.6 53.05 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.887 1.467 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER 66.82 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.496 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.22 49.11 14.93 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.012 HG21 HG12 ' A' ' 49' ' ' VAL . 11.3 m -96.83 123.71 40.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -65.22 142.63 58.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 110.165 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.22 120.74 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.482 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 46.5 mmm -112.7 137.49 21.75 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.099 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.8 Cg_endo -74.2 -7.39 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.62 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -52.49 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.488 ' CB ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 mpt? -87.78 62.12 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.329 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 56' ' ' MET . 28.8 t -128.57 106.47 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.171 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 9.4 mmtt -49.92 -84.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.79 91.79 8.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CD1' ' HB2' ' A' ' 69' ' ' SER . 0.8 OUTLIER -48.66 135.82 14.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 8.2 pm0 -78.41 -37.81 43.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -0.939 . . . . 0.0 110.53 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 24.9 t70 -84.39 99.99 11.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.89 31.12 4.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -99.78 -64.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -108.82 -14.35 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.597 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -70.27 -171.47 0.16 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 47.3 Cg_endo -77.52 -4.83 15.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.778 1.409 . . . . 0.0 110.497 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.57 40.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.37 158.88 15.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 110.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.307 0.575 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -67.09 137.03 56.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.202 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 114.13 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -95.08 147.55 23.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.666 ' CG1' HD23 ' A' ' 55' ' ' LEU . 53.0 t -79.57 120.11 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 110.181 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.686 HG13 ' N ' ' A' ' 54' ' ' THR . 6.4 t -126.53 110.19 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.264 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -54.73 135.02 47.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.69 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -87.42 -71.35 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 2.2 pt20 -58.44 144.8 40.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -71.42 126.6 30.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.519 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.8 pt -126.38 144.21 48.61 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.202 -0.936 . . . . 0.0 110.363 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.91 -158.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.982 1.517 . . . . 0.0 110.349 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.698 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.8 mt -95.74 -172.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.698 ' H ' HG22 ' A' ' 13' ' ' ILE . 9.9 p30 39.86 30.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -104.83 115.81 30.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -64.25 98.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.591 HD11 HD23 ' A' ' 40' ' ' LEU . 1.7 pp -70.4 152.62 43.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.7 p -130.17 -160.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.3 mp -77.05 -43.11 35.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pt -69.18 -16.88 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -97.37 -12.73 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 110.33 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.554 ' HG3' HD13 ' A' ' 17' ' ' LEU . 39.3 mmm -124.13 107.46 11.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.153 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 21.9 mttt -99.22 144.18 28.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.76 98.56 11.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.4 mp0 -113.24 143.51 44.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 2' ' ' LYS . 8.1 p -96.75 62.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.92 -174.51 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -0.857 . . . . 0.0 110.39 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 8.8 t -100.34 150.86 37.3 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.103 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 51.0 Cg_endo -81.84 153.74 78.65 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.689 -2.213 . . . . 0.0 110.563 -0.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -82.66 159.78 22.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.866 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -113.31 0.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -99.99 141.41 22.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 44.4 Cg_endo -71.43 -164.05 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.004 1.528 . . . . 0.0 110.466 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -116.91 27.29 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.925 . . . . 0.0 110.376 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.487 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -74.46 -17.13 60.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.246 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 pm0 -102.68 1.41 34.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.282 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.889 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -41.32 -54.56 5.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.496 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -70.5 -8.11 22.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.647 1.341 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -114.39 -18.61 11.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.067 -1.021 . . . . 0.0 110.501 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.591 HD23 HD11 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -102.4 -26.71 13.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.582 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 37' ' ' ILE . 10.6 t -42.63 127.96 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.97 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.25 -0.65 47.07 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -87.53 152.24 22.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -1.123 . . . . 0.0 110.139 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -99.72 174.73 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 13' ' ' ILE . 1.6 p -113.43 163.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 1.2 m-20 -102.81 -29.34 11.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 110.611 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 17.2 mtp180 -121.74 164.99 16.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.548 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -57.56 150.1 19.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.39 -0.819 . . . . 0.0 110.508 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.119 ' CG1' HG21 ' A' ' 53' ' ' THR . 80.5 t -127.88 107.27 20.28 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.056 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.72 -171.94 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.06 1.558 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -73.89 160.69 31.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.867 . . . . 0.0 110.184 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.54 46.92 7.19 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.119 HG21 ' CG1' ' A' ' 49' ' ' VAL . 8.1 t -92.38 104.87 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.686 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -51.54 157.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.93 112.0 2.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.474 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 3.0 tpt -112.51 127.58 26.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.91 -20.55 19.5 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.857 1.451 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -65.84 -23.1 66.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 45' ' ' VAL . 33.0 mtm -113.51 49.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 61.5 t -127.09 139.53 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' CE ' ' A' ' 43' ' ' MET . 37.3 t30 -90.34 92.66 9.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 86.3 m-85 -44.69 149.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -94.58 -47.21 6.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -88.89 95.39 10.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.58 5.34 83.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -9.69 47.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.0 110.176 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 3.2 p -106.04 -178.56 3.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.282 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -50.76 -56.0 22.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.467 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.2 Cg_endo -72.21 112.54 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.916 1.482 . . . . 0.0 110.522 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.29 49.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 72' ' ' LEU . 11.3 mt -80.93 -2.71 48.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -1.115 . . . . 0.0 110.329 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.252 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.312 0.577 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 162.75 12.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -65.01 126.79 29.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.286 -0.884 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 14.4 t -95.01 166.44 11.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.88 . . . . 0.0 110.156 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ILE . 15.0 t -85.54 110.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' GLU . 3.9 t -111.32 113.2 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 110.088 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -49.09 128.78 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.695 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.2 t-20 -80.59 -55.69 4.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -91.02 177.69 6.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.068 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.9 tt -99.65 130.53 45.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.786 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -126.8 133.17 24.74 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.3 Cg_endo -73.15 56.96 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.983 1.517 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 mt 45.66 -172.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.076 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 1.6 m-20 43.63 63.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.197 -0.939 . . . . 0.0 110.114 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 m -159.61 119.09 2.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.4 85.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 43' ' ' MET . 1.2 pp -50.71 155.29 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.5 OUTLIER -130.01 159.91 35.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.178 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.1 tt -59.72 -48.42 81.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.821 ' N ' HD23 ' A' ' 19' ' ' LEU . 88.3 mt -57.7 -31.6 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.233 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -86.19 -26.15 25.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 18' ' ' THR . 15.9 mmt -110.91 131.2 55.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -107.41 165.33 11.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -102.67 99.97 9.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.2 tt0 -104.57 135.47 45.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.191 -0.943 . . . . 0.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 3' ' ' ALA . 12.2 t -85.38 71.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.9 t -133.07 160.4 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.4 t -88.13 152.22 50.21 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.8 Cg_endo -77.77 160.31 93.05 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.546 -0.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtm -82.68 101.13 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.65 -119.9 0.25 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.582 ' CD1' HD12 ' A' ' 55' ' ' LEU . 1.8 mt -99.59 129.31 29.19 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 110.02 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.71 178.38 5.82 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.889 1.468 . . . . 0.0 110.761 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.747 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -79.3 2.79 20.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.378 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 34' ' ' ALA . 8.3 tt0 -43.58 -39.86 3.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -104.92 39.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.233 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.747 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -55.99 -54.56 50.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 110.233 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -70.61 -4.48 14.68 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.661 1.348 . . . . 0.0 110.45 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -111.45 -31.18 7.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.139 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -73.5 -39.61 64.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.141 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 41' ' ' VAL . 24.4 t -45.24 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.113 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 119.57 19.27 4.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.499 ' CE ' HG11 ' A' ' 60' ' ' VAL . 2.0 ttt -98.5 144.34 27.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -1.095 . . . . 0.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.83 146.53 28.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.162 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 13' ' ' ILE . 7.5 m -104.87 153.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.08 28.71 8.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 8.8 ptt180 -151.21 137.93 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -48.95 130.86 18.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.926 HG13 ' HB ' ' A' ' 53' ' ' THR . 9.9 t -117.32 106.86 46.17 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.98 -168.14 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.539 . . . . 0.0 110.398 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -70.37 136.82 50.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 60.98 52.67 50.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.926 ' HB ' HG13 ' A' ' 49' ' ' VAL . 63.3 m -96.49 124.87 40.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -1.119 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 54' ' ' THR . 4.8 t -68.45 149.84 48.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.142 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.12 111.34 12.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.336 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtt -104.8 133.01 20.38 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . 50.0 Cg_endo -76.99 6.23 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.948 1.499 . . . . 0.0 110.677 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 -42.19 21.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.055 -1.028 . . . . 0.0 110.521 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.551 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 3.2 mmt -110.54 67.28 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.6 t -126.25 122.36 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.867 . . . . 0.0 110.141 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.3 -77.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.09 105.62 17.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 70' ' ' PRO . 59.1 m-85 -67.26 155.61 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 110.223 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -104.54 -65.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.9 -43.91 67.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.02 90.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 68' ' ' THR . 6.6 m -105.07 -83.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 110.213 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 67' ' ' THR . 59.0 m -106.96 -80.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -51.8 -61.7 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.1 Cg_endo -71.13 154.6 62.1 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.814 1.428 . . . . 0.0 110.428 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.88 162.38 31.23 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.14 109.94 4.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -1.105 . . . . 0.0 110.216 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.305 0.574 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 26' ' ' VAL . 21.4 mmtt -90.59 -16.93 27.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 26' ' ' VAL . . . -47.88 112.44 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -102.15 148.21 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.016 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 34' ' ' ALA . 59.4 t -72.86 104.33 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.173 -0.954 . . . . 0.0 110.269 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 4' ' ' SER . 4.6 t -107.97 105.87 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.048 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.56 115.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -72.75 -62.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.056 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -86.61 152.43 22.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.3 tt -59.34 142.26 52.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 11' ' ' ILE . 35.2 mm -123.04 139.18 31.01 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 -162.11 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.024 1.539 . . . . 0.0 110.329 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 6.5 mt -116.55 157.82 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 64.31 38.26 8.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 6.1 m -132.49 138.4 47.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.245 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -61.89 158.72 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.2 mt -110.01 148.16 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -129.96 132.23 46.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.767 HD23 HG21 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -49.41 -31.28 9.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' CG1' ' HB ' ' A' ' 18' ' ' THR . 13.4 pt -69.51 -16.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 109.985 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.84 -15.65 22.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 110.073 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -121.64 119.66 32.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.29 164.55 14.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 3' ' ' ALA . . . -94.75 115.63 27.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -111.28 124.88 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 2' ' ' LYS . 16.5 t -90.17 65.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.55 -173.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -111.94 153.0 44.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.086 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.33 161.93 92.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.432 -0.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.3 mtp -82.82 92.01 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.64 -144.73 0.28 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -79.63 136.24 55.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.325 -1.103 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.51 -174.26 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.002 1.527 . . . . 0.0 110.644 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.666 ' CA ' HD13 ' A' ' 37' ' ' ILE . . . -112.32 17.34 19.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.316 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -34.03 77.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.136 -0.977 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.5 mm-40 -89.24 26.41 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.666 HD13 ' CA ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.96 -40.81 81.22 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.0 111.217 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.5 Cg_endo -74.81 -18.54 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.315 1.166 . . . . 0.0 111.256 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -114.31 -11.75 12.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 110.272 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.598 HD12 ' CD ' ' A' ' 64' ' ' GLU . 9.3 tt -102.42 -44.01 5.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 HD23 ' A' ' 19' ' ' LEU . 33.3 t -41.8 148.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.434 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -16.3 61.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.6 mtp -73.27 157.01 37.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -1.107 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' THR . 4.4 mp0 -110.05 170.34 8.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 12.8 m -109.5 166.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 110.252 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.92 -4.23 18.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' HD13 ' A' ' 13' ' ' ILE . 3.4 mtp180 -143.18 168.45 19.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.192 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' CA ' HG12 ' A' ' 13' ' ' ILE . . . -78.11 139.24 39.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.899 HG13 HG21 ' A' ' 53' ' ' THR . 88.8 t -112.04 127.28 27.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.84 . . . . 0.0 110.164 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.06 -171.88 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.841 1.442 . . . . 0.0 110.523 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' A' ' 10' ' ' LEU . 2.1 mp -74.97 153.13 38.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.502 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 42.69 53.33 5.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.899 HG21 HG13 ' A' ' 49' ' ' VAL . 83.0 m -96.97 109.57 22.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.26 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.66 148.51 2.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.885 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.0 102.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.973 . . . . 0.0 110.211 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.1 mmt -111.35 149.63 40.89 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 Cg_endo -75.66 4.07 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.975 1.513 . . . . 0.0 110.798 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.32 -42.16 62.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 110.644 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.12 55.15 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 57' ' ' PRO . 5.2 t -130.28 102.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -66.88 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.06 86.87 6.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' OH ' ' O ' ' A' ' 57' ' ' PRO . 27.8 m-85 -44.29 155.58 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.598 ' CD ' HD12 ' A' ' 40' ' ' LEU . 1.4 pt-20 -76.38 -158.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.955 . . . . 0.0 110.342 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.1 m-20 -68.6 73.35 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -111.68 92.53 0.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 67' ' ' THR . 85.6 m -97.39 21.71 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.3 p -97.43 -15.06 20.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.087 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.59 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -173.54 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.046 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.0 Cg_endo -72.24 169.76 20.78 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.854 1.449 . . . . 0.0 110.227 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.35 56.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.15 75.17 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.087 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.238 0.542 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -92.92 170.4 9.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.126 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.95 127.65 35.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -102.24 137.34 40.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' ILE . 15.9 m -78.22 129.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 54' ' ' THR . 11.4 t -122.13 131.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.712 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.69 129.31 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.89 -70.82 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -80.0 160.85 25.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.9 tt -77.98 130.97 37.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 49' ' ' VAL . 4.4 mt -116.59 113.54 40.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.151 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.852 ' C ' HD13 ' A' ' 13' ' ' ILE . 46.9 Cg_endo -73.25 66.12 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.83 1.437 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.852 HD13 ' C ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 32.78 -161.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.534 0.683 . . . . 0.0 111.696 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 5.1 m120 36.52 42.17 0.19 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -147.72 124.53 11.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 119.58 7.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.812 . . . . 0.0 110.02 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 45' ' ' VAL . 60.7 mt -62.33 133.46 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.68 155.78 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -67.79 -29.1 68.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.345 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 21' ' ' MET . 1.4 pt -65.15 -19.67 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 110.139 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.523 ' N ' HG13 ' A' ' 20' ' ' ILE . 3.2 mtm -97.98 -2.25 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.9 118.57 32.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.272 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.6 pttt -114.81 142.27 46.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.56 96.32 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.957 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -112.2 133.93 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 3' ' ' ALA . 18.2 t -90.71 87.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.194 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG13 ' C ' ' A' ' 26' ' ' VAL . 18.1 m -148.76 -167.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.384 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.6 t -118.71 153.44 52.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 110.236 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -77.2 160.63 94.11 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.446 -0.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.1 mmm -82.62 71.27 9.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.154 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -55.96 -108.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.713 ' O ' HG22 ' A' ' 5' ' ' VAL . 2.6 mt -113.12 136.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -1.141 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -162.0 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.928 1.488 . . . . 0.0 110.352 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -93.69 32.91 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 110.089 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -56.86 4.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 15.5 mm-40 -88.67 33.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.43 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.9 mm -60.04 -54.71 52.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.0 Cg_endo -71.39 -8.85 24.2 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.262 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.99 -47.71 4.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 0.0 110.14 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -68.3 -41.25 81.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -54.78 119.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.7 -8.26 10.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.535 ' CE ' HG13 ' A' ' 60' ' ' VAL . 1.4 ttm -100.78 162.25 13.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -1.115 . . . . 0.0 110.218 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -109.86 138.2 46.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 17' ' ' LEU . 12.6 m -91.48 154.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -104.61 -2.73 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 4.2 mtt180 -113.14 131.35 55.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.002 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.86 132.27 9.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.384 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.641 HG13 ' CB ' ' A' ' 53' ' ' THR . 55.8 t -113.17 102.4 54.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 110.058 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.4 Cg_endo -72.03 -167.13 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.543 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.58 138.54 40.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.24 34.93 91.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.2 m -73.5 97.87 2.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -44.98 137.9 3.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.22 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -62.24 98.66 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.429 ' CG ' ' HG3' ' A' ' 59' ' ' MET . 2.9 ptm -113.11 146.5 35.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.53 -5.44 17.15 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.541 . . . . 0.0 110.458 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -76.99 -25.48 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.295 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' CB ' ' A' ' 47' ' ' ARG . 11.0 mtt -108.21 41.53 1.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG13 ' CE ' ' A' ' 43' ' ' MET . 49.7 t -130.26 104.92 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 19.2 tptm -69.16 -60.35 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -98.37 71.57 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 13.1 t80 -53.36 158.47 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mm-40 -87.84 -65.63 1.0 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.36 85.21 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.65 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.91 17.86 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.171 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -80.22 -137.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.8 -55.98 4.22 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.92 . . . . 0.0 110.594 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.5 Cg_endo -72.35 -163.89 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.912 1.48 . . . . 0.0 110.457 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.7 87.79 0.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 72' ' ' LEU . 8.9 tt -85.49 -7.68 58.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 110.342 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.227 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.253 0.549 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -93.37 142.65 27.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.69 126.55 29.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' GLU . 3.5 t -95.86 -178.48 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 55' ' ' LEU . 77.3 t -89.18 119.9 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 HG12 ' C ' ' A' ' 52' ' ' GLY . 3.5 t -126.82 101.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.219 -0.926 . . . . 0.0 110.165 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -47.15 116.48 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.106 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -79.66 -63.65 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.05 135.55 41.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.309 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.615 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.0 tt -60.45 142.06 55.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD13 HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -130.1 116.69 17.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.581 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.84 59.71 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.849 1.447 . . . . 0.0 110.1 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 13.9 pt 39.92 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.661 . . . . 0.0 110.727 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 40.34 47.25 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.467 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -156.71 110.36 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.825 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.56 118.12 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 22' ' ' MET . 5.9 mt -75.92 128.48 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -171.15 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.132 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.66 -45.96 67.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.119 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.31 -9.24 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -28.89 21.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE3' HD13 ' A' ' 17' ' ' LEU . 1.4 mmt -118.92 143.26 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 8' ' ' ASN . 8.5 mttt -115.68 166.68 11.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.735 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -100.33 79.1 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.82 152.99 20.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -90.08 14.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 25' ' ' GLU . 22.8 t -62.36 142.44 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -88.14 163.82 35.7 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.136 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.79 174.17 53.79 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.608 -2.246 . . . . 0.0 110.42 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.61 86.95 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 54' ' ' THR . . . -68.49 -150.75 0.3 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 55' ' ' LEU . 1.5 mt -76.26 137.59 68.28 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.361 -1.082 . . . . 0.0 110.063 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 170.56 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.955 1.503 . . . . 0.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.037 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -94.07 38.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.863 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -25.54 53.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.119 -0.988 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.77 ' CB ' HD23 ' A' ' 40' ' ' LEU . 7.6 mm-40 -105.09 41.97 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.63 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.037 HD11 ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -44.78 -50.18 25.62 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.89 -11.99 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.632 1.332 . . . . 0.0 110.619 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.89 -30.6 11.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.77 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -83.11 -47.07 12.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.105 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 31.4 t -43.22 104.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.056 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.825 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.07 11.98 11.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.4 ttm -83.37 134.33 34.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 144.8 31.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.339 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 14.4 m -119.11 160.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -110.85 0.63 17.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 0.0 110.359 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -120.02 122.3 40.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 110.366 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -47.12 140.61 4.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.34 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.881 HG13 HG21 ' A' ' 53' ' ' THR . 12.0 t -124.84 130.36 24.26 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.3 Cg_endo -69.6 -174.38 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.944 1.497 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -79.69 154.67 28.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 48.66 43.67 29.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.881 HG21 HG13 ' A' ' 49' ' ' VAL . 55.4 m -92.02 134.18 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -1.154 . . . . 0.0 110.266 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.438 ' CG2' ' HA3' ' A' ' 31' ' ' GLY . 7.6 m -67.38 141.24 57.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.095 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -61.93 99.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 mtp -102.83 142.51 24.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 49.3 Cg_endo -75.31 2.59 6.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.013 1.533 . . . . 0.0 110.593 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.11 -32.47 24.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.133 -0.979 . . . . 0.0 110.521 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 mtt -96.31 3.49 52.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 110.393 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.68 82.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.324 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 51.7 pttt -59.53 -37.11 77.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TYR . 18.5 p30 -100.45 74.2 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 109.852 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.539 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -46.13 175.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.51 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.601 ' HG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.12 -152.82 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.028 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 11.9 t70 -58.77 83.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.798 -1.189 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -123.74 112.98 1.96 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 31.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -1.189 . . . . 0.0 110.471 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -106.63 -23.4 12.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.6 -61.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.65 150.39 56.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.921 1.485 . . . . 0.0 110.579 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.05 -48.51 0.37 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.0 mm? -81.44 125.03 29.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.331 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 pttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.151 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.495 ' CE ' ' HB3' ' A' ' 33' ' ' PRO . 12.6 pttt -71.07 153.56 42.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -63.1 138.64 58.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.2 t -103.46 -174.48 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 22' ' ' MET . 59.3 t -92.14 123.59 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.3 t -125.86 118.47 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -55.43 138.99 44.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.103 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 4.0 t-20 -90.8 -62.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.287 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -77.36 162.43 27.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.21 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.2 tt -93.06 130.78 38.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.112 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 26.3 pt -130.03 137.87 31.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.49 71.88 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.067 1.561 . . . . 0.0 110.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.67 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.7 mt 54.65 -172.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.67 ' H ' HG22 ' A' ' 13' ' ' ILE . 49.7 m-80 42.13 -141.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 14' ' ' ASN . 42.6 m 57.48 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.27 132.28 47.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 110.065 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -75.46 143.89 42.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.5 p -123.46 160.07 27.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.217 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 19' ' ' LEU . 4.8 tt -67.58 -34.6 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.287 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' N ' HD23 ' A' ' 19' ' ' LEU . 2.3 mp -59.08 -36.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.4 mtm -93.76 6.88 46.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.374 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.567 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -98.97 123.56 43.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 147.71 34.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -105.7 75.91 1.16 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.161 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.81 20.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -81.65 91.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.181 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.31 154.92 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 8.9 t -113.13 150.02 42.31 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -76.67 171.09 69.83 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.678 -2.218 . . . . 0.0 110.433 -0.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -80.61 81.43 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.03 -112.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 55' ' ' LEU . 1.6 mt -103.87 138.89 19.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 110.153 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HB3' ' CE ' ' A' ' 2' ' ' LYS . 45.7 Cg_endo -73.19 -177.22 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.117 1.588 . . . . 0.0 110.394 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.784 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -95.82 20.99 9.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -76.61 -36.88 57.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.406 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -92.49 27.35 2.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.116 -0.99 . . . . 0.0 110.481 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -58.76 -48.75 96.26 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -77.0 -5.62 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.801 1.422 . . . . 0.0 110.44 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 17.9 m120 -114.29 -20.01 11.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.341 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -97.46 -38.63 9.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.283 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' ILE . 25.1 t -43.63 123.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.331 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.625 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 114.59 -4.83 23.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.63 152.91 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -1.135 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 51.7 mt-30 -103.75 145.36 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.106 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 10.9 m -91.98 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.105 -0.997 . . . . 0.0 110.256 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 13' ' ' ILE . 1.7 m-20 -111.12 -9.03 14.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG ' ' A' ' 59' ' ' MET . 11.6 ptm180 -119.22 171.59 8.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.341 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -78.39 123.67 27.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.815 . . . . 0.0 110.413 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 53' ' ' THR . 72.2 t -107.85 96.0 16.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.952 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.444 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.5 Cg_endo -71.97 -165.23 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -69.25 141.17 54.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 55.56 49.43 65.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.743 ' HB ' HG13 ' A' ' 49' ' ' VAL . 52.7 m -92.65 134.74 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 144.15 51.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.43 105.98 8.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 110.27 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.469 ' HG2' ' HB2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -96.85 129.66 32.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.6 Cg_endo -75.01 1.89 7.24 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.928 1.489 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HB2' ' HG2' ' A' ' 56' ' ' MET . 70.4 m-20 -81.46 -70.34 0.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 47' ' ' ARG . 4.4 mmt -72.94 66.35 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.515 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 57' ' ' PRO . 62.0 t -126.64 128.93 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -96.78 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -0.939 . . . . 0.0 110.475 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' MET . 47.4 t30 -82.11 85.99 6.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.989 -1.07 . . . . 0.0 110.23 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.435 ' HB3' ' CA ' ' A' ' 71' ' ' GLY . 40.4 t80 -48.69 169.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.07 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 1.5 tt0 -64.67 -133.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.977 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -36.38 75.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 71' ' ' GLY . . . 62.04 55.52 27.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 0.08 51.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.583 HG23 ' HD2' ' A' ' 70' ' ' PRO . 14.8 t -110.03 -28.69 8.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -176.5 -61.31 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.08 -1.012 . . . . 0.0 110.825 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 68' ' ' THR . 44.2 Cg_endo -70.57 -175.49 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.904 1.476 . . . . 0.0 110.768 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 85.21 44.34 6.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -98.55 63.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 110.15 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.171 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.8 p30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.266 0.555 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.53 -161.34 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.243 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -73.04 132.18 43.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -110.08 160.76 16.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG13 ' HB3' ' A' ' 22' ' ' MET . 67.8 t -89.44 113.72 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 23.4 t -111.68 113.34 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -54.25 118.89 4.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -76.27 -75.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -63.39 144.0 57.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.127 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.5 136.17 57.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 10.2 mt -125.02 131.59 24.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.55 -157.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.221 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.782 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.93 -179.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 8.8 p30 40.95 27.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.197 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 13' ' ' ILE . 7.7 m -126.68 114.51 18.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.136 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.31 148.56 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 157.67 45.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.402 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -102.58 169.83 8.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.72 -10.58 53.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.115 ' N ' HD13 ' A' ' 19' ' ' LEU . 34.4 mm -69.82 -21.73 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.768 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.8 mtp -98.1 10.36 40.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.309 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.545 ' HB3' HG13 ' A' ' 5' ' ' VAL . 3.6 mtp -117.69 138.81 51.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -117.11 167.05 11.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 110.121 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.45 95.21 5.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.922 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 128.35 55.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 3' ' ' ALA . 5.2 t -91.99 58.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.97 160.06 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.4 t -74.9 149.39 85.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -75.72 169.83 73.44 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.668 -2.222 . . . . 0.0 110.398 -0.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.292 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.4 -142.25 19.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.948 ' HB ' HD13 ' A' ' 55' ' ' LEU . 2.9 mt -100.83 134.06 20.72 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.121 -1.223 . . . . 0.0 110.177 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.68 -166.28 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.908 1.478 . . . . 0.0 110.367 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -98.82 34.04 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.37 -39.93 62.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.928 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HB2' HD13 ' A' ' 40' ' ' LEU . 63.7 mm-40 -103.45 32.38 3.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.6 mm -53.04 -46.91 97.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.3 Cg_endo -73.88 -1.17 10.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.486 1.256 . . . . 0.0 110.447 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.73 -37.97 4.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.897 . . . . 0.0 110.101 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.3 -41.6 27.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.7 t -44.66 125.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.92 9.09 59.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 64' ' ' GLU . 23.4 ttt -101.35 158.34 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.18 . . . . 0.0 110.245 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 158.38 18.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' MET . 26.8 m -107.09 168.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -110.76 5.78 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.301 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 10.2 mmt85 -138.09 135.53 35.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.74 146.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.367 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.837 HG13 HG21 ' A' ' 53' ' ' THR . 95.2 t -129.97 120.84 19.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.713 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.6 Cg_endo -73.48 -160.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.871 1.458 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -85.32 157.13 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.83 39.47 4.9 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.837 HG21 HG13 ' A' ' 49' ' ' VAL . 95.8 m -85.25 109.17 18.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -1.105 . . . . 0.0 110.399 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.9 m -47.41 149.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.948 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -62.1 103.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -97.85 133.89 22.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.133 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 46.4 Cg_endo -73.05 -34.88 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.955 1.503 . . . . 0.0 110.66 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 10.6 p-10 -57.18 -17.08 9.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 0.0 110.552 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 6.8 mtt -108.85 25.27 11.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.41 129.22 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 110.314 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -69.42 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -78.08 83.99 4.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 57' ' ' PRO . 88.8 m-85 -44.26 129.21 6.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 40' ' ' LEU . 2.9 mp0 -92.27 -37.47 12.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 17.5 p-10 -67.33 97.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.66 147.99 12.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 68' ' ' THR . 51.8 m -81.01 -92.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -1.149 . . . . 0.0 110.197 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' THR . 18.3 m -110.16 107.64 17.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.132 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.558 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 172.2 -58.98 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.2 Cg_endo -73.01 -22.41 19.57 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.021 1.537 . . . . 0.0 110.503 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.68 159.79 13.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.07 -6.95 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.165 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.349 0.595 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.85 140.17 38.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -63.0 148.31 48.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.2 p -103.8 161.1 14.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.245 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.97 101.67 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.38 107.17 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -62.61 116.84 5.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 1.1 t-20 -79.92 -57.51 3.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 110.063 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 1.2 tp-100 -59.93 117.92 5.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.594 ' HB3' HD12 ' A' ' 51' ' ' LEU . 1.7 pt? -62.08 129.21 39.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 HG21 ' A' ' 15' ' ' THR . 4.7 pt -130.06 146.04 59.8 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 0.0 109.941 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 45.1 Cg_endo -71.78 -94.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.0 110.158 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 45' ' ' VAL . 1.5 mt -152.01 -179.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.038 . . . . 0.0 109.972 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' H ' HG22 ' A' ' 13' ' ' ILE . 11.4 m-80 51.75 21.12 1.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.795 HG21 HD12 ' A' ' 11' ' ' ILE . 8.0 t -99.75 128.65 45.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.44 100.62 4.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.065 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' MET . 3.8 mt -49.0 124.24 8.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.276 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.33 158.01 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tt -49.6 -46.01 48.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.437 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.7 mt -51.4 -47.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' HB3' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -78.67 -25.2 44.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.43 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 20.8 mtm -85.35 110.51 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.34 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.29 151.16 25.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.151 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 95.76 7.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.23 123.49 50.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.134 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 3' ' ' ALA . 3.9 t -77.47 98.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.53 139.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.2 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -77.68 151.59 80.02 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.5 Cg_endo -75.52 156.34 99.29 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.433 -0.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -82.56 86.4 6.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -144.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.1 mt -72.56 130.45 85.7 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 109.966 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.54 -179.44 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.984 1.518 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -94.2 2.15 55.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.6 -21.72 7.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HB2' HD13 ' A' ' 40' ' ' LEU . 7.1 mm-40 -104.64 23.5 13.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.418 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -42.27 -53.02 9.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.3 Cg_endo -72.01 -6.0 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.641 1.337 . . . . 0.0 110.757 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' ND2' ' OD2' ' A' ' 65' ' ' ASP . 4.2 m120 -113.84 -20.25 11.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.6 mp -85.85 -43.88 12.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.6 t -44.8 122.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.11 37.19 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.467 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.64 136.95 34.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 110.181 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -106.7 129.27 54.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 13' ' ' ILE . 33.3 m -84.88 163.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -111.3 5.46 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 27.3 mtt180 -144.03 167.55 22.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -68.54 144.68 54.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.598 HG13 ' CB ' ' A' ' 53' ' ' THR . 30.2 t -126.52 126.07 24.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.24 -176.67 2.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.521 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.91 137.96 42.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 60.68 51.15 60.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.598 ' CB ' HG13 ' A' ' 49' ' ' VAL . 96.5 m -96.3 129.52 43.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -1.128 . . . . 0.0 110.185 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 m -66.54 136.39 55.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.36 105.67 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -109.39 154.59 42.15 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.333 -0.855 . . . . 0.0 110.1 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.4 1.6 7.21 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.002 1.527 . . . . 0.0 110.56 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -45.57 31.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.428 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.508 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 14.6 mtm -107.58 57.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.351 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 56' ' ' MET . 98.8 t -125.03 84.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 14.7 tptm -52.85 -65.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -99.59 86.39 3.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.882 . . . . 0.0 110.218 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.56 150.34 12.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.472 ' CD ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -73.75 -162.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' ND2' ' A' ' 39' ' ' ASN . 44.3 p-10 -73.0 75.11 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.32 127.86 4.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -77.18 55.93 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -1.099 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 171.37 8.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -45.77 -55.69 12.03 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 110.455 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -73.42 88.48 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.925 1.487 . . . . 0.0 110.436 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.79 37.46 1.86 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 73.06 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.244 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.131 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.214 0.531 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 16.96 9.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.906 . . . . 0.0 110.221 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.97 111.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.2 t -99.75 164.88 11.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 32' ' ' ILE . 32.2 t -73.05 117.91 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG12 ' HA2' ' A' ' 52' ' ' GLY . 17.0 t -127.34 99.35 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.737 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -59.28 141.34 54.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.945 . . . . 0.0 110.2 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.85 -63.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.21 145.12 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.009 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -59.55 150.0 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 11' ' ' ILE . 17.3 mt -130.13 137.54 31.1 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.04 166.32 30.37 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.498 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.603 HG22 HG23 ' A' ' 45' ' ' VAL . 11.2 pt -81.49 175.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 3.0 m120 58.23 16.77 4.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 110.22 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.406 ' C ' ' HG2' ' A' ' 44' ' ' GLN . 1.6 m -125.12 105.94 9.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -59.32 122.63 14.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.75 155.46 23.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.912 . . . . 0.0 110.392 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 22' ' ' MET . 1.7 m -106.69 169.83 8.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 22' ' ' MET . 1.5 pp -65.0 -33.1 75.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.462 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.54 -20.34 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.173 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.99 -14.99 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.533 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.494 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.69 127.68 51.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.96 . . . . 0.0 110.495 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 31.4 mttt -121.07 179.37 4.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.985 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.89 99.36 9.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.21 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 tp10 -101.8 145.33 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.0 t -90.4 76.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 155.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.6 t -101.37 150.01 36.83 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.151 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.19 176.29 44.42 Favored 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.708 -2.205 . . . . 0.0 110.513 -0.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -73.55 -139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 30' ' ' MET . . . 151.89 -117.01 0.79 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.971 HD12 HD12 ' A' ' 55' ' ' LEU . 2.9 mt -110.56 118.97 47.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 50.1 Cg_endo -75.26 5.08 4.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.852 1.448 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . 71.92 20.69 4.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.457 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.0 -26.51 4.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.006 -1.059 . . . . 0.0 109.729 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB2' ' OE1' ' A' ' 64' ' ' GLU . 43.3 mm-40 -105.16 60.47 0.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.851 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -56.89 -41.48 91.57 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 111.058 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -75.69 -9.74 19.9 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.288 1.152 . . . . 0.0 110.508 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -114.47 -26.88 7.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD12 ' OE1' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.44 -45.6 15.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.329 -0.857 . . . . 0.0 110.398 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 40' ' ' LEU . 20.3 t -42.22 115.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.605 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.93 0.27 25.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.25 136.98 48.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -1.16 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 26.8 mt-30 -110.1 163.9 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 13' ' ' ILE . 7.2 m -120.54 170.29 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 47.7 p-10 -110.81 -8.73 14.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 1.8 mtt180 -126.33 121.21 31.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -48.23 140.44 7.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 53' ' ' THR . 67.2 t -127.46 135.14 26.99 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . 45.1 Cg_endo -73.13 -161.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.79 168.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.15 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.698 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 46.8 80.89 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.794 HG23 HG11 ' A' ' 49' ' ' VAL . 64.0 m -94.31 90.54 6.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.114 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 5.6 m -66.88 133.1 49.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.234 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.971 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.44 88.63 0.91 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.3 mtm -111.82 164.27 15.54 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.33 10.15 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -54.44 5.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.805 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.519 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 36.5 mtt -113.04 69.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.853 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 63' ' ' TYR . 12.8 t -130.31 103.4 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.044 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 46' ' ' ASN . 5.6 mtpt -55.6 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.277 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.88 84.0 4.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 110.352 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 70' ' ' PRO . 2.1 t80 -46.57 144.89 2.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' OE1' HD12 ' A' ' 40' ' ' LEU . 1.9 pt-20 -68.64 -151.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.25 -0.906 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.3 m-20 -59.39 -46.4 88.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.67 146.96 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -87.42 -30.91 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -1.184 . . . . 0.0 110.079 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -93.06 23.46 4.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.15 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.602 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 4.3 t 54.55 44.12 1.64 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 111.001 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -74.26 103.54 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.692 1.364 . . . . 0.0 110.415 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.02 128.47 3.56 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -77.41 -21.46 53.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.31 0.576 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.48 ' HE3' ' SD ' ' A' ' 30' ' ' MET . 3.2 ptpt -70.97 146.92 49.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.33 36.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -106.28 152.99 22.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 36.8 t -87.44 96.1 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.329 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG12 ' C ' ' A' ' 52' ' ' GLY . 2.9 t -107.04 112.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.037 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.007 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -62.72 136.82 58.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.72 -54.91 5.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -83.21 146.27 28.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.9 pt? -63.57 145.85 54.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' VAL . 6.6 mt -130.37 136.3 28.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.51 -162.43 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.934 1.491 . . . . 0.0 110.273 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 14' ' ' ASN . 5.7 mt -104.3 -173.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.693 ' H ' HG22 ' A' ' 13' ' ' ILE . 9.4 p30 40.08 28.11 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 110.571 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 13' ' ' ILE . 25.6 m -120.57 121.64 38.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.247 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -57.17 162.66 2.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 110.14 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mt -121.13 144.79 48.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -116.95 169.17 9.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.2 tt -60.66 -50.26 74.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.622 ' N ' HD23 ' A' ' 19' ' ' LEU . 58.0 mt -55.39 -38.74 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -13.89 60.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.41 112.01 20.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.6 mttt -106.0 145.0 31.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -94.0 102.63 14.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 4' ' ' SER . 41.6 tt0 -108.16 133.56 52.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.8 t -85.71 74.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 m -143.41 -173.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.2 t -109.52 150.66 41.49 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.153 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -76.16 168.11 78.21 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.613 -2.244 . . . . 0.0 110.465 -0.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.48 ' SD ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -76.95 -112.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.098 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.79 -134.58 10.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.8 mt -99.12 125.69 40.75 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -1.122 . . . . 0.0 110.03 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.29 -170.96 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.931 1.49 . . . . 0.0 110.547 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.17 16.76 17.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -47.76 84.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 mm-40 -89.36 47.78 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.108 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 5.9 tp -69.79 -30.68 2.14 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 111.719 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.4 Cg_endo -80.15 -7.93 14.13 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 122.813 0.901 . . . . 0.0 109.928 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -108.55 -35.14 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -79.63 -44.5 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 110.049 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 29.2 t -48.57 103.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 110.013 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.17 -0.55 19.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.567 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.52 157.09 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 110.053 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB2' ' HG3' ' A' ' 61' ' ' LYS . 18.0 mt-30 -109.54 171.13 7.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.332 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.55 HG13 HD11 ' A' ' 17' ' ' LEU . 11.7 m -116.93 156.66 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -103.5 5.06 36.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.4 mtt180 -136.39 159.91 40.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 150.59 48.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.13 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.954 ' CG1' HG21 ' A' ' 53' ' ' THR . 21.8 t -129.31 111.66 18.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -164.19 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.886 1.466 . . . . 0.0 110.432 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 3.2 mp -79.38 163.58 24.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.066 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.21 28.97 0.91 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.007 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -65.14 124.52 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.391 -1.064 . . . . 0.0 110.417 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 140.52 40.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.66 101.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.106 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtt -111.55 153.81 44.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.989 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.4 -0.26 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.958 1.504 . . . . 0.0 110.493 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.31 -46.82 21.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 110.319 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 1.4 mpt? -97.92 50.0 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG13 ' CE ' ' A' ' 43' ' ' MET . 39.4 t -121.4 103.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.905 . . . . 0.0 110.17 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -50.27 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.184 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 64' ' ' GLU . 17.1 p-10 -95.57 92.25 6.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.945 . . . . 0.0 110.246 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -44.69 135.73 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.278 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 77.8 mm-40 -88.12 -75.5 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.68 76.84 2.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.82 52.9 0.63 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 p -90.01 25.56 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -1.138 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 p -101.95 -11.76 18.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.561 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -178.64 -59.76 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.11 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.3 Cg_endo -72.74 -90.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.0 -79.86 1.13 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.59 86.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -1.091 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.214 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.276 0.56 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -67.33 175.82 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.54 141.72 28.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -121.29 153.79 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG11 ' SD ' ' A' ' 22' ' ' MET . 25.3 t -87.44 127.49 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.272 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 54' ' ' THR . 11.9 t -130.09 121.63 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.89 142.15 6.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 10.1 t-20 -89.09 -59.33 2.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -97.07 148.26 23.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.702 ' C ' HD23 ' A' ' 10' ' ' LEU . 7.7 tt -64.75 131.84 47.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 10' ' ' LEU . 7.6 pt -130.18 130.28 23.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.134 -0.979 . . . . 0.0 110.644 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.3 Cg_endo -74.86 71.03 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.941 1.495 . . . . 0.0 109.841 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 32.4 pt 39.39 -164.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.732 -0.605 . . . . 0.0 110.692 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER 65.56 -62.31 0.23 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -58.36 106.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.349 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.78 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.179 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -106.75 129.4 54.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.28 -0.887 . . . . 0.0 110.095 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -125.75 156.12 39.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 110.349 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -46.25 -62.49 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mt -59.82 -13.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.462 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -91.53 -47.38 7.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.435 ' SD ' HG11 ' A' ' 5' ' ' VAL . 17.5 ptt? -104.84 148.26 26.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -120.17 160.76 22.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.86 103.2 14.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.25 137.58 50.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 52.2 t -96.42 80.41 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.258 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 28' ' ' THR . 14.0 p -174.2 168.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.511 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.3 t -82.9 151.75 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -75.89 133.13 29.93 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.602 -0.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.403 ' C ' ' HG1' ' A' ' 54' ' ' THR . 19.5 mtp -82.46 175.29 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.88 -132.77 1.4 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -90.23 136.85 28.17 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.213 -1.169 . . . . 0.0 109.924 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.56 -170.79 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.003 1.528 . . . . 0.0 110.676 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.75 31.73 5.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.275 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -48.04 82.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.016 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 74.3 mm-40 -100.0 65.65 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 38' ' ' PRO . 8.7 tp -70.62 -29.87 1.65 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 111.929 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.0 Cg_endo -78.01 -7.19 16.26 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.704 0.844 . . . . 0.0 109.944 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.27 -19.6 11.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -88.34 -40.96 13.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.161 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 37' ' ' ILE . 90.8 t -46.53 105.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.54 10.0 8.91 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.21 121.48 23.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.46 148.47 22.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.1 m -117.98 155.87 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.11 5.05 19.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 66.4 mtt-85 -120.99 127.0 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.233 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.78 133.44 8.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 110.496 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.958 HG13 HG21 ' A' ' 53' ' ' THR . 24.8 t -117.9 121.54 31.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -72.6 -174.93 1.62 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.96 1.505 . . . . 0.0 110.513 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.89 156.16 39.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.556 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 46.83 44.77 18.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.958 HG21 HG13 ' A' ' 49' ' ' VAL . 4.9 m -93.47 114.64 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.147 . . . . 0.0 110.126 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.589 ' N ' HG13 ' A' ' 6' ' ' VAL . 2.4 t -57.79 144.15 39.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -64.11 108.85 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.515 ' CG ' ' HD2' ' A' ' 57' ' ' PRO . 20.7 ttm -103.18 145.62 30.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.515 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 47.0 Cg_endo -74.13 -0.5 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.075 1.566 . . . . 0.0 110.613 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -41.35 13.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.16 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 8.9 mtm -90.9 45.38 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 56' ' ' MET . 3.0 t -129.96 126.03 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.107 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -74.38 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' TYR . 7.6 p30 -100.05 104.25 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -47.22 176.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.331 -0.855 . . . . 0.0 110.334 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -144.51 0.05 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.101 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 8.1 p-10 -75.18 80.37 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.75 97.48 0.11 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -101.65 39.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -1.111 . . . . 0.0 110.406 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -72.76 -11.83 60.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.955 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -177.31 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 48.3 Cg_endo -73.61 98.12 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.715 1.376 . . . . 0.0 110.399 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.43 -31.25 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -65.54 96.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -1.181 . . . . 0.0 110.287 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.127 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.241 0.543 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 175.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.72 128.68 35.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' MET . 3.7 p -116.12 145.48 43.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.151 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 39.2 t -86.48 135.24 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -129.47 124.37 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -57.46 115.52 2.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.85 -51.88 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 110.19 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -84.32 142.7 30.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.173 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -74.11 127.94 34.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.2 pt -130.49 119.91 18.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -73.53 64.66 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.881 1.464 . . . . 0.0 110.544 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.4 pt 39.32 -164.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' ILE . 71.6 m-20 40.8 32.29 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.885 . . . . 0.0 110.456 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 m -145.53 107.2 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.144 -0.973 . . . . 0.0 110.339 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' CA ' ' HG2' ' A' ' 44' ' ' GLN . . . -59.59 163.84 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.06 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.883 HD13 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -141.12 157.71 44.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -119.42 -157.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.845 . . . . 0.0 110.188 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.1 mp -69.27 -62.28 1.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -47.52 -23.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.348 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -72.34 -57.32 4.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.091 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.883 ' HG3' HD13 ' A' ' 17' ' ' LEU . 1.4 mtt -107.88 141.11 39.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.22 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.08 108.35 19.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.338 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.04 145.1 41.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 80.3 t -86.86 97.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -168.04 154.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.211 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -77.78 159.15 77.09 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.44 -163.68 3.31 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.72 -2.2 . . . . 0.0 110.547 -0.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 4' ' ' SER . 9.3 mtt -81.82 -73.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.31 -144.1 33.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -103.56 130.76 22.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 110.142 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 -172.3 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.327 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.025 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -97.7 32.33 2.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -76.83 -28.81 55.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.92 40.78 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.025 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -59.66 -51.91 77.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.6 Cg_endo -73.43 -1.81 11.21 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.741 1.39 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 89.8 m-20 -114.26 -42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.227 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' MET . 66.7 tp -73.42 -42.07 62.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' ILE . 40.4 t -46.8 116.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.35 10.89 50.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 ttt -104.64 147.73 27.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.535 ' HG2' ' CA ' ' A' ' 16' ' ' ALA . 44.1 mt-30 -110.06 164.53 12.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.281 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 8.4 m -115.66 164.33 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.98 -1.45 16.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB2' ' CB ' ' A' ' 59' ' ' MET . 14.5 mtt180 -118.22 131.58 56.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.12 127.28 8.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.56 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 53' ' ' THR . 22.4 t -116.15 108.75 45.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -73.37 -176.09 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.987 1.519 . . . . 0.0 110.466 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.05 134.34 48.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 70.42 46.28 49.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.739 ' CB ' HG13 ' A' ' 49' ' ' VAL . 67.1 m -96.63 113.82 25.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -1.153 . . . . 0.0 110.386 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 53.1 m -54.52 142.51 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.304 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -63.11 100.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.44 ' HB2' ' HG3' ' A' ' 59' ' ' MET . 2.9 mmt -98.47 139.08 20.91 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 -2.26 11.84 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.059 1.557 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.35 -37.79 14.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.519 ' CB ' ' HB2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -73.05 -14.2 61.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 25.4 t -85.35 118.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.32 -74.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' CE ' ' A' ' 43' ' ' MET . 71.6 m-20 -100.58 93.48 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE1' ' OG1' ' A' ' 67' ' ' THR . 9.4 t80 -46.65 165.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 23.6 mm-40 -89.8 -171.37 3.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 63.75 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 0.0 110.143 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.04 -71.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 63' ' ' TYR . 2.2 m -79.76 108.82 13.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 68' ' ' THR . 5.3 t -72.1 69.2 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.576 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -171.68 -62.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.383 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -71.51 65.08 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.833 1.438 . . . . 0.0 110.432 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.09 97.41 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.74 -55.31 3.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 110.159 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.154 179.96 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.261 0.553 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.67 131.45 49.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.73 154.11 22.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 7.3 p -121.41 168.29 11.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.8 t -88.38 117.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 0.0 110.279 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.64 123.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -52.61 118.99 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -74.54 -68.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -89.27 147.0 24.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 10' ' ' LEU . 1.8 pt? -67.74 134.19 50.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.291 -0.881 . . . . 0.0 110.512 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.479 HG13 ' HB ' ' A' ' 49' ' ' VAL . 2.0 pt -120.38 156.12 55.66 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.339 -0.851 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.59 -158.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.07 1.563 . . . . 0.0 109.991 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 4.5 mt -103.25 166.73 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.878 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER 58.99 25.84 14.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.359 179.953 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -102.93 124.26 48.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.735 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -63.12 157.36 22.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.645 HD12 ' CB ' ' A' ' 43' ' ' MET . 2.5 mt -93.81 131.65 38.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' SD ' ' A' ' 22' ' ' MET . 1.1 p -116.8 172.92 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.163 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.45 -55.57 15.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' MET . 5.8 pt -48.32 -24.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 4.6 mtt -97.55 3.9 50.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -117.34 96.47 5.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -112.8 127.05 56.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -80.05 99.3 7.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.211 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.19 139.44 46.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.892 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -79.64 93.69 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.1 146.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.504 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.9 t -87.86 149.43 45.78 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.233 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.89 176.14 45.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.691 -2.212 . . . . 0.0 110.503 -0.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' SER . 3.2 mtp -75.87 -57.86 3.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 110.318 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.75 -145.67 35.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 55' ' ' LEU . 2.3 mt -88.3 124.86 65.5 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -1.208 . . . . 0.0 109.928 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.83 -163.48 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.465 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -103.15 25.48 9.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -38.99 69.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' OE2' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.76 38.77 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.877 ' O ' HG23 ' A' ' 41' ' ' VAL . 8.6 mm -65.98 -45.24 63.52 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.6 Cg_endo -75.38 0.75 8.69 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.513 1.27 . . . . 0.0 110.456 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 3.6 t-20 -111.18 -33.95 6.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -83.13 -29.6 28.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.9 t -43.1 116.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 110.73 7.54 25.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.645 ' CB ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -94.55 132.64 39.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 110.298 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.735 HE21 ' HB2' ' A' ' 16' ' ' ALA . 10.7 mp0 -93.73 150.08 20.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 9.6 m -87.72 174.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -102.93 -25.49 13.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.576 -179.67 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 7.6 ptm180 -135.05 179.88 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 110.209 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 13' ' ' ILE . . . -70.47 149.9 46.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.631 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 53' ' ' THR . 19.5 t -127.92 124.79 23.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.874 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.48 -159.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.961 1.506 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 1.1 mp -90.61 166.43 13.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.42 33.1 2.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.793 HG21 HG13 ' A' ' 49' ' ' VAL . 92.3 m -78.13 98.44 5.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -1.175 . . . . 0.0 110.075 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.0 m -44.84 148.33 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.84 88.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.163 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 156.04 43.68 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.059 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' CB ' ' HB3' ' A' ' 70' ' ' PRO . 45.3 Cg_endo -72.34 -0.54 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.925 1.487 . . . . 0.0 110.598 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -52.01 65.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.75 ' SD ' HG22 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -109.99 33.07 4.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 63' ' ' TYR . 12.4 t -128.59 109.47 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.541 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG3' ' CE ' ' A' ' 43' ' ' MET . 11.1 ptmt -65.8 -149.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 109.835 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 62.6 t30 -64.88 84.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 109.92 179.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 60' ' ' VAL . 36.5 p90 -83.45 -159.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 55.8 mm-40 -63.44 -124.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 8.3 p-10 -58.61 94.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 110.63 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 63' ' ' TYR . . . -149.14 54.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -107.93 -12.92 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -1.133 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' A' ' 69' ' ' SER . 6.0 t -70.74 -6.01 34.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.589 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER 174.57 -62.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -72.37 -158.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 110.137 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 62' ' ' ASN . . . 86.32 -83.94 1.59 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.6 mm? -65.93 143.52 57.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 tttp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.261 -179.904 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.292 0.568 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.23 172.73 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.32 115.21 7.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' MET . 2.8 t -102.66 141.46 35.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' HB ' HD21 ' A' ' 55' ' ' LEU . 23.5 t -73.25 105.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.726 HG12 ' HA2' ' A' ' 52' ' ' GLY . 18.0 t -123.62 117.7 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.211 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -71.87 144.56 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.091 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 17.7 t-20 -83.49 -52.81 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 110.503 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.49 142.5 32.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 110.358 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.747 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -60.38 138.57 57.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.091 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HB1' ' A' ' 7' ' ' ALA . 4.0 mt -129.33 133.76 25.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.16 -179.13 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.971 1.511 . . . . 0.0 110.395 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.861 HG22 HG23 ' A' ' 45' ' ' VAL . 2.6 pt -93.67 -174.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.63 16.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -130.58 118.33 20.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.069 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.9 160.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.474 ' CD2' HG21 ' A' ' 11' ' ' ILE . 6.2 mt -118.7 145.26 45.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -119.89 -166.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 110.281 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 19' ' ' LEU . 27.9 mt -76.61 -52.32 9.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mt -50.37 -21.76 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.163 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.65 -44.83 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -108.22 120.13 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.266 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -111.11 165.88 11.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 98.42 8.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.01 160.1 17.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.11 50.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 t -117.22 166.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 48.2 p -81.99 159.75 64.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.0 Cg_endo -74.83 -167.49 5.65 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.536 -0.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' SER . 51.6 mtp -81.64 -46.47 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.474 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.73 -156.35 0.43 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.02 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.6 mt -90.5 142.22 27.94 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.22 -1.164 . . . . 0.0 110.409 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 47.4 Cg_endo -73.56 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.086 1.571 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -107.4 42.63 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.174 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.61 -42.43 51.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -103.26 36.91 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -53.04 -54.08 48.22 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.469 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.1 Cg_endo -70.9 -5.88 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.702 1.369 . . . . 0.0 110.709 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.13 -19.05 11.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.955 . . . . 0.0 110.355 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.4 tp -88.14 -29.54 20.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 47.3 t -46.1 116.32 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 109.31 10.59 23.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.29 135.45 33.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 1.5 mt-30 -106.38 138.69 42.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.345 -0.847 . . . . 0.0 110.285 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 13' ' ' ILE . 18.3 m -99.49 170.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.358 -0.839 . . . . 0.0 110.114 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.631 ' C ' HG21 ' A' ' 13' ' ' ILE . 25.9 t30 -110.67 -4.85 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' N ' HG21 ' A' ' 13' ' ' ILE . 6.0 mtt180 -129.05 126.43 39.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.43 143.19 56.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.325 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 53' ' ' THR . 80.9 t -129.97 135.7 27.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -70.09 -173.78 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.961 1.506 . . . . 0.0 110.427 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -43.05 164.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.955 179.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.726 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 51.82 61.31 6.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.963 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 53.5 m -84.39 87.72 7.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -1.093 . . . . 0.0 110.628 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.5 m -71.83 121.17 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.634 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -61.37 114.43 3.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.83 -179.276 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.657 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.8 mtm -113.67 156.72 43.18 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.0 1.02 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.97 1.511 . . . . 0.0 110.669 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' MET . 33.7 p30 -91.88 -21.88 20.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.018 . . . . 0.0 110.74 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 44.8 mtt -112.0 -7.75 14.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 56' ' ' MET . 10.8 t -101.14 91.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.082 -1.011 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -48.85 39.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -95.04 74.37 3.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 110.043 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 1.02 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -54.12 -165.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.87 . . . . 0.0 110.549 -179.793 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -104.99 -172.39 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.09 66.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.356 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -114.87 114.44 3.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 m -88.56 59.44 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -1.14 . . . . 0.0 110.062 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -106.71 -40.28 5.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.15 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.548 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 171.9 -59.25 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.129 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.4 Cg_endo -72.93 55.6 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.974 1.513 . . . . 0.0 110.461 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.77 57.8 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -45.56 10.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -1.148 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.247 0.546 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -87.01 136.08 33.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.211 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.56 138.59 39.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -121.98 162.72 20.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.466 HG12 HD23 ' A' ' 55' ' ' LEU . 53.0 t -72.97 102.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.496 HG21 HG12 ' A' ' 27' ' ' VAL . 14.3 t -113.7 103.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' MET . . . -46.67 121.67 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 m120 -72.96 -64.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.877 . . . . 0.0 110.27 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tp60 -81.58 149.13 28.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 110.227 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -59.54 133.62 56.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.956 179.863 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.803 HD12 ' SD ' ' A' ' 21' ' ' MET . 13.1 mm -121.75 136.08 25.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.73 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.058 1.557 . . . . 0.0 110.191 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.035 HG22 HG23 ' A' ' 45' ' ' VAL . 4.2 pt -120.1 -174.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -0.994 . . . . 0.0 110.485 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m120 56.53 16.54 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.06 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 19.1 m -123.05 154.33 38.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.958 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -77.03 163.77 26.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.405 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -111.63 122.62 48.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 179.93 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.1 170.96 7.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -67.24 -54.7 18.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.324 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.952 HD13 ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -51.27 -21.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.803 ' SD ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -80.97 -48.38 12.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 9.4 ptt? -110.98 141.09 44.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -0.961 . . . . 0.0 110.191 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 21.0 mmtt -120.92 172.63 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.91 92.74 7.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.248 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.74 141.37 32.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -84.29 76.92 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 HG21 ' A' ' 6' ' ' VAL . 10.1 p -133.71 150.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.128 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -111.39 161.01 27.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.221 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.74 153.29 99.09 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.704 -2.207 . . . . 0.0 110.479 -0.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.5 ptt? -80.48 125.87 30.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.48 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -90.54 -100.71 1.17 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' LEU . 1.5 mt -109.06 131.67 21.66 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 110.137 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.21 177.84 6.75 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.902 1.475 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.698 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . -92.56 24.15 3.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.92 -77.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 pm0 -78.18 55.19 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.057 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.904 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -70.73 -30.5 1.79 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.376 -0.827 . . . . 0.0 111.764 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.904 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.5 Cg_endo -78.73 -4.46 14.07 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 122.686 0.835 . . . . 0.0 110.047 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 1.8 m120 -112.52 -37.95 4.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.99 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -76.25 -44.39 37.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.1 t -45.71 109.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 122.76 6.75 7.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.543 ' CE ' ' HG3' ' A' ' 64' ' ' GLU . 1.6 ttt -91.69 157.54 16.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.168 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' THR . 42.5 mt-30 -110.14 136.26 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.035 HG23 HG22 ' A' ' 13' ' ' ILE . 15.9 m -88.64 171.63 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.53 -15.85 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.0 111.255 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.6 ptm85 -128.16 150.73 49.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.88 -1.137 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.53 156.44 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.446 -0.784 . . . . 0.0 110.752 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.998 HG13 HG21 ' A' ' 53' ' ' THR . 91.6 t -130.17 127.55 22.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.57 -168.96 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.832 1.438 . . . . 0.0 110.509 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -80.17 155.95 27.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.188 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 43.66 43.94 6.64 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.998 HG21 HG13 ' A' ' 49' ' ' VAL . 84.9 m -86.33 128.28 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -69.39 141.23 54.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.78 110.4 2.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.481 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -109.42 159.93 29.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 46.2 Cg_endo -73.97 0.12 8.76 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.089 1.573 . . . . 0.0 110.648 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD1' ' CG ' ' A' ' 59' ' ' MET . 1.3 p30 -91.7 -26.2 18.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.653 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.818 ' O ' HG12 ' A' ' 45' ' ' VAL . 3.4 mtt -97.2 32.31 2.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 110.077 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 t -130.47 125.97 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.552 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -75.39 -80.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 109.84 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 8.0 p30 -100.74 101.44 12.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -45.78 167.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.799 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 40' ' ' LEU . 2.1 mp0 -83.05 -68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.94 -30.47 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.46 51.99 23.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 68' ' ' THR . 38.6 m -72.23 -89.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.087 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -94.17 5.46 51.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 179.766 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -111.27 -178.44 0.54 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 44.7 Cg_endo -72.86 117.4 5.11 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.917 1.482 . . . . 0.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.6 48.78 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' LEU . 2.1 tp -89.84 130.4 36.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -1.119 . . . . 0.0 110.164 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.956 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.314 0.578 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -102.26 170.35 8.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 25' ' ' GLU . . . -76.9 150.77 35.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 40.4 t -116.53 164.56 14.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.3 t -92.54 102.36 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.347 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' HA2' ' A' ' 52' ' ' GLY . 3.4 t -123.71 121.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -70.21 138.85 52.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.115 -0.99 . . . . 0.0 109.998 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.45 -52.49 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.977 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' LEU . 20.7 tt0 -82.2 162.71 22.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.75 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 pp -67.63 142.97 56.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.466 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' CB ' ' A' ' 7' ' ' ALA . 14.7 mt -131.25 127.34 21.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.219 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.69 -159.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.79 1.416 . . . . 0.0 110.037 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 45' ' ' VAL . 36.1 pt -112.44 -165.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.115 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 p30 39.9 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 110.412 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 47.7 m -130.38 136.6 49.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.55 130.62 34.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -103.34 161.48 13.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -130.07 -175.6 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.629 HD21 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -51.88 -34.28 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -50.06 -60.01 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.76 30.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.317 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.96 115.32 21.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.297 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.81 124.81 45.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.917 . . . . 0.0 110.215 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.96 97.22 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 26.6 pt-20 -113.13 157.86 21.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 23.0 t -98.51 57.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -126.06 154.65 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 62.7 p -79.14 158.95 73.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.48 176.67 42.57 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.722 -2.199 . . . . 0.0 110.5 -0.167 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.3 mtt -77.13 -107.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.209 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.72 -129.37 9.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.04 132.45 22.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.239 -1.153 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.83 -158.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.962 1.506 . . . . 0.0 110.304 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -115.09 30.92 7.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.433 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -77.41 -15.92 59.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.033 -1.042 . . . . 0.0 109.605 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.927 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.3 mp0 -105.02 24.66 11.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.574 -0.704 . . . . 0.0 109.966 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.4 mm -41.7 -53.5 7.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.701 -179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -71.24 -4.65 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.564 1.297 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.32 -36.23 4.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' HB2' ' A' ' 36' ' ' GLU . 2.7 mp -79.8 -42.47 24.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.259 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.7 t -42.18 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.367 -0.833 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.67 -6.5 13.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.51 148.96 30.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -1.202 . . . . 0.0 110.207 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' THR . 31.5 mt-30 -109.36 172.25 6.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 13' ' ' ILE . 4.8 m -119.53 172.54 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.471 ' O ' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -111.16 -12.81 14.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' CD ' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -123.88 140.61 52.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.34 144.34 27.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 110.083 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.894 HG11 ' HA ' ' A' ' 53' ' ' THR . 34.1 t -130.41 130.23 22.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.1 Cg_endo -77.01 99.77 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.174 1.618 . . . . 0.0 110.331 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER 58.4 136.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 110.597 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 64.33 75.79 0.34 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.894 ' HA ' HG11 ' A' ' 49' ' ' VAL . 23.4 p -96.63 96.37 8.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.428 HG21 ' HG2' ' A' ' 29' ' ' PRO . 9.1 m -63.47 136.43 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.273 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.957 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -79.52 103.96 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 110.123 179.973 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.0 ptp -109.48 143.58 28.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.031 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HB3' ' OH ' ' A' ' 63' ' ' TYR . 47.4 Cg_endo -74.25 0.29 8.68 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.035 1.545 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' HB3' ' SD ' ' A' ' 56' ' ' MET . 50.4 t0 -83.09 -47.2 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.43 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG3' ' CD ' ' A' ' 47' ' ' ARG . 25.7 mmt -99.58 47.52 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.341 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 56' ' ' MET . 36.1 t -126.51 91.7 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.091 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 62' ' ' ASN . 28.9 pttt -71.42 -32.18 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 61' ' ' LYS . 61.1 t30 -96.29 52.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -44.59 152.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.985 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.48 -125.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 66' ' ' GLY . 44.4 m-20 -59.34 -43.67 92.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.139 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 46.22 96.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -96.4 -7.35 35.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -1.188 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -96.59 -161.56 0.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -41.11 -55.94 4.56 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 179.97 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -73.88 153.5 47.76 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.963 1.507 . . . . 0.0 110.437 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.449 ' HA2' ' HA3' ' A' ' 66' ' ' GLY . . . 176.24 -57.05 0.11 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -154.06 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -1.126 . . . . 0.0 110.174 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.6 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.37 152.49 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.433 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -87.79 113.59 23.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.895 . . . . 0.0 110.215 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -88.52 129.76 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 5.0 t -78.13 125.69 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 0.0 110.273 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 54' ' ' THR . 15.2 t -118.39 118.68 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.96 . . . . 0.0 110.281 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -44.97 117.58 1.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.5 t30 -73.58 -52.76 12.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 tp60 -95.2 148.03 22.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.2 tt -59.62 119.77 8.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 9' ' ' GLN . 1.0 OUTLIER -129.74 134.33 26.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.2 Cg_endo -72.96 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.963 1.507 . . . . 0.0 110.124 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 14' ' ' ASN . 3.1 mt -146.9 -171.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.212 -0.93 . . . . 0.0 109.99 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.667 ' H ' HG22 ' A' ' 13' ' ' ILE . 9.9 p30 36.26 48.83 0.6 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.63 . . . . 0.0 110.999 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -123.93 103.34 8.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 110.154 179.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -65.53 144.44 57.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 43' ' ' MET . 1.4 mp -98.64 140.48 32.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.3 p -129.34 84.5 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.637 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' MET . 7.7 tp 52.15 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.332 -0.855 . . . . 0.0 110.808 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' THR . 3.3 mt -41.41 -53.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.634 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 mtt -65.58 -13.09 58.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.26 119.87 39.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.26 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 19.9 mmtm -118.86 90.83 3.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.96 95.04 2.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.433 HG22 ' CA ' ' A' ' 3' ' ' ALA . 28.9 t -78.69 71.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 28' ' ' THR . 63.6 t -142.07 161.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -75.29 151.89 85.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -77.19 -174.93 15.72 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.558 -2.268 . . . . 0.0 110.455 -0.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.2 mpt? -76.63 -109.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.919 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 97.52 -145.29 17.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 HD12 ' A' ' 55' ' ' LEU . 23.3 mm -74.52 112.3 16.75 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.344 -1.092 . . . . 0.0 110.398 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.714 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.7 Cg_endo -75.14 -1.86 11.8 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.928 1.488 . . . . 0.0 110.303 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 33' ' ' PRO . . . 69.49 24.64 5.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.82 -44.93 63.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 61.0 mm-40 -99.4 67.43 1.54 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.89 HG22 ' HD3' ' A' ' 38' ' ' PRO . 1.9 tp -70.08 -30.97 2.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 112.137 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.89 ' HD3' HG22 ' A' ' 37' ' ' ILE . 45.2 Cg_endo -74.59 -8.25 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 N-CA-C 109.93 -0.835 . . . . 0.0 109.93 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -114.18 -31.1 6.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.368 -0.833 . . . . 0.0 109.529 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.1 tp -69.82 -36.99 76.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 110.059 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 37' ' ' ILE . 22.7 t -43.53 103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.6 24.52 7.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.649 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.4 ttm -95.92 138.97 32.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -1.093 . . . . 0.0 110.241 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 44.7 mt-30 -106.72 151.45 25.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 13' ' ' ILE . 4.7 m -95.91 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.06 16.71 20.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' N ' HG23 ' A' ' 13' ' ' ILE . 20.8 mtt180 -144.1 161.96 37.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.38 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -72.52 134.95 45.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 21.3 t -128.65 128.25 23.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.63 -158.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.825 1.434 . . . . 0.0 110.445 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -87.37 155.31 20.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 110.822 -179.438 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.502 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 41.57 40.67 2.94 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.2 m -96.97 125.2 41.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.556 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 m -63.47 108.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 HG13 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -70.38 122.93 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 110.514 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.442 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 7.6 mtt -100.48 171.23 5.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 109.923 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 45.4 Cg_endo -73.04 -0.65 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.905 1.476 . . . . 0.0 110.55 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.93 -43.65 52.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.323 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG2' ' HB2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -92.13 60.7 3.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.259 -179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 63' ' ' TYR . 25.4 t -130.16 95.57 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -94.49 82.51 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.835 ' CD2' HG11 ' A' ' 60' ' ' VAL . 7.8 t80 -62.31 139.34 58.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.75 -56.64 4.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -96.05 83.17 3.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 70' ' ' PRO . . . -109.4 91.66 0.66 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -107.6 -38.75 5.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -1.142 . . . . 0.0 110.303 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 81.9 p -93.24 -137.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.79 -58.53 3.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.549 -179.798 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -71.07 118.49 5.72 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.907 1.477 . . . . 0.0 110.563 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.3 13.48 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -178.4 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.218 0.532 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.88 133.22 41.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.18 125.8 25.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.931 . . . . 0.0 110.356 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 p -121.76 149.78 42.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 110.006 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.82 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 56.0 t -83.13 113.0 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 54' ' ' THR . 5.1 t -121.09 104.59 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.065 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -42.54 131.53 3.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.412 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -88.75 -63.49 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -73.16 141.72 47.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.067 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -59.35 131.11 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mt -122.96 140.1 32.74 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.56 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.087 1.572 . . . . 0.0 110.366 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 14' ' ' ASN . 2.3 mt -110.63 -175.77 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.7 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 13' ' ' ILE . 10.0 p30 39.35 29.98 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.613 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 13' ' ' ILE . 52.4 m -122.02 133.34 54.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.11 151.93 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.233 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 43' ' ' MET . 1.4 pp -119.96 157.05 29.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.56 159.06 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -50.06 -43.34 51.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.533 ' N ' HD23 ' A' ' 19' ' ' LEU . 17.8 mt -53.97 -29.98 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 mtt -85.77 -21.28 28.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.319 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.504 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.94 106.66 17.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.442 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -106.17 118.13 35.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.55 109.92 14.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.143 -0.973 . . . . 0.0 110.306 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.18 152.16 25.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.4 t -90.69 63.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 26' ' ' VAL . 11.5 m -147.75 -178.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -94.84 162.15 26.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.61 165.41 85.73 Favored 'Cis proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.404 -0.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.0 OUTLIER -61.66 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 -149.28 28.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.719 HD13 ' OH ' ' A' ' 63' ' ' TYR . 4.9 mt -104.28 136.74 19.14 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.04 -159.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.999 1.526 . . . . 0.0 110.377 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -116.53 46.61 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.444 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 6.2 pt-20 -74.27 -27.04 60.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.11 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 6.9 mm-40 -104.55 36.18 2.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.679 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.9 mm -54.79 -51.1 81.93 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 110.8 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.8 Cg_endo -71.02 -5.1 16.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.389 1.205 . . . . 0.0 110.715 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 63.1 m-80 -114.2 -50.18 2.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.367 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -68.27 -35.21 77.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 17.2 t -53.74 122.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.96 -14.91 31.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.594 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -85.0 159.78 20.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.146 . . . . 0.0 110.161 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -105.42 178.3 4.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 15.5 m -116.78 173.01 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 59' ' ' MET . 59.2 t30 -111.06 -9.04 14.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 13' ' ' ILE . 0.9 OUTLIER -130.56 172.06 12.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -0.923 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -76.09 151.55 37.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 53' ' ' THR . 37.3 t -127.95 108.0 20.13 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.801 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.9 Cg_endo -71.61 -165.26 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.032 1.543 . . . . 0.0 110.461 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.6 150.08 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.404 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.12 49.19 24.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.48 ' CB ' HG13 ' A' ' 49' ' ' VAL . 16.7 m -91.69 120.09 32.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.473 ' N ' HG13 ' A' ' 6' ' ' VAL . 10.7 t -61.13 149.38 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -68.38 105.73 2.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.6 mtm -110.34 139.35 21.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 110.277 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 46.5 Cg_endo -73.9 -4.11 14.88 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.989 1.521 . . . . 0.0 110.631 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.91 -20.85 48.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' ASN . 3.8 mtt -105.23 12.37 31.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.232 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . 21.3 t -106.44 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 46' ' ' ASN . 73.0 mttt -43.9 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.091 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 63' ' ' TYR . 4.1 m120 -100.78 104.43 15.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.088 -1.007 . . . . 0.0 110.085 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.719 ' OH ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -44.33 165.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.155 179.956 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 2.4 mm-40 -64.36 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.116 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -48.75 79.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.82 -22.64 16.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 30.2 2.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 110.183 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' SER . 20.7 m -100.73 -60.0 1.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER 173.27 -59.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.203 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.17 90.99 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.887 1.467 . . . . 0.0 110.373 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.44 120.32 0.76 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -28.13 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -1.164 . . . . 0.0 110.319 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.326 0.584 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.38 131.97 47.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.35 143.1 24.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -119.38 125.89 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.971 ' O ' HD23 ' A' ' 55' ' ' LEU . 53.8 t -65.97 124.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.295 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' C ' ' A' ' 53' ' ' THR . 25.6 t -116.99 123.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -46.57 134.89 9.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.258 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' CG ' ' HE2' ' A' ' 23' ' ' LYS . 57.3 t30 -90.37 -69.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.4 144.54 30.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -62.92 135.82 57.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.063 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.535 HG22 HG21 ' A' ' 15' ' ' THR . 1.4 pt -124.9 119.72 25.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' ILE . 45.4 Cg_endo -72.09 57.79 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.847 1.446 . . . . 0.0 110.251 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.8 mt 49.64 179.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.705 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' H ' HG22 ' A' ' 13' ' ' ILE . 2.8 m-80 43.76 26.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 110.241 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.535 HG21 HG22 ' A' ' 11' ' ' ILE . 17.8 m -119.92 103.05 9.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.862 . . . . 0.0 110.1 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . . . -57.86 152.89 15.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 110.405 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.849 HD11 HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -112.93 156.35 23.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.835 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.646 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -128.76 -169.83 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 7.7 mp -64.55 -46.83 81.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.14 -20.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.05 3.61 54.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.938 ' SD ' HG11 ' A' ' 5' ' ' VAL . 1.7 mmm -112.47 106.18 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' CG ' ' A' ' 8' ' ' ASN . 6.9 mtmt -105.98 115.33 30.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.03 98.07 4.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.9 142.05 46.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 26' ' ' VAL . 56.0 t -88.0 85.84 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 110.18 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.52 153.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.4 p -91.69 157.6 41.52 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.89 -172.7 11.34 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.573 -2.261 . . . . 0.0 110.486 -0.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 ptp -82.4 -151.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.334 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 33' ' ' PRO . . . 154.69 -127.46 2.1 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 20.1 mm -91.12 108.86 31.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.279 -1.13 . . . . 0.0 110.277 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 31' ' ' GLY . 50.2 Cg_endo -76.5 50.41 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.936 1.492 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 45.67 24.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.33 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' OE1' HG21 ' A' ' 67' ' ' THR . 36.1 tt0 -77.01 -33.81 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.88 39.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.906 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 2.4 mm -54.75 -57.2 20.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.77 -1.78 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.652 1.343 . . . . 0.0 110.744 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.94 -51.21 2.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.396 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.22 -39.79 78.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.331 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 18' ' ' THR . 58.4 t -52.6 103.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.223 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -35.1 2.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.51 159.58 18.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -1.123 . . . . 0.0 110.286 -179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.551 ' HG3' ' CA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -110.26 -169.28 1.44 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.821 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 13' ' ' ILE . 3.7 m -120.19 172.24 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.19 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 2.8 m120 -111.18 0.47 16.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.411 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -123.31 142.54 50.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -62.2 129.14 39.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 HG21 ' A' ' 53' ' ' THR . 54.6 t -121.12 123.67 27.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.606 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.9 Cg_endo -72.05 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.849 1.447 . . . . 0.0 110.513 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -86.5 144.09 27.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG12 ' A' ' 6' ' ' VAL . . . 61.31 39.92 97.89 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.859 HG21 HG13 ' A' ' 49' ' ' VAL . 79.5 m -88.75 145.73 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -1.174 . . . . 0.0 110.106 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.3 m -72.45 143.97 48.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.7 mm? -69.93 80.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.419 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -94.06 143.82 27.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.915 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.19 -1.42 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.96 1.505 . . . . 0.0 110.377 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 18.7 p-10 -70.44 -12.01 61.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.28 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -108.75 -25.06 11.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.83 105.56 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.181 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -63.11 1.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 110.196 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' TYR . 10.2 m120 -95.04 86.41 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.37 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -44.46 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 0.0 110.168 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 43' ' ' MET . 33.4 mm-40 -79.93 -97.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.56 -32.14 18.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 0.0 110.223 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' CA ' ' HA3' ' A' ' 71' ' ' GLY . . . 102.85 105.02 2.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.676 HG21 ' OE1' ' A' ' 35' ' ' GLU . 1.7 m -107.69 -54.76 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -1.133 . . . . 0.0 110.436 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.432 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 60.8 p -101.98 -157.18 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -44.63 -57.27 6.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 69' ' ' SER . 44.8 Cg_endo -71.49 79.93 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.999 1.526 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA3' ' CA ' ' A' ' 66' ' ' GLY . . . -173.67 47.88 0.15 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -94.24 -40.9 9.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.31 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.197 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -80.58 -172.96 3.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.724 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -87.7 138.05 31.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -120.42 146.91 45.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.237 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 45.0 t -77.39 111.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.38 124.5 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -69.5 119.89 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.838 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.9 p-10 -74.97 -43.57 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -96.56 135.64 38.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.182 179.887 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.827 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.98 153.82 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.674 -179.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.772 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -130.45 126.8 22.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.995 . . . . 0.0 110.07 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' ILE . 50.6 Cg_endo -76.85 47.97 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.831 1.437 . . . . 0.0 110.82 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.578 HD11 ' H ' ' A' ' 48' ' ' ALA . 2.2 mt 51.72 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 44.98 31.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -126.32 105.17 8.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -54.95 138.85 42.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.212 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -92.26 139.49 30.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 22' ' ' MET . 0.8 OUTLIER -108.16 167.92 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 19' ' ' LEU . 6.1 tt -58.84 -42.78 90.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.947 . . . . 0.0 110.266 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 21' ' ' MET . 18.1 pt -67.03 -41.37 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.911 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.515 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.774 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.495 ' O ' ' CG ' ' A' ' 22' ' ' MET . 6.0 ptt? -115.38 123.8 49.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -121.15 159.94 24.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.0 101.78 13.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.362 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -113.07 136.91 52.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 3' ' ' ALA . 54.9 t -91.64 88.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.99 -173.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 29' ' ' PRO . 23.9 m -116.31 146.03 36.4 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 110.013 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.707 ' HA ' HG23 ' A' ' 28' ' ' THR . 50.2 Cg_endo -75.58 -178.51 23.9 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.788 -2.172 . . . . 0.0 110.509 -0.174 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -159.51 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.14 -148.48 10.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 55' ' ' LEU . 2.1 mt -85.11 131.48 48.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.294 -1.121 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.26 178.99 5.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.63 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -98.48 25.79 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 18.2 pt-20 -76.96 -18.68 58.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 110.206 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 10.2 mm-40 -104.85 48.81 0.83 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.286 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -54.53 -50.59 84.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.943 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -74.53 -0.58 9.93 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.818 1.43 . . . . 0.0 110.703 -179.594 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.29 -28.03 7.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.932 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.732 HD21 ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -89.13 -38.09 14.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 110.371 -179.857 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 37' ' ' ILE . 54.9 t -49.08 91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.919 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.64 28.39 1.59 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.446 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -98.93 131.5 44.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -1.182 . . . . 0.0 110.256 179.957 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -109.46 126.77 53.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 13.2 m -83.71 168.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HA ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 t30 -110.96 1.64 17.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -134.84 133.65 39.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.578 ' H ' HD11 ' A' ' 13' ' ' ILE . . . -50.55 140.58 13.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.336 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.086 HG13 HG21 ' A' ' 53' ' ' THR . 55.1 t -130.09 135.94 28.25 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.071 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.2 Cg_endo -72.13 -173.26 1.04 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.717 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -76.5 162.36 27.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.91 . . . . 0.0 110.536 -179.717 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.24 44.67 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.086 HG21 HG13 ' A' ' 49' ' ' VAL . 82.1 m -96.43 119.86 35.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -1.212 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.486 HG21 ' O ' ' A' ' 29' ' ' PRO . 22.3 p -54.75 127.3 27.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.732 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -61.68 113.34 2.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.177 -179.933 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.0 ptp -106.99 151.69 40.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.46 1.59 7.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.135 1.597 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' CE ' ' A' ' 59' ' ' MET . 1.8 t70 -76.71 -43.88 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 110.558 -179.752 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 9.2 mmt -105.5 63.54 0.69 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.361 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 63' ' ' TYR . 55.2 t -130.17 99.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -61.02 -71.62 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -90.8 75.37 6.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.118 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 25.6 t80 -51.71 145.36 9.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.381 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' N ' ' HE3' ' A' ' 43' ' ' MET . 7.4 pm0 -64.42 -141.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.18 78.24 0.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.85 100.05 0.74 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -81.6 4.51 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -1.162 . . . . 0.0 110.248 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -76.67 -160.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.182 179.965 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -42.4 -56.42 5.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.301 179.867 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.1 Cg_endo -72.46 162.49 41.29 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.972 1.512 . . . . 0.0 110.493 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.64 61.58 0.62 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.25 -44.82 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.0 110.254 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.182 179.982 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.284 0.564 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 128.35 35.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 164.97 19.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -123.17 158.6 30.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.77 114.72 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG22 HG22 ' A' ' 54' ' ' THR . 4.2 t -126.49 122.09 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.014 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -56.67 127.62 32.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.45 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 24.2 t-20 -77.45 -48.68 16.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.09 158.29 15.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.132 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.02 132.49 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.014 HD11 ' HB1' ' A' ' 7' ' ' ALA . 1.1 mp -117.65 122.67 30.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 46.0 Cg_endo -71.57 -95.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.749 1.394 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.775 HD13 HD22 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -162.02 -173.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.095 179.527 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.775 HD22 HD13 ' A' ' 13' ' ' ILE . 9.9 p30 40.21 31.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 11' ' ' ILE . 5.7 t -124.11 138.2 54.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -71.55 154.97 41.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 11' ' ' ILE . 51.3 mt -120.97 104.42 9.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.886 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.46 HG23 HG13 ' A' ' 41' ' ' VAL . 3.4 m -96.81 167.89 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.978 179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.96 -25.15 67.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.6 mt -69.63 -19.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.6 ttp -97.73 -20.88 17.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.443 ' HG3' ' HA ' ' A' ' 7' ' ' ALA . 1.4 mtt -118.91 143.51 46.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.112 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.75 172.09 7.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.07 102.05 14.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.3 tp10 -112.03 128.58 56.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.5 p -91.95 77.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.38 166.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.18 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 13.9 t -92.83 144.83 29.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' HG21 ' A' ' 54' ' ' THR . 49.4 Cg_endo -75.55 157.21 99.12 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.416 -0.248 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.3 mtt -72.79 -26.25 61.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.77 -132.02 43.99 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.875 ' HB ' HD13 ' A' ' 55' ' ' LEU . 3.8 mt -106.28 134.79 19.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.287 -1.125 . . . . 0.0 110.223 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -170.52 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.942 1.496 . . . . 0.0 110.407 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.47 46.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.272 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.05 -40.07 54.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.903 ' HB2' HD12 ' A' ' 40' ' ' LEU . 14.9 mm-40 -104.91 31.2 4.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.981 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.2 mm -42.68 -54.27 8.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 46.4 Cg_endo -71.53 -2.22 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.615 1.323 . . . . 0.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.473 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.02 -32.15 6.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.894 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -85.55 -24.6 27.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.351 -179.848 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 37' ' ' ILE . 24.8 t -42.58 119.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 108.2 8.78 28.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD23 ' A' ' 40' ' ' LEU . 18.9 ttp -72.34 134.66 45.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -1.194 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' THR . 16.2 mt-30 -110.01 125.59 53.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 17' ' ' LEU . 3.7 m -79.99 154.97 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 110.141 179.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -108.26 10.1 27.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.405 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.57 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.52 137.44 26.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -45.06 128.19 7.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.018 HG13 HG21 ' A' ' 53' ' ' THR . 47.5 t -111.85 134.75 21.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.56 ' C ' ' HG1' ' A' ' 53' ' ' THR . 47.6 Cg_endo -74.12 -171.57 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.023 1.539 . . . . 0.0 110.477 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.31 164.01 22.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 110.281 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 43.43 30.32 1.31 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.018 HG21 HG13 ' A' ' 49' ' ' VAL . 72.9 m -76.15 104.16 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -1.196 . . . . 0.0 110.401 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -52.39 153.69 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.053 179.808 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.875 HD13 ' HB ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -62.16 100.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.314 -179.841 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.7 mtm -113.55 145.34 33.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.435 -0.791 . . . . 0.0 110.287 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.62 0.18 9.02 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.001 1.527 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.97 -55.36 14.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' A' ' 47' ' ' ARG . 46.8 mtt -103.35 40.72 1.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 110.431 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 93.6 t -130.47 133.34 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -142.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' C ' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-20 -76.39 79.61 3.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 110.297 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CD2' ' N ' ' A' ' 64' ' ' GLU . 18.0 p90 -84.62 -167.96 2.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.172 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' N ' ' CD2' ' A' ' 63' ' ' TYR . 47.5 tp10 -71.94 76.79 0.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 70' ' ' PRO . 10.1 t0 -99.31 -64.74 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.46 -126.94 1.06 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.534 ' HA ' HD23 ' A' ' 72' ' ' LEU . 15.8 m -108.92 -70.72 0.79 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 110.477 -179.77 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -18.29 59.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -72.51 -179.16 0.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.956 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.9 Cg_endo -72.55 84.67 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.958 1.504 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -165.7 -36.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -67.7 113.76 5.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.144 . . . . 0.0 110.252 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.3 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.143 179.949 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.195 0.521 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 140.97 58.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.01 138.26 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.3 p -123.74 157.5 33.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.655 HG12 HD23 ' A' ' 55' ' ' LEU . 61.6 t -80.1 124.28 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -129.2 107.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 179.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -46.65 116.18 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 51' ' ' LEU . 52.6 t30 -77.79 -46.52 21.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.15 136.22 33.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 10' ' ' LEU . 1.7 pt? -78.12 131.68 37.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.34 -179.891 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.534 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 10.4 pt -128.9 155.73 79.06 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.872 . . . . 0.0 109.989 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.0 Cg_endo -72.85 -96.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.89 1.468 . . . . 0.0 110.159 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.563 ' HA ' ' CG2' ' A' ' 45' ' ' VAL . 3.1 mt -152.24 172.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.961 -1.087 . . . . 0.0 109.889 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.81 21.38 5.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 110.353 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.3 m -97.91 117.07 31.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.03 157.55 5.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 41' ' ' VAL . 30.1 mt -98.43 111.16 23.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.296 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 p -95.41 155.91 16.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -28.08 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.378 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mt -68.64 -36.88 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.922 . . . . 0.0 110.235 -179.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 42.3 mtp -88.74 11.82 16.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.612 ' HA ' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -112.35 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -109.59 112.83 25.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.18 105.53 3.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.326 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -109.68 155.37 21.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.157 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 26' ' ' VAL . 10.8 t -91.65 24.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 28' ' ' THR . 31.7 t -95.68 148.38 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -77.34 168.25 29.55 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.955 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' CG ' HG21 ' A' ' 54' ' ' THR . 48.8 Cg_endo -73.77 -170.58 7.97 Favored 'Cis proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.624 -2.24 . . . . 0.0 110.417 -0.134 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 31' ' ' GLY . 5.3 ptt? -76.56 -34.82 58.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.248 180.0 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 30' ' ' MET . . . 45.56 -131.45 9.42 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 55' ' ' LEU . 4.7 mt -112.26 137.35 21.49 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.276 179.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 -166.86 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.008 1.531 . . . . 0.0 110.479 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.804 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -116.84 33.83 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -41.35 85.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 73.4 mm-40 -104.78 32.53 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.804 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 5.3 mm -42.88 -51.32 12.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.599 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -72.04 -1.4 9.97 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.483 1.254 . . . . 0.0 110.681 -179.776 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -113.75 -38.08 4.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 179.933 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -75.26 -34.12 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.911 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 37' ' ' ILE . 21.6 t -46.96 139.61 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -11.69 54.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.4 tpp -82.01 132.52 35.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.116 . . . . 0.0 110.209 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -92.94 -179.41 5.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.17 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 17.0 m -118.42 163.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.343 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -111.19 3.42 18.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.542 -179.91 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 2.7 mmt180 -139.18 -176.75 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 0.0 110.41 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -79.8 140.83 36.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.25 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 53' ' ' THR . 4.5 t -119.28 116.49 33.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.336 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -76.89 152.01 35.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 48.45 42.01 25.81 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.685 HG21 HG13 ' A' ' 49' ' ' VAL . 61.4 m -82.36 115.02 21.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.568 HG21 ' CG ' ' A' ' 29' ' ' PRO . 11.2 t -54.74 155.63 4.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -71.98 103.63 3.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.924 . . . . 0.0 110.229 179.971 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.483 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -112.17 145.14 32.2 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.997 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -12.24 25.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.982 1.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -62.17 -56.76 15.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.288 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.529 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 5.9 mtt -93.45 39.81 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 56' ' ' MET . 53.3 t -130.44 126.87 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 110.233 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -161.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 110.056 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.557 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 27.3 p-10 -69.2 79.81 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 3.4 p90 -82.2 -170.11 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -63.76 145.46 55.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.075 -1.016 . . . . 0.0 111.205 -178.679 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 10.3 t0 -98.17 79.06 2.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.577 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.22 -87.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.259 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -52.39 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.793 -179.286 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 21.2 p -69.72 -174.07 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.386 -179.611 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 6.5 t -119.02 41.16 0.39 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 111.564 -179.456 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 69' ' ' SER . 43.8 Cg_endo -72.33 -169.44 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.569 1.299 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 62' ' ' ASN . . . 66.5 33.79 85.74 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -70.01 -43.98 70.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -1.158 . . . . 0.0 110.205 179.935 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.277 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.235 0.541 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -99.17 170.71 8.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -85.38 151.24 24.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.99 135.7 54.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 22' ' ' MET . 94.7 t -78.88 121.82 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.2 t -127.59 116.66 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.104 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -67.16 122.35 17.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.133 179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -78.11 -42.29 32.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.429 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -88.05 143.53 27.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.263 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.6 tt -63.92 143.93 57.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 mt -130.38 112.53 16.77 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.278 -0.889 . . . . 0.0 110.401 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.35 59.56 5.45 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.787 1.414 . . . . 0.0 110.408 179.615 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 42.3 pt 38.19 -163.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.557 0.694 . . . . 0.0 111.182 -179.834 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.1 m-80 42.46 27.75 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.821 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.3 m -140.93 121.32 14.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -58.18 171.31 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.917 . . . . 0.0 110.161 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mt -113.8 138.03 50.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -124.47 -179.67 4.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.262 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.19 -53.53 16.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.36 -15.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.229 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtt -82.45 -47.02 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.539 ' HG3' HG13 ' A' ' 5' ' ' VAL . 1.7 ptt? -119.91 149.42 42.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -111.9 169.33 8.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.03 92.29 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.213 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.52 137.64 50.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 26' ' ' VAL . 76.3 t -90.73 60.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 28' ' ' THR . 55.3 t -132.7 170.23 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.102 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.854 HG22 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -79.93 151.86 73.85 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.998 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.854 ' HA ' HG22 ' A' ' 28' ' ' THR . 48.8 Cg_endo -75.69 178.95 32.65 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.678 -2.217 . . . . 0.0 110.535 -0.227 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -74.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.89 -166.88 53.09 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.772 HD11 ' OH ' ' A' ' 63' ' ' TYR . 16.2 mm -63.19 133.64 95.52 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.155 -1.203 . . . . 0.0 110.005 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 43.6 Cg_endo -72.75 -174.5 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.851 1.448 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.57 23.41 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.731 -179.496 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -77.33 -19.08 56.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.11 10.03 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.789 . . . . 0.0 110.116 -179.52 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 41' ' ' VAL . 5.8 mm -41.9 -55.33 6.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 110.552 -179.79 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 45.1 Cg_endo -70.51 -4.55 14.76 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.584 1.307 . . . . 0.0 110.72 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.8 m120 -114.18 -25.96 8.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 110.457 -179.835 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -91.27 -25.29 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.863 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 37' ' ' ILE . 33.1 t -42.99 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 121.01 15.15 4.83 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.423 ' HE3' ' HG2' ' A' ' 64' ' ' GLU . 36.3 tpp -87.75 136.5 32.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -1.169 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -102.54 149.09 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 6.2 m -113.6 161.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 2.3 t30 -111.32 -1.82 15.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 179.792 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 3.5 mtt180 -115.12 137.98 51.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.253 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.53 145.13 1.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.333 -179.516 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.066 ' CG1' HG21 ' A' ' 53' ' ' THR . 2.8 t -126.05 110.82 24.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.086 -179.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' O ' ' HB ' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -176.34 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.929 1.489 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' LEU . 1.6 mp -71.45 157.23 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.046 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 42.82 32.21 1.33 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.8 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.104 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 6.7 t -69.16 138.44 54.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.463 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 12.6 t -85.21 142.28 29.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.611 179.255 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 mm? -61.67 117.94 6.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.1 mtt -111.99 150.02 41.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.922 . . . . 0.0 110.338 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 -16.83 24.31 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.021 1.537 . . . . 0.0 110.364 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.73 -16.31 42.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.472 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 mtm -111.78 38.24 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.957 . . . . 0.0 110.182 -179.917 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.575 HG11 ' CE1' ' A' ' 63' ' ' TYR . 77.5 t -130.33 114.91 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.07 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -57.12 -99.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.374 -179.725 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 62' ' ' ASN . 22.0 p-10 -100.34 96.98 7.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.99 -1.068 . . . . 0.0 110.182 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -49.24 146.7 3.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 110.26 179.936 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 72.9 mm-40 -76.72 -56.05 4.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 42.0 p-10 -84.22 55.13 3.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.029 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.44 67.54 3.69 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -93.49 -20.27 20.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.054 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.52 -158.81 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -40.93 -55.78 4.47 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.899 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' SER . 47.5 Cg_endo -73.53 138.13 26.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.019 1.536 . . . . 0.0 110.395 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -25.98 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.18 27.13 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.232 179.989 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.21 0.528 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 144.24 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.26 130.88 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 159.67 15.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.15 127.38 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.249 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.3 t -124.44 127.32 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB3' ' H ' ' A' ' 53' ' ' THR . . . -45.56 127.79 7.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 110.19 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 28.0 t30 -89.57 -58.22 2.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.204 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -91.88 145.65 24.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.0 tt -64.2 109.64 1.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 pt -123.6 137.36 28.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.069 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.014 1.534 . . . . 0.0 110.14 179.845 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.752 HG22 HG23 ' A' ' 45' ' ' VAL . 2.0 pt -146.41 -164.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.128 -0.982 . . . . 0.0 110.197 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.8 p30 40.37 27.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 0.0 110.561 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ILE . 20.3 m -116.61 111.71 20.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -62.88 133.99 55.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.771 HD22 ' SD ' ' A' ' 22' ' ' MET . 47.9 mt -81.18 145.64 30.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 110.061 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -129.93 137.5 50.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 110.322 179.915 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 20' ' ' ILE . 3.6 tt -43.76 -43.67 6.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.516 ' N ' HD23 ' A' ' 19' ' ' LEU . 8.1 mt -67.55 -21.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.358 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -97.54 -23.36 16.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.771 ' SD ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -116.42 120.0 37.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.34 147.95 27.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 110.164 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.0 116.41 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.32 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.33 151.2 30.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.37 78.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.288 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.8 149.91 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.141 179.931 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 43.6 p -97.7 159.96 29.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.85 152.88 97.42 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.439 -0.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.06 127.2 32.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.834 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.9 -110.66 3.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.786 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.838 HG13 HD22 ' A' ' 55' ' ' LEU . 8.5 mm -86.03 114.69 58.51 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.107 . . . . 0.0 110.628 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.51 -161.57 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.449 179.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 37' ' ' ILE . . . -109.76 27.79 9.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.23 -38.24 51.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.958 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 65' ' ' ASP . 48.0 mm-40 -94.12 32.68 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.133 -0.979 . . . . 0.0 110.943 -179.288 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -43.65 -51.72 15.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.963 -1.085 . . . . 0.0 110.4 179.722 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.6 Cg_endo -73.23 -11.39 24.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.732 1.385 . . . . 0.0 110.996 -179.427 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -105.66 -46.43 4.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.099 179.835 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' HG21 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -62.2 -43.98 97.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.202 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 37' ' ' ILE . 39.9 t -43.61 119.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.993 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 93.91 16.02 46.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.497 ' HE1' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ttm -83.91 135.09 34.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -1.147 . . . . 0.0 110.259 -179.86 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -106.92 124.83 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.752 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -85.08 158.55 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -103.73 -3.57 24.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.124 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.545 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 10.2 mtt180 -123.28 155.66 36.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.7 58.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.425 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG13 ' HB ' ' A' ' 53' ' ' THR . 28.2 t -127.86 113.61 20.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 179.893 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.07 -162.9 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.946 1.498 . . . . 0.0 110.6 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.32 155.98 28.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.968 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 51' ' ' LEU . . . 43.5 45.82 6.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.591 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 87.4 m -94.02 100.07 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.157 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' MET . 23.8 m -44.91 123.77 4.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.838 HD22 HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -61.97 115.47 4.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 54' ' ' THR . 19.8 mtp -112.25 164.24 15.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.48 -0.763 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 56' ' ' MET . 49.7 Cg_endo -76.37 6.5 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.08 1.568 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -42.16 11.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.07 -1.019 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -100.22 52.6 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 -179.9 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 17.4 t -129.97 123.42 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.898 . . . . 0.0 110.22 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -73.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 6.7 t-20 -100.52 93.31 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.497 ' HA ' ' HE1' ' A' ' 43' ' ' MET . 96.3 m-85 -52.64 151.9 4.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' HD12 ' A' ' 40' ' ' LEU . 1.5 mp0 -68.44 -70.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.148 179.865 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 33.2 p-10 -84.49 94.89 8.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.938 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 71' ' ' GLY . . . -85.67 38.39 3.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.4 m -107.81 -16.5 14.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.96 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.445 ' OG1' ' HD2' ' A' ' 70' ' ' PRO . 61.6 p -100.58 -140.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.511 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -75.65 -56.94 1.67 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 -179.828 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 46.8 Cg_endo -72.97 73.21 3.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.919 1.484 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . -130.81 0.65 5.42 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.21 137.74 34.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.242 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.544 ' HB2' HG11 ' A' ' 26' ' ' VAL . 14.1 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.297 0.57 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 117.22 19.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.496 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -61.62 124.55 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 t -82.93 173.2 12.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.172 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.23 108.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 53' ' ' THR . 4.1 t -123.78 107.4 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 53' ' ' THR . . . -58.68 121.62 11.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 3.5 m-20 -72.65 -55.34 7.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.73 156.45 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.746 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' HG ' ' HA ' ' A' ' 50' ' ' PRO . 8.0 tt -70.31 124.41 24.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 9' ' ' GLN . 22.0 mm -124.0 113.19 28.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 13' ' ' ILE . 46.0 Cg_endo -73.82 -92.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.0 110.404 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.871 HG22 HG23 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -161.89 -177.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.108 -0.995 . . . . 0.0 110.291 179.99 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 50.74 21.74 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.5 m -124.5 113.34 17.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.085 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.662 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -55.66 152.79 8.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.126 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -96.76 138.62 34.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -167.02 1.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.276 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.68 -63.36 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.295 -179.954 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -49.09 -24.93 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 110.194 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.93 3.72 40.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.7 mtt -116.37 118.37 32.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.0 160.07 23.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.092 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -105.08 83.03 1.92 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.34 135.83 44.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 1' ' ' ASN . 18.8 t -94.38 77.83 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 -179.839 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.7 120.03 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.2 p -83.25 150.39 60.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 110.152 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.82 129.89 19.93 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.483 -0.151 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -71.25 118.37 13.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -102.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' OH ' ' A' ' 63' ' ' TYR . 3.0 mt -118.15 137.62 24.73 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.238 -1.154 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -162.68 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.12 1.589 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -107.69 45.63 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.92 -35.58 67.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 mm-40 -104.97 35.29 2.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.817 . . . . 0.0 109.872 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -40.5 -52.17 6.21 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -71.39 -9.49 25.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.594 1.313 . . . . 0.0 110.766 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -106.25 -25.62 11.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.087 179.715 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -94.6 -40.36 9.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.83 . . . . 0.0 110.26 179.996 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -45.08 107.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.662 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 112.42 18.26 7.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.526 ' HE2' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -96.82 147.61 23.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -104.16 148.73 25.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.871 HG23 HG22 ' A' ' 13' ' ' ILE . 3.2 m -111.27 161.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -109.44 17.74 21.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.608 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -136.44 128.01 28.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.39 179.889 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' PRO . . . -62.19 130.17 44.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.117 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.086 HG11 HG23 ' A' ' 53' ' ' THR . 9.1 t -128.67 128.17 23.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -73.77 -166.06 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.847 1.446 . . . . 0.0 110.314 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.66 126.75 26.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.954 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 90.15 73.72 1.27 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.086 HG23 HG11 ' A' ' 49' ' ' VAL . 68.9 m -92.06 99.1 11.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -1.127 . . . . 0.0 110.326 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 56' ' ' MET . 41.1 p -64.58 132.37 49.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -61.93 85.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.112 179.935 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 54' ' ' THR . 4.2 mtt -103.33 142.9 25.53 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.25 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -75.2 2.78 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.078 1.567 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.13 -20.8 21.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.355 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.7 mtm -108.36 -6.86 16.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.445 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 63' ' ' TYR . 85.6 t -93.95 107.69 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -77.42 -60.68 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.1 t-20 -95.68 74.4 3.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.334 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -54.48 163.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.158 179.937 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.666 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -65.04 -178.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.108 179.892 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLY . 1.4 m-20 -59.75 -58.2 9.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 65' ' ' ASP . . . 61.4 131.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 m -88.86 -62.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 14.6 t -108.7 51.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.549 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -154.32 -178.83 0.94 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.878 . . . . 0.0 110.0 179.904 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -72.93 103.06 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.909 1.478 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 72' ' ' LEU . . . -171.89 56.25 0.17 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' HA ' HD13 ' A' ' 72' ' ' LEU . 4.0 mm? -103.91 85.42 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -1.129 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.268 0.556 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -103.24 176.98 4.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.234 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -87.29 159.0 18.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.16 179.933 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -122.47 145.81 47.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.823 ' CG2' ' HB2' ' A' ' 34' ' ' ALA . 58.6 t -79.95 112.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 52' ' ' GLY . 6.1 t -118.63 132.49 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 0.0 110.158 -179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.102 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -80.15 130.29 35.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.278 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 39.5 t30 -80.02 -69.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG3' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -65.78 130.85 44.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 179.85 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 51' ' ' LEU . 2.0 pt? -62.26 133.0 54.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.58 -179.716 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.729 HG13 HG23 ' A' ' 49' ' ' VAL . 1.3 pt -130.13 134.77 26.5 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ILE . 46.1 Cg_endo -73.68 168.78 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.935 1.492 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -46.66 174.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' OD1' HD13 ' A' ' 13' ' ' ILE . 6.9 m120 60.35 -152.4 0.39 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 58.49 109.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.92 . . . . 0.0 110.057 -179.835 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -56.28 154.02 8.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.43 144.14 26.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 0.2 OUTLIER -124.86 155.22 39.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 110.31 -179.934 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.769 HD23 ' N ' ' A' ' 20' ' ' ILE . 2.0 tt -68.07 -46.35 71.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.72 -14.63 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.943 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.459 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -87.85 -47.34 8.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.265 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.992 ' HE3' ' HB2' ' A' ' 7' ' ' ALA . 20.1 mtp -97.36 142.14 29.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -108.46 167.65 9.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.046 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.69 106.81 18.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.43 144.42 32.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 45.7 t -97.1 66.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.207 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.06 -166.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 35.3 p -118.13 160.14 40.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.873 . . . . 0.0 110.132 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 50.5 Cg_endo -77.13 145.18 80.24 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.47 -0.137 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -76.1 75.24 2.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.957 179.742 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -59.08 -119.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.988 HG13 HD12 ' A' ' 55' ' ' LEU . 10.2 mm -82.49 115.14 56.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.446 -1.032 . . . . 0.0 110.47 -179.619 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 49.0 Cg_endo -75.64 50.21 2.65 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.95 1.5 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.823 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . 41.82 29.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -42.98 99.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 110.457 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 59.3 mm-40 -104.16 34.08 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -42.77 -54.57 8.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.5 Cg_endo -71.7 -4.56 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.639 1.336 . . . . 0.0 110.676 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -114.03 -21.58 10.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.874 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' CD1' ' HE2' ' A' ' 43' ' ' MET . 16.0 tp -92.1 -40.1 11.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.255 -179.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 37' ' ' ILE . 75.0 t -44.53 115.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 110.184 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 103.53 14.96 24.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.538 ' CE ' ' CG1' ' A' ' 60' ' ' VAL . 5.0 ttp -104.45 157.94 16.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -106.75 141.4 38.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 13' ' ' ILE . 26.4 m -90.22 164.62 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -110.49 10.7 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.172 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.69 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -153.17 124.71 7.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.022 179.996 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -52.74 150.09 5.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.827 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -128.22 137.85 31.74 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.18 -168.79 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.99 1.521 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -70.14 155.59 40.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 110.06 179.864 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 44.36 40.71 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.102 HG22 ' HB3' ' A' ' 7' ' ' ALA . 15.2 t -78.37 130.11 35.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 110.326 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 t -78.05 145.04 36.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.988 HD12 HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -62.15 107.37 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -106.64 146.46 33.11 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 179.988 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.28 -0.77 10.06 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.428 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.94 -20.27 26.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.615 ' SD ' HG13 ' A' ' 49' ' ' VAL . 4.1 mtt -112.45 32.82 5.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.923 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 11.8 t -121.09 118.95 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.031 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -86.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.857 . . . . 0.0 110.271 -179.785 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.95 89.57 7.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -45.11 160.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CE ' ' A' ' 43' ' ' MET . 1.3 mp0 -103.97 -47.96 4.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.14 85.6 3.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 72.57 0.53 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 14.1 m -84.53 54.65 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 69' ' ' SER . 58.1 p -106.27 -89.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.79 -57.97 2.32 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 -179.967 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 44.6 Cg_endo -72.52 -3.02 12.67 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.904 1.476 . . . . 0.0 110.321 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 67' ' ' THR . . . -108.62 128.37 9.04 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -15.36 16.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 -179.932 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.255 0.55 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 148.45 51.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.3 135.78 33.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -105.84 144.72 32.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.912 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 34' ' ' ALA . 29.9 m -76.31 130.05 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.253 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 54' ' ' THR . 12.4 t -129.57 118.06 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.61 116.94 2.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.148 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 5.1 p-10 -75.07 -43.8 51.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 11' ' ' ILE . 7.0 tt0 -97.12 150.96 20.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.9 tt -63.88 105.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 109.89 179.769 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 9' ' ' GLN . 7.9 mm -99.5 139.37 20.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.516 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.6 -157.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.124 1.592 . . . . 0.0 110.201 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.745 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.26 -165.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.008 179.715 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.4 p30 38.45 32.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.649 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ILE . 85.6 m -133.39 142.98 48.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.341 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' MET . . . -75.27 148.83 39.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 45' ' ' VAL . 39.1 mt -105.88 151.36 24.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -115.05 -170.58 1.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.16 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.99 -49.45 45.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.856 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' HG2' ' A' ' 21' ' ' MET . 3.4 pt -55.36 -18.98 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.201 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.441 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.5 mmm -90.57 9.38 29.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.27 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.73 ' CE ' HD23 ' A' ' 40' ' ' LEU . 33.6 mtp -123.3 122.83 39.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -117.16 114.04 23.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.259 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.75 83.89 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.47 126.09 42.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 73.0 t -86.42 79.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 28' ' ' THR . 9.6 p -147.6 169.57 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.968 . . . . 0.0 110.368 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -117.21 150.16 45.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.982 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.554 ' O ' HG21 ' A' ' 54' ' ' THR . 48.2 Cg_endo -75.48 134.73 37.14 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.679 -2.217 . . . . 0.0 110.395 -0.132 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 30' ' ' MET . 1.1 ptt? -80.83 136.93 36.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 110.552 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . -89.9 -116.35 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 55' ' ' LEU . 9.9 mm -81.24 136.28 49.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.281 -1.129 . . . . 0.0 109.802 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 47.3 Cg_endo -74.05 4.88 3.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.965 1.508 . . . . 0.0 111.238 -179.478 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.967 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . 68.12 18.4 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -11.43 59.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 179.642 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -105.04 28.27 7.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 110.324 -179.375 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.8 mm -42.19 -53.34 8.79 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.566 -179.852 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.9 Cg_endo -71.23 -5.07 16.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.61 1.321 . . . . 0.0 110.81 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 8.4 m-80 -114.03 -49.02 2.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.973 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.73 HD23 ' CE ' ' A' ' 22' ' ' MET . 2.3 tp -66.69 -39.97 88.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 38.9 t -50.87 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' LEU . . . 116.96 24.57 3.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.655 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.8 ppp? -104.53 154.58 19.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -1.169 . . . . 0.0 110.265 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -109.39 123.86 50.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 13' ' ' ILE . 33.3 m -77.76 165.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' MET . 44.5 t30 -110.35 -12.28 14.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 110.139 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' C ' ' CG2' ' A' ' 13' ' ' ILE . 1.8 mtp85 -120.32 146.57 45.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 149.86 15.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 53' ' ' THR . 38.5 t -126.13 112.52 24.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.1 Cg_endo -72.72 -167.78 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.852 1.448 . . . . 0.0 110.522 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -73.64 149.04 42.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 43.82 53.21 6.38 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 49' ' ' VAL . 84.6 m -96.52 122.16 39.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.591 ' N ' HG13 ' A' ' 6' ' ' VAL . 1.3 m -64.14 123.37 18.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.863 . . . . 0.0 110.135 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 32' ' ' ILE . 1.3 tt -62.03 113.01 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.064 179.895 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.5 mtt -111.63 162.57 20.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.52 0.74 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.044 1.55 . . . . 0.0 110.435 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.79 -23.98 22.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -98.87 1.0 45.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 179.87 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.655 HG13 ' CE ' ' A' ' 43' ' ' MET . 7.1 t -91.5 116.47 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -80.18 -72.73 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.918 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 73' ' ' LYS . 65.0 m-80 -100.22 87.86 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.409 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.99 144.58 28.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . 8.7 mm-40 -83.23 -95.79 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.986 . . . . 0.0 110.352 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 13.8 t70 -94.45 82.95 4.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.99 93.1 0.28 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -74.36 -39.68 62.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 32.36 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.22 -179.6 1.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 69' ' ' SER . 45.6 Cg_endo -72.36 174.97 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.887 1.467 . . . . 0.0 110.56 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.24 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -65.73 153.16 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -1.177 . . . . 0.0 110.317 -179.853 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.251 0.548 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.79 128.97 35.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.288 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.52 135.35 51.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -112.53 148.8 33.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.929 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 29.3 t -73.58 107.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 52' ' ' GLY . 5.1 t -107.53 102.18 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -50.05 130.28 21.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.228 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -57.97 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.136 -179.942 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' CD ' ' SD ' ' A' ' 21' ' ' MET . 4.6 pt20 -81.44 162.08 23.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.188 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.7 tt -86.48 149.18 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.036 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.522 ' CG1' ' HB ' ' A' ' 49' ' ' VAL . 13.1 pt -129.79 127.91 22.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 110.399 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' C ' ' CG1' ' A' ' 13' ' ' ILE . 48.4 Cg_endo -75.53 54.01 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.033 1.544 . . . . 0.0 110.38 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER 47.44 -177.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 -179.902 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ILE . 7.1 m-20 41.15 28.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 0.0 110.389 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 13' ' ' ILE . 54.0 m -118.36 114.4 22.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.19 128.44 35.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.051 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mt -83.03 143.19 30.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 110.226 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -122.21 176.42 5.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 19' ' ' LEU . 7.2 tt -68.32 -44.86 74.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.279 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.503 HG13 ' N ' ' A' ' 21' ' ' MET . 4.7 pt -60.03 -22.51 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.503 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -95.88 -21.62 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.954 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.475 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mtm -108.39 108.0 18.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -111.68 139.59 47.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.955 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.75 84.99 6.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 179.985 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 148.55 28.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.34 93.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 0.0 110.085 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 28' ' ' THR . 94.9 t -131.01 161.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 29' ' ' PRO . 28.8 m -114.51 145.74 34.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 -179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' O ' HG21 ' A' ' 54' ' ' THR . 50.5 Cg_endo -80.29 147.65 76.29 Favored 'Cis proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.716 -2.202 . . . . 0.0 110.42 -0.445 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -68.2 68.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -42.17 -83.95 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.835 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 55' ' ' LEU . 4.8 mt -135.27 142.84 43.11 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.0 110.224 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.7 Cg_endo -72.36 -159.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.332 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.817 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -115.57 40.01 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.96 -29.86 64.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -102.9 24.58 10.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.946 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.1 mm -45.19 -53.32 17.56 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.6 Cg_endo -71.02 -6.43 19.2 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.505 1.266 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.27 -27.08 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.116 179.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 36' ' ' GLU . 1.1 mp -88.97 -26.46 21.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.081 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 37' ' ' ILE . 53.3 t -51.46 99.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.08 2.59 12.38 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.598 ' CE ' HG13 ' A' ' 60' ' ' VAL . 2.0 tmm? -94.86 143.75 26.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -1.187 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 49.3 mt-30 -106.45 134.0 50.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 13' ' ' ILE . 17.8 m -77.48 154.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.171 179.866 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -97.75 1.49 48.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB2' ' CG ' ' A' ' 59' ' ' MET . 0.8 OUTLIER -132.59 142.41 49.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 13' ' ' ILE . . . -56.96 136.76 56.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.45 -179.76 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 53' ' ' THR . 45.5 t -124.29 120.71 26.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.955 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.772 ' HA ' HD12 ' A' ' 10' ' ' LEU . 44.4 Cg_endo -72.65 -161.26 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.973 1.512 . . . . 0.0 110.647 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 52' ' ' GLY . 2.4 mp -81.04 160.11 24.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.335 -0.853 . . . . 0.0 110.471 -179.658 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 6' ' ' VAL . . . 43.37 49.5 6.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.037 HG21 HG13 ' A' ' 49' ' ' VAL . 39.7 m -96.75 106.37 18.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -1.152 . . . . 0.0 110.081 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 ' O ' ' A' ' 29' ' ' PRO . 5.6 m -50.35 147.98 3.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -65.07 108.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.115 179.925 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.41 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -110.07 150.31 41.28 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.981 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.08 0.44 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.051 1.553 . . . . 0.0 110.58 -179.981 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.15 -50.89 7.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.515 ' CG ' ' HB2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.74 47.65 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.84 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' CE ' ' A' ' 43' ' ' MET . 19.5 t -127.88 109.85 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -82.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.255 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -91.86 88.58 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.856 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -59.74 139.0 57.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 179.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG3' HD12 ' A' ' 40' ' ' LEU . 4.7 mm-40 -87.9 -92.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.01 82.75 3.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.0 110.398 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.74 94.28 0.25 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.18 18.15 21.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -1.146 . . . . 0.0 110.266 -179.887 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 69' ' ' SER . 88.0 m -100.41 -33.91 10.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.05 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER 173.25 -56.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.995 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 69' ' ' SER . 46.5 Cg_endo -73.14 85.68 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.928 1.489 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.3 70.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.64 -32.63 72.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -1.165 . . . . 0.0 110.328 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 tptt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.257 179.992 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.169 0.509 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.64 129.12 44.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.161 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.41 156.99 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.219 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.84 161.27 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.253 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 55' ' ' LEU . 39.4 t -79.04 121.42 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.093 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' C ' ' A' ' 52' ' ' GLY . 4.6 t -125.42 107.59 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -55.9 111.09 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 51.1 t30 -74.91 -59.91 2.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -72.18 139.43 48.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.67 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.98 132.58 51.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 179.919 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.88 ' HB ' HG21 ' A' ' 15' ' ' THR . 1.6 pt -130.13 110.89 16.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' O ' ' CG1' ' A' ' 13' ' ' ILE . 47.2 Cg_endo -74.82 69.69 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.93 1.49 . . . . 0.0 110.43 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 12' ' ' PRO . 20.7 pt 39.0 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 45.9 29.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.88 HG21 ' HB ' ' A' ' 11' ' ' ILE . 5.1 t -131.0 130.32 43.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 110.135 -179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 142.68 53.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.179 -179.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 40' ' ' LEU . 5.5 mt -77.79 124.72 28.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 110.27 -179.92 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.443 ' HB ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.94 172.04 8.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.993 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 ' CG2' ' A' ' 41' ' ' VAL . 17.5 mt -77.23 -30.99 54.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 21' ' ' MET . 6.3 pt -62.62 -25.55 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.538 ' CE ' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -97.38 -14.06 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.588 ' HG3' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.04 126.28 32.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 12.7 mttt -111.55 124.06 51.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.21 10.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.406 ' HG2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -110.92 150.08 29.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 179.964 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 26' ' ' VAL . 61.3 t -81.68 4.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG2' ' A' ' 25' ' ' GLU . 41.1 t -53.47 130.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.21 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -84.8 168.27 21.91 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.813 ' O ' HG21 ' A' ' 54' ' ' THR . 48.0 Cg_endo -73.76 156.69 99.61 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.579 -2.259 . . . . 0.0 110.428 -0.191 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' GLY . 5.5 mtt -76.34 83.23 3.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.69 -116.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' OH ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -110.48 139.9 22.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.219 -1.165 . . . . 0.0 109.948 179.946 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 32' ' ' ILE . 46.7 Cg_endo -73.9 168.7 24.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.553 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.699 ' HB1' ' CD1' ' A' ' 37' ' ' ILE . . . -84.14 47.1 1.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -77.15 -27.06 53.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.797 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -104.72 45.34 0.97 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 111.023 -179.406 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.699 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -63.05 -51.43 70.46 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.008 179.637 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 45.9 Cg_endo -75.08 -5.4 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.755 1.398 . . . . 0.0 110.722 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 3.9 m-80 -114.77 -35.3 4.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 110.591 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD2' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -87.51 -38.9 15.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.799 -179.46 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' CG2' HD21 ' A' ' 19' ' ' LEU . 9.1 t -41.93 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.9 -7.3 6.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.652 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.54 131.0 35.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -1.089 . . . . 0.0 110.194 179.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 15' ' ' THR . 15.2 mt-30 -99.33 151.39 21.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.961 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 13' ' ' ILE . 4.1 m -99.92 161.78 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -111.18 0.29 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG2' ' CG ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -114.39 135.85 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 110.042 -179.858 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -55.8 123.15 13.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.325 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CB ' ' A' ' 53' ' ' THR . 19.7 t -109.99 125.47 31.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 179.605 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HA ' HD12 ' A' ' 10' ' ' LEU . 46.1 Cg_endo -72.67 -167.63 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.858 1.452 . . . . 0.0 110.512 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -81.53 155.28 25.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.231 -179.9 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . 45.29 44.61 10.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' HG13 ' A' ' 49' ' ' VAL . 43.6 m -90.61 122.58 33.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -1.174 . . . . 0.0 110.203 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.813 HG21 ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -54.69 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.987 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD12 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -80.04 106.5 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.194 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.491 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -113.1 143.27 28.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 179.822 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.36 1.46 7.34 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.951 1.5 . . . . 0.0 110.634 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.84 -15.55 44.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.812 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HG2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -99.47 -21.43 15.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 110.187 179.976 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.52 120.75 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.311 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.95 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 179.879 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 22.6 p-10 -92.06 87.79 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.103 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.751 ' OH ' HG21 ' A' ' 32' ' ' ILE . 2.7 t80 -45.45 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' HG3' ' C ' ' A' ' 39' ' ' ASN . 1.5 tm-20 -66.91 -60.14 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' ' OG1' ' A' ' 67' ' ' THR . 2.0 m-20 -65.97 -49.89 66.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.62 2.54 78.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -90.16 4.65 49.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -1.19 . . . . 0.0 110.203 -179.934 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -98.4 -150.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.953 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.57 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -61.03 -60.17 11.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.04 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 69' ' ' SER . 47.2 Cg_endo -72.67 140.06 31.93 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.533 . . . . 0.0 110.201 179.714 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.67 48.68 0.55 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.04 -170.7 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -1.157 . . . . 0.0 110.239 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.211 179.92 . . . . . . . . 1 1 . 1 stop_ save_